<SEC-DOCUMENT>0000711404-23-000072.txt : 20231208
<SEC-HEADER>0000711404-23-000072.hdr.sgml : 20231208
<ACCEPTANCE-DATETIME>20231208161518
ACCESSION NUMBER:		0000711404-23-000072
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		113
CONFORMED PERIOD OF REPORT:	20231031
FILED AS OF DATE:		20231208
DATE AS OF CHANGE:		20231208

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COOPER COMPANIES, INC.
		CENTRAL INDEX KEY:			0000711404
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				942657368
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08597
		FILM NUMBER:		231475563

	BUSINESS ADDRESS:	
		STREET 1:		6101 BOLLINGER CANYON ROAD
		STREET 2:		SUITE 500
		CITY:			SAN RAMON
		STATE:			CA
		ZIP:			94583
		BUSINESS PHONE:		9254603600

	MAIL ADDRESS:	
		STREET 1:		6101 BOLLINGER CANYON ROAD
		STREET 2:		SUITE 500
		CITY:			SAN RAMON
		STATE:			CA
		ZIP:			94583

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COOPER COMPANIES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COOPERVISION INC
		DATE OF NAME CHANGE:	19870701
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>coo-20231031.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:0c65df22-c15f-4b61-bd32-d5e051159c75,g:61acad92-dfa7-4255-a259-2e1b3c8d59bb,d:73c86eef1c5e443ab4ef06a723adb0ef--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:coo="http://www.coopercos.com/20231031" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>coo-20231031</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-36">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-37">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-38">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-39">0000711404</ix:nonNumeric><ix:nonNumeric contextRef="c-22" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="f-230">http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-485">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-486">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-489">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-490">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-493">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-494">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-635">http://fasb.org/us-gaap/2023#DebtCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-636">http://fasb.org/us-gaap/2023#DebtCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-651">http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-652">http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-145" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-692">0.50</ix:nonFraction><ix:nonNumeric contextRef="c-204" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-975">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-206" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-980">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-1022">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-1023">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-1024">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-1082">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-1083">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-1084">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-1088">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-1089">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-1090">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="coo-20231031.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="business_unit"><xbrli:measure>coo:business_unit</xbrli:measure></xbrli:unit><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-06</xbrli:startDate><xbrli:endDate>2022-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesFourthInstallmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-06</xbrli:startDate><xbrli:endDate>2022-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesThirdInstallmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-06</xbrli:startDate><xbrli:endDate>2022-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesFirstInstallmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-06</xbrli:startDate><xbrli:endDate>2022-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesSecondInstallmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-06</xbrli:startDate><xbrli:endDate>2022-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-17</xbrli:startDate><xbrli:endDate>2021-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-17</xbrli:startDate><xbrli:endDate>2021-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">coo:SightGlassVisionIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">coo:EssilorInternationalSASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="installment"><xbrli:measure>coo:installment</xbrli:measure></xbrli:unit><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesFirstInstallmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesSecondInstallmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reporting_unit"><xbrli:measure>coo:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:CompositeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:CompositeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:LicenseAndDistributionRightsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:LicenseAndDistributionRightsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:OverdraftAndOtherCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:OverdraftAndOtherCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">coo:OtherDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">coo:OtherDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">coo:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-17</xbrli:startDate><xbrli:endDate>2021-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">coo:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021BaseRateLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-17</xbrli:startDate><xbrli:endDate>2021-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">coo:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021AdjustedLIBORRateLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-17</xbrli:startDate><xbrli:endDate>2021-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanAgreement2021364DayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-02</xbrli:startDate><xbrli:endDate>2021-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanAgreement2021364DayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:TermLoanFacility2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:TermLoanFacility2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">coo:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">coo:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:TermLoanFacility2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:EuropeanCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:EuropeanCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:AsianPacificCreditFacilitiesYenDenominatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:AsianPacificCreditFacilitiesYenDenominatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-17</xbrli:startDate><xbrli:endDate>2021-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2011-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-07</xbrli:startDate><xbrli:endDate>2023-12-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-01</xbrli:startDate><xbrli:endDate>2016-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="director"><xbrli:measure>coo:director</xbrli:measure></xbrli:unit><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:A2023LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-31</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:A2023LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:A2023LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-18</xbrli:startDate><xbrli:endDate>2019-03-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:BalancedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:BalancedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:BalancedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:AlternativeInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:AlternativeInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:AlternativeInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:BalancedFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:BalancedFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:BalancedFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:AlternativeInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:AlternativeInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:AlternativeInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>coo:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:ToricLensMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:ToricLensMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:ToricLensMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:MultifocalLensMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:MultifocalLensMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:MultifocalLensMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:SingleUseSphereLensMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:SingleUseSphereLensMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:SingleUseSphereLensMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:NonSingleUseSphereAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:NonSingleUseSphereAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:NonSingleUseSphereAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:OfficeAndSurgicalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:OfficeAndSurgicalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:OfficeAndSurgicalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:FertilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:FertilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:FertilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="interest_rate_swap_contract"><xbrli:measure>coo:interest_rate_swap_contract</xbrli:measure></xbrli:unit><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">________________________</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:90%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:2.276%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE FISCAL YEAR ENDED <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-4"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-3">OCTOBER 31</ix:nonNumeric>, 2023</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:2.276%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE TRANSITION PERIOD FROM       TO</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">COMMISSION FILE NO. <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-08597</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">________________________</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:90%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">THE COOPER COMPANIES, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">________________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">94-2657368</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">6101 Bollinger Canyon Road</ix:nonNumeric>,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-11">Suite 500</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-12">San Ramon</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-13">California</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-14">94583</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-15">925</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-16">460-3600</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">________________________</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:32.877%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, $.10 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">COO</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">Nasdaq Global Select Market</ix:nonNumeric> </span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Securities registered pursuant to Section&#160;12(g) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-20">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-21">No</ix:nonNumeric>&#160;&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-22">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  &#160;&#160;&#160;No  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-23">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  &#160;&#160;&#160;No  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   <ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-24">Large accelerated filer</ix:nonNumeric> &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">     Accelerated filer  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;    Non-accelerated filer  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;    Smaller reporting company  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="f-25">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-26">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;                                                    </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="f-27">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   &#160;&#160;&#160;No  &#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-28">&#9744;</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">to &#167;240.10D-1(b). </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160; No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-29">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of April 28, 2023, the last business day of registrant's most recently completed second fiscal quarter, the aggregate market value of shares of the registrant's common stock held by non-affiliates was $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="f-30">18.8</ix:nonFraction> billion.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Number of shares outstanding of the registrant's common stock, as of December&#160;1, 2023: <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-31">49,525,982</ix:nonFraction></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Documents Incorporated by Reference:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-32" escape="true"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.343%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Part of Form 10-K</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portions of the Proxy Statement for the Annual Meeting<br/>of Stockholders scheduled to be held in March 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part&#160;III</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our independent registered public accounting firm is <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-33">KPMG LLP</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-34">San Francisco, CA</ix:nonNumeric>, Auditor ID: <ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-35">185</ix:nonNumeric>.</span></div></ix:nonNumeric><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Annual Report on Form 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">for the Fiscal Year Ended October&#160;31, 2023 </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">PART&#160;I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Business</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_16">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Risk Factors</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_19">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Unresolved Staff Comments</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_22">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Properties</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_25">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Legal Proceedings</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_28">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 4. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mine Safety Disclosures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_31">41</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">PART II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_37">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Reserved</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_46">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_49">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Quantitative and Qualitative Disclosure about Market Risk</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_64">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Financial Statements and Supplementary Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_67">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_136">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Controls and Procedures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_139">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_142">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_145">88</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">PART III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Directors, Executive Officers and Corporate Governance</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_151">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Executive Compensation</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_154">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_157">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Certain Relationships and Related Transactions, and Director Independence</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_160">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Principal Accounting Fees and Services</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_163">89</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">PART IV</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exhibits and Financial Statement Schedules</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_169">90</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Form 10-K Summary</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i73c86eef1c5e443ab4ef06a723adb0ef_178">94</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">PART I</span></div><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">This Annual Report on Form 10-K contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These include statements relating to plans, prospects, goals, strategies, future actions, events or performance and other statements which are other than statements of historical fact, including: statements regarding the expected impact of global macroeconomic conditions, and statements regarding acquisitions (including the acquired companies' financial position, market position, product development and business strategy, expected cost synergies, expected timing and benefits of the transaction, difficulties in integrating entities or operations, as well as estimates of our and the acquired entities' future expenses, sales and earnings per share) that are forward-looking. In addition, all statements regarding anticipated growth in our net sales, anticipated effects of any product recalls, anticipated market conditions, planned product launches and expected results of operations and integration of any acquisition are forward-looking. To identify these statements, look for words like &#8220;believes,&#8221; &#8220;outlook,&#8221; &#8220;probable,&#8221; &#8220;expects,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;seeks,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;estimates&#8221; or &#8220;anticipates&#8221; and similar words or phrases. Forward-looking statements necessarily depend on assumptions, data or methods that may be incorrect or imprecise and are subject to risks and uncertainties. Among the factors that could cause our actual results and future actions to differ materially from those described in forward-looking statements are those described in our Securities and Exchange Commission filings, including the &#8220;Business,&#8221; &#8220;Risk Factors&#8221; and &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections in this Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2023, as such Risk Factors may be updated in quarterly filings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We caution investors that forward-looking statements reflect our analysis only on their stated date. We disclaim any intent to update them except as required by law.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Summary Risk Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our business faces significant risks. In addition to the summary below, you should carefully review the &#8220;Risk Factors&#8221; section of this Annual Report on Form 10-K. We may be subject to additional risks and uncertainties not presently known to us or that we currently deem immaterial. Our business, financial condition and results of operations could be materially adversely affected by any of these risks, and the trading prices of our common stock could decline by virtue of these risks. These risks should be read in conjunction with the other information in this report. Some of the more significant risks relating to our business include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Adverse changes in the global or regional general business, political and economic conditions, including the impact of continuing uncertainty and instability of certain countries, man-made or natural disasters and pandemic conditions, that could adversely affect our global markets, and the potential adverse economic impact and related uncertainty caused by these items.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">The impact of international conflicts, such as Russia's invasion of Ukraine, and the global response to international conflicts on the global economy, European economy, financial markets, energy markets, currency rates and our ability to supply product to, or through, affected countries.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Our substantial and expanding international operations and the challenges of managing an organization spread throughout multiple countries and complying with a variety of legal, compliance and regulatory requirements.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Foreign currency exchange rate and interest rate fluctuations including the risk of fluctuations in the value of foreign currencies or interest rates that would decrease our net sales and earnings.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Our existing and future variable rate indebtedness and associated interest expense is impacted by rate increases, which could adversely affect our financial health or limit our ability to borrow additional funds.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:32.68pt">Changes in tax laws, examinations by tax authorities, and changes in our geographic composition of income. </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Acquisition-related adverse effects including the failure to successfully achieve the anticipated net sales, margins and earnings benefits of acquisitions, integration delays or costs and the requirement to record significant adjustments to the preliminary fair value of assets acquired and liabilities assumed within the measurement period, required regulatory approvals for an acquisition not being obtained or being delayed or subject to conditions that are not anticipated, adverse impacts of changes to accounting controls and reporting procedures, contingent liabilities or indemnification obligations, increased leverage and lack of access to available financing (including financing for the acquisition or refinancing of debt owed by us on a timely basis and on reasonable terms).</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Compliance costs and potential liability in connection with U.S. and foreign laws and health care regulations pertaining to privacy and security of personal information, such as HIPAA and the California Consumer Privacy Act (CCPA) in the U.S. and the General Data Protection Regulation (GDPR) requirements in Europe, including but not limited to those resulting from data security breaches.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">A major disruption in the operations of our manufacturing, accounting and financial reporting, research and development, distribution facilities or raw material supply chain due to challenges associated with integration of acquisitions, man-made or natural disasters, pandemic conditions, cybersecurity incidents or other causes.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">A major disruption in the operations of our manufacturing, accounting and financial reporting, research and development or distribution facilities due to technological problems, including any related to our information systems maintenance, enhancements or new system deployments, integrations or upgrades.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Market consolidation of large customers globally through mergers or acquisitions resulting in a larger proportion or concentration of our business being derived from fewer customers.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Disruptions in supplies of raw materials, particularly components used to manufacture our silicone hydrogel lenses</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">New U.S. and foreign government laws and regulations, and changes in existing laws, regulations and enforcement guidance, which affect areas of our operations including, but not limited to, those affecting the health care industry, including the contact lens industry specifically and the medical device or pharmaceutical industries generally, including but not limited to the EU Medical Devices Regulation (MDR) and the EU In Vitro Diagnostic Medical Devices Regulation (IVDR).</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Legal costs, insurance expenses, settlement costs and the risk of an adverse decision, prohibitive injunction or settlement related to product liability, patent infringement, contractual disputes, or other litigation.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Limitations on sales following product introductions due to poor market acceptance.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">New competitors, product innovations or technologies, including but not limited to, technological advances by competitors, new products and patents attained by competitors, and competitors' expansion through acquisitions.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Reduced sales, loss of customers and costs and expenses related to product recalls and warning letters.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Failure to receive, or delays in receiving, regulatory approvals or certifications for products.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Failure of our customers and end users to obtain adequate coverage and reimbursement from third-party payers for our products and services.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">The requirement to provide for a significant liability or to write off, or accelerate depreciation on, a significant asset, including goodwill, other intangible assets and idle manufacturing facilities and equipment.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">The success of our research and development activities and other start-up projects.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Dilution to earnings per share from acquisitions or issuing stock.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Impact and costs incurred from changes in&#160;accounting&#160;standards and policies.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Risks related to environmental laws and requirements applicable to our facilities, products or manufacturing processes, including evolving regulations regarding the use of hazardous substances or chemicals in our products.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Risks related to environmental, social and corporate governance (ESG) issues, including those related to climate change and sustainability.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_16"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">. Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">OVERVIEW </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Cooper Companies, Inc. (Cooper, we or the Company), is a global medical device company with a mission to improve lives one person at a time. We partner with health care providers worldwide to improve patient outcomes and deliver practice-building resources and training. By listening closely to the healthcare providers and patients, we fulfill the needs of today while focusing on the opportunities of tomorrow through innovation and strategic investment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Cooper operates through two business segments, CooperVision and CooperSurgical. Our two business segments elevate standards of care with products and services in the fields of vision, fertility and women&#8217;s health. For financial information relating to these business segments, refer to Note 12. Business Segment Information in Item&#160;8. Financial Statements and Supplementary Data of this Annual Report.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperVision is a global manufacturer providing products for contact lens wearers. CooperVision develops, manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. CooperVision designs its products to address vision challenges such as astigmatism, presbyopia and myopia with a broad collection of spherical, toric and multifocal contact lenses. CooperVision offers contact lenses in materials like silicone hydrogel Aquaform technology. CooperVision also manufactures and markets myopia management products, including the internally developed MiSight 1 day lens, as well as other specialty eyecare products such as orthokeratology (ortho-k) and scleral lenses. In November 2019, the MiSight 1 day lens became the first and only product approved by the United States Food and Drug Administration (FDA) for slowing the progression of myopia in children aged 8-12 at the initiation of treatment, and in August 2021, CooperVision received Chinese National Medical Products Administration (NMPA) approval for use of the MiSight 1 day lens in China. CooperVision&#8217;s major manufacturing and distribution facilities are located in Belgium, Costa Rica, Hungary, Puerto Rico, the United Kingdom and the United States, with other smaller facilities in multiple locations around the world. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperSurgical offers a broad array of products and services focused on fertility and women's health. We categorize CooperSurgical product sales based on the point of health care delivery, which includes: products used in medical offices, ambulatory surgical centers and hospitals primarily by Obstetricians/Gynecologists (OB/GYN); and fertility products and services used primarily in fertility clinics. Our portfolio encompasses more than 600 products and services. Our medical devices are used in gynecology and obstetrics, including but not limited to contraception and labor and delivery as well as cord blood and cord storage services. Our fertility portfolio encompasses medical devices supporting the in vitro fertilization (IVF) cycle, egg and sperm donation, cryopreservation, and genomic services (including genetic testing). CooperSurgical has established its market presence and distribution system by developing products and acquiring companies, products and services that complement its business model. CooperSurgical's major manufacturing, cryostorage and distribution facilities are located in Costa Rica, the Netherlands, the United Kingdom and the United States, with other smaller facilities in multiple locations around the world. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">SEGMENT INFORMATION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CooperVision</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision competes in the worldwide soft contact lens market and services three primary regions: the Americas, EMEA (Europe, Middle East and Africa) and Asia Pacific. The two major product categories of contact lenses sold by CooperVision are:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Spherical lenses, including lenses that correct near- and farsightedness uncomplicated by more complex visual defects, myopia management lenses, which slow the progression of and correct myopia in age-appropriate children, and other specialty lenses.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Toric and multifocal lenses, including lenses that, in addition to correcting near- and farsightedness, address more complex visual defects such as astigmatism, myopia and presbyopia by adding optical properties of cylinder and axis, which correct for irregularities in the shape of the cornea. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In order to achieve a comfortable and healthier lens wearing experience, products are sold with recommended wearing and replacement schedules, often referred to as modalities, with the primary modalities being single-use lenses designed for one-day use and frequent replacement (FRP) lenses  designed for two-week and monthly replacement. CooperVision offers spherical, toric, multifocal and toric multifocal lens products in most modalities and in a wide range of lens parameters. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">CooperVision Product Modalities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Frequent replacement lenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Under the Biofinity brand, CooperVision markets monthly silicone hydrogel spherical (including Biofinity Energys), toric, multifocal and toric multifocal (made-to-order) lens products. Our Biofinity brand is CooperVision's highest grossing product. CooperVision also markets two-week silicone hydrogel spherical and toric lenses under the Avaira Vitality brand. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Single-use lenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision markets single-use silicone hydrogel lenses under our MyDay</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">brand and our clariti 1 day brand. The MyDay</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">brand is our softest line of 1-day silicone hydrogel lenses and offers spherical (including MyDay Energys</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">), toric, and multifocal lenses. The clariti 1-day brand is our most affordable line of silicone hydrogel 1-day lenses and offers spherical, toric, and multifocal lenses. CooperVision also offers traditional single-use hydrogel lenses under our Proclear and Biomedics brands.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision focuses on supporting the growth of all customers including key accounts (which include optical chains, global retailers, certain buying groups and mass merchandisers) by investing in selling, promotional and advertising activities. Further, we are increasing investment in our distribution and packaging capabilities to support the growth of our business and to continue providing quality service with our industry leading stock keeping unit ("SKU") range and customized offerings. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Market for Contact Lenses</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The market for spherical lenses is growing with the addition of new value-added products, such as spherical lenses that may provide improved comfort for contact lens related dryness during lens wear and that add aspherical optical properties, more higher oxygen permeable lenses such as silicone hydrogels, and myopia management contact lenses for children aged 8 to 12 years old. CooperVision believes that there are opportunities for contact lenses to gain market share, particularly in markets where the penetration of contact lenses in the vision correction market is low.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">We believe that myopia management opens up an attractive new market for contact lenses. With MiSight, we offer the only FDA approved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> and first Chinese NMPA approved product to slow the progression of, and correct, myopia in age-appropriate children. This is a critical differentiator as the proactive management of myopia becomes standard-of-care within the eye care community to help reduce the progression of myopia in children, along with reducing the risks of long-term eye health problems associated with myopia such as cataracts, retinal detachment, and macular degeneration. We are investing to develop this new market by educating eye care practitioners, patients and their families, which increases awareness.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperVision is focused on greater worldwide market penetration of recently introduced products, and we continue to expand our presence in existing and emerging markets, both organically and through acquisitions. In fiscal 2023, CooperVision acquired a private U.S.-based company that provides a broad portfolio of technologically advanced contact lens products, including scleral and hybrid lenses. In fiscal 2022, CooperVision acquired a private Denmark-based ortho-k contact lens distributor. These acquisitions expanded CooperVision&#8217;s specialty eye care portfolio and its leadership in addressing the increasing severity and prevalence of myopia. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">CooperSurgical</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperSurgical focuses on advancing fertility and women's health through a diversified portfolio including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. We offer quality products, innovative technologies and superior services to health care professionals and patients worldwide. CooperSurgical collaborates with health care professionals to identify products and new technologies to bring to market. The result is a broad portfolio of products and services that are intended to aid in the delivery of improved clinical outcomes for patients and are routinely used by health care professionals in the diagnosis and treatment of a wide spectrum of women's health and reproductive issues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical distributes its products and services through OB/GYN and medical offices, hospital and ambulatory surgery centers and fertility clinics, as well as direct-to-consumer. A focus area for CooperSurgical is key accounts, which include large group practices, integrated delivery networks and certain buying groups within the office/surgical business and fertility clinic networks within the fertility business. We believe our portfolio of offerings and focus on service, quality and clinical education will help increase our share of business within these key account groups.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indications for use of MiSight 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with &#8804; 0.75 diopters of astigmatism. The lens is to be discarded after each removal.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Since its inception in 1990, CooperSurgical has established its market presence and distribution system by developing products and acquiring products and companies that complement its business model. In fiscal 2022, CooperSurgical acquired both a private cryopreservation services company and Generate Life Sciences (Generate), a private leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood and cord tissue). We expect to continue investing in CooperSurgical's business, including through strategic transactions, with the goal of expanding our integrated solutions model within the areas of fertility and women's health.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:112%">CooperSurgical Product Categories</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Office/Surgical </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperSurgical sells a wide variety of innovative medical devices and services used in gynecology and obstetrics, including in labor and delivery, as well as to screen, diagnose and treat women's health and reproductive issues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperSurgical offers the cryostorage of newborn cord blood and cord tissue, which are potent sources of stem cells that have the potential for treatment and healing. Our newborn stem cell storage services are available in the United States, Canada and Australia.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">PARAGARD is a hormone-free intrauterine device (IUD) offered by CooperSurgical that prevents pregnancy for up to ten years using copper as the only active ingredient. It is the only FDA approved non-hormonal IUD contraceptive option and is exclusively sold in the United States. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Fertility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;text-decoration:underline"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperSurgical has broad product offerings for fertility evaluations and IVF procedures by OB/GYN professionals, reproductive endocrinologists and embryologists. In fertility clinics, our products include media, micro-tools and lab equipment. Additionally, CooperSurgical offers services to clinics and families undergoing assisted reproductive technologies including donor gametes, cryostorage, and genomic services.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Market for Fertility and Women's Health Care</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical participates in the market for women's and family health care with its diversified product lines at various points of health care delivery: OB/GYN medical offices, hospitals and surgical centers, and fertility clinics. In recent years, including with the acquisition of Generate in fiscal 2022, CooperSurgical&#8217;s business increasingly includes marketing and selling to end consumers through our cryostorage (such as cord blood and cord tissue storage) and reproductive planning products and services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperSurigcal expects that OB/GYN medical offices and fertility clinics will continue to move away from private practice ownership and toward group practices and networks.  As the consolidation trend continues it will have increased influence over supply chain control, group purchases, value analysis committees, product evaluation and procurement.  We believe CooperSurgical's broad product portfolio can benefit in this changing environment as customers look to standardize and consolidate vendors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Trends specific in the OB/GYN market include: </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">The increase in office-based and outpatient procedures, given high patient satisfaction, reduction of healthcare costs and comparative clinical outcomes.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">A focus on reducing pregnancy and childbirth complications.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">The obstetrician being a key contributor to stem cell storage, facilitating the collection of cord blood and cord tissue following delivery in most markets. </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Initial evaluation and treatments for infertility, such as uterine assessment, ovulatory medications and intrauterine insemination (IUI), beginning with the OB/GYN and then transitioning to fertility clinics. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Trends specific in the fertility market include: </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Infertility rates are increasing globally, and there is a significant unmet need for fertility products and services.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">The maternal age is increasing.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Patient awareness of, and access to, services is increasing.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;padding-left:14.68pt">The number of fertility clinics is rising worldwide.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:14.68pt">Single parents by choice and LGBTQIA+ individuals are starting families.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:14.68pt">Improved product offerings such as donor activity and cryopreservation services are becoming available.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:14.68pt">Technology improvements are being developed for both male and female infertility challenges.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:14.68pt">Worldwide disposable income is increasing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">COMPETITION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The markets in which we participate are highly competitive and involve the continual search for technological and scientific innovations. Competitive factors in these markets include technological and scientific advances, product quality and availability, price, customer service including response time and effective communication of product information to clinicians and consumers, and manufacturing processes. Competitors may have greater financial resources, larger research and development budgets, larger sales forces, greater market penetration and/or larger manufacturing capacity. Both CooperVision and CooperSurgical compete predominantly on the basis of product quality and differentiation, technological benefits, price, service levels and reliability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CooperVision Competition </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision's largest competitors in the worldwide market and its primary competitors in the spherical, toric and multifocal lens categories of that market are Johnson &amp; Johnson Vision Care, Inc., Alcon Inc. and Bausch + Lomb. To a lesser extent, CooperVision also competes with manufacturers of eyeglasses and providers of other forms of vision correction including ophthalmic surgery. We believe that in order to compete successfully in the numerous categories of the contact lens market, companies must offer differentiated products that are priced competitively and manufactured efficiently. CooperVision competes in its markets by producing high, medium and low-volume lenses made with a variety of materials for a broader range of market niches, as well as offering a wide range of lens parameters, leading to a higher rate of successful fitting for practitioners and better visual acuity for patients. Our ability to compete successfully with a full range of silicone hydrogel products is an important factor to achieving success in our business. We also compete based on our customer and professional services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CooperSurgical Competition </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical focuses on selected segments of the fertility and women's health care market with a diversified portfolio  including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperSurgical's strategy includes developing and acquiring new solutions to complement our current offerings. In the fertility market, CooperSurgical competes against Vitrolife Group, FujiFilm-Irvine Scientific, Cook Medical, Hamilton Thorne, and Fairfax Cryobank and Fairfax EggBank. We also compete with fertility clinics offering their own services. Larger companies such as Johnson &amp; Johnson, Medtronic and Hologic have offerings that compete with our medical device products. In the stem cell storage field, we compete primarily with ViaCord, a division of Revvity, in the United States, as well as other smaller companies globally. With PARAGARD, we compete with manufacturers of hormonal IUDs including Bayer and AbbVie, Long Acting Reversible Contraceptives (LARCs) including Organon, and other forms of birth control. We are aware of a non-hormonal IUD under development, which may compete with PARAGARD in the future. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">RESEARCH AND DEVELOPMENT</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company employs approximately 400 people in research and development. CooperVision's product development and clinical research is supported by internal and external specialists in lens design, formulation science, polymer chemistry, engineering, clinical trials, microbiology and biochemistry. CooperVision's research and development activities primarily include programs to develop new contact lens designs, myopia management, and manufacturing technologies, along with improving formulations and existing products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical conducts research and development in-house, and works with external specialists when necessary, in mechanical, electrical, biomedical and software engineering, as well as life sciences. CooperSurgical research and development activities are focused on innovating, improving, and advancing our products and services including, instruments, devices, consumables, digital services, and manufacturing technologies. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">GOVERNMENT REGULATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Our products are subject to extensive regulation by the FDA in the United States and a variety of regulatory agencies in other countries. The process of obtaining regulatory approvals and the subsequent compliance with applicable federal, state, local and foreign statutes and regulations requires the expenditure of substantial time and financial resources. These regulations govern, among other things, the design and development, testing, manufacturing, labeling, storage, record keeping, premarket clearance, approval or certification, post-market vigilance reporting, advertising and promotion, and sales and distribution of medical devices and pharmaceutical products. Failure to comply with the applicable regulations, which are subject to established and new legislation and change, could result in enforcement action by the FDA, or other U.S. or foreign government agencies which may include, among other things, any of the following consequences: warning letters, civil penalties, refusal or withdrawal of approvals or certifications, license suspension or revocation, product recalls, operating restrictions, suspension or shutdown of production, and criminal prosecution. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Regulation in the United States</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Medical Devices </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Most of our products are medical devices, which must comply with the Federal Food, Drug and Cosmetic Act (FDCA) and the regulations promulgated by the FDA thereunder. The FDA classifies medical devices into one of three classes&#8212;Class I, II or III&#8212;depending on the degree of risk associated with each medical device and the extent of control needed to ensure the medical device's safety and effectiveness. Both CooperVision and CooperSurgical develop and market medical devices subject to different levels of FDA regulation depending on the classification and risk profile of the device. Class III devices, such as extended wear contact lenses, require extensive premarket testing and approval, while Class I and II devices require lower levels of regulation. The majority of CooperSurgical's products are Class II devices. Unless an exemption applies, each medical device we wish to distribute commercially in the United States will require either premarket notification to the FDA requesting clearance for commercial distribution under Section 510(k) of the FDCA, a premarket approval (PMA) from the FDA, or a de novo classification and request for marketing authorization submitted to and granted by the FDA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">If we are required to obtain a 510(k) clearance for a device that we wish to market, we must submit a premarket notification to the FDA demonstrating that the device is substantially equivalent to a device commercially distributed in the United States before May 28, 1976 (a pre-amendments device), or to a device that was found to be substantially equivalent to a pre-amendments device. If the FDA agrees that the device is substantially equivalent, it will grant 510(k) clearance to commercially market the device. If the FDA determines that the device is not substantially equivalent to a legally marketed device, the FDA automatically designates the device as a Class III device. The sponsor of a device automatically designated as Class III must either fulfill more rigorous PMA requirements or request a risk-based classification determination for the device in accordance with the de novo process. The de novo process is a pathway to market for novel medical devices that are low to moderate risk and are not substantially equivalent to a predicate device.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A PMA application must be submitted if the device cannot be cleared through the 510(k) premarket notification procedures, or if the device has been previously classified as Class III. The PMA process is much more demanding than the 510(k) premarket notification process. A PMA application must be supported by extensive data including, but not limited to, technical, pre-clinical, clinical trials, manufacturing and labeling to demonstrate to the FDA's satisfaction the safety and effectiveness of the device for its intended use. Prior to commencing human clinical trials, submission of an application for an investigational device exemption (IDE) and receipt of IDE approval from the FDA is required if the device under evaluation presents a significant risk to human health. The process of gathering supporting information leading up to PMA application, and the subsequent FDA review, can take several years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A majority of the medical devices we currently market have received FDA clearance through the 510(k) process or approval through the PMA process. Because we cannot be assured that any new products we develop, or any product enhancements, will be exempt from the premarket clearance or approval requirements, or will be subject to the shorter 510(k) clearance process rather than the PMA process, significant delays in the introduction of any new products or product enhancements may occur. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">After a device is placed on the market, numerous regulatory requirements apply. These include: establishment registration and device listing with the FDA; the FDA's Quality System Regulation (QSR), which requires manufacturers to follow design, testing, production, control, complaint handling, documentation and other quality assurance procedures during the manufacturing process; labeling regulations, which prohibit the promotion of products for uncleared or unapproved or &#8220;off-label&#8221; uses and impose other restrictions on labeling, advertising and promotion; FDA unique device identifier regulations, which require changes to labeling and packaging; and medical device reporting regulations, which require that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur. The FDA has </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">broad post-market and regulatory enforcement powers. We are subject to unannounced inspections for cause by the FDA to determine our compliance with the QSR and other regulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the United States, under the FDCA and the FDA&#8217;s regulatory framework, in vitro diagnostic devices (IVDs) are a type of medical device that can be used in the diagnosis or detection of diseases, such as cancer, or other conditions. The FDA considers Laboratory Developed Tests (LDTs) to be a subset of IVDs that are designed, manufactured, and used within a single laboratory. Furthermore, in October 2023, the FDA published a proposed rule to amend its regulations to make explicit that LDTs are devices under the FDCA. As we operate a genetic testing laboratory, we are required to hold certain federal, state and local licenses, certifications and permits to conduct our business. Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations, we are required to hold a certificate applicable to the type of laboratory tests we perform and to comply with standards applicable to our operations, including test processes, personnel, facilities administration, equipment maintenance, recordkeeping, quality systems and proficiency testing. We have current certification under CLIA to perform testing at our New Jersey facility. In addition to federal certification requirements of laboratories under CLIA, licensure is required and maintained for our laboratory under state law.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Human cells, tissues, and cellular and tissue-based products</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">We currently operate a provider of donated reproductive tissue (eggs and sperm) for fertility treatments, fertility cryopreservation services and newborn stem cell storage. Eggs and sperm are regulated by the FDA as human cells, tissues, and cellular and tissue-based products (HCT/Ps). In addition, Section 361 of the Public Health Service Act (PHSA) authorizes the FDA to issue regulations with respect to HCT/Ps. To be regulated as a "361 HCT/P", the product must, among other things, be minimally manipulated and intended only for homologous uses. HCT/Ps regulated as 361 HCT/Ps are subject to requirements relating to registering facilities and listing products with the FDA, and stringent requirements for processing, storing, labeling and distributing HCT/Ps, including required labeling information, screening and testing for tissue donor eligibility, record keeping and adverse event reporting, among other applicable requirements and laws. 361 HCT/Ps do not require 510(k) clearance, PMA approval, submission of a Biologics License Application, or other premarket authorization from the FDA before marketing. We believe our HCT/Ps are regulated as 361 HCT/Ps. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Pharmaceutical Products</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In the United States, the FDA regulates pharmaceutical products under the FDCA and its implementing drug regulations. The FDA has determined that the primary mode of action for PARAGARD is the drug component and is therefore regulated by the FDA&#8217;s Center for Drug Evaluation and Research as a drug product. The process required by the FDA before a drug may be marketed in the United States generally involves numerous and time-consuming steps, including preclinical laboratory tests, human clinical trials, FDA reviews, inspections and audits and compliance with post-approval requirements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Any drug products manufactured or distributed by us pursuant to FDA approvals are subject to continuing regulation by the FDA as the FDA may withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Drug manufacturers and their subcontractors are required to be in compliance with Good Manufacturing Practices, or cGMPs, and other requirements. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain cGMP compliance. In addition, the FDA closely regulates the marketing, promotion and distribution of pharmaceutical products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Foreign Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Health authorities in foreign countries regulate Cooper's clinical studies and medical device sales. Even if the FDA has cleared or approved a product in the United States, the regulatory agencies or notified bodies in other countries must approve or certify new products and product modifications before they may be marketed in those countries. The regulations vary widely from country to country, although there is a trend towards harmonization of quality system standards among the European Union (EU), United States, Canada and various other industrialized countries. Medical devices marketed or sold in the EU must meet the CE mark requirements and maintain certain certifications. CooperVision maintains ISO 13485 certification and CE marks for its products and CooperSurgical maintains ISO 13485 certification and CE marks for medical devices and ISO 15189 certification for the genomics laboratories. The ISO 13485 Quality Management System certification is now also required for registration of products in Asia Pacific and Latin American countries, among many other requirements for registration in these countries. In order to maintain these quality benchmarks, the Company is subjected to rigorous biannual reassessment audits of its quality systems and procedures. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The EU rules below are generally applicable in the European Economic Area (EEA) which consists of the 27 EU member states plus Norway, Liechtenstein and Iceland, while the majority of the United Kingdom now operates under a separate regulatory regime following the United Kingdom's withdrawal from the EU on January 31, 2020. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Medical Device and In Vitro Diagnostic Medical Device Regulation in the EU</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Until May 25, 2021, medical devices sold in the EU were regulated by the Medical Device Directive (the EU MDD), which has been repealed and replaced by the Medical Device Regulation (the EU MDR). Similarly, the EU has adopted the In Vitro Diagnostic Medical Device Regulation (the EU IVDR), which repealed and replaced the In Vitro Diagnostic Medical Device Directive (the EU IVDD) and became applicable on May 26, 2022. The majority of our current certificates have been granted under the EU MDD and the EU IVDD. Devices lawfully placed on the market pursuant to the EU MDD and EU IVDD may generally continue to be made available on the market or put into service provided that the requirements of transitional provisions are fulfilled. Pursuing marketing of medical devices (including IVDs) in the EU will require that our devices be certified under the new regimes set forth in the EU MDR and the EU IVDR. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In the EU, the safety and performance of medical devices (including IVDs) are evaluated by the designated Notified Bodies via the submission of Technical Dossiers, depending on the product classifications. A Declaration of Conformity to the Medical Device Directive (MDD) or Medical Device Regulation (MDR) is drawn out as a basis for European conformity marking (CE Mark). All medical devices placed on the EU market must meet general safety and performance requirements, including the requirement that a medical device must be designed and manufactured in such a way that, during normal conditions of use, it is suitable for its intended purpose. Medical devices must be safe and effective and must not compromise the clinical condition or safety of patients, or the safety and health of users and, where applicable, other persons, provided that any risks which may be associated with their use constitute acceptable risks when weighed against the benefits to the patient and are compatible with a high level of protection of health and safety, taking into account the generally acknowledged state of the art. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Compliance with the general safety and performance requirements is also a prerequisite for CE mark, without which medical devices cannot be marketed or sold in the EU. To demonstrate compliance with the general safety and performance requirements, medical device manufacturers must undergo a conformity assessment procedure, which varies according to the type of medical device and its risk classification. With certain exceptions, a conformity assessment procedure requires the intervention of notified bodies, which are independent organizations designated by EU member states to assess the conformity of devices before being placed on the market. Typically, satisfactory completion of an audit and examinations of a product&#8217;s technical dossiers and the manufacturer&#8217;s quality system is required before the issuance of a certificate by the notified body. This certificate, along with the Declaration of Conformity, are then used by the manufacturer as basis for CE mark. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Throughout the term of the certificate, the manufacturer will be subject to periodic surveillance audits to verify continued compliance with the applicable requirements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In addition, all manufacturers placing medical devices on the market in the EU are subject to various other regulations, including compliance with the EU medical device vigilance system, directives and requirements regarding the advertisement and promotion of medical devices and inspections rights of regulatory authorities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Laboratory Developed Test Regulation in the EU</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the EU, laboratory developed tests (LDTs) are exempt from the regulations that govern medical devices and IVDs under certain conditions. In order to fall within this exemption under the EU IVDD, medical devices, including LDTs, had to be designed and used within such health institutions (which may include hospitals, laboratories and public health institutions that support the healthcare system and/or address patient needs but do not treat or care for patients directly) on a non-industrial scale, without being released into the market. While the legal framework for applying the exemption under the EU IVDD to LDTs was not entirely clear, the EU IVDR may provide greater clarity on the regulation of LDTs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our current and future tests will need to be analyzed as to whether any or all of them would qualify for an exemption under EU IVDR; otherwise, we will be required to comply with various certification and documentation criteria, and we may be subject to conformity assessments and inspections. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:115%">Medical Devices and In Vitro Diagnostic Medical Devices Regulations in the United Kingdom</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Following the United Kingdom&#8217;s withdrawal from the EU, commonly referred to as Brexit, EU laws no longer apply directly in Great Britain (England, Wales and Scotland). Under the terms of the Ireland/Northern Ireland Protocol agreed between the EU and United Kingdom, many EU laws, including those relating to medical devices and IVDs do still apply in Northern Ireland.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In Great Britain, the legislative regime currently continues to be based on the requirements set out in the EU MDD, the Active Implantable Medical Devices Directive (EU AIMDD), and the EU IVDD. However, the Government is currently developing substantial reforms to the Great Britain regulatory regime for medical devices and IVDs. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Medical Device and In Vitro Diagnostic Medical Device Regulation in Asia Pacific</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">As in other regions, securing regulatory approvals in Asia Pacific is a critical aspect of commercializing our products. While medical device regulations in the Asia Pacific are based on similar regulatory fundamentals (such as risk-based classification of devices) as other regions, navigating the regulatory landscape in Asia Pacific is extremely complex. Medical device regulation in Asia Pacific differs significantly country by country, requiring specific regulatory affairs expertise in each country, as well as country-based regulatory strategies. The regulatory framework maturity in Asia Pacific is widely varied ranging from well-established to emerging, approval timelines can be lengthy and unpredictable and there is less access to and engagement with regulators compared to other markets. Several key Asia Pacific markets require regulatory approval in other countries prior to registration, increasing the time from completion of product development to product launch. For example, in China, manufacturers must provide proof of home country approval (such as the United States or EU) as part of the regulatory registration/approval process. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The National Medical Products Administration (NMPA) regulates medical devices in China. Medical devices in China are classified by risk into Class I (lowest risk), Class II or Class III (highest risk). China requires physical testing (known as &#8216;type testing&#8217;) of medical device samples by in-country testing centers to confirm compliance with specifications and standards, both pre- and post-market. Additionally, NMPA generally requires in-country clinical trials to support new product registrations, rather than relying on foreign clinical data.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">In Japan, the primary regulation governing medical devices is the Pharmaceutical and Medical Device Act (PMD Act). The Ministry of Health, Labor and Welfare (MHLW) and the Pharmaceutical and Medical Device Agency (PMDA) regulate medical devices. The PMDA evaluates the safety and effectiveness of medical devices prior to granting marketing authorization or approval, and monitors post-market safety of approved devices. The PMDA is also the Quality Management System (QMS) Inspection Authority. Medical devices are placed into one of four risk classes based on potential risk, with Class I being the lowest potential risk and Class IV being the highest. Contact lenses, for example, are regulated as Class III devices and require premarket approval (registration), an expensive and lengthy process depending on the application category. A novel or new medical device application will generally require local clinical trial data, extending the time to approval. The registration process in Japan requires a QMS application and inspection. Additionally, separate from the registration process, a Foreign Manufacturer Registration is required before a company can import medical devices manufactured outside Japan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Japan and Australia participate in the Medical Device Single Audit Program, which allows for the acceptance of QMS audit reports from other participating Regulatory Authorities, including the FDA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Other Health Care Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are subject to various federal, state and foreign laws to prevent fraud and abuse in the healthcare industry and protect personal health-related information, including the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:14.68pt">state, federal and similar foreign anti-kickback laws, which generally prohibit payments and other forms of remuneration to induce or in return for the purchase, lease, order or arranging for the purchase, lease or order of a product or service;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the federal physician self-referral law, known as the Stark Law, which generally prohibits physicians from referring Medicare or Medicaid patients to receive designated health services from an entity which the physician, or a member of the physician's immediate family, has a financial interest in;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:14.68pt">the federal False Claims Act, which prohibits any individual or entity from presenting or causing to be presented false claims for payment to the federal government;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">federal and state laws that prohibit executing, or attempting to execute, a scheme to obtain money from any healthcare benefit program under false pretenses;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the Physician Payments Sunshine Act and similar state and foreign laws that require medical device and pharmaceutical manufacturers to disclose financial relationships with health care professionals and teaching hospitals; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">data privacy and security laws and regulations, such as the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the EU General Data Protection Regulation (GDPR), which are intended to protect the collection, use, access to, confidentiality and security of health-related and other personal information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Coverage and Reimbursement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Market acceptance and sales of our CooperSurgical products to our customers, who primarily consist of hospitals and surgical centers, OB/GYN medical offices and fertility clinics, will depend on the availability of payor coverage and the adequacy of reimbursement, for the procedures using our products, by government insurance programs and other third-</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">party payors. Payor coverage and reimbursement for procedures using medical devices in the United States and international markets vary significantly by country. With respect to drug coverage and reimbursement, third-party payors are increasingly challenging the price and examining the medical necessity and cost-effectiveness of drugs, in addition to their safety and efficacy. We believe the overall escalating cost of medical products and services being paid for by the government and private health insurance has led to, and will continue to lead to, increased pressures on the healthcare and medical device industry to reduce the costs of products and services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Healthcare Reform</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In the United States and foreign countries, there has been, and continues to be, several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities, and affect the profitable sale of product candidates. We expect that additional state, federal and foreign healthcare reform measures will be adopted in the future, any of which could limit the amounts that state, federal and foreign governments will pay for healthcare products and services, which could result in reduced demand for our products or additional pricing pressures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Among policy makers and payors in the United States, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. Passed in March 2010, the Patient Protection and Affordable Care Act (the ACA) substantially changed the way healthcare is financed by both governmental and private insurers, and significantly affected the pharmaceutical, medical device and clinical laboratory industries. Additionally, there has recently been heightened scrutiny by governmental authorities, individual hospitals, and third-party payors over product prices, which has resulted in proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for pharmaceutical products. Most recently, on August 16, 2022, the Inflation Reduction Act of 2022, or IRA, was signed into law. Among other things, the IRA requires manufacturers of certain drugs to engage in price negotiations with Medicare (beginning in 2026), with prices that can be negotiated subject to a cap; imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation (first due in 2023); and replaces the Part D coverage gap discount program with a new discounting program (beginning in 2025). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In the EU, regulations have been adopted which are intended to boost cooperation among EU member states in assessing health technologies, including certain high-risk medical devices, and providing the basis for cooperation at the EU level for joint clinical assessments in these areas. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Other Laws and Regulations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">We are subject to numerous federal, state, local and foreign environmental laws, including provisions that regulate the discharge of materials into the environment, laws applicable to our facilities, products or manufacturing processes, including evolving regulations regarding the use of hazardous substances or chemicals in our products, and laws related to the protection of the environment, environmental health and safety regulations, Restriction of Hazardous Substances (RoHS) in electrical and electronic equipment in the EU, and Registration, Evaluation, Authorization and Restriction of Chemical substances (REACH).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">We are subject to various other federal, state and foreign laws related to the manufacturing and distribution of our products and to our international operations, including export control and trade compliance laws. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:115%">CYBERSECURITY</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the normal course of business, we may collect and store personal information and other sensitive information, including proprietary and confidential business information, trade secrets, intellectual property, information regarding trial participants in connection with clinical trials, sensitive third-party information and employee information. To protect this information, our existing cybersecurity policies require continuous monitoring and detection programs, network security precautions, and in-depth security assessment of vendors. We maintain various protections designed to safeguard against cyberattacks, including firewalls and virus detection software. We have established and regularly test our disaster recovery plan and we protect against business interruption by backing up our major systems. In addition, we periodically scan our environment for any vulnerabilities, perform penetration testing and engage third parties to assess effectiveness of our data security practices. A third-party security consultant conducts regular network security reviews, scans and audits. In addition, we maintain insurance that includes cybersecurity coverage. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our cybersecurity program is led by a team of skilled cybersecurity professionals, including dedicated internal cybersecurity resources. The security team currently has CISSP credentials, GIAC/SANS cybersecurity certificates, and other security and network certifications. In addition to our internal security staff, we partner with various third-party security service providers to augment our staffing, expertise, and hours of operation. The program incorporates industry-standard frameworks, policies and practices designed to protect the privacy and security of our sensitive information. The </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">program also includes a suite of security technologies and tools to implement and automate security protections for our networks, employees, and customers. Our cybersecurity team reports to the Audit Committee quarterly on information security and cybersecurity matters, or as needed. Our Audit Committee, which is comprised of several members from our Board of Directors, has oversight responsibility for our data security practices and we believe the committee has the requisite skills and visibility into the design and operation of our data security practices to fulfill this responsibility effectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">See &#8220;Risk Factors &#8211; Risks Relating to Our Business&#8221; for additional information about the risks to our business associated with a breach or compromise to our information security systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">RAW MATERIALS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our businesses utilize various chemicals, packaging materials, components, parts and raw materials which are generally available from more than one source. However, in certain instances we acquire components and materials from sole suppliers to make our silicone hydrogel contact lens, certain medical devices and IVF products. Supply of these materials is protected by contractual agreements and safety stocks. However, if current raw material suppliers fail to supply sufficient materials on a timely basis, or at all for any reason, we could experience inventory shortages and disruption in the supply of products if we were required to use an alternative supplier on short notice.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">MARKETING AND DISTRIBUTION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision markets our products through our own field sales representatives, distributors and eye care practitioners, including optometrists, ophthalmologists, opticians and optical chains. CooperVision also sells to distributors and to mass merchandisers who offer eye care services. To support the sale and use of CooperVision products, CooperVision engages in various activities and offers a variety of services. These include clinical training, digital marketing for the customer, e-commerce, telemarketing, social media, and journal advertisements. CooperVision also invested in tools that allow our customers to offer their patients monthly purchase and delivery subscriptions. In certain smaller countries, CooperVision often uses distributors and leverages our distributors' sales and marketing resources to attract major customers to CooperVision. With the addition of MiSight, CooperVision has expanded the breadth and depth of its sales capabilities by adding myopia management specialists while expanding awareness campaigns to include direct-to-consumer elements including print, internet/social media, radio and television. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical's products are marketed by a network of dedicated field sales representatives, independent agents and distributors. CooperSurgical augments its sales and marketing activities by participating in national and regional industry trade shows, professional educational programs and internet promotions including e-commerce, social media and collaborative efforts with professional organizations, telemarketing, direct mail and advertising in professional journals. Since the addition of PARAGARD and cord blood and cord tissue storage services, CooperSurgical has also expanded its awareness campaigns to include direct-to-consumer elements including print, internet/social media, radio and television. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">We protect our products through patents and trademark registrations, both in the United States and in international markets. We monitor competitive products trademark use worldwide and, when determined appropriate, we have enforced and plan to continue to enforce and defend our patent and trademark rights. We also rely upon trade secrets, licenses, technical know-how and continuing technological innovation to develop and maintain our competitive position. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperVision, CooperSurgical, and other trade names, trademarks or service marks of Cooper and its subsidiaries appearing in this report are the property of Cooper and its subsidiaries. Trade names, trademarks and service marks of the other companies appearing in this report are the property of their respective holders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">DEPENDENCE ON CUSTOMERS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">No customer accounted for 10% or more of our consolidated net revenue in fiscal 2023 and 2022. See Note 12. Business Segment Information of the Consolidated Financial Statements for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">SEASONALITY</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision and CooperSurgical net sales in the fiscal first quarter, which runs from November 1 through January&#160;31, are typically lower than subsequent quarters, as patient traffic to practitioners' offices, fertility clinics, and hospitals/surgical centers for surgical procedures is less during the holiday season.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">HUMAN CAPITAL RESOURCES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2023, we had a workforce of more than 15,000. Our employees are located around the world, with 53% in Americas, 42% in EMEA and 5% in Asia Pacific. Human capital management areas of focus include a people-focused culture; embedding diversity and inclusion; fostering an environment of health, safety, and well-being; investing in and developing our employees through training and engagement. Our employees are a key differentiator in our overall strategy. We believe we have good relations with our workforce, and we invest in our workforce to meet current and future business objectives, always driving towards our goal of being a global employer of choice. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Chart below shows percentage of employees located in Americas, EMEA and Asia Pacific as of October&#160;31, 2023.</span></div><div style="text-align:center"><img src="coo-20231031_g1.jpg" alt="104268" style="height:250px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Diversity and Inclusion </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We believe that an inclusive work environment that truly appreciates the diversity of employees&#8217; talents, experiences, and ideas leads to more innovation and progress. Through our Diversity &amp; Inclusion (D&amp;I) strategy, we drive a culture where individual qualities and backgrounds are highly valued and respected, and our employees feel a sense of belonging. Our D&amp;I strategy includes initiatives to promote D&amp;I conversations and training to inform and educate our workforce, forming communities of advocates and allies to help advance our culture of inclusion, and completion of various reviews of our programs to minimize the impact of unconscious bias on our reward decisions. Our commitment to D&amp;I starts with our executives and is further executed through local initiatives in order to create sustainable change. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Health, Safety and Well-being</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our culture of health, safety, and well-being helps our people and businesses thrive. We comply with applicable health and safety laws and regulations and help protect our employees through continuous improvement, education, engagement, and risk management. Our Environmental, Health, and Safety (EHS) Global Policies formalize our commitment to high standards of EHS performance for employees, consultants, contract workers, and temporary staff worldwide. Our employee handbooks specify health and safety expectations, working condition policies, and other relevant topics. We encourage an open reporting culture and require any unsafe conditions or potential hazards be reported immediately. Wellness is an important part of our culture. Our global Mind &amp; Body Well-being Employee Resource Group focuses on enhancing physical wellness and raising the importance of mental health through virtual and in-person events. We offer on- and off-site fitness and wellness facilities and programs, an assortment of team-building activities, and have a robust offering of physical, social, nutritional and mental health resources.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Training, Development and Engagement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We empower employees to succeed and grow, reward great thinking, results and hard work, and engage our employees. Across our businesses, we offer job-specific training, certifications, mentoring, developmental assignments, and other opportunities to help our employees develop the skills needed to achieve long-term success. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We conduct regular formal and informal surveys to proactively seek out employee feedback, ideas, and collect data on</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">the employee experience. We encourage candid participation, and these insights help us develop targeted strategies to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">enhance our workplace and culture. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Compensation and Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We provide competitive compensation and benefits in order to attract and retain talent. We regularly review our pay practices to confirm there are no significant pay disparities across gender or race, and we conduct an annual market assessments to provide consistency in rewards we offer. We have implemented robust processes for setting personal goals, individual development actions and review employees&#8217; performance and pay on an annual basis. We also offer comprehensive and continually evolving benefits to help employees balance their work lives and personal lives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">AVAILABLE INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Cooper Companies, Inc. Internet address is https://www.coopercos.com. The information on the Company's website is not part of this or any other report we file with, or furnish to, the Securities and Exchange Commission (SEC). Our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, along with all other reports and amendments filed with or furnished to the SEC, are publicly available free of charge on our website as soon as reasonably practicable. The SEC maintains a website that contains such reports, proxy and information statements and other information whose Internet address is https://www.sec.gov. The Company's Corporate Governance Principles, Code of Conduct and charters of each standing committee of the Board of Directors are also posted on the Company's website.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_19"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Risk Factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Our business faces significant risks. These risks include those described below and may include additional risks and uncertainties not presently known to us or that we currently deem immaterial. Our business, financial condition and results of operations could be materially adversely affected by any of these risks, and the trading prices of our common stock could decline by virtue of these risks. These risks should be read in conjunction with the other information in this report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Risks Relating to Our Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Current market conditions and recessionary pressures in one or more of our markets could impact our ability to grow our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Over the last few years in the United States and globally, market and economic conditions have been challenging. The United States and foreign countries have experienced recessionary pressures and face continued concerns about the systemic impacts of adverse economic conditions and geopolitical issues. Any negative impact on economic conditions and international markets, continued volatility or deterioration in the debt and equity capital markets, inflation, deflation or other adverse economic conditions may adversely affect our liquidity and financial condition. It may limit our ability to replace maturing liabilities and to access the capital markets to meet liquidity needs, which could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Ongoing uncertain economic and financial market conditions may also adversely affect the financial condition of our customers, suppliers and other business partners. When our customers&#8217; financial conditions are adversely affected, customers may reduce their purchases of our products or we may not be able to collect accounts receivable, each of which could have a material adverse impact on our business. Our global business has been negatively affected by local economic conditions, including inflation, increasing labor costs, recession, and currency exchange rate fluctuations, which has adversely affected our cost to manufacture and provide our products and services and revenues generated through sales of such products and services. We cannot guarantee that we will be able to fully absorb any such additional costs or revenue declines in the prices for our products and services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision and CooperSurgical are encountering consolidation in their customer bases and emergence of more centralized large customer groups and retail chains. Due to this trend, global and regional key account customers now represent a larger proportion or concentration of our business and any disruption to these relationships may have a material adverse impact on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Inflation could materially adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our operating results could be materially impacted by changes in the overall macroeconomic environment and other economic factors that impact our cost structure and revenue. Changes in economic conditions, supply chain constraints, logistics challenges, labor shortages, the war in Ukraine and other international conflicts, and steps taken by governments and central banks, as well as other stimulus and spending programs, have led to higher inflation, which is likely to lead to an increase in costs and may cause changes in fiscal and monetary policy, including increased interest rates. In a higher inflationary environment, we may be unable to raise the prices of our products and services sufficiently to keep up with the rate of inflation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our substantial and expanding international operations are subject to uncertainties which could affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A significant portion of our current operations are conducted and located outside the United States, and our growth strategy involves expanding our existing foreign operations and entering into new foreign jurisdictions. We have significant manufacturing and distribution sites in North America, Latin America and Europe. More than half of our net sales for the fiscal years ended October&#160;31, 2023 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">, were derived from the sale of products outside the United States. We believe that sales outside the United States will continue to account for a material portion of our total net sales for the foreseeable future. International operations and business expansion plans are subject to numerous additional risks, including the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">difficulty managing a large organization spread throughout various countries;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">fluctuations in currency exchange rates adversely affecting our results;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">challenges associated with enforcing intellectual property rights in some foreign countries;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">difficulty gaining market share in countries such as China because of regulatory restrictions and customer preferences;</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">difficulty growing our sales in emerging markets such as China, India, Russia, Brazil and other developing nations due to, among other things, customer acceptance, undeveloped and/or unfamiliar distribution channels, regulatory restrictions and changes, and business knowledge of these new markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">foreign earnings being subject to withholding requirements or the imposition of tariffs, exchange controls or other restrictions, including the tariffs enacted by the Chinese government on certain U.S. goods, the scope and duration of which remain uncertain;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">challenges in complying with a variety of international legal, compliance and regulatory requirements such as the Foreign Corrupt Practices Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the UK Bribery Act, international data security and privacy laws, EU MDR and EU IVDR. and environmental laws and requirements applicable to our facilities, products or manufacturing processes, including evolving regulations regarding the use of hazardous substances or chemicals in our products.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">foreign customers creating longer payment cycles than customers in the United States;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">failure to comply with U.S. Department of Commerce and other nations' import-export controls may result in fines and/or penalties;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">general economic and political conditions in the countries where we operate having an adverse effect on our operations in those countries or being unfavorable to our growth strategy;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">natural disasters, pandemics, war, terrorism, labor disruptions and international conflicts may cause significant economic disruption and political and social instability, resulting in decreased demand for our products, adversely affecting our manufacturing and distribution capabilities, or causing interruptions in our supply chain; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">foreign governments adopting regulations, including those similar to the EU MDR and EU IVDR or take other actions that would have a direct or indirect adverse impact on our business and market opportunities, including but not limited to increased enforcement of potentially conflicting and ambiguous anti-bribery and privacy laws;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">challenges enforcing agreements and collecting receivables through some foreign legal systems; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">unforeseen economic or political events in certain countries that may have an impact on our customers' ability or preferences to buy our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As we continue to expand our business globally, our success will depend, in large part, on our ability to anticipate and effectively manage these and other risks associated with our international operations. However, any of these factors could adversely affect our international operations and, consequently, our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">International Conflicts, such as the war between Russia and Ukraine, could adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On February 24, 2022, Russian military forces launched a military action in Ukraine. The military conflict is ongoing and the length, impact, and outcome is highly unpredictable. It has led and could continue to lead to significant market and other disruptions, including significant volatility in commodity prices and supply of energy resources, instability in financial markets, supply chain interruptions, political and social instability, trade disputes or trade barriers, changes in consumer or purchaser preferences, as well as an increase in cyberattacks and espionage.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The war has led to significant sanctions programs imposed by the United States, the EU, the UK, Canada, Switzerland, Japan, and other countries against Russia, Belarus, the Crimea Region of Ukraine, the so-called Donetsk People&#8217;s Republic, and the so-called Luhansk People&#8217;s Republic.  In retaliation against new international sanctions and as part of measures to stabilize and support the volatile Russian financial and currency markets, the Russian authorities also imposed significant currency control measures aimed at restricting the outflow of foreign currency and capital from Russia, imposed various restrictions on transacting with non-Russian parties, banned exports of various products, and imposed other economic and financial restrictions. The situation continues to evolve and additional sanctions by Russia on the one hand, and by the other countries on the other hand, could adversely affect the global economy, financial markets, energy supply and prices, certain critical materials and metals, supply chains, and global logistics and could adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Our business must be conducted in compliance with applicable economic and trade sanctions laws and regulations, including those administered and enforced by the U.S. Department of Treasury&#8217;s Office of Foreign Assets Control, the U.S. Department of State, the U.S. Department of Commerce, the United Nations Security Council, and other relevant governmental authorities. If we are found to be in violation of U.S. sanctions or export control laws, it could result in substantial fines and penalties for us and for individuals working for us. We are actively monitoring the situation in Ukraine and Russia and assessing its impact on our business, including our business partners, employees and customers. To date, we have not experienced any material interruptions in our infrastructure, supplies, technology systems, or networks needed to support our operations. The conflict has caused us to modify our operations in Russia and could lead to additional modifications in Russia. We cannot predict the progress or outcome of the war or its impacts in the territories where we operate. The extent and duration of the military action, sanctions, other consequences, such as Russia imposing restrictions on transactions or banning the export of energy products, including natural gas, and the resulting market disruptions could be significant and could potentially have substantial impact on the global economy and our business for an unknown period of time. Any such disruption may also magnify the impact of other risks described in this section.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Acquisitions and other strategic transactions that we have made and may make in the future involve numerous risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have a history of acquiring businesses and products that have significantly contributed to our growth in recent years. As part of our growth strategy, we intend to continue to consider acquiring complementary technologies, products and businesses and establishing joint ventures or other strategic relationships. Future transactions could result in potentially dilutive issuances of equity securities, the incurrence of debt and contingent liabilities and an increase in amortization and/or impairments of goodwill and other intangible assets, which could have a material adverse effect upon our business. In fiscal 2022, CooperVision acquired a private Denmark-based ortho-k contact lens distributor. In fiscal 2022, CooperSurgical acquired a private cryopreservation services company and Generate Life Sciences (Generate), a private provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood and cord tissue). Risks we could face with respect to these acquisitions and other strategic transaction include:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">failure to successfully obtain the anticipated revenues, margins and earnings benefits;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">difficulties in, and expenses related to, the integration of the operations, technologies, information technology and other enterprise resource planning systems, products and personnel of the acquired company and establishment of appropriate accounting controls and reporting procedures, data protection systems and other regulatory compliance procedures, including but not limited to third-party compliance and due diligence;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">increased leverage and the risk of lack of access to available financing, including financing for the acquisition or refinancing of debt owed by us on a timely basis and on reasonable terms;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">risks of entering markets in which we have no or limited prior experience;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">potential loss of employees;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">an inability to identify and consummate future acquisitions on favorable terms or at all;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">diversion of management's attention away from other business concerns;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">risks of the acquired company&#8217;s noncompliance with applicable laws or regulations;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">expenses of any undisclosed or potential liabilities, contingent liabilities or indemnification obligations of the acquired company;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">expenses, including restructuring expenses, to shut down our own locations or terminate our employees;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">application of and compliance with new and unfamiliar regulatory frameworks such as regulation applicable to our newly acquired fertility-related businesses;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">failure to successfully obtain or maintain reimbursements under the third-party payor plans, including but not limited to governmental programs, due to complex reporting and payment obligations;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">our ability to develop satisfactory working arrangements with our strategic partners in joint ventures or other affiliations;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">a dilution of earnings per share; and</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">risks inherent in accounting allocations and the risk that we are required to record significant adjustments to the preliminary fair value of assets acquired and liabilities assumed within the measurement period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We face risks associated with disruption of our manufacturing, distribution and storage operations, including possible failure to develop necessary manufacturing processes, or constrained, idle or excess capacity, which could adversely affect our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">We manufacture a significant portion of the medical device products we sell. Any prolonged disruption in the operations of our existing manufacturing or distribution facilities or our fertility and stem cell storage facilities, whether due to work stoppages, technical or labor difficulties, integration difficulties, destruction of or damage to any facility (as a result of natural disaster, use and storage of hazardous materials or other events), enforcement action by the FDA or other regulatory body if we are found to be in non-compliance with current Good Manufacturing Practices (cGMP) or similar foreign requirements or other reasons, could have a material adverse effect on our business. In addition, materials such as silicone hydrogel require improvements to our manufacturing processes to make them cost-effective. While we have improved our manufacturing capabilities for our silicone hydrogel products, our failure to continue to develop improvements to our manufacturing processes and reduce our cost of goods could significantly impact our ability to compete. Conversely, constrained, excess or idle capacity, which could result from acquisitions, unexpected demand, inaccurate sales forecasting or unexpected manufacturing efficiencies, could significantly impact our profitability, capital investments, customer service levels and near-term financial condition.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision manufactures molded contact lenses, which represent the majority of our contact lens revenues, primarily at our facilities in Costa Rica, Hungary, Puerto Rico, the United Kingdom and the United States, with other smaller facilities also existing in multiple locations around the world. CooperSurgical manufactures the majority of its products in Costa Rica, the United Kingdom and the United States, with other smaller locations also existing in multiple locations around the world. We manufacture certain products at only one manufacturing site for certain markets, and certain of our products are approved for manufacturing only at one site. Further, certain media products have limited storage lives, limiting inventory back-up strategies. If there were any prolonged disruption in the operations of the approved facility, it could take a significant amount of time to obtain required regulatory approvals, validate a second site and replace lost product, which could result in lost customers and thereby reduce sales, profitability and market share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision distributes products out of Belgium, Hungary, the United Kingdom and the United States and various smaller international distribution sites. CooperSurgical primarily distributes products out of its facilities in the United States and the Netherlands and operates fertility and stem cell storage facilities in the United States, Canada and Australia. Any prolonged disruption in the operations of our existing distribution or storage facilities, whether due to technical or labor difficulties, challenges related to system implementation, destruction of or damage to any facility (as a result of natural disaster, use and storage of hazardous materials or other events) or other reasons, could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cybersecurity threats continue to increase in frequency and sophistication; a successful cybersecurity attack could interrupt or disrupt our information technology systems, or those of our third-party service providers, or cause the loss of confidential or protected data which could disrupt our business, force us to incur excessive costs or cause reputational harm.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Security breaches, computer malware and computer hacking attacks have become more prevalent across industries and may occur on our systems or those of our third-party service providers or partners. The size and complexity of our information systems make such systems potentially vulnerable to service interruptions or to security breaches from inadvertent or intentional actions by our employees or vendors, or from attacks by malicious third parties. Such attacks are increasing in their frequency, levels of persistence, levels of sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives and expertise, especially given increased vulnerability of corporate information technology systems as distributed work environments have become prevalent. In addition to unauthorized access to or acquisition of personal data, confidential information, intellectual property or other sensitive information, such attacks could include the deployment of harmful malware and ransomware, and may use a variety of methods, including denial-of-service attacks, social engineering and other means, to attain such unauthorized access or acquisition or otherwise affect service reliability and threaten the confidentiality, integrity and availability of information. Like many other companies, we experience attempted cybersecurity actions on a frequent basis, and the frequency of such attempts could increase in the future. While we have invested in the protection of data and information technology, we cannot be assured that our efforts will prevent or quickly identify service interruptions or security breaches. The techniques used by cybercriminals change frequently, may not be recognized until launched and can originate from a wide variety of sources, including outside groups such as external service providers, organized crime affiliates, terrorist organizations or hostile foreign governments or agencies. We cannot be assured that our data protection efforts and our investment in information technology will prevent significant breakdowns, data leakages or breaches in our systems or those of our third-party services providers or partners. Any such interruption or breach of our systems could adversely affect our business operations and/or result in the loss of critical or sensitive confidential information or intellectual property, and could result in financial, legal, business and reputational harm to us. We maintain cyber liability insurance; however, this insurance may not be sufficient to cover the financial, legal, business or reputational losses that may result from an interruption or breach of our systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We manage our businesses utilizing multiple complex integrated software and hardware information technology operating systems that are regularly maintained and upgraded; an interruption or disruption to these systems could disrupt our business or force us to incur excessive costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We utilize multiple complex integrated software and hardware operating systems, including enterprise resource planning and warehouse management systems,&#160;to support our business units and we have a continuous improvement strategy in place to keep our systems and overarching technology stable and in line with business needs and growth. Regular upgrades of our computer hardware and software revisions are typical and expected. We employ controlled change management methodologies to plan, test and execute all such system upgrades and improvements, and we believe that we assign adequate staffing and other resources to projects to ensure successful implementation. However, we cannot be assured that our systems will meet our future business needs or that upgrades will operate as designed. We cannot be assured that there will not be associated excessive costs or disruptions in portions of our business in the course of our maintenance, support and/or upgrade of these systems.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are in the midst of a multiyear process of implementing new enterprise resource planning (ERP) systems at CooperVision and CooperSurgical. Implementing a new ERP system is not only costly but complex and difficult. Implementing a new ERP system can negatively affect not only financial accounting and reporting processes but also external commercial activities such as order receipt and product delivery. We cannot be assured that we will successfully implement our new ERP system or that we will avoid these and other negative impacts from our implementation efforts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Pricing pressure from our competitors, customers and changes in third-party coverage and reimbursement may adversely affect demand for our products and negatively impact our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Competition in our industry has increased as a result of new market entrants, new technologies and as more established companies have intensified competitive pricing pressure. As a result of these competitive forces, we believe there will continue to be pricing pressure in the future. Because our CooperSurgical products are generally purchased by hospitals and surgical centers, OB/GYN medical offices and fertility clinics, and billed to various third-party payors, changes in the purchasing behavior of such customers or the amount such payors are willing to reimburse our customers for procedures using our products, including as a result of healthcare reform initiatives, could create additional pricing pressure on us. In addition to these competitive forces, we continue to see pricing pressure as our customers introduce new pricing structures into their contracts and agreements, including fixed price formulas, capitated pricing and structured pricing intended to contain healthcare costs. Such trends may adversely affect demand for our products and may drive down the prices we are able to charge for our products, both of which would negatively affect our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We rely on independent suppliers in our supply chain for raw materials, packaging materials and components, mechanical equipment and some finished goods; we could experience inventory shortages if any of these suppliers encounter a manufacturing or distribution disruption.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our businesses utilize various chemicals, packaging materials, components, parts and raw materials which are generally available from more than one source. However, in certain instances we acquire components and materials from sole or primary suppliers to make our silicone hydrogel contact lens, certain medical devices and IVF products. We also source mechanical equipment and in certain instances finished goods from OEM suppliers. Supply of these goods, items and materials is protected by contractual agreements, availability of alternative suppliers and/or safety stocks. However, if current suppliers fail to supply sufficient goods, items or materials to us on a timely basis, or at all for any reason, we could experience inventory shortages and disruption in our supply of products. For example, among other situations, some of the primary material used to make our silicone hydrogel contact lens products, including MyDay, Biofinity, Avaira and clariti, are supplied by few or sole suppliers, and the failure of a key or sole supplier to timely supply sufficient items and materials necessary for the manufacture of our silicone hydrogel contact lenses could in turn disrupt our supply of those lenses to the market, which would have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our supply chain and our cost of goods also may be negatively impacted by unanticipated price increases due to factors such as inflation, including wage inflation, or to supply restrictions beyond our control or the control of our suppliers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our results of operations have been adversely affected, and our results of operations, cash flow and financial condition could be materially adversely affected in the future, by the global COVID-19 pandemic and related economic disruptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The COVID-19 pandemic has negatively impacted business and healthcare activity globally and has created significant volatility, uncertainty and economic disruption within the markets in which we operate. The pandemic has adversely affected and is likely to further adversely affect nearly all aspects of our business and markets, including our sales, operations, cash flow and workforce and the operations of our customers, suppliers, vendors and business partners. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic and related economic disruptions impact our business, results of operations, cash flow and financial condition will depend on future developments, which are highly uncertain, difficult to predict and largely outside of our control. Even after the COVID-19 pandemic has subsided, we may continue to experience materially adverse effects on our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">If we fail to protect our intellectual property adequately, our business could suffer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We consider our intellectual property rights, including patents, trade secrets, trademarks and licensing agreements, to be an integral component of our business. We attempt to protect our intellectual property rights through a combination of patent, trademark, copyright and trade secret laws, as well as licensing agreements and third-party nondisclosure and assignment agreements. Our failure to obtain or maintain adequate protection of our intellectual property rights for any reason could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We also may seek to enforce our intellectual property rights on others through litigation. Our claims, even if meritorious, may be found invalid or inapplicable to a party we believe infringes or has misappropriated our intellectual property rights. In addition, litigation can:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">be expensive and time consuming to prosecute or defend; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">result in a finding that we do not have certain intellectual property rights or that such rights lack sufficient scope or strength; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">divert management's attention and resources; or </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">require us to license our intellectual property.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have applied for patent protection in the United States, the United Kingdom and other foreign jurisdictions relating to certain existing and proposed processes and products. We cannot be assured that any of our patent applications will be approved. Patent applications in the United States, the United Kingdom and other foreign jurisdictions are maintained in secrecy for a period of time, which may last until patents are issued, and since publication of discoveries in the scientific or patent literature tends to lag behind actual discoveries by several months, we cannot be certain that we will be the first creator of inventions covered by any patent application we make or the first to file patent applications on such inventions. The patents we own could be challenged, invalidated or circumvented by others and may not be of sufficient scope or strength to provide us with any meaningful protection or commercial advantage. We also cannot assure that we will have adequate resources to enforce our patents.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Both CooperVision and CooperSurgical also rely on proprietary technology that is unpatented. It is possible that others will independently develop the same or similar technology or otherwise obtain access to our unpatented technology. To protect our trade secrets and other proprietary information, our employees, consultants, advisors and collaborators enter into confidentiality agreements and assignment agreements, which generally provide that inventions conceived by the party in the course of rendering services to us will be our exclusive property. However, we cannot be assured that these confidentiality agreements will provide meaningful protection for our trade secrets, know-how or other proprietary information in the event of any unauthorized use, misappropriation or disclosure of such trade secrets, know-how or other proprietary information. Enforcing a claim that a party illegally obtained and is using our trade secrets is difficult, expensive and time consuming and the outcome is unpredictable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We rely on trademarks to establish a market identity for our products. To maintain the value of our trademarks, we might have to file lawsuits against third parties to prevent them from using trademarks confusingly similar to or dilutive of our registered or unregistered trademarks. We also might not be successful in obtaining registrations for our pending or future trademark applications and might have to defend our registered trademark and pending applications against challenge by third parties. Enforcing or defending our registered and unregistered trademarks might result in significant litigation costs and damages, including the inability to continue using certain trademarks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The laws of foreign countries in which we do business or contemplate doing business in the future may not recognize intellectual property rights or protect them to the same extent as do the laws of the United States. Adverse determinations in a judicial or administrative proceeding could prevent us from manufacturing and selling our products or prevent us from stopping others from manufacturing and selling competing products, and thereby have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our products or processes could be subject to claims of infringement of the intellectual property of others.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our competitors in both the United States and foreign countries, some of which have substantially greater resources and have made substantial investments in competing technologies, as well as other third parties, may have applied for or obtained, or may in the future apply for and obtain, patents that will prevent, limit or otherwise interfere with our ability to make and sell our existing and planned products. In the contact lens industry, CooperVision, its competitors and other third parties hold patents covering contact lens designs, materials, processes and business methods. Claims that our products, business methods or processes infringe upon the proprietary rights of others often are not asserted until after commencement of commercial sales of products incorporating our technology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Significant litigation regarding intellectual property rights exists in our industries. For example, CooperVision in the past faced significant patent litigation over its silicone hydrogel contact lens products. Third parties have made, and may make in the future, claims of infringement against us or our contract manufacturers in connection with the use of our technology. Any claims, even those without merit, could:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">be expensive and time consuming to defend; </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">cause us to cease making, licensing or selling products that incorporate the challenged intellectual property; </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">require us to redesign or re-engineer our products, if feasible; </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">divert management's attention and resources; or </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">require us to enter into royalty or licensing agreements in order to obtain the right to use a necessary product, component or process.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We cannot be certain of the outcome of any litigation. A successful claim of infringement against us or our contract manufacturers in connection with the use of our technology, in particular if we are unable to manufacture or sell any of our planned products in any major market, could adversely affect our business. Any royalty or licensing agreement, if required, may not be available to us on acceptable terms or at all. Our failure to obtain the necessary licenses or other rights could prevent the sale, manufacture, or distribution of some of our products and, therefore, could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We could experience losses from product liability claims or legal claims relating to our service offerings, including such claims and other losses resulting from sales of counterfeit and other infringing products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">We face an inherent risk of exposure to product liability claims in the event that the use of our products results in personal injury. We also face the risk that defects in the design or manufacture of our products or sales of counterfeit or other infringing products might necessitate a product recall and other actions by manufacturers, distributors or retailers in order to safeguard the health of consumers and protect the integrity of the subject brand. Additionally, we face the inherent risk of exposure to legal claims, including negligence, relating to our provision of certain service offerings, including the accuracy and quality of our genomic services, fertility cryopreservation, fertility donor gamete supply, and stem cell storage services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">These risks may be heightened due to our direct-to-consumer marketing efforts for some of our products and services (e.g., stem cell storage and Paragard IUDs). Consumers may halt or delay purchases of a product or service that is the subject of a claim or recall or has been counterfeited. We handle some risk with third-party carrier policies that are subject to deductibles and limitations. These insurance policies may become more expensive (or not be available) for new risks we may assume when we acquire new businesses. We cannot be assured that we will not experience material losses due to product liability claims or recalls, legal claims relating to our service offerings, or a decline in sales resulting from sales of counterfeit or other infringing products, in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">If our products are not accepted by the market, we will not be able to sustain or expand our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Certain of our proposed products have not yet been clinically tested or commercially introduced, and some of our existing products are marketed and sold on the basis of potential future medical or therapeutic value (assuming technology advances), and we cannot be sure that any of them will achieve market acceptance or generate revenues or operating profits. The development of a market for our products may be influenced by many factors, some of which are out of our control, including:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">acceptance of our products by eye care and health care practitioners;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the cost competitiveness of our products;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">consumer reluctance to try and use a new product;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">regulatory and legislative requirements;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">adequate coverage and reimbursement by third-party payors;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">lack of scientific advancements to validate the medical value of certain products, such as stored cord blood or cord tissue (or scientific advancements in other medical approaches that reduce or eliminate the value of such products); and</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the earlier release of competitive products, such as new silicone hydrogel products or contraceptive technologies, into the market by our competitors; and the emergence of newer and more competitive products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We operate in the highly competitive health care industry, and we cannot be assured that we will be able to compete successfully.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Each of our businesses operates within a highly competitive environment. In our soft contact lens business, CooperVision faces intense competition from competitors' products, in particular silicone hydrogel contact lenses, and may face increasing competition as other new products enter the market. Our largest competitors in the contact lens business, Johnson &amp; Johnson Vision Care, Inc., Alcon Inc. and Bausch Health Companies Inc. may have substantially greater financial resources, larger research and development budgets, larger sales forces, greater market penetration and/or larger manufacturing volumes than CooperVision. They offer competitive products and differentiated materials, plus a variety of other eye care products including lens care products and ophthalmic pharmaceuticals, which may give them a competitive </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">advantage in marketing their lenses. The market for contact lenses is intensely competitive and is characterized by declining sales volumes for older product lines and growing demand for silicone hydrogel-based products. Our ability to respond to these competitive pressures will depend on our ability to decrease our costs and maintain gross margins and operating results and to introduce new products successfully, on a timely basis in the Americas, EMEA and Asia Pacific, and to achieve manufacturing efficiencies and sufficient manufacturing capacity and capabilities for such products. Any significant decrease in our costs per lens will depend, in part, on our ability to increase sales volume and production capabilities and our ability to secure adequate supply of materials used in production at reasonable costs. Our failure to respond to competitive pressures in a timely manner could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">To a lesser extent, CooperVision also competes with manufacturers of eyeglasses and providers of other forms of vision correction including ophthalmic surgery.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We cannot be assured that we will not encounter increased competition in the future, for example with increased product entries from Asia Pacific contact lens manufacturers, or that our competitors' newer contact lens products will not successfully erode CooperVision's contact lens business, which could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The contact lens industry also continues to evolve with respect to the introduction of new distribution and fulfillment models and service technologies which may conflict with CooperVision&#8217;s strategy or interfere with its customers&#8217; relationships and loyalty. For example, more contact lenses are being fulfilled directly to the consumer by manufacturers and wholesalers via online platforms, telemedicine is gaining popularity and more vision correction prescriptions are being provided through online refractive exams rather than in office by an eye care practitioner. CooperVision&#8217;s failure to adapt to the threats posed by these new and emerging distribution models and Internet driven services may have a material adverse impact on our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical focuses on selected segments of the family and women's health care market with a diversified portfolio of products and services including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. Competitive factors in these segments in which CooperSurgical competes include technological and scientific advances, product quality and availability, price, customer service including response time and effective communication of product information to physicians, consumers, fertility clinics and hospitals. Competition in the medical device industry is dynamic and involves the search for technological and therapeutic innovations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical competes with a number of manufacturers and service providers in its women&#8217;s family health care market areas. Some of these competitors have substantially greater financial and personnel resources and sell a broader range of products, which may give them an advantage in marketing competitive products. In addition, some of CooperSurgical&#8217;s markets, such as genomics, contraception and cord blood and cord tissue storage, are characterized by rapid technological advancement. We face the risk that demand for our products will not grow or will decline if our competitors are more successful than us at innovating in these and other areas. There is also risk that emerging technologies or technology advancements could reduce the medical value of certain of our products and services, such as cord blood and cord tissue storage, which could adversely affect our business. In recent years, CooperSurgical has also expanded direct-to-consumer products and services, which requires implementing new competitive strategies and increases the importance of customer service and consumer reputation as competitive factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">New medical and technological developments may reduce the need for our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Technological developments in the vision, fertility and women&#8217;s health, may limit demand for our products and services. For example, corneal refractive surgical procedures such as Lasik surgery and the development of new pharmaceutical products may decrease the demand for our optical products. If these new advances provide a practical alternative to traditional vision correction, the demand for contact lenses and eyeglasses may materially decrease. We cannot be assured that medical advances and technological developments will not have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Product innovations are important in the industry in which we operate, and we face the risk of product obsolescence if we are unable to develop new products or gain regulatory approvals or certifications or if our competitors introduce new products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Product innovations are important in the contact lens market in which CooperVision competes and in the areas of the health care industry in which CooperSurgical competes. CooperVision, both internally and externally with third parties, invests in new product development, including the development of new silicone hydrogel-based contact lenses. While much of CooperVision&#8217;s research and development activities are performed internally, it also uses external research and development investment in collaborations and joint development with third parties. CooperSurgical has historically purchased, leveraged or licensed the technology developments of others. CooperSurgical also has invested in expanding the internal research and development function with the goal of organic growth and to complement our acquisitions </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">strategy. Research and development time commitments, higher feasibility risk with longer term projects, greater dependence on, and reduced control over, third-party deliverables, the cost of obtaining necessary regulatory approval or certification and other costs related to product innovations can be substantial. We cannot be assured that we will successfully obtain necessary regulatory approvals, certifications or clearances for our new products or that our new products will successfully compete in the marketplace and, as a result, justify the expense involved in their development and regulatory approval or certification. In addition, our competitors may have developed or may in the future develop new products or technologies. Failure to develop new product offerings and technological changes and to offer products that provide performance that is at least comparable to competing products could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We face risks related to environmental, social and governance matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We and our facilities are subject to a broad range of U.S federal, state, local and foreign environmental laws and requirements, including those governing discharges to the air and water, the handling or disposal of solid and hazardous substances and wastes, remediation of contamination associated with the release of hazardous substances at our facilities and offsite disposal locations and occupational safety and health. We have made, and will continue to make, expenditures to comply with such laws and requirements. Future events, such as changes in existing laws and regulations, or the enforcement thereof, or the discovery of contamination at our facilities, may give rise to additional compliance or remediation costs that could have a material adverse effect on our business. Such laws and requirements are constantly changing, are different in every jurisdiction and can impose substantial fines and sanctions for violations. As a manufacturer of various products, we are exposed to some risk of claims with respect to environmental matters, and we cannot be assured that material costs or liabilities will not be incurred in connection with any such claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We continue to evaluate the necessary steps for compliance with regulations as they are enacted. These regulations include, for example, regulations enacted in the EU such as the Registration, Evaluation, Authorization and Restriction of Chemical Substances, which requires the registration of and regulates use of certain chemicals, the Restriction on the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive, which regulates the use of certain hazardous substances in certain products our CooperSurgical division manufactures. These and similar legislation that has been or is in the process of being enacted in Japan, China and various states of the United States may require us to re-design certain products to ensure compliance with the applicable laws and regulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, new disclosure standards and rules related to environmental, social and corporate governance (ESG) matters have been adopted and may continue to be introduced in various states and other jurisdiction. For example, the European Union Corporate Sustainability Reporting Directive (CSRD) became effective in 2023 and applies to both EU and non-EU entities. In October 2023, California adopted new carbon and climate-related reporting requirements for large public and private companies doing business in the state. Further, the SEC is expected to finalize a climate change disclosure proposal in 2023. International ESG disclosure standards have also been produced (and further standards will be produced) under the auspices of the International Sustainability Standards Board (ISSB), which some countries (such as the UK) have indicated they may incorporate into ESG disclosure standards required of certain companies. As the nature, scope and complexity of ESG reporting, diligence and disclosure requirements expand, significant effort and expenses could be required to comply with the evolving requirements. As our disclosure obligations increase, third parties may make claims or bring litigation relating to those disclosures which may be costly. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Environmental, social and corporate governance (ESG) issues, including those related to climate change and sustainability, may have an adverse effect on our business and damage our reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">There is an increasing focus from certain investors, customers, consumers, employees and other stakeholders concerning ESG matters. Additionally, public interest and legislative pressure related to public companies&#8217; ESG practices continue to grow. If our ESG practices fail to meet regulatory requirements or investor, customer, consumer, employee or other stakeholders' evolving expectations and standards for responsible corporate citizenship in areas including environmental stewardship, support for local communities, Board of Director and employee diversity, human capital management, employee health and safety practices, product quality, supply chain management, corporate governance and transparency, our reputation, brand and employee retention may be negatively impacted, and our customers and suppliers may be unwilling to continue to do business with us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Customers, consumers, investors and other stakeholders are increasingly focusing on environmental issues, including climate change, energy and water use, plastic waste and other sustainability concerns. Concern over climate change or plastics and packaging materials, in particular, may result in new or increased legal and regulatory requirements to reduce or mitigate impacts to the environment. Changing customer and consumer preferences or increased regulatory requirements may result in increased demands or requirements regarding plastics and packaging materials, including single-use and non-recyclable plastic products and packaging, other components of our products and their environmental impact on sustainability, or increased customer and consumer concerns or perceptions (whether accurate or inaccurate) </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">regarding the effects of substances present in certain of our products. Complying with these demands or requirements could cause us to incur additional manufacturing, operating or product development costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If we do not adapt to or comply with new regulations, or fail to meet evolving investor, industry or stakeholder expectations and concerns regarding ESG issues, investors may reconsider their capital investment in our Company, and customers and consumers may choose to stop purchasing our products, which could have a material adverse effect on our reputation and business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">If we do not retain our key personnel and attract and retain other highly skilled employees, our business could suffer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">If we fail to recruit, develop and retain the necessary personnel, our business and our ability to obtain new customers, develop new products and provide acceptable levels of customer service could suffer. The success of our business is heavily dependent on the leadership of our key management personnel. Our success also depends on our ability to recruit, develop and retain and motivate highly skilled sales, marketing, manufacturing engineering and scientific personnel. Competition for these persons in our industry is intense, and we may not be able to successfully recruit, train or retain qualified personnel. We are experiencing increasing challenges in building and retaining our workforce in certain markets, where pressure from inflation and competition have exacerbated turnover and retention trends continuing from the COVID-19 pandemic. Labor shortages and competition for qualified personnel could cause disruptions in our business operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Provisions of our governing documents and Delaware law may have anti-takeover effects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Certain provisions of our Second Restated Certificate of Incorporation and Amended and Restated By-Laws may inhibit changes in control of the Company not approved by our Board of Directors. These provisions include&#160;advance notice requirements for stockholder proposals and nominations. We also have the protections of Section&#160;203 of the Delaware General Corporation Law, which could have anti-takeover effects. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Risks Relating to Government Regulation of Manufacture and Sale of Our Products and Services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Legislative or regulatory reforms in the United States, Europe or other countries may make it more difficult and costly for us to obtain regulatory clearances, approvals or certifications for our products or to manufacture, market or distribute our products after clearance or approval is obtained.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">From time to time, legislation is drafted and introduced in Congress that could significantly change the statutory provisions governing the regulation of drugs and medical devices. In addition, the FDA may change its premarket clearance and approval policies for drugs and medical devices, adopt additional regulations or revise existing regulations, or take other actions, which may prevent or delay approval or clearance of our future products under development or impact our ability to modify our currently cleared products on a timely basis. For example, over the last several years, the FDA has proposed reforms to its 510(k) clearance process, and such proposals could include increased requirements for clinical data and a longer review period, or could make it more difficult for manufacturers to utilize the 510(k) clearance process for their products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, FDA regulations and guidance are often revised or reinterpreted by the FDA in ways that may significantly affect our business and our products. Any new statutes, regulations or revisions or reinterpretations of existing regulations may impose additional costs or lengthen review times of any future products or make it more difficult to obtain clearance or approval for, manufacture, market or distribute our products. We cannot determine what effect changes in regulations, statutes, legal interpretation or policies, when and if promulgated, enacted or adopted may have on our business in the future. Such changes could, among other things, require additional testing prior to obtaining clearance or approval; changes to manufacturing methods; recall, replacement or discontinuance of our products; or additional record keeping.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In addition to traditional regulatory controls on drugs and medical devices, our business could be affected by emerging laws or regulations limiting our ability to offer certain of our products and services. For example, in the United States, the reversal by the U.S. Supreme Court of Roe v. Wade has raised concerns in the fertility industry that more restrictive laws could limit access to various reproductive services. New and emerging laws may be interpreted to limit access to contraceptive technologies or cryostorage services, which could adversely affect certain aspects of CooperSurgical&#8217;s business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In addition, the EU landscape concerning medical devices (including IVDs) has recently evolved. A new set of two EU regulations have been adopted on April 5, 2017. On May 26, 2021, the EU MDR became applicable and replaced previous directives and established transitional provisions. The EU IVDR became applicable on May 26, 2022. However, on October 14, 2021, the European Commission proposed a &#8220;progressive&#8221; roll-out of the EU IVDR to prevent disruption in the supply of IVDs. The European Parliament and Council adopted the proposed regulation on December 15, 2021. The </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">EU IVDR fully applies since May 26, 2022, but there is a tiered system extending the grace period for many devices (depending on their risk classification) before they have to be fully compliant with the regulation. Both regulations have been adopted to establish a uniform, transparent, predictable and sustainable regulatory framework across the EU for medical devices (including IVDs) and ensure a high level of safety and health while supporting innovation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">These modifications may have an effect on the way we intend to develop our business in the EU and EEA. For example, as a result of the transition towards the new regimes, notified body review times have lengthened, and product introductions could be delayed or canceled. Additionally, only a few notified bodies have been designated for EU IVDR certification, which could adversely affect our ability to grow our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Following the end of the &#8220;Brexit&#8221; transitional period, from January 1, 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) became the UK&#8217;s independent regulatory agency for medical devices. Post-Brexit, amendments have been made to the existing UK medical devices legislation which require medical devices to be registered with the MHRA before being placed on the Great Britain market. Manufacturers based outside of the UK need to appoint a UK Responsible Person to register devices with the MHRA. Following a government consultation on changes to the UK&#8217;s medical device regulations, the response to which was published on June 26, 2022, it is anticipated that the core aspects of the future regime will now apply from July 1, 2025 so that medical devices placed on the market in Great Britain (England, Scotland, and Wales) will require a UK Conformity Assessment (UKCA) mark. However, the MHRA has recently confirmed that, subject to certain conditions, general medical devices compliant with the EU medical devices directive (EU MDD) or EU active implantable medical devices directive (EU AIMDD) with a valid declaration and CE marking can be placed on the Great Britain market up until the sooner of expiry of certificate or June 30, 2028. IVDs with valid certification can continue to be placed on the market until the earlier of certificate expiry or June 30, 2030. In advance of the new regime, the government also intends to introduce specific legislation on post-market surveillance, with new provisions expected to apply from mid-2024. However, UKCA marking alone will not be recognized in the EU. The rules for placing medical devices on the Northern Ireland market will differ from those in Great Britain. These modifications may have an effect on the way we intend to conduct our business in these countries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our medical device products are subject to reporting requirements and recalls, even after receiving regulatory clearance, approval or certification, which could harm our reputation and business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">After a device is placed on the market, numerous regulatory requirements apply, including the FDA's QSR regulations, which require manufacturers to follow, among other things, design, testing, production, control, documentation and other quality assurance procedures during the manufacturing process; labeling regulations; and medical device reporting regulations that require us to report to FDA or similar governmental bodies in other countries if our products may have caused or contributed to a death or serious injury or malfunction in a way that would be reasonably likely to contribute to death or serious injury if the malfunction were to recur. The FDA and similar governmental bodies in other countries have the authority to require the recall of our products in the event of material deficiencies or defects in design or manufacture or in the event that a product poses an unacceptable risk to health. Medical device manufacturers, such as CooperVision and CooperSurgical, may, under their own initiative, recall a product if a reasonable possibility of serious injury or&#160;any material deficiency in a device is found, or withdraw a product to improve device performance or for other reasons. The FDA requires that certain corrections or removals, including recalls, be reported to the FDA within ten working days of initiating the correction or removal. Recalls of any of our products may divert managerial and financial resources and have an adverse effect on our financial condition and results of operations. A recall could harm our reputation with customers and consumers which could reduce the sales of our products. In addition, the FDA or other foreign governmental agencies may implement enforcement actions in connection with a recall which could impair our product offerings and be harmful to our business and financial results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">If our manufacturing operations fail to comply with applicable regulations, our manufacturing could be delayed or disrupted, our products could be subject to recall, and sales and profitability could suffer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Our manufacturing operations and processes are required to comply with numerous federal, state and foreign regulatory requirements, including the FDA's cGMP for medical devices, known as the QSR regulations, which govern the procedures related to the design, testing, production processes, controls, quality assurance, labeling, packaging, storage, importing, exporting and shipping of our products. We also are subject to state requirements and licenses applicable to manufacturers of medical devices. In addition, we must engage in extensive recordkeeping and reporting and must make available our manufacturing facilities and records for periodic unscheduled inspections by governmental agencies, including the FDA, state authorities and comparable agencies (as well as audits by notified bodies) in other countries. Failure to comply with QSR requirements and other applicable domestic or international regulatory requirements or to respond to any adverse inspectional observations or product safety issues could result in disruption of our operations and manufacturing delays in addition to, among other things, warning letters, significant fines, injunctions, suspension of approvals, seizures, recalls or import holds of products, operating restrictions and criminal prosecutions. As a result, any failure to comply with applicable requirements could adversely affect our product sales and profitability. </span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On February 23, 2022, the FDA issued a proposed rule to amend the QSR regulations to align more closely with the International Organization for Standardization standards. This proposal has not yet been finalized or adopted. Accordingly, it is unclear the extent to which this or any other proposals, if adopted, could impose additional or different regulatory requirements on CooperVision and CooperSurgical that could increase the costs of compliance or otherwise create competition that may negatively affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The manufacture of pharmaceutical therapeutics, such as Paragard, is complex and requires significant expertise and capital investment. We and our contract manufacturers must comply with cGMP regulations and guidelines. Manufacturers of pharmaceutical therapeutics often encounter difficulties in production, including difficulties with production costs and yields, quality control, quality assurance testing, operator error, shortages of qualified personnel, as well as compliance with strictly enforced federal, state and foreign regulations. Furthermore, if microbial, viral or other contaminations are discovered in our therapeutics or in the manufacturing facilities in which our therapeutics, if approved, are made, such manufacturing facilities may need to be closed for an extended period of time to investigate and remedy the contamination. We cannot be assured that any stability or other issues relating to the manufacture of any of our therapeutics will not occur in the future. Additionally, our manufacturers may experience manufacturing difficulties due to resource constraints or as a result of labor disputes or unstable political environments. If our manufacturers were to encounter any of these difficulties, or otherwise fail to comply with their contractual obligations, our ability to provide any therapeutic candidates to patients in clinical trials would be jeopardized. Any delay or interruption in the supply of clinical trial supplies could delay the completion of clinical trials, increase the costs associated with maintaining clinical trial programs and, depending upon the period of delay, require us to commence new clinical trials at additional expense or terminate clinical trials completely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Any adverse developments affecting clinical or commercial manufacturing of our therapeutics may result in shipment delays, inventory shortages, lot failures, therapeutic withdrawals or recalls, or other interruptions in the supply of our therapeutics or therapeutic candidates. We may also have to take inventory write-offs and incur other charges and expenses for therapeutics or therapeutic candidates that fail to meet specifications, undertake costly remediation efforts or seek more costly manufacturing alternatives. Accordingly, failures or difficulties faced at any level of our supply chain could materially adversely affect our business and delay or impede the development and commercialization of any of our therapeutics or therapeutic candidates and could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our failure to comply with regulatory requirements or to receive regulatory clearance, approval or certification for our products or operations could adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our products and operations are subject to rigorous regulation by the FDA, and numerous other federal, state and foreign governmental authorities. In the United States, the FDA regulates virtually all aspects of medical device and pharmaceutical design, development, testing, manufacture, safety, labeling (including, for example, unique device identifier regulations), storage, recordkeeping, reporting, marketing, promotion, advertising and distribution, as well as product import and export. Our failure to comply with FDA regulations could lead to the imposition of administrative or judicial sanctions, including injunctions, fines, warning letters, suspensions or the loss of regulatory approvals, product recalls, termination of distribution or product seizures. In the most egregious cases, criminal sanctions or closure of our manufacturing facilities are possible.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our medical devices and pharmaceutical products require clearance or approval by the FDA before they can be commercially distributed in the United States and may require similar approvals by foreign regulatory agencies before distribution in foreign jurisdictions. Medical devices and drug products may only be marketed for the indications for which they are approved or cleared. The process of obtaining, renewing and maintaining regulatory clearances and approvals to market a medical device, particularly from the FDA, can be costly and time consuming. We cannot be assured that such clearances and approvals will be granted on a timely basis, if at all, and significant delays in the introduction of any new products or product enhancements may occur, which could adversely affect our competitive position and results of operations. In addition, the FDA and authorities in foreign jurisdictions may change their policies, adopt additional regulations or revise existing regulations, each of which could prevent or delay premarket approval or clearance of our products, increase the cost of compliance, impose additional regulatory requirements on us, or otherwise impact our ability to market our currently approved or cleared products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Modifications and enhancements to medical devices also require a new FDA clearance or approval if they could significantly affect its safety or effectiveness or would constitute a major change in its intended use, design or manufacture. The FDA requires every medical device manufacturer to make this determination in the first instance, but the FDA may review any manufacturer's decision. We have made modifications and enhancements to our medical devices that we do not believe require a new clearance or application, but we cannot confirm that the FDA will agree with our decisions. If the FDA requires us to seek clearance or approval for a modification of a previously cleared product for which we have concluded that new clearances or approvals are unnecessary, we may be required to cease marketing or to recall the modified product until we obtain clearance or approval, and we may be subject to significant regulatory fines or penalties, which could have a material adverse effect on our financial results and competitive position. We also cannot assure that we will be successful in obtaining clearances or approvals for our modifications, if required.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our efforts to promote some of our products and services via direct-to-consumer marketing initiatives may subject us to additional scrutiny by the FDA, FTC or other agencies. For example, we promote Paragard and cord blood and cord tissue storage directly to end consumers. Regulatory agencies may scrutinize our practices with respect to effective communication of risk information, benefits or claims with respect to such products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Any failure to comply with ongoing regulatory requirements may significantly and adversely affect our ability to commercialize and generate revenue from our products and product candidates. If regulatory sanctions are applied or if regulatory approval is withdrawn, the value of our Company and our operating results may be adversely affected. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The FDA&#8217;s and other regulatory authorities&#8217; policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may be subject to enforcement action and we may not achieve or sustain profitability, which would adversely affect our business. We also cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative or executive action, either in the United States or abroad.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Subject to transitional provisions and in order to sell our products in the EU, our products must respectively comply with general safety and performance requirements of the EU MDR and the EU IVDR. Compliance with these requirements is a prerequisite to be able to affix the European Conformity (CE) mark to our products, without which they cannot be sold or marketed in the EU. All medical devices placed on the market in the EU must meet the general safety and performance requirements laid down in the Annexes to the EU MDR and EU IVDR including that a medical device must be designed and manufactured in such a way that, during normal conditions of use, it is suitable for its intended purpose. Medical devices must be safe and effective and must not compromise the clinical condition or safety of patients, or the safety and health of users and, where applicable, other persons, provided that any risks which may be associated with their use constitute acceptable risks when weighed against the benefits to the patient and are compatible with a high level of protection of health and safety, taking into account the generally acknowledged state of the art. To demonstrate compliance with the general safety and performance requirements we must undergo a conformity assessment procedure, which varies according to the type of medical device and its (risk) classification. Except for low-risk medical devices (Class I) or general IVDs (Class A), where the manufacturer can self-assess the conformity of its products with the general safety and performance requirements (except for any parts which relate to sterility, metrology or reuse aspects of a medical device), a conformity assessment procedure requires the intervention of a notified body. Notified bodies are independent organizations designated by EU member states to assess the conformity of devices before being placed on the market. A notified body would typically audit and examine a product&#8217;s technical dossiers and the manufacturer&#8217;s quality system (notified body must presume that quality systems which implement the relevant harmonized standards&#8212;ISO 13485:2016 for Quality Management Systems&#8212;conform to these requirements). If satisfied that the relevant product conforms to the general safety and performance requirements, the notified body issues an EU certificate, which the manufacturer uses as a basis for its own declaration of conformity. The manufacturer may then apply the CE mark to the device, which allows the device to be placed on the market throughout the EU. If we fail to remain in compliance with applicable EU laws, directives or regulations, we would be unable to continue to affix the CE mark to our products, which would prevent us from selling them within the EU and EEA. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In the EU, regulatory authorities have the power to carry out announced and, if necessary, unannounced inspections of companies, as well as suppliers and/or sub-contractors and, where necessary, the facilities of professional users. Failure to comply with regulatory requirements (as applicable) could require time and resources to respond to the regulatory authorities&#8217; observations and to implement corrective and preventive actions, as appropriate. Regulatory authorities have broad compliance and enforcement powers and if such issues cannot be resolved to their satisfaction can take a variety of actions, including untitled or warning letters, fines, consent decrees, injunctions, or civil or criminal penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The EU regulatory landscape concerning medical devices (including IVDs) has recently evolved and the new requirements may have a significant effect on the way we conduct our business in the EU and the EEA. Following Brexit, the UK regulatory landscape concerning medical devices (including IVDs) is evolving and may have a significant effect on the way we conduct our business in the UK. See Risk Factors &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:112%"> &#8220;Legislative or regulatory reforms in the United States or Europe may make it more difficult and costly for us to obtain regulatory clearances, approvals or certifications for our products or to manufacture, market or distribute our products after clearance or approval is obtained&#8221;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Development and marketing of our products are subject to strict governmental regulation by foreign regulatory agencies, and failure to receive, or delay in receiving, foreign qualifications or certifications could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In many of the foreign countries in which we market our products, we are subject to regulations affecting, among other things, product standards, packaging requirements, labeling requirements, import restrictions, tariff regulations, the reporting of certain payments to health care practitioners in certain markets (for example, the French anti-gift legislation), </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">duties and tax requirements. Many of the regulations applicable to our devices and products in such countries are similar to those of the FDA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The advertising and promotion of medical devices is subject to some general principles set forth in the EU legislation. Directive 2006/114/EC concerning misleading and comparative advertising and Directive 2005/29/EC on unfair commercial practices, while not specific to the advertising of medical devices, apply to the advertising thereof and contain general rules, for example, requiring that advertisements be evidenced, balanced and not misleading. Specific requirements are defined at a national level. EU member states&#8217; laws related to the advertising and promotion of medical devices, which vary between jurisdictions, may limit or restrict the advertising and promotion of products to the general public and may impose limitations on promotional activities with healthcare professionals.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In many countries, the national health or social security organizations require our products to be qualified before they can be marketed with the benefit of reimbursement eligibility. To date, we have not experienced difficulty in complying with these regulations. However, our failure to receive, or delays in the receipt of, relevant foreign qualifications could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Increased regulatory scrutiny of genetic testing may adversely affect our business through increased costs and risks associated with gaining marketing approvals or certifications and potential decreased demand for our genetic testing services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">We offer certain genetic testing services to help identify the likelihood of pregnancy as well as identify possible disorders or diseases of a child prior to birth. Regulatory and legislative proposals addressing oversight of genetic testing have been introduced in the United States, and we expect that new proposals will be introduced from time to time both in the United States and in foreign countries in the future. Although the FDA has statutory authority to assure that medical devices, including IVDs, are safe and effective for their intended uses, the FDA has historically exercised its enforcement discretion and not enforced applicable provisions of the FDCA and regulations with respect to laboratory developed tests (LDTs). The FDA defines LDTs as a type of in vitro diagnostic test that is designed, manufactured, and used within a single laboratory. We believe our tests fall within the definition of an LDT. As a result, we believe our tests are not currently subject to the FDA&#8217;s enforcement of its medical device regulations and the applicable FDCA provisions. However, if there are changes in the FDA&#8217;s policy, or if the FDA disagrees that our marketed tests are LDTs or that we are marketing our tests outside the scope of the FDA&#8217;s current policy of enforcement discretion, we may become subject to extensive regulatory requirements and may be required to stop selling our existing tests or launching any other tests we may develop and to conduct additional clinical trials or take other actions prior to continuing to market our tests. This could significantly increase the costs and expenses of conducting, or otherwise harm, our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Legislative proposals addressing the FDA&#8217;s oversight of LDTs have been introduced by Congress in the past and new legislative proposals may be introduced from time to time in the future. The likelihood that Congress will pass such legislation and the extent to which such legislation may affect the FDA&#8217;s ability to enforce its medical device regulations with respect to certain LDTs is difficult to predict at this time. If the FDA ultimately begins to enforce its medical device requirements with respect to LDTs, our genetic tests may be subject to additional regulatory requirements imposed by the FDA, the nature and extent of which would depend upon applicable final guidance or regulation by the FDA or instruction by Congress. For example, as part of the Spring 2023 Unified Agenda, the FDA published a proposed rule to the Office of Management and Budget to amend FDA regulations to make explicit that LDTs are devices under the FDCA. If the FDA imposes significant changes to the regulation of LDTs it could reduce our revenue or increase our costs and adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Any new FDA enforcement policies affecting LDTs or new legislation, regulations such as the EU IVDR regulation may result in increased regulatory burdens on our ability to continue marketing our genetic products and to develop and introduce new products in the future, which could reduce our revenue or increase our costs and adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In addition, changes in the way the EU regulates LDTs could result in additional expenses for offering our current and any future tests or possibly delay or suspend development or commercialization of such tests. In the EU, the regulatory landscape has recently evolved and the general safety and performance requirements set out in the EU Good Manufacturing Practice guidelines are also applicable to devices manufactured and used only within health institutions. Manufacturers of such devices are required to demonstrate conformity with the general safety and performance requirements through performance evaluations and the manufacturer&#8217;s quality management system framework. The EU IVDR provides that, with the exception of the relevant general safety and performance requirements, the requirements imposed by the EU IVDR on in vitro diagnostic medical devices do not generally apply to devices manufactured and used only within health institutions established in the EU, provided that certain conditions are met. Under the EU IVDR, health institutions may manufacture, modify and use medical devices within such institutions, thereby addressing the specific needs of target patient groups on a non-industrial scale. Under such circumstances, where the LDTs are manufactured and used strictly within health institutions (which may include hospitals, laboratories, public health institutions that support the healthcare system and/or address patient needs but do not treat or care for patients directly), LDTs would continue to be </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">exempt from regulation. However, compared to the EU IVDD, the exemptions for LDTs will, overall, be narrowed, as even in relation to LDTs, health institutions&#8212;among others&#8212;are required to provide information upon request on the use of such devices to their competent authority and each health institution will have to draw up a declaration which it will make publicly available. If these conditions are not met and/or diagnostic tests are manufactured and used only within health institutions but &#8220;on an industrial scale,&#8221; such tests will qualify as in vitro diagnostic medical devices with the full applicability of the EU IVDR. LDTs regulated by the EU IVDR will be subject to conformity assessments and inspections by the relevant competent authority, who will also review the declarations and statements made by the health institutions in relation to their LDTs. If our tests do not qualify for an exemption, we may be subject to the full application of the EU IVDR with respect to some or all of our existing, as well as future, tests, and we would be required to expend additional time and resources to complying with the requirements of the EU IVDR.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">If we fail to comply with applicable federal, state, local and foreign laboratory licensing requirements, we could lose the ability to perform our genetic tests or experience disruptions to our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are subject to the Clinical Laboratory Improvement Amendments of 1988 (CLIA), a federal law regulating clinical laboratories that perform testing on specimens derived from humans for the purpose of providing information for the diagnosis, prevention or treatment of disease. Our clinical laboratories must be certified under CLIA and ISO 15189 in order for us to perform testing on human specimens. In addition, our proprietary tests must also be recognized as part of our accredited programs under CLIA so that we can offer them in our laboratory. CLIA is intended to ensure the quality and reliability of clinical laboratories in the United States by mandating specific standards in the areas of personnel qualifications, administration, and participation in proficiency testing, patient test management, quality control, quality assurance and inspections. The law also requires us to maintain a state laboratory license to conduct testing in that state. In addition, we are subject to the UK Human Fertilization &amp; Embryology Association (HFEA) regulating IVF. Our laboratories are located in Japan, the United Kingdom and United States, and we must maintain the requisite licenses in each jurisdiction.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Any sanction imposed under CLIA, its implementing regulations, or state or foreign laws or regulations governing licensure, or our failure to renew a CLIA certificate, a state or foreign license or accreditation, could have a material and adverse effect on our diagnostic testing business, operating results and financial condition. The CMS also has the authority to impose a wide range of sanctions, including revocation of the CLIA certification along with a bar on the ownership or operation of a CLIA-certified laboratory by any owners or operators of the deficient laboratory. If we were to lose our CLIA certification or required state or foreign licensure, we would not be able to operate our clinical laboratory and conduct our tests, worldwide or in particular jurisdictions, which would adversely impact our diagnostic testing business, operating results, and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our HCT/P products are subject to extensive government regulation and our failure to comply with these requirements could cause our business to suffer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the United States, we provide donor egg and sperm for fertility treatments, in addition to fertility cryopreservation services and newborn stem cell storage (cord blood and cord tissue). Donated reproductive tissues, including eggs and sperm, as well as cord blood and cord tissue, are regulated to by the FDA as human cells, tissues and cellular or tissue-based products (HCT/Ps). In the United States, we are marketing these HCT/Ps pursuant to Section 361 of the Public Health Service Act (PHSA) and 21 C.F.R. Part 1271 of FDA&#8217;s regulations. The so-called &#8220;361 HCT/Ps&#8221; are not currently subject to the FDA requirements to obtain marketing authorizations, so long as they meet certain criteria set forth in FDA regulations. However, HCT/Ps regulated as 361 HCT/Ps are currently subject to requirements relating to registering facilities and listing products with the FDA, as well as stringent requirements relating to processing, storing, labeling and distributing HCT/Ps, including, screening and testing for tissue donor eligibility, providing required labeling information, record keeping and adverse event reporting. If we fail to comply with these requirements, we could be subject to FDA allegations of noncompliance or enforcement action, including, for example, warning letters, fines, injunctions, product recalls or seizures, and, in the most serious cases, criminal penalties. To be regulated as 361 HCT/Ps, these products must meet the FDA&#8217;s criteria to be considered &#8220;minimally manipulated&#8221; and intended for &#8220;homologous use,&#8221; among other requirements. HCT/Ps that do not meet the criteria to be considered 361 HCT/Ps are subject to the FDA&#8217;s regulatory requirements applicable to medical devices, biologics or drugs, including, importantly, the requirement for premarket review and approval or clearance prior to marketing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We believe our HCT/Ps are regulated solely under Section 361 of the PHSA, and therefore, we have not sought or obtained 510(k) clearance, PMA approval, or licensure through a Biologics License Application (BLA) for such HCT/Ps. However, the FDA could disagree with our determination that these human tissue products are 361 HCT/Ps and could determine that these products are biologics requiring a BLA or medical devices requiring 510(k) clearance or PMA approval, and could require that we cease marketing such products and/or recall them pending appropriate clearance, approval or licensure from the FDA, which would adversely affect our business. </span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, the FDA may in the future modify the scope of its enforcement discretion with respect to 361 HCT/Ps or change its position on which current or future products qualify as 361 HCT/Ps, or determine that some or all of our HCT/P products may not be lawfully marketed without a marketing authorization. Any regulatory changes could have adverse consequences for us and make it more difficult or expensive for us to conduct our business by requiring pre-market clearance or approval and compliance with additional post-market regulatory requirements with respect to those products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Disruptions at the FDA and other government agencies or notified bodies caused by funding shortages or global health concerns could hinder their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified products from being developed, cleared or approved or commercialized in a timely manner or at all, which could negatively impact our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The ability of the FDA, foreign agencies and notified bodies to review and clear, approve or certify new products can be affected by a variety of factors, including government budget and funding levels, statutory, regulatory, and policy changes, the FDA&#8217;s, foreign agencies&#8217; and notified bodies&#8217; ability to hire and retain key personnel and accept the payment of user fees, and other events that may otherwise affect the FDA&#8217;s, foreign agencies&#8217; and notified bodies&#8217; ability to perform routine functions. Average review times at the FDA, foreign agencies and notified bodies have fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable. Disruptions at the FDA, foreign agencies and notified bodies and other agencies may also slow the time necessary for new drugs and medical devices or modifications to cleared or approved drugs and medical devices to be reviewed, approved and/or certified by necessary government agencies or notified bodies, which would adversely affect our business.&#160;For example, over the last several years, the United States government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical employees and stop critical activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Separately, in response to the COVID-19 pandemic, the FDA postponed most inspections of foreign and domestic manufacturing facilities. Even though the FDA has since resumed standard inspection operations of domestic facilities where feasible, the FDA has continued to monitor and implement changes to its inspectional activities to ensure the safety of its employees and those of the firms it regulates as it adapts to the evolving COVID-19 pandemic, and any resurgence of the virus or emergence of new variants may lead to further inspectional delays. Regulatory authorities outside the United States have adopted similar restrictions or other policy measures in response to the COVID-19 pandemic. If a prolonged government shutdown occurs, or if global health concerns continue to prevent the FDA, other regulatory authorities, or notified bodies from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA, other regulatory authorities or notified bodies to timely review and process our regulatory submissions, which could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In the EU, notified bodies must be officially designated to certify products and services in accordance with the EU MDR and EU IVDR. Several notified bodies have been designated under the EU MDR but only a few notified bodies have been designated under the EU IVDR so far. The COVID-19 pandemic has significantly slowed down their designation process and the current designated notified bodies are facing a large amount of requests with the new regulations, as a consequence of which review times may have lengthened. This situation may impact the ability of our notified body to timely review and process our regulatory submissions and perform its audits. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Ethical, legal and social concerns related to the use of genetic information, sperm and egg selection services and stem cells could reduce demand for our service offerings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Genetic testing, sperm and egg selection services and the use of stem cells have raised ethical, legal and social issues regarding privacy and the appropriate uses of information related to these services. Government authorities could, for social or other purposes, limit or regulate the use of genetic information or genetic testing or prohibit testing for genetic predisposition to certain conditions, particularly for those that have no known cure. They also could limit, regulate or prohibit (1) sperm and egg selection services or (2) the use of stem cells. Ethical, legal or social concerns may lead patients to refuse to use, or physicians to be reluctant to order or recommend, genetic tests, sperm and egg selection services and stem cell storage services even if permissible. These and other ethical, legal and social concerns may limit market acceptance and adoption of our service offerings or reduce the potential markets for our service offerings, either of which could have an adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">The costs of complying with the requirements of federal, state and foreign laws pertaining to the privacy and security of personal information, including health related information and the potential liability associated with failure to do so could materially adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Numerous laws and regulations govern the collection, dissemination, use, privacy, confidentiality, security, availability and integrity of personally identifiable information (PII), including protected health information (PHI). We collect and process PII in multiple ways in our various business lines and are subject to risk associated with compliance with many of these laws and regulations. Some of our businesses expose us to increasingly stringent regulations for handling personal information (where, for example, we collect or process PII deemed to be sensitive by regulatory authorities, such as PHI). </span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Under U.S. law, HIPAA establishes national privacy and security standards for protection of PHI by covered entities and the business associates with whom such entities contract for services. HIPAA requires both covered entities and business associates to develop and maintain policies and procedures for PHI that is used or disclosed, and to adopt administrative, physical and technical safeguards to protect PHI. Mandatory penalties for HIPAA violations can be significant. A single breach incident can result in violations of multiple standards. If a person knowingly or intentionally obtains or discloses PHI in violation of HIPAA requirements, criminal penalties may also be imposed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We maintain technical, organizational and contractual safeguards that we believe are reasonable and appropriate to protect the privacy and security of PHI and other personally identifiable information consistent with applicable laws and our contractual obligations; however, we may not be able to prevent incidences of inappropriate use or unauthorized access to PHI by our employees, contractors or external factors, despite the safeguards. Any such breaches of our systems or those of our vendors, customers or other third parties could result in exposure to liability under federal and state laws and/or under our contractual arrangements and could adversely impact our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are also subject to various other laws in the United States such as Section 5(a) of the Federal Trade Commission Act, which requires a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities and the CCPA, which gives California residents certain rights to access and delete their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is used. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that has increased the likelihood of, and risks associated with data breach litigation. Further, the California Privacy Rights Act, which went into effect on January 1, 2023, significantly amends the CCPA and imposes additional data protection obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk processing, and opt outs for certain uses of sensitive data. It also creates a new California data protection agency authorized to issue substantive regulations and could result in increased privacy and information security enforcement. Similar laws have been proposed or enacted in other states and at the federal level, and when passed, such laws may have potentially conflicting requirements that would make compliance challenging.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">We are also subject to laws and regulations in countries other than United States covering data privacy and the protection of health-related and other personal information. EU and EEA member states and other jurisdictions have adopted data protection laws and regulations, which impose significant compliance obligations. For example, the GDPR imposes stringent operational requirements for processors and controllers of personal data in the context of an establishment in the EEA or the processing of personal data of individuals within the EEA and increases the scrutiny of transfer of personal data from the EEA. Following the UK's withdrawal from the EEA and the EU, and the expiry of the transition period, companies will have to comply with the GDPR and the GDPR as incorporated into the UK national law (the UK GDPR). In addition, countries of the EEA may impose further obligations relating to the processing of genetic, biometric or health data, which could further add to our compliance costs and limit how we process this information. Some of the personal data we process in respect of clinical trial participants is special category or sensitive personal data under the GDPR, and subject to additional compliance obligations and to local law derogations. We may be subject to diverging requirements under EU member state laws and UK law. We are also subject to China's Personal Information Protection Law (PIPL), which imposes requirements regarding processing PII, data localization and cross-border transfers of PII, as well as a number of other laws in the Asia Pacific area, As these laws develop, we may need to make operational changes to adapt to these diverging rules, which could increase our costs and adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Compliance with U.S. and foreign privacy and security laws, rules and regulations could require us to take on more onerous obligations in our contracts, require us to engage in costly compliance exercises, restrict our ability to collect, use and disclose data, or in some cases, impact our or our partners&#8217; or suppliers&#8217; ability to operate in certain jurisdictions. Each of these constantly evolving laws can be subject to varying interpretations. Any failure or perceived failure by us to comply with privacy or security laws, policies, legal obligations or industry standards or any security incident that results in the unauthorized release or transfer of PII may result in governmental enforcement actions and investigations including by European Data Protection Supervisory Authorities, fines and penalties, litigation, orders to cease or change our data processing activities, enforcement notices, assessment notices for a compulsory audit and/or civil claims</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(including class actions), adverse publicity and reputational damage.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Such failures could have a material adverse effect on our financial condition and operations. If the third parties we work with violate applicable laws, contractual obligations or suffer a security breach, such violations may also put us in breach of our obligations under privacy laws and regulations and could in turn have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">When we acquire companies or business that engage personal data processing, we may become subject to additional regulation or scrutiny, particularly if such activity is different in nature from what we have done in the past. For example, with the recent addition of cord blood and cord tissue storage (and other cryostorage) businesses, we interact directly with our customers and collect and maintain personal information regarding our customers and donors. Acquisitions like this could subject us to additional regulatory and consumer liability risk and the cost of analyzing and integrating new privacy compliance programs.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Changes in legislation and government regulation of the health care industry both in the United States and internationally, as well as third-party payors' efforts to control the costs of health care could materially adversely affect our business.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The ACA made extensive changes to the delivery of health care in the United States. Among the provisions of the ACA, of greatest importance to the medical device industry and pharmaceutical industry are the following:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Establishment of the Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Payment system reforms including a national pilot program on payment bundling to encourage hospitals, physicians and other providers to improve the coordination, quality and efficiency of certain health care services through bundled payment models;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Establishment of a Center for Medicare &amp; Medicaid Innovation at CMS to test innovative payment and service delivery models to lower Medicare and Medicaid spending; and</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">An increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program to 23.1% and 13% of the average manufacturer price for most branded and generic drugs, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">These measures could result in decreased net revenues or increased expenses from our fertility, office and surgical portfolios and decrease potential returns from our development efforts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Other legislative changes have been proposed and adopted since the ACA was enacted. The Budget Control Act of 2011, among other things, included aggregate reductions to Medicare payments to providers. In addition, the Medicare Access and CHIP Reauthorization Act of 2015, among other things, repealed the formula by which Medicare made annual payment adjustments to physicians and replaced the former formula with fixed annual updates and a new system of incentive payments began in 2019 that are based on various performance measures and physicians&#8217; participation in alternative payment models such as accountable care organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Other legislative changes have been proposed and adopted in the United States since the ACA was enacted. For example, on March 11, 2021, President Biden signed the American Rescue Plan Act of 2021 into law, which eliminates the statutory Medicaid drug rebate cap, currently set at 100% of a drug&#8217;s average manufacturer price (AMP), beginning January 1, 2024. Most recently, on August 16, 2022, the Inflation Reduction Act of 2022, or IRA, was signed into law. Among other things, the IRA requires manufacturers of certain drugs to engage in price negotiations with Medicare (beginning in 2026), with prices that can be negotiated subject to a cap; imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation (first due in 2023); and replaces the Part D coverage gap discount program with a new discounting program (beginning in 2025). The IRA permits the Secretary of the Department of Health and Human Services (HHS) to implement many of these provisions through guidance, as opposed to regulation, for the initial years. For that and other reasons, it is currently unclear how the IRA will be effectuated and the impact of the IRA on the pharmaceutical industry cannot yet be fully determined.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In foreign countries where we market our products, recent healthcare reform has taken place as well. For instance, in December 2021, the EU Regulation No 2021/2282 on Health Technology Assessment (HTA) amending Directive 2011/24/EU was adopted. While the regulation entered into force in January 2022, it will only begin to apply from January 2025 onwards, with preparatory and implementation-related steps to take place in the interim. Once the regulation becomes applicable, it will have a phased implementation depending on the concerned products. This regulation intends to boost cooperation among EU member states in assessing health technologies, including certain high-risk medical devices, and providing the basis for cooperation at the EU level for joint clinical assessments in these areas. The regulation will permit EU member states to use common HTA tools, methodologies, and procedures across the EU, working together in four main areas, including joint clinical assessment of the innovative health technologies with the most potential impact for patients, joint scientific consultations whereby developers can seek advice from HTA authorities, identification of emerging health technologies to identify promising technologies early, and continuing voluntary cooperation in other areas. Individual EU member states will continue to be responsible for assessing non-clinical (e.g., economic, social, ethical) aspects of health technologies, and making decisions on pricing and reimbursement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We expect that additional state, federal and foreign health care reform measures will be adopted in the future, including those initiatives affecting coverage and reimbursement for our products, any of which could limit the amounts that federal state and foreign governments will pay for health care products and services, which could adversely affect the growth of the market for our products or demand for our products, or result in additional pricing pressures. Also, any adoption of health care reform proposals on a state-by-state basis could require us to develop state-specific marketing and sales approaches. We cannot predict the effect such reforms or the prospect of their enactment may have on our business.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, third-party payors, whether governmental or commercial, whether inside the United States or abroad, increasingly attempt to contain or reduce the costs of health care. These cost-control methods include prospective payment systems, capitated rates, group purchasing, redesign of benefits, requiring pre-authorizations or second opinions prior to certain medical procedures, encouragement of healthier lifestyles and exploration of more cost-effective methods of delivering health care. Although cost controls or other requirements imposed by third-party payors have not historically had a significant effect on contact lens prices or distribution practices, this could change in the future and could adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We may enroll as in-network providers and suppliers with certain payors. Although, becoming an in-network provider or enrolling as a supplier means that we have agreed with these payors to provide certain of our tests at negotiated rates, it does not obligate any physicians to order our tests or guarantee that we will receive reimbursement for our tests from these or any other payors at adequate levels. Thus, these payor relationships, or any similar relationships we may establish in the future, may not result in acceptable levels of reimbursement for our tests or meaningful increases in our physician customer base. We cannot predict whether, under what circumstances, or at what payment levels payors will cover and reimburse for our tests. If we fail to establish and maintain broad coverage and reimbursement for our tests, our ability to generate increased revenue and grow our test volume and customer base could be limited and our future prospects and our business could suffer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Laws pertaining to health care fraud and abuse could materially adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We may be subject to various federal, state and foreign laws pertaining to health care fraud and abuse, including anti-kickback, physician self-referral false claims and physician payment transparency laws and regulations. These laws may constrain the business or financial arrangements and relationships through which we conduct our operations, including our commercial laboratory operations and how we research, market, sell and distribute any products for which we obtain marketing approval. Such laws include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the federal Anti-Kickback Statute, which prohibits, among other things, persons or entities from knowingly and willfully soliciting, offering, receiving or providing any remuneration (including any kickback, bribe or certain rebates), directly or indirectly, overtly or covertly, in cash or in kind, in return for, either the referral of an individual or the purchase, lease, or order, or arranging for or recommending the purchase, lease, or order of any good, facility, item or service, for which payment may be made, in whole or in part, under a federal healthcare program such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it in order to have committed a violation;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the federal physician self-referral prohibitions, commonly known as the Stark Law, which generally prohibit entities from billing a patient or the Medicare or Medicaid programs for certain designated health services, including clinical laboratory services, when the physician ordering the service, or any member of such physician&#8217;s immediate family, has a financial interest, such as an ownership or investment interest in or compensation arrangement with us, unless the arrangement meets an exception to the prohibition. These prohibitions apply regardless of any intent by the parties to induce or reward referrals or the reasons for the financial relationship and the referral;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the federal false claims laws, including the civil False Claims Act, and civil monetary penalties laws, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, to the federal government, claims for payment or approval that are false or fraudulent, or knowingly making, using or causing to be made or used, a false record or statement material to a false or fraudulent claim, or knowingly making or causing to be made a false statement to avoid, decrease or conceal an obligation to pay money to the federal government. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute or Stark Law constitutes a false or fraudulent claim for purposes of the civil False Claims Act;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the federal Health Insurance Portability and Accountability Act of 1996, which imposes criminal and civil liability for, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, or knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement, in connection with the delivery of, or payment for, healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:14.68pt">the federal Physician Payments Sunshine Act, which requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) to report annually to the CMS, information related to payments and other &#8220;transfers of value&#8221; made to physicians (defined to include doctors, dentists, optometrists, podiatrists and </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">chiropractors), certain non-physician practitioners including physician assistants and nurse practitioners, and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members; and</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws, which may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers and self-pay patients; some state laws that require biotechnology companies to comply with the industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government and may require drug and device manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; some state laws that require biotechnology companies to report information on the pricing of certain drug products; and some state and local laws that require the registration of sales representatives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, federal government price reporting laws, among other things, require us to calculate and report complex pricing metrics to government programs, where such reported prices may be used in the calculation of reimbursement and/or discounts on our marketed drugs. Participation in these programs and compliance with the applicable requirements may subject us to potentially significant discounts on our products, increased infrastructure costs and potentially limit our ability to offer certain marketplace discounts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Violations of these laws are punishable by criminal and civil sanctions, including, in some instances, exclusion from participation in federal and state health care programs, including Medicare, Medicaid, Veterans Administration health programs and TRICARE. Similarly, if the physicians or other providers or entities with whom we do business are found to be non-compliant with applicable laws, they may be subject to sanctions, which could indirectly have a negative impact on our business, financial condition and results of operations. Because of the complex and far-reaching nature of these laws, we cannot be assured that we would not be required to alter one or more of our practices to be in compliance with these laws. Any violations of these laws or regulations could result in a material adverse effect on our business, financial condition and results of operations. In addition, changes in these laws, regulations, or administrative or judicial interpretations, may require us to further change our business practices or subject our existing business practices to legal challenges, which could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Risks Relating to Interest and Foreign Exchange Rates, Debt and Equity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Exchange rate fluctuations and foreign currency hedges could adversely affect our financial results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As a result of our international operations, currency exchange rate fluctuations may affect our results of operations and financial position. Our most significant currency exposures are the British pound, Euro and Japanese yen. We expect to generate an increasing portion of our revenue and incur a significant portion of our expenses in currencies other than U.S. dollars. To the extent we are unable to materially offset non-functional currency flows, exchange rate fluctuations could have a positive or negative impact on our financial condition and results of operations. Because our consolidated financial results are reported in U.S. dollars, if we generate sales or earnings in other currencies, the translation of those results into U.S. dollars can result in a significant increase or decrease in the amount of those sales or earnings and can make it more difficult for our stockholders to understand the relative strengths or weaknesses of the underlying business on a period-over-period comparative basis. Although we may enter into foreign exchange agreements with financial institutions to reduce our net exposure to fluctuations in foreign currency values relative to our non-functional currency obligations or balances, they would not eliminate that risk entirely. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We are vulnerable to interest rate risk with respect to our debt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">We are subject to interest rate risk in connection with the issuance of variable and fixed-rate debt. In order to maintain a desired mix of fixed-rate and variable-rate debt, from time to time we may use interest rate swap agreements to fix a portion of our variable-rate debt as further described in Note 13. Financial Derivatives and Hedging of the Consolidated Financial Statements. We may not be successful in structuring such swap agreements to manage our risks effectively, which could adversely affect our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Effective February 1, 2023, the Company transitioned its credit agreements from the London Interbank Offered Rate&#160;(LIBOR) to the Secured Overnight Financing Rate ("SOFR"). The Company adopted this guidance prospectively on February 1, 2023, and it did not have a material impact on our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our indebtedness could adversely affect our financial health and prevent us from fulfilling our debt obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have now and expect to continue to have a significant amount of indebtedness. </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our indebtedness could:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">increase our vulnerability to general adverse economic and industry conditions;</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing the availability of our cash flow to fund working capital, capital expenditures, acquisitions, research and development efforts and other general corporate purposes;</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">place us at a competitive disadvantage compared to our competitors that have less debt;</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">result in greater interest rate risk and volatility;</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">limit our ability to borrow additional funds; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">make it more difficult for us to satisfy our obligations with respect to our debt, including our obligation to repay our credit facilities under certain circumstances, or refinance our indebtedness on favorable terms or at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our credit facilities contain financial and other restrictive covenants that could limit our ability to engage in activities that may be in our long-term best interests. Our failure to comply with those covenants could result in an event of default which, if not cured or waived, could result in the acceleration of all of our debt, which could adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Volatility in the securities markets, interest rates, and other factors could substantially increase our defined benefit plan costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We sponsor a defined benefit plan for certain employees in the United States. This defined benefit plan is funded with trust assets invested in a diversified portfolio of securities and other investments. Changes in interest rates, mortality rates, early retirement rates, investment returns, discount rates and the market value of plan assets can affect the funded status of our defined benefit plan and cause volatility in the net periodic benefit cost and future funding requirements of the plan. A significant increase in our obligations or future funding requirements could increase our cash requirements and adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Risks Relating to Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Changes in tax laws, examinations by tax authorities, and changes in our geographic composition of income could adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Income taxes and other taxes are based on enacted tax laws and the results of operations in each jurisdiction. Taxes could significantly increase due to changes in tax laws or changes in our interpretation of those laws. Changes in tax laws could result from a framework being developed by the Organisation for Economic Co-operation and Development (OECD), a global policy forum, that, if implemented, includes a global minimum tax rate of 15%. Taxes could also significantly increase due to changes in accounting guidance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Income taxes and other taxes could significantly increase based on the resolution of tax authority examinations. Tax authorities could challenge our interpretations of tax laws and estimates we use to calculate taxes. Tax authorities could also challenge our positions related to transfer pricing and intercompany transactions, including the valuation of intangible assets. Tax examinations can result in costly litigation with significant interest and penalties and ultimate settlement can take several years. For example, we have engaged (and expect to continue to engage) with tax authorities over tax positions we have taken in connection with acquisitions, and such examinations could cause us to incur significant expense (and adverse determinations by the tax authority could result in penalties).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Our effective tax rate could fluctuate based on the geographic composition of income, which could significantly change based on our business results and acquisitions. Our effective tax rate could also fluctuate based on changes in estimates, changes in excess tax benefits from share-based compensation, changes in non-deductible expenses, and the valuation of deferred tax assets and liabilities. These fluctuations could have an adverse effect on our business.</span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_22"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 1B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Unresolved Staff Comments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">None.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_25"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Properties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following is a summary of Cooper's principal facilities as of October&#160;31, 2023. We generally lease our office and operations facilities but own several manufacturing and research and development facilities, including 303,872 square feet in the United Kingdom, 347,329 square feet in Costa Rica, 115,000 square feet in Puerto Rico, 493,833 square feet in New York, 80,000 square feet in Arizona and 34,453 square feet in Texas. The following table lists those properties that we lease. Our lease agreements expire at various dates through the year 2045. We believe our properties are suitable and adequate for our businesses. </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Location</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Approximate Leased</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Square Feet</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Operations</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">AMERICAS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;California  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">200,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Executive offices; CooperVision manufacturing, research &amp; development and administrative offices; CooperSurgical research &amp; development, distribution and administrative offices</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">132,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision and CooperSurgical distribution and administrative offices</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">New Jersey</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">37,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical research and development, distribution and administrative offices</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Connecticut</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">275,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical distribution and administrative offices</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Arizona</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision manufacturing and distribution</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Puerto Rico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">740,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision manufacturing, research and development and distribution</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,836&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision manufacturing and administrative office; CooperSurgical research &amp; development, distribution and administrative offices</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution and administrative office</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">58,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution and administrative offices; CooperSurgical research &amp; development, distribution and administrative offices</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">667,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision manufacturing, distribution, research &amp; development and administrative offices; CooperSurgical research &amp; development, administrative offices</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">330,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision manufacturing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">282,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">181,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution and administrative office; CooperSurgical administrative office</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">279,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision administrative offices; CooperSurgical research &amp; development and distribution</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">148,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution and administrative offices; CooperSurgical administrative offices</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">ASIA PACIFIC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">109,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution and administrative offices; CooperSurgical laboratory/research &amp; development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision marketing and distribution; CooperSurgical research &amp; development and distribution</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution, marketing and administrative offices; CooperSurgical marketing and administrative office</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_28"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Information regarding legal proceedings is included in Note 11. Contingencies of the Consolidated Financial Statements.</span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_31"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Mine Safety Disclosures.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_34"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Cooper's common stock, par value $0.10 per share, is traded on the Nasdaq under the symbol &#8220;COO.&#8221; Prior to September 26, 2023, Cooper's common stock traded on the New York Stock Exchange under the symbol "COO". At December&#160;1, 2023, there were 256 common stockholders of record.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Dividend Policy</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the past, we have paid annual cash dividends on our common stock of $0.06 per share, in two semiannual payments of $0.03 per share each. In dollar terms, we paid cash for dividends of $3.0&#160;million in each of fiscal 2023 and 2022. Dividends are paid when, as and if declared at the discretion of our Board of Directors from funds legally available for that purpose. Our Board of Directors considers the Company's earnings, financial condition, liquidity needs, business plans and opportunities and other factors in determining whether to declare a dividend. In December 2023, our Board of Directors decided to end the declaration of the semiannual dividend.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Performance Graph</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following graph compares the cumulative total return on Cooper's common stock with the cumulative total return of the Standard &amp; Poor 500 and the Standard&#160;&amp; Poor's Health Care Equipment Index for the five-year period ended October&#160;31, 2023. The graph assumes that the value of the investment in Cooper and in each index was $100 on October&#160;31, 2018, and assumes that all dividends were reinvested. </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Among The Cooper Companies, Inc., </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">the S&amp;P 500 Index and the S&amp;P Health Care Equipment Index</span></div><div style="text-align:justify"><span><br/></span></div><div><img src="coo-20231031_g2.jpg" alt="1453" style="height:360px;margin-bottom:5pt;vertical-align:text-bottom;width:600px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">*$100 invested on October&#160;31, 2018, in stock or index, including reinvestment of dividends.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Fiscal year ending October 31.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Copyright&#169; 2023 Standard &amp; Poor's, a division of S&amp;P Global. All rights reserved.</span></div><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_40"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">There was no share repurchase activity during the three-month period ended October&#160;31, 2023.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_43"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth certain information as of October&#160;31, 2023, concerning the shares of our Common Stock that may be issued under any form of award granted under our equity compensation plans in effect as of October&#160;31, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.140%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Plan Category</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(A)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(B)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column A)<br/>(C)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity compensation plans approved by shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,505,841</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$277.29</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,325,881</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity compensation plans not approved by shareholders</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,505,841</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$277.29</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,325,881</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Includes (i) 290,029 shares subject to outstanding Restricted Stock Units (RSU), (ii) 138,256 shares subject to Performance Share Units (PSU), calculated at the maximum potential payout and (iii) 1,077,556 shares subject to outstanding options.  Does not include rights to purchase shares under the 2019 Employee Stock Purchase Plan (2019 ESPP).  </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> The weighted-average exercise price is calculated based solely on the exercise prices of outstanding options and do not reflect shares to be issued upon the vesting of RSUs and PSUs, which have no exercise price.</span></div><div style="padding-left:13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> Includes information with respect to the Third Amended and Restated 2007 Long Term Incentive Plan for Employees (2007 Plan), the 2023 Long-Term Incentive Plan (2023 Plan), which replaces the 2007 Plan, and the 2019 ESPP, as discussed in Note 9. Stock Plans of the Consolidated Financial Statements. Also includes information from the 2020 Long Term Incentive Plan for Non-Employee Directors (2020 Directors' Plan). As of October&#160;31, 2023, up to 1,376,240 shares of Common Stock may be issued pursuant to the 2023 Plan, up to</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">921,974</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">hares of Common Stock may be issued pursuant to the 2019 ESPP and up to</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">27,667</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">shares of Common Stock may be issued pursuant to the 2020 Directors' Plan. </span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_46"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Reserved</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_49"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:underline">Note numbers refer to &#8220;Notes to Consolidated Financial Statements&#8221; in Item&#160;8. Financial Statements and Supplementary Data.</span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_52"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In this section, we discuss the results of our operations for fiscal 2023 compared with fiscal 2022. We discuss our cash flows and current financial condition under &#8220;Capital Resources and Liquidity.&#8221; For a discussion related to fiscal 2022 compared with fiscal 2021, please refer to Item 7 of Part II, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our Annual Report on Form 10-K for the year ended October&#160;31, 2022, which was filed with the United States Securities and Exchange Commission (SEC) on December 9, 2022, and is available on the SEC's website at www.sec.gov and our Investor Relations website at investor.coopercos.com.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Within the tables presented, percentages are calculated based on the underlying whole-dollar amounts and, therefore, may not recalculate exactly from the rounded numbers used for disclosure purposes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Outlook</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are optimistic about the long-term prospects for the worldwide contact lens and general health care markets, and the resilience of and growth prospects for our businesses and products. However, we face significant risks and uncertainties in our global operating environment as further described in the &#8220;Risk Factors&#8221; section in Part I, Item 1A of this filing. These risks include uncertain global and regional business, political and economic conditions, including but not limited to those associated with man-made or natural disasters, pandemic conditions, inflation, foreign exchange rate fluctuations, regulatory developments, supply chain disruptions, and escalating global trade barriers. These risks and uncertainties have adversely affected our sales, cash flow and performance in the past and could further adversely affect our future sales, cash flow and performance.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">CooperVision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> - We compete in the worldwide contact lens market with our spherical, toric, multifocal and toric multifocal contact lenses offered in materials like silicone hydrogel Aquaform technology. We believe that there will be lower contact lens wearer dropout rates as technology improves and enhances the wearing experience through a combination of improved designs and materials and the growth of preferred modalities such as single-use and monthly wearing options. CooperVision also competes in the myopia management and specialty eye care contact lens markets with myopia management contact lenses using its ActivControl technology and with products such as orthokeratology (ortho-k) and scleral lenses. CooperVision has FDA approval for its MiSight 1 day lens, which is the first and only FDA-approved product indicated to slow the progression of myopia in children with treatment initiated between the ages of 8-12. Further, CooperVision has Chinese NMPA approval for its MiSight 1 day lens for use in China. CooperVision is focused on greater worldwide market penetration using recently introduced products, and we continue to expand our presence in existing and emerging markets, including through acquisitions. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our ability to compete successfully with a full range of silicone hydrogel products is an important factor to achieving our desired future levels of sales growth and profitability. CooperVision manufactures and markets a wide variety of silicone hydrogel contact lenses. Our single-use silicone hydrogel product franchises, clariti, MyDay and MyDay Energys remain a focus as we expect increasing demand for these products, as well as future single-use products, as the global contact lens market continues to shift to this modality. Outside of single-use, the Biofinity and Avaira Vitality product families comprise our focus in the FRP, or frequent replacement product, market which encompasses the monthly and two-week modalities. Included in this segment are unique products such as Biofinity Energys, which helps individuals with digital eye fatigue.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">CooperSurgical -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Our CooperSurgical business competes in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperSurgical has established its market presence and distribution system by developing products and acquiring companies, products and services that complement its business model. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Competitive factors in the segments in which CooperSurgical competes include technological and scientific advances, product quality and availability, price and customer service (including response time and effective communication of product information to physicians, consumers, fertility clinics and hospitals). </span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Net Sales</span></div><div style="margin-top:9pt;text-align:center"><img src="coo-20231031_g3.jpg" alt="13854" style="height:254px;margin-bottom:5pt;vertical-align:text-bottom;width:386px"/></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CooperVision Net Sales</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The contact lens market has two major product categories:</span></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Spherical lenses including lenses that correct near- and farsightedness uncomplicated by more complex visual defects; and</span></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Toric and multifocal lenses including lenses that, in addition to correcting near- and farsightedness, address more complex visual defects such as astigmatism and presbyopia by adding optical properties of cylinder and axis, which correct for irregularities in the shape of the cornea.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CooperVision Net Sales by Category</span></div><div style="margin-top:9pt;text-align:center"><img src="coo-20231031_g4.jpg" alt="14381" style="height:288px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/><img src="coo-20231031_g5.jpg" alt="14382" style="height:286px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Single-use spheres</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> &#8211; This includes Biomedics 1 day, clariti 1 day, MiSight, MyDay, and Proclear 1 day</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Toric</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> &#8211; This includes Avaira Vitality toric, Biofinity toric, Biomedics toric, clariti 1 day toric, MyDay toric and Proclear toric</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Multifocal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> &#8211; This includes Biofinity multifocal, Biofinity toric multifocal, clariti 1 day multifocal, MyDay multifocal and Proclear 1 day multifocal</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Non single-use sphere, other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> &#8211; This includes our frequent replacement product (FRP) lens portfolio (Avaira Vitality spheres, Biofinity spheres, Biofinity Energys spheres, Biomedics spheres, clariti spheres, Proclear spheres), specialty lenses (custom, ortho-k, and scleral lenses) and other.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023 vs. 2022 %&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Toric</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">828.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">737.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Multifocal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">305.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Single-use spheres</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">705.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">661.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non single-use sphere, other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">583.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">579.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,423.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,243.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the fiscal year ended October&#160;31, 2023, the growth experienced across all categories was partially offset by unfavorable foreign exchange rate fluctuations, which approximated $61.0&#160;million. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Toric and multifocal lenses grew primarily through the success of MyDay and Biofinity.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Single-use sphere lenses grew primarily through MyDay, MiSight, and clariti lenses.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Non single-use sphere lenses grew primarily through specialty lenses.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">"Other" products represented approximately 1% of net sales in fiscal 2023 and 2022.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CooperVision Net Sales by Geography</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision competes in the worldwide soft contact lens market and services in three primary regions: the Americas, EMEA (Europe, Middle East and Africa) and Asia Pacific.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.201%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023 vs. 2022 %&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">991.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">887.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">891.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">843.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">540.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">512.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,423.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,243.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision's growth in net sales across all regions was primarily attributable to market gains of silicone hydrogel contact lenses. Refer to CooperVision Net Sales by Category above for further discussion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CooperSurgical Net Sales by Category</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical supplies the fertility and women's health care market with a diversified portfolio of products and services. Our office and surgical offerings include products that facilitate surgical and non-surgical procedures that are commonly performed primarily by obstetricians and gynecologists in hospitals, surgical centers, fertility clinics and medical offices. Fertility offerings include highly specialized products and services that target the IVF process, including diagnostics testing with a goal to make fertility treatment safer, more efficient and convenient.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The chart below shows the percentage of net sales of office and surgical and fertility.</span></div><div style="margin-top:9pt;text-align:center"><img src="coo-20231031_g6.jpg" alt="17088" style="height:288px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/><img src="coo-20231031_g7.jpg" alt="17089" style="height:286px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Office/Surgical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> &#8211; This includes Endosee endometrial imaging products, Fetal Pillow cephalic elevation devices for use in Cesarean sections, illuminated speculum products, Lone Star retractor systems, loop electrosurgical excision procedure (LEEP) products, Mara water ablation systems, cryostorage (such as cord blood and cord tissue storage), Paragard contraceptive IUDs, point-of-care products and uterine positioning products.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Fertility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> &#8211; This includes fertility consumables and equipment, donor gamete services, and genomic services (including genetic testing).</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023 vs. 2022 %&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Office and surgical</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">689.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">633.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fertility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">480.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">431.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,169.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,065.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">e fiscal year ended October&#160;31, 2023, the net sales increase in both categories was partially due to the addition of Generate Life Sciences (Generate) on December 17, 2021. Additionally, office and surgical net sales increased due to an increase in sales from products such as Uterine Manipulators, Fetal Pillow and Surgical Retractors, and fertility net sales increased due to an increase in revenue from consumable products and genomic services. The increase was partially offset by unfavorable foreign exchange rate fluctuations, which approximated $15.1&#160;million.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Gross Margin</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Consolidated Gross Margin was relatively flat at 66% in fiscal 2023 compared to 65% in fiscal 2022.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Selling, General and Administrative (SGA) Expenses</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023 vs. 2022 <br/>% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">871.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">826.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">461.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">70.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,342.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision's SGA expenses increased in fiscal 2023 compared to fiscal 2022 primarily due to an increase in selling and marketing activities, distribution costs, and an intangible assets impairment charge associated with the discontinuation of </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">certain products, partially offset by $31.8 million release of contingent consideration liability associated with SightGlass Vision's regulatory approval milestone. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical's SGA expenses increased in fiscal 2023 compared to fiscal 2022 primarily due to an increase in selling and marketing activities and the payment of a $45.0 million termination fee under an asset purchase agreement related to Cook Medical&#8217;s reproductive health business. See Note 3. Acquisitions and Joint Venture for further information on the termination fee. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Corporate SGA expenses increased in fiscal 2023 compared to fiscal 2022 primarily due to share-based compensation related expenses.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Research and Development (R&amp;D) Expenses </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.320%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023 vs. 2022 <br/>% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">137.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">110.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision's R&amp;D expenses increased in fiscal 2023 compared to fiscal 2022 primarily due to European Medical Device Regulation costs and myopia management programs, and timing of R&amp;D projects. CooperVision's R&amp;D activities are primarily focused on the development of contact lenses, manufacturing technology and process enhancements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical's R&amp;D expenses increased in fiscal 2023 compared to fiscal 2022 mainly due to European Medical Device Regulation costs. CooperSurgical's R&amp;D activities are focused on developing and refining diagnostic and therapeutic products including medical interventions, surgical devices and fertility solutions.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Amortization Expense</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023 vs. 2022 <br/>% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">186.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">179.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision's amortization expense for fiscal 2023 compared to fiscal 2022 remained relatively flat year over year.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical's amortization expense increased in fiscal 2023 compared to fiscal 2022, primarily due to the amortization of intangible assets recently acquired through acquisitions.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Operating Income </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023 vs. 2022 <br/>% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">587.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">494.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(70.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(53.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">533.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">507.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision's operating income increased in fiscal 2023 compared to fiscal 2022, primarily due to an increase in net sales partially offset by net changes in operating expenses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical's operating income decreased in fiscal 2023 compared to fiscal 2022, primarily due to an increase in SGA and R&amp;D expenses, partially offset by an increase in net sales.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Corporate operating loss increased in fiscal 2023 compared to fiscal 2022, primarily due to higher share-based compensation expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023 vs. 2022 <br/>% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Interest expense increased during fiscal 2023 compared to the prior year, primarily due to higher interest rates.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Other Expense (Income), Net</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.959%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Investment gain</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(47.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign exchange loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Investment gain in fiscal 2022 primarily consists of a gain on remeasurement of the fair value of retained equity investment in SGV as a result of deconsolidation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Foreign exchange loss is primarily associated with the weakening of the U.S. dollar against foreign currencies and the effect on intercompany receivables.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Other expenses (income), net increased in fiscal 2023, primarily due to a loss on minority investments, partially offset by defined benefit plan related income.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The effective tax rates for fiscal 2023 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> were 28.7% and 18.8%, respectively. The increase was primarily due to changes in the geographic composition of pre-tax earnings, an increase in the UK statutory tax rate from 19% to 25%, capitalization of research and experimental expenditures for fiscal 2023 as required by the 2017 Tax Cuts and Jobs Act, and changes in unrecognized tax benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The effective tax rate for fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> was higher than the US federal statutory rate primarily due to foreign earnings subject to US tax. The effective tax rate for fiscal 2022 was lower than the US federal statutory rate primarily due to foreign earnings in jurisdictions with lower tax rates and changes in unrecognized tax benefits, partially offset by foreign earnings subject to US tax. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">See Note 6. Income Taxes for further information.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_55"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CAPITAL RESOURCES AND LIQUIDITY </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Working capital at October&#160;31, 2023 and October&#160;31, 2022, was $735.9&#160;million and $253.4&#160;million, respectively. The increase in working capital was primarily due to repayment of the 364-day term loan during fiscal 2023 and an increase in inventories. See Note 5. Financing Arrangements for further information.</span></div><div style="margin-top:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cash Flow</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.841%"><tr><td style="width:1.0%"></td><td style="width:64.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">607.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">692.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">738.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(449.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(1,831.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(450.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(173.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">1,193.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Effect of exchange rate changes on cash, cash equivalents, restricted<br/>cash and restricted cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(Decrease) increase  in cash, cash equivalents, restricted cash and</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">restricted cash equivalents</span></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(17.7)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">42.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(20.2)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Operating Cash Flow</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Cash provided by operating activities in fiscal 2023 decreased compared to fiscal 2022, primarily due to the payment of a $45 million termination fee under an asset purchase agreement and net changes in operating capital, partially offset by net changes in other non-cash items.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The $45.0 million termination fee under an asset purchase agreement related to Cook Medical&#8217;s reproductive health business was accrued for during the second quarter of fiscal 2023 and paid on August 9, 2023. See Note 3. Acquisitions and Joint Venture for further information on the termination fee.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Investing Cash Flow</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Cash used in investing activities in fiscal 2023 was lower than cash used in investing activities in fiscal 2022, primarily attributable to $1.6 billion cash paid, net of cash acquired, for the Generate acquisition in fiscal 2022. The decrease in cash used for acquisitions was partially offset by an increase in purchases of property, plant and equipment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Financing Cash Flow</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Cash used in financing activities in fiscal 2023 was primarily due to repayments of $338.0&#160;million on the 2021 364-day term loan, partially offset by $172.6&#160;million of funds drawn on the 2020 Revolving Credit.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Cash provided by financing activities in fiscal 2022 was primarily due to funds received from the 2021 term loan facility ($1.5&#160;billion) and the 2021 364-day term loan facility ($840.0&#160;million), partially offset by $561.5&#160;million repayments of the 2020 Revolving Credit, $502.0&#160;million repayments of the 2021 364-day term loan facility, and $78.5&#160;million repurchases of common stock. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The following is a summary of the maximum commitments and the net amounts available to us under different credit facilities as of October&#160;31, 2023:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.730%"><tr><td style="width:1.0%"></td><td style="width:28.481%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.832%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Facility Limit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Outstanding Borrowings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Outstanding Letters of Credit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Amount Available</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Revolving Credit:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2020 Revolving Credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">April 1, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Term Loan:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2020 Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">April 1, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2021 Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 17, 2026</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,640.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,522.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,115.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2023, the Company was in compliance with all debt covenants. See Note 5. Financing Arrangements for further information.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Considering recent market conditions, we have re-evaluated our operating cash flows and cash requirements and continue to believe that current cash, cash equivalents, future cash flow from operating activities and cash available under our 2020 Credit Agreement will be sufficient to meet our anticipated cash needs, including working capital needs, capital expenditures and contractual obligations for at least 12 months from the issuance date of the Consolidated Financial Statements included in this annual report. To the extent additional funds are necessary to meet our liquidity needs such as that for acquisitions, share repurchases, cash dividends or other activities as we execute our business strategy, we anticipate that additional funds could be obtained through the incurrence of additional indebtedness, additional equity financings or a combination of these potential sources of funds; however, such financing may not be available on favorable terms, or at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In December 2011, the Company's Board of Directors authorized the 2012 Share Repurchase Program ("2012 Program") and through subsequent amendments, the most recent in March 2017, the total repurchase authorization was increased from $500.0 million to $1.0 billion of the Company's common stock. The program has no expiration date and may be discontinued at any time. Purchases under the 2012 Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In fiscal 2023, there were no share repurchases under the 2012 Program. At October&#160;31, 2023, $256.4 million remained authorized for repurchase under the program. See Note 8. Stockholders&#8217; Equity for additional information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In fiscal 2023 and 2022, the Company declared regular dividends of 6 cents per share (a semiannual dividend of 3 cents per share) and paid a total of $3.0&#160;million in each fiscal year. In December 2023, our Board of Directors decided to end the declaration of the semiannual dividend.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2023, we had the following contractual obligations: </span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.047%"><tr><td style="width:1.0%"></td><td style="width:40.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Payments Due by Fiscal Year</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2025 &amp; 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2027 &amp; 2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2029 &amp; Beyond</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">249.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Transition tax on unremitted foreign earnings and profits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchase obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">408.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total contractual obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">746.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">337.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">341.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2023, we had $88.6 million of income tax liabilities related to the one-time transition tax that resulted from the enactment of the 2017 US Tax Act, which is payable in annual installments through fiscal 2026. The installment for fiscal 2023 is classified in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities" i</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">n our Consolidated Balance Sheet.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are unable to reliably estimate the timing of future payments related to uncertain tax positions and have excluded $24.0 million of long-term income taxes payable from the table above. See Note 6. Income Taxes for additional information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Purchase obligations consist of agreements to purchase goods and services that are enforceable and legally binding and includes obligations for inventory, capital expenditures and other operating expense commitments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The table above excludes future payments for operating leases, long-term debt, and our defined benefit plan. The minimum future payments for operating leases are disclosed in Note 2. Operating Leases and future maturities of long-term debt are disclosed in Note 5. Financing Arrangements. The expected future benefit payments for our Retirement Income Plan through 2033 are disclosed in Note 10. Employee Benefits.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Transition from LIBOR</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">The UK&#8217;s Financial Conduct Authority (FCA), which regulates the London Interbank Offered Rate&#160;(LIBOR), announced in July 2017 that it will no longer persuade or require banks to submit rates for&#160;LIBOR&#160;after 2021. In March 2021, the FCA confirmed its intention to stop requiring banks to submit rates required to calculate LIBOR after 2021. However, for U.S. dollar-denominated (USD) LIBOR, only one-week and two-month USD LIBOR will cease to be published after 2021, and all remaining USD LIBOR tenors will continue being published until June 2023. Further, in March 2020, the Financial Accounting Standards Board (FASB) issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reference Rate Reform (Topic 848): Facilitation of the Effects </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">. This guidance provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. Effective February 1, 2023, the Company transitioned its credit agreements from LIBOR to the Secured Overnight Financing Rate ("SOFR").</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_58"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Management estimates and judgments are an integral part of financial statements prepared in accordance with GAAP. We consider an accounting estimate critical if changes in the estimate may have a material impact on our financial condition or results of operations. We believe that the accounting estimates employed are appropriate and resulting balances are reasonable, however, actual results could differ from the original estimates, requiring adjustment to these balances in future period. The critical accounting policies described in this section address the more significant estimates required of management when preparing the Consolidated Financial Statements in accordance with GAAP. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:32.68pt">Revenue recognition - We recognize revenue from product sales when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the goods to customers and/or when services are rendered. Our payment terms are typically between 30 to 120 days. Provisions for certain rebates, sales incentives, volume discounts, contractual pricing allowances and product returns are accounted for as variable consideration and recorded as a reduction in sales. </span></div><div style="margin-top:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Product discounts, including certain rebates, sales incentives, and volume discounts are granted based on terms of the arrangement with direct distribution customers and at times the indirect end consumer. We evaluate contractual terms, historical experience, and perform internal analysis to estimate total product discounts at the time revenue is recognized. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.</span></div><div style="margin-top:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Sales returns are estimated and recorded based on historical sales return data. Promotional programs, such as cooperative advertising arrangements, are recorded in the same period as related sales. Reasonably likely changes to assumptions used to calculate the accruals for rebates, sales incentives, volume discounts, contractual pricing allowances and product returns are not anticipated to have a material effect on the financial statements. We currently disclose the impact of changes to assumptions in the quarterly or annual filing in which there is a material financial statement impact.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Business combinations - We routinely consummate business combinations. Results of operations for acquired companies are included in our consolidated results of operations from the date of acquisition. We recognize separately from goodwill, the identifiable assets acquired, including acquired in-process research and development, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date fair values as defined by accounting standards related to fair value measurements. Key assumptions routinely utilized the allocation of purchase price to intangible assets include discount rates, and projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. Direct acquisition costs are expensed as incurred.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Income taxes - Income taxes are estimated based on enacted income tax laws and the results of operations in each jurisdiction. Deferred tax assets and liabilities are estimated based on temporary differences between the financial reporting basis and income tax basis of assets and liabilities. Deferred tax assets are reduced by a valuation allowance to the extent it is more likely than not they are not expected to be realized. Long-term tax payable is estimated income tax to be paid for unrecognized tax benefits. A tax benefit is recognized if it is more likely than not a tax position will be sustained based on its technical merits in a tax authority examination, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority.</span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_61"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information regarding new accounting pronouncements is included in Note 1. Organization and Significant Accounting Policies.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_64"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;7A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosure About Market Risk.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are exposed to market risks that relate principally to changes in interest rates and foreign currency fluctuations. We do not enter into derivative financial instrument transactions for speculative purposes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We operate multiple foreign subsidiaries that manufacture and market our products worldwide. As a result, our earnings, cash flow and financial position are exposed to foreign currency risk from foreign currency denominated receivables and payables, sales transactions, capital expenditures and net investment in certain foreign operations. Most of our operations outside the United States have their local currency as their functional currency. We have exposure to multiple foreign currencies, including, among others, the British pound, Euro and Japanese yen. We have taken steps to minimize our balance sheet exposure by entering into foreign currency forward contracts to minimize the short-term impact of foreign currency exchange rate fluctuations on certain trade and intercompany receivables and payables.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">At October&#160;31, 2023, a uniform hypothetical 10% increase or decrease in the foreign currency exchange rates in comparison to the value of the U.S. dollar would have resulted in a corresponding increase or decrease of approximately $95.6&#160;million in operating income for the fiscal year ended October&#160;31, 2023. Refer to Item&#160;1A. Risk Factors - "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Our substantial and expanding international operations are subject to uncertainties which could affect our business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">" and Note 1. Organization and Significant Accounting Policies for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are exposed to risks associated with changes in interest rates, as the interest rates on our revolving lines of credit and term loans may vary with the federal funds rate and SOFR (and, previously, LIBOR). As of October&#160;31, 2023, we had outstanding debt for an aggregate carrying amount of $2.6&#160;billion. We have entered, and in the future may enter, into interest rate swaps to manage interest rate risk. Effective February 1, 2023, the base interest rate on our credit agreements was converted from LIBOR to SOFR.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our ultimate realized gain or loss with respect to interest rate fluctuations will depend on interest rates, the exposures that arise during the period and our hedging strategies at that time. As an example, if interest rates were to increase or decrease by 1% or 100 basis points, the quarterly interest expense would not have a material impact, based on average debt outstanding, after consideration of our interest rate swap contracts, during the fourth quarter of fiscal 2023. Refer to Item&#160;1A. Risk Factors - "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">We are vulnerable to interest rate risk with respect to our debt.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">" and Note 5. Financing Arrangements for further information.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_67"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements and Supplementary Data.</span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_70"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Cooper Companies, Inc.:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of The Cooper Companies, Inc. and subsidiaries (the Company) as of October&#160;31, 2023 and 2022, the related consolidated statements of income, comprehensive income, stockholders&#8217; equity, and cash flows for each of the years in the three-year period ended October&#160;31, 2023, and the related notes and financial statement Schedule II (collectively, the consolidated financial statements). We also have audited the Company&#8217;s internal control over financial reporting as of October&#160;31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of October&#160;31, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the three-year period ended October&#160;31, 2023, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of October&#160;31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinions </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements and an opinion on the Company&#8217;s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">       Evaluation of the sufficiency of audit evidence over inventories and net sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As discussed in Notes 1 and 12 to the consolidated financial statements and disclosed in the consolidated balance sheet and consolidated statement of income, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-40">735.6</ix:nonFraction> million in inventories and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-41">3,593.2</ix:nonFraction> million in net sales as of and for the year ended October&#160;31, 2023, respectively. Inventories are primarily comprised of raw materials, work-in-process, and finished goods that are physically located at certain of the Company's locations. Net sales are recognized primarily from the sale of products from each of the Company's locations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We identified the evaluation of the sufficiency of audit evidence over inventories and net sales as a critical audit matter. Evaluating the sufficiency of the audit evidence obtained required subjective auditor judgment because of the decentralized structure and geographic dispersion of the Company's manufacturing and distribution locations. This included determining the locations for which procedures were performed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter. We applied auditor judgment to determine the nature and extent of procedures to be performed over inventories and net sales, including the determination of the Company&#8217;s locations for which those procedures were performed. For certain locations where procedures were performed, we evaluated the design and tested the operating effectiveness of certain internal controls over the Company's inventories and net sales processes, including controls over the amounts recorded in inventories and the amounts recorded in net sales. We assessed the recorded inventories for each location where procedures were performed by participating in a physical inventory count and observing a sample of inventories on hand and comparing the cost recorded for a sample of inventories on hand to underlying documentation. We assessed recorded net sales for each location where procedures were performed by selecting a sample of net sales transactions and comparing the amount recognized to underlying documentation, such as contracts with customers and shipping documentation. We evaluated the overall sufficiency of audit evidence obtained by assessing the results of procedures performed over inventories and net sales, including the appropriateness of the nature and extent of audit effort.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">/s/ KPMG LLP</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1982.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">San Francisco, California</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">December&#160;8, 2023</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_73"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Consolidated Statements of Income</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions, except for earnings per share)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-42">3,593.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-43">3,308.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-44">2,922.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-45">1,235.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-46">1,168.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-47">966.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-48">2,357.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-49">2,139.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-50">1,955.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-51">1,501.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-52">1,342.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-53">1,211.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-54">137.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-55">110.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-56">92.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-57">186.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-58">179.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-59">146.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-60">533.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-61">507.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-62">505.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-63">105.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-64">57.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-65">23.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other expense (income)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-66">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-67">25.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-68">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-69">412.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-70">475.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-71">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-72">118.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-73">89.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-74">2,453.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-75">294.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-76">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-77">2,944.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Earnings per share (Note 7)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-78">5.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-79">7.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-80">59.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-81">5.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-82">7.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-83">59.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Number of shares used to compute earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-84">49.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-85">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-86">49.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-87">49.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-88">49.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-89">49.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Consolidated Financial Statements.</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_76"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-90">294.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-91">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-92">2,944.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash flow hedges, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="f-93">2.4</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="f-94">26.1</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="f-95">8.2</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-96">7.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-97">81.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-98">26.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Change in minimum pension liability, net of tax of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="f-99">1.0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="f-100">8.7</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="f-101">7.2</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-102">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-103">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-104">22.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-105">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-106">234.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-107">82.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income (loss) </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-108">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-109">125.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-110">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-111">307.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-112">260.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-113">3,075.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Consolidated Financial Statements.</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_79"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October 31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-114">120.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-115">138.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trade accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-116">31.3</ix:nonFraction> at October&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-117">20.7</ix:nonFraction> at October&#160;31, 2022 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-118">609.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-119">557.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories (Note 1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-120">735.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-121">628.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Prepaid expense and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-122">238.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-123">208.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-124">1,704.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-125">1,533.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-126">1,632.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-127">1,432.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Goodwill (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-128">3,624.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-129">3,609.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other intangibles, net (Note 4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-130">1,710.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-131">1,885.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-132">2,349.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-133">2,443.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-134">637.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-135">587.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-136">11,658.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-137">11,492.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt (Note 5)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="f-138">45.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="f-139">412.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-140">261.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-141">248.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-142">174.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-143">152.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-144">123.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-145">93.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="f-146">363.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="f-147">373.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="f-148">969.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-149">1,280.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt (Note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="f-150">2,523.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="f-151">2,350.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-152">101.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-153">149.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="f-154">90.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="f-155">113.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-156">184.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-157">198.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-158">239.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-159">225.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-160">4,107.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-161">4,317.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Contingencies (Note 11)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-162"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-7" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-163"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-164"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="f-165">10</ix:nonFraction></ix:nonFraction> cents par value, <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="f-166"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="f-167">1.0</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="f-168"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="f-169"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="f-170"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="f-171">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-172">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-173">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="-2" id="f-174"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="-2" id="f-175">10</ix:nonFraction></ix:nonFraction> cents par value, <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="f-176"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="f-177">120.0</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-178">53.9</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-179">49.5</ix:nonFraction> outstanding at October&#160;31, 2023 and <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-180">53.8</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-181">49.3</ix:nonFraction> outstanding at October&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-182">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-183">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-184">1,833.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-185">1,765.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-186">453.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-187">466.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-188">6,876.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-189">6,584.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Treasury stock at cost: <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-190">4.4</ix:nonFraction> shares at October&#160;31, 2023 and <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-191">4.5</ix:nonFraction> shares at October&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="f-192">710.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="f-193">714.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Cooper stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-194">7,550.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-195">7,174.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="f-196">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="f-197">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stockholders&#8217; equity (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-198">7,551.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-199">7,174.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-200">11,658.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-201">11,492.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders' Equity </span></div><div style="margin-top:5pt;padding-left:72pt;padding-right:72pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.465%"><tr><td style="width:1.0%"></td><td style="width:25.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.485%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.611%"></td><td style="width:0.1%"></td></tr><tr style="height:30pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Stockholders'<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-202">49.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-203">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-204">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-205">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-206">1,646.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-207">472.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-208">3,261.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-209">617.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-210">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-211">3,824.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-212">2,944.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-213">2,944.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-214">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-215">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock for stock plans, net and employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="f-216">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="f-217">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="f-218">24.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="f-219">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="f-220">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Treasury stock repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-18" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-221">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-222">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-223">24.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-224">24.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividends on common stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-225">0.03</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-226">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-227">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-228">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-229">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-230">ASU 2016-13 adoption</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-231">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-232">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-233">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-234">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-235">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-236">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-237">1,715.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-238">341.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-239">6,202.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-240">639.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-241">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-242">6,942.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-243">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-244">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-245">125.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-246">125.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock for stock plans, net and employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="f-247">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="f-248">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="f-249">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="f-250">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Treasury stock repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-35" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-251">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-252">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-253">78.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-254">78.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividends on common stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-255">0.03</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-256">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-257">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-258">52.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-259">52.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-260">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-261">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-262">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-263">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-264">1,765.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-265">466.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-266">6,584.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-267">714.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-268">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-269">7,174.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-270">294.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-271">294.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-272">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-273">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock for stock plans, net and employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-47" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="f-274">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-48" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="f-275">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="f-276">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="f-277">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="f-278">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividends on common stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-279">0.03</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-280">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-281">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-282">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-283">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-50" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-284">49.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-285">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-286">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-287">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-288">1,833.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-289">453.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-290">6,876.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-291">710.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-292">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-293">7,551.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_85"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-294">294.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-295">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-296">2,944.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-297">367.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-298">346.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-299">309.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-300">62.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-301">54.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-302">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-cash operating lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-303">40.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-304">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-305">31.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asset impairment charges, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="coo:AssetImpairmentChargesAndOther" scale="6" id="f-306">49.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="coo:AssetImpairmentChargesAndOther" scale="6" id="f-307">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="coo:AssetImpairmentChargesAndOther" scale="6" id="f-308">5.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-309">31.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-310">10.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-311">66.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-312">44.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-313">53.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-314">2,502.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Change in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-315">60.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-316">33.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-317">75.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-318">105.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-319">40.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-320">9.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="f-321">89.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="f-322">16.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="f-323">69.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets and liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" scale="6" id="f-324">34.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" scale="6" id="f-325">51.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" scale="6" id="f-326">27.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="f-327">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="f-328">49.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="f-329">16.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-330">71.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-331">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-332">59.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-333">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-334">27.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-335">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="6" id="f-336">6.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="6" id="f-337">34.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="6" id="f-338">21.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlement of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="coo:IncreaseDecreaseInContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-339">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="coo:IncreaseDecreaseInContingentConsiderationLiability" scale="6" id="f-340">52.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="coo:IncreaseDecreaseInContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-341">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-342">607.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-343">692.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-344">738.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-345">392.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-346">242.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-347">214.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Acquisitions of businesses and assets, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" scale="6" id="f-348">56.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="f-349">1,641.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" scale="6" id="f-350">235.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from sale of interest in a subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" format="ixt:fixed-zero" scale="6" id="f-351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" scale="6" id="f-352">52.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" format="ixt:fixed-zero" scale="6" id="f-353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-354">449.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="f-355">1,831.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-356">450.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from long-term debt, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-357">2,124.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-358">1,511.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-359">1,427.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-360">1,953.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="f-361">561.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-362">1,416.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net proceeds from (repayments of) short-term debt, other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="f-363">351.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="f-364">329.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="f-365">321.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="f-366">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-367">78.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-368">24.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds related to share-based compensation awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="f-369">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="f-370">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="f-371">33.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Payments related to share-based compensation awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-372">13.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-373">16.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-374">13.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividends on common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="f-375">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="f-376">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="f-377">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock for employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="f-378">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="f-379">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="f-380">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlement of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-381">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="f-382">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-383">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-384">173.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-385">1,193.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-386">311.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-387">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-388">12.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-389">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents and restricted cash </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-390">17.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-391">42.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-392">20.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash and cash held for sale at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-393">138.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-394">96.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-395">116.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-396">120.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-397">138.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-398">96.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Supplemental disclosures of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Cash paid for:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="f-399">117.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="f-400">49.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="f-401">28.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-402">67.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-403">66.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-404">63.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-405">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-406">45.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-407">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease ROU assets obtained in exchange for lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-408">42.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-409">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-410">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reconciliation of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-411">120.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-412">138.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-413">95.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="f-414">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="f-415">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="f-416">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="f-417">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="f-418">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="f-419">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total cash, cash equivalents, restricted cash and cash held for sale</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-420">120.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-421">138.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-422">96.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Consolidated Financial Statements.</span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_88"></div><div style="text-align:center"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_91"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock" id="f-423" continuedAt="f-423-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 1. Organization and Significant Accounting Policies</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Organization</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Cooper Companies, Inc. (Cooper, we or the Company) is a global medical device company publicly traded on the Nasdaq (Nasdaq: COO). Prior to September 26, 2023, Cooper's common stock traded on the New York Stock Exchange under the symbol "COO". Cooper operates through <ix:nonFraction unitRef="business_unit" contextRef="c-1" decimals="INF" name="coo:NumberOfBusinessUnits" format="ixt-sec:numwordsen" scale="0" id="f-424">two</ix:nonFraction> business units, CooperVision and CooperSurgical.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">CooperVision primarily develops, manufactures and markets a broad range of soft contact lenses for the worldwide vision correction market.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">CooperSurgical primarily develops, manufactures, markets medical devices and procedures solutions, and provides services to improve health care delivery to women, babies and families. </span></div><div style="padding-left:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-425" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The financial statements in this report include the results of all of Cooper's consolidated entities. All significant intercompany transactions and balances are eliminated on consolidation.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-426" continuedAt="f-426-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Use of Estimates</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:continuation id="f-426-1">The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates. The Company continually monitors and evaluates the estimates used as additional information becomes available. Adjustments will be made to these provisions periodically to reflect new facts and circumstances that may indicate that historical experience may not be indicative of current and/or future results.</ix:continuation>  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-427" continuedAt="f-427-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Net Sales </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers may subsequently resell the Company&#8217;s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately negotiated rebates, chargebacks and discounts with respect to the purchase of the Company&#8217;s products. The Company considers purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. As part of its consideration of the contract, the Company evaluates certain factors including the customer&#8217;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Revenues from product sales are recognized when the Customer obtains control of the Company&#8217;s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is <ix:nonNumeric contextRef="c-57" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:durwordsen" id="f-428">one year</ix:nonNumeric> or less. See Note 12. Business Segment Information for disaggregation of revenue.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Reserves for Variable Consideration</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company&#8217;s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liabilities. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company applies that method consistently.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company&#8217;s historical experience, current contractual and statutory requirements, specific known </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-423-1" continuedAt="f-423-2"><ix:continuation id="f-427-1"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Trade Discounts and Allowances</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. Historically, returns have been infrequent and insignificant relative to our total sales. Our refund liability for product returns is included in "Other current liabilities" in our Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Rebates and Chargebacks</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company&#8217;s direct customers. For certain office and surgical portfolio in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Deferred revenue primarily represents prepaid stem cell storage as part of the CooperSurgical business unit. Revenue related to stem cell storage is recognized over the service period, which can range from one year to the lifetime of a customer. The current portion of the deferred revenue balances at the beginning of each year presented were generally fully recognized in the subsequent 12-month period.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-429" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We grant various share-based compensation awards, including stock options, performance unit shares, restricted stock and restricted stock units. The Company accounts for share-based compensation expense based on estimated grant-date fair value, and expenses the amount over the vesting period of the award. Determining the fair value of share-based awards at the grant date requires judgment, including estimating Cooper's stock price volatility, employee exercise behaviors and related employee forfeiture rates. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The expected life of the share-based awards is based on the expected time to post-vesting forfeiture and/or exercise. Groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. In determining the expected volatility, management considers implied volatility from publicly-traded options on Cooper's common stock at the date of grant, historical volatility and other factors. The risk-free interest rate is based on the continuous rates provided by the United States Treasury with a term equal to the expected life of the award. The dividend yield is based on the projected annual dividend payment per share, divided by the stock price at the date of grant.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Forfeitures are estimated at the time of grant, based on historical experience, and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-430" continuedAt="f-430-1" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric><div style="margin-top:9pt"><ix:continuation id="f-430-1"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Most of our operations outside the United States use their local currency as their functional currency. We translate these assets and liabilities into U.S. dollars at year-end exchange rates. We translate income and expense accounts at average exchange rates for the period. We record gains and losses from the translation of financial statements in foreign currencies into U.S. dollars in other comprehensive income. We record gains and losses from changes in exchange rates on transactions denominated in currencies other than each reporting location's functional currency in net income for each period</span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-423-2" continuedAt="f-423-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesPolicyTextBlock" id="f-431" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Financial Derivatives and Hedging</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Derivatives are recorded on the Consolidated Balance Sheets at fair value. Accounting for gains or losses resulting from changes in the values of those derivatives depends on the use of the derivative instrument and whether it qualifies for hedge accounting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The gain or loss on derivative instruments designated and qualifying for cash flow hedge accounting is deferred in other comprehensive income. The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period earnings. Deferred gains or losses from designated cash flow hedges are reclassified into earnings in the period that the hedged interest expense affects earnings. The effectiveness of cash flow hedges is assessed at inception and quarterly thereafter. The Company does not offset fair value amounts recognized for derivative instruments in its Consolidated Balance Sheets for presentation purposes.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-432" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%">Fair Value Measurements</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset&#8217;s or liability&#8217;s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The carrying value of the Company's revolving credit facility and term loans approximates fair value based on current market rates (Level 2). Refer to Note 5. Financing Arrangements for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the Company's&#160;interest&#160;rate&#160;swap&#160;contracts is measured on a recurring basis by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates (forward curves) derived from observable market interest rate&#160;curves. The&#160;interest&#160;rate&#160;swap&#160;contracts were categorized as Level 2 in the fair value hierarchy, as the inputs to the derivative pricing model are generally observable and do not contain a high level of subjectivity. The fair value of derivative instruments is included in "Other assets" in our Consolidated Balance Sheets. On our Consolidated Financial Statements. the gain or loss on the derivatives is recorded as a component of "Accumulated other comprehensive loss" and subsequently reclassified into "Interest expense" in the same period during which the hedged transaction affects earnings. Refer to Note 13. Financial Derivatives and Hedging for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses fair value measures for assets and liabilities acquired in an acquisition, which are considered a Level 3 measurement. C</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">ontingent consideration for which a liability is recorded and the initial measurement of the joint venture interest are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> also categorized as Level 3 in the fair value hierarchy;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and the change in fair value is recognized in "Selling, general and administrative expense" in the Consolidated Statements of Income.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> The fair value is measured by discounting expected future cash flows. The discount rate used for cash flows reflects capital market conditions and the specific risks associated with the business. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Note 3. Acquisitions and Joint Venture for further information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-433" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Income taxes are estimated based on enacted income tax laws and the results of operations in each jurisdiction. Deferred tax assets and liabilities are estimated based on temporary differences between the financial reporting basis and income tax basis of assets and liabilities. Deferred tax assets are also estimated based on net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance to the extent it is more likely than not they are not expected to be realized. Adjustments to deferred tax assets and liabilities due to changes in tax laws, changes in jurisdiction from intra-group transfers of assets, and changes in judgment regarding a valuation allowance are recognized in provision for income taxes in the quarter in which such changes occur. Long-term tax payable is estimated income tax to be paid for unrecognized tax benefits. A tax benefit is recognized if it is more likely than not a tax position will be sustained based on its technical merits in a tax authority examination, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. Adjustments to unrecognized tax benefits due to changes in judgment are recognized in provision for income taxes in the quarter in which such changes occur. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-423-3" continuedAt="f-423-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-434" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We determine basic earnings per share (EPS) by using the weighted-average number of shares outstanding. We determine diluted EPS by increasing the weighted-average number of shares outstanding in the denominator by the number of outstanding dilutive equity awards using the treasury stock method.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-435" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be&#160;cash equivalents.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryPolicyTextBlock" id="f-436" continuedAt="f-436-1" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-437" escape="true"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-438">207.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-439">173.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-440">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-441">15.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-442">509.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-443">439.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-444">735.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-445">628.7</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:continuation id="f-436-1">In assessing the value of inventories, we make estimates and judgments regarding aging of inventories and other relevant issues potentially affecting the salable condition of products and estimated prices at which those products will sell. On an ongoing basis, we review the carrying value of our inventory, measuring number of months on hand and other indications of salability. We reduce the value of inventory if there are indications that the carrying value is greater than net realizable value, resulting in a new, lower-cost basis for that inventory. Subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. While estimates are involved, historically, obsolescence has not been a significant factor due to long product dating and lengthy product life cycles.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-446" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We record property, plant, and equipment at cost. We compute depreciation expense using the straight-line method over the estimated useful lives of the assets. Useful lives are generally <ix:nonNumeric contextRef="c-57" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-447">3</ix:nonNumeric> to <ix:nonNumeric contextRef="c-58" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-448">15</ix:nonNumeric> years except for buildings which are depreciated over <ix:nonNumeric contextRef="c-59" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-449">30</ix:nonNumeric> to <ix:nonNumeric contextRef="c-60" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-450">40</ix:nonNumeric> years and leasehold improvements, which we amortize over the shorter of the useful life or the lease term. We charge maintenance and repairs to expense as we incur them.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-451" escape="true"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Land and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-452">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-453">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-454">488.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-455">415.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-456">2,187.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-457">1,973.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-458">486.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-459">393.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-460">3,182.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-461">2,800.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-462">1,553.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-463">1,387.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-464">1,628.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-465">1,413.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease ROU assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" scale="6" id="f-466">3.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" scale="6" id="f-467">19.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-468">1,632.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-469">1,432.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-470" continuedAt="f-470-1" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Leases </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We consider an arrangement a lease if the arrangement transfers the right to control the use of an identified asset in exchange for consideration. We have operating leases, but do not have material financing leases. The Company primarily has operating leases for office, manufacturing and warehouse space, vehicles, and office equipment.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="f-423-4" continuedAt="f-423-5"><ix:continuation id="f-470-1" continuedAt="f-470-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future lease payments over the lease term. The lease term reflects the noncancellable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the Consolidated Balance Sheets. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Leases with a term of one year or less are not recognized in the Consolidated Balance Sheets, while the associated lease payments are expensed in the Consolidated Statements of Income and Comprehensive Income on a straight-line basis over the lease term.</span></div></ix:continuation><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:continuation id="f-470-2">Operating leases are classified in &#8220;Other current liabilities&#8221;, &#8220;Other liabilities&#8221;, and &#8220;Other assets&#8221; in our Consolidated Balance Sheets. Operating lease expense is recognized on a straight-line basis over the expected lease term and included in "Selling, general and administrative expense" in our Consolidated Statements of Income. Financing leases are classified in "Property, plant and equipment, net", "Short-term debt", and "Long-term debt" in our Consolidated Balance Sheets.</ix:continuation> See Note 2. Operating Leases and Note 5. Financing Arrangements for further information.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InternalUseSoftwarePolicy" id="f-471" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Cloud Computing Arrangements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The Company capitalizes certain costs related to the acquisition and development of internal use software, including implementation costs incurred in a cloud computing arrangement, during the application development stages of projects. Capitalized implementation costs are amortized on a straight-line basis over the expected term of the hosting arrangement, which includes consideration of the non-cancellable contractual term and reasonably certain renewals. Costs incurred during the preliminary project or the post-implementation/operation stages of the project are expensed as incurred. Implementation costs are included in &#8220;Other assets&#8221; in our Consolidated Balance Sheets. Amortization of capitalized implementation costs is included in the same line item in the Consolidated Statements of Income as the expense for fees for the associated hosting arrangement.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="f-472" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Valuation of Goodwill</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. Goodwill is tested for impairment at the reporting unit level by performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. We perform a qualitative assessment to test each reporting unit's goodwill for impairment, which includes industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the fair value of a reporting unit will be compared with its carrying amount and an impairment charge will be recognized for the amount that the carrying value exceeds the fair value of the reporting unit.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="f-473" continuedAt="f-473-1" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Long-lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#160;</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:continuation id="f-473-1">We review long-lived assets held and used for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group are compared to the asset group's carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds the fair value.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" id="f-474" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Indefinite-lived Intangible Assets</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We assess indefinite-lived intangible assets annually in the third quarter of the fiscal year, or whenever events or changes in circumstances indicate that the carrying amount of an indefinite-lived intangible asset (asset group) may not be recoverable. We evaluate whether the indefinite-lived intangible asset is impaired by comparing its carrying value to its fair value. If the carrying value of an indefinite-lived intangible asset is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationsPolicy" id="f-475" continuedAt="f-475-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Business Combinations</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-423-5" continuedAt="f-423-6"><ix:continuation id="f-475-1"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We routinely consummate business combinations. Results of operations for acquired companies are included in our consolidated results of operations from the date of acquisition. We recognize separately from goodwill, the identifiable assets acquired, including acquired in-process research and development, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date fair values as defined by accounting standards related to fair value measurements. Key assumptions routinely utilized in allocation of purchase price to intangible assets include discount rates and projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. Direct acquisition costs are expensed as incurred.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For business acquisitions, the Company records tangible and intangible assets acquired and liabilities assumed at their fair values as of the applicable date of acquisition.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="f-476" continuedAt="f-476-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Litigation</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:continuation id="f-476-1">We are subject to various legal proceedings, claims, litigation, investigations and contingencies arising out of the ordinary course of business. If we believe the likelihood of an adverse legal outcome is probable and the amount is estimable, we accrue a liability in accordance with accounting guidance for contingencies. We consult with legal counsel on matters related to litigation and seek input both within and outside the Company.</ix:continuation>&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityPolicyTextBlock" id="f-477" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Exit Charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">During the second quarter of fiscal 2022, the Company initiated a plan to exit its contact lens care business, a non-core business unit of the CooperVision segment, which was completed in fiscal 2023. Exit charges recognized during the year ended October 31, 2023, were not material. Exit charges recognized during the year ended October 31, 2022, were $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:BusinessExitCosts1" format="ixt:num-dot-decimal" scale="6" id="f-478">33.2</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="us-gaap:BusinessExitCosts1" format="ixt:num-dot-decimal" scale="6" id="f-479">26.7</ix:nonFraction>&#160;million were recognized in "Cost of sales" and $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:BusinessExitCosts1" format="ixt:num-dot-decimal" scale="6" id="f-480">6.5</ix:nonFraction>&#160;million were recognized in "Selling, general and administrative expense" in our Consolidated Statements of Income. Exit charges primarily related to inventory write-down, asset impairments and employee-related costs. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:GovernmentAssistancePolicyTextBlock" id="f-481" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Government Assistance</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">The Company at times receives government assistance primarily to support manufacturing capital expansion, to create or retain jobs, or to provide tax credits mainly for eligible research and development activities. The Company generally accounts for such government assistance by analogy to IAS 20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Accounting for Government Grants and Disclosure of Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> and recognizes the assistance when it is probable that it will be received by complying with the prerequisite terms and conditions. The government assistance is recognized in income as a reduction to the cost basis of the applicable property, plant, and equipment or reduction to the related expense.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-482" continuedAt="f-482-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">. This update requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. This standard was effective for fiscal years beginning after December 15, 2021. The Company adopted this guidance prospectively on November 1, 2022, and such adoption did not have a material impact on the Company's Consolidated Financial Statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reference</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Topic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"> Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> and subsequent amendment to the initial guidance: ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reference Rate Reform (Topic 848): Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> (collectively, &#8220;Topic 848&#8221;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. In December 2022, the FASB issued ASU 2022-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">. ASU 2022-06 defers the sunset date of Topic 848 from December 31, 2022, to December 31, 2024. Effective February 1, 2023, the Company transitioned its credit agreements from LIBOR to the Secured Overnight Financing Rate ("SOFR"). The Company adopted this guidance prospectively on February 1, 2023, and it did not have a material impact on the Consolidated Financial Statements.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-482-1" continuedAt="f-482-2"><ix:continuation id="f-423-6" continuedAt="f-423-7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements Issued Not Yet Adopted</span></div></ix:continuation></ix:continuation><div style="margin-bottom:8pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"><ix:continuation id="f-482-2"><ix:continuation id="f-423-7">No other recently issued accounting pronouncements had or are expected to have a material impact on our Consolidated Financial Statements.</ix:continuation></ix:continuation>&#160;</span></div><div style="margin-bottom:8pt;margin-top:9pt"><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_94"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-483" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 2. Operating Leases</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="coo:AssetsAndLiabilitiesLesseeTableTextBlock" id="f-484" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table presents information about leases on the Consolidated Balance Sheets: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.013%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.581%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">October&#160;31,<br/>(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-485"><span style="-sec-ix-hidden:f-486">Operating lease right-of-use assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-487">241.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-488">230.1</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-489"><span style="-sec-ix-hidden:f-490">Operating lease liabilities, current</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-491">38.2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-492">35.5</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-493"><span style="-sec-ix-hidden:f-494">Operating lease liabilities, non-current</span></span> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-495">215.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-496">205.5</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-497">253.8</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-498">241.0</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-499">10.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-7" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-500">9.8</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="2" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-501">4</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="2" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-502">3</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Operating lease expense for the fiscal years ended October&#160;31, 2023, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-503">48.1</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-504">45.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-505">44.1</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Maturity of Lease Liabilities </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-506" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The minimum rental payments required under operating leases that have initial or remaining noncancellable lease terms in excess of one year as of October&#160;31, 2023 are: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.386%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-507">46.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-508">41.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-509">37.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-510">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="f-511">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="f-512">123.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="f-513">308.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-514">54.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-515">253.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_97"></div><ix:nonNumeric contextRef="c-1" name="coo:BusinessCombinationAndAssetAcquisitionTextBlock" id="f-516" continuedAt="f-516-1" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 3. Acquisitions and Joint Venture</span></div><div style="margin-bottom:5pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">All acquisitions were funded by cash generated from operations or facility borrowings.</span></div><div style="margin-bottom:5pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company believes these acquisitions strengthen CooperSurgical's and CooperVision's businesses through the addition of new distributors or complementary products and services.</span></div><div style="margin-bottom:5pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Fiscal Year 2023</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On November 1, 2022, CooperVision completed the acquisition of a privately-held U.S.-based company that provides a broad portfolio of technologically advanced contact lens products, including scleral and hybrid lenses. The purchase price of the acquisition was $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-517">33.0</ix:nonFraction>&#160;million. Assets acquired primarily comprised of $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-518">12.6</ix:nonFraction>&#160;million of customer relationship related intangibles, </span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-516-1" continuedAt="f-516-2"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-519">7.6</ix:nonFraction>&#160;million of technology, $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="coo:BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-520">5.1</ix:nonFraction>&#160;million of net assets and $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-521">7.7</ix:nonFraction>&#160;million of goodwill. The goodwill is <ix:nonFraction unitRef="usd" contextRef="c-74" decimals="0" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:fixed-zero" scale="0" id="f-522">not</ix:nonFraction> deductible for tax purposes. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Fiscal Year 2022</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On May 31, 2022, CooperVision completed the acquisition of a privately-held Denmark-based contact lens distributor focusing on orthokeratology and scleral contact lenses. This acquisition expands CooperVision's ortho-k eye care portfolio in the Nordic market.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On April 6, 2022, CooperSurgical completed the acquisition of a private cryopreservation services company that specializes in cryogenic services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">Refer to the "Joint Venture" section below for details on formation of a joint venture with Essilor International and related activities that occurred in fiscal year 2023 and 2022 following the acquisition of SightGlass Vision, Inc. (SGV) in fiscal year 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On April 6, 2022, CooperSurgical entered into an asset purchase agreement to acquire Cook Medical's Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets. The aggregate consideration is $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-523">875.0</ix:nonFraction>&#160;million in cash, with $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="f-524">675.0</ix:nonFraction>&#160;million payable at the closing and the remaining $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-525">200.0</ix:nonFraction>&#160;million payable in $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-526"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-527"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-528"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-529">50.0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;million installments following each of the first, second, third and fourth anniversaries of the closing. The transaction is subject to customary closing conditions, such as receipt of required regulatory approvals. During the year ended October 31, 2023, CooperSurgical determined that the fulfillment of certain closing conditions related to regulatory approvals was no longer probable and paid $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="coo:AccruedAcquisitionTerminationFee" format="ixt:num-dot-decimal" scale="6" id="f-530">45.0</ix:nonFraction>&#160;million in expenses for a termination fee under the asset purchase agreement on August 9, 2023. The termination fee is recorded in "Selling, general and administrative expense" on the Consolidated Statements of Income. Refer to the "Subsequent Event" section below for details on the revised scope of the transaction and the closing of the updated transaction.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">On December 17, 2021, CooperSurgical completed the acquisition of <ix:nonFraction unitRef="number" contextRef="c-81" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-531">100</ix:nonFraction>% of the equity interests in Generate Life Sciences (Generate), a privately held leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood &amp; cord tissue), and paid an aggregate purchase consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="9" id="f-532">1.663</ix:nonFraction>&#160;billion, reflecting working capital, and other adjustments. The cash consideration was funded through a combination of $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-8" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="9" id="f-533">1.5</ix:nonFraction>&#160;billion in proceeds from the issuance of a senior unsecured term loan and available cash on hand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%">Joint Venture</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On January 19, 2021, CooperVision acquired all of the remaining equity interests of SGV, a privately-held medical device company that developed spectacle lenses for myopia management. The transaction included potential payments of future consideration that were contingent upon the achievement of the regulatory approval milestone (the regulatory approval payment) and the acquired business reaching certain revenue thresholds over a specified period (the revenue payments). The undiscounted range of the contingent consideration was <ix:nonFraction unitRef="usd" contextRef="c-84" decimals="0" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" format="ixt:fixed-zero" scale="0" id="f-534">zero</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="f-535">139.1</ix:nonFraction>&#160;million payable to the other former equity interest owners.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the regulatory approval payment was determined using an option pricing framework based on the expected payment under the contractual terms and the estimates of the probability of achieving the regulatory approval. The fair value of the revenue payments was determined using a Monte Carlo simulation based on the revenue projections and the expected payment for each simulation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In March 2022, the entities amended the terms of the contingent consideration, which resulted in CooperVision paying $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="coo:BusinessCombinationPaymentToSettleContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="f-536">42.9</ix:nonFraction>&#160;million to the former equity interest owners in exchange for the elimination of the revenue payments to such former equity interest owners. CooperVision recognized a net gain of $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" format="ixt:num-dot-decimal" scale="6" id="f-537">12.2</ix:nonFraction>&#160;million during fiscal 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Further, CooperVision and Essilor International SAS (Essilor) executed a Contribution Agreement and a Stock Purchase Agreement (the "Agreements") in March 2022. Essilor paid CooperVision $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="f-538">52.1</ix:nonFraction>&#160;million in exchange for a <ix:nonFraction unitRef="number" contextRef="c-88" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-539">50</ix:nonFraction>% interest in SGV and their proportionate share of the revenue payments. As part of the Agreements, each party contributed their interest in SGV and $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-6" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-540"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-6" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-541">10</ix:nonFraction></ix:nonFraction>&#160;million in cash to form a new joint venture. CooperVision then remeasured the fair value of its retained equity investment in the joint venture at $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-542">90.0</ix:nonFraction>&#160;million which resulted in a $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="f-543">56.9</ix:nonFraction>&#160;million gain in Other (income) expense on deconsolidation of SGV in fiscal 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">During fiscal 2023, CooperVision determined that approval would not be achieved within the timeline set forth in the contractual terms of the regulatory approval payment and released the remaining $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="f-544">31.8</ix:nonFraction>&#160;million contingent consideration liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Subsequent Event</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On November 1, 2023, CooperSurgical closed the acquisition of select assets of Cook Medical for an aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-545">300.0</ix:nonFraction>&#160;million, with $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="f-546">200.0</ix:nonFraction>&#160;million paid at closing and $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-547">100.0</ix:nonFraction>&#160;million to be paid in <ix:nonFraction unitRef="installment" contextRef="c-92" decimals="0" name="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments" format="ixt-sec:numwordsen" scale="0" id="f-548">two</ix:nonFraction> $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-549"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="f-550">50.0</ix:nonFraction></ix:nonFraction>&#160;million annual installments. The </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-516-2"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">assets acquired primarily comprised of minimally invasive medical devices within the obstetrics, doppler monitoring and gynecology surgery markets. The Company is in the process of finalizing purchase accounting information.</span></div></ix:continuation><div id="i73c86eef1c5e443ab4ef06a723adb0ef_100"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="f-551" continuedAt="f-551-1" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 4. Intangible Assets</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="reporting_unit" contextRef="c-1" decimals="0" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="f-552">three</ix:nonFraction> reporting units: CooperVision and within the CooperSurgical segment, Office/Surgical and Fertility, reflecting the current way the Company manages its business. There was <ix:nonFraction unitRef="usd" contextRef="c-6" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-553"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-554"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-555">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment of goodwill in its reporting units in fiscal 2023, 2022, and 2021.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfGoodwillTextBlock" id="f-556" escape="true"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperVision</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperSurgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-557">1,710.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-558">1,899.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-559">3,609.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net changes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="f-560">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" sign="-" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="f-561">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="f-562">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="f-563">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="f-564">18.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="f-565">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-566">1,747.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-567">1,876.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-568">3,624.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Of the October&#160;31, 2023, goodwill balance, $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="f-569">237.6</ix:nonFraction> million for CooperSurgical and $<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="f-570">20.1</ix:nonFraction> million for CooperVision is expected to be deductible for tax purposes. Of the October&#160;31, 2022, goodwill balance, $<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="f-571">214.1</ix:nonFraction>&#160;million for CooperSurgical and $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="f-572">22.4</ix:nonFraction>&#160;million for CooperVision was expected to be deductible for tax purposes.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-574" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="f-573" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31, 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Weighted-average Amortization Period (in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-575">208.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-576">81.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-577">209.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-578">62.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-101" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-579">15</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Composite intangible asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-580">1,061.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-581">424.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-582">1,061.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-583">354.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-103" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-584">15</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-585">494.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-586">335.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-587">504.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-588">317.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-105" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-589">13</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-590">1,099.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-591">345.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-592">1,092.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-593">287.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-107" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-594">19</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">License and distribution rights and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-595">51.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-596">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-597">50.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-598">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-109" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-599">11</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-600">2,916.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-601">1,215.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-602">2,919.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-603">1,044.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-604">16</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: accumulated amortization and translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-605">1,215.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-606">1,044.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-607">1,701.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-608">1,874.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="f-609">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="f-610">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total other intangibles, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-611">1,710.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-612">1,885.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Intangible assets with indefinite lives include technology and trademarks.</span></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Balances include foreign currency translation adjustments. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="f-613" continuedAt="f-613-1" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2023, the estimate of future amortization expenses for intangible assets with definite lives is as follows:</span></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-551-1" continuedAt="f-551-2"><ix:continuation id="f-613-1"><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal years:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="f-614">179.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="f-615">169.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="f-616">162.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="f-617">147.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="f-618">143.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="f-619">899.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total remaining amortization for intangible assets with definite lives</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-620">1,701.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the fourth quarter of fiscal 2023, CooperVision fully impaired some intangible assets associated with the discontinuation of certain products. The carrying value of these intangible assets were immaterial. The Company performed its annual impairment assessment in the third quarter of fiscal 2023 and determined there was <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="f-621"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-622">no</ix:nonFraction></ix:nonFraction> other impairment to either its definite-lived or indefinite-lived intangible assets during fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023. </span></div></ix:continuation><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:continuation id="f-551-2">There were <ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="f-623"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="f-624"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-625"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-626">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment to the Company's definite-lived or indefinite-lived intangible assets during fiscal 2022 and 2021.</ix:continuation> </span></div><div style="margin-top:9pt"><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_103"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-627" continuedAt="f-627-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 5. Financing Arrangements</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtTableTextBlock" id="f-628" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company had outstanding debt as follows:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.413%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Overdraft and other credit facilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="f-629">44.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="f-630">57.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="f-631">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="f-632">338.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt, excluding financing leases</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="f-633">44.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="f-634">395.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-635"><span style="-sec-ix-hidden:f-636">Financing lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="f-637">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="f-638">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="f-639">45.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="f-640">412.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Revolving credit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-641">172.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="f-642">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-643">2,350.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-644">2,350.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-645">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-646">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredFinanceCostsNoncurrentNet" scale="6" id="f-647">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredFinanceCostsNoncurrentNet" scale="6" id="f-648">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt, excluding financing leases</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-649">2,520.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-650">2,347.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-651"><span style="-sec-ix-hidden:f-652">Financing lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-653">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-654">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="f-655">2,523.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="f-656">2,350.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="f-657">2,569.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="f-658">2,763.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2023, the Company was in compliance with all debt covenants. On February 1, 2023, the Company amended its credit agreements to transition the interest rates applicable to the loans denominated in U.S. dollars from LIBOR to SOFR, as defined in the credit agreements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Term Loan Agreement on December 17, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On December 17, 2021, the Company entered into a Term Loan Agreement (the 2021 Credit Agreement) by and among the Company, the lenders from time to time party thereto, and PNC Bank, National Association, as administrative agent. The 2021 Credit Agreement provides for a term loan facility (the 2021 Term Loan Facility) in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="f-659">1.5</ix:nonFraction>&#160;billion, which, unless terminated earlier, matures on December 17, 2026. In addition, the Company has the ability from time to time to request an increase to the commitments under the 2021 Term Loan Facility or to establish a new term loan facility under the 2021 Credit Agreement in an aggregate principal amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-6" name="coo:LineOfCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="9" id="f-660">1.125</ix:nonFraction>&#160;billion, upon prior written </span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-627-1" continuedAt="f-627-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">notice to the administrative agent and subject to the discretionary participation of the lenders funding such term loans and certain limitations set forth in the 2021 Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Amounts outstanding under the 2021 Term Loan Facility will bear interest, at the Company&#8217;s option, at either (i) the alternate base rate, which is a rate per annum equal to the greatest of (a) the administrative agent&#8217;s prime rate, (b) one-half of one percent in excess of the federal funds effective rate and (c) <ix:nonFraction unitRef="number" contextRef="c-122" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" format="ixt-sec:numwordsen" scale="-2" id="f-661">one</ix:nonFraction> percent in excess of the adjusted SOFR for a one-month interest period in effect on such day, or (ii) the adjusted SOFR, plus, in each case, an applicable rate of, initially, <ix:nonFraction unitRef="number" contextRef="c-123" decimals="0" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" format="ixt:fixed-zero" scale="-4" id="f-662">zero</ix:nonFraction> basis points, in respect of base rate loans, and <ix:nonFraction unitRef="number" contextRef="c-124" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-663">75</ix:nonFraction> basis points, in respect of adjusted SOFR loans. Following a specified period after the closing date, the applicable rates will be determined quarterly by reference to a grid based upon the Company&#8217;s ratio of consolidated net indebtedness to consolidated EBITDA, each as defined in the 2021 Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company may prepay loan balances from time to time, in whole or in part, without premium or penalty (other than any related breakage costs).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On October&#160;31, 2023, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-8" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="9" id="f-664">1.5</ix:nonFraction>&#160;billion outstanding on the 2021 Term Loan Facility and the weighted-average interest rate was <ix:nonFraction unitRef="number" contextRef="c-125" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="f-665">6.41</ix:nonFraction>%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio, each as defined in the 2021 Credit Agreement, consistent with the 2020 Credit Agreement discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Term Loan Agreement on November 2, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On November 2, 2021, the Company entered into a <ix:nonNumeric contextRef="c-126" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="f-666">364</ix:nonNumeric>-day, $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-667">840.0</ix:nonFraction>&#160;million, term loan agreement by and among the Company, the lenders party thereto and The Bank of Nova Scotia, as administrative agent, which matured subsequent to year end on November 1, 2022. The Company used part of the funds to partially repay outstanding borrowings under the 2020 Revolving Credit Facility and for general corporate purposes. The loan was fully repaid by the maturity date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Revolving Credit and Term Loan Agreement on April 1, 2020</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On April 1, 2020, the Company entered into a Revolving Credit and Term Loan Agreement (the 2020 Credit Agreement), among the Company, CooperVision International Holding Company, LP, CooperSurgical Netherlands B.V., CooperVision Holding Kft. the lenders from time to time party thereto, and KeyBank National Association, as administrative agent. The 2020 Credit Agreement provides for (a)&#160;a multicurrency revolving credit facility (the 2020 Revolving Credit Facility) in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="f-668">1.29</ix:nonFraction> billion and (b)&#160;a term loan facility (the 2020 Term Loan Facility) in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-669">850.0</ix:nonFraction> million, each of which, unless terminated earlier, mature on April 1, 2025. The Company used $<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-670">850.0</ix:nonFraction>&#160;million under the 2020 Term Loan Facility and $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-671">445.0</ix:nonFraction>&#160;million under the 2020 Revolving Credit Facility to fully repay all borrowings outstanding under a previously existing term loan agreement and transfer all letters of credit and borrowings outstanding under a previously existing credit agreement to the 2020 Credit Agreement. The Company has an uncommitted option to increase the revolving credit facility or establish a new term loan in an aggregate amount up to $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-6" name="coo:LineOfCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="9" id="f-672">1.605</ix:nonFraction>&#160;billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On October 30, 2020, the Company entered into Amendment No. 1 to the 2020 Credit Agreement, adding CooperVision International Limited as a revolving borrower and releasing certain borrowers in the 2020 Credit Agreement. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">On December 17, 2021, the Company entered into Amendment No.2 to the 2020 Credit Agreement, modifying the 2020 Credit Agreement by, among other things, adding CooperSurgical Holdings Limited as a revolving borrower, releasing CooperVision Holding Kft as a borrower, and updating the benchmark replacement language in the 2020 Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">The 2020 Credit Agreement will bear interest, at the Company&#8217;s option, at either the alternate base rate, or the adjusted SOFR, or adjusted foreign currency rate, plus, in each case, an applicable rate of between <ix:nonFraction unitRef="number" contextRef="c-133" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-673">0.00</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-134" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-674">0.50</ix:nonFraction>% in respect of base rate loans, and between <ix:nonFraction unitRef="number" contextRef="c-135" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-675">0.75</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-136" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-676">1.50</ix:nonFraction>% in respect of adjusted SOFR or adjusted foreign currency rate loans, in each case in accordance with a pricing grid tied to the Total Leverage Ratio, as defined in the 2020 Credit Agreement. The Company may borrow, repay and re-borrow amounts available under the Revolving Credit Facility, subject to voluntary reduction of the revolving commitment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company pays an annual commitment fee that ranges from <ix:nonFraction unitRef="number" contextRef="c-137" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-677">0.10</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-138" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-678">0.20</ix:nonFraction>% of the unused portion of the 2020 Revolving Credit Facility based upon the Company&#8217;s Total Leverage Ratio, as defined in the 2020 Credit Agreement. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On October&#160;31, 2023, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-679">850.0</ix:nonFraction> million outstanding under the 2020 Term Loan Facility and $<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-680">172.6</ix:nonFraction> million outstanding under the 2020 Revolving Credit Facility. The interest rate on the 2020 Term Loan Facility was <ix:nonFraction unitRef="number" contextRef="c-139" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="f-681">6.41</ix:nonFraction>% at October&#160;31, 2023. The weighted-average interest rate on the 2020 Revolving Credit Facility was <ix:nonFraction unitRef="number" contextRef="c-140" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="f-682">6.41</ix:nonFraction>% at October&#160;31, 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-627-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Payments on the outstanding long-term debt balance of $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-683">850.0</ix:nonFraction>&#160;million are due in the fiscal year ending October 31, 2025.</span></div><div style="margin-top:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">European and Asian Pacific Credit Facilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company maintains European credit facilities. The aggregate facility limit was $<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-684">32.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-685">30.7</ix:nonFraction>&#160;million at October&#160;31, 2023 and 2022, respectively. At October&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-686">0.7</ix:nonFraction> million of the facilities was utilized and the weighted-average interest rate on the outstanding balances was <ix:nonFraction unitRef="number" contextRef="c-141" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="f-687">7.82</ix:nonFraction>%. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company maintains yen-denominated credit facilities in Japan. The aggregate facility limit was $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-688">74.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-689">73.0</ix:nonFraction>&#160;million at October&#160;31, 2023 and 2022, respectively. At October&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-690">41.4</ix:nonFraction> million of the combined facilities was utilized and the weighted-average interest rate on the outstanding balances was <ix:nonFraction unitRef="number" contextRef="c-143" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="f-691">0.40</ix:nonFraction>%. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Each facility is supported by a continuing and unconditional guaranty.</span></div></ix:continuation><div style="margin-top:9pt"><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_109"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-693" continuedAt="f-693-1" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 6. Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In November 2020, the Company completed an intra-group transfer of certain intellectual property and related assets of CooperVision to a UK subsidiary as part of a group restructuring to establish headquarters operations in the UK. Determining fair value involved significant judgment related to future revenue growth, operating margins, and discount rates. The transfer resulted in a step-up of the UK tax-deductible basis in the intellectual property and goodwill, creating a temporary difference between the book basis and the tax basis of these assets. As a result, the Company recognized a deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" format="ixt:num-dot-decimal" scale="6" id="f-694">1,987.9</ix:nonFraction>&#160;million, with a corresponding income tax benefit, during the first quarter of fiscal 2021. During the third quarter of fiscal 2021, the Company recognized a $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-695">536.7</ix:nonFraction>&#160;million tax benefit related primarily to the remeasurement of this deferred tax asset caused by the UK enactment of a 25% corporate tax rate.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-696" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Components of income before income taxes:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/>(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-697">135.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-698">31.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-699">31.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-700">548.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-701">443.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-702">522.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-703">412.9</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-704">475.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-705">491.5</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-706" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Components of provision for income taxes: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-707">37.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-708">10.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-709">21.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-710">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-711">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-712">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-713">33.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-714">21.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-715">26.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-716">74.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-717">35.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-718">49.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-719">36.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-720">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-721">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-722">7.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-723">2.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-724">0.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-725">88.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-726">45.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-727">2,492.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-728">44.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-729">53.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-730">2,502.2</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-731">118.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-732">89.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-733">2,453.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-693-1" continuedAt="f-693-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-734" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes at United States statutory tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="f-735">86.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="f-736">99.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="f-737">103.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Decrease) increase in taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign earnings in jurisdictions with different tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="f-738">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="f-739">22.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="f-740">43.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign earnings subject to United States tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings" scale="6" id="f-741">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings" scale="6" id="f-742">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings" scale="6" id="f-743">25.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Excess tax benefits from share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="f-744">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="f-745">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="f-746">13.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intra-group transfer to UK subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationDispositionOfAssets" format="ixt:fixed-zero" scale="6" id="f-747">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxReconciliationDispositionOfAssets" format="ixt:fixed-zero" scale="6" id="f-748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationDispositionOfAssets" format="ixt:num-dot-decimal" scale="6" id="f-749">1,987.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Remeasurement of deferred tax assets from UK rate change</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:fixed-zero" scale="6" id="f-750">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:fixed-zero" scale="6" id="f-751">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="f-752">536.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" format="ixt:fixed-zero" scale="6" id="f-753">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" scale="6" id="f-754">12.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" scale="6" id="f-755">7.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="f-756">4.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="f-757">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="f-758">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="f-759">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="f-760">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="f-761">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-762">118.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-763">89.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-764">2,453.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-765" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Components of deferred tax assets and liabilities:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="f-766">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="f-767">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="f-768">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="f-769">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued liabilities, reserves and compensation accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="f-770">94.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="f-771">79.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign deferred tax assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" format="ixt:num-dot-decimal" scale="6" id="f-772">2,369.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" format="ixt:num-dot-decimal" scale="6" id="f-773">2,500.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="f-774">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="f-775">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net operating loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="coo:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" scale="6" id="f-776">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="coo:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" scale="6" id="f-777">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capitalized research and experimental expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="6" id="f-778">23.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="6" id="f-779">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-780">2,548.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-781">2,641.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-782">20.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-783">60.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-784">2,528.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-785">2,581.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax deductible goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" scale="6" id="f-786">47.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" scale="6" id="f-787">39.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="f-788">132.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="f-789">153.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="f-790">51.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="f-791">48.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="coo:DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" scale="6" id="f-792">49.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="coo:DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" scale="6" id="f-793">45.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="f-794">280.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="f-795">287.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="f-796">2,248.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="f-797">2,293.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, the Company analyzes whether some or all deferred tax assets will not be realized. This analysis considers historical taxable income, the projected reversal of deferred tax liabilities, projected taxable income and tax planning strategies. Based upon this analysis, it is more likely than not the deferred tax assets, net of valuation allowance, will be realized. The decrease in valuation allowance is primarily related to foreign tax attributes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">At October&#160;31, 2023, the Company had federal net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-798">78.7</ix:nonFraction>&#160;million and state net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-799">87.1</ix:nonFraction>&#160;million. Federal net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-800">46.0</ix:nonFraction>&#160;million expire on various dates between 2024 and 2037 and $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-801">32.7</ix:nonFraction>&#160;million do not expire. The state net operating loss carryforwards expire on various dates between 2027 through 2044.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="f-693-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A tax benefit is recognized if it is more likely than not that a tax position will be sustained on its technical merits, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="f-802" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Changes in unrecognized tax benefits:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-803">353.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Decrease based on tax positions in prior fiscal years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-804">12.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="f-805">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lapses of statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="f-806">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-807">336.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Decrease based on tax positions in prior fiscal years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-808">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Increase based on tax positions in current fiscal year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-809">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lapses of statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="f-810">6.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-811">331.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">These tax benefits, if recognized, would reduce provision for income taxes for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">, by $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-812">323.2</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-813">324.3</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-814">336.5</ix:nonFraction>&#160;million, respectively. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes. As of October 31, 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">, accrued gross interest and penalties related to unrecognized tax benefits was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="f-815">5.8</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="f-816">5.4</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="f-817">6.4</ix:nonFraction>&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Included in the balance of unrecognized tax benefits at October&#160;31, 2023, is $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" format="ixt:num-dot-decimal" scale="6" id="f-818">8.1</ix:nonFraction>&#160;million related to tax positions for which it is reasonably possible that the total amounts could change during the next twelve months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Filed tax returns are subject to examination by tax authorities in major tax jurisdictions after fiscal 2018, including the UK and the US.</span></div></ix:continuation><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_112"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-819" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 7. Earnings Per Share</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-820" escape="true"><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.135%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions, except for earnings per share)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-821">294.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-822">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-823">2,944.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted-average common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-824">49.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-825">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-826">49.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-827">5.94</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-828">7.83</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-829">59.80</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted-average common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-830">49.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-831">49.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-832">49.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effect of dilutive stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-833">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-834">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-835">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted weighted-average common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-836">49.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-837">49.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-838">49.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-839">5.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-840">7.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-841">59.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-842" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth stock options to purchase our common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except exercise prices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stock option shares excluded</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-150" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-843">311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-151" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-844">227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-152" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-845">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exercise prices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-846">300.12</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-847">406.17</ix:nonFraction></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-848">300.12</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-849">406.17</ix:nonFraction></span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-850"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-851">345.74</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restricted stock units excluded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-153" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-852">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-154" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-853">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-155" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-854">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_115"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-855" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 8. Stockholders&#8217; Equity</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-856" continuedAt="f-856-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Analysis of Changes in Accumulated Other Comprehensive Income (Loss):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Minimum Pension Liability</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-857">402.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-858">13.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-859">56.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-860">472.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-861">82.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-862">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-863">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-864">146.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="f-865">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="f-866">8.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="f-867">7.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="f-868">15.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-869">320.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-870">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-871">34.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-872">341.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-873">234.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-874">107.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-875">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-876">90.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="f-877">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="f-878">26.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="f-879">8.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="f-880">34.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-881">555.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-882">94.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-883">6.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-884">466.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-885">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-886">9.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-887">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-888">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="f-889">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="f-890">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="f-891">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="f-892">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-893">538.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-894">87.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-895">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-896">453.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share Repurchases </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In December 2011, the Company's Board of Directors authorized the 2012 Program and through subsequent amendments, the most recent in March 2017, the total repurchase authorization was increased from $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-897">500.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="f-898">1.0</ix:nonFraction> billion of the Company's common stock. This program has no expiration date and may be discontinued at any time. Purchases under the 2012 Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements. As of October&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="f-899">256.4</ix:nonFraction> million remained authorized for repurchase under the program.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">During the year ended October&#160;31, 2023, there were <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="0" id="f-900">no</ix:nonFraction> share repurchases under the 2012 Program. During the year ended October&#160;31, 2022, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="f-901">191.2</ix:nonFraction> thousand</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="f-902">78.5</ix:nonFraction> million, at an average purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-903">410.41</ix:nonFraction> per share. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In fiscal 2023 and 2022, the Company declared regular dividends of <ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" format="ixt:num-dot-decimal" scale="-2" id="f-904"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" format="ixt:num-dot-decimal" scale="-2" id="f-905">6</ix:nonFraction></ix:nonFraction>&#160;cents per share (a semiannual dividend of <ix:nonFraction unitRef="usdPerShare" contextRef="c-179" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" format="ixt:num-dot-decimal" scale="-2" id="f-906"><ix:nonFraction unitRef="usdPerShare" contextRef="c-180" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" format="ixt:num-dot-decimal" scale="-2" id="f-907"><ix:nonFraction unitRef="usdPerShare" contextRef="c-181" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" format="ixt:num-dot-decimal" scale="-2" id="f-908"><ix:nonFraction unitRef="usdPerShare" contextRef="c-182" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" format="ixt:num-dot-decimal" scale="-2" id="f-909">3</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;cents per share) and paid a total of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-910"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-911">3.0</ix:nonFraction></ix:nonFraction>&#160;million in each fiscal year. In December 2023, our Board of Directors decided to end the declaration of the semiannual dividend.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Subsequent Event</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On December 7, 2023, we announced that our Board of Directors had approved a <ix:nonFraction unitRef="number" contextRef="c-183" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" format="ixt-sec:numwordsen" scale="0" id="f-912">four</ix:nonFraction>-for-one stock split of our outstanding shares of common stock which we expect to be effected as of February 16, 2024.</span></div></ix:nonNumeric><div id="i73c86eef1c5e443ab4ef06a723adb0ef_118"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-913" continuedAt="f-913-1" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 9. Stock Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2007 Long-Term Incentive Plan (2007 Plan)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In March 2007, we received stockholder approval of the 2007 Plan. The 2007 Plan was subsequently amended and restated, and granted stockholder approval in March 2009, March 2011, and March 2016.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Third Amended and Restated 2007 Plan authorizes either our Board of Directors, or a designated committee thereof composed of <ix:nonFraction unitRef="director" contextRef="c-184" decimals="INF" name="coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" format="ixt-sec:numwordsen" scale="0" id="f-914">two</ix:nonFraction> or more Non-Employee Directors, to grant to eligible individuals during the period ending December&#160;31, 2026, up to <ix:nonFraction unitRef="shares" contextRef="c-185" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-915">6,930,000</ix:nonFraction> shares in the form of specified equity awards including stock options, restricted stock units and performance share awards. RSUs have no dividend or voting rights prior to vesting. Awards under the 2007 Plan remain outstanding but new awards are no longer being granted.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023 Long-Term Incentive Plan (2023 Plan)</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-913-1" continuedAt="f-913-2"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In March 2023, we received stockholder approval of the 2023 Plan. The 2023 Plan authorizes either our Board of Directors, or a designated committee thereof composed of <ix:nonFraction unitRef="director" contextRef="c-186" decimals="INF" name="coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" format="ixt-sec:numwordsen" scale="0" id="f-916">two</ix:nonFraction> or more Non-Employee Directors, to grant to eligible individuals up to <ix:nonFraction unitRef="shares" contextRef="c-187" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-917">1,365,000</ix:nonFraction> shares in the form of specified equity awards including stock options, restricted stock units (RSUs) and performance share units (PSUs), subject to adjustment for future stock splits, stock dividends, expirations, forfeitures, and similar events. In addition, the 2023 Plan includes any shares which were available for issuance under the 2007 Plan at the time of stockholder approval of this plan and shares which become available as a result of the forfeiture or expiration of awards made under the 2007 Plan. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="c-188" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-918">1,376,240</ix:nonFraction> shares remained available under the 2023 Plan for future grants. The amount of available shares includes shares which may be distributed under performance shares.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-919" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The compensation expense and related income tax benefit recognized in our Consolidated Statements of Income for share-based awards, including the Employee Stock Purchase Plan, were as follows:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October 31,</span></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-920">54.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-921">46.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-922">38.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-923">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-924">4.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-925">3.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-926">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-927">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-928">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-929">62.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-930">54.2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-931">44.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Related income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-932">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-933">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-934">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Stock Options </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of each stock option award granted is estimated on the date of grant using the Black-Scholes option valuation model and assumptions noted in the following table. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-935" escape="true"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.037%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-196" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-936">4.5</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-197" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-937">4.1</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-938">4.0</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-196" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-939">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-197" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-940">25.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-198" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-941">30.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-196" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-942">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-197" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-943">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-198" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-944">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-196" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-945">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-197" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-946">0.02</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-198" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-947">0.02</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-948" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The activity and status of our stock option plans are summarized below: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise&#160;Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Outstanding at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-199" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-949">1,063,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-199" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-950">264.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-196" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-951">86,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-196" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-952">329.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-196" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-953">71,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-196" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-954">155.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-196" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="f-955">720</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-196" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-956">337.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Outstanding at October&#160;31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-200" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-957">1,077,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-200" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-958">277.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-196" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-959">5.36</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="f-960">53,510,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and expected to vest at October 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-961">1,059,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-962">276.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-963">5.32</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="f-964">53,475,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and exercisable at October&#160;31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-965">729,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-966">248.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-967">4.38</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="0" id="f-968">50,797,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The weighted-average fair value of options granted during fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">, estimated as of the grant date using the Black-Scholes option pricing model, was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-201" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-969">103.17</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-202" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-970">90.41</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-203" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-971">84.10</ix:nonFraction>, respectively. The total intrinsic value of options exercised during the fiscal years ended October&#160;31, 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> was $<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-972">13.4</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-973">6.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-974">64.7</ix:nonFraction>&#160;million, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-913-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Stock options outstanding under our current plans have been granted at prices which are either equal to or above the market value of the common stock on the date of grant. Options granted under the 2007 Plan and 2023 Plan generally vest over a range of <span style="-sec-ix-hidden:f-975">three</span> to <ix:nonNumeric contextRef="c-205" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-976">five years</ix:nonNumeric> based on service conditions and expire no later than <ix:nonNumeric contextRef="c-201" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-977">ten years</ix:nonNumeric> after the grant date. We generally recognize compensation expense ratably over the vesting period. As of October&#160;31, 2023, there was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="f-978">17.6</ix:nonFraction>&#160;million of total unrecognized compensation cost related to nonvested options, which is expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric contextRef="c-196" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-979">2.1</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">RSUs granted under the 2007 Plan and the 2023 Plan generally vest over <span style="-sec-ix-hidden:f-980">three</span> to <ix:nonNumeric contextRef="c-207" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-981">five years</ix:nonNumeric>. The grant-date fair value of RSUs is estimated based on the market price of our common stock. We recognize compensation expense ratably over the vesting period. As of October&#160;31, 2023, there was $<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="f-982">63.1</ix:nonFraction>&#160;million of total unrecognized compensation cost related to nonvested RSUs, which is expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric contextRef="c-209" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-983">2.4</ix:nonNumeric> years. The total fair value of RSU grants that vested during the fiscal years ended October&#160;31, 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> was $<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-984">37.3</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-985">46.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-986">50.1</ix:nonFraction>&#160;million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="f-987" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The status of our non-vested RSUs is summarized below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant&#160;Date&#160;Fair<br/>Value&#160;Per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-vested RSUs at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-212" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-988">289,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-212" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-989">340.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-209" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-990">145,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-209" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-991">335.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-209" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-992">107,403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-209" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-993">320.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-209" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-994">37,461</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-209" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-995">344.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-vested RSUs at October&#160;31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-208" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-996">290,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-208" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-997">345.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Performance Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Performance units may be granted to selected key employees with vesting contingent upon meeting certain performance goals over a defined performance cycle, usually <ix:nonNumeric contextRef="c-213" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-998">three years</ix:nonNumeric>. Performance units, if earned, may be paid in cash or shares of common stock. We granted performance unit awards on December 13, 2022, December 7, 2021, and December 8, 2020, under the 2007 Plan, with <ix:nonNumeric contextRef="c-213" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-999">three-year</ix:nonNumeric> performance periods ending in fiscal 2025, fiscal 2024, and fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> respectively. The performance shares actually earned will range from <ix:nonFraction unitRef="number" contextRef="c-214" decimals="INF" name="coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" format="ixt:fixed-zero" scale="-2" id="f-1000">zero</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="c-215" decimals="INF" name="coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" scale="-2" id="f-1001">200</ix:nonFraction>% of the target number of performance shares. Subject to limited exceptions set forth in the performance share agreement, any shares earned will be distributed in the subsequent fiscal year after the performance period. The fair value of performance unit awards is estimated on the date of grant based on the current market price of our common stock. The amount of compensation expense related to these performance unit awards is reviewed each fiscal quarter and adjustments are recorded after assessing the probability of achieving the performance goals.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We recognize compensation expense ratably over the vesting period. As of October&#160;31, 2023, there was $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="f-1002">12.3</ix:nonFraction>&#160;million of total unrecognized compensation cost related to non-vested performance units, which is expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric contextRef="c-213" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1003">1.7</ix:nonNumeric> years.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On March 18, 2019, the Company received stockholder approval for the Employee Stock Purchase Plan (ESPP). The first offering period began on November 4, 2019, and offerings are generally made on a quarterly basis. The purpose of the ESPP is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at <ix:nonFraction unitRef="number" contextRef="c-217" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="f-1004">85</ix:nonFraction>% of the market price on the last business day of each offering period by means of accumulated payroll deductions. The ESPP initially authorized the issuance of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-218" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1005">1,000,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> shares of common stock. These shares will be made available from shares of common stock reacquired by the Company as Treasury Stock. During fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> and 2022, we issued <ix:nonFraction unitRef="shares" contextRef="c-219" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1006">26,116</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-220" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1007">22,695</ix:nonFraction> shares to our employees under the ESPP, respectively. At October&#160;31, 2023, the number of shares remaining available for future issuance under the ESPP was <ix:nonFraction unitRef="shares" contextRef="c-221" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-1008">921,975</ix:nonFraction> shares. Total ESPP share-based compensation recognized during fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> and 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-1009">1.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-1010">1.1</ix:nonFraction> million, respectively.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_121"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="f-1011" continuedAt="f-1011-1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 10. Employee Benefits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cooper's Retirement Income Plan</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company's Retirement Income Plan (Plan), a defined benefit plan, is only available to full-time United States employees, subject to the soft freeze mentioned below. The Company's contributions are designed to fund normal cost on a current basis and to fund the estimated prior service cost of benefit improvements. The unit credit actuarial cost method is used to determine the annual cost. The Company pays the entire cost of the Plan and funds such costs as they accrue. Virtually all of the assets of the Plan are comprised of equities and participation in equity and fixed income funds.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses individual spot rates along the yield curve that correspond with the timing of each benefit payment to determine the service and interest costs of components of its net periodic benefit cost utilizing the correlation of projected cash outflows and corresponding spot rates on the yield curve. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" id="f-1012" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth the Plan's benefit obligations and fair value of the Plan assets at October&#160;31, 2023, 2022 and 2021 and the funded status of the Plan and net periodic pension costs for each of the years in the three-year periods ended October&#160;31, 2023. The net amounts recognized in the Consolidated Balance Sheets consist of noncurrent liabilities. The accumulated benefit obligation was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="f-1013">131.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="f-1014">134.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="f-1015">207.6</ix:nonFraction> million for the years ended October&#160;31, 2023, 2022 and 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Retirement Income Plan</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change in benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-1016">148.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-1017">230.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-1018">218.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1019">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1020">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1021">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1022"><span style="-sec-ix-hidden:f-1023"><span style="-sec-ix-hidden:f-1024">Interest cost</span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1025">7.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1026">5.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1027">4.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="f-1028">10.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="f-1029">13.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="f-1030">11.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-1031">10.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-1032">93.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-1033">2.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-1034">144.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-1035">148.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="f-1036">230.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1037">142.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1038">199.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1039">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="f-1040">4.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="f-1041">43.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="f-1042">38.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="f-1043">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="6" id="f-1044">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="f-1045">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="f-1046">10.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="f-1047">13.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="f-1048">11.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1049">137.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1050">142.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1051">199.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Funded status at end of year</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-1052">6.9</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-1053">5.1</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="f-1054">31.4</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" id="f-1055" escape="true"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amounts recognized in accumulated other comprehensive income consist of:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="f-1056">4.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="f-1057">8.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="f-1058">44.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="f-1059">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="f-1060">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="f-1061">44.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-1011-1" continuedAt="f-1011-2"><ix:nonNumeric contextRef="c-1" name="coo:ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" id="f-1062" escape="true"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reconciliation of (prepaid) accrued pension cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Prepaid)/Accrued pension cost at prior fiscal year end</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="coo:AccruedPrepaidPensionCosts" scale="6" id="f-1063">2.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" sign="-" name="coo:AccruedPrepaidPensionCosts" scale="6" id="f-1064">13.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" sign="-" name="coo:AccruedPrepaidPensionCosts" scale="6" id="f-1065">14.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1066">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1067">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1068">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Contributions made during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="f-1069">1.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="6" id="f-1070">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="f-1071">12.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Prepaid)/Accrued pension cost at fiscal year end</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="coo:AccruedPrepaidPensionCosts" scale="6" id="f-1072">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="coo:AccruedPrepaidPensionCosts" scale="6" id="f-1073">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" sign="-" name="coo:AccruedPrepaidPensionCosts" scale="6" id="f-1074">13.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="f-1075" escape="true"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1076">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1077">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-1078">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1079">7.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1080">5.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-1081">4.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1082"><span style="-sec-ix-hidden:f-1083"><span style="-sec-ix-hidden:f-1084">Expected return on plan assets</span></span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-1085">11.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-1086">15.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-1087">12.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1088"><span style="-sec-ix-hidden:f-1089"><span style="-sec-ix-hidden:f-1090">Recognized actuarial loss</span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" format="ixt:fixed-zero" scale="6" id="f-1091">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="f-1092">2.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="f-1093">5.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1094">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1095">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-1096">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="f-1097" escape="true"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Other changes in plan assets and benefit obligations recognized in other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net (gain) loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="f-1098">4.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="f-1099">34.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="f-1100">24.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortizations of net gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" format="ixt:fixed-zero" scale="6" id="f-1101">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" scale="6" id="f-1102">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" scale="6" id="f-1103">5.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in other comprehensive (income) loss</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="f-1104">4.0</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="f-1105">36.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="f-1106">29.8</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and other comprehensive (income) loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-1107">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-1108">26.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="f-1109">15.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="f-1110" escape="true"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate for determining net periodic pension cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Projected Benefit Obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" scale="-2" id="f-1111">5.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" scale="-2" id="f-1112">2.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" scale="-2" id="f-1113">2.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service Cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" scale="-2" id="f-1114">5.77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" scale="-2" id="f-1115">2.79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" scale="-2" id="f-1116">2.86</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest Cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" scale="-2" id="f-1117">5.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" scale="-2" id="f-1118">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" scale="-2" id="f-1119">2.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate for determining benefit obligations at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-1120">6.22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-1121">5.74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-32" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-1122">2.76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rate of compensation increase for determining expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-1123">3.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-1124">3.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-1125">3.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rate of compensation increase for determining benefit obligations at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="f-1126">3.60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="f-1127">3.60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-32" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="f-1128">3.60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected rate of return on plan assets for determining net periodic pension cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-1129">8.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-1130">8.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-1131">8.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected rate of return on plan assets at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" scale="-2" id="f-1132">8.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" scale="-2" id="f-1133">8.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-32" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" scale="-2" id="f-1134">8.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Measurement date for determining assets and benefit obligations at year end</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2021</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The discount rate enables us to state expected future cash flows at a present value on the measurement date. The discount rate used for the Plan is based primarily on the yields of a universe of high-quality corporate bonds rated AA or above, with durations corresponding to the expected durations of the benefit obligations. A change in the discount rate will cause the present value of benefit obligations to change in the opposite direction.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-1011-2" continuedAt="f-1011-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The expected rate of return on plan assets was determined based on a review of historical returns, both for this plan and for medium- to large-sized defined benefit pension funds with similar asset allocations. This review generated separate expected returns for each asset class listed below. These expected future returns were then blended based on this Plan's target asset allocation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Reasons for Significant Liability Gains and Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The projected benefit obligation experienced a net gain of approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="f-1135">10.9</ix:nonFraction> million during the year. This net gain is the result of assumption changes resulting in a gain of approximately $<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="f-1136">12.9</ix:nonFraction> million, offset by losses of approximately $<ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="f-1137">2.0</ix:nonFraction> million due to demographic experience. The key assumption changes were the increase in the discount rate (gain of $<ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="f-1138">7.8</ix:nonFraction> million), a changes in assumptions for lump sum determination (gain of $<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="f-1139">5.1</ix:nonFraction> million). Demographic losses were due to the net effect of retirement rates, termination rates, salary increases and other experience that was different from assumed. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="f-1140" continuedAt="f-1140-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Assets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Weighted-average asset allocations at year end, by asset category are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Asset category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-226" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1141">2.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-227" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1142">2.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-228" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1143">5.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Corporate common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-229" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1144">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-230" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1145">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-231" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1146">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity mutual funds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-232" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1147">39.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-233" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1148">33.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-234" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1149">32.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balanced funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-235" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1150">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-236" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1151">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-237" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1152">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Alternative investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-238" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1153">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-239" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1154">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-240" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1155">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Bond mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-241" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1156">28.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-242" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1157">27.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-243" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1158">28.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1159">100.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1160">100.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-32" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1161">100.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Plan invests in a diversified portfolio of assets intended to minimize risk of poor returns while maximizing expected portfolio returns. To achieve the long-term rate of return, plan assets will be invested in a mixture of instruments, including but not limited to, corporate common stock (may include the Company's stock), investment grade bond funds, cash, balanced funds, real estate funds, small or large cap equity funds and international equity funds. The allocation of assets will be determined by the investment manager and will typically include <ix:nonFraction unitRef="number" contextRef="c-244" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="f-1162">50</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-245" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="f-1163">70</ix:nonFraction>% equities with the remainder invested in fixed income, hedging strategy funds and cash. Presently, this diversified portfolio is expected to return roughly <ix:nonFraction unitRef="number" contextRef="c-4" decimals="2" name="coo:DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" scale="-2" id="f-1164">8</ix:nonFraction>% in the long run.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1140-1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of the measurement date of October&#160;31, 2023, the fair value measurement of plan assets is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.541%"><tr><td style="width:1.0%"></td><td style="width:47.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.499%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets for<br/>Identical&#160;Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Significant<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Asset category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1165">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1166">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1167">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1168">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Corporate common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1169">35.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1170">35.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1171">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1172">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1173">53.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1174">53.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1175">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1176">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balanced Funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1177">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1178">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1179">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1180">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Alternative investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1181">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1182">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1183">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1184">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1185">39.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1186">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1187">24.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1188">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1189">137.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1190">113.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="f-1191">24.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="f-1192">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Plan has an established process for determining the fair value of plan assets. For investments in equity and bond mutual funds, and real estate funds, fair value is based on observable, Level 1 inputs.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-1011-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Cash Flows</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Contributions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company made $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="f-1193">1.1</ix:nonFraction> million and <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="0" id="f-1194">no</ix:nonFraction> contributions to the Plan in fiscal 2023 and fiscal 2022, respectively. The Company contribution to the Plan was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="f-1195">12.7</ix:nonFraction>&#160;million for fiscal 2021. The Company closely monitors the funded status of the Plan with respect to legislative and accounting rules. The Company expected to make contributions totaling $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="f-1196">1.1</ix:nonFraction> million to the Plan during fiscal 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="f-1197" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Estimated Future Benefit Payments</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.451%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="f-1198">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2025</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="f-1199">11.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="f-1200">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2027</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="f-1201">11.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2028</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="f-1202">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2029-2033</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="f-1203">65.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Soft Freeze</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On June 18, 2019, the Board of Directors of the Company approved a soft freeze of the Plan effective August 1, 2019. The Plan was closed to employees hired on or after August 1, 2019, including former participants or employees rehired on or after August 1, 2019, and employees hired in connection with a stock or asset acquisition, merger or other similar transaction on or after August 1, 2019. Existing employees already covered by the Plan, continue to accrue their benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cooper's 401(k) Savings Plan</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Cooper's 401(k) savings plan provides for the deferral of compensation as described in the Internal Revenue Code and is available to substantially all United States employees. Employees who participate in the 401(k) plan may elect to have up to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="f-1204">75</ix:nonFraction>% of their pre-tax salary or wages deferred and contributed to the trust established under the Plan. Cooper's contributions on account of participating employees, were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="f-1205">10.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="f-1206">9.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="f-1207">7.2</ix:nonFraction> million for the years ended October&#160;31, 2023, 2022 and 2021, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_124"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1208" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 11. Contingencies </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company is involved in various lawsuits, claims and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company does not believe that the ultimate resolution of these proceedings or claims pending against it could have a material adverse effect on its financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">. Legal fees are expensed as incurred.</span></div></ix:nonNumeric><div id="i73c86eef1c5e443ab4ef06a723adb0ef_127"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1209" continuedAt="f-1209-1" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 12. Business Segment Information</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company discloses information about its operating segments, which were established based on the way that management organizes segments within the Company for making operating decisions and assessing financial performance. The Company's <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-1210">two</ix:nonFraction> operating segments are described below. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.68pt">CooperVision. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Competes in the worldwide contact lens market by developing, manufacturing and marketing a broad range of products for contact lens wearers, featuring advanced materials and optics.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="f-1209-1" continuedAt="f-1209-2"><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.68pt">CooperSurgical. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Competes in the general health care market with a focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women's health and fertility.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses operating income, as presented in our financial reports, as the primary measure of segment profitability. The Company does not allocate costs from corporate functions to segment operating income. The Company uses the same accounting policies to generate segment results as it does for consolidated results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">No customers accounted for 10% or more of our consolidated net revenue in fiscal 2023, 2022 and 2021. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Total identifiable assets are those used in continuing operations except cash and cash equivalents, which the Company includes as corporate assets. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="f-1211" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table presents a summary of our business segment net sales:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision net sales by category:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Toric lens</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1212">828.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1213">737.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1214">697.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Multifocal lens</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1215">305.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1216">264.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1217">238.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Single-use sphere lens</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1218">705.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1219">661.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1220">616.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non single-use sphere, other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1221">583.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1222">579.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1223">599.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total CooperVision net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1224">2,423.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1225">2,243.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1226">2,152.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical net sales by category:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Office and surgical </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1227">689.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1228">633.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1229">451.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fertility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1230">480.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1231">431.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1232">319.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total CooperSurgical net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1233">1,169.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1234">1,065.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1235">770.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1236">3,593.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1237">3,308.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1238">2,922.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-1239" escape="true"><ix:continuation id="f-1209-2" continuedAt="f-1209-3"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information by business segment for each of the years in the three-year period ended October&#160;31, 2023 follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.120%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperVision</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperSurgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1240">2,423.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1241">1,169.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="f-1242">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1243">3,593.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1244">587.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1245">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1246">70.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1247">533.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-1248">105.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1249">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1250">412.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1251">7,044.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1252">4,351.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-5" name="us-gaap:Assets" scale="6" id="f-1253">263.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1254">11,658.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1255">156.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1256">24.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-5" name="us-gaap:Depreciation" format="ixt:fixed-zero" scale="6" id="f-1257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1258">181.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-1259">32.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-1260">153.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:fixed-zero" scale="6" id="f-1261">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-1262">186.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-5" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1263">364.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-5" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1264">28.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-5" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" format="ixt:fixed-zero" scale="6" id="f-1265">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1266">392.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1267">2,243.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1268">1,065.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="f-1269">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1270">3,308.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1271">494.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1272">67.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1273">53.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1274">507.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-1275">57.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1276">25.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1277">475.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1278">6,778.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1279">4,407.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-5" name="us-gaap:Assets" scale="6" id="f-1280">305.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1281">11,492.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1282">144.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1283">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" name="us-gaap:Depreciation" format="ixt:fixed-zero" scale="6" id="f-1284">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1285">166.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-1286">32.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-1287">147.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:fixed-zero" scale="6" id="f-1288">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-1289">179.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1290">223.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1291">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" format="ixt:fixed-zero" scale="6" id="f-1292">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1293">242.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1294">2,152.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1295">770.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="f-1296">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1297">2,922.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1298">481.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1299">71.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1300">47.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1301">505.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-1302">23.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1303">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1304">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1305">6,965.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1306">2,395.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-5" name="us-gaap:Assets" scale="6" id="f-1307">244.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-1308">9,606.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1309">148.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1310">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-5" name="us-gaap:Depreciation" format="ixt:fixed-zero" scale="6" id="f-1311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1312">163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-1313">35.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-1314">110.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:fixed-zero" scale="6" id="f-1315">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-1316">146.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-3" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1317">190.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-3" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1318">24.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-3" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" format="ixt:fixed-zero" scale="6" id="f-1319">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1320">214.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="f-1321" escape="true"><ix:continuation id="f-1209-3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information by geographical area by country of domicile for each of the years in the three-year period ended October&#160;31, 2023 follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Rest of<br/>World,&#160;Other<br/>Eliminations<br/>&amp; Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1322">1,812.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1323">1,041.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1324">739.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1325">3,593.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1326">563.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1327">1,016.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1328">1,579.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1329">2,375.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1330">2,057.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1331">840.0</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1332">3,593.2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="f-1333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1334">516.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1335">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1336">533.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1337">1,027.6</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="f-1338">325.9</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="f-1339">279.1</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1340">1,632.6</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1341">1,638.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1342">987.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1343">682.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1344">3,308.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1345">514.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1346">897.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1347">1,411.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1348">2,152.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1349">1,884.5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1350">729.0</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1351">3,308.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1352">71.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1353">403.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1354">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1355">507.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="f-1356">856.1</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="f-1357">310.8</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="f-1358">266.0</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1359">1,432.9</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1360">1,339.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1361">957.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1362">625.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1363">2,922.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1364">494.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1365">815.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1366">1,310.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1367">1,834.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1368">1,773.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1369">684.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1370">2,922.5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1371">26.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1372">416.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1373">116.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1374">505.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-341" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="f-1375">737.5</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="f-1376">377.2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="f-1377">232.9</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1378">1,347.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_130"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="f-1379" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 13. Financial Derivatives and Hedging</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As part of the Company&#8217;s overall risk management practices the Company enters into financial derivatives, interest rate swaps designated as cash flow hedges, to hedge the Company's exposure to changes in cash flows associated with its variable rate debt.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Credit risk related to derivative transactions reflects the risk that a party to the transaction could fail to meet its obligation under the derivative contracts. Therefore, the Company&#8217;s exposure to the counterparty&#8217;s credit risk is generally limited to the amounts, if any, by which the counterparty&#8217;s obligations to the Company exceed the Company&#8217;s obligations to the counterparty. The Company&#8217;s policy is to enter into contracts only with financial institutions which meet certain minimum credit ratings to help mitigate counterparty credit risk. From time to time, the Company enters into foreign currency forward contracts to minimize the short-term impact of foreign currency exchange rate fluctuations on certain trade and intercompany receivables and payables. These foreign currency forward contracts are not designated as hedging instruments, and therefore the net change in their fair value is reported as a gain or loss in the Consolidated Statements of Income and Comprehensive Income. As of October&#160;31, 2023, the notional amount of outstanding foreign currency forward contracts was $<ix:nonFraction unitRef="usd" contextRef="c-344" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-1380">56.2</ix:nonFraction>&#160;million. The resulting impact on our Consolidated Financial Statements from currency hedging activities was not significant for the years ended October&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2023, the Company has <ix:nonFraction unitRef="interest_rate_swap_contract" contextRef="c-345" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="f-1381">six</ix:nonFraction> interest rate swap contracts that have a total notional amount of $<ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="f-1382">1.3</ix:nonFraction>&#160;billion and remaining maturities of <ix:nonNumeric contextRef="c-346" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durwordsen" id="f-1383">four years</ix:nonNumeric> or less. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="f-1384" escape="true"><div style="margin-bottom:7pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table summarizes the amounts recognized with respect to our derivative instruments within the accompanying Consolidated Statements of Income:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.301%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Periods Ended October 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Location of (Gain)/Loss Recognized on Derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense (income)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-1385">43.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-1386">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-1387">8.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The cumulative pre-tax impact of the gain on derivatives designated for hedge accounting is recognized in "Accumulated other comprehensive loss". <ix:continuation id="f-856-1" continuedAt="f-856-2">The following table details the changes in the cumulative pre-tax impact of the gain on derivatives designated for hedge accounting:</ix:continuation></span></div><ix:continuation id="f-856-2"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.658%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-1388">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="f-1389">79.7</ix:nonFraction>, net of tax)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-1390">105.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="f-1391">1.7</ix:nonFraction>, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-1392">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-1393">124.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="f-1394">25.7</ix:nonFraction>, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-1395">33.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="f-1396">32.7</ix:nonFraction>), net of tax)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-1397">43.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-1398">115.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Refer to Note 8. Stockholders&#8217; Equity for amounts presented net of the related tax impact in "Accumulated other comprehensive loss".</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company expects that $(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="f-1399">48.2</ix:nonFraction>)&#160;million recorded as a component of "Accumulated other comprehensive loss" will be realized in our Consolidated Statements of Income over the next twelve months and the amount will vary depending on prevailing interest rates.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_136"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_139"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 9A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Controls and Procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company has established and currently maintains disclosure controls and procedures designed to ensure that information required to be disclosed in its reports filed under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission's rules and forms and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures. In designing and evaluating the disclosure controls and procedures, management recognizes that controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving desired control objectives. In reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In conjunction with the close of each fiscal quarter, the Company conducts a review and evaluation, under the supervision and with the participation of the Company's management, including the Chief Executive Officer (our Principal Executive Officer) and Chief Financial Officer (our Principal Financial Officer), of the effectiveness of the design and operation of the Company's disclosure controls and procedures. The Company's Chief Executive Officer and Chief Financial Officer based upon their evaluation as of October&#160;31, 2023, the end of the fiscal period covered in this report, concluded that the Company's disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Management's Annual Report on Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect all misstatements, errors or fraud. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Management assessed the effectiveness of the Company's internal control over financial reporting as of October&#160;31, 2023, based on the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">. Based on this assessment, management, under the supervision and with the participation of the Company's Chief Executive Officer and Chief Financial Officer, concluded that the Company's internal control over financial reporting was effective as of October&#160;31, 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company's independent registered public accounting firm, KPMG LLP, has audited the effectiveness of the Company's internal control over financial reporting as of October&#160;31, 2023, as stated in their report in Part II, Item 8 of this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">There have been no changes in the Company's internal control over financial reporting during the Company's fiscal quarter ended October&#160;31, 2023, that materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_142"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 9B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Other Information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_145"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 9C. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_148"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">PART III</span></div><div style="text-align:center"><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_151"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 10. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Directors, Executive Officers and Corporate Governance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the Company&#8217;s Proxy Statement for the 2024 Annual Meeting of Stockholders (the 2024 Proxy Statement).</span></div><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_154"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Executive Compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the 2024 Proxy Statement.</span></div><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_157"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">See Item 5. Market for Registrant's Common Equity and Related Stockholder Matters - Equity Compensation Plan Information. Additional information required by this item is incorporated by reference to the 2024 Proxy Statement.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_160"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 13. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Certain Relationships and Related Transactions, and Director Independence.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the 2024 Proxy Statement.</span></div><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_163"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 14. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Principal Accounting Fees and Services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the 2024 Proxy Statement.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_166"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_169"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 15. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Exhibits and Financial Statement Schedules.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;1. Financial Statements</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following financial statements are filed as a part of this report:</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Report of KPMG LLP, Independent Registered Public Accounting Firm</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Consolidated Financial Statements:</span></div><div style="padding-left:85.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Statements of Income for the years ended October&#160;31, 2023, 2022 and 2021</span></div><div style="padding-left:85.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Statements of Comprehensive Income for the years ended October&#160;31, 2023, 2022 and 2021</span></div><div style="padding-left:85.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Balance Sheets as of October&#160;31, 2023 and 2022</span></div><div style="padding-left:85.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Statements of Stockholders' Equity for the years ended October&#160;31, 2023, 2022 and 2021</span></div><div style="padding-left:85.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Statements of Cash Flows for the years ended October&#160;31, 2023, 2022 and 2021</span></div><div style="padding-left:85.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;2. Financial Statement Schedules of the Company.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule Number</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%;text-decoration:underline">Description</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Schedule II&#160;&#160;&#160;&#160;Valuation and Qualifying Accounts</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;Exhibits.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The exhibits listed on the accompanying Exhibit Index are filed as part of this report.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">All other schedules which are included in the applicable accounting regulations of the Securities and Exchange Commission are not required here because they are not applicable.</span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_172"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="f-1400" escape="true"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Schedule II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Three Years Ended October&#160;31, 2023 </span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.203%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reductions/ Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance<br/>at End<br/>of Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income tax valuation allowance:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Year Ended October&#160;31, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1401">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1402">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1403">42.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1404">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Year Ended October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-356" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1405">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-357" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1406">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-357" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1407">5.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1408">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Year Ended October&#160;31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-358" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1409">45.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-359" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1410">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-359" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1411">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-356" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1412">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-top:5pt;padding-left:27pt;padding-right:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.782%"><tr><td style="width:1.0%"></td><td style="width:6.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Incorporated by Reference</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description of Document</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Form</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Filing Date/</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Period End</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312506006352/dex31.htm">Second Restated Certificate of Incorporation</a></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/13/2006</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312518351217/d657351dex31.htm">Amended and Restated By-Laws, The Cooper Companies, Inc., dated December 12, 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/18/2018</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140423000048/coo-form8xatransferfromnys.htm">Description of Securities of The Cooper Companies, Inc. Registered under Section 12 of the Exchange Act</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-A</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/25/2023</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312507197691/dex101.htm">The Cooper Companies, Inc. Change in Control Severance Plan, dated May 21, 2007</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/31/2007</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140419000026/coo-ex101_2019x04x30x10q.htm">Executive Employment Agreement by and between The Cooper Companies, Inc. and Albert G. White III, effective as of November 1, 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/30/2019</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140419000026/coo-ex103_2019x04x30x10q.htm">Executive Employment Agreement by and between The Cooper Companies, Inc. and Daniel G. McBride, effective as of November 1, 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/30/2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140419000026/coo-ex102_2019x04x30x10q.htm">Executive Employment Agreement by and between The Cooper Companies, Inc. and Brian G. Andrews, effective as of November 1, 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/30/2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.5#<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140419000026/coo-ex104_2019x04x30x10q.htm">Executive Employment Agreement by and between The Cooper Companies, Inc. and Holly R. Sheffield, effective as of November 1, 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/30/2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.6#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312516443302/d117679ddef14a.htm">The Third Amended and Restated 2007 Long-Term Incentive Plan of The Cooper Companies, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14A</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/29/2016</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.7#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312507270797/dex1032.htm">Form of Non-Qualified Stock Option Agreement Pursuant to the 2007 Long-Term Incentive Plan of The Cooper Companies, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.32</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/31/2007</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.8#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312507270797/dex1034.htm">Form of Deferred Stock Agreement Pursuant to the 2007 Long-Term Incentive Plan of The Cooper Companies, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.34</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/31/2007</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312509029284/dex101.htm">Form of Long Term Performance Share Award Agreement Pursuant to the 2007 Long-Term Incentive Plan of The Cooper Companies, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/13/2009</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.10#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312519025849/d686735ddef14a.htm">The Cooper Companies, Inc.&#8217;s 2019 Employee Stock Purchase Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14A</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2019</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312520024203/d873721ddef14a.htm#toc873721_23">The 2020 Long Term Incentive Plan for Non-Employee Directors of The Cooper Companies, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14A</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/4/2020</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312519315153/d844723dex101.htm">Form of Restricted Stock Unit Agreement pursuant to the 2020 Long Term Incentive Plan for Non-Employee Directors of The Cooper Companies, Inc.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.13</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/31/2020</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312508257120/dex1041.htm">License Agreement dated as of November 19, 2007, by and among CIBA Vision AG, CIBA Vision Corporate and CooperVision, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.41</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/31/2008</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312512513185/d458352dex991.htm">Amendment No. 1 to the License Agreement dated as of November 19, 2007, by and among CIBA Vision AG, CIBA Vision Corporate and CooperVision, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/21/2012</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312505004815/dex101.htm">Lease Contract dated as of November 6, 2003, by and between The Puerto Rico Industrial Development Company and Ocular Sciences Puerto Rico, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/12/2005</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312505004815/dex102.htm">First Supplement and Amendment to Lease Contract dated as of December 30, 2003, by and between The Puerto Rico Industrial Development Company and Ocular Sciences Puerto Rico, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/12/2005</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312505004815/dex103.htm">Assignment of Lease Agreement dated as of June 29, 2004, by and among Ocular Sciences Puerto Rico, Inc., Ocular Sciences Cayman Islands Corporation and The Puerto Rico Industrial Development Company</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/12/2005</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000156459020014844/coo-ex101_8.htm">Revolving Credit and Term Loan Agreement, dated as of April 1, 2020, among the Company, CooperVision International Holding Company, LP, CooperSurgical Netherlands B.V., CooperVision Holding Kft., the lenders from time to time party thereto and KeyBank National Association, as administrative agent</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/2/2020</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/711404/000071140420000042/c00-ex102020201031x10k.htm">Amendment No. 1 and Joinder, dated as of October 30, 2020, to Revolving Credit and Term Loan Agreement, dated as of April 1, 2020, among the Company, CooperVision International Holding Company, LP, CooperSurgical Netherlands B.V., CooperVision Holding Kft., the lenders from time to time party thereto and KeyBank National Association, as administrative agent</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/31/2020</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312521361145/d272863dex101.htm">Term Loan Agreement, dated as of December 17, 2021, by and among The Cooper Companies, Inc., the lenders from time to time party thereto, and PNC Bank, National Association, as administrative agent.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/17/2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.21</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140422000015/coo-ex103_2022x01x31x10q.htm">Amendment No.2 and Joinder, dated as of December 17, 2021, to Revolving Credit and Term Loan Agreement, dated as of April 1, 2020, among the Company, CooperVision International Limited, CooperVision Holding Kft., CooperSurgical Holdings Limited, the lenders party thereto, and KeyBank, National Association, as administrative agent</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/31/2022</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/711404/000119312521326207/d204711dex21.htm">Agreement and Plan of Merger, dated as of November 6, 2021, by and among The Cooper Companies, Inc., CooperSurgical, Inc., Bruin Merger Sub, LLC, GI Generate Parent LLC, and GI Partners Acquisitions LLC.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/10/2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140423000013/coo-ex101_2023x01x31x10q.htm">Amendment No.1, dated as of February 1, 2023, to the Term Loan Agreement, dated as of December 17, 2021, by and among The Cooper Companies, Inc. and PNC Bank, National Association, as the administrative agent.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/31/2023</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140423000013/coo-ex102_2023x01x31x10q.htm">Amendment No. 3, dated as of February 1, 2023, to the Revolving Credit and Term Loan Agreement, dated as of April 1, 2020, by and among the Company, CooperVision International Limited, and CooperSurgical Holdings Limited, the borrowers party thereto, and KeyBank National Association, as administrative agent.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/31/2023</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.25#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140422000058/a2023incentivepaymentplan.htm">The Cooper Companies, Inc. 2023 Incentive Payment Plan.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12/19/2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.26#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312523019077/d448199ddef14a.htm#toc448199_29">The Cooper Companies, Inc. 2023 Long-Term Incentive Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14A</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/30/2023</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt;padding-left:27pt;padding-right:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.782%"><tr><td style="width:1.0%"></td><td style="width:6.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Incorporated by Reference</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description of Document</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Form</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Filing Date/</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Period End</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.27#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140423000033/coo-ex102_2023x04x30x10q.htm">Form of Stock Option Agreement for the 2023 Long-Term Incentive Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/30/2023</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.28#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140423000033/coo-ex103_2023x04x30x10q.htm">Form of Restricted Stock Unit Agreement for the 2023 Long-Term Incentive Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/30/2023</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.29#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140423000033/coo-ex104_2023x04x30x10q.htm">Form of Performance Stock Unit Agreement for the 2023 Long-Term Incentive Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/30/2023</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.31#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312517021098/d306891ddef14a.htm">The Cooper Companies, Inc. 2017 Executive Incentive Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14A</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/27/2017</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.32#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex1032_20231031x10k.htm">The Cooper Companies, Inc. Compensation Recovery Policy</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex19_20231031x10k.htm">Stock</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex19_20231031x10k.htm"> Trading P</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex19_20231031x10k.htm">olicy</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex21_20231031x10k.htm">Subsidiaries</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:45pt;padding-right:27pt;text-align:justify;text-indent:-45pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex23_20231031x10k.htm">Consent of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex311_20231031x10k.htm">Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex312_20231031x10k.htm">Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex321_20231031x10k.htm">Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex322_20231031x10k.htm">Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The following materials from the Company's Annual Report on Form 10-K for the year ended October 31, 2023, formatted in Inline XBRL (Extensible Business Reporting Language):(i) Consolidated Statements of Income for the years ended October 31, 2023, 2022 and 2021 (ii) Consolidated Statements of Comprehensive Income for the years ended October 31, 2023, 2022 and 2021 (iii) Consolidated Balance Sheets at October 31, 2023 and 2022, (iv) Consolidated Statements of Stockholders' Equity for the years ended October 31, 2023, 2022 and 2021 (v) Consolidated Statements of Cash Flows for the years ended October 31, 2023, 2022 and 2021, (vi) related notes to consolidated financial statements and (vii) Schedule II Valuation and Qualifying Accounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;padding-right:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The agreement received confidential treatment from the Securities and Exchange Commission with respect to certain portions of this exhibit. Omitted portions have been filed separately with the Commission. </span></div><div style="padding-left:22.5pt;padding-right:27pt;text-indent:-22.5pt"><span><br/></span></div><div style="padding-left:22.5pt;padding-right:27pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">#&#160;&#160;&#160;&#160;Indicates management contract or compensatory plan.</span></div><div style="padding-left:22.5pt;padding-right:27pt;text-indent:-20.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">*      The certifications attached as Exhibits 32.1 and 32.2 that accompany this Annual Report on Form 10-K are not deemed filed with the SEC and are not to be incorporated by reference into any filing of The Cooper Companies, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-K, irrespective of any general incorporation language contained in such filing.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_178"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 16. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Form 10-K Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_181"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on December&#160;8, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:288pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC.</span></div><div style="padding-left:288pt;text-align:justify"><span><br/></span></div><div style="padding-left:288pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:underline">By:       /s/ Albert G. White, III     </span></div><div style="padding-left:288pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">              </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Albert G. White, III </span></div><div style="padding-left:288pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> President &amp; Chief Executive Officer</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on the dates set forth opposite their respective names.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.774%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Capacity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    ALBERT G. WHITE, III </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">President, Chief Executive Officer and Director (Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 8, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Albert G. White, III)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    ROBERT S. WEISS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Chairman of the Board</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 8, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Robert S. Weiss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    WILLIAM A. KOZY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vice Chairman of the Board and Lead Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 8, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(William A. Kozy)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    BRIAN G. ANDREWS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 8, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Brian G. Andrews)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    AGOSTINO RICUPATI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Senior Vice President and Chief Accounting Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 8, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Agostino Ricupati)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    COLLEEN E. JAY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 8, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Colleen E. Jay)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    CYNTHIA L. LUCCHESE</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 8, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Cynthia L. Lucchese)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    GARY S. PETERSMEYER</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 8, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Gary S. Petersmeyer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 8, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Lawrence Kurzius)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    MARIA RIVAS M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 8, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Maria Rivas M.D.)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    TERESA S. MADDEN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 8, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Teresa S. Madden)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="i73c86eef1c5e443ab4ef06a723adb0ef_184"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CORPORATE INFORMATION</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:31.805%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.644%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.647%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">BOARD OF DIRECTORS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Robert S. Weiss</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Chairman of the Board</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">William A. Kozy</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vice Chairman and Lead Director; Chief Executive Officer (interim), LivaNova PLC</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Colleen E. Jay</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Cynthia L. Lucchese</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Gary S. Petersmeyer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Lawrence Kurzius</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Teresa S. Madden</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Maria Rivas M.D.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Global Chief Medical Affairs Officer and Head of Evidence Generation, Pfizer, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Albert G. White, III</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">President &amp; Chief Executive Officer</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">COMMITTEES OF THE BOARD</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Audit Committee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Teresa S. Madden (Chairman)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cynthia L. Lucchese </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gary S. Petersmeyer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lawrence Kurzius</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Maria Rivas M.D.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Corporate Governance and Nominating Committee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">William A. Kozy (Chairman)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Colleen E. Jay</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cynthia L. Lucchese</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Maria Rivas M.D.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Organization and Compensation Committee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Colleen E. Jay (Chairman)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gary S. Petersmeyer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lawrence Kurzius</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Teresa S. Madden</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">William A. Kozy</span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">EXECUTIVE OFFICERS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Albert G. White, III</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Daniel G. McBride</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Executive Vice President and Chief Operating Officer </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Brian G. Andrews</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Agostino Ricupati</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Senior Vice President and Chief Accounting Officer</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Nicholas S. Khadder</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vice President, General Counsel and Corporate Secretary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Holly R. Sheffield</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">President of CooperSurgical, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Gerard H. Warner III</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">President of CooperVision, Inc.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">PRINCIPAL SUBSIDIARIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">CooperVision, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6101 Bollinger Canyon Road</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Suite 500</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">San Ramon, CA 94583</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">925-460-3600</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">www.coopervision.com</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">CooperSurgical, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">75 Corporate Drive</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trumbull, CT 06611</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">203-601-5200</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">www.coopersurgical.com</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">CORPORATE OFFICES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">The Cooper Companies, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6101 Bollinger Canyon Road</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Suite 500</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">San Ramon, CA 94583</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">925-460-3600</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">www.coopercos.com</span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">INVESTOR INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Recent news releases, the annual report on Securities and Exchange Commission Form 10-K, information about the Company's corporate governance program, recent investor presentations, replays of quarterly conference calls and historical stock quotes are available on our Web site at www.coopercos.com.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">INVESTOR RELATIONS CONTACT</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Kim Duncan</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vice President, Investor Relations and Risk Management</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6101 Bollinger Canyon Road</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Suite 500</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">San Ramon, CA 94583</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Voice: 925-460-3663</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">E-mail: ir@cooperco.com</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">ANNUAL MEETING</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">The Cooper Companies will hold its Annual Stockholders' Meeting in March 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">TRANSFER AGENT</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equiniti Trust LLC</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">48 Wall Street, Floor 23</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">New York, NY 10005</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">800-937-5449</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">TRADEMARKS  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision, CooperSurgical, and other trade names, trademarks or service marks of CooperCompanies and its subsidiaries appearing in this report are the property of CooperCompanies and its subsidiaries. Trade names, trademarks and service marks of the other companies appearing in this report are the property of their respective holders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">INDEPENDENT AUDITORS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">KPMG LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">STOCK EXCHANGE LISTING</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Nasdaq Global Select Market </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Ticker Symbol &#8220;COO&#8221;</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.32
<SEQUENCE>2
<FILENAME>coo-ex1032_20231031x10k.htm
<DESCRIPTION>EX-10.32
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2a634123f67c43ecb782097d5c6398f3_1"></div><div style="min-height:72pt;width:100%"><div><img alt="image.jpg" src="image.jpg" style="height:41px;margin-bottom:5pt;vertical-align:text-bottom;width:216px"></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THE COOPER COMPANIES, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COMPENSATION RECOVERY POLICY</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Compensation Recovery Policy (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is intended to maintain a culture of focused, diligent, and responsible management that discourages conduct detrimental to the growth of The Cooper Companies, Inc. and its subsidiaries (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and reinforce the Company&#8217;s pay-for-performance compensation philosophy. Accordingly, as set forth in this Policy, it may be appropriate for the Company to recovery of erroneously awarded incentive-based compensation upon the occurrence of certain events. This Policy was adopted as of October 27, 2021, and amended as of October 24, 2023. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Recovery of Erroneously Awarded Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to Section 6, if the Company is required to prepare an accounting restatement due to its material noncompliance with any financial reporting requirement under securities laws, including restatements that (a) correct an error in previously issued financial statements that is material to the previously issued financial statements or (b) would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Recoverable Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Company shall recover any Recoverable Amount with respect to Incentive Compensation (each, as defined below) received by a Covered Employee during the three completed fiscal years that immediately precedes the date that the Company&#8217;s Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), a committee of the Board, or any of the Company&#8217;s officers that are so authorized, concludes, or reasonably should have concluded, that the Company is required to prepare such an accounting restatement, or, if earlier, the date on which a court, regulator or other legally authorized body directs the Company to prepare such an accounting restatement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Recovery Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Applicability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt;text-decoration:underline">Covered Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Policy applies to all current or former &#8220;executive officers&#8221; of the Company, as defined under the Securities Exchange Act of 1934, as amended, that served at any time during the Recovery Period (collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Covered Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt;text-decoration:underline">Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Policy applies to any compensation that is granted, earned, or vested based wholly or in part upon the attainment of one or more Financial Reporting Measures (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) received by a Covered Employee and during the Recovery Period. For purposes of this Policy, Incentive Compensation shall be deemed &#8220;received&#8221; when the Financial Reporting Measure is attained or satisfied, without regard to whether the grant, vesting, or payment of the Incentive Compensation occurs after. </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Financial Reporting Measures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; are measures that are determined and presented in accordance with the accounting principles used in preparing the issuer&#8217;s financial statements, and any measures derived wholly or in part from such financial statements, including both GAAP and non-GAAP financial measures, as well as stock price and total stockholder return (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">TSR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For the avoidance of doubt, any Incentive Compensation received by a Covered Employee prior to October 2, 2023 or prior to their commencement of service as an executive officer is not subject to this Policy. Equity awards that vest exclusively upon completion of a specified employment period, without any performance condition, and bonus awards that are discretionary or based on subjective goals or goals unrelated to Financial Reporting Measures shall not constitute Incentive Compensation.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Administration of the Policy. </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt;text-decoration:underline">Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Policy will be administered by the Compensation Committee of the Board of Directors unless the Board of Directors determines to administer the Policy itself (the Compensation Committee or the Board of Directors, as applicable, in its role administering the Policy is the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Administrator shall have full and final authority to make all </font></div><div style="height:81.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">CooperCompanies Compensation Recovery Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adopted&#58; October 2021</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amended&#58; October 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">determinations necessary, appropriate, or advisable for the administration of the Policy. It is intended that this Policy be interpreted in a manner that is consistent with the requirements of Section 10D of the Securities Exchange Act of 1934, and the guidance and regulations promulgated thereunder, and any applicable rules or standards adopted by the Securities and Exchange Commission or any national securities exchange on which the Company&#8217;s securities are listed.. All determinations and decisions made by the Administrator pursuant to the provisions of this Policy shall be final, conclusive, and binding on all persons, including the Company, its affiliates, its stockholders and employees. The Administrator may delegate ministerial administrative duties to one or more officers or employees of the Company, as permitted under applicable law.</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt;text-decoration:underline">Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. No member of the Administrator shall be personally liable for any action or determination made in good faith with respect to this Policy or to any settlement of any dispute between a Covered Employee and the Company. The Administrator shall be entitled to rely upon the advice or opinions of any attorneys, consultants, accountants, appraisers, brokers or other persons with respect to all matters concerning this Policy.</font></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Determination of Recoverable Amounts.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Recoverable Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall be equal to the excess of the amount of Incentive Compensation received based on the achievement of a Financial Reporting Measure that was subsequently revised due to the Recoverable Event, over the amount of Incentive Compensation that would have been received based on the restated Financial Reporting Measure, as determined on a pre-tax basis. For Incentive Compensation based on TSR or stock price, the Recoverable Amount will be based on the Administrator&#8217;s reasonable estimate of the effect of the Recoverable Event on the applicable measure, with such analysis documented and provided to the applicable listing exchange. </font></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Manner of Recovery. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Administrator shall determine, in its sole discretion, the manner of recovery of any Recoverable Amount, which may include, without limitation, to the extent permitted by applicable law&#58; </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">requiring reimbursement of cash Incentive Compensation previously paid&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer or other disposition of any equity-based awards&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">offsetting the Recoverable Amount from any compensation otherwise owed by the Company to the Covered Employee&#59; </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">cancelling outstanding vested or unvested equity awards&#59; and&#47;or </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">taking any other remedial and recovery action, as determined by the Administrator&#59;</font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the method for recovery of Incentive Compensation selected by the Administrator shall not cause a violation of the payment timing rules of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) or result in the Covered Employee being subject to the interest and additional tax provisions of Section 409A(a)(1)(B) of the Code.     </font></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Impracticability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If the Administrator determines that (a) the direct costs paid to third parties to assist in enforcing recovery would exceed the Recoverable Amount, (b) the recovery would violate the Company&#8217;s home country law, adopted before November 28, 2022, pursuant to the opinion of home country counsel, or (c) the recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and regulations thereunder, then, subject to the following sentence, the Company shall not be required to recover the Recoverable Amounts. </font></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, the Company shall make reasonable attempts to recover the Recoverable Amounts before determining that it is impracticable to do so for the aforementioned reasons and must document such attempts and provide such documentation to the relevant listing exchange.</font></div><div style="height:81.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">CooperCompanies Compensation Recovery Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adopted&#58; October 2021</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amended&#58; October 2023</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">No Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company shall not indemnify any Covered Employee against the loss of any erroneously awarded Incentive Compensation pursuant to the Policy, nor shall the Company directly or indirectly pay or reimburse any Covered Employee for any premiums for third-party insurance policies that such Covered Employees may elect to purchase to fund potential recovery obligations under the Policy. </font></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Amendment, Modification and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Policy may at any time or from time to time be amended, modified or terminated by the Administrator, in whole or in part, provided that such amendment, modification or termination complies with applicable law. </font></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Enforceability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The adoption of this Policy does not mitigate, and is intended to enhance, the effect of any recoupment, forfeiture or similar policies in any employment agreement, bonus plan, equity-based award agreement or similar agreement. The remedy specified in this Policy shall not be exclusive and shall be in addition to every other right or remedy at law or in equity that may be available to the Company.</font></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The provisions in this Policy are intended to be applied to the fullest extent of the law&#59; provided, however, to the extent that any provision of this Policy is found to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted, and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:81.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">CooperCompanies Compensation Recovery Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adopted&#58; October 2021</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amended&#58; October 2023</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19
<SEQUENCE>3
<FILENAME>coo-ex19_20231031x10k.htm
<DESCRIPTION>EX-19
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if497a4c8eec54b96ae19e0c10ef55366_39"></div><div style="min-height:87.12pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><img alt="image_2.jpg" src="image_2.jpg" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:199px"></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:16pt;font-weight:700;line-height:100%">STOCK TRADING POLICY</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Procedures And Guidelines Governing</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Securities Trades By Directors And Senior Executives </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">I.&#160;&#160;&#160;&#160;POLICY</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">State and federal securities laws prohibit the use of material non-public information in breach of a duty of trust or confidence by any person in purchasing or selling securities, as well as the communication of such information to any other person who may purchase or sell securities. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In order to comply with these laws, The Cooper Companies, Inc. (together with its subsidiaries, the &#8220;Company&#8221;) has adopted this Stock Trading Policy (&#8220;Policy&#8221;). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">II.&#160;&#160;&#160;&#160;SCOPE</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.&#160;&#160;&#160;&#160;This Policy covers the directors and Senior Executives of the Company (as listed in </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of this Policy), their spouses, dependent children, and others living in their households and all entities (such as trusts and corporations) over which such directors and Senior Executives have or share voting or investment control (collectively referred to herein as </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#34;directors and Senior Executives&#34;). </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Directors and Senior Executives are responsible for ensuring compliance by their families, other members of their households and entities over which they exercise voting or investment control.</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.&#160;&#160;&#160;&#160;The Company has designated certain of the directors and Senior Executives as the directors, officers and entities who are subject to the reporting provisions and trading restrictions of Section 16 of the Exchange Act, and the underlying rules and regulations promulgated by the Securities and Exchange Commission (the &#34;SEC&#34;). Each of these individuals is identified as such on </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and is referred to herein as a &#34;Section 16 Party.&#34; The Company will amend </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> from time to time as necessary to update the list of Section 16 Parties.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.&#160;&#160;&#160;&#160;Directors and Senior Executives whose service with the Company terminates during a quarterly or special blackout period as provided for by Section&#160;V.A. shall remain subject to this Policy through the end of such blackout period. In addition, directors and Senior Executives whose service with the Company terminates at a time when they are in possession of material non-public information shall remain subject to this Policy until such time that the information has become public or is no longer material.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D.&#160;&#160;&#160;&#160;This Policy shall not apply to a trustee or custodian which holds shares for the benefit of any person subject to this Policy so long as (1) the trustee or custodian is not also a person subject to this Policy and (2) no person subject to this Policy, directly or indirectly, has or shares voting or investment control over such shares (including the right to direct the actions of the trustee or custodian), or has the right to replace the trustee</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or custodian without cause or to terminate or revoke the trust without cause.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">E.&#160;&#160;&#160;&#160;This Policy applies to any and all transactions in the Company's securities, including its common stock and options to purchase common stock, and any other type of securities that the Company may issue, such as preferred stock, convertible debentures, warrants and exchange-traded options or other derivative securities, by persons and entities subject to this Policy.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:81.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font><font style="color:#7f7f7f;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Page</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#124; 1</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">CooperCompanies Stock Trading Policy</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Adopted&#58; March 22, 2023</font></div></div></div><hr style="page-break-after:always"><div style="min-height:87.12pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><img alt="image_2.jpg" src="image_2.jpg" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:199px"></div></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">III.&#160;&#160;&#160;&#160;MATERIAL NON-PUBLIC INFORMATION</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Information is considered &#8220;material&#8221; if there is a substantial likelihood that a reasonable investor would consider it important in making a decision to buy, sell, or hold a security, or if the information is likely to have a significant effect on the market price of the security. Material information can be positive or negative and can relate to virtually any aspect of a company&#8217;s business or to any type of security, debt, or equity. Also, information that something is likely to happen in the future&#8212;or even just that it may happen&#8212;could be deemed material.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Examples of material information may include (but are not limited to) information about&#58;</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">corporate earnings or earnings forecasts&#59; </font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">possible mergers, acquisitions, tender offers, or dispositions&#59; </font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">major new products or product developments&#59; </font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">important business developments, such as the results of clinical trials and developments regarding strategic collaborations&#59; </font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">management or control changes&#59; </font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">significant financing developments including pending public sales or offerings of debt or equity securities&#59;</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">defaults on borrowings&#59; </font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">bankruptcies&#59; </font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">cybersecurity or data security incidents&#59; and</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">significant litigation or regulatory actions. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Information is &#8220;non-public&#8221; if it is not available to the general public. In order for information to be considered &#8220;public,&#8221; it must be widely disseminated in a manner that makes it generally available to investors in a Regulation FD-compliant method, such as through a press release, a filing with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) or a Regulation FD-compliant conference call. The General Counsel shall have sole discretion to decide whether information is public for purposes of this Policy.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The circulation of rumors, even if accurate and reported in the media, does not constitute public dissemination. In addition, even after a public announcement, a reasonable period of time may need to lapse in order for the market to react to the information. Generally, the passage of two full trading days following release of the information to the public is a reasonable waiting period before such information is deemed to be public.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IV.&#160;&#160;&#160;&#160;POLICY AND PROCEDURES</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.&#160;&#160;&#160;&#160;PROHIBITED ACTIVITIES</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;No director or Senior Executive may trade in Company securities, in breach of a duty of trust or confidence, while in possession of material non-public information concerning the Company or its securities. It does not matter that there is an independent, justifiable reason for a purchase or sale. The foregoing restriction(s) shall not apply to trades validly made pursuant to a Trading Plan adopted and approved in compliance with Sections VI.A and VI.B below.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;No director or Senior Executive may disclose material non-public information concerning the Company or its securities to any outside person (including family members, analysts, individual investors, or members of the investment community and news media), unless required as part of that director&#8217;s or Senior Executive&#8217;s regular duties for the Company or authorized by the Company&#8217;s General Counsel. In any instance in which such information is disclosed to outsiders, the Company will take such steps as are necessary to preserve the confidentiality of the </font></div><div style="height:81.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font><font style="color:#7f7f7f;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Page</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#124; 2</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">CooperCompanies Stock Trading Policy</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Adopted&#58; March 22, 2023</font></div></div></div><hr style="page-break-after:always"><div style="min-height:87.12pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><img alt="image_2.jpg" src="image_2.jpg" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:199px"></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">information, including requiring the outsider to agree in writing to comply with the terms of this Policy and&#47;or to sign a confidentiality agreement. All inquiries from outsiders regarding material non-public information about the Company or its securities should be forwarded to the Company&#8217;s Investor Relations department. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;No director or Senior Executive may give trading advice of any kind about the Company to anyone while possessing material non-public information about the Company or its securities, except that directors and Senior Executives should advise others not to trade if doing so might violate the law or this Policy. The Company strongly discourages all directors and Senior Executives from giving trading advice concerning the Company to third parties even when the directors and Senior Executives do not possess material non-public information about the Company or its securities.</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;No director or Senior Executive may&#58;</font></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;trade in the securities of any other public company while possessing material non-public information concerning that company or its securities obtained in the course of service as a director, officer, or employee of the Company, </font></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;disclose such material non-public information concerning such other public company or its securities to anyone not subject to appropriate measures to preserve the confidentiality of the information and prohibit the trading on the basis of such material non-public information by such person, or</font></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;give trading advice of any kind to anyone concerning such other public company while possessing such material non-public information about that company or its securities.</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;No director or Senior Executive may trade in the securities of any companies with which discussions of mergers, acquisitions, material contracts, or other negotiations are being conducted by the Company.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;The Company may change these procedures or adopt such other procedures in the future as the Company considers appropriate in order to carry out the purposes of this Policy.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.&#160;&#160;&#160;&#160;HEDGING&#47;PLEDGING POLICY</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt;text-decoration:underline">Hedging</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; In addition to the prohibitions set out in Section IV.A above, no director or Senior Executive may engage in any of the following transactions in securities that suggest speculation in the Company&#8217;s stock (e.g., trying to profit in short-term movements, either increases or decreases, in the stock price)&#58; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt;text-decoration:underline">Short Selling</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; selling borrowed securities that the seller anticipates can be replaced with securities purchased at a lower price in the future&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt;text-decoration:underline">Short Selling Against the Box</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; selling securities but not delivering them in a timely fashion&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt;text-decoration:underline">Put or Call Options of All Types</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; acquiring rights to sell and&#47;or purchase securities within a certain time period at a specified price&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt;text-decoration:underline">Forward Sale (or Purchase) Contracts</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; agreements to sell (or purchase) securities at a fixed price on a later date, thus avoiding (or assuming) the risks or rewards of ownership&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt;text-decoration:underline">Equity Swaps</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; financial derivative contracts where a set of future cash flows are to be exchanged between two counterparties at a set future date&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="height:81.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font><font style="color:#7f7f7f;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Page</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#124; 3</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">CooperCompanies Stock Trading Policy</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Adopted&#58; March 22, 2023</font></div></div></div><hr style="page-break-after:always"><div style="min-height:87.12pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><img alt="image_2.jpg" src="image_2.jpg" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:199px"></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt;text-decoration:underline">Exchange Funds</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; a mechanism allowing holders of a single stock to diversify into a group of other stocks without directly selling their stock. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Note that many hedging transactions, such as &#8220;cashless&#8221; collars, forward sales, equity swaps and other similar or related arrangements may indirectly involve a short sale. Also, certain forms of short sales by executive officers and Directors are also currently illegal under the Securities Exchange Act of 1934, as amended (the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#34;Exchange Act&#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">).</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt;text-decoration:underline">Pledging</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; The Company requires that its executives and members of the Board do not margin or pledge Company stock to secure a loan or purchase Company stock &#8220;on margin&#8221; (that is, borrow funds to purchase stock, including in connection with exercising any Company stock options) without prior notification to and approval from the General Counsel or their designee(s). </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.&#160;&#160;&#160;&#160;PRIORITY OF STATUTORY OR REGULATORY TRADING RESTRICTIONS</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The trading prohibitions and restrictions set forth in this Policy will be superseded by any greater prohibitions or restrictions prescribed by federal or state securities laws and regulations, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">e.g.,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> contractual restrictions on the sale of securities, short-swing trading by Section 16 Parties or restrictions on the sale of securities subject to Rule 144 under the Securities Act of 1933, as amended (the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#34;Securities Act&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">). Any director or Senior Executive who is uncertain whether other prohibitions or restrictions apply should ask the General Counsel or their designee(s).</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">V.&#160;&#160;&#160;&#160;BLACKOUT PERIODS</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.&#160;&#160;&#160;&#160;BLACKOUT PERIODS. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The directors and Senior Executives are subject to the policies and procedures adopted with regard to trading windows and blackout periods, as amended from time to time. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Such policies and procedures include provisions for regular blackout periods prior to the Company's public release of quarterly or year-end earnings information. From time to time, additional special blackout periods also may be implemented during which time trading restrictions will apply because of developments that have not yet been disclosed. Written notification of regular and special blackout periods will be sent by the General Counsel or their designee(s). </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No director or Senior Executive may trade in Company securities outside of the applicable trading windows or during any special blackout periods that the Company may designate. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.&#160;&#160;&#160;&#160;TRANSACTIONS WITH THE COMPANY</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Trading blackouts do not apply to purchases of the Company&#8217;s securities from the Company, or to sales of the Company&#8217;s securities to the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.&#160;&#160;&#160;&#160;STOCK OPTIONS AND OTHER EQUITY AWARDS.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Trading blackouts do not apply to vesting of equity-based awards or exercises of stock options or other equity awards, or to the surrender of shares to the Company in payment of the exercise price or in satisfaction of any tax withholding obligations in a manner permitted by the applicable equity award agreement, that do not involve a market sale of the Company&#8217;s securities (the &#8220;cashless exercise&#8221; of a Company stock option or other equity award through a broker does involve a market sale of the Company&#8217;s securities, and therefore would not qualify under this exception). Notice of any transaction must still be provided in accordance with the procedures and policies adopted by the Company with regard to executive trading and Section 16 reporting.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:81.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font><font style="color:#7f7f7f;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Page</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#124; 4</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">CooperCompanies Stock Trading Policy</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Adopted&#58; March 22, 2023</font></div></div></div><hr style="page-break-after:always"><div style="min-height:87.12pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><img alt="image_2.jpg" src="image_2.jpg" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:199px"></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D.&#160;&#160;&#160;&#160;GIFT TRANSFERS. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, a director or Senior Executive may make a gift transfer, including a transfer to a trust or custodian for the benefit of a minor, during a blackout period </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided that</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the donee is subject to this Policy and the restrictions of this Policy to the same extent as the donor for the duration of such blackout period. Otherwise, gift transfers may only be made by a director or Senior Executive outside of a blackout period.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">E.&#160;&#160;&#160;&#160;EXCEPTIONS FOR HARDSHIP CASES. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company may, on a case-by-case basis, authorize trading in Company securities during blackout periods due to financial hardships. Hardship authorizations for directors and Senior Executives will only be considered if the person trading has notified the General Counsel in writing of the circumstances of the hardship and the amount and nature of the proposed trade(s) at least two days in advance. Any hardship authorization for a director or Senior Executive will require approval by both the General Counsel and the Board.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The existence of the foregoing approval procedures does not in any way obligate the approval of any trades requested by hardship applicants. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">VI.&#160;&#160;&#160;&#160;RULE 10B5-1 PLANS </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.&#160;&#160;&#160;&#160;TRADING PLANS. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A person subject to this Policy may adopt a written plan for trading Company securities </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(&#34;Trading Plan&#34;)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and trade Company securities pursuant to such Trading Plan provided that each of the following conditions is satisfied&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">the Trading Plan is intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c) and comply with all requirements of Rule 10b5-1 and includes a statement to that general effect (it being understood that a Trading Plan satisfying the conditions of this section is not intended to be the exclusive means by which a person subject to this Policy may avail himself or herself of the affirmative defense conditions of Exchange Act Rule 10b5-1(c))&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt;text-decoration:underline">for any Section 16 Party</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Trading Plan, or any amendment or modification thereto, includes a representation that the Section&#160;16 Party is (i)&#160;not aware of any material nonpublic information about the Company or its securities&#59; and (2)&#160;adopting the Trading Plan, or the amendment or modification thereto, in good faith and not as part of a plan or scheme to evade Rule&#160;10b5&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">with respect to any purchase or sale, the Trading Plan either (i) expressly specifies the amount, price and date, (ii) provides a written formula, algorithm or computer program for determining amounts, prices and dates, or (iii) does not permit the person subject to this Policy to exercise any subsequent influence over how, when, or whether to effect such purchase or sale (provided any other person with such influence does not have access to any material non-public information regarding the Company or its securities when exercising such influence)&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">the Trading Plan is adopted, or amended or modified, in good faith at a time when the person is (i)&#160;not in possession of material non-public information concerning the Company and (ii) not subject to a blackout period with respect to the Company, and the person who entered into the Trading Plan has acted in good faith with respect to the Trading Plan&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">the person does not have more than one Trading Plan in effect at a time, except under the limited circumstances permitted by Rule&#160;10b5-1 and subject to preapproval by the General Counsel&#59;</font></div><div style="height:81.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font><font style="color:#7f7f7f;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Page</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#124; 5</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">CooperCompanies Stock Trading Policy</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Adopted&#58; March 22, 2023</font></div></div></div><hr style="page-break-after:always"><div style="min-height:87.12pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><img alt="image_2.jpg" src="image_2.jpg" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:199px"></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">the trades under the Trading Plan, alone or taken together with the person's trading activity outside the Trading Plan, do not violate the trading restrictions of Section 16 of the Exchange Act or Rule 144 of the Securities Act&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">the trades under the Trading Plan, without consideration to the person&#8217;s trading activity outside the Trading Plan, would not cause the person to be in violation of any stock ownership guideline or requirement set by Company policy&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">during the term of the Trading Plan, the person shall not enter into or alter a hedging transaction or position with respect</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to the Company securities covered by the Trading Plan while in possession of material non-public information concerning the Company or its securities&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">a copy of the Trading Plan, and any subsequent amendment or modification thereto, and notice of termination of the Trading Plan is provided to the General Counsel </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">at least ten (10) business</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">days prior</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">to the time they are to become effective</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">trades under the Trading Plan, or any subsequent amendment or modification thereto that changes the amount, price or dates of purchases or sales (or the formula, algorithm, or computer program for determining the amount, price or dates of purchases or sales) (a &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Trading Term-Altering Amendment</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), do not commence until&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:100%">o&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">for any Section 16 Party</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">later</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of (i)&#160;90 days after the adoption of the Trading Plan or of any Trading Term-Altering Amendment to the Trading Plan, as the case may be, or (ii)&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">two business days</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> after the Company&#8217;s filing of the Annual Report on Form 10-K or Quarterly Report on Form 10-Q covering the fiscal quarter in which the Trading Plan was adopted or in which a Trading Term-Altering Amendment to the Trading Plan was adopted, as the case may be&#59; and</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:100%">o&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">for any other employees or persons</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">at least thirty (30) days</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> have elapsed from the date the Trading Plan or a Trading Term-Altering Amendment to the Trading Plan was adopted, as the case may be.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.&#160;&#160;&#160;&#160;APPROVAL OF TRADING PLAN. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No trades may take place pursuant to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">any</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Trading Plan until (i) it is submitted to the General Counsel for review, together with a written certification from the person that all of the applicable conditions specified above are satisfied and (ii) it is approved by the General Counsel, who shall certify their approval in writing. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Provided the Trading Plan is so approved, individual trades under the Trading Plan need </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> be resubmitted for approval by the General Counsel. However, any subsequent amendment or modification to the Trading Plan, or termination of such plan, must be resubmitted to the General Counsel for approval in the preceding manner. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.&#160;&#160;&#160;&#160;NO OBLIGATION TO APPROVE TRADES. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The existence of the foregoing approval procedures does not in any way obligate the General Counsel to approve any Trading Plans requested by a director or Senior Executive. The General Counsel may reject any request at its reasonable discretion. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Please also note that persons subject to this Policy bear responsibility for the compliance of their Trading Plans with Rule 10b5-1 and other applicable securities laws, and that approval by the General Counsel</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of a Trading Plan's compliance with this Policy does not constitute an assurance or an opinion by the Company or the General Counsel that the plan complies with Rule 10b5-1 or other applicable securities laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D.&#160;&#160;&#160;&#160;DISCLOSURE OF TRADING PLANS.</font></div><div style="height:81.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font><font style="color:#7f7f7f;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Page</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#124; 6</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">CooperCompanies Stock Trading Policy</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Adopted&#58; March 22, 2023</font></div></div></div><hr style="page-break-after:always"><div style="min-height:87.12pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><img alt="image_2.jpg" src="image_2.jpg" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:199px"></div></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company reserves the right to publicly disclose, announce or respond to inquiries from the media regarding the adoption, amendment, modification or termination of a Trading Plan and non-Rule 10b5-1 trading arrangements, or the execution of transactions made under a Trading Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">E.&#160;&#160;&#160;&#160;SUSPENSION OR DISCONTINUANCE OF TRADING PLANS.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company reserves the right from time to time to suspend, discontinue, or otherwise prohibit transactions under a Trading Plan if the General Counsel or the Board, in its discretion, determines that such suspension, discontinuance or other prohibition is in the best interests of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">VII.&#160;&#160;&#160;&#160;POTENTIAL CIVIL, CRIMINAL AND DISCIPLINARY SANCTIONS</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.&#160;&#160;&#160;&#160;COMPANY DISCIPLINE</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Violation of this Policy or federal or state insider trading or tipping laws by any director or Senior Executive may subject a director to dismissal proceedings and a Senior Executive to disciplinary action by the Company up to and including termination for cause. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company may, in its discretion, issue any necessary stop-transfer orders to the Company's transfer agent to enforce compliance with this Policy and reserves the right to determine, in its own discretion and on the basis of the information available to it, whether its Policy has been violated. The Company may determine that specific conduct violates its Policy, whether or not the conduct also violates the law. It is not necessary for the Company to await the filing or conclusion of a civil or criminal action against the alleged violator before taking disciplinary action.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.&#160;&#160;&#160;&#160;REPORTING OF VIOLATIONS</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any director or Senior Executive who violates this Policy or any federal or state laws governing insider trading or tipping, or who knows of any such violation by any other directors, officers, or employees, must report the violation immediately to the General Counsel. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon learning of any such violation, the General Counsel, in consultation with the Company's external legal counsel, will determine whether the Company should release any material non-public information, or whether the Company should report the violation to the SEC or other appropriate governmental authority.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">VIII.&#160;&#160;&#160;&#160;INTERPRETATION, AMENDMENT, AND IMPLEMENTATION OF THIS POLICY</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The General Counsel shall have the authority to interpret and update this Policy and all related policies and procedures. In particular, such interpretations and updates of this Policy, as authorized by the General Counsel, may include amendments to, or departures from, the terms of this Policy, to the extent consistent with the general purpose of this Policy and applicable securities laws.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Actions taken by the Company, the General Counsel, or any other Company personnel do not constitute legal advice, nor do they insulate persons subject to this Policy from the consequences of noncompliance with this Policy or with securities laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IX.&#160;&#160;&#160;&#160;CERTIFICATION OF COMPLIANCE</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All directors and Senior Executives subject to this Policy may be asked periodically to certify their compliance with the terms and provisions of this Policy and any related policies or procedures.</font></div><div style="height:81.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #d9d9d9;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font><font style="color:#7f7f7f;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Page</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#124; 7</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">CooperCompanies Stock Trading Policy</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Adopted&#58; March 22, 2023</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>4
<FILENAME>coo-ex21_20231031x10k.htm
<DESCRIPTION>EX-21
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2df9cf535b0140fbbad7bf678de36bf1_1"></div><div style="min-height:13.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SUBSIDIARIES OF THE COOPER COMPANIES, INC. A DELAWARE CORPORATION</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.382%"></td><td style="width:0.1%"></td></tr><tr><td colspan="72" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NAME</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">JURISDICTION OF INCORPORATION</font></td></tr><tr><td colspan="72" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Cooper Companies, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="66" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="60" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Eyecare Prime LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="60" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Paragon Vision Sciences, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Arizona</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">SynergEyes, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">SynergEyes UK Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="60" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cooper Global Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">TCC Holdings LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">The Cooper Companies Global Holdings LP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">England-Wales</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Global Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperVision International Holding Company, LP</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">England-Wales</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision do Brasil Ltda</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Singapore Pte Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Optical Trade (Shanghai) Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CVI Contact Lens Pvt. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision International Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Vision Manufacturing Puerto Rico LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Manufacturing Costa Rica SRL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision (UK) Holdings Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Manufacturing Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Australia Pty Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Distribution SRL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Canada Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision S.A.S.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Italia srl</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Nederland BV</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Nederland, Belgian Branch</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Japan, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Iberia SL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision S.A. (Pty) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">South Africa</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Nordic AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Sarl</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision RUS LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Israel Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Lens Care Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sauflon CL Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision CL Kft</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Hungary</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="66" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cooper Medical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="60" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperGenomics, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Invitro Genetics LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Reprogenetics LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">LifeGlobal Group LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Connecticut</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate Parent LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="54" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate Intermediate LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate Life Sciences, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate GCP Coinvest LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate L Blocker LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate NQ Blocker LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate LNQ Holdings LLC </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cryobank Holdings LLC </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">California Cryobank LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CCB-Kitazato LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:13.5pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.382%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CCB-DEB LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CCB-Fertility Tech LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Donor Application LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">DEB Donor Egg Bank Canada Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">California Cryobank Stem Cell Services LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CCB-NWC LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CCB-MCB LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate IP Holdings LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate Sperm Bank Canada Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CBR Acquisition Holding Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CBR Systems, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate International LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Insception Biosciences, Inc. </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate Life Sciences Australia Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate CC Australia Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">SC Storage Holdings Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">SC Storage Finance Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">SC Storage Operations Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cell Care Australia Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cell Care Australia Pty Ltd, New Zealand Branch</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="60" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical Distribution B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="60" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Cooper Surgical Holdings Ltd.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperMedical S.r.l.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Invitro Genetics Ltd.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Research Instruments Ltd.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Origio A&#47;S</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Denmark</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Each subsidiary is wholly-owned either by The Cooper Companies, Inc. or by the wholly-owned subsidiary under which it is indented in the list above.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>5
<FILENAME>coo-ex23_20231031x10k.htm
<DESCRIPTION>EX-23
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic00d7615d89d43c5a759ed851851185f_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 23</font></div><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;text-decoration:underline">Consent of Independent Registered Public Accounting Firm</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We consent to the incorporation by reference in the registration statements (Nos. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-22417, 333-25051, 333-27639, 333-40431, 333-80795, 333-34206, 333-48152, and 333-108066) on Form S-3 and registration statements (Nos. 333-10997, 333-58839, 333-67954, 333-101366, 333-104346, 333-115520, 333-133719, 333-133720, 333-143338, 333-158892, 333-174682, 333-233577, 333-237505, and 333-270957) on Form S-8 of our report dated December&#160;8, 2023, with respect to the consolidated financial statements of The Cooper Companies, Inc. and the effectiveness of internal control over financial reporting.</font></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47;s&#47; KPMG LLP</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">San Francisco, California</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">December&#160;8, 2023</font></div><div style="margin-bottom:13pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>coo-ex311_20231031x10k.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib609fbf4b98a46238c4d8924e911dbde_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a) </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">AS ADOPTED PURSUANT TO SECTION 302 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Albert G. White III, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this annual report on Form 10-K of The Cooper Companies, Inc. (the &#8220;registrant&#8221;)&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 8, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Albert G. White III</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albert G. White III</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer </font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>coo-ex312_20231031x10k.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifcf468f5c51b479dbe92e01d26912b14_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a) </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">AS ADOPTED PURSUANT TO SECTION 302 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian G. Andrews, certify that&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this annual report on Form 10-K of The Cooper Companies, Inc. (the &#8220;registrant&#8221;)&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 8, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian G. Andrews</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian G. Andrews</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer<br></font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>coo-ex321_20231031x10k.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="idc39f642c7f04c219641caaeda3357d1_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Albert G. White III, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Annual Report on Form 10-K of The Cooper Companies, Inc. (the &#34;Company&#34;) for the fiscal year ended October&#160;31, 2023, as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and  </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></div><div style="margin-top:9pt;padding-left:45pt"><font><br></font></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 8, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Albert G. White III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albert G. White III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div style="margin-top:9pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>coo-ex322_20231031x10k.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic0cff0e778ef4a0999e25f0c68471413_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian G. Andrews, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Annual Report on Form 10-K of The Cooper Companies, Inc. (the &#34;Company&#34;) for the fiscal year ended October&#160;31, 2023, as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and  </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></div><div style="margin-top:9pt;padding-left:45pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 8, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian G. Andrews</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian G. Andrews</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>coo-20231031.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:0c65df22-c15f-4b61-bd32-d5e051159c75,g:61acad92-dfa7-4255-a259-2e1b3c8d59bb-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:coo="http://www.coopercos.com/20231031" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.coopercos.com/20231031">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="coo-20231031_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="coo-20231031_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="coo-20231031_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="coo-20231031_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.coopercos.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.coopercos.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofIncome">
        <link:definition>0000003 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000004 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeParenthetical" roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical">
        <link:definition>0000005 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.coopercos.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000006 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000007 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>0000008 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityParenthetical" roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical">
        <link:definition>0000009 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000010 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPolicies" roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies">
        <link:definition>0000011 - Disclosure - Organization and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeases" roleURI="http://www.coopercos.com/role/OperatingLeases">
        <link:definition>0000012 - Disclosure - Operating Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandJointVenture" roleURI="http://www.coopercos.com/role/AcquisitionsandJointVenture">
        <link:definition>0000013 - Disclosure - Acquisitions and Joint Venture</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.coopercos.com/role/IntangibleAssets">
        <link:definition>0000014 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangements" roleURI="http://www.coopercos.com/role/FinancingArrangements">
        <link:definition>0000015 - Disclosure - Financing Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.coopercos.com/role/IncomeTaxes">
        <link:definition>0000016 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.coopercos.com/role/EarningsPerShare">
        <link:definition>0000017 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.coopercos.com/role/StockholdersEquity">
        <link:definition>0000018 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlans" roleURI="http://www.coopercos.com/role/StockPlans">
        <link:definition>0000019 - Disclosure - Stock Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefits" roleURI="http://www.coopercos.com/role/EmployeeBenefits">
        <link:definition>0000020 - Disclosure - Employee Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.coopercos.com/role/Contingencies">
        <link:definition>0000021 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformation" roleURI="http://www.coopercos.com/role/BusinessSegmentInformation">
        <link:definition>0000022 - Disclosure - Business Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialDerivativesandHedging" roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedging">
        <link:definition>0000023 - Disclosure - Financial Derivatives and Hedging</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleII" roleURI="http://www.coopercos.com/role/ScheduleII">
        <link:definition>0000024 - Disclosure - Schedule II</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesPolicies" roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies">
        <link:definition>9954471 - Disclosure - Organization and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesTables" roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables">
        <link:definition>9954472 - Disclosure - Organization and Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesTables" roleURI="http://www.coopercos.com/role/OperatingLeasesTables">
        <link:definition>9954473 - Disclosure - Operating Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://www.coopercos.com/role/IntangibleAssetsTables">
        <link:definition>9954474 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsTables" roleURI="http://www.coopercos.com/role/FinancingArrangementsTables">
        <link:definition>9954475 - Disclosure - Financing Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.coopercos.com/role/IncomeTaxesTables">
        <link:definition>9954476 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.coopercos.com/role/EarningsPerShareTables">
        <link:definition>9954477 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.coopercos.com/role/StockholdersEquityTables">
        <link:definition>9954478 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansTables" roleURI="http://www.coopercos.com/role/StockPlansTables">
        <link:definition>9954479 - Disclosure - Stock Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsTables" roleURI="http://www.coopercos.com/role/EmployeeBenefitsTables">
        <link:definition>9954480 - Disclosure - Employee Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationTables" roleURI="http://www.coopercos.com/role/BusinessSegmentInformationTables">
        <link:definition>9954481 - Disclosure - Business Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialDerivativesandHedgingTables" roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingTables">
        <link:definition>9954482 - Disclosure - Financial Derivatives and Hedging (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>9954483 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesInventoryDetails" roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails">
        <link:definition>9954484 - Disclosure - Organization and Significant Accounting Policies - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails">
        <link:definition>9954485 - Disclosure - Organization and Significant Accounting Policies - Property Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails" roleURI="http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails">
        <link:definition>9954486 - Disclosure - Operating Leases - Leases on the Consolidated Condensed Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesNarrativeDetails" roleURI="http://www.coopercos.com/role/OperatingLeasesNarrativeDetails">
        <link:definition>9954487 - Disclosure - Operating Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails" roleURI="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails">
        <link:definition>9954488 - Disclosure - Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1" roleURI="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1">
        <link:definition>9954488 - Disclosure - Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandJointVentureDetails" roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureDetails">
        <link:definition>9954489 - Disclosure - Acquisitions and Joint Venture (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNarrativeDetails" roleURI="http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails">
        <link:definition>9954490 - Disclosure - Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsGoodwillDetails" roleURI="http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails">
        <link:definition>9954491 - Disclosure - Intangible Assets - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsOtherIntangibleAssetsDetails" roleURI="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails">
        <link:definition>9954492 - Disclosure - Intangible Assets - Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails" roleURI="http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails">
        <link:definition>9954493 - Disclosure - Intangible Assets - Estimated Amortization Expenses for Intangible Assets with Definite Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsTotalDebtDetails" roleURI="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails">
        <link:definition>9954494 - Disclosure - Financing Arrangements - Total Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsNarrativeDetails" roleURI="http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails">
        <link:definition>9954495 - Disclosure - Financing Arrangements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.coopercos.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>9954496 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeBeforeIncomeTaxesDetails" roleURI="http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails">
        <link:definition>9954497 - Disclosure - Income Taxes - Income Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxProvisionBenefitDetails" roleURI="http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails">
        <link:definition>9954498 - Disclosure - Income Taxes - Income Tax Provision (Benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails" roleURI="http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails">
        <link:definition>9954499 - Disclosure - Income Taxes - Reconciliation between the Expected Provision for Income taxes at the US Federal Statutory Rate and the Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9954500 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails" roleURI="http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails">
        <link:definition>9954501 - Disclosure - Income Taxes - Changes in Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareBasicandDilutedDetails" roleURI="http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails">
        <link:definition>9954502 - Disclosure - Earnings Per Share - Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails" roleURI="http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails">
        <link:definition>9954503 - Disclosure - Earnings Per Share - Stock Options to Purchase Common Stock and Restricted Stock Units Not Included in Diluted Earnings Per Share Due to Antidilutive Effect (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails" roleURI="http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails">
        <link:definition>9954504 - Disclosure - Stockholders' Equity - Changes in Accumulated Other Comprehensive Income (Loss) Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.coopercos.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>9954505 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansNarrativeDetails" roleURI="http://www.coopercos.com/role/StockPlansNarrativeDetails">
        <link:definition>9954506 - Disclosure - Stock Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails" roleURI="http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails">
        <link:definition>9954507 - Disclosure - Stock Plans - Compensation Expense and Related Income Tax Benefit for Share-Based Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails" roleURI="http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails">
        <link:definition>9954508 - Disclosure - Stock Plans - Assumptions Used in Estimating Fair Value of Stock Options Award Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansStockOptionPlansDetails" roleURI="http://www.coopercos.com/role/StockPlansStockOptionPlansDetails">
        <link:definition>9954509 - Disclosure - Stock Plans - Stock Option Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansNonVestedRSUsDetails" roleURI="http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails">
        <link:definition>9954510 - Disclosure - Stock Plans - Non-Vested RSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsNarrativeDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails">
        <link:definition>9954511 - Disclosure - Employee Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails">
        <link:definition>9954512 - Disclosure - Employee Benefits - Changes in Benefit Obligation, Changes in Plan Assets and Funded Status (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>9954513 - Disclosure - Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails">
        <link:definition>9954514 - Disclosure - Employee Benefits - Reconciliation of Prepaid (Accrued) Pension Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails">
        <link:definition>9954515 - Disclosure - Employee Benefits - Components of Net Periodic Pension Costs and Other Amounts Recognized in Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails">
        <link:definition>9954516 - Disclosure - Employee Benefits - Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails">
        <link:definition>9954517 - Disclosure - Employee Benefits - Weighted-Average Assumptions Used in Computing Net Periodic Pension Cost and Projected Benefit Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails">
        <link:definition>9954518 - Disclosure - Employee Benefits - Weighted-Average Asset Allocations by Asset Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails">
        <link:definition>9954519 - Disclosure - Employee Benefits - Fair Value Measurement of Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails">
        <link:definition>9954520 - Disclosure - Employee Benefits - Estimated Future Benefit Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationNarrativeDetails" roleURI="http://www.coopercos.com/role/BusinessSegmentInformationNarrativeDetails">
        <link:definition>9954521 - Disclosure - Business Segment Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationBusinessSegmentNetSalesDetails" roleURI="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails">
        <link:definition>9954522 - Disclosure - Business Segment Information - Business Segment Net Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationBusinessSegmentInformationDetails" roleURI="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails">
        <link:definition>9954523 - Disclosure - Business Segment Information - Business Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails" roleURI="http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails">
        <link:definition>9954524 - Disclosure - Business Segment Information - Information by Geographical Area by Country of Domicile (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialDerivativesandHedgingNarrativeDetails" roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails">
        <link:definition>9954525 - Disclosure - Financial Derivatives and Hedging - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails" roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails">
        <link:definition>9954526 - Disclosure - Financial Derivatives and Hedging - Derivative Instruments Recognized in Condensed Consolidated Statements of Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>9954527 - Disclosure - Financial Derivatives and Hedging - Changes in Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIDetails" roleURI="http://www.coopercos.com/role/ScheduleIIDetails">
        <link:definition>9954528 - Disclosure - Schedule II (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="coo_SecuredOvernightFinancingRateSOFRMember" abstract="true" name="SecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" abstract="true" name="AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_OtherDebtMember" abstract="true" name="OtherDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_PayablesThirdInstallmentMember" abstract="true" name="PayablesThirdInstallmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_CommonStockExcludingTreasuryStockParNetValueMember" abstract="true" name="CommonStockExcludingTreasuryStockParNetValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_TermLoanFacility2021BaseRateLoansMember" abstract="true" name="TermLoanFacility2021BaseRateLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" abstract="true" name="PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_CookMedicalsReproductiveHealthBusinessMember" abstract="true" name="CookMedicalsReproductiveHealthBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_ToricLensMember" abstract="true" name="ToricLensMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" abstract="true" name="BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="coo_SingleUseSphereLensMember" abstract="true" name="SingleUseSphereLensMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_PayablesFourthInstallmentMember" abstract="true" name="PayablesFourthInstallmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" abstract="true" name="ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="coo_BondMutualFundsMember" abstract="false" name="BondMutualFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_AccruedPensionCostRollForward" abstract="true" name="AccruedPensionCostRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" abstract="true" name="BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" abstract="false" name="DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="coo_NonSingleUseSphereAndOtherMember" abstract="true" name="NonSingleUseSphereAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" abstract="true" name="RevolvingCreditFacilityAndTermLoanFacility2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_BusinessCombinationPaymentToSettleContingentConsideration" abstract="false" name="BusinessCombinationPaymentToSettleContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" abstract="true" name="DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" abstract="true" name="ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_CooperVisionSegmentMember" abstract="true" name="CooperVisionSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" abstract="true" name="ThirdAmendedAndRestated2007LongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="coo_GenerateLifeSciencesMember" abstract="true" name="GenerateLifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_CookMedicalMember" abstract="true" name="CookMedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" abstract="true" name="ScheduleofLongTermAndShortTermDebtInstrumentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="coo_TermLoanFacility2021Member" abstract="true" name="TermLoanFacility2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_A2023LongTermIncentivePlanMember" abstract="true" name="A2023LongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_EssilorInternationalSASMember" abstract="true" name="EssilorInternationalSASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_OverdraftAndOtherCreditFacilitiesMember" abstract="true" name="OverdraftAndOtherCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_BusinessCombinationAndAssetAcquisitionTextBlock" abstract="false" name="BusinessCombinationAndAssetAcquisitionTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="coo_RestOfTheWorldMember" abstract="true" name="RestOfTheWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_PayablesSecondInstallmentMember" abstract="true" name="PayablesSecondInstallmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" abstract="false" name="LineOfCreditFacilityAccordionFeatureIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_AccruedAcquisitionTerminationFee" abstract="false" name="AccruedAcquisitionTerminationFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_AssetImpairmentChargesAndOther" abstract="false" name="AssetImpairmentChargesAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_NumberOfBusinessUnits" abstract="false" name="NumberOfBusinessUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="coo_TermLoanFacility2020Member" abstract="true" name="TermLoanFacility2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_CompositeMember" abstract="true" name="CompositeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" abstract="false" name="DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_CreditAgreement2020Member" abstract="true" name="CreditAgreement2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember" abstract="true" name="ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" abstract="false" name="BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" abstract="false" name="PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_OfficeAndSurgicalProductsMember" abstract="true" name="OfficeAndSurgicalProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_AlternativeInvestmentsMember" abstract="true" name="AlternativeInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems" abstract="true" name="ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" abstract="false" name="DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember" abstract="true" name="PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" abstract="false" name="ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="coo_IncreaseDecreaseInContingentConsiderationLiability" abstract="false" name="IncreaseDecreaseInContingentConsiderationLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_TermLoanAgreement2021364DayMember" abstract="true" name="TermLoanAgreement2021364DayMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="coo_AsianPacificCreditFacilitiesYenDenominatedMember" abstract="true" name="AsianPacificCreditFacilitiesYenDenominatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_AccruedPrepaidPensionCosts" abstract="false" name="AccruedPrepaidPensionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments" abstract="false" name="BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" abstract="true" name="DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" abstract="true" name="ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_TermLoanFacility2021AdjustedLIBORRateLoansMember" abstract="true" name="TermLoanFacility2021AdjustedLIBORRateLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" abstract="true" name="ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_TermLoansMember" abstract="true" name="TermLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_PayablesFirstInstallmentMember" abstract="true" name="PayablesFirstInstallmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_EuropeanCreditFacilityMember" abstract="false" name="EuropeanCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_SightGlassVisionIncMember" abstract="true" name="SightGlassVisionIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_FertilityMember" abstract="true" name="FertilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="coo_LicenseAndDistributionRightsAndOtherMember" abstract="true" name="LicenseAndDistributionRightsAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_CooperSurgicalSegmentMember" abstract="true" name="CooperSurgicalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_CorporateReconcilingItemsAndEliminationsMember" abstract="true" name="CorporateReconcilingItemsAndEliminationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_TreasuryStockParNetValueMember" abstract="false" name="TreasuryStockParNetValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_MultifocalLensMember" abstract="true" name="MultifocalLensMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" abstract="true" name="AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>coo-20231031_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:0c65df22-c15f-4b61-bd32-d5e051159c75,g:61acad92-dfa7-4255-a259-2e1b3c8d59bb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="coo-20231031.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_12fe3215-3b45-4098-9c7a-c4999dcf5715" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_561fb375-3559-4361-b6bd-96847fe31d10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_12fe3215-3b45-4098-9c7a-c4999dcf5715" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_561fb375-3559-4361-b6bd-96847fe31d10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7a864cca-4ba9-425c-aee7-3527613e8151" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_12fe3215-3b45-4098-9c7a-c4999dcf5715" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7a864cca-4ba9-425c-aee7-3527613e8151" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b74b740c-8d02-4b8b-9263-19150e90dae1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_1eff6591-2231-4b2d-b66c-cc44887d5b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b74b740c-8d02-4b8b-9263-19150e90dae1" xlink:to="loc_us-gaap_GrossProfit_1eff6591-2231-4b2d-b66c-cc44887d5b2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_fb9f05c8-0424-4520-aad8-4c311c2edae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b74b740c-8d02-4b8b-9263-19150e90dae1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_fb9f05c8-0424-4520-aad8-4c311c2edae4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f87fbaca-f731-48d5-a361-da940abfe766" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b74b740c-8d02-4b8b-9263-19150e90dae1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f87fbaca-f731-48d5-a361-da940abfe766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_23f19c1f-f004-4e43-8be7-bbb6e881050d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b74b740c-8d02-4b8b-9263-19150e90dae1" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_23f19c1f-f004-4e43-8be7-bbb6e881050d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2682169c-badb-416a-b346-0fe0819d362b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_212bd089-1f40-428c-905c-c1a2b0cdf499" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_2682169c-badb-416a-b346-0fe0819d362b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_212bd089-1f40-428c-905c-c1a2b0cdf499" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_395840bc-eae4-463b-87e5-c6feb4482e86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_2682169c-badb-416a-b346-0fe0819d362b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_395840bc-eae4-463b-87e5-c6feb4482e86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86e39080-1592-4b79-9ade-0aba1fda32ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_761d4972-6da3-44c5-9a6b-f54257c546e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86e39080-1592-4b79-9ade-0aba1fda32ba" xlink:to="loc_us-gaap_OperatingIncomeLoss_761d4972-6da3-44c5-9a6b-f54257c546e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_52355005-5b45-4058-be32-74b3c62a7394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86e39080-1592-4b79-9ade-0aba1fda32ba" xlink:to="loc_us-gaap_InterestExpense_52355005-5b45-4058-be32-74b3c62a7394" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_44d5849c-c87a-4e5e-b547-e265974f6aff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86e39080-1592-4b79-9ade-0aba1fda32ba" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_44d5849c-c87a-4e5e-b547-e265974f6aff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="coo-20231031.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e9aa505a-a8d7-4b73-a17b-6a5063f89582" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_77c466b3-7d4a-45d3-b643-112bc699d870" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e9aa505a-a8d7-4b73-a17b-6a5063f89582" xlink:to="loc_us-gaap_NetIncomeLoss_77c466b3-7d4a-45d3-b643-112bc699d870" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fff5c8dd-cd69-4edd-9680-686c0877d2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e9aa505a-a8d7-4b73-a17b-6a5063f89582" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fff5c8dd-cd69-4edd-9680-686c0877d2f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_426382c9-a972-4eba-b740-be995251bedd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_578f3bc9-4608-43b6-a511-a177d50af34e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_426382c9-a972-4eba-b740-be995251bedd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_578f3bc9-4608-43b6-a511-a177d50af34e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c220ed64-126c-4a78-b360-830227d27ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_426382c9-a972-4eba-b740-be995251bedd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c220ed64-126c-4a78-b360-830227d27ca4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_132397bd-fb37-4b64-a8b6-a4b19d9ccfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_426382c9-a972-4eba-b740-be995251bedd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_132397bd-fb37-4b64-a8b6-a4b19d9ccfe6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="coo-20231031.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c1191f30-2bc1-4b25-9799-b0e581993cef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_48f32c4e-da0e-437c-a040-d74c48a8e720" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c1191f30-2bc1-4b25-9799-b0e581993cef" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_48f32c4e-da0e-437c-a040-d74c48a8e720" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_67eed794-15c6-4f9b-9c31-b6e5af7f3a45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c1191f30-2bc1-4b25-9799-b0e581993cef" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_67eed794-15c6-4f9b-9c31-b6e5af7f3a45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9fa228f5-686a-4701-a522-b20b6bd0c162" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c1191f30-2bc1-4b25-9799-b0e581993cef" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9fa228f5-686a-4701-a522-b20b6bd0c162" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_41b31ffc-8c84-4bf3-90fc-117f63e5f919" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c1191f30-2bc1-4b25-9799-b0e581993cef" xlink:to="loc_us-gaap_InventoryNet_41b31ffc-8c84-4bf3-90fc-117f63e5f919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1af37ab1-ee67-4425-87d6-653cc5bd0da6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a3589109-08b3-4560-9005-9d71d841d53f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1af37ab1-ee67-4425-87d6-653cc5bd0da6" xlink:to="loc_us-gaap_StockholdersEquity_a3589109-08b3-4560-9005-9d71d841d53f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d07a9304-8f0a-48a9-bd4b-db5473d8e0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1af37ab1-ee67-4425-87d6-653cc5bd0da6" xlink:to="loc_us-gaap_MinorityInterest_d07a9304-8f0a-48a9-bd4b-db5473d8e0e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_521176ef-5c15-4736-b6fa-0fe149fef308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2108a9f9-cfef-4746-b107-a6c3ac9e082f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_521176ef-5c15-4736-b6fa-0fe149fef308" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2108a9f9-cfef-4746-b107-a6c3ac9e082f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b86fc27b-06f9-4884-92f8-f0c9b41d59cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_521176ef-5c15-4736-b6fa-0fe149fef308" xlink:to="loc_us-gaap_Liabilities_b86fc27b-06f9-4884-92f8-f0c9b41d59cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_80d46c01-c46a-4eb7-a1d0-79bf5b15601f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_521176ef-5c15-4736-b6fa-0fe149fef308" xlink:to="loc_us-gaap_CommitmentsAndContingencies_80d46c01-c46a-4eb7-a1d0-79bf5b15601f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6c3dccfa-83db-4356-8aad-de504f064244" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6312a452-5b2b-40fa-b7de-d63e0bbd23b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6c3dccfa-83db-4356-8aad-de504f064244" xlink:to="loc_us-gaap_AssetsCurrent_6312a452-5b2b-40fa-b7de-d63e0bbd23b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0df60f1b-7017-43dd-9b81-8fc0d65caec9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6c3dccfa-83db-4356-8aad-de504f064244" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0df60f1b-7017-43dd-9b81-8fc0d65caec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_62b2bbd3-042f-46e0-8345-b31086ff0f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6c3dccfa-83db-4356-8aad-de504f064244" xlink:to="loc_us-gaap_Goodwill_62b2bbd3-042f-46e0-8345-b31086ff0f2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_16f4cc05-e3d4-44eb-ad57-2d2e2217d8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6c3dccfa-83db-4356-8aad-de504f064244" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_16f4cc05-e3d4-44eb-ad57-2d2e2217d8a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a496b4f7-fe4c-4812-84d3-69045701d9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6c3dccfa-83db-4356-8aad-de504f064244" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a496b4f7-fe4c-4812-84d3-69045701d9c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_da67caae-ec00-40e7-9b81-4683f3cb85ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6c3dccfa-83db-4356-8aad-de504f064244" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_da67caae-ec00-40e7-9b81-4683f3cb85ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ba03d831-eca5-4405-b16a-cfe19806d8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_108c66d3-7530-4302-b3dd-4479e12e10d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ba03d831-eca5-4405-b16a-cfe19806d8f5" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_108c66d3-7530-4302-b3dd-4479e12e10d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_cfb53824-8c2b-4b75-8617-675b2245cb74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ba03d831-eca5-4405-b16a-cfe19806d8f5" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_cfb53824-8c2b-4b75-8617-675b2245cb74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_e9311a8d-68bd-40e9-b714-d69b254d75fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ba03d831-eca5-4405-b16a-cfe19806d8f5" xlink:to="loc_us-gaap_DebtCurrent_e9311a8d-68bd-40e9-b714-d69b254d75fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_5ad9ab5f-8a6b-45ba-ad1b-ba7ed7f5ec5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ba03d831-eca5-4405-b16a-cfe19806d8f5" xlink:to="loc_us-gaap_AccountsPayableCurrent_5ad9ab5f-8a6b-45ba-ad1b-ba7ed7f5ec5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d7b87a40-2b9a-497d-9b08-700c29cede47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ba03d831-eca5-4405-b16a-cfe19806d8f5" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d7b87a40-2b9a-497d-9b08-700c29cede47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0fcdeda8-9202-42e8-9225-52cdc17040f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_db80af78-3aad-4d58-b5df-6ef4c95dc8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0fcdeda8-9202-42e8-9225-52cdc17040f6" xlink:to="loc_us-gaap_LiabilitiesCurrent_db80af78-3aad-4d58-b5df-6ef4c95dc8fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_599202dc-c0c7-48bc-aca6-8cd8b61fcbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0fcdeda8-9202-42e8-9225-52cdc17040f6" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_599202dc-c0c7-48bc-aca6-8cd8b61fcbe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d1bb5ea3-6907-4a3d-8650-3ba649155603" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0fcdeda8-9202-42e8-9225-52cdc17040f6" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d1bb5ea3-6907-4a3d-8650-3ba649155603" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3dcb29ec-f71f-49e0-8508-39fa07869652" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0fcdeda8-9202-42e8-9225-52cdc17040f6" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3dcb29ec-f71f-49e0-8508-39fa07869652" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_3114bc34-31fc-4235-8ea6-4439744a3944" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0fcdeda8-9202-42e8-9225-52cdc17040f6" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_3114bc34-31fc-4235-8ea6-4439744a3944" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_d8ae973c-2f6f-4c6f-85ed-917e9f1afa6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0fcdeda8-9202-42e8-9225-52cdc17040f6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_d8ae973c-2f6f-4c6f-85ed-917e9f1afa6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2c0862f3-0e86-4957-8cbe-ad830ec5a728" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6a5e9853-fdb8-470c-9be8-e51ccad38690" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2c0862f3-0e86-4957-8cbe-ad830ec5a728" xlink:to="loc_us-gaap_CommonStockValue_6a5e9853-fdb8-470c-9be8-e51ccad38690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_732f7aae-1e38-4fc6-b067-67ec250e9d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2c0862f3-0e86-4957-8cbe-ad830ec5a728" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_732f7aae-1e38-4fc6-b067-67ec250e9d6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fa19570a-d300-40e4-b27e-fe497542f8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2c0862f3-0e86-4957-8cbe-ad830ec5a728" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fa19570a-d300-40e4-b27e-fe497542f8d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_983277b3-a2ca-4afa-bb77-ed1435f567eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2c0862f3-0e86-4957-8cbe-ad830ec5a728" xlink:to="loc_us-gaap_TreasuryStockCommonValue_983277b3-a2ca-4afa-bb77-ed1435f567eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_febd9a9e-f630-4cc9-b759-b4b281c8a04d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2c0862f3-0e86-4957-8cbe-ad830ec5a728" xlink:to="loc_us-gaap_AdditionalPaidInCapital_febd9a9e-f630-4cc9-b759-b4b281c8a04d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_fa69fc6f-cdd9-4e2a-a513-9319029a99ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2c0862f3-0e86-4957-8cbe-ad830ec5a728" xlink:to="loc_us-gaap_PreferredStockValue_fa69fc6f-cdd9-4e2a-a513-9319029a99ed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="coo-20231031.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3e44b192-9bea-41d9-8419-b767d152b2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1a2be239-cd51-4c1e-bfe2-7df1adaa3a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3e44b192-9bea-41d9-8419-b767d152b2d0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1a2be239-cd51-4c1e-bfe2-7df1adaa3a4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b704c6a-abf7-4801-8e17-9f5830e80808" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3e44b192-9bea-41d9-8419-b767d152b2d0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b704c6a-abf7-4801-8e17-9f5830e80808" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_338cbafa-084a-402e-a84f-c2c4e9459141" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3e44b192-9bea-41d9-8419-b767d152b2d0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_338cbafa-084a-402e-a84f-c2c4e9459141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b0922ea2-cd85-4462-8ced-1e1f889127e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3e44b192-9bea-41d9-8419-b767d152b2d0" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b0922ea2-cd85-4462-8ced-1e1f889127e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec37d901-cda1-4630-a37a-aa0a134a9221" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f0bebf3c-8705-4dd1-9570-811ee80306ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec37d901-cda1-4630-a37a-aa0a134a9221" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f0bebf3c-8705-4dd1-9570-811ee80306ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_4086afdb-bed9-4a34-9385-d916f8616d6b" xlink:href="coo-20231031.xsd#coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec37d901-cda1-4630-a37a-aa0a134a9221" xlink:to="loc_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_4086afdb-bed9-4a34-9385-d916f8616d6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_7e8e1ac5-716f-40b3-89d1-91ac79ab362f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec37d901-cda1-4630-a37a-aa0a134a9221" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_7e8e1ac5-716f-40b3-89d1-91ac79ab362f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03c504e2-b3e1-43f9-80a9-f4b752bb1009" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_c6a0838b-bea7-4fc1-9e3d-637ace20d275" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03c504e2-b3e1-43f9-80a9-f4b752bb1009" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_c6a0838b-bea7-4fc1-9e3d-637ace20d275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_24f7b472-ac76-49e2-83b7-bc51fae74726" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03c504e2-b3e1-43f9-80a9-f4b752bb1009" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_24f7b472-ac76-49e2-83b7-bc51fae74726" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_dcd09155-e49e-443e-a997-739ee5957c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03c504e2-b3e1-43f9-80a9-f4b752bb1009" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_dcd09155-e49e-443e-a997-739ee5957c4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_84314bce-c7ac-4394-8f8c-f0c596b88f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03c504e2-b3e1-43f9-80a9-f4b752bb1009" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_84314bce-c7ac-4394-8f8c-f0c596b88f1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ec65f80a-17c8-478c-a011-50f4a099d427" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03c504e2-b3e1-43f9-80a9-f4b752bb1009" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ec65f80a-17c8-478c-a011-50f4a099d427" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3c8ecb8c-fa22-4f38-8c52-554a5662c51f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03c504e2-b3e1-43f9-80a9-f4b752bb1009" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3c8ecb8c-fa22-4f38-8c52-554a5662c51f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_6850c1c6-95ed-4c5c-9355-940906c968ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03c504e2-b3e1-43f9-80a9-f4b752bb1009" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_6850c1c6-95ed-4c5c-9355-940906c968ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_ad89e37a-a1a3-4257-b99b-49c43f2d50b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03c504e2-b3e1-43f9-80a9-f4b752bb1009" xlink:to="loc_us-gaap_ProceedsFromStockPlans_ad89e37a-a1a3-4257-b99b-49c43f2d50b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_55139ff8-f468-409b-9085-e6cc575c8656" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03c504e2-b3e1-43f9-80a9-f4b752bb1009" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_55139ff8-f468-409b-9085-e6cc575c8656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_29bb8e2c-445f-4e0b-8e7f-122e3b05804b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_29bb8e2c-445f-4e0b-8e7f-122e3b05804b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetImpairmentChargesAndOther_a49a4fc9-cbd9-45d7-a10b-1b205513f04a" xlink:href="coo-20231031.xsd#coo_AssetImpairmentChargesAndOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_coo_AssetImpairmentChargesAndOther_a49a4fc9-cbd9-45d7-a10b-1b205513f04a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1614bbe8-2934-46e8-a471-a8012cefa725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_us-gaap_NetIncomeLoss_1614bbe8-2934-46e8-a471-a8012cefa725" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_68b0bc68-a233-4311-9ddb-821afd1a4341" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_68b0bc68-a233-4311-9ddb-821afd1a4341" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d1535812-acf3-477a-9be5-9cc682961010" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d1535812-acf3-477a-9be5-9cc682961010" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_9f56dc4c-e806-49a3-a476-ebae28652647" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_9f56dc4c-e806-49a3-a476-ebae28652647" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1a8768c7-a946-4475-8851-6fabe8c7d201" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1a8768c7-a946-4475-8851-6fabe8c7d201" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_b170f8e1-e2ff-4d55-aa64-f1eaf1bb9d10" xlink:href="coo-20231031.xsd#coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_b170f8e1-e2ff-4d55-aa64-f1eaf1bb9d10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5e745ebf-158e-4c18-9ce1-616ea86d214f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5e745ebf-158e-4c18-9ce1-616ea86d214f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_00c686dd-9e6b-4eaa-9dbe-fd4fdd00915e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_00c686dd-9e6b-4eaa-9dbe-fd4fdd00915e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ebeb501b-87a3-437b-aabd-f7f96abd2b38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ebeb501b-87a3-437b-aabd-f7f96abd2b38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_a345a25d-f2b9-44e5-a0fc-da6fb5a39ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_a345a25d-f2b9-44e5-a0fc-da6fb5a39ff1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f64d12bb-4d43-4be5-986b-00ceb5f540ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f64d12bb-4d43-4be5-986b-00ceb5f540ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5ac359dd-7b7d-48df-b628-231337265e32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5ac359dd-7b7d-48df-b628-231337265e32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_24ffeb30-9dcc-4bc0-a96c-30afc3b5be9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_us-gaap_ShareBasedCompensation_24ffeb30-9dcc-4bc0-a96c-30afc3b5be9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_IncreaseDecreaseInContingentConsiderationLiability_2a57f1b5-c1f0-416f-8b79-be5e4729abf0" xlink:href="coo-20231031.xsd#coo_IncreaseDecreaseInContingentConsiderationLiability"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c266792a-1c63-4ce9-97fd-a5f6864ca0ef" xlink:to="loc_coo_IncreaseDecreaseInContingentConsiderationLiability_2a57f1b5-c1f0-416f-8b79-be5e4729abf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c32532e-17e1-44f8-bb8c-b19d8e5c415f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_386a9067-6f94-4290-8a10-b45d600dd4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c32532e-17e1-44f8-bb8c-b19d8e5c415f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_386a9067-6f94-4290-8a10-b45d600dd4e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f7958897-8027-4cde-8792-1b8c3f13e2db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c32532e-17e1-44f8-bb8c-b19d8e5c415f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f7958897-8027-4cde-8792-1b8c3f13e2db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_8bdf5c0f-809b-4974-94af-93d9a89733f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c32532e-17e1-44f8-bb8c-b19d8e5c415f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_8bdf5c0f-809b-4974-94af-93d9a89733f4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#OrganizationandSignificantAccountingPoliciesInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_700e1b10-cb16-4d9f-b10a-f3e4c867854e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_22f72fb2-b6a0-4e09-b894-191328a0554e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_700e1b10-cb16-4d9f-b10a-f3e4c867854e" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_22f72fb2-b6a0-4e09-b894-191328a0554e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0ab371fe-4635-42b0-a4af-04c04b8f9231" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_700e1b10-cb16-4d9f-b10a-f3e4c867854e" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0ab371fe-4635-42b0-a4af-04c04b8f9231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4cc1122c-10e2-444f-b502-f0f8bec9f533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_700e1b10-cb16-4d9f-b10a-f3e4c867854e" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4cc1122c-10e2-444f-b502-f0f8bec9f533" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d072f674-cc3a-4f37-a5ce-64b6fe16ea3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_73621d37-522e-4887-9c7b-53cfb03c2233" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d072f674-cc3a-4f37-a5ce-64b6fe16ea3a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_73621d37-522e-4887-9c7b-53cfb03c2233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f03a6fe9-583f-4bbd-b02b-fde20a49d816" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d072f674-cc3a-4f37-a5ce-64b6fe16ea3a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f03a6fe9-583f-4bbd-b02b-fde20a49d816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d6f0561b-7842-4a6e-9ccf-132fdc6cea12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_a0ff4ba1-1341-4e27-b418-a1cc196665ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d6f0561b-7842-4a6e-9ccf-132fdc6cea12" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_a0ff4ba1-1341-4e27-b418-a1cc196665ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2710b0fc-62d6-459b-b674-b2fd3546bc58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d6f0561b-7842-4a6e-9ccf-132fdc6cea12" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2710b0fc-62d6-459b-b674-b2fd3546bc58" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2b7e8ebb-3b92-4ef8-9f8b-170f59b30bea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5b040918-22d2-43eb-b2ca-c951d0f6677f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_2b7e8ebb-3b92-4ef8-9f8b-170f59b30bea" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5b040918-22d2-43eb-b2ca-c951d0f6677f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9e88494a-526a-4677-ae44-54f54bf58ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_2b7e8ebb-3b92-4ef8-9f8b-170f59b30bea" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9e88494a-526a-4677-ae44-54f54bf58ae0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fe17c0f0-d60b-446d-86a7-aef128d97f48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_04103d6d-aeb0-4fec-bafb-925af870b76b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fe17c0f0-d60b-446d-86a7-aef128d97f48" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_04103d6d-aeb0-4fec-bafb-925af870b76b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_86adf4ba-013e-452d-9678-941e2d37ac0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fe17c0f0-d60b-446d-86a7-aef128d97f48" xlink:to="loc_us-gaap_OperatingLeaseLiability_86adf4ba-013e-452d-9678-941e2d37ac0f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1" xlink:type="simple" xlink:href="coo-20231031.xsd#OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6ae8eb8e-0e89-40ea-813d-e86138dc5fac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_3ebd8d81-20a7-4be4-af74-92908babef19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6ae8eb8e-0e89-40ea-813d-e86138dc5fac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_3ebd8d81-20a7-4be4-af74-92908babef19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4ec4aa9d-a22c-425e-b562-7f7f30612236" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6ae8eb8e-0e89-40ea-813d-e86138dc5fac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4ec4aa9d-a22c-425e-b562-7f7f30612236" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1e8076b1-db35-4b4f-83fc-3739ef343f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6ae8eb8e-0e89-40ea-813d-e86138dc5fac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1e8076b1-db35-4b4f-83fc-3739ef343f0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e85e6c70-8009-4700-9c17-5a5def2387f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6ae8eb8e-0e89-40ea-813d-e86138dc5fac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e85e6c70-8009-4700-9c17-5a5def2387f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6364b4b1-aade-4833-ad71-632f5c0693f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6ae8eb8e-0e89-40ea-813d-e86138dc5fac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6364b4b1-aade-4833-ad71-632f5c0693f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d9e321fe-3496-4514-88f6-a1fe680fe286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6ae8eb8e-0e89-40ea-813d-e86138dc5fac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d9e321fe-3496-4514-88f6-a1fe680fe286" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IntangibleAssetsOtherIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_55132a3a-c65c-4b46-b7cd-f0406ea3fe5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_358f06e6-b9fb-4513-b6bc-a40ed2404ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_55132a3a-c65c-4b46-b7cd-f0406ea3fe5c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_358f06e6-b9fb-4513-b6bc-a40ed2404ec8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e072d90d-5be5-482a-bcc4-88c4a4e6e4be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_55132a3a-c65c-4b46-b7cd-f0406ea3fe5c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e072d90d-5be5-482a-bcc4-88c4a4e6e4be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e930467e-c21f-46b4-a11d-9a059ba45d48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_11656a02-f9d5-46da-95e7-b03ae3bbe8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e930467e-c21f-46b4-a11d-9a059ba45d48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_11656a02-f9d5-46da-95e7-b03ae3bbe8e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_92b125f6-a642-4fd9-9ce0-1effb7cea3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e930467e-c21f-46b4-a11d-9a059ba45d48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_92b125f6-a642-4fd9-9ce0-1effb7cea3a4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0f40506a-c9c7-4ac3-af01-1cbdcae668d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_78e83654-f185-427e-a79b-78ccdc249179" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0f40506a-c9c7-4ac3-af01-1cbdcae668d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_78e83654-f185-427e-a79b-78ccdc249179" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_56da9f37-0b4b-4975-bb55-7b260e0ca00d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0f40506a-c9c7-4ac3-af01-1cbdcae668d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_56da9f37-0b4b-4975-bb55-7b260e0ca00d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3db6c514-6899-4bff-a66f-03e464da9210" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0f40506a-c9c7-4ac3-af01-1cbdcae668d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3db6c514-6899-4bff-a66f-03e464da9210" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_bfe83a03-e2a1-4b67-a523-bdd7457603b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0f40506a-c9c7-4ac3-af01-1cbdcae668d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_bfe83a03-e2a1-4b67-a523-bdd7457603b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_bdbcc375-f7bd-41e9-a1d5-7ee7f91a7604" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0f40506a-c9c7-4ac3-af01-1cbdcae668d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_bdbcc375-f7bd-41e9-a1d5-7ee7f91a7604" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7d6a025e-406d-4cf8-81de-8bcab8e01b81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0f40506a-c9c7-4ac3-af01-1cbdcae668d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7d6a025e-406d-4cf8-81de-8bcab8e01b81" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancingArrangementsTotalDebtDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e09cdfbc-a239-4e42-954f-456d20ed9dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4c14f747-af6c-415a-ae80-e7838df125d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e09cdfbc-a239-4e42-954f-456d20ed9dc2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4c14f747-af6c-415a-ae80-e7838df125d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_eda5a81a-5ee7-458d-9f38-8c4740ecde62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e09cdfbc-a239-4e42-954f-456d20ed9dc2" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_eda5a81a-5ee7-458d-9f38-8c4740ecde62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4b0c4b09-5ade-40b5-8e29-d4fb876af53c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_82df777c-510b-48c5-94b9-d0455af21389" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_4b0c4b09-5ade-40b5-8e29-d4fb876af53c" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_82df777c-510b-48c5-94b9-d0455af21389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_6e06a001-8716-4e2f-b33f-6136630024cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_4b0c4b09-5ade-40b5-8e29-d4fb876af53c" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_6e06a001-8716-4e2f-b33f-6136630024cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_6c5f280e-f767-4b02-a2cd-84bb14b69d35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f63639a2-1a41-4631-a3c9-a99386f0958f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_6c5f280e-f767-4b02-a2cd-84bb14b69d35" xlink:to="loc_us-gaap_ShortTermBorrowings_f63639a2-1a41-4631-a3c9-a99386f0958f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_f1b1cf15-6509-46c6-a732-dd29cc5cfa0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_6c5f280e-f767-4b02-a2cd-84bb14b69d35" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_f1b1cf15-6509-46c6-a732-dd29cc5cfa0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_76375db6-ffa2-4909-bee5-b080d97c444e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_bc2268de-3379-4fac-8a78-2fab24aac6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_76375db6-ffa2-4909-bee5-b080d97c444e" xlink:to="loc_us-gaap_DebtCurrent_bc2268de-3379-4fac-8a78-2fab24aac6ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5bc9d2ab-45a1-4a70-831d-82944949ad7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_76375db6-ffa2-4909-bee5-b080d97c444e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5bc9d2ab-45a1-4a70-831d-82944949ad7f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_89cc4ece-8ffb-42f8-a675-7c39bb8f714c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_9cb0624e-85ec-49dd-b351-01ee3babca31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_89cc4ece-8ffb-42f8-a675-7c39bb8f714c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_9cb0624e-85ec-49dd-b351-01ee3babca31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_6e94a017-b6f5-4541-9431-51bc193efa69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_89cc4ece-8ffb-42f8-a675-7c39bb8f714c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_6e94a017-b6f5-4541-9431-51bc193efa69" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IncomeTaxesIncomeTaxProvisionBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_01cf4e65-4a87-4316-9d39-0a803124bca0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_e4f6bba5-15ab-4f0d-9f3b-47ce3fbe6cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_01cf4e65-4a87-4316-9d39-0a803124bca0" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_e4f6bba5-15ab-4f0d-9f3b-47ce3fbe6cc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8b685ec7-56f9-4a9a-b92a-d992bd0e2258" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_01cf4e65-4a87-4316-9d39-0a803124bca0" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8b685ec7-56f9-4a9a-b92a-d992bd0e2258" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a9eab1be-5b4b-483a-86f6-1c98b4048883" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_01cf4e65-4a87-4316-9d39-0a803124bca0" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a9eab1be-5b4b-483a-86f6-1c98b4048883" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ffb15a10-6971-4ad1-98e9-3de78dc8555f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ea8417a0-82ea-41cc-9ed6-8240cda280b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ffb15a10-6971-4ad1-98e9-3de78dc8555f" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ea8417a0-82ea-41cc-9ed6-8240cda280b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e4513399-db83-4a38-8fba-193d57b13ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ffb15a10-6971-4ad1-98e9-3de78dc8555f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e4513399-db83-4a38-8fba-193d57b13ef3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7d04f268-50bb-4eaf-b327-2317d143b5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_afd82d44-255d-46bc-87eb-7be2368e6d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7d04f268-50bb-4eaf-b327-2317d143b5ad" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_afd82d44-255d-46bc-87eb-7be2368e6d0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_fc6718de-3a36-473c-9eb5-570f91072dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7d04f268-50bb-4eaf-b327-2317d143b5ad" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_fc6718de-3a36-473c-9eb5-570f91072dd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2e0ebd83-0ea3-46f3-afef-28eeff8f2545" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7d04f268-50bb-4eaf-b327-2317d143b5ad" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2e0ebd83-0ea3-46f3-afef-28eeff8f2545" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1711bcdb-b720-46b6-9f37-074f0cfceeb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_7984eaa0-c005-4854-81c9-30b86d5a2269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1711bcdb-b720-46b6-9f37-074f0cfceeb6" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_7984eaa0-c005-4854-81c9-30b86d5a2269" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_cc7514e0-15fa-4312-9f80-3e3fd7fc1a3a" xlink:href="coo-20231031.xsd#coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1711bcdb-b720-46b6-9f37-074f0cfceeb6" xlink:to="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_cc7514e0-15fa-4312-9f80-3e3fd7fc1a3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_4be910c3-4a9f-42c0-8e39-3977a5f9e61f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1711bcdb-b720-46b6-9f37-074f0cfceeb6" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_4be910c3-4a9f-42c0-8e39-3977a5f9e61f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfAssets_25169800-f560-46c0-899e-d89b804c4036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationDispositionOfAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1711bcdb-b720-46b6-9f37-074f0cfceeb6" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfAssets_25169800-f560-46c0-899e-d89b804c4036" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_62f5ee38-4c4f-4885-bb19-a8bace017748" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1711bcdb-b720-46b6-9f37-074f0cfceeb6" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_62f5ee38-4c4f-4885-bb19-a8bace017748" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_778ad4c9-ddbc-4519-b429-a797463d955a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1711bcdb-b720-46b6-9f37-074f0cfceeb6" xlink:to="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_778ad4c9-ddbc-4519-b429-a797463d955a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_52034589-72eb-4e7e-8724-0a8359189e21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1711bcdb-b720-46b6-9f37-074f0cfceeb6" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_52034589-72eb-4e7e-8724-0a8359189e21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_93fdc460-90e1-4718-8b86-89d394ea46bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1711bcdb-b720-46b6-9f37-074f0cfceeb6" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_93fdc460-90e1-4718-8b86-89d394ea46bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2ecb804a-64a5-4447-b599-f227719be3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1711bcdb-b720-46b6-9f37-074f0cfceeb6" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2ecb804a-64a5-4447-b599-f227719be3b2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_38f30d87-eab5-416e-85ef-8f8be9c288b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_26142fb2-66a4-4a30-ba4c-6cbf5973d53a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_38f30d87-eab5-416e-85ef-8f8be9c288b3" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_26142fb2-66a4-4a30-ba4c-6cbf5973d53a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d7cbaeb2-ca4e-455a-94df-28af844ad6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_38f30d87-eab5-416e-85ef-8f8be9c288b3" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d7cbaeb2-ca4e-455a-94df-28af844ad6bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_b3e030db-3b39-4a42-ab0b-871c23d4b991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_37c535bc-30bd-411f-b209-1b1be6339005" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_b3e030db-3b39-4a42-ab0b-871c23d4b991" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_37c535bc-30bd-411f-b209-1b1be6339005" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_aefc0cde-cba3-4e85-937f-9926f2c89e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_b3e030db-3b39-4a42-ab0b-871c23d4b991" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_aefc0cde-cba3-4e85-937f-9926f2c89e2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_124a21cb-d038-432b-9fa6-0eb0c53bb499" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_34ac238e-bf02-4715-a477-5adf926721c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_124a21cb-d038-432b-9fa6-0eb0c53bb499" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_34ac238e-bf02-4715-a477-5adf926721c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_202d8c91-c06c-4602-b446-94a67c35b050" xlink:href="coo-20231031.xsd#coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_124a21cb-d038-432b-9fa6-0eb0c53bb499" xlink:to="loc_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_202d8c91-c06c-4602-b446-94a67c35b050" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a9ac7cb9-0e0e-45c3-8bd5-234927939b14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_124a21cb-d038-432b-9fa6-0eb0c53bb499" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a9ac7cb9-0e0e-45c3-8bd5-234927939b14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_76867036-46d2-43e0-a2a5-7e69b5e3d145" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_124a21cb-d038-432b-9fa6-0eb0c53bb499" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_76867036-46d2-43e0-a2a5-7e69b5e3d145" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1b1c24f2-9159-41c8-83af-1bf1be37d7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_aff89a96-51af-423e-947b-69f5a6bb9c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1b1c24f2-9159-41c8-83af-1bf1be37d7b8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_aff89a96-51af-423e-947b-69f5a6bb9c4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_029e0ae1-5e3f-448a-a825-b54cba65c640" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1b1c24f2-9159-41c8-83af-1bf1be37d7b8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_029e0ae1-5e3f-448a-a825-b54cba65c640" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_c2307fdb-7999-498a-a991-2e7e1e2f5a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1b1c24f2-9159-41c8-83af-1bf1be37d7b8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_c2307fdb-7999-498a-a991-2e7e1e2f5a9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_280c4e75-0576-4f0d-bbd0-60278d5eeee4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1b1c24f2-9159-41c8-83af-1bf1be37d7b8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_280c4e75-0576-4f0d-bbd0-60278d5eeee4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_90041f0b-d2b7-4063-aa91-79a998f0a6c2" xlink:href="coo-20231031.xsd#coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1b1c24f2-9159-41c8-83af-1bf1be37d7b8" xlink:to="loc_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_90041f0b-d2b7-4063-aa91-79a998f0a6c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_2698f382-23f2-40b0-b2ac-26a4f3e1f20c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1b1c24f2-9159-41c8-83af-1bf1be37d7b8" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_2698f382-23f2-40b0-b2ac-26a4f3e1f20c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_32cff24e-f55f-47b1-bf92-03b306b25d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1b1c24f2-9159-41c8-83af-1bf1be37d7b8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_32cff24e-f55f-47b1-bf92-03b306b25d5d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EarningsPerShareBasicandDilutedDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_56541ccc-fb71-4b99-afba-716487dbc598" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4d762027-bd6a-4571-a8a2-027b0afae9de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_56541ccc-fb71-4b99-afba-716487dbc598" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4d762027-bd6a-4571-a8a2-027b0afae9de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_88979f1c-8f50-48bd-8012-360fa28ce59d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_56541ccc-fb71-4b99-afba-716487dbc598" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_88979f1c-8f50-48bd-8012-360fa28ce59d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_c47d8aa4-019f-45df-bf7b-c208c3bc2f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_531ac683-617e-42f2-9201-eef2f7044a33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_c47d8aa4-019f-45df-bf7b-c208c3bc2f6c" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_531ac683-617e-42f2-9201-eef2f7044a33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7c1dc0df-6626-4d93-b7d7-e6912c787929" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_c47d8aa4-019f-45df-bf7b-c208c3bc2f6c" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7c1dc0df-6626-4d93-b7d7-e6912c787929" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_d4e4ea09-18c3-4242-a166-f50400456a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_d515928f-3b65-48ba-9834-a7843381ab3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_d4e4ea09-18c3-4242-a166-f50400456a74" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_d515928f-3b65-48ba-9834-a7843381ab3b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9b433c99-d921-413c-b0a5-618a52f1f083" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_10b8979e-548d-4710-b3ff-0946f50db1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9b433c99-d921-413c-b0a5-618a52f1f083" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_10b8979e-548d-4710-b3ff-0946f50db1ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_4e374d66-69e5-431b-a78b-64848ece978d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9b433c99-d921-413c-b0a5-618a52f1f083" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_4e374d66-69e5-431b-a78b-64848ece978d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_dd596ad3-af8f-4d80-956d-456d89c4d841" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9b433c99-d921-413c-b0a5-618a52f1f083" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_dd596ad3-af8f-4d80-956d-456d89c4d841" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_acea67b6-d2ca-41dd-abf2-69d9e3fc8d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9b433c99-d921-413c-b0a5-618a52f1f083" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_acea67b6-d2ca-41dd-abf2-69d9e3fc8d9a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_ea925d19-0bf3-4b58-aca7-09a36b1460ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_fbc2782c-1771-4e86-ab02-f45a397ad0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_ea925d19-0bf3-4b58-aca7-09a36b1460ed" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_fbc2782c-1771-4e86-ab02-f45a397ad0a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_0ee0e1ed-e128-416a-b402-4168b059b402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_ea925d19-0bf3-4b58-aca7-09a36b1460ed" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_0ee0e1ed-e128-416a-b402-4168b059b402" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>coo-20231031_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:0c65df22-c15f-4b61-bd32-d5e051159c75,g:61acad92-dfa7-4255-a259-2e1b3c8d59bb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="coo-20231031.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_70fa125f-66f5-4bc5-b49b-4d2d8f884138" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70fa125f-66f5-4bc5-b49b-4d2d8f884138" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1103d1b8-2c01-4aa6-a7a0-2db977f41b87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1103d1b8-2c01-4aa6-a7a0-2db977f41b87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_7d086e60-aff6-4851-a912-7238d11c7a81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_TreasuryStockCommonShares_7d086e60-aff6-4851-a912-7238d11c7a81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_111f9b29-3af3-4555-b8bb-01a65199f2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_111f9b29-3af3-4555-b8bb-01a65199f2b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17e0b2f7-f8e1-471a-9f2a-e51094fe5857" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_NetIncomeLoss_17e0b2f7-f8e1-471a-9f2a-e51094fe5857" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_36cedc23-3adb-46f2-a983-4e87906352fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_36cedc23-3adb-46f2-a983-4e87906352fb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0d3d9b8d-b3cb-4c4d-bc69-71a18e3fa453" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0d3d9b8d-b3cb-4c4d-bc69-71a18e3fa453" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_da6e71d7-6f1c-4d0c-87cd-aabbba2025cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_da6e71d7-6f1c-4d0c-87cd-aabbba2025cc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_3fde649f-8cce-4017-8154-dbbbd262bda6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_3fde649f-8cce-4017-8154-dbbbd262bda6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6182847f-9eae-488b-9ea8-958c1f813d35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6182847f-9eae-488b-9ea8-958c1f813d35" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_2baeb42f-8e1a-40be-bac1-c29146b4d32d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_DividendsCommonStockCash_2baeb42f-8e1a-40be-bac1-c29146b4d32d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d635f5f0-d3b6-4eaa-a5ea-0be75c3d3942" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d635f5f0-d3b6-4eaa-a5ea-0be75c3d3942" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6e63eac8-71fb-49f8-92a1-bf07a5b384a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_c98e1cd0-b557-4e1f-a761-033372d9fba1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1401d703-641c-4f27-ad3d-915ab8b2a205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_863df111-aeb7-4430-bbbf-e5387eddeb87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70fa125f-66f5-4bc5-b49b-4d2d8f884138" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_863df111-aeb7-4430-bbbf-e5387eddeb87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6a6c5809-8844-41b6-94ac-3b65c4f8504d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_70fa125f-66f5-4bc5-b49b-4d2d8f884138" xlink:to="loc_us-gaap_StatementTable_6a6c5809-8844-41b6-94ac-3b65c4f8504d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cff218f5-2c3c-47f5-9c36-ca2b1bcdffdf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6a6c5809-8844-41b6-94ac-3b65c4f8504d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cff218f5-2c3c-47f5-9c36-ca2b1bcdffdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cff218f5-2c3c-47f5-9c36-ca2b1bcdffdf_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cff218f5-2c3c-47f5-9c36-ca2b1bcdffdf" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cff218f5-2c3c-47f5-9c36-ca2b1bcdffdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_89ac44dc-7c8b-4ba6-b7e0-f3e8e4e67468" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cff218f5-2c3c-47f5-9c36-ca2b1bcdffdf" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_89ac44dc-7c8b-4ba6-b7e0-f3e8e4e67468" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2024e07e-7c3e-4c0d-ab8e-5db94ead187e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_89ac44dc-7c8b-4ba6-b7e0-f3e8e4e67468" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2024e07e-7c3e-4c0d-ab8e-5db94ead187e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b58dd064-fd5f-464f-84dc-934007727bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6a6c5809-8844-41b6-94ac-3b65c4f8504d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b58dd064-fd5f-464f-84dc-934007727bfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b58dd064-fd5f-464f-84dc-934007727bfc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b58dd064-fd5f-464f-84dc-934007727bfc" xlink:to="loc_us-gaap_EquityComponentDomain_b58dd064-fd5f-464f-84dc-934007727bfc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b58dd064-fd5f-464f-84dc-934007727bfc" xlink:to="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CommonStockExcludingTreasuryStockParNetValueMember_28a604c6-b737-4ffc-8fb4-77c854782b93" xlink:href="coo-20231031.xsd#coo_CommonStockExcludingTreasuryStockParNetValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_coo_CommonStockExcludingTreasuryStockParNetValueMember_28a604c6-b737-4ffc-8fb4-77c854782b93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_ba9d8205-6f83-484f-9a4b-f143a3b2f860" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_us-gaap_TreasuryStockCommonMember_ba9d8205-6f83-484f-9a4b-f143a3b2f860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TreasuryStockParNetValueMember_e1fb62b2-8681-4ec0-b888-d5f5cf6a8839" xlink:href="coo-20231031.xsd#coo_TreasuryStockParNetValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_coo_TreasuryStockParNetValueMember_e1fb62b2-8681-4ec0-b888-d5f5cf6a8839" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f7de1a5d-8472-4ffd-b2e8-e4c7697c8a02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f7de1a5d-8472-4ffd-b2e8-e4c7697c8a02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9ba0a3cc-875a-4a96-900f-1ba81ab1ce82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9ba0a3cc-875a-4a96-900f-1ba81ab1ce82" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3c467ab6-4bb2-4906-bd9c-85131f42f6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_us-gaap_RetainedEarningsMember_3c467ab6-4bb2-4906-bd9c-85131f42f6fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b35fdb48-4c81-4640-9511-a5d87cd7f7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b35fdb48-4c81-4640-9511-a5d87cd7f7f0" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#OrganizationandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_966f5baf-c9f0-428b-b202-1fd869854b00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NumberOfBusinessUnits_186435b3-71c7-4b92-a951-214d9e896428" xlink:href="coo-20231031.xsd#coo_NumberOfBusinessUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_966f5baf-c9f0-428b-b202-1fd869854b00" xlink:to="loc_coo_NumberOfBusinessUnits_186435b3-71c7-4b92-a951-214d9e896428" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_fe0d3ba1-3ae6-473e-811e-35c8487b95b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_966f5baf-c9f0-428b-b202-1fd869854b00" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_fe0d3ba1-3ae6-473e-811e-35c8487b95b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_5f326213-f96e-4d3d-96d5-25662a8dfda6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_966f5baf-c9f0-428b-b202-1fd869854b00" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_5f326213-f96e-4d3d-96d5-25662a8dfda6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_27447a8a-d4a8-49ed-aed1-fb9cafb32b28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_966f5baf-c9f0-428b-b202-1fd869854b00" xlink:to="loc_us-gaap_BusinessExitCosts1_27447a8a-d4a8-49ed-aed1-fb9cafb32b28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d99ffd22-4de6-4fe8-87d2-b634deb0eb14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_966f5baf-c9f0-428b-b202-1fd869854b00" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d99ffd22-4de6-4fe8-87d2-b634deb0eb14" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc8778f8-ce98-4e20-8ca4-eeab75617b0c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d99ffd22-4de6-4fe8-87d2-b634deb0eb14" xlink:to="loc_srt_RangeAxis_cc8778f8-ce98-4e20-8ca4-eeab75617b0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc8778f8-ce98-4e20-8ca4-eeab75617b0c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cc8778f8-ce98-4e20-8ca4-eeab75617b0c" xlink:to="loc_srt_RangeMember_cc8778f8-ce98-4e20-8ca4-eeab75617b0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_71e6ada0-b13b-488a-b3dc-ba4b7eefab0b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cc8778f8-ce98-4e20-8ca4-eeab75617b0c" xlink:to="loc_srt_RangeMember_71e6ada0-b13b-488a-b3dc-ba4b7eefab0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_deda0509-d43d-4aff-a2eb-ec7c514a94e1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_71e6ada0-b13b-488a-b3dc-ba4b7eefab0b" xlink:to="loc_srt_MinimumMember_deda0509-d43d-4aff-a2eb-ec7c514a94e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1ee6f2f3-855c-470b-ac5a-438822106612" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_71e6ada0-b13b-488a-b3dc-ba4b7eefab0b" xlink:to="loc_srt_MaximumMember_1ee6f2f3-855c-470b-ac5a-438822106612" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_033230f5-f8d2-4b3b-a7c2-6352216fe81f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d99ffd22-4de6-4fe8-87d2-b634deb0eb14" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_033230f5-f8d2-4b3b-a7c2-6352216fe81f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_033230f5-f8d2-4b3b-a7c2-6352216fe81f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_033230f5-f8d2-4b3b-a7c2-6352216fe81f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_033230f5-f8d2-4b3b-a7c2-6352216fe81f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02c2c02b-641b-477f-a7ae-e575d21567d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_033230f5-f8d2-4b3b-a7c2-6352216fe81f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02c2c02b-641b-477f-a7ae-e575d21567d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_b1c00219-b088-456d-86e0-242439f94f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02c2c02b-641b-477f-a7ae-e575d21567d6" xlink:to="loc_us-gaap_BuildingMember_b1c00219-b088-456d-86e0-242439f94f4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1784355e-cbff-4694-acae-ed0535715629" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d99ffd22-4de6-4fe8-87d2-b634deb0eb14" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1784355e-cbff-4694-acae-ed0535715629" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1784355e-cbff-4694-acae-ed0535715629_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1784355e-cbff-4694-acae-ed0535715629" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1784355e-cbff-4694-acae-ed0535715629_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3e1f5238-6f76-48bf-8c01-f5808f4546df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1784355e-cbff-4694-acae-ed0535715629" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3e1f5238-6f76-48bf-8c01-f5808f4546df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_bc4a9a01-ca3e-42dc-872e-2e8a2b5b2e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3e1f5238-6f76-48bf-8c01-f5808f4546df" xlink:to="loc_us-gaap_CostOfSalesMember_bc4a9a01-ca3e-42dc-872e-2e8a2b5b2e4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_056d5160-1162-45b7-9453-fa79dcce480d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3e1f5238-6f76-48bf-8c01-f5808f4546df" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_056d5160-1162-45b7-9453-fa79dcce480d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_15bdfee1-9eb7-4a9d-86da-2fd711ab7142" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_15bdfee1-9eb7-4a9d-86da-2fd711ab7142" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_28069172-b71c-45a0-81e9-225bed373ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_28069172-b71c-45a0-81e9-225bed373ac2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ce64b384-f8ff-4fd0-9fc3-e7a9c7596a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ce64b384-f8ff-4fd0-9fc3-e7a9c7596a0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_f07ca2d6-f3fb-4a9a-8db4-28a4d6453f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_f07ca2d6-f3fb-4a9a-8db4-28a4d6453f3f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_25f254db-fbf4-496d-8ea7-78baea9a0f94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_25f254db-fbf4-496d-8ea7-78baea9a0f94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0caec7de-9a33-452f-a62f-6e2114dfe86a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0caec7de-9a33-452f-a62f-6e2114dfe86a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30988206-df38-4dd5-a2bc-4c7824bbaa7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0caec7de-9a33-452f-a62f-6e2114dfe86a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30988206-df38-4dd5-a2bc-4c7824bbaa7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30988206-df38-4dd5-a2bc-4c7824bbaa7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30988206-df38-4dd5-a2bc-4c7824bbaa7d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30988206-df38-4dd5-a2bc-4c7824bbaa7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_239a086d-1cab-416f-b351-9bf959b43fba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30988206-df38-4dd5-a2bc-4c7824bbaa7d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_239a086d-1cab-416f-b351-9bf959b43fba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_eb36c5a1-3250-483b-b9e5-f4336161a744" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_239a086d-1cab-416f-b351-9bf959b43fba" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_eb36c5a1-3250-483b-b9e5-f4336161a744" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_879a9bd8-406d-45e7-838c-6d01eaaf25f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_239a086d-1cab-416f-b351-9bf959b43fba" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_879a9bd8-406d-45e7-838c-6d01eaaf25f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_0a5a11e1-ad5a-4033-858f-7348930cdec5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_239a086d-1cab-416f-b351-9bf959b43fba" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_0a5a11e1-ad5a-4033-858f-7348930cdec5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_ce667a7f-c3d2-4f16-ae4b-3b871323ed5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_239a086d-1cab-416f-b351-9bf959b43fba" xlink:to="loc_us-gaap_ConstructionInProgressMember_ce667a7f-c3d2-4f16-ae4b-3b871323ed5a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#AcquisitionsandJointVentureDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0d468bda-962f-4d11-8738-d5a38d6199ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0d468bda-962f-4d11-8738-d5a38d6199ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d3d85d1c-a7a0-4a0d-942f-aab10e362dca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d3d85d1c-a7a0-4a0d-942f-aab10e362dca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_7b4fe420-78d3-4d96-b779-653bdd375fd9" xlink:href="coo-20231031.xsd#coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_7b4fe420-78d3-4d96-b779-653bdd375fd9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3c34fb2d-9eb2-4369-a5a8-b7e725810fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_Goodwill_3c34fb2d-9eb2-4369-a5a8-b7e725810fa4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6ca5eb8c-e3d2-4c54-876e-3e4f634ed1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6ca5eb8c-e3d2-4c54-876e-3e4f634ed1c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_efb4c23d-129b-41db-bd26-edd0d5a9752c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_efb4c23d-129b-41db-bd26-edd0d5a9752c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_e26bd4fd-b47d-4012-9857-b89941823e55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_e26bd4fd-b47d-4012-9857-b89941823e55" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccruedAcquisitionTerminationFee_4aa44b64-d27e-43ca-b075-4795fd474b42" xlink:href="coo-20231031.xsd#coo_AccruedAcquisitionTerminationFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_coo_AccruedAcquisitionTerminationFee_4aa44b64-d27e-43ca-b075-4795fd474b42" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ad5c6552-9cfa-4c63-a690-6312b0794557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ad5c6552-9cfa-4c63-a690-6312b0794557" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_bb873c11-e954-443a-a3f9-307f95dcc5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_bb873c11-e954-443a-a3f9-307f95dcc5d7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_79c505d8-e2ed-4217-b47f-8a3e7d1ffbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_79c505d8-e2ed-4217-b47f-8a3e7d1ffbeb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a3d8aaa9-d8ad-4698-bf14-8381baced43b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a3d8aaa9-d8ad-4698-bf14-8381baced43b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationPaymentToSettleContingentConsideration_a10a0460-05cd-4cdb-a80f-4e758fb97ecc" xlink:href="coo-20231031.xsd#coo_BusinessCombinationPaymentToSettleContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_coo_BusinessCombinationPaymentToSettleContingentConsideration_a10a0460-05cd-4cdb-a80f-4e758fb97ecc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_78c7faf5-8cf6-4e0c-9b9b-98ed768a1a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_78c7faf5-8cf6-4e0c-9b9b-98ed768a1a74" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_8993fee3-9113-4b0b-8af5-78a1bdedffe0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_8993fee3-9113-4b0b-8af5-78a1bdedffe0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f9a4afb0-26b4-4774-8e35-e8891e7d3950" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f9a4afb0-26b4-4774-8e35-e8891e7d3950" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_c1aa2820-b2a9-40ae-9a29-377b7dfb9924" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_c1aa2820-b2a9-40ae-9a29-377b7dfb9924" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_faad7a3c-a2f3-44ca-81f9-7460a634ec07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_EquityMethodInvestments_faad7a3c-a2f3-44ca-81f9-7460a634ec07" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_865ec476-4f50-4ebe-8ede-9b9dce65b3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_865ec476-4f50-4ebe-8ede-9b9dce65b3ea" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cbe01252-a451-438f-b0db-20a6a81d9f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cbe01252-a451-438f-b0db-20a6a81d9f7c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments_2509c1fe-c38b-419b-9a5e-6859a3ba618c" xlink:href="coo-20231031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments_2509c1fe-c38b-419b-9a5e-6859a3ba618c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b8dd938c-4876-4b6d-966a-5f25eca8d84d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b8dd938c-4876-4b6d-966a-5f25eca8d84d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8dd938c-4876-4b6d-966a-5f25eca8d84d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b8dd938c-4876-4b6d-966a-5f25eca8d84d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8dd938c-4876-4b6d-966a-5f25eca8d84d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b8dd938c-4876-4b6d-966a-5f25eca8d84d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember_171d1b49-88ad-44a1-a821-053997b5fe61" xlink:href="coo-20231031.xsd#coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:to="loc_coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember_171d1b49-88ad-44a1-a821-053997b5fe61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CookMedicalsReproductiveHealthBusinessMember_bf7d8352-f28c-48f0-abf1-9da1fbff6b22" xlink:href="coo-20231031.xsd#coo_CookMedicalsReproductiveHealthBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:to="loc_coo_CookMedicalsReproductiveHealthBusinessMember_bf7d8352-f28c-48f0-abf1-9da1fbff6b22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_GenerateLifeSciencesMember_b2ac8845-fa67-4074-b430-24abde5fae5e" xlink:href="coo-20231031.xsd#coo_GenerateLifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:to="loc_coo_GenerateLifeSciencesMember_b2ac8845-fa67-4074-b430-24abde5fae5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_8218b4a7-a2c9-4ced-ac85-12e3deadeb63" xlink:href="coo-20231031.xsd#coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:to="loc_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_8218b4a7-a2c9-4ced-ac85-12e3deadeb63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CookMedicalMember_bb838a4c-53ee-4b12-ab27-0b51007a764b" xlink:href="coo-20231031.xsd#coo_CookMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:to="loc_coo_CookMedicalMember_bb838a4c-53ee-4b12-ab27-0b51007a764b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b18bab18-8d08-439b-8f7d-da253b46d949" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b18bab18-8d08-439b-8f7d-da253b46d949" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b18bab18-8d08-439b-8f7d-da253b46d949_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b18bab18-8d08-439b-8f7d-da253b46d949" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b18bab18-8d08-439b-8f7d-da253b46d949_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2de9ea4-2cb5-4e4a-83a4-4e8c3f33f3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b18bab18-8d08-439b-8f7d-da253b46d949" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2de9ea4-2cb5-4e4a-83a4-4e8c3f33f3eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6985f89c-71fd-4539-a52b-4fe4b23a81d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2de9ea4-2cb5-4e4a-83a4-4e8c3f33f3eb" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6985f89c-71fd-4539-a52b-4fe4b23a81d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b9f4dfb2-ad4e-4772-a8b8-adbb6d335bce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2de9ea4-2cb5-4e4a-83a4-4e8c3f33f3eb" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b9f4dfb2-ad4e-4772-a8b8-adbb6d335bce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_1aaa00ad-7247-4bcd-8776-d3dbc3f2740c" xlink:href="coo-20231031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_1aaa00ad-7247-4bcd-8776-d3dbc3f2740c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_1aaa00ad-7247-4bcd-8776-d3dbc3f2740c_default" xlink:href="coo-20231031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_1aaa00ad-7247-4bcd-8776-d3dbc3f2740c" xlink:to="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_1aaa00ad-7247-4bcd-8776-d3dbc3f2740c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_a38fb42a-d9e4-4898-b6fa-394e6cdcc403" xlink:href="coo-20231031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_1aaa00ad-7247-4bcd-8776-d3dbc3f2740c" xlink:to="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_a38fb42a-d9e4-4898-b6fa-394e6cdcc403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesFirstInstallmentMember_828cc483-2738-4576-83b0-6a171716af69" xlink:href="coo-20231031.xsd#coo_PayablesFirstInstallmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_a38fb42a-d9e4-4898-b6fa-394e6cdcc403" xlink:to="loc_coo_PayablesFirstInstallmentMember_828cc483-2738-4576-83b0-6a171716af69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesSecondInstallmentMember_520b9609-290f-40f6-8e99-2884bfde353e" xlink:href="coo-20231031.xsd#coo_PayablesSecondInstallmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_a38fb42a-d9e4-4898-b6fa-394e6cdcc403" xlink:to="loc_coo_PayablesSecondInstallmentMember_520b9609-290f-40f6-8e99-2884bfde353e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesThirdInstallmentMember_6ab6efd7-e709-4723-a8f9-4a4e242a78ec" xlink:href="coo-20231031.xsd#coo_PayablesThirdInstallmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_a38fb42a-d9e4-4898-b6fa-394e6cdcc403" xlink:to="loc_coo_PayablesThirdInstallmentMember_6ab6efd7-e709-4723-a8f9-4a4e242a78ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesFourthInstallmentMember_457d20be-5f40-432f-8a37-145485f395d1" xlink:href="coo-20231031.xsd#coo_PayablesFourthInstallmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_a38fb42a-d9e4-4898-b6fa-394e6cdcc403" xlink:to="loc_coo_PayablesFourthInstallmentMember_457d20be-5f40-432f-8a37-145485f395d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a8352120-f7ea-4b4e-87df-7fe14ab6ff12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_us-gaap_CreditFacilityAxis_a8352120-f7ea-4b4e-87df-7fe14ab6ff12" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a8352120-f7ea-4b4e-87df-7fe14ab6ff12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_a8352120-f7ea-4b4e-87df-7fe14ab6ff12" xlink:to="loc_us-gaap_CreditFacilityDomain_a8352120-f7ea-4b4e-87df-7fe14ab6ff12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b492a7f0-c3fd-4f00-875d-fcbf77322e65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_a8352120-f7ea-4b4e-87df-7fe14ab6ff12" xlink:to="loc_us-gaap_CreditFacilityDomain_b492a7f0-c3fd-4f00-875d-fcbf77322e65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d19a8401-c0c8-4bb0-9ea2-0ede5a1011da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b492a7f0-c3fd-4f00-875d-fcbf77322e65" xlink:to="loc_us-gaap_LineOfCreditMember_d19a8401-c0c8-4bb0-9ea2-0ede5a1011da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1d597985-1c4e-47d6-9ce8-076c58be10a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_us-gaap_DebtInstrumentAxis_1d597985-1c4e-47d6-9ce8-076c58be10a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1d597985-1c4e-47d6-9ce8-076c58be10a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d597985-1c4e-47d6-9ce8-076c58be10a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1d597985-1c4e-47d6-9ce8-076c58be10a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_de95d470-50ff-4292-83cb-163169799a67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d597985-1c4e-47d6-9ce8-076c58be10a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_de95d470-50ff-4292-83cb-163169799a67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021Member_c85969d8-45c4-4bf2-974d-ed5d8503f24f" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de95d470-50ff-4292-83cb-163169799a67" xlink:to="loc_coo_TermLoanFacility2021Member_c85969d8-45c4-4bf2-974d-ed5d8503f24f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8e979446-2fe3-4911-9811-eedf7b608dfa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8e979446-2fe3-4911-9811-eedf7b608dfa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8e979446-2fe3-4911-9811-eedf7b608dfa_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8e979446-2fe3-4911-9811-eedf7b608dfa" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8e979446-2fe3-4911-9811-eedf7b608dfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_08a67e16-be32-499b-acfb-b8ae19bdbe99" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8e979446-2fe3-4911-9811-eedf7b608dfa" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_08a67e16-be32-499b-acfb-b8ae19bdbe99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SightGlassVisionIncMember_03cdd60e-2b18-4f4b-b1c5-3d79e4b6d5f2" xlink:href="coo-20231031.xsd#coo_SightGlassVisionIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_08a67e16-be32-499b-acfb-b8ae19bdbe99" xlink:to="loc_coo_SightGlassVisionIncMember_03cdd60e-2b18-4f4b-b1c5-3d79e4b6d5f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_00a86ff3-32a3-4e7d-a05d-7d87b65ce55d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_dei_LegalEntityAxis_00a86ff3-32a3-4e7d-a05d-7d87b65ce55d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_00a86ff3-32a3-4e7d-a05d-7d87b65ce55d_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_00a86ff3-32a3-4e7d-a05d-7d87b65ce55d" xlink:to="loc_dei_EntityDomain_00a86ff3-32a3-4e7d-a05d-7d87b65ce55d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_88351a64-2827-411e-aa73-e6ed36f571a5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_00a86ff3-32a3-4e7d-a05d-7d87b65ce55d" xlink:to="loc_dei_EntityDomain_88351a64-2827-411e-aa73-e6ed36f571a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EssilorInternationalSASMember_ccd56678-48de-44c5-9519-4b87f0421215" xlink:href="coo-20231031.xsd#coo_EssilorInternationalSASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_88351a64-2827-411e-aa73-e6ed36f571a5" xlink:to="loc_coo_EssilorInternationalSASMember_ccd56678-48de-44c5-9519-4b87f0421215" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1dcb3d93-7bad-4dbe-a34e-3ab33d84f626" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1dcb3d93-7bad-4dbe-a34e-3ab33d84f626" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1dcb3d93-7bad-4dbe-a34e-3ab33d84f626_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1dcb3d93-7bad-4dbe-a34e-3ab33d84f626" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1dcb3d93-7bad-4dbe-a34e-3ab33d84f626_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_64948d6e-6d28-488c-91c0-7dd2c40d59cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1dcb3d93-7bad-4dbe-a34e-3ab33d84f626" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_64948d6e-6d28-488c-91c0-7dd2c40d59cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_3c8fa9d0-2578-480a-a017-8b9ba4b16ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_64948d6e-6d28-488c-91c0-7dd2c40d59cd" xlink:to="loc_us-gaap_SubsequentEventMember_3c8fa9d0-2578-480a-a017-8b9ba4b16ccc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_91517b7d-e2ef-43a6-86f4-f5f3a8563e09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:to="loc_us-gaap_NumberOfReportingUnits_91517b7d-e2ef-43a6-86f4-f5f3a8563e09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_6bf9d750-6da5-48b2-bbf9-9d794da4836e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_6bf9d750-6da5-48b2-bbf9-9d794da4836e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_de3b859d-f0b0-4239-b50e-5c718857467d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_de3b859d-f0b0-4239-b50e-5c718857467d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_f5629614-a087-4a6a-bd10-141bd18a9a99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_f5629614-a087-4a6a-bd10-141bd18a9a99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_a67b79ff-2412-472b-a2f5-d5e68c34dd96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_a67b79ff-2412-472b-a2f5-d5e68c34dd96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ebb7215f-cfb6-40f3-be63-7eaa94e1b15e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ebb7215f-cfb6-40f3-be63-7eaa94e1b15e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_73ad8641-c27b-4e8d-ba95-e599c8291767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ebb7215f-cfb6-40f3-be63-7eaa94e1b15e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_73ad8641-c27b-4e8d-ba95-e599c8291767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_73ad8641-c27b-4e8d-ba95-e599c8291767_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_73ad8641-c27b-4e8d-ba95-e599c8291767" xlink:to="loc_us-gaap_SegmentDomain_73ad8641-c27b-4e8d-ba95-e599c8291767_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_45e43cae-2671-4fab-803f-673fc2902e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_73ad8641-c27b-4e8d-ba95-e599c8291767" xlink:to="loc_us-gaap_SegmentDomain_45e43cae-2671-4fab-803f-673fc2902e5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperSurgicalSegmentMember_32350875-42fd-4142-b8a7-6eb230848130" xlink:href="coo-20231031.xsd#coo_CooperSurgicalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_45e43cae-2671-4fab-803f-673fc2902e5b" xlink:to="loc_coo_CooperSurgicalSegmentMember_32350875-42fd-4142-b8a7-6eb230848130" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperVisionSegmentMember_412d5447-2fc6-4054-b30b-121d47dbf67f" xlink:href="coo-20231031.xsd#coo_CooperVisionSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_45e43cae-2671-4fab-803f-673fc2902e5b" xlink:to="loc_coo_CooperVisionSegmentMember_412d5447-2fc6-4054-b30b-121d47dbf67f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_adc2be6e-0287-473b-a377-63d4ca6c600c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_33843e20-e2af-4e31-94c8-2b5af4b95faa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_adc2be6e-0287-473b-a377-63d4ca6c600c" xlink:to="loc_us-gaap_GoodwillRollForward_33843e20-e2af-4e31-94c8-2b5af4b95faa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9ec5c176-7c09-4fe4-98dc-d3fd6a6395cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_33843e20-e2af-4e31-94c8-2b5af4b95faa" xlink:to="loc_us-gaap_Goodwill_9ec5c176-7c09-4fe4-98dc-d3fd6a6395cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_98c9ae6a-313f-4e63-89a2-e36be1cbaf71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_33843e20-e2af-4e31-94c8-2b5af4b95faa" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_98c9ae6a-313f-4e63-89a2-e36be1cbaf71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_6586314d-224f-4326-9865-45a466d16e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_33843e20-e2af-4e31-94c8-2b5af4b95faa" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_6586314d-224f-4326-9865-45a466d16e5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_52ef58e1-c6b2-4cc9-995e-d6cb0ea09036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5989de41-b8b1-4a6b-ba25-627ad374f304" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_adc2be6e-0287-473b-a377-63d4ca6c600c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5989de41-b8b1-4a6b-ba25-627ad374f304" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_93941e58-a712-4e1c-a2a1-691d49c6912b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5989de41-b8b1-4a6b-ba25-627ad374f304" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_93941e58-a712-4e1c-a2a1-691d49c6912b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_93941e58-a712-4e1c-a2a1-691d49c6912b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_93941e58-a712-4e1c-a2a1-691d49c6912b" xlink:to="loc_us-gaap_SegmentDomain_93941e58-a712-4e1c-a2a1-691d49c6912b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0efa8e18-32fc-4201-b0e1-9b784e7d799c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_93941e58-a712-4e1c-a2a1-691d49c6912b" xlink:to="loc_us-gaap_SegmentDomain_0efa8e18-32fc-4201-b0e1-9b784e7d799c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperVisionSegmentMember_b89e2c98-f5ba-4905-9f64-9e9d0e8ddf3e" xlink:href="coo-20231031.xsd#coo_CooperVisionSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0efa8e18-32fc-4201-b0e1-9b784e7d799c" xlink:to="loc_coo_CooperVisionSegmentMember_b89e2c98-f5ba-4905-9f64-9e9d0e8ddf3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperSurgicalSegmentMember_ccdd01f5-368f-46d4-8662-5bc96abb6b09" xlink:href="coo-20231031.xsd#coo_CooperSurgicalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0efa8e18-32fc-4201-b0e1-9b784e7d799c" xlink:to="loc_coo_CooperSurgicalSegmentMember_ccdd01f5-368f-46d4-8662-5bc96abb6b09" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IntangibleAssetsOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9e07b9ca-c7ca-4d1f-9a9c-b1af5112c5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9e07b9ca-c7ca-4d1f-9a9c-b1af5112c5a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_456ffe75-962a-4777-9326-e198c19002bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_456ffe75-962a-4777-9326-e198c19002bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dcea77f9-a193-4592-856d-29c1627586de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dcea77f9-a193-4592-856d-29c1627586de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_49a3d0a5-a33b-4997-8d6d-28c012f79219" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_49a3d0a5-a33b-4997-8d6d-28c012f79219" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_777d5790-490c-4e4b-8711-0414e3a3b2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_777d5790-490c-4e4b-8711-0414e3a3b2d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c699fd9c-bb92-4b2d-bf6e-98206f5c7783" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c699fd9c-bb92-4b2d-bf6e-98206f5c7783" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_14f9e95d-4735-4891-a85d-0d71690e7a26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_14f9e95d-4735-4891-a85d-0d71690e7a26" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3a198899-f44d-420c-8e37-e18a40270d06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_14f9e95d-4735-4891-a85d-0d71690e7a26" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3a198899-f44d-420c-8e37-e18a40270d06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3a198899-f44d-420c-8e37-e18a40270d06_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3a198899-f44d-420c-8e37-e18a40270d06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3a198899-f44d-420c-8e37-e18a40270d06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3a198899-f44d-420c-8e37-e18a40270d06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_bf324dee-49a5-4d6f-9a5e-460f3fd43b83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:to="loc_us-gaap_TrademarksMember_bf324dee-49a5-4d6f-9a5e-460f3fd43b83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CompositeMember_f9226a0b-400b-4a9d-a222-82b4301c5d8a" xlink:href="coo-20231031.xsd#coo_CompositeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:to="loc_coo_CompositeMember_f9226a0b-400b-4a9d-a222-82b4301c5d8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_7cc11527-9a6b-4330-a189-04cc807d27cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_7cc11527-9a6b-4330-a189-04cc807d27cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_41a17871-63bc-4a3f-8bd5-5b24bc8386fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:to="loc_us-gaap_CustomerRelationshipsMember_41a17871-63bc-4a3f-8bd5-5b24bc8386fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LicenseAndDistributionRightsAndOtherMember_4139a7f2-e1d3-4663-a5c1-1f75b5ef1e86" xlink:href="coo-20231031.xsd#coo_LicenseAndDistributionRightsAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:to="loc_coo_LicenseAndDistributionRightsAndOtherMember_4139a7f2-e1d3-4663-a5c1-1f75b5ef1e86" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancingArrangementsTotalDebtDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_52d9adbc-2430-4934-9204-33e86816fe93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract_638d91aa-7ebd-43f2-a47f-54036f76c179" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_52d9adbc-2430-4934-9204-33e86816fe93" xlink:to="loc_us-gaap_ShortTermBorrowingsAbstract_638d91aa-7ebd-43f2-a47f-54036f76c179" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_71a13942-0d0a-4528-b7bd-723a1c842aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_638d91aa-7ebd-43f2-a47f-54036f76c179" xlink:to="loc_us-gaap_ShortTermBorrowings_71a13942-0d0a-4528-b7bd-723a1c842aa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_ac03687c-e39a-4c56-a200-90a5f78b497b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_638d91aa-7ebd-43f2-a47f-54036f76c179" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_ac03687c-e39a-4c56-a200-90a5f78b497b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8fe7cfef-3cf9-41eb-82f4-1e11c4c23d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent_ac03687c-e39a-4c56-a200-90a5f78b497b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8fe7cfef-3cf9-41eb-82f4-1e11c4c23d4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_d3bd79f4-0f7e-48b8-86b3-0299b3b7b00e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_638d91aa-7ebd-43f2-a47f-54036f76c179" xlink:to="loc_us-gaap_DebtCurrent_d3bd79f4-0f7e-48b8-86b3-0299b3b7b00e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_52d9adbc-2430-4934-9204-33e86816fe93" xlink:to="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8773efa7-3526-46af-a6d9-9611392bc57e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8773efa7-3526-46af-a6d9-9611392bc57e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_ac72c9c8-fe50-436f-a0e5-7f9e98238320" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_ac72c9c8-fe50-436f-a0e5-7f9e98238320" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d6906793-8db6-4cb7-a95e-d684ec2c12b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d6906793-8db6-4cb7-a95e-d684ec2c12b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6c72f978-730a-493d-af82-01a5783187f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6c72f978-730a-493d-af82-01a5783187f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_9c812196-e514-4871-948a-e13fd579d47c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6c72f978-730a-493d-af82-01a5783187f9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_9c812196-e514-4871-948a-e13fd579d47c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_89ca0df2-ec01-460a-88f9-068039ab007c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_89ca0df2-ec01-460a-88f9-068039ab007c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9c1a0b37-a0b7-4e9e-8020-c44f2926ff69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_52d9adbc-2430-4934-9204-33e86816fe93" xlink:to="loc_us-gaap_DebtInstrumentTable_9c1a0b37-a0b7-4e9e-8020-c44f2926ff69" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_9cddc7b1-60a7-4636-b6ec-e68dd62dd318" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9c1a0b37-a0b7-4e9e-8020-c44f2926ff69" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_9cddc7b1-60a7-4636-b6ec-e68dd62dd318" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_9cddc7b1-60a7-4636-b6ec-e68dd62dd318_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_9cddc7b1-60a7-4636-b6ec-e68dd62dd318" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_9cddc7b1-60a7-4636-b6ec-e68dd62dd318_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_bf3b3727-bd04-4bf5-9202-3c1489b8be49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_9cddc7b1-60a7-4636-b6ec-e68dd62dd318" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_bf3b3727-bd04-4bf5-9202-3c1489b8be49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OverdraftAndOtherCreditFacilitiesMember_ef35a211-7b9e-407e-91e2-008dbcfd071c" xlink:href="coo-20231031.xsd#coo_OverdraftAndOtherCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_bf3b3727-bd04-4bf5-9202-3c1489b8be49" xlink:to="loc_coo_OverdraftAndOtherCreditFacilitiesMember_ef35a211-7b9e-407e-91e2-008dbcfd071c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoansMember_ef129b1a-7032-4178-b548-34aef6a928ef" xlink:href="coo-20231031.xsd#coo_TermLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_bf3b3727-bd04-4bf5-9202-3c1489b8be49" xlink:to="loc_coo_TermLoansMember_ef129b1a-7032-4178-b548-34aef6a928ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b151138c-647a-47b4-972c-ba7b502e82a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9c1a0b37-a0b7-4e9e-8020-c44f2926ff69" xlink:to="loc_us-gaap_CreditFacilityAxis_b151138c-647a-47b4-972c-ba7b502e82a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b151138c-647a-47b4-972c-ba7b502e82a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b151138c-647a-47b4-972c-ba7b502e82a3" xlink:to="loc_us-gaap_CreditFacilityDomain_b151138c-647a-47b4-972c-ba7b502e82a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4e652f42-44c7-48f7-9a08-00af0e79de10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b151138c-647a-47b4-972c-ba7b502e82a3" xlink:to="loc_us-gaap_CreditFacilityDomain_4e652f42-44c7-48f7-9a08-00af0e79de10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d0387d00-dca9-4a41-8b33-6259123b53e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_4e652f42-44c7-48f7-9a08-00af0e79de10" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d0387d00-dca9-4a41-8b33-6259123b53e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ffad2399-43a3-4118-a1cc-4b90db1fb55d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9c1a0b37-a0b7-4e9e-8020-c44f2926ff69" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ffad2399-43a3-4118-a1cc-4b90db1fb55d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ffad2399-43a3-4118-a1cc-4b90db1fb55d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ffad2399-43a3-4118-a1cc-4b90db1fb55d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ffad2399-43a3-4118-a1cc-4b90db1fb55d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9eb8ae3e-ae57-436f-810c-a932d7b6195c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ffad2399-43a3-4118-a1cc-4b90db1fb55d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9eb8ae3e-ae57-436f-810c-a932d7b6195c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_a22f2f47-637e-4619-b01d-b54d0bc67b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9eb8ae3e-ae57-436f-810c-a932d7b6195c" xlink:to="loc_us-gaap_LineOfCreditMember_a22f2f47-637e-4619-b01d-b54d0bc67b0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_7d827e4e-1546-479d-92e9-59bdb63592e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9eb8ae3e-ae57-436f-810c-a932d7b6195c" xlink:to="loc_us-gaap_MediumTermNotesMember_7d827e4e-1546-479d-92e9-59bdb63592e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OtherDebtMember_dfa2990d-102c-4efc-9037-5659bd359c1a" xlink:href="coo-20231031.xsd#coo_OtherDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9eb8ae3e-ae57-436f-810c-a932d7b6195c" xlink:to="loc_coo_OtherDebtMember_dfa2990d-102c-4efc-9037-5659bd359c1a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancingArrangementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:href="coo-20231031.xsd#coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6b963630-96ff-4704-8a3b-bc5dc59ce7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6b963630-96ff-4704-8a3b-bc5dc59ce7cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_a40e1793-fa2d-4a91-af37-ffac3f5585d5" xlink:href="coo-20231031.xsd#coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_a40e1793-fa2d-4a91-af37-ffac3f5585d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_88c32dfa-96af-4b28-88b9-7ab15233bfce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_88c32dfa-96af-4b28-88b9-7ab15233bfce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_b6787dfb-8c4c-42bf-990d-366751d48d01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_LongTermLineOfCredit_b6787dfb-8c4c-42bf-990d-366751d48d01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_cc7b9a08-5e10-47ab-b27a-8cfda13b1d64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_cc7b9a08-5e10-47ab-b27a-8cfda13b1d64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_a3aa7bcb-0b04-498f-80e3-02dfef982c11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_DebtInstrumentTerm_a3aa7bcb-0b04-498f-80e3-02dfef982c11" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5e6b3e90-a81b-4a6f-b180-7c93fcdf53fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5e6b3e90-a81b-4a6f-b180-7c93fcdf53fb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_0323d03a-1fea-47ec-ad74-3b990766b67b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_0323d03a-1fea-47ec-ad74-3b990766b67b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_625b56b8-b94a-4df1-930d-d55e561293f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_625b56b8-b94a-4df1-930d-d55e561293f6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_501584be-9c52-4301-9810-c86c1942237e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_LineOfCredit_501584be-9c52-4301-9810-c86c1942237e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9193588e-64cc-4425-923d-dde2597d7107" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9193588e-64cc-4425-923d-dde2597d7107" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:href="coo-20231031.xsd#coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2db1ac90-febd-4172-9a1e-faef5c568343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:to="loc_us-gaap_CreditFacilityAxis_2db1ac90-febd-4172-9a1e-faef5c568343" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2db1ac90-febd-4172-9a1e-faef5c568343_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_2db1ac90-febd-4172-9a1e-faef5c568343" xlink:to="loc_us-gaap_CreditFacilityDomain_2db1ac90-febd-4172-9a1e-faef5c568343_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_da256488-7ebd-4571-9d2e-68a5b6379001" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_2db1ac90-febd-4172-9a1e-faef5c568343" xlink:to="loc_us-gaap_CreditFacilityDomain_da256488-7ebd-4571-9d2e-68a5b6379001" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_bf17d6ff-0f87-4894-b573-9d86b0258a45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_da256488-7ebd-4571-9d2e-68a5b6379001" xlink:to="loc_us-gaap_LineOfCreditMember_bf17d6ff-0f87-4894-b573-9d86b0258a45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_47c742ea-e39d-444a-813f-f200fa5f6d97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_da256488-7ebd-4571-9d2e-68a5b6379001" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_47c742ea-e39d-444a-813f-f200fa5f6d97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2020Member_8a06b78f-f0e9-40dc-8c79-633bfd06dffd" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_da256488-7ebd-4571-9d2e-68a5b6379001" xlink:to="loc_coo_TermLoanFacility2020Member_8a06b78f-f0e9-40dc-8c79-633bfd06dffd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_a7e82264-ab5f-4878-b158-ace7458373f1" xlink:href="coo-20231031.xsd#coo_RevolvingCreditFacilityAndTermLoanFacility2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_da256488-7ebd-4571-9d2e-68a5b6379001" xlink:to="loc_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_a7e82264-ab5f-4878-b158-ace7458373f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_84e227db-7344-462c-919b-458e16dd83ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:to="loc_us-gaap_DebtInstrumentAxis_84e227db-7344-462c-919b-458e16dd83ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_84e227db-7344-462c-919b-458e16dd83ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_84e227db-7344-462c-919b-458e16dd83ce" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_84e227db-7344-462c-919b-458e16dd83ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_84e227db-7344-462c-919b-458e16dd83ce" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021Member_484664fb-300f-4c58-a1a7-f9eae456fb3f" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_TermLoanFacility2021Member_484664fb-300f-4c58-a1a7-f9eae456fb3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021BaseRateLoansMember_aee36252-047b-4e59-bd9b-cd0be53a5d3f" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2021BaseRateLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_TermLoanFacility2021BaseRateLoansMember_aee36252-047b-4e59-bd9b-cd0be53a5d3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021AdjustedLIBORRateLoansMember_d9d8bbde-2066-4ac1-a481-5b19fc3fb606" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2021AdjustedLIBORRateLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_TermLoanFacility2021AdjustedLIBORRateLoansMember_d9d8bbde-2066-4ac1-a481-5b19fc3fb606" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanAgreement2021364DayMember_3bc2d083-f451-4c4e-8316-389af60e2727" xlink:href="coo-20231031.xsd#coo_TermLoanAgreement2021364DayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_TermLoanAgreement2021364DayMember_3bc2d083-f451-4c4e-8316-389af60e2727" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CreditAgreement2020Member_026824d1-9c7a-493b-91b6-5c3cd5940559" xlink:href="coo-20231031.xsd#coo_CreditAgreement2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_CreditAgreement2020Member_026824d1-9c7a-493b-91b6-5c3cd5940559" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EuropeanCreditFacilityMember_0caa902b-7bdc-4310-a1dc-2a6396a2f54d" xlink:href="coo-20231031.xsd#coo_EuropeanCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_EuropeanCreditFacilityMember_0caa902b-7bdc-4310-a1dc-2a6396a2f54d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AsianPacificCreditFacilitiesYenDenominatedMember_e34bf6c5-49ea-47fb-b60d-8fa7e681cd45" xlink:href="coo-20231031.xsd#coo_AsianPacificCreditFacilitiesYenDenominatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_AsianPacificCreditFacilitiesYenDenominatedMember_e34bf6c5-49ea-47fb-b60d-8fa7e681cd45" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_a1987bf1-7eb9-46e7-8ce4-9934e33eee30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:to="loc_us-gaap_VariableRateAxis_a1987bf1-7eb9-46e7-8ce4-9934e33eee30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a1987bf1-7eb9-46e7-8ce4-9934e33eee30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_a1987bf1-7eb9-46e7-8ce4-9934e33eee30" xlink:to="loc_us-gaap_VariableRateDomain_a1987bf1-7eb9-46e7-8ce4-9934e33eee30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a930e590-15d2-45af-b548-c544f9e46afa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_a1987bf1-7eb9-46e7-8ce4-9934e33eee30" xlink:to="loc_us-gaap_VariableRateDomain_a930e590-15d2-45af-b548-c544f9e46afa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SecuredOvernightFinancingRateSOFRMember_f8c8f0c9-3e06-4b62-8575-93346fdaac1e" xlink:href="coo-20231031.xsd#coo_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_a930e590-15d2-45af-b548-c544f9e46afa" xlink:to="loc_coo_SecuredOvernightFinancingRateSOFRMember_f8c8f0c9-3e06-4b62-8575-93346fdaac1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_4c13a91a-ce11-406f-b137-875ad715efc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_a930e590-15d2-45af-b548-c544f9e46afa" xlink:to="loc_us-gaap_BaseRateMember_4c13a91a-ce11-406f-b137-875ad715efc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_827dbad1-b1fe-49a7-bfab-12c60fb77cde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_a930e590-15d2-45af-b548-c544f9e46afa" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_827dbad1-b1fe-49a7-bfab-12c60fb77cde" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_252f5a78-29bc-4f97-9219-af8aa91036f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_252f5a78-29bc-4f97-9219-af8aa91036f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_252f5a78-29bc-4f97-9219-af8aa91036f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_252f5a78-29bc-4f97-9219-af8aa91036f1" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_252f5a78-29bc-4f97-9219-af8aa91036f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_4397ef2a-121a-4106-99f4-637084e35e70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_252f5a78-29bc-4f97-9219-af8aa91036f1" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_4397ef2a-121a-4106-99f4-637084e35e70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoansMember_3a51fe4f-76f6-49c1-aa4f-78ff8a3a193a" xlink:href="coo-20231031.xsd#coo_TermLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_4397ef2a-121a-4106-99f4-637084e35e70" xlink:to="loc_coo_TermLoansMember_3a51fe4f-76f6-49c1-aa4f-78ff8a3a193a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_63908419-4bde-4d94-81f2-b068da755cae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_63908419-4bde-4d94-81f2-b068da755cae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_63908419-4bde-4d94-81f2-b068da755cae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_63908419-4bde-4d94-81f2-b068da755cae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_63908419-4bde-4d94-81f2-b068da755cae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_96001e60-2b59-40bc-acfd-969d135db460" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_63908419-4bde-4d94-81f2-b068da755cae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_96001e60-2b59-40bc-acfd-969d135db460" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_2980ba5c-8e6f-411c-9e48-4f3bcdb72ded" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_96001e60-2b59-40bc-acfd-969d135db460" xlink:to="loc_us-gaap_LineOfCreditMember_2980ba5c-8e6f-411c-9e48-4f3bcdb72ded" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_49620205-2d50-4791-9ba3-cfdeb29ae9ad" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:to="loc_srt_RangeAxis_49620205-2d50-4791-9ba3-cfdeb29ae9ad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_49620205-2d50-4791-9ba3-cfdeb29ae9ad_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_49620205-2d50-4791-9ba3-cfdeb29ae9ad" xlink:to="loc_srt_RangeMember_49620205-2d50-4791-9ba3-cfdeb29ae9ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_51ef3e88-729d-4bd2-bc9f-46778f51ce20" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_49620205-2d50-4791-9ba3-cfdeb29ae9ad" xlink:to="loc_srt_RangeMember_51ef3e88-729d-4bd2-bc9f-46778f51ce20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_49240867-c07c-4a43-a360-3d56b8dc7d68" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_51ef3e88-729d-4bd2-bc9f-46778f51ce20" xlink:to="loc_srt_MinimumMember_49240867-c07c-4a43-a360-3d56b8dc7d68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_76fd027d-4123-4423-a8a9-b1a9fc5f85ff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_51ef3e88-729d-4bd2-bc9f-46778f51ce20" xlink:to="loc_srt_MaximumMember_76fd027d-4123-4423-a8a9-b1a9fc5f85ff" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_ef65770b-84fb-49e7-a823-223520920457" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_ef65770b-84fb-49e7-a823-223520920457" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_cfa7f4cb-12ad-449e-b68e-0c2d6382bc66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_cfa7f4cb-12ad-449e-b68e-0c2d6382bc66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_ab1059a9-a3c7-471f-9748-d0dada135570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_OperatingLossCarryforwards_ab1059a9-a3c7-471f-9748-d0dada135570" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_db7f528f-b1d3-40fa-b2e8-419b572795d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_db7f528f-b1d3-40fa-b2e8-419b572795d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_6b3c0011-81ac-4828-a3b9-8380d11357ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_6b3c0011-81ac-4828-a3b9-8380d11357ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8c312ae5-98aa-4d5b-83bf-57a46f4b6872" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8c312ae5-98aa-4d5b-83bf-57a46f4b6872" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_e9518768-a152-4755-9ec7-ea92fa7ab4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_e9518768-a152-4755-9ec7-ea92fa7ab4e6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_3ce97554-9139-48eb-9fe4-2c027043d542" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_3ce97554-9139-48eb-9fe4-2c027043d542" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_5e2b125c-0d77-428e-ad91-7a78cd517c57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_5e2b125c-0d77-428e-ad91-7a78cd517c57" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_9bf21a8a-106c-4f68-b60c-fafc788e9a42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5e2b125c-0d77-428e-ad91-7a78cd517c57" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_9bf21a8a-106c-4f68-b60c-fafc788e9a42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_9bf21a8a-106c-4f68-b60c-fafc788e9a42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_9bf21a8a-106c-4f68-b60c-fafc788e9a42" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_9bf21a8a-106c-4f68-b60c-fafc788e9a42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_11b8a2eb-c199-4ff9-a7f5-0e4175982f42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_9bf21a8a-106c-4f68-b60c-fafc788e9a42" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_11b8a2eb-c199-4ff9-a7f5-0e4175982f42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_1d32e805-92d2-49fe-b19d-b55f2bbe035a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_11b8a2eb-c199-4ff9-a7f5-0e4175982f42" xlink:to="loc_us-gaap_DomesticCountryMember_1d32e805-92d2-49fe-b19d-b55f2bbe035a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f113a992-7674-4c8c-95ac-17538e14d71c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_11b8a2eb-c199-4ff9-a7f5-0e4175982f42" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f113a992-7674-4c8c-95ac-17538e14d71c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6a6d6ce0-a34b-4429-8666-fe956acb0f55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7c0b2426-4828-4dab-b47e-1a86586a9bee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6a6d6ce0-a34b-4429-8666-fe956acb0f55" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7c0b2426-4828-4dab-b47e-1a86586a9bee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_005f0d55-647e-4d96-ac37-841b48e4b044" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6a6d6ce0-a34b-4429-8666-fe956acb0f55" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_005f0d55-647e-4d96-ac37-841b48e4b044" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_8704c4ce-d6bd-4426-ba68-c6a2e8e33f33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6a6d6ce0-a34b-4429-8666-fe956acb0f55" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_8704c4ce-d6bd-4426-ba68-c6a2e8e33f33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_af7f9855-b6e2-42be-9c5e-4cee50f78c51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6a6d6ce0-a34b-4429-8666-fe956acb0f55" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_af7f9855-b6e2-42be-9c5e-4cee50f78c51" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27365e83-0a98-4852-8a53-e53590bf4692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_af7f9855-b6e2-42be-9c5e-4cee50f78c51" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27365e83-0a98-4852-8a53-e53590bf4692" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_27365e83-0a98-4852-8a53-e53590bf4692_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27365e83-0a98-4852-8a53-e53590bf4692" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_27365e83-0a98-4852-8a53-e53590bf4692_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f26a1149-0625-4cac-b3de-8887b44e7546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27365e83-0a98-4852-8a53-e53590bf4692" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f26a1149-0625-4cac-b3de-8887b44e7546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b8f3b611-8b6f-4962-9380-a72baab596d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f26a1149-0625-4cac-b3de-8887b44e7546" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b8f3b611-8b6f-4962-9380-a72baab596d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_72f1d1d9-ca54-4555-ac44-b771f31a60a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f26a1149-0625-4cac-b3de-8887b44e7546" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_72f1d1d9-ca54-4555-ac44-b771f31a60a6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ac2c4a79-e6f7-4ae5-a835-ec6109740008" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_114ecd4d-5ec1-42a4-a10f-d8a9f0759e51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ac2c4a79-e6f7-4ae5-a835-ec6109740008" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_114ecd4d-5ec1-42a4-a10f-d8a9f0759e51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b3670021-7ed8-47e9-8cc2-4f066529bb10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_114ecd4d-5ec1-42a4-a10f-d8a9f0759e51" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b3670021-7ed8-47e9-8cc2-4f066529bb10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_0a766d55-c2d0-4128-8bc8-a8e6509033b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_114ecd4d-5ec1-42a4-a10f-d8a9f0759e51" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_0a766d55-c2d0-4128-8bc8-a8e6509033b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_0dc49cce-963a-454d-8beb-097e76d140ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_114ecd4d-5ec1-42a4-a10f-d8a9f0759e51" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_0dc49cce-963a-454d-8beb-097e76d140ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_906af61c-8edc-47fd-8bfc-b8cf27b60951" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_379eacc6-cd0a-4168-b055-6f7cb420333f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ac2c4a79-e6f7-4ae5-a835-ec6109740008" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_379eacc6-cd0a-4168-b055-6f7cb420333f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_46eb784c-1ae8-454b-9fd1-fe3d1752e83f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_379eacc6-cd0a-4168-b055-6f7cb420333f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_46eb784c-1ae8-454b-9fd1-fe3d1752e83f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_46eb784c-1ae8-454b-9fd1-fe3d1752e83f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_46eb784c-1ae8-454b-9fd1-fe3d1752e83f" xlink:to="loc_us-gaap_EquityComponentDomain_46eb784c-1ae8-454b-9fd1-fe3d1752e83f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_679e8bdc-0a6c-4685-9e4c-0f5e1ebec07f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_46eb784c-1ae8-454b-9fd1-fe3d1752e83f" xlink:to="loc_us-gaap_EquityComponentDomain_679e8bdc-0a6c-4685-9e4c-0f5e1ebec07f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_adf5cfd1-7df1-48f0-aa74-bb293bc21eab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_679e8bdc-0a6c-4685-9e4c-0f5e1ebec07f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_adf5cfd1-7df1-48f0-aa74-bb293bc21eab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_71c33f45-27ac-429e-a218-f757788dd17e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_adf5cfd1-7df1-48f0-aa74-bb293bc21eab" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_71c33f45-27ac-429e-a218-f757788dd17e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_6c090be4-659b-4538-8138-6544381787e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_adf5cfd1-7df1-48f0-aa74-bb293bc21eab" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_6c090be4-659b-4538-8138-6544381787e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b41e70d1-e256-4e02-a354-07386c8f2f60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_adf5cfd1-7df1-48f0-aa74-bb293bc21eab" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b41e70d1-e256-4e02-a354-07386c8f2f60" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b9785214-90c0-430b-9ee2-439208ded095" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b9785214-90c0-430b-9ee2-439208ded095" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b13c1474-aaef-4f42-a8fd-82f3254a4ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b13c1474-aaef-4f42-a8fd-82f3254a4ddf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_6f60ce58-bfdd-46a0-a84a-78fba88b5ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_6f60ce58-bfdd-46a0-a84a-78fba88b5ab2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b2225c7c-4b98-4e5e-a321-3c4691e48719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b2225c7c-4b98-4e5e-a321-3c4691e48719" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_caaaa5c1-1c48-4293-a6e5-b71bca8e0569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_caaaa5c1-1c48-4293-a6e5-b71bca8e0569" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_667cba83-1b1f-4289-adc7-67756da17108" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_667cba83-1b1f-4289-adc7-67756da17108" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_056f5789-9156-4966-bb82-c0fa8176da46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_056f5789-9156-4966-bb82-c0fa8176da46" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_246aad21-6a62-4bcc-830f-2bc5f40dfd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_246aad21-6a62-4bcc-830f-2bc5f40dfd1d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_8daf9324-552f-49a0-bb29-dba071234f71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_8daf9324-552f-49a0-bb29-dba071234f71" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ca9c2002-5d58-4f83-bfde-84b1273cfa42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ca9c2002-5d58-4f83-bfde-84b1273cfa42" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_909573ed-3c0f-4059-baf4-100a9507ef49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ca9c2002-5d58-4f83-bfde-84b1273cfa42" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_909573ed-3c0f-4059-baf4-100a9507ef49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_909573ed-3c0f-4059-baf4-100a9507ef49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_909573ed-3c0f-4059-baf4-100a9507ef49" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_909573ed-3c0f-4059-baf4-100a9507ef49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2aaf6ba6-9c62-4943-b2a0-6f8c59ce2221" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_909573ed-3c0f-4059-baf4-100a9507ef49" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2aaf6ba6-9c62-4943-b2a0-6f8c59ce2221" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6b41e57b-ecb6-4869-8603-90151358898b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2aaf6ba6-9c62-4943-b2a0-6f8c59ce2221" xlink:to="loc_us-gaap_SubsequentEventMember_6b41e57b-ecb6-4869-8603-90151358898b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/StockPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_6a2cd727-6eca-4aad-a168-190c40fe144a" xlink:href="coo-20231031.xsd#coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_6a2cd727-6eca-4aad-a168-190c40fe144a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_33e23bef-efcd-48fb-9865-162e9848b59e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_33e23bef-efcd-48fb-9865-162e9848b59e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_428eb01a-99a9-404e-831b-a23c3d838740" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_428eb01a-99a9-404e-831b-a23c3d838740" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_beb42a93-c1d8-408a-a064-10dfff3400d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_beb42a93-c1d8-408a-a064-10dfff3400d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_983be4ec-3252-4f6a-bc1e-63d122574901" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_983be4ec-3252-4f6a-bc1e-63d122574901" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_283452a5-330b-4750-ab0c-7d3b3d96c027" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_283452a5-330b-4750-ab0c-7d3b3d96c027" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3a50300a-f059-448f-bea4-20404c9ef6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3a50300a-f059-448f-bea4-20404c9ef6b6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_51f7bd06-41d4-46eb-95ec-2182f3e7532e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_51f7bd06-41d4-46eb-95ec-2182f3e7532e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6d4c3003-05b5-4734-ba4f-d942d560e121" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6d4c3003-05b5-4734-ba4f-d942d560e121" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_aa9f0a15-677e-44c3-a13c-1f6bb014f4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_aa9f0a15-677e-44c3-a13c-1f6bb014f4b7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4b5876c0-e399-4f8c-8b10-cf83d49398bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4b5876c0-e399-4f8c-8b10-cf83d49398bd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_bf44754f-74bf-413d-adb7-4353de4acdc0" xlink:href="coo-20231031.xsd#coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_bf44754f-74bf-413d-adb7-4353de4acdc0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_002acd27-227e-49eb-abb6-9f683d2c3a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_002acd27-227e-49eb-abb6-9f683d2c3a8d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_fe70d5b8-e546-41bb-bf42-056f701b777c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_fe70d5b8-e546-41bb-bf42-056f701b777c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7e8299dd-7330-4649-a10f-fba49bb66dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7e8299dd-7330-4649-a10f-fba49bb66dd7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_632e8b62-f650-472a-816f-fadb152e82a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_632e8b62-f650-472a-816f-fadb152e82a1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1c67a-6582-4c14-8abf-fe024fefd5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1c67a-6582-4c14-8abf-fe024fefd5fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_002900b4-a324-43cc-822c-29b7a53fe8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1c67a-6582-4c14-8abf-fe024fefd5fb" xlink:to="loc_us-gaap_PlanNameAxis_002900b4-a324-43cc-822c-29b7a53fe8f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_002900b4-a324-43cc-822c-29b7a53fe8f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_002900b4-a324-43cc-822c-29b7a53fe8f0" xlink:to="loc_us-gaap_PlanNameDomain_002900b4-a324-43cc-822c-29b7a53fe8f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_df7e5b67-3b15-469f-ab51-051bd7e042b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_002900b4-a324-43cc-822c-29b7a53fe8f0" xlink:to="loc_us-gaap_PlanNameDomain_df7e5b67-3b15-469f-ab51-051bd7e042b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_2c2e9dd8-86b9-4878-ba46-957b6cbc8104" xlink:href="coo-20231031.xsd#coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_df7e5b67-3b15-469f-ab51-051bd7e042b5" xlink:to="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_2c2e9dd8-86b9-4878-ba46-957b6cbc8104" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_A2023LongTermIncentivePlanMember_2f287d7e-3868-4378-abeb-48280aa180d4" xlink:href="coo-20231031.xsd#coo_A2023LongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_df7e5b67-3b15-469f-ab51-051bd7e042b5" xlink:to="loc_coo_A2023LongTermIncentivePlanMember_2f287d7e-3868-4378-abeb-48280aa180d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember_f643cf2f-624c-4a6d-84b5-01ccbbb85f3a" xlink:href="coo-20231031.xsd#coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_df7e5b67-3b15-469f-ab51-051bd7e042b5" xlink:to="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember_f643cf2f-624c-4a6d-84b5-01ccbbb85f3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EmployeeStockPurchasePlanMember_1d816314-fe27-438b-b0b7-4fb8e63f1beb" xlink:href="coo-20231031.xsd#coo_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_df7e5b67-3b15-469f-ab51-051bd7e042b5" xlink:to="loc_coo_EmployeeStockPurchasePlanMember_1d816314-fe27-438b-b0b7-4fb8e63f1beb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_73088a6f-0a5b-408a-8aa9-019a8649fcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1c67a-6582-4c14-8abf-fe024fefd5fb" xlink:to="loc_us-gaap_AwardTypeAxis_73088a6f-0a5b-408a-8aa9-019a8649fcd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73088a6f-0a5b-408a-8aa9-019a8649fcd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_73088a6f-0a5b-408a-8aa9-019a8649fcd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73088a6f-0a5b-408a-8aa9-019a8649fcd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dce7be8e-5474-40e6-a234-2635cdf09953" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_73088a6f-0a5b-408a-8aa9-019a8649fcd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dce7be8e-5474-40e6-a234-2635cdf09953" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f632d539-6680-4b0b-b717-5004caa2576f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dce7be8e-5474-40e6-a234-2635cdf09953" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f632d539-6680-4b0b-b717-5004caa2576f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_71c062a0-bb14-4368-8a21-3c819102cc45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dce7be8e-5474-40e6-a234-2635cdf09953" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_71c062a0-bb14-4368-8a21-3c819102cc45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_a9cfbfdf-b02d-429b-9bf4-bc0e9f3124be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dce7be8e-5474-40e6-a234-2635cdf09953" xlink:to="loc_us-gaap_PerformanceSharesMember_a9cfbfdf-b02d-429b-9bf4-bc0e9f3124be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_21133e30-ea77-405c-a3d5-1ff59ee07a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dce7be8e-5474-40e6-a234-2635cdf09953" xlink:to="loc_us-gaap_EmployeeStockMember_21133e30-ea77-405c-a3d5-1ff59ee07a7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_716409b4-cf77-46bf-aca8-a4e487726815" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1c67a-6582-4c14-8abf-fe024fefd5fb" xlink:to="loc_srt_RangeAxis_716409b4-cf77-46bf-aca8-a4e487726815" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_716409b4-cf77-46bf-aca8-a4e487726815_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_716409b4-cf77-46bf-aca8-a4e487726815" xlink:to="loc_srt_RangeMember_716409b4-cf77-46bf-aca8-a4e487726815_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8a899e03-6588-4edd-9b52-0483eca07f6b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_716409b4-cf77-46bf-aca8-a4e487726815" xlink:to="loc_srt_RangeMember_8a899e03-6588-4edd-9b52-0483eca07f6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_503fb06b-347f-4bda-93ba-d773948a57fb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8a899e03-6588-4edd-9b52-0483eca07f6b" xlink:to="loc_srt_MinimumMember_503fb06b-347f-4bda-93ba-d773948a57fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fc96e3fc-b744-4bf9-8477-e67211e2bc72" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8a899e03-6588-4edd-9b52-0483eca07f6b" xlink:to="loc_srt_MaximumMember_fc96e3fc-b744-4bf9-8477-e67211e2bc72" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a614e88c-4cfd-4ccf-b4a4-8ebd4031686f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_34d53373-935a-422a-8d72-9da9c48e1006" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a614e88c-4cfd-4ccf-b4a4-8ebd4031686f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_34d53373-935a-422a-8d72-9da9c48e1006" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0425cc02-3302-4a3e-b8a8-74de32cd650a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a614e88c-4cfd-4ccf-b4a4-8ebd4031686f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0425cc02-3302-4a3e-b8a8-74de32cd650a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_57eaec08-bb78-4452-a2ac-75d7b990113c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a614e88c-4cfd-4ccf-b4a4-8ebd4031686f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_57eaec08-bb78-4452-a2ac-75d7b990113c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ddf9d857-e311-4ff4-ac68-3999bc519949" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_57eaec08-bb78-4452-a2ac-75d7b990113c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ddf9d857-e311-4ff4-ac68-3999bc519949" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ddf9d857-e311-4ff4-ac68-3999bc519949_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ddf9d857-e311-4ff4-ac68-3999bc519949" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ddf9d857-e311-4ff4-ac68-3999bc519949_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ef62aa34-6809-4fa8-8871-1227aabe0d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ddf9d857-e311-4ff4-ac68-3999bc519949" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ef62aa34-6809-4fa8-8871-1227aabe0d8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9b029f49-1ca2-4d13-b675-06a1a93cf694" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ef62aa34-6809-4fa8-8871-1227aabe0d8e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9b029f49-1ca2-4d13-b675-06a1a93cf694" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_cd837b4a-5413-41ec-8410-24abf2248b93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ef62aa34-6809-4fa8-8871-1227aabe0d8e" xlink:to="loc_us-gaap_CostOfSalesMember_cd837b4a-5413-41ec-8410-24abf2248b93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2f366185-ddde-4aa9-93e0-30dc3a057337" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ef62aa34-6809-4fa8-8871-1227aabe0d8e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2f366185-ddde-4aa9-93e0-30dc3a057337" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_051b2bbf-488e-4360-8457-5e77d86f7eac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5f3a4cb6-b176-4dfc-acbe-203e41ab54b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_051b2bbf-488e-4360-8457-5e77d86f7eac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5f3a4cb6-b176-4dfc-acbe-203e41ab54b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8fa44e6f-2c02-4dc7-8d40-6218195ddf04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_051b2bbf-488e-4360-8457-5e77d86f7eac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8fa44e6f-2c02-4dc7-8d40-6218195ddf04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f824bef4-e59e-45ef-9c95-0d94550f50b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_051b2bbf-488e-4360-8457-5e77d86f7eac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f824bef4-e59e-45ef-9c95-0d94550f50b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_05a2eca5-dd6c-4f4a-8572-104eb711f230" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_051b2bbf-488e-4360-8457-5e77d86f7eac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_05a2eca5-dd6c-4f4a-8572-104eb711f230" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb4ffe-d979-42c6-bb59-c9eb82d896ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_051b2bbf-488e-4360-8457-5e77d86f7eac" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb4ffe-d979-42c6-bb59-c9eb82d896ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_78abbc63-91cf-4676-b1b4-4db26b0beaea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb4ffe-d979-42c6-bb59-c9eb82d896ff" xlink:to="loc_us-gaap_AwardTypeAxis_78abbc63-91cf-4676-b1b4-4db26b0beaea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78abbc63-91cf-4676-b1b4-4db26b0beaea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_78abbc63-91cf-4676-b1b4-4db26b0beaea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78abbc63-91cf-4676-b1b4-4db26b0beaea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b082733-ae33-4da5-87b0-eefb355f862c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_78abbc63-91cf-4676-b1b4-4db26b0beaea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b082733-ae33-4da5-87b0-eefb355f862c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bc2612c1-ada1-4413-9dd5-185d67cdcf7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b082733-ae33-4da5-87b0-eefb355f862c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bc2612c1-ada1-4413-9dd5-185d67cdcf7f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansStockOptionPlansDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockPlansStockOptionPlansDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/StockPlansStockOptionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f88fa728-3cd8-4668-bd15-d4c92993ef59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f88fa728-3cd8-4668-bd15-d4c92993ef59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3c7b3571-6b6c-4cd0-8042-a780fff077e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3c7b3571-6b6c-4cd0-8042-a780fff077e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4cc09d71-2fb6-4e7a-97f4-187f38530843" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4cc09d71-2fb6-4e7a-97f4-187f38530843" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d4aa6905-c77e-4e29-9d1f-1b718e237b76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d4aa6905-c77e-4e29-9d1f-1b718e237b76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_8dc6fc19-865a-4406-81a5-7735ada1a3df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_8dc6fc19-865a-4406-81a5-7735ada1a3df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5c079f5c-130d-4bf3-b57d-06efd24aa6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_40664231-6105-48d1-ba12-3c2307aa4069" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_40664231-6105-48d1-ba12-3c2307aa4069" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d3fa9458-3aa5-4373-865a-62aa4449b82c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d3fa9458-3aa5-4373-865a-62aa4449b82c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f88fa728-3cd8-4668-bd15-d4c92993ef59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b1ae19d2-a13b-4178-9692-ac34ee62473a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b1ae19d2-a13b-4178-9692-ac34ee62473a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fa21c192-e74f-4ce4-8a80-8bbd0294ac74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fa21c192-e74f-4ce4-8a80-8bbd0294ac74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_62cd872d-aa46-4a6d-8740-6ac9cb6dbabc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_62cd872d-aa46-4a6d-8740-6ac9cb6dbabc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_630c98d5-927c-4fce-982c-24e904b6bd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_630c98d5-927c-4fce-982c-24e904b6bd4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_423c772d-b398-442d-ba13-3ebc7d326114" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_38faa7c1-9639-4c7d-b0fa-3fb73516f0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_38faa7c1-9639-4c7d-b0fa-3fb73516f0e1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_102a91cb-f42f-4429-b6d7-4d1871ad26da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_102a91cb-f42f-4429-b6d7-4d1871ad26da" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f88fa728-3cd8-4668-bd15-d4c92993ef59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7d0e3a76-4cce-4d69-b34f-80016e2db764" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7d0e3a76-4cce-4d69-b34f-80016e2db764" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_3066fb11-8ee0-4144-9672-35a9225406b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_3066fb11-8ee0-4144-9672-35a9225406b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_98682207-e85c-4e0c-99fb-106fc0665122" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_98682207-e85c-4e0c-99fb-106fc0665122" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cc74c015-2067-4570-8059-074ff582b825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cc74c015-2067-4570-8059-074ff582b825" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b5ca5685-8347-4581-9ef6-2974164729bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b5ca5685-8347-4581-9ef6-2974164729bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_d9420998-312b-4a07-ab14-27a39c7c9102" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_d9420998-312b-4a07-ab14-27a39c7c9102" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e23b47f-9a36-4f71-9b71-ff25d5b38328" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f88fa728-3cd8-4668-bd15-d4c92993ef59" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e23b47f-9a36-4f71-9b71-ff25d5b38328" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0997c194-9cec-45e8-854c-04af98ec0eca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e23b47f-9a36-4f71-9b71-ff25d5b38328" xlink:to="loc_us-gaap_AwardTypeAxis_0997c194-9cec-45e8-854c-04af98ec0eca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0997c194-9cec-45e8-854c-04af98ec0eca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0997c194-9cec-45e8-854c-04af98ec0eca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0997c194-9cec-45e8-854c-04af98ec0eca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_38b61cda-fc40-47f3-bfe4-276009905acc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0997c194-9cec-45e8-854c-04af98ec0eca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_38b61cda-fc40-47f3-bfe4-276009905acc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_585cfadf-039a-4ff0-b87b-1de2d9bc81d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_38b61cda-fc40-47f3-bfe4-276009905acc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_585cfadf-039a-4ff0-b87b-1de2d9bc81d3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockPlansNonVestedRSUsDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f451b457-7d2d-42f2-942e-c7f119cefc59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1b08659b-9c5b-4b9b-a69c-ba5e88cfb4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f451b457-7d2d-42f2-942e-c7f119cefc59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1b08659b-9c5b-4b9b-a69c-ba5e88cfb4b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7da4730a-91c0-42e4-bdde-c2d6710e9e07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1b08659b-9c5b-4b9b-a69c-ba5e88cfb4b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7da4730a-91c0-42e4-bdde-c2d6710e9e07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f9ebf840-e982-4e98-b3ef-67e4e2bf2c74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1b08659b-9c5b-4b9b-a69c-ba5e88cfb4b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f9ebf840-e982-4e98-b3ef-67e4e2bf2c74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_57d82a32-3265-4f75-bb60-2d04a8cc210d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1b08659b-9c5b-4b9b-a69c-ba5e88cfb4b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_57d82a32-3265-4f75-bb60-2d04a8cc210d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1df23075-fea9-4392-b044-d61a416be598" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1b08659b-9c5b-4b9b-a69c-ba5e88cfb4b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1df23075-fea9-4392-b044-d61a416be598" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b5ac9c6e-b068-4a6f-a3b1-cbf1806a9fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_952dcf58-27e1-4f88-8217-1deb460c2848" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f451b457-7d2d-42f2-942e-c7f119cefc59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_952dcf58-27e1-4f88-8217-1deb460c2848" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f1acad1f-dc97-47b4-849f-98f8ec62b061" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_952dcf58-27e1-4f88-8217-1deb460c2848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f1acad1f-dc97-47b4-849f-98f8ec62b061" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f262113a-ecb0-4b78-9aa7-f691b00dedb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_952dcf58-27e1-4f88-8217-1deb460c2848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f262113a-ecb0-4b78-9aa7-f691b00dedb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_de5b1b00-b970-4a2f-b624-7c948508bc62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_952dcf58-27e1-4f88-8217-1deb460c2848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_de5b1b00-b970-4a2f-b624-7c948508bc62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d17c5349-f760-4709-9e4e-2b02b518af30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_952dcf58-27e1-4f88-8217-1deb460c2848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d17c5349-f760-4709-9e4e-2b02b518af30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_26a1658b-f1c5-4d4b-884c-8f19590c54e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6edf03d8-e582-440e-be25-cdbf8f8e87bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f451b457-7d2d-42f2-942e-c7f119cefc59" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6edf03d8-e582-440e-be25-cdbf8f8e87bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b8581c5d-60b8-491e-be20-7399f5d075f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6edf03d8-e582-440e-be25-cdbf8f8e87bc" xlink:to="loc_us-gaap_AwardTypeAxis_b8581c5d-60b8-491e-be20-7399f5d075f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8581c5d-60b8-491e-be20-7399f5d075f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b8581c5d-60b8-491e-be20-7399f5d075f2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8581c5d-60b8-491e-be20-7399f5d075f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d524a88c-0145-4747-9f70-01c9448e56b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b8581c5d-60b8-491e-be20-7399f5d075f2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d524a88c-0145-4747-9f70-01c9448e56b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c2835fb2-7f13-4538-b11b-62cb09eb5761" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d524a88c-0145-4747-9f70-01c9448e56b8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c2835fb2-7f13-4538-b11b-62cb09eb5761" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_e2931fcf-79e9-4ebd-a374-2e30f2506d48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_e2931fcf-79e9-4ebd-a374-2e30f2506d48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_10f3aa2a-da03-4b29-871c-83f2ba511841" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_10f3aa2a-da03-4b29-871c-83f2ba511841" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_55310502-3d7f-4f4e-9610-e8bcb75d6f35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_55310502-3d7f-4f4e-9610-e8bcb75d6f35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_49410d36-1274-499d-9380-4a759a29a733" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_49410d36-1274-499d-9380-4a759a29a733" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_8200dd49-81b0-4e0c-bd65-15aaf18d089c" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_8200dd49-81b0-4e0c-bd65-15aaf18d089c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_47e4dfc1-61b9-4c14-9d64-87aa02c0baf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_47e4dfc1-61b9-4c14-9d64-87aa02c0baf4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_fdddbe44-705f-4408-9183-eb4c3c4b6e79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_fdddbe44-705f-4408-9183-eb4c3c4b6e79" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_6518a7a4-e19d-4832-89b8-5f7dd92af0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_6518a7a4-e19d-4832-89b8-5f7dd92af0a7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_2128002d-254f-4722-a432-cd04c2839b25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_2128002d-254f-4722-a432-cd04c2839b25" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a90714c-d8e9-49bb-bde7-fc7fae6367de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a90714c-d8e9-49bb-bde7-fc7fae6367de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_c0816e12-1e7e-4054-a6b0-fb02fdbff11e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a90714c-d8e9-49bb-bde7-fc7fae6367de" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_c0816e12-1e7e-4054-a6b0-fb02fdbff11e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_c0816e12-1e7e-4054-a6b0-fb02fdbff11e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_c0816e12-1e7e-4054-a6b0-fb02fdbff11e" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_c0816e12-1e7e-4054-a6b0-fb02fdbff11e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_992a15dc-2d76-4426-9b60-83367342d1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_c0816e12-1e7e-4054-a6b0-fb02fdbff11e" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_992a15dc-2d76-4426-9b60-83367342d1f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_ca2ecd2b-d427-419f-9103-275a50db4d8b" xlink:href="coo-20231031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_992a15dc-2d76-4426-9b60-83367342d1f3" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_ca2ecd2b-d427-419f-9103-275a50db4d8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_83f07d20-a818-4bed-a5a3-52b147984211" xlink:href="coo-20231031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_992a15dc-2d76-4426-9b60-83367342d1f3" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_83f07d20-a818-4bed-a5a3-52b147984211" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_5900e5aa-c9a8-4e04-9c6b-8110a3ae409f" xlink:href="coo-20231031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_992a15dc-2d76-4426-9b60-83367342d1f3" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_5900e5aa-c9a8-4e04-9c6b-8110a3ae409f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_096c1a70-e381-4154-bc59-4d9d01ee55d6" xlink:href="coo-20231031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_992a15dc-2d76-4426-9b60-83367342d1f3" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_096c1a70-e381-4154-bc59-4d9d01ee55d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6cf52a11-f993-42ea-a82b-caa3bc5fcf87" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a90714c-d8e9-49bb-bde7-fc7fae6367de" xlink:to="loc_srt_RangeAxis_6cf52a11-f993-42ea-a82b-caa3bc5fcf87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6cf52a11-f993-42ea-a82b-caa3bc5fcf87_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6cf52a11-f993-42ea-a82b-caa3bc5fcf87" xlink:to="loc_srt_RangeMember_6cf52a11-f993-42ea-a82b-caa3bc5fcf87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d3bf9039-2b4d-4f1e-8319-6358f7982ddf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6cf52a11-f993-42ea-a82b-caa3bc5fcf87" xlink:to="loc_srt_RangeMember_d3bf9039-2b4d-4f1e-8319-6358f7982ddf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6e35ed0b-15f3-4b36-8acf-ab293f7f8812" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d3bf9039-2b4d-4f1e-8319-6358f7982ddf" xlink:to="loc_srt_MinimumMember_6e35ed0b-15f3-4b36-8acf-ab293f7f8812" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_16941513-3863-4851-b249-4885b5df68b8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d3bf9039-2b4d-4f1e-8319-6358f7982ddf" xlink:to="loc_srt_MaximumMember_16941513-3863-4851-b249-4885b5df68b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dbcf8121-7a93-4284-a49d-6d3c296d6269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a90714c-d8e9-49bb-bde7-fc7fae6367de" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dbcf8121-7a93-4284-a49d-6d3c296d6269" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_dbcf8121-7a93-4284-a49d-6d3c296d6269_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dbcf8121-7a93-4284-a49d-6d3c296d6269" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_dbcf8121-7a93-4284-a49d-6d3c296d6269_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_da867a4f-0ea6-4bec-a02a-ba97c0776dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dbcf8121-7a93-4284-a49d-6d3c296d6269" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_da867a4f-0ea6-4bec-a02a-ba97c0776dc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_ab51ea46-c246-47e2-98e0-059184d9cda8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_da867a4f-0ea6-4bec-a02a-ba97c0776dc2" xlink:to="loc_us-gaap_EquitySecuritiesMember_ab51ea46-c246-47e2-98e0-059184d9cda8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_8aac9478-c76b-4476-95af-7cb1517ed397" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_adf073e9-9f95-483e-be3a-a25cb4be9725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_8aac9478-c76b-4476-95af-7cb1517ed397" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_adf073e9-9f95-483e-be3a-a25cb4be9725" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_1b71fbeb-9d73-4994-8a15-befe85031b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_8aac9478-c76b-4476-95af-7cb1517ed397" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_1b71fbeb-9d73-4994-8a15-befe85031b9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_35c0b858-4a08-4a6a-bc90-879a59406b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_1b71fbeb-9d73-4994-8a15-befe85031b9d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_35c0b858-4a08-4a6a-bc90-879a59406b3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_35c0b858-4a08-4a6a-bc90-879a59406b3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_35c0b858-4a08-4a6a-bc90-879a59406b3c" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_35c0b858-4a08-4a6a-bc90-879a59406b3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_35c0b858-4a08-4a6a-bc90-879a59406b3c" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_0497cef7-293d-4df6-b917-ae0b8d9bafb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_0497cef7-293d-4df6-b917-ae0b8d9bafb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember_def6a50b-a9ce-4f8a-88a4-1165f5504cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember_def6a50b-a9ce-4f8a-88a4-1165f5504cd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember_a508276c-1647-486d-8dce-616aeb4f5af8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:to="loc_us-gaap_EquityFundsMember_a508276c-1647-486d-8dce-616aeb4f5af8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalancedFundsMember_5482a628-d8be-4c97-a8c6-a401bf101797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalancedFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:to="loc_us-gaap_BalancedFundsMember_5482a628-d8be-4c97-a8c6-a401bf101797" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AlternativeInvestmentsMember_6d8c46c3-fc91-4f37-a95e-40574a5c87a8" xlink:href="coo-20231031.xsd#coo_AlternativeInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:to="loc_coo_AlternativeInvestmentsMember_6d8c46c3-fc91-4f37-a95e-40574a5c87a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BondMutualFundsMember_f106bdeb-9ebb-42ba-9d92-c810b19dbe45" xlink:href="coo-20231031.xsd#coo_BondMutualFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:to="loc_coo_BondMutualFundsMember_f106bdeb-9ebb-42ba-9d92-c810b19dbe45" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_219be785-0dd4-4738-940a-dfcd32620e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_dfde9a39-5dd0-46b9-b4a1-663e7e740b38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_219be785-0dd4-4738-940a-dfcd32620e6b" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_dfde9a39-5dd0-46b9-b4a1-663e7e740b38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_fd83dd3d-f6a7-4b45-a7c8-0645e91fed8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_219be785-0dd4-4738-940a-dfcd32620e6b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_fd83dd3d-f6a7-4b45-a7c8-0645e91fed8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2e48546c-0436-48c8-b8fb-92d4f2ee0938" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_fd83dd3d-f6a7-4b45-a7c8-0645e91fed8c" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2e48546c-0436-48c8-b8fb-92d4f2ee0938" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_2e48546c-0436-48c8-b8fb-92d4f2ee0938_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2e48546c-0436-48c8-b8fb-92d4f2ee0938" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_2e48546c-0436-48c8-b8fb-92d4f2ee0938_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2e48546c-0436-48c8-b8fb-92d4f2ee0938" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_968382e3-5918-4718-8587-c3f2d338f799" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_968382e3-5918-4718-8587-c3f2d338f799" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember_24e21f5d-d45b-4cac-8e96-2592d1a82738" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember_24e21f5d-d45b-4cac-8e96-2592d1a82738" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember_99f3126f-8085-442e-ba09-8901e1f65f21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:to="loc_us-gaap_EquityFundsMember_99f3126f-8085-442e-ba09-8901e1f65f21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalancedFundsMember_35f7d7ba-9fa8-4c65-9c85-128c06b7a2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalancedFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:to="loc_us-gaap_BalancedFundsMember_35f7d7ba-9fa8-4c65-9c85-128c06b7a2c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AlternativeInvestmentsMember_6523427d-e673-4e68-8250-ca0268c49ff2" xlink:href="coo-20231031.xsd#coo_AlternativeInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:to="loc_coo_AlternativeInvestmentsMember_6523427d-e673-4e68-8250-ca0268c49ff2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeInvestmentsMember_fab3f6ef-ec3d-457c-9aa7-7c252adf32f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:to="loc_us-gaap_FixedIncomeInvestmentsMember_fab3f6ef-ec3d-457c-9aa7-7c252adf32f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5a575afd-8669-488d-b6a0-2950afc989e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_fd83dd3d-f6a7-4b45-a7c8-0645e91fed8c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5a575afd-8669-488d-b6a0-2950afc989e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5a575afd-8669-488d-b6a0-2950afc989e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5a575afd-8669-488d-b6a0-2950afc989e6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5a575afd-8669-488d-b6a0-2950afc989e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52058789-4d78-49c1-b34e-3422fbc75651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5a575afd-8669-488d-b6a0-2950afc989e6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52058789-4d78-49c1-b34e-3422fbc75651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1b20eb79-f353-444b-aa66-534868491bad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52058789-4d78-49c1-b34e-3422fbc75651" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1b20eb79-f353-444b-aa66-534868491bad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7be4a6d9-facb-4501-9aa2-407738118b60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52058789-4d78-49c1-b34e-3422fbc75651" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7be4a6d9-facb-4501-9aa2-407738118b60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d886264a-f4dd-48c3-a61b-e00c66eee8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52058789-4d78-49c1-b34e-3422fbc75651" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d886264a-f4dd-48c3-a61b-e00c66eee8bc" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#BusinessSegmentInformationBusinessSegmentNetSalesDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f2e85690-f2ed-48dc-b557-87bf72455257" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_80039cf5-a2c9-4b0d-ab22-42c04a4f9b75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2e85690-f2ed-48dc-b557-87bf72455257" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_80039cf5-a2c9-4b0d-ab22-42c04a4f9b75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_266a6b81-d747-4824-b307-510d9aefb9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2e85690-f2ed-48dc-b557-87bf72455257" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_266a6b81-d747-4824-b307-510d9aefb9dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3cc8390a-bb16-4643-a464-88bfe45393a3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_266a6b81-d747-4824-b307-510d9aefb9dd" xlink:to="loc_srt_ProductOrServiceAxis_3cc8390a-bb16-4643-a464-88bfe45393a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3cc8390a-bb16-4643-a464-88bfe45393a3_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3cc8390a-bb16-4643-a464-88bfe45393a3" xlink:to="loc_srt_ProductsAndServicesDomain_3cc8390a-bb16-4643-a464-88bfe45393a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3cc8390a-bb16-4643-a464-88bfe45393a3" xlink:to="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ToricLensMember_0c73b885-01af-4607-9fcc-4235236310d8" xlink:href="coo-20231031.xsd#coo_ToricLensMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:to="loc_coo_ToricLensMember_0c73b885-01af-4607-9fcc-4235236310d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_MultifocalLensMember_37a56716-2322-44d2-80dc-660edeece7b3" xlink:href="coo-20231031.xsd#coo_MultifocalLensMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:to="loc_coo_MultifocalLensMember_37a56716-2322-44d2-80dc-660edeece7b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SingleUseSphereLensMember_5cd03a87-4f40-48bd-a714-101e40eea28f" xlink:href="coo-20231031.xsd#coo_SingleUseSphereLensMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:to="loc_coo_SingleUseSphereLensMember_5cd03a87-4f40-48bd-a714-101e40eea28f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NonSingleUseSphereAndOtherMember_66095eac-5124-4e9f-ae8c-9b7dc08429c2" xlink:href="coo-20231031.xsd#coo_NonSingleUseSphereAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:to="loc_coo_NonSingleUseSphereAndOtherMember_66095eac-5124-4e9f-ae8c-9b7dc08429c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OfficeAndSurgicalProductsMember_28a85ba1-e9eb-49f9-bc94-60ef2c65764e" xlink:href="coo-20231031.xsd#coo_OfficeAndSurgicalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:to="loc_coo_OfficeAndSurgicalProductsMember_28a85ba1-e9eb-49f9-bc94-60ef2c65764e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_FertilityMember_d6adc49d-bce9-4956-bd8a-c1c752724cdc" xlink:href="coo-20231031.xsd#coo_FertilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:to="loc_coo_FertilityMember_d6adc49d-bce9-4956-bd8a-c1c752724cdc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e5cad34e-55fd-41ac-b943-2930102337c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_266a6b81-d747-4824-b307-510d9aefb9dd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e5cad34e-55fd-41ac-b943-2930102337c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e5cad34e-55fd-41ac-b943-2930102337c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e5cad34e-55fd-41ac-b943-2930102337c8" xlink:to="loc_us-gaap_SegmentDomain_e5cad34e-55fd-41ac-b943-2930102337c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2fb89488-2be6-41b8-9afd-3cc60324ae2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e5cad34e-55fd-41ac-b943-2930102337c8" xlink:to="loc_us-gaap_SegmentDomain_2fb89488-2be6-41b8-9afd-3cc60324ae2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperVisionSegmentMember_8b47f137-667b-473b-8f8f-d6ab9b7acf3f" xlink:href="coo-20231031.xsd#coo_CooperVisionSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2fb89488-2be6-41b8-9afd-3cc60324ae2f" xlink:to="loc_coo_CooperVisionSegmentMember_8b47f137-667b-473b-8f8f-d6ab9b7acf3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperSurgicalSegmentMember_91243f2b-2703-40c9-a70f-3e08e32dc478" xlink:href="coo-20231031.xsd#coo_CooperSurgicalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2fb89488-2be6-41b8-9afd-3cc60324ae2f" xlink:to="loc_coo_CooperSurgicalSegmentMember_91243f2b-2703-40c9-a70f-3e08e32dc478" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#BusinessSegmentInformationBusinessSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5abee818-8384-4965-9f5e-614515ca7976" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5abee818-8384-4965-9f5e-614515ca7976" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b96f0549-a345-4df2-8696-bc6a4aa60f99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_OperatingIncomeLoss_b96f0549-a345-4df2-8696-bc6a4aa60f99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_57c8c073-5d70-4a78-bf18-f0df757265f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_InterestExpense_57c8c073-5d70-4a78-bf18-f0df757265f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c21a9a2f-9198-4595-bbce-149f7a3b40e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c21a9a2f-9198-4595-bbce-149f7a3b40e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_12184966-d833-45d5-8ca2-2d90eeebe4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_12184966-d833-45d5-8ca2-2d90eeebe4c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a4048ca3-b825-4dab-9bad-c4954279e545" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_Assets_a4048ca3-b825-4dab-9bad-c4954279e545" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_e9885344-1423-41a5-ba27-b2d866e1de23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_Depreciation_e9885344-1423-41a5-ba27-b2d866e1de23" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_1f6e8398-18ad-43b0-b326-8647baa8dd02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_AdjustmentForAmortization_1f6e8398-18ad-43b0-b326-8647baa8dd02" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_b0a03d49-4154-4bf7-9f73-aeecedb81f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_b0a03d49-4154-4bf7-9f73-aeecedb81f5c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_233aa829-b765-48cb-b66c-0426e82214d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_233aa829-b765-48cb-b66c-0426e82214d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7b262eb9-4026-480c-971a-2c17b6632e84" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_233aa829-b765-48cb-b66c-0426e82214d1" xlink:to="loc_srt_ConsolidationItemsAxis_7b262eb9-4026-480c-971a-2c17b6632e84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7b262eb9-4026-480c-971a-2c17b6632e84_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_7b262eb9-4026-480c-971a-2c17b6632e84" xlink:to="loc_srt_ConsolidationItemsDomain_7b262eb9-4026-480c-971a-2c17b6632e84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_eec55be9-a387-45e0-8cb7-f7182f5c2c93" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_7b262eb9-4026-480c-971a-2c17b6632e84" xlink:to="loc_srt_ConsolidationItemsDomain_eec55be9-a387-45e0-8cb7-f7182f5c2c93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_02037571-6699-44af-8139-4bc00955cb14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_eec55be9-a387-45e0-8cb7-f7182f5c2c93" xlink:to="loc_us-gaap_OperatingSegmentsMember_02037571-6699-44af-8139-4bc00955cb14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9de79469-bec7-4a0e-9c94-15b80b4a4e41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_eec55be9-a387-45e0-8cb7-f7182f5c2c93" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9de79469-bec7-4a0e-9c94-15b80b4a4e41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_42703a65-a282-44c9-8bf1-6b3a384a465e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_233aa829-b765-48cb-b66c-0426e82214d1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_42703a65-a282-44c9-8bf1-6b3a384a465e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_42703a65-a282-44c9-8bf1-6b3a384a465e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_42703a65-a282-44c9-8bf1-6b3a384a465e" xlink:to="loc_us-gaap_SegmentDomain_42703a65-a282-44c9-8bf1-6b3a384a465e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e212c058-ce36-4318-bbff-c468ebb686b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_42703a65-a282-44c9-8bf1-6b3a384a465e" xlink:to="loc_us-gaap_SegmentDomain_e212c058-ce36-4318-bbff-c468ebb686b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperVisionSegmentMember_72acd82b-c48f-4e7f-9843-a2dc53120474" xlink:href="coo-20231031.xsd#coo_CooperVisionSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e212c058-ce36-4318-bbff-c468ebb686b4" xlink:to="loc_coo_CooperVisionSegmentMember_72acd82b-c48f-4e7f-9843-a2dc53120474" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperSurgicalSegmentMember_c1ae38c3-af15-4226-8abc-56f7aa3ca9b5" xlink:href="coo-20231031.xsd#coo_CooperSurgicalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e212c058-ce36-4318-bbff-c468ebb686b4" xlink:to="loc_coo_CooperSurgicalSegmentMember_c1ae38c3-af15-4226-8abc-56f7aa3ca9b5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3fb7b0a7-0594-4277-82ed-6bccc0a45b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fb97ccd6-12c1-45b6-a9d2-e80a702753b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fb7b0a7-0594-4277-82ed-6bccc0a45b7b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fb97ccd6-12c1-45b6-a9d2-e80a702753b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_95ab0406-5383-40e9-9761-0c3c5cb18a28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fb7b0a7-0594-4277-82ed-6bccc0a45b7b" xlink:to="loc_us-gaap_OperatingIncomeLoss_95ab0406-5383-40e9-9761-0c3c5cb18a28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1d0de255-97a8-4bc5-9da5-af91ea9e72b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fb7b0a7-0594-4277-82ed-6bccc0a45b7b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1d0de255-97a8-4bc5-9da5-af91ea9e72b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fadd5852-a596-4402-999e-c1fc68761201" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fb7b0a7-0594-4277-82ed-6bccc0a45b7b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fadd5852-a596-4402-999e-c1fc68761201" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5bbb12bd-f3fc-4730-be6b-ef5cd8d5105a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fadd5852-a596-4402-999e-c1fc68761201" xlink:to="loc_srt_ConsolidationItemsAxis_5bbb12bd-f3fc-4730-be6b-ef5cd8d5105a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5bbb12bd-f3fc-4730-be6b-ef5cd8d5105a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5bbb12bd-f3fc-4730-be6b-ef5cd8d5105a" xlink:to="loc_srt_ConsolidationItemsDomain_5bbb12bd-f3fc-4730-be6b-ef5cd8d5105a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_649f0790-061e-41d2-8a67-fea23fbcf231" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5bbb12bd-f3fc-4730-be6b-ef5cd8d5105a" xlink:to="loc_srt_ConsolidationItemsDomain_649f0790-061e-41d2-8a67-fea23fbcf231" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_GeographyEliminationsMember_8a00e904-0dea-446b-9955-094ceec567de" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_GeographyEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_649f0790-061e-41d2-8a67-fea23fbcf231" xlink:to="loc_srt_GeographyEliminationsMember_8a00e904-0dea-446b-9955-094ceec567de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReportableGeographicalComponentsMember_b5fb94b8-c744-4056-a7b4-bbe7f8ddae34" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ReportableGeographicalComponentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_649f0790-061e-41d2-8a67-fea23fbcf231" xlink:to="loc_srt_ReportableGeographicalComponentsMember_b5fb94b8-c744-4056-a7b4-bbe7f8ddae34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CorporateReconcilingItemsAndEliminationsMember_3a725c15-4c4b-43e6-95ad-28a74afdc656" xlink:href="coo-20231031.xsd#coo_CorporateReconcilingItemsAndEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_649f0790-061e-41d2-8a67-fea23fbcf231" xlink:to="loc_coo_CorporateReconcilingItemsAndEliminationsMember_3a725c15-4c4b-43e6-95ad-28a74afdc656" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6b7eaf23-f82c-46d5-a3d5-ebdad5bdf6c9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fadd5852-a596-4402-999e-c1fc68761201" xlink:to="loc_srt_StatementGeographicalAxis_6b7eaf23-f82c-46d5-a3d5-ebdad5bdf6c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6b7eaf23-f82c-46d5-a3d5-ebdad5bdf6c9_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6b7eaf23-f82c-46d5-a3d5-ebdad5bdf6c9" xlink:to="loc_srt_SegmentGeographicalDomain_6b7eaf23-f82c-46d5-a3d5-ebdad5bdf6c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f214c700-8d2b-48a8-b48d-5999191e2022" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6b7eaf23-f82c-46d5-a3d5-ebdad5bdf6c9" xlink:to="loc_srt_SegmentGeographicalDomain_f214c700-8d2b-48a8-b48d-5999191e2022" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1aac54c3-32cc-4203-a6c7-48b908dd0f51" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f214c700-8d2b-48a8-b48d-5999191e2022" xlink:to="loc_country_US_1aac54c3-32cc-4203-a6c7-48b908dd0f51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_d74ade00-b017-4956-8df0-f887d2721d8a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f214c700-8d2b-48a8-b48d-5999191e2022" xlink:to="loc_srt_EuropeMember_d74ade00-b017-4956-8df0-f887d2721d8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_RestOfTheWorldMember_880e4990-f273-45ef-8807-1236b9a52894" xlink:href="coo-20231031.xsd#coo_RestOfTheWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f214c700-8d2b-48a8-b48d-5999191e2022" xlink:to="loc_coo_RestOfTheWorldMember_880e4990-f273-45ef-8807-1236b9a52894" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancialDerivativesandHedgingNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f6b415b2-aff4-4dbb-9835-cf2e56cc724d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6085cd93-9ceb-4d88-b176-11ba305d55b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f6b415b2-aff4-4dbb-9835-cf2e56cc724d" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6085cd93-9ceb-4d88-b176-11ba305d55b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_f52d1b28-6bf4-44bc-b138-75c3cc8fb23d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f6b415b2-aff4-4dbb-9835-cf2e56cc724d" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_f52d1b28-6bf4-44bc-b138-75c3cc8fb23d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_b35c63a6-716a-468d-a358-f4970946b0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f6b415b2-aff4-4dbb-9835-cf2e56cc724d" xlink:to="loc_us-gaap_DerivativeTermOfContract_b35c63a6-716a-468d-a358-f4970946b0a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_18fe6c84-26ae-4c48-a5a9-0afbbcdb0bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f6b415b2-aff4-4dbb-9835-cf2e56cc724d" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_18fe6c84-26ae-4c48-a5a9-0afbbcdb0bcd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_36b442d8-f468-45b9-80d3-c718232e832c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f6b415b2-aff4-4dbb-9835-cf2e56cc724d" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_36b442d8-f468-45b9-80d3-c718232e832c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1db58933-2eb2-48d3-9ba8-ba964eadcb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_36b442d8-f468-45b9-80d3-c718232e832c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1db58933-2eb2-48d3-9ba8-ba964eadcb2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1db58933-2eb2-48d3-9ba8-ba964eadcb2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1db58933-2eb2-48d3-9ba8-ba964eadcb2e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1db58933-2eb2-48d3-9ba8-ba964eadcb2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f95e5d7d-1b45-4a69-a325-db66e4b59f43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1db58933-2eb2-48d3-9ba8-ba964eadcb2e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f95e5d7d-1b45-4a69-a325-db66e4b59f43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_08ed26ec-258c-4b8e-af91-78878837aa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f95e5d7d-1b45-4a69-a325-db66e4b59f43" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_08ed26ec-258c-4b8e-af91-78878837aa3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_0137226d-b51e-44cd-b9f4-278fd093d13e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f95e5d7d-1b45-4a69-a325-db66e4b59f43" xlink:to="loc_us-gaap_InterestRateSwapMember_0137226d-b51e-44cd-b9f4-278fd093d13e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f6775ce-f3a3-4628-8efa-ab6e82ea87e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5ce08942-a833-4401-b225-00f53f7c5981" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f6775ce-f3a3-4628-8efa-ab6e82ea87e1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5ce08942-a833-4401-b225-00f53f7c5981" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_22e6809a-d844-4905-9017-31b43e63f715" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f6775ce-f3a3-4628-8efa-ab6e82ea87e1" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_22e6809a-d844-4905-9017-31b43e63f715" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5a8337a8-d8b6-44d2-9370-857fafce0b26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_22e6809a-d844-4905-9017-31b43e63f715" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5a8337a8-d8b6-44d2-9370-857fafce0b26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5a8337a8-d8b6-44d2-9370-857fafce0b26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5a8337a8-d8b6-44d2-9370-857fafce0b26" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5a8337a8-d8b6-44d2-9370-857fafce0b26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7c762fe1-95b3-49c7-b526-d46c3e94ff77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5a8337a8-d8b6-44d2-9370-857fafce0b26" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7c762fe1-95b3-49c7-b526-d46c3e94ff77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_e4e1b8d4-2d13-4766-8101-86994e995ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7c762fe1-95b3-49c7-b526-d46c3e94ff77" xlink:to="loc_us-gaap_InterestExpenseMember_e4e1b8d4-2d13-4766-8101-86994e995ca0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6ffc4597-b5a4-4f12-beff-3ae6e23abffb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_22e6809a-d844-4905-9017-31b43e63f715" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6ffc4597-b5a4-4f12-beff-3ae6e23abffb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6ffc4597-b5a4-4f12-beff-3ae6e23abffb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6ffc4597-b5a4-4f12-beff-3ae6e23abffb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6ffc4597-b5a4-4f12-beff-3ae6e23abffb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d791d4e7-31d3-4fd8-8ea2-0436a7da253b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6ffc4597-b5a4-4f12-beff-3ae6e23abffb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d791d4e7-31d3-4fd8-8ea2-0436a7da253b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_867dee31-d520-48c2-800d-bd1aad533ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d791d4e7-31d3-4fd8-8ea2-0436a7da253b" xlink:to="loc_us-gaap_InterestRateSwapMember_867dee31-d520-48c2-800d-bd1aad533ed7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e057a8bf-9cc2-4044-b521-25fc92dde3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:href="coo-20231031.xsd#coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e057a8bf-9cc2-4044-b521-25fc92dde3dc" xlink:to="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dea6c3fe-adc9-4aeb-99a7-34a027c90252" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dea6c3fe-adc9-4aeb-99a7-34a027c90252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1e0cec64-7073-4379-867b-f2401151fd13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1e0cec64-7073-4379-867b-f2401151fd13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_d048121d-3b9c-4c12-821b-293a1e0df918" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_d048121d-3b9c-4c12-821b-293a1e0df918" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_b34cc57c-4a83-4192-8804-8558bb2f1fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_b34cc57c-4a83-4192-8804-8558bb2f1fa3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2504d302-adf1-4917-abe9-4ce1e2f96f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2504d302-adf1-4917-abe9-4ce1e2f96f3b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a23f6b5-d55b-4b33-a626-bbda6a14d2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_09d5ed0c-1f69-4e24-b255-ca697ee7aeec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e057a8bf-9cc2-4044-b521-25fc92dde3dc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_09d5ed0c-1f69-4e24-b255-ca697ee7aeec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_06e81c52-5f33-4ecd-8592-33ab90ab8e61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_09d5ed0c-1f69-4e24-b255-ca697ee7aeec" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_06e81c52-5f33-4ecd-8592-33ab90ab8e61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_06e81c52-5f33-4ecd-8592-33ab90ab8e61_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_06e81c52-5f33-4ecd-8592-33ab90ab8e61" xlink:to="loc_us-gaap_EquityComponentDomain_06e81c52-5f33-4ecd-8592-33ab90ab8e61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_445e698f-6796-445e-8409-d0cbe429935c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_06e81c52-5f33-4ecd-8592-33ab90ab8e61" xlink:to="loc_us-gaap_EquityComponentDomain_445e698f-6796-445e-8409-d0cbe429935c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_1a8e68e5-f54f-420b-9a91-a89746dcf123" xlink:href="coo-20231031.xsd#coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_445e698f-6796-445e-8409-d0cbe429935c" xlink:to="loc_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_1a8e68e5-f54f-420b-9a91-a89746dcf123" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5998130e-ad22-4dc3-9e98-08d802634fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_445e698f-6796-445e-8409-d0cbe429935c" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5998130e-ad22-4dc3-9e98-08d802634fcf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ScheduleIIDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#ScheduleIIDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/ScheduleIIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_67277ee5-e0f9-4009-8a07-6889340f5509" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_9ed56ad3-6c9b-43b6-8fb8-afeea7142500" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_67277ee5-e0f9-4009-8a07-6889340f5509" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_9ed56ad3-6c9b-43b6-8fb8-afeea7142500" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_b14de7aa-1bd2-4a9f-a723-3cd7066bb3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_67277ee5-e0f9-4009-8a07-6889340f5509" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_b14de7aa-1bd2-4a9f-a723-3cd7066bb3c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_7231c9fb-37a9-497f-a128-98e817d8cfd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_67277ee5-e0f9-4009-8a07-6889340f5509" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_7231c9fb-37a9-497f-a128-98e817d8cfd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_91c40243-996f-448f-a007-5c553d1eabca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e8f38ba8-2e15-48e8-8d9b-d984bd8624cc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_67277ee5-e0f9-4009-8a07-6889340f5509" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e8f38ba8-2e15-48e8-8d9b-d984bd8624cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a7750f35-3816-4995-811b-118ab5da7132" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e8f38ba8-2e15-48e8-8d9b-d984bd8624cc" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a7750f35-3816-4995-811b-118ab5da7132" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_a7750f35-3816-4995-811b-118ab5da7132_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a7750f35-3816-4995-811b-118ab5da7132" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_a7750f35-3816-4995-811b-118ab5da7132_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_576797b7-6b4c-48b5-8f66-c6f8ca12f422" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a7750f35-3816-4995-811b-118ab5da7132" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_576797b7-6b4c-48b5-8f66-c6f8ca12f422" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_b7c2faea-ee1e-4ff7-a7b4-13722290adce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_576797b7-6b4c-48b5-8f66-c6f8ca12f422" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_b7c2faea-ee1e-4ff7-a7b4-13722290adce" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>coo-20231031_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:0c65df22-c15f-4b61-bd32-d5e051159c75,g:61acad92-dfa7-4255-a259-2e1b3c8d59bb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_VariableRateDomain_156fe867-af2a-4a37-a792-0b88f2520fbc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_GeographyEliminationsMember_f21f4294-1bf5-4cff-a29f-aa7df15e0bf2_terseLabel_en-US" xlink:label="lab_srt_GeographyEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geography Eliminations</link:label>
    <link:label id="lab_srt_GeographyEliminationsMember_label_en-US" xlink:label="lab_srt_GeographyEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geography Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_GeographyEliminationsMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_GeographyEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_GeographyEliminationsMember" xlink:to="lab_srt_GeographyEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_78f5cc37-92c1-4480-94ba-6a6a01db20fd_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_c6aad8e4-fed6-4848-a3d7-ce602f87ddfd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign earnings subject to United States tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:to="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_2fd793ad-f3f3-421c-9e3d-c77f783082e4_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d39d22a8-e824-4e94-b170-e7c4b44fbdc7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_bb8bc56d-28fc-4aba-a71b-56c6af2e2156_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a91b25ad-c062-4d01-9ae2-f355ddc71685_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3179a698-4d5c-4805-9226-6a886e1c54c0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award expiration date (no more than)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8be0af94-d166-484c-980b-fd3e0c98327f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_421dc8ba-9b82-4838-b1d3-2a36d43a2a8c_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost And Benefit Obligation [Abstract]</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost And Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" xlink:to="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_e31b2bb6-dda6-40ca-b9ca-616afdf068c4_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1d98507b-bfa3-4bb8-a161-ef6edc93c4da_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested RSUs, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9130cb67-bd05-483a-bcb6-4fb1ee045540_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested RSUs, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_2b062ff8-674a-479c-802c-206a6f47938e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_6e1b685c-bf5f-45be-89f1-c9810619eddf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_3f41bed6-54ea-467e-bc1c-cb835b3f29e3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_e8935ff1-0ef0-40c1-9cdd-b4a1a9186e5c_terseLabel_en-US" xlink:label="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrecognized tax benefits</link:label>
    <link:label id="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_label_en-US" xlink:label="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In Unrecognized Tax Benefits, Amount</link:label>
    <link:label id="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_documentation_en-US" xlink:label="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In Unrecognized Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:href="coo-20231031.xsd#coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:to="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_1ad58649-6193-4c2f-956d-e5336e074d00_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_64dae90d-1ab1-4380-b90e-817a61fe566f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_c403c59a-1e5e-455e-b918-281037983328_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc540860-4552-42f8-8348-a3b58a5ffbca_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4aaf7a00-12c8-47f7-8057-88a9296fde92_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of definite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_be9b76c9-f7a2-47ce-9a3f-0b2aaf98ed4b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_6d0ba3f6-9314-47a6-b0f0-581e87c1a6f4_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_03cd7769-8bde-4db6-b638-86582c53a525_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_d399a934-7a2d-4b99-b864-843795b097c1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a0eaff6d-98e5-4bc7-a2e3-d4eb7eca570e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period, Weighted-Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f9d54e1-9ef6-450c-ac4d-7c25a5516824_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_6f64fd38-f365-4109-978b-311fee0aaf8a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_6b2ac699-6131-4bba-9ce8-c123c957ad1f_negatedLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_c32c3ce7-d5ec-4ac7-8a9f-efb9f09820e8_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies (Note 11)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_d5c41cb9-ad7e-4ad2-a0b1-e05eefb2b8b4_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1b845177-d2b2-42c1-afb3-6f4c797e018f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_0cc16ac8-62b3-4cfa-a468-86f27b1990a6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_label_en-US" xlink:label="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment, Expenditure, Addition to Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:to="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_421dca09-1f12-4105-ae80-d3540b2da66c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ce815071-7cff-45e6-9c35-be3d07f2fdda_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_a6863c17-9df6-460b-85f7-d7b4ed5733ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at end of period, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_9a68f016-1c63-4eaa-a6b7-f665a02bbb2f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information by geographical area by country of domicile</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_646ac55e-0881-42d6-a485-92fd1324eca6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_fda7935a-f484-4339-8cb6-db56a1768875_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_08349409-17f6-4a50-9dec-0f051356db1b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_61cedba0-876f-4d94-a7cd-a5162fbc4f4e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_52145c82-1d60-4061-859f-62542409b7f0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8164f385-770f-4747-aee9-ccd7e6a33e01_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_bc850700-009a-43b5-b45e-5659e6594e9c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_87f89ed4-52d2-4ee8-adcb-cad37fc0457c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interest rate swap contracts held</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_7104d662-267d-458f-a264-c606d52bb404_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average assumptions used in computing net periodic pension cost and projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_6ee9d826-ab2f-47e5-930c-ff1f86d31a4b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_35958892-3319-439f-a23a-44f186234494_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_2ee3edb6-9d82-45d8-a429-4d82531730ae_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_84610b7c-040f-4f79-895c-4514df7c7964_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $10 cents par value, 1.0 shares authorized, zero shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_6376c0bd-5d06-4a77-99d3-f459ee03b61f_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt issuance cost</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_df4f03da-82b6-447c-82d2-256242b8644b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6dcaf543-ae0c-47e6-bc39-9d1466d47b61_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Grant&#160;Date&#160;Fair Value&#160;Per&#160;Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_eb24b9eb-7c30-4258-b64f-040a2c2b9a82_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of deferred tax assets from UK rate change</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_e91a0cb1-4ef7-471c-8f10-ee9f6d59b6ca_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_GenerateLifeSciencesMember_2d853a7c-7848-4c1d-a339-b7aa35a411c5_terseLabel_en-US" xlink:label="lab_coo_GenerateLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generate Life Sciences</link:label>
    <link:label id="lab_coo_GenerateLifeSciencesMember_label_en-US" xlink:label="lab_coo_GenerateLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generate Life Sciences [Member]</link:label>
    <link:label id="lab_coo_GenerateLifeSciencesMember_documentation_en-US" xlink:label="lab_coo_GenerateLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generate Life Sciences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_GenerateLifeSciencesMember" xlink:href="coo-20231031.xsd#coo_GenerateLifeSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_GenerateLifeSciencesMember" xlink:to="lab_coo_GenerateLifeSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_605db9fb-982f-481f-8ec1-c0b6023fd46c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_8fb69029-6014-40ec-a53f-373e469bccdf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_b76b4db6-421c-45d2-840f-f0e650976d90_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_96bed892-2706-4cca-9679-6148273fecc2_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_9563ec76-14a7-4b4f-84f7-ebd2b0fc173e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_d5793c7c-8bf6-4f3f-9c8d-b2421dc16b88_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7f31110a-de71-428f-a76b-5c9a59131b8c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_767f4f1c-0d68-4c2a-a845-83e14beb5d7f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net of allowance for credit losses of $31.3 at October&#160;31, 2023 and $20.7 at October&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_114814ed-32b1-4aa0-b68a-298d2c3ed883_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount reclassified from other comprehensive income into earnings, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_bd55fdae-b7c7-4121-8bdd-070f39b53337_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_66d2d1e7-6fda-449c-8e15-995ef09e5951_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_0832b009-f223-4198-92c8-2b320e3b3e35_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase for determining benefit obligations at year end</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_be01a513-deab-4bf8-a7cc-baf02753fcd2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_f76de675-1d77-456b-af98-5ffdf7746dac_terseLabel_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_label_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination [Member]</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_documentation_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" xlink:href="coo-20231031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" xlink:to="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_9b29573b-0096-4394-9d7e-2a47fc1e82d1_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and Land Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovementsMember" xlink:to="lab_us-gaap_LandAndLandImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_fbc1ad95-e62a-4a39-995f-cea7942cdfe5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average asset allocations and fair value measurement of plan assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_cd51abc3-3717-427b-8d81-c428722d533f_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_8d9890e0-4e7c-424a-b7d4-e2b08f4db383_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_67b688d4-69c7-4409-8766-7b55691e7b23_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_cac9e8f7-fdd9-432c-a6f7-688cbf855eda_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b22879a8-9050-4d0a-9c02-2547cd50822e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_08575dbc-2edb-4467-8ad8-85268a1608d3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b8a0ba0f-7345-4b71-bb45-f040271d8c4b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_007fda7f-9afa-4b59-9dc7-bd6fff1d7113_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_16e0120d-b0ba-4698-998f-915af9619a34_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of net periodic pension costs and other amounts recognized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_512daf74-d80f-4f5e-a1a9-29d25291c2f4_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_b7d52caf-c7e8-4e91-a4b5-86def57c9f61_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_f8c97d1b-8219-4459-b5cd-b9760dcea7e3_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_760af1a0-6dd8-4c4a-8189-60a3313ec92b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AlternativeInvestmentsMember_26eba2df-920f-4b80-b5b9-4ac34139ac8f_terseLabel_en-US" xlink:label="lab_coo_AlternativeInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative investments</link:label>
    <link:label id="lab_coo_AlternativeInvestmentsMember_label_en-US" xlink:label="lab_coo_AlternativeInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative Investments [Member]</link:label>
    <link:label id="lab_coo_AlternativeInvestmentsMember_documentation_en-US" xlink:label="lab_coo_AlternativeInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AlternativeInvestmentsMember" xlink:href="coo-20231031.xsd#coo_AlternativeInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AlternativeInvestmentsMember" xlink:to="lab_coo_AlternativeInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_b25310fb-7996-4644-83fd-e5af70262a55_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to form joint venture</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7d110a95-7d11-4cb7-aee1-7a08abc0c750_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1f76ec9e-7fe0-4821-960e-ec75496df61d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value of each option granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_e84906c1-1190-4391-89bb-590e486bba89_terseLabel_en-US" xlink:label="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-Held Medical Device Company, Spectacle Lenses, Portion Attributable To Former Equity Interest Owners</link:label>
    <link:label id="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_label_en-US" xlink:label="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-Held Medical Device Company, Portion Attributable To Former Equity Interest Owners [Member]</link:label>
    <link:label id="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_documentation_en-US" xlink:label="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-Held Medical Device Company, Portion Attributable To Former Equity Interest Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" xlink:href="coo-20231031.xsd#coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" xlink:to="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_af0739ba-0431-44fd-87f2-de1c40bfb7af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_6f7f51f1-6209-443c-98aa-086199b63096_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_485818aa-61b6-4545-83ec-423e2d232c0c_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_ec9b7bca-3daf-4569-82f2-5148f4c3be2d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_904aaace-bc14-4647-b81e-bb26ba7b457b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_75c07a12-c182-41f6-b3d3-8e1b469f8708_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_d32bcbd6-ec93-4e26-a9b6-562a31ed9f56_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_e51ea989-5241-44dc-a88f-cec795c98ff7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_EmployeeStockPurchasePlanMember_2d2ecdac-e3b8-4a66-b716-da436bc21be6_terseLabel_en-US" xlink:label="lab_coo_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_coo_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_coo_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_coo_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_coo_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EmployeeStockPurchasePlanMember" xlink:href="coo-20231031.xsd#coo_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_EmployeeStockPurchasePlanMember" xlink:to="lab_coo_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_58b08497-8b5d-408e-a211-d8cd291afdf4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Immediate Recognition of Actuarial Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Immediate Recognition of Actuarial Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0ed1fee7-ee79-4be0-a8a6-247ddd8f1b3d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_b564562d-c414-46ec-a619-6c4a615dcebc_verboseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_ec72e2c4-fa8b-482e-aef9-700640ca2b66_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_16a09562-1422-4d3e-9639-1f23821680f3_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0bd8bbcb-5025-4d8f-91d7-b345427386df_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_54cd86d5-be2c-4ca6-a044-101f37932e5e_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_329cefbe-b180-43a6-a546-ddc8f8611dcf_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b920af6b-b07a-459b-8623-c885164583d8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_9fe86235-c2e9-4ed1-9b18-d6add4579170_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_b4a580b2-3118-4db8-a63d-3cbe957cc6bc_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_aed8cc6a-9329-4fd2-abac-58b1fb3f64a2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undiscounted range of the contingent consideration, minimum</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_94240578-b154-4fe9-aa50-67b4f9c74343_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_6628d6fa-d20d-4311-ad9e-715ae93bd750_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_35fb33a6-87c8-4376-ad31-c52afaba0ffa_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_7c17bbc0-5a97-4156-abad-66fe4cabb999_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount recognized in other comprehensive income on interest rate swap contracts, gross</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ebe8a89a-97c8-472a-b848-3e767ddcb0b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9f69a6a2-2a05-4429-bdc3-f335fb5b8f20_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of earnings per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_5c9b0ad3-a9ed-4402-8783-83406e81016f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_3bedc343-c140-4095-be1d-5b265ad75d83_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PayablesFirstInstallmentMember_a0883b27-5025-4248-9bd5-e3e4f5f05e6c_terseLabel_en-US" xlink:label="lab_coo_PayablesFirstInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables First Installment</link:label>
    <link:label id="lab_coo_PayablesFirstInstallmentMember_label_en-US" xlink:label="lab_coo_PayablesFirstInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables First Installment [Member]</link:label>
    <link:label id="lab_coo_PayablesFirstInstallmentMember_documentation_en-US" xlink:label="lab_coo_PayablesFirstInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables First Installment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesFirstInstallmentMember" xlink:href="coo-20231031.xsd#coo_PayablesFirstInstallmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PayablesFirstInstallmentMember" xlink:to="lab_coo_PayablesFirstInstallmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_de44f8a6-e310-43d8-a605-8f81dcec38a8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_11f1a342-0533-49bf-b399-e57ee5ca54c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a66911dd-50af-4e74-a6fc-a1c308c18033_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_11a67fc9-4094-4c50-9067-d71bae1bba0a_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_85eff3a9-9b95-4a55-a596-1db5eee51bdd_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_b9c15039-8205-4634-b5fe-dfb1f51bb335_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (Note 4)</link:label>
    <link:label id="lab_us-gaap_Goodwill_0c9065f1-c05a-42b4-892b-cd0e7021c3e4_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_5798cadf-b622-4f63-9c21-e6d119127ccd_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning</link:label>
    <link:label id="lab_us-gaap_Goodwill_e8458592-e66b-4598-bb95-1209af050eb5_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, ending</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_09a0c1f7-b6b0-4044-b903-1be879c32487_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_6da7e2a4-b1f5-4b06-b453-2c5ea7dde0f4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_aaaf959b-4179-4ffe-b65a-50c36b4679bf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_af521723-488e-4c91-be48-dca46940fb49_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares remaining for future grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_a6ac6622-c32c-4a4f-ac3d-5680dfddfe44_terseLabel_en-US" xlink:label="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in net periodic benefit cost and other comprehensive (income) loss</link:label>
    <link:label id="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b35d4353-815e-4899-9355-b649fb7ad1fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_6a092650-94b9-4d4f-bfbb-f661897306e5_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of business segment net sales</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_e855110b-e714-4fb3-b6f9-f1dacd091017_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5e465030-5a3a-4b0b-b9d6-2b063a461d1a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d1bcd99b-63b1-4cca-9add-83df15dc434f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_ce17587f-e941-4e45-a0a7-bd64a5f9919a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_e15409fd-bea5-4fd8-8354-a1814f7521be_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_fc9d9161-d1b3-48a4-a049-e961863f6359_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared on common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_83759f4f-fb8b-400e-965a-e617d291e63a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f58a6c75-3a77-4ded-b7f4-5b1c9d1b1d6f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_0dcc70ea-542b-42f5-90aa-0174bc1ef24d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_0d0700ee-c0ca-453d-bb72-b7d15c943f0e_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_5f7ae38f-4c8f-4da4-bf56-d043612756e4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_2be99269-8810-4ce6-8829-413efbc3fa10_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_058fd93d-280d-440a-8c01-0c1f81f4b6a5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AuditInformationAbstract_label_en-US" xlink:label="lab_coo_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_coo_AuditInformationAbstract_documentation_en-US" xlink:label="lab_coo_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AuditInformationAbstract" xlink:href="coo-20231031.xsd#coo_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AuditInformationAbstract" xlink:to="lab_coo_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_e352184b-8b68-4e76-90ea-3f7cd43ecd81_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits from share-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_3ebddf01-fad4-44f6-b41a-c5fbb2baf7f6_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments_9e52ec7b-be06-4858-9f1c-3ab556f31a32_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of installments</link:label>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments_label_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred, Number of Installments</link:label>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments_documentation_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred, Number of Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments" xlink:href="coo-20231031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments" xlink:to="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_deceaa65-40fa-47a4-8a0a-0c87ee068632_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_40a98065-af36-4977-8daa-b8583cd06204_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ReportableGeographicalComponentsMember_f1418552-4e35-48ae-b8b0-2699430c09e4_terseLabel_en-US" xlink:label="lab_srt_ReportableGeographicalComponentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable Geographical Components</link:label>
    <link:label id="lab_srt_ReportableGeographicalComponentsMember_label_en-US" xlink:label="lab_srt_ReportableGeographicalComponentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable Geographical Components [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReportableGeographicalComponentsMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ReportableGeographicalComponentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ReportableGeographicalComponentsMember" xlink:to="lab_srt_ReportableGeographicalComponentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_EssilorInternationalSASMember_a78a4e66-6673-4b0b-82ab-932358b5ae69_terseLabel_en-US" xlink:label="lab_coo_EssilorInternationalSASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Essilor International SAS</link:label>
    <link:label id="lab_coo_EssilorInternationalSASMember_label_en-US" xlink:label="lab_coo_EssilorInternationalSASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Essilor International SAS [Member]</link:label>
    <link:label id="lab_coo_EssilorInternationalSASMember_documentation_en-US" xlink:label="lab_coo_EssilorInternationalSASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Essilor International SAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EssilorInternationalSASMember" xlink:href="coo-20231031.xsd#coo_EssilorInternationalSASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_EssilorInternationalSASMember" xlink:to="lab_coo_EssilorInternationalSASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_c852340d-3366-4574-bed2-ae57c83a7947_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_6436c313-eba4-4f15-ab53-4b176f490e43_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8ce9c888-ed24-4c4c-bd02-5e29e7f102c4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum rental payments required under operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AccruedPrepaidPensionCosts_25cd567c-e61f-4e0c-b7bd-dbda1c3632af_periodStartLabel_en-US" xlink:label="lab_coo_AccruedPrepaidPensionCosts" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Prepaid)/Accrued pension cost at prior fiscal year end</link:label>
    <link:label id="lab_coo_AccruedPrepaidPensionCosts_8e642f2b-ca36-4850-b80c-ba2322b1b966_periodEndLabel_en-US" xlink:label="lab_coo_AccruedPrepaidPensionCosts" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Prepaid)/Accrued pension cost at fiscal year end</link:label>
    <link:label id="lab_coo_AccruedPrepaidPensionCosts_label_en-US" xlink:label="lab_coo_AccruedPrepaidPensionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued (Prepaid) Pension Costs</link:label>
    <link:label id="lab_coo_AccruedPrepaidPensionCosts_documentation_en-US" xlink:label="lab_coo_AccruedPrepaidPensionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued (Prepaid) Pension Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccruedPrepaidPensionCosts" xlink:href="coo-20231031.xsd#coo_AccruedPrepaidPensionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AccruedPrepaidPensionCosts" xlink:to="lab_coo_AccruedPrepaidPensionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_1f058f9b-607a-4f05-a109-6869e74d1117_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_4466d700-41e0-41ce-9e0e-2e446a57ee39_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_a76fc55b-97fc-4df2-ba44-31f9bc4c23c8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash held for sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_1c5d7d60-5f8b-42ce-9f77-c9b99d931c2f_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_16f07f61-efb4-4187-a4e0-49159dee8ef7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AccruedPensionCostRollForward_ccf1d6a0-2bb9-49d3-9926-3025789197e2_terseLabel_en-US" xlink:label="lab_coo_AccruedPensionCostRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of (prepaid) accrued pension cost:</link:label>
    <link:label id="lab_coo_AccruedPensionCostRollForward_label_en-US" xlink:label="lab_coo_AccruedPensionCostRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Pension Cost [Roll Forward]</link:label>
    <link:label id="lab_coo_AccruedPensionCostRollForward_documentation_en-US" xlink:label="lab_coo_AccruedPensionCostRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Pension Cost [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccruedPensionCostRollForward" xlink:href="coo-20231031.xsd#coo_AccruedPensionCostRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AccruedPensionCostRollForward" xlink:to="lab_coo_AccruedPensionCostRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_829cbc3b-5345-4fce-9e9f-8cc892ac18d8_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term return on diversified portfolio</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Expected Long Term Return, Percentage</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Expected Long Term Return, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" xlink:to="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_bb73291d-6365-4082-9505-9384ebda9757_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Allocation [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Allocation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_9dbc0482-8143-4a30-858b-f71e26984adf_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d31e5722-d44b-40eb-ba9b-3545fa8476b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options to purchase common stock and restricted stock units not included in diluted earnings per share calculation due to antidilutive effect</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_01802f88-d4db-4da3-a590-939f9668b100_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_816dbabc-ec91-439d-ba35-a5dfeb51f0e0_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bb5c6ed9-6d3f-4f9d-b2cb-a9fb4a1f1087_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember_258072e9-c2c7-4e4b-b592-df1e76031c26_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate common stock</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AssetImpairmentChargesAndOther_c73bb48c-e13b-4a03-bb97-a234dc1f5e73_terseLabel_en-US" xlink:label="lab_coo_AssetImpairmentChargesAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment charges, and other</link:label>
    <link:label id="lab_coo_AssetImpairmentChargesAndOther_label_en-US" xlink:label="lab_coo_AssetImpairmentChargesAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges And Other</link:label>
    <link:label id="lab_coo_AssetImpairmentChargesAndOther_documentation_en-US" xlink:label="lab_coo_AssetImpairmentChargesAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetImpairmentChargesAndOther" xlink:href="coo-20231031.xsd#coo_AssetImpairmentChargesAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AssetImpairmentChargesAndOther" xlink:to="lab_coo_AssetImpairmentChargesAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_bae5acb2-d66d-4e3d-b859-da9d60b19706_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b5f15676-4495-40e2-b12f-a9cdd3657454_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option shares and restricted stock units excluded (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_20f9390a-913e-42e8-8b54-931d21fdfce5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_24bd8f7e-cadc-4406-b686-aa27a17fad7b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_4c906e6d-fcb9-40c7-bf12-93cf9d218aa9_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_cdb29f56-c138-4b78-bc24-ae764177368b_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_e1cd4d3e-852d-4433-b5e7-00d8ef990964_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f6868265-68e7-4a15-b02c-a9c6882cbeba_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation cost related to nonvested units</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6fe12c10-2e50-4646-8b59-f24f8f143deb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_d0f57e67-a741-4777-86e6-974e6136257c_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_17226bf1-1d37-451a-9509-29b544a6e10c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized to be granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_fdf8c2f8-f04a-4673-829d-44782e0ca5cc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_ac7ec974-cb0c-4a11-88a7-ac470590728f_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_OfficeAndSurgicalProductsMember_14ee136d-ea6f-4550-8f43-79969b5fed76_terseLabel_en-US" xlink:label="lab_coo_OfficeAndSurgicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office and surgical</link:label>
    <link:label id="lab_coo_OfficeAndSurgicalProductsMember_label_en-US" xlink:label="lab_coo_OfficeAndSurgicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office And Surgical Products [Member]</link:label>
    <link:label id="lab_coo_OfficeAndSurgicalProductsMember_documentation_en-US" xlink:label="lab_coo_OfficeAndSurgicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office And Surgical Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OfficeAndSurgicalProductsMember" xlink:href="coo-20231031.xsd#coo_OfficeAndSurgicalProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_OfficeAndSurgicalProductsMember" xlink:to="lab_coo_OfficeAndSurgicalProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a1abdae1-da3b-4574-9b62-043097a9cc72_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance, Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_28a4711b-7890-45c2-8d5b-73ec957d37e9_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease ROU assets obtained in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_cc089865-8d65-421b-992b-7981d95b7e99_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_8c28fc02-6592-467a-bd46-9c8fb6c26c05_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_3039c769-657c-466b-a437-9556151006ed_terseLabel_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Discount Rate</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_label_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Discount Rate [Member]</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_documentation_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" xlink:href="coo-20231031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" xlink:to="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TermLoanAgreement2021364DayMember_7a7e0aae-f0cc-4c23-8247-a2f7b8875d17_terseLabel_en-US" xlink:label="lab_coo_TermLoanAgreement2021364DayMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement 2021, 364 Day</link:label>
    <link:label id="lab_coo_TermLoanAgreement2021364DayMember_label_en-US" xlink:label="lab_coo_TermLoanAgreement2021364DayMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement 2021, 364 Day [Member]</link:label>
    <link:label id="lab_coo_TermLoanAgreement2021364DayMember_documentation_en-US" xlink:label="lab_coo_TermLoanAgreement2021364DayMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement 2021, 364 Day</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanAgreement2021364DayMember" xlink:href="coo-20231031.xsd#coo_TermLoanAgreement2021364DayMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TermLoanAgreement2021364DayMember" xlink:to="lab_coo_TermLoanAgreement2021364DayMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fd69b220-053d-4f8f-98ec-d5a8c84142e6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_b72e7397-ac39-46d6-ba3d-d84698fe9ee1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_bd335904-5868-41f6-83aa-3181cc9166b0_negatedNetLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions made during the year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_10406cfb-52a5-4926-92a0-990087312b1a_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8ca17e6d-667e-405a-85bd-f8a3a772699e_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_f60c6740-a380-4d70-9800-f6bbaac117f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_f2dc2636-32aa-41ba-ad68-9a2b63ddb471_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ab4a790d-c15c-4ef5-8d18-ab815cddce0f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_683139c6-a7d8-4466-96fd-e4722fa0bbf7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember_4d4bc54a-5b17-4842-830b-e9ec95c120d6_terseLabel_en-US" xlink:label="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asian Pacific Credit Facilities - Yen-Denominated</link:label>
    <link:label id="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember_label_en-US" xlink:label="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asian Pacific Credit Facilities - Yen-Denominated [Member]</link:label>
    <link:label id="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember_documentation_en-US" xlink:label="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asian Pacific Credit Facilities - Yen-Denominated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AsianPacificCreditFacilitiesYenDenominatedMember" xlink:href="coo-20231031.xsd#coo_AsianPacificCreditFacilitiesYenDenominatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AsianPacificCreditFacilitiesYenDenominatedMember" xlink:to="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_364b3aba-2723-41d7-96cf-c06df8ad53a6_terseLabel_en-US" xlink:label="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and tax credit carryforwards</link:label>
    <link:label id="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_label_en-US" xlink:label="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards</link:label>
    <link:label id="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_documentation_en-US" xlink:label="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:href="coo-20231031.xsd#coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:to="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_9137d1cd-3d13-4043-aa58-2b7e62f19e02_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_cc104f99-d834-4240-a9d7-8bdc08e49b1e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_2dd44dc1-bc43-4a87-a780-5bbaa134507c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_0cacc63a-8658-4bef-9863-20e652b4dc3b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, term of contract (or less)</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember_b1722677-912f-49dc-9b24-a290ac14ffc4_terseLabel_en-US" xlink:label="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Amended And Restated 2007 Long-Term Incentive Plan And 2023 Long-Term Incentive Plan</link:label>
    <link:label id="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember_label_en-US" xlink:label="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Amended And Restated 2007 Long-Term Incentive Plan And 2023 Long-Term Incentive Plan [Member]</link:label>
    <link:label id="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Amended And Restated 2007 Long-Term Incentive Plan And 2023 Long-Term Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember" xlink:href="coo-20231031.xsd#coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember" xlink:to="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistancePolicyTextBlock_df025020-32b6-403c-99dd-9b87071fcef5_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistancePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistancePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistancePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistancePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GovernmentAssistancePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistancePolicyTextBlock" xlink:to="lab_us-gaap_GovernmentAssistancePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_5833fbc8-a657-4044-aeaf-2e506d72438f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease based on tax positions in prior fiscal years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_40c9fbf1-3038-49b8-a094-b163e2f1872d_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_4965a75e-c369-4c0c-9955-c6380e160955_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_f7ad3077-7d7e-4b51-b834-1fc34be8dcce_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_280766cc-1b7c-41b9-9ff1-1d82f67ec952_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_623aa1fa-2e36-46c3-a9ab-9292f7dc9532_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_464a3194-f36c-47f2-aef5-7625652bb62b_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets with definite lives, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_ab0fd885-261a-4b7f-99b6-3f4c0aeb3171_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a4941b62-7c54-456f-9374-814e9434ba50_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Pronouncements Recently Adopted and Accounting Pronouncements Issued Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_ab66c8e4-5132-4507-bcdd-98c3c7321dea_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_fea98442-928f-4c18-a84f-1170ab55be2c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected future employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_219f0abd-6057-4c6b-9bf9-1040d8f744f5_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets</link:label>
    <link:label id="lab_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_label_en-US" xlink:label="lab_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Assets Acquired And Liabilities Assumed, Tangible Assets</link:label>
    <link:label id="lab_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_documentation_en-US" xlink:label="lab_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Assets Acquired And Liabilities Assumed, Tangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:href="coo-20231031.xsd#coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:to="lab_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3dc963c1-b03e-41b1-b2a2-3290104b02ed_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average repurchase price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_a7c092f1-0115-4956-9dc1-9e00111426ac_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_337d4361-03ed-44f8-a340-9f3ba6102ada_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase based on tax positions in current fiscal year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ded72935-e88d-439a-9210-343015467da6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and cash held for sale at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_feaf9cf0-63ba-42d1-9fc6-bde0dc407f20_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cd13fcc0-a590-48c0-9be3-fa6db00e07d4_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents, restricted cash and cash held for sale</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4ad16acc-75f6-4756-b6e1-179289f3c323_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_62c69717-2544-45e4-9a5e-646cc7b669e6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_5928ec70-4cd4-4633-b893-36489a67e8e2_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset allocation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AccruedAcquisitionTerminationFee_959fef17-d4fc-4bd3-871f-b42631f13d16_terseLabel_en-US" xlink:label="lab_coo_AccruedAcquisitionTerminationFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition termination fee</link:label>
    <link:label id="lab_coo_AccruedAcquisitionTerminationFee_label_en-US" xlink:label="lab_coo_AccruedAcquisitionTerminationFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Acquisition Termination Fee</link:label>
    <link:label id="lab_coo_AccruedAcquisitionTerminationFee_documentation_en-US" xlink:label="lab_coo_AccruedAcquisitionTerminationFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Acquisition Termination Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccruedAcquisitionTerminationFee" xlink:href="coo-20231031.xsd#coo_AccruedAcquisitionTerminationFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AccruedAcquisitionTerminationFee" xlink:to="lab_coo_AccruedAcquisitionTerminationFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_2c1437f1-4059-4bc7-b608-f30b71854b19_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_116ebc50-fe85-437f-979c-ed808f491d92_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_ec3f22d9-8f35-43cb-b831-d75257b6566c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_a41ab0d7-bd06-4185-8531-978095a6ea6f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_bf3af43e-a6a8-40eb-be88-09b72233c54e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of non-vested RSUs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_49b4ed0a-09d8-43df-9e79-fa0ce7f4f74a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b8e26d4f-bbbd-4fbe-8513-f2b54f580ea0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_aa41eae1-cbd0-4e5f-85d8-8eb7c669d425_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_97d0a0de-9a0a-49b4-9b63-d62d15362d8e_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f1806e50-a325-4574-919a-cfb3ce6280fe_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_85e1e073-3a06-404e-8826-a71500a98d50_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2ce94470-b3c4-481f-bab7-924959012c74_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions used in estimating fair value of stock options award granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_c3fa99ea-f521-4468-b38f-302287015f6d_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock at cost: 4.4 shares at October&#160;31, 2023 and 4.5 shares at October&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_72cc5080-4a8c-45ff-8519-e9c9b9c2035e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_a048d064-23d1-4d4c-b2c7-0ab06b743d10_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PayablesSecondInstallmentMember_278f3d89-cca3-46b9-a086-afbb684d8aac_terseLabel_en-US" xlink:label="lab_coo_PayablesSecondInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Second Installment</link:label>
    <link:label id="lab_coo_PayablesSecondInstallmentMember_label_en-US" xlink:label="lab_coo_PayablesSecondInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Second Installment [Member]</link:label>
    <link:label id="lab_coo_PayablesSecondInstallmentMember_documentation_en-US" xlink:label="lab_coo_PayablesSecondInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Second Installment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesSecondInstallmentMember" xlink:href="coo-20231031.xsd#coo_PayablesSecondInstallmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PayablesSecondInstallmentMember" xlink:to="lab_coo_PayablesSecondInstallmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_610a9520-62cd-4060-8f34-92bab82e94a4_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f2a3b0fb-ac19-4d4b-9420-8291d13cd9ad_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_5fe1807f-0f2b-467c-ab92-83c547ce603d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_24bd1876-8c13-4072-be2a-a2ed2b7d62ee_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_4dc2dc15-ed41-436a-8aee-a0630688749c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Derivatives and Hedging</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_80f36068-59c4-4517-aa6d-18905b5e67e7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining amortization expenses for intangible assets with definite lives</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_42ba709c-2061-4588-82f7-703d53a3715a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Beginning of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_88ee180d-7e98-4b26-8495-abf1a545cce7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_a708fa64-1c80-42f6-9963-4a722239cc14_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d07f4a26-b136-4024-94eb-145215d712b1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation cost expected to be recognized over a remaining weighted-average vesting period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ee07d310-c2b2-4cc0-aa41-59f8d2456baf_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_fc1c76cb-960c-4a5a-9f0f-01c60bec54ee_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_5063fc4d-cccd-4993-b0eb-43b8d99f10f3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future benefit payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_OtherDebtMember_b651ade9-761c-4104-843b-a7201f4ff79f_terseLabel_en-US" xlink:label="lab_coo_OtherDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_coo_OtherDebtMember_label_en-US" xlink:label="lab_coo_OtherDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt [Member]</link:label>
    <link:label id="lab_coo_OtherDebtMember_documentation_en-US" xlink:label="lab_coo_OtherDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OtherDebtMember" xlink:href="coo-20231031.xsd#coo_OtherDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_OtherDebtMember" xlink:to="lab_coo_OtherDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_dbbae134-cf00-455a-b599-79bb1b58d0a4_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CompositeMember_ffa145ff-e734-4115-9747-5ffaf08988c9_verboseLabel_en-US" xlink:label="lab_coo_CompositeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Composite intangible asset</link:label>
    <link:label id="lab_coo_CompositeMember_label_en-US" xlink:label="lab_coo_CompositeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Composite [Member]</link:label>
    <link:label id="lab_coo_CompositeMember_documentation_en-US" xlink:label="lab_coo_CompositeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Composite [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CompositeMember" xlink:href="coo-20231031.xsd#coo_CompositeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CompositeMember" xlink:to="lab_coo_CompositeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_45af2508-d104-4338-a070-b20a372eb271_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_15479480-b5ef-494b-8ad0-ff2a3a58152a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_59523258-0eb5-4ffe-aa92-6eb65d8e0a8f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal net operating losses expiring</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_aa6db711-1c55-45d7-945c-fef79da8e3da_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock repurchase</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_b2c7d243-807f-4686-9d75-f47ed0a93594_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock repurchase</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_dd480d1e-419b-4c87-aee9-dda1a61d6072_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_9be0f3fe-634d-42dd-8689-f326cd5bdadb_terseLabel_en-US" xlink:label="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</link:label>
    <link:label id="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_label_en-US" xlink:label="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</link:label>
    <link:label id="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_documentation_en-US" xlink:label="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" xlink:href="coo-20231031.xsd#coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" xlink:to="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_57ec167d-6511-4d4e-b23d-472c076d1dd0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_6fd2b210-da9e-42ed-af8f-bb1bbbb61d6e_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CorporateReconcilingItemsAndEliminationsMember_1d2287d8-b2dc-4d2f-b004-56e6637e6e9c_terseLabel_en-US" xlink:label="lab_coo_CorporateReconcilingItemsAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliminations, Corporate and Reconciling Items</link:label>
    <link:label id="lab_coo_CorporateReconcilingItemsAndEliminationsMember_label_en-US" xlink:label="lab_coo_CorporateReconcilingItemsAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Reconciling Items And Eliminations [Member]</link:label>
    <link:label id="lab_coo_CorporateReconcilingItemsAndEliminationsMember_documentation_en-US" xlink:label="lab_coo_CorporateReconcilingItemsAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Reconciling Items And Eliminations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CorporateReconcilingItemsAndEliminationsMember" xlink:href="coo-20231031.xsd#coo_CorporateReconcilingItemsAndEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CorporateReconcilingItemsAndEliminationsMember" xlink:to="lab_coo_CorporateReconcilingItemsAndEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_2c10b902-dabc-4e29-8f61-36a511ee3a76_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Cost</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:to="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_b8701d52-d3ce-48ce-b644-0cbe139451bb_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_6dfcce93-23c9-4e4c-bfed-a585f30b443b_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a869840f-bfcc-47e7-98a9-958aff40d5b2_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_af2ea147-6da4-41db-9ccf-7113220faddd_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e3f111ec-4446-4232-83ad-dd97a38fb10f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment realized gain</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_363e8406-7f5e-49d4-9888-837a6b2b226e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise&#160;Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember_da37d7d0-9779-4317-8807-d8f01a0182ef_terseLabel_en-US" xlink:label="lab_coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-Held U.S.-Based Company, Technologically Advanced Contact Lens Products</link:label>
    <link:label id="lab_coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember_label_en-US" xlink:label="lab_coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-Held U.S.-Based Company, Technologically Advanced Contact Lens Products [Member]</link:label>
    <link:label id="lab_coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember_documentation_en-US" xlink:label="lab_coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-Held U.S.-Based Company, Technologically Advanced Contact Lens Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember" xlink:href="coo-20231031.xsd#coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember" xlink:to="lab_coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_9e1fdce9-d650-4413-a18e-1c3c3c771ea9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_60c06129-459f-458e-b75f-de7e530df20c_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ae5d4b66-4a86-4a5b-b9e7-17d942ac7345_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_b7ff62df-b59b-4e71-a0e8-57cfd684c47b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_32e528f5-ebff-4086-9976-4b1285e531ce_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued gross interest and penalties related to uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_c3f4ceaf-d242-4b88-9459-c30485102557_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_a05aa898-2446-49db-a0f7-0a83abcf0b40_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_42a31198-dae3-4859-a812-67b605f158b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_2aef1c9d-dc5e-4c3a-b40d-f555e95c7d53_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_35b6e345-61cd-4f02-a314-e9e1b4dff282_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_72d16d83-c060-4b33-9690-ea3e6aaa0114_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_788415a2-0e2a-40ae-bc6f-54767ab01184_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_ef66d398-7977-4652-92ef-8adbf67c71e2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_023228b5-3911-40fd-9e74-4dfd1c7657a3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e2cf3c87-07b2-45e7-b9e3-e19ffc67421b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_1299b130-6433-40c5-94d3-5931a53428d6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_0c5e79fd-1df4-4a72-99e8-96c0cde0d688_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit obligation, actuarial gain (loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_e688b285-5b55-4a60-b032-d53c1cec4349_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gain)/loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_9a65ba8a-acbf-443b-9c65-1891463c019c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized contract cost, amortization period (or less)</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:to="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_da425d75-5067-4268-af54-50faca8cf1dd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_7dcf3236-2f68-4ed5-b7de-23b963d107ed_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:to="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_b39886fc-b941-45c0-864e-4849600c9ac0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_ec7008cc-5d47-497a-aba3-2d58c9cc1fa9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities, reserves and compensation accruals</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5ac598b6-b895-4631-8283-02f979738dc2_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets with indefinite lives, net</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_643c855b-273c-4968-97ba-263e2efc85f5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_881dc091-4402-4c4a-abb9-757d1c001db3_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested RSUs, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_45221392-3a64-422c-a3d4-596782002903_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested RSUs, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_cfc9113b-21d1-4c4c-b54a-802c41311ceb_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_1a4cd380-1e7f-4f2e-9c33-5b76a9f93b5f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_acf546c5-d4cb-4ae6-b9ac-a848246b59d2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes at United States statutory tax rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_22d2c0cd-3645-4fd2-94d8-bfd736bd05cc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_18f2e586-5713-496d-a0df-8377adcc950f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_72414b6d-ee38-4c2e-b69c-74decebf7934_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_RestOfTheWorldMember_f677b68b-e497-444d-96ea-4b4eb7a0afb0_terseLabel_en-US" xlink:label="lab_coo_RestOfTheWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_coo_RestOfTheWorldMember_label_en-US" xlink:label="lab_coo_RestOfTheWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of The World [Member]</link:label>
    <link:label id="lab_coo_RestOfTheWorldMember_documentation_en-US" xlink:label="lab_coo_RestOfTheWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of The World [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_RestOfTheWorldMember" xlink:href="coo-20231031.xsd#coo_RestOfTheWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_RestOfTheWorldMember" xlink:to="lab_coo_RestOfTheWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_efa97076-1502-4879-ab48-302fc71b47ca_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_b5b60e96-973a-42da-8b90-13fda2812677_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_e8133a74-4b4f-4700-945f-fd44b2814754_totalLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-Term and Short-Term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_3e65496a-0bd9-4ae6-819f-9338c2f57eed_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories (Note 1)</link:label>
    <link:label id="lab_us-gaap_InventoryNet_58247376-5df7-4544-ac06-95eaa34e2c27_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_c006a8fe-a78f-4ba2-81c5-a875532e5fce_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_label_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLineOfCredit" xlink:to="lab_us-gaap_LongTermLineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_90871762-b0ea-4bbc-8bc8-dc56f74e0ea6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (gain) loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_34329db6-f97c-4dcf-afb3-3522be47ce79_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_732bfa2b-8902-4efa-9be4-087297085bca_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_716d59fe-2e24-4890-96c3-42a39f0ede2f_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_1c6b3acb-9806-42cf-8307-3116616d9c09_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_a1f1bc54-e685-454d-8944-7267ca4837f2_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant change in unrecognized tax benefits that is reasonably possible during the next twelve months</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_EuropeanCreditFacilityMember_d315affd-cd53-4894-8ce8-1003c6a5f46b_terseLabel_en-US" xlink:label="lab_coo_EuropeanCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Credit Facilities</link:label>
    <link:label id="lab_coo_EuropeanCreditFacilityMember_label_en-US" xlink:label="lab_coo_EuropeanCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Credit Facility [Member]</link:label>
    <link:label id="lab_coo_EuropeanCreditFacilityMember_documentation_en-US" xlink:label="lab_coo_EuropeanCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EuropeanCreditFacilityMember" xlink:href="coo-20231031.xsd#coo_EuropeanCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_EuropeanCreditFacilityMember" xlink:to="lab_coo_EuropeanCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_a0d83b39-48e9-4a5e-9d3f-b7e179a344f5_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash flow information:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_297d826f-38a0-4b9f-98cc-6db79e6f691e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_5d23e48c-d6bc-4aa2-b442-e4a1ea8a730c_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PayablesThirdInstallmentMember_0e929172-fae3-4c7d-8f82-70958bdd1981_terseLabel_en-US" xlink:label="lab_coo_PayablesThirdInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Third Installment</link:label>
    <link:label id="lab_coo_PayablesThirdInstallmentMember_label_en-US" xlink:label="lab_coo_PayablesThirdInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Third Installment [Member]</link:label>
    <link:label id="lab_coo_PayablesThirdInstallmentMember_documentation_en-US" xlink:label="lab_coo_PayablesThirdInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Third Installment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesThirdInstallmentMember" xlink:href="coo-20231031.xsd#coo_PayablesThirdInstallmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PayablesThirdInstallmentMember" xlink:to="lab_coo_PayablesThirdInstallmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_137e4317-3753-406c-ae7e-e5fc7624e5f3_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-Known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2d525957-e4cb-4bc1-942a-dabe1c58dbe9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_c4cdb12c-8088-4381-a1ff-6e8693350bcf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in minimum pension liability, tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_095eac08-0db9-42e3-9d30-029e6084340b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_b894bbdf-8e57-4957-9ee4-39c7e8d0a97e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9bfccc3a-81fb-4430-b8bb-622d9ccd0745_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration_c904adf9-04ee-4b84-9255-d47166f6e355_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to settle former equity interest owners</link:label>
    <link:label id="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration_label_en-US" xlink:label="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Payment to Settle Contingent Consideration</link:label>
    <link:label id="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration_documentation_en-US" xlink:label="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Payment to Settle Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationPaymentToSettleContingentConsideration" xlink:href="coo-20231031.xsd#coo_BusinessCombinationPaymentToSettleContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationPaymentToSettleContingentConsideration" xlink:to="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_2725acf3-95e3-48be-87f2-66196f703f3a_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_5b47027f-c878-4435-98e6-a1b711b5dcee_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_75adffbc-ea91-4e8c-bba3-3d6d398719d4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7f1d02ad-0d47-4511-a0da-cf0f2bd77e1f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_86fe767e-cb79-4b81-9ffa-69ef65eb9a92_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_4e759c78-ce8c-4f11-8d9d-21f28359092d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_9fc7085f-ccb5-4cfa-b56e-8aecd3e20956_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5aaf3fa9-7709-47b1-aa03-b90679078e53_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_IncreaseDecreaseInContingentConsiderationLiability_9fa00c17-1a40-422c-b17f-e6b5cdfbdcb8_terseLabel_en-US" xlink:label="lab_coo_IncreaseDecreaseInContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of contingent consideration</link:label>
    <link:label id="lab_coo_IncreaseDecreaseInContingentConsiderationLiability_label_en-US" xlink:label="lab_coo_IncreaseDecreaseInContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contingent Consideration Liability</link:label>
    <link:label id="lab_coo_IncreaseDecreaseInContingentConsiderationLiability_documentation_en-US" xlink:label="lab_coo_IncreaseDecreaseInContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contingent Consideration Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_IncreaseDecreaseInContingentConsiderationLiability" xlink:href="coo-20231031.xsd#coo_IncreaseDecreaseInContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_IncreaseDecreaseInContingentConsiderationLiability" xlink:to="lab_coo_IncreaseDecreaseInContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_50f26ebc-499f-4061-a118-23f3e9ed764c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_MultifocalLensMember_3328e65b-4b07-45bb-8d48-978f1d8bbe5d_terseLabel_en-US" xlink:label="lab_coo_MultifocalLensMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multifocal lens</link:label>
    <link:label id="lab_coo_MultifocalLensMember_label_en-US" xlink:label="lab_coo_MultifocalLensMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multifocal Lens [Member]</link:label>
    <link:label id="lab_coo_MultifocalLensMember_documentation_en-US" xlink:label="lab_coo_MultifocalLensMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multifocal Lens [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_MultifocalLensMember" xlink:href="coo-20231031.xsd#coo_MultifocalLensMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_MultifocalLensMember" xlink:to="lab_coo_MultifocalLensMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_77e3ab9e-4067-4826-9b3d-4ceab586305c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation of Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_8fecd815-8e7b-4511-8006-a37daa3b370e_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_2eb9a02f-7532-4634-b718-0607ec0093bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ed0f1185-62e9-47b6-8e58-755183e7f503_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_17602001-c2f6-4618-bf31-61863cbc41a8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax deductible goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_e7b3c9bb-bc9c-40ba-ac6b-30617c1b6a6f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Derivatives and Hedging</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e213c817-643b-4601-b1ce-1682c8c83fba_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_60ff5276-0028-41ad-942f-e30a6b1791da_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CreditAgreement2020Member_bde5d235-fd2a-4da3-814e-13b82ae6dda5_terseLabel_en-US" xlink:label="lab_coo_CreditAgreement2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2020</link:label>
    <link:label id="lab_coo_CreditAgreement2020Member_label_en-US" xlink:label="lab_coo_CreditAgreement2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2020 [Member]</link:label>
    <link:label id="lab_coo_CreditAgreement2020Member_documentation_en-US" xlink:label="lab_coo_CreditAgreement2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CreditAgreement2020Member" xlink:href="coo-20231031.xsd#coo_CreditAgreement2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CreditAgreement2020Member" xlink:to="lab_coo_CreditAgreement2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_90d4d590-1ef2-4be3-bb1e-7c54648e9c97_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_fa8613ea-379a-4e07-9b76-348501795899_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f7835dd3-a369-4ffd-a6dd-cc941751a7d8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9fa25c86-da07-42a9-a982-eff6ca6666ac_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_2e061077-460c-4103-8730-f0c345efe06f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_99a08784-2c63-4e81-b853-58a4844aa75d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions by employer in 401k savings plan</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_c9aed4c5-f9f1-444c-89a7-e47af6a3a495_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_607125fc-2f98-4deb-bce5-d0cb63413248_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_A2023LongTermIncentivePlanMember_eedf06cc-5173-4c66-b4ff-df4d50a2173f_terseLabel_en-US" xlink:label="lab_coo_A2023LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Long-Term Incentive Plan</link:label>
    <link:label id="lab_coo_A2023LongTermIncentivePlanMember_label_en-US" xlink:label="lab_coo_A2023LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Long-Term Incentive Plan [Member]</link:label>
    <link:label id="lab_coo_A2023LongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_coo_A2023LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Long-Term Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_A2023LongTermIncentivePlanMember" xlink:href="coo-20231031.xsd#coo_A2023LongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_A2023LongTermIncentivePlanMember" xlink:to="lab_coo_A2023LongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_d5a16ff6-d690-4de8-b649-38ec637259a2_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_7511650b-68a4-426f-ad29-ef0c80485cc1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1ca87c52-2ada-49a0-96c4-c0806ead7553_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_221ebae6-0b64-40ce-82aa-796e6c0237fb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_24323c89-279d-428a-afe3-7a5af95ee3b3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8ff2995a-b3db-4bfa-8f5b-2ec35b1630ba_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_640e8be0-a783-4f91-ae10-3265310fa0da_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_c0119743-a22f-45c5-be10-8d6254dba743_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_5d010c91-af18-4867-9252-2bc40fdc5947_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum annual contributions per employee in 401k savings plan</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd_e48ffb45-64af-42f4-8cbb-989f70faa96a_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected rate of return on plan assets at year end</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate Of Return On Plan Assets At Year End</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate Of Return On Plan Assets At Year End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" xlink:to="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_6cdeba7d-ab71-4757-94e2-260de581a087_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_09a2f139-ca48-475f-84d1-449142e614a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss recognized on derivatives within interest expense</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_973847ba-1cbe-4ae4-a1c6-87750e7394a6_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount reclassified from other comprehensive income into earnings, gross</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b2fcbb79-b720-410f-aeea-00c2702aab9d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_a81760d6-8e6f-462a-b74d-86a307738065_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_cf474ab2-aec9-4908-97a3-9b8f5f226683_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizations of net gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0002c8a9-54cf-4d1e-bb31-6f65a6dc2795_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_SecuredOvernightFinancingRateSOFRMember_ef75ba1c-b20a-4b7c-91f6-dbf035b53d82_terseLabel_en-US" xlink:label="lab_coo_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:label id="lab_coo_SecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_coo_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_coo_SecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_coo_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SecuredOvernightFinancingRateSOFRMember" xlink:href="coo-20231031.xsd#coo_SecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_SecuredOvernightFinancingRateSOFRMember" xlink:to="lab_coo_SecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_d6e71f1a-5f69-4d80-bbbd-adeaf15a8116_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_6246737a-8ed9-4339-b008-7fa68d644438_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net changes</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_2464b8a0-5fd0-4578-830f-c825581c9560_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3213a2fe-21b5-4272-8862-6879931b5cd8_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_e6b5cfb6-784c-421f-ba72-f54ab787eddb_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e6c20479-074c-4f6e-981b-438a94e19948_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in other comprehensive (income) loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_99fc29d9-c1b4-4637-a60f-42a5bb1ed5b5_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_f67a12ae-c0c8-4673-afe1-5c0e1f8ff778_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges, tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_90c56675-8388-4e5c-a2b5-bbe72f21814f_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_df7e8f6c-3976-4f26-bbb0-4a57e34e0648_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_9fd9777a-b700-45be-9edd-22da8b4d2777_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a727e648-7f9a-4d8c-9d42-c45d975b3442_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eafc81e1-10e5-4608-afe3-61dd87b10f72_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3de80b0d-d570-4996-a96e-2112707bcdeb_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_32747dbb-5bbc-4fd3-88b1-5ae5e5568c76_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_4d490014-8d12-4939-b1bc-8a443636900a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares remaining available for future issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_6767a54a-825c-4133-999b-d784d61e1526_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_dbb9fdac-8dec-4fbb-aefc-e377cc57a411_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7687b4d8-cfec-421d-8e4c-a5949f684b97_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_64efcae9-98b8-4a6b-b14f-e3f9548c0581_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Pension Liability</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_3b34aba8-e3b4-48c4-b384-27d63b37676a_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_d50e35b3-cb8d-4f04-964a-9f4ad0e84108_terseLabel_en-US" xlink:label="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential additional borrowing capacity</link:label>
    <link:label id="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_label_en-US" xlink:label="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:label id="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_documentation_en-US" xlink:label="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:href="coo-20231031.xsd#coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:to="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TreasuryStockParNetValueMember_f5fdafd6-8a88-4458-ad03-c17ab533efd4_terseLabel_en-US" xlink:label="lab_coo_TreasuryStockParNetValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Par Net Value</link:label>
    <link:label id="lab_coo_TreasuryStockParNetValueMember_label_en-US" xlink:label="lab_coo_TreasuryStockParNetValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Par Net Value [Member]</link:label>
    <link:label id="lab_coo_TreasuryStockParNetValueMember_documentation_en-US" xlink:label="lab_coo_TreasuryStockParNetValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Par Net Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TreasuryStockParNetValueMember" xlink:href="coo-20231031.xsd#coo_TreasuryStockParNetValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TreasuryStockParNetValueMember" xlink:to="lab_coo_TreasuryStockParNetValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_345bb9a6-ff9e-4039-9505-cad813fe49ba_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_91c78d2a-0d0a-4cc2-abb9-51f2c76e7239_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_51593b30-3e21-4c19-b661-9ab83eb408ba_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_91c6d882-d5bd-4ba9-979b-b474adf6fd01_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate for determining net periodic pension cost:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_5432c4d5-c65f-4f87-884f-712d944e695b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share (Note 7)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_49c8ceec-2dba-4c11-b208-f725e067d583_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_c258b6e5-4610-456b-acaa-1b61227617f6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock_67b03411-2a4a-464b-a3ba-8b0ff261bf81_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Joint Venture</link:label>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock_label_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisition [Text Block]</link:label>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock_documentation_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionTextBlock" xlink:href="coo-20231031.xsd#coo_BusinessCombinationAndAssetAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationAndAssetAcquisitionTextBlock" xlink:to="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_78413997-b785-4f8c-8aab-c0b381390bad_terseLabel_en-US" xlink:label="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent</link:label>
    <link:label id="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_label_en-US" xlink:label="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent [Member]</link:label>
    <link:label id="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_documentation_en-US" xlink:label="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" xlink:href="coo-20231031.xsd#coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" xlink:to="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_caa2855f-b9fb-4742-89a6-fb259145ecc7_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $10 cents par value, 120.0 shares authorized, 53.9 issued and 49.5 outstanding at October&#160;31, 2023 and 53.8 issued and 49.3 outstanding at October&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_0a2a8261-c205-49fd-b0f7-1cefb2b2d6c1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross change in value</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_815265c1-2e03-4204-93d3-40df11c094dd_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_46f669c1-937f-4172-b24b-706534e09fda_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_03da9d6a-f1a9-4987-bd9b-de9cd4e3b24c_terseLabel_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_label_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience [Member]</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_documentation_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" xlink:href="coo-20231031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" xlink:to="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_2fdc4e1a-fbd2-4e6b-ad11-ae72d1d59968_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_d8755e6d-5e7d-4615-9708-8e0022cd09b4_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_239014e5-fa45-423a-b6ff-d4871fab7e25_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_de2e34f9-ca38-4efb-afb6-df89a40b7462_terseLabel_en-US" xlink:label="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Amended and Restated 2007 Long-Term Incentive Plan</link:label>
    <link:label id="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_label_en-US" xlink:label="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Amended And Restated 2007 Long-Term Incentive Plan [Member]</link:label>
    <link:label id="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Amended And Restated 2007 Long-Term Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" xlink:href="coo-20231031.xsd#coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" xlink:to="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_6d805088-29a0-47e8-8563-afba034093ea_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6c9410b8-30fb-4c9f-b459-95c091d47e5a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_75928200-9b3f-4764-8200-44d7aa5b58e0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_fc8fa121-4d80-4289-837b-d352bf68f99f_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_c1eb9ebd-2131-4dea-aa77-3afcca2b95f5_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_b07ac8be-2bc8-4123-8b36-c9594e5cc851_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TermLoansMember_c18a8d4b-6b69-481f-bcd4-f0f16df91754_terseLabel_en-US" xlink:label="lab_coo_TermLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loans</link:label>
    <link:label id="lab_coo_TermLoansMember_label_en-US" xlink:label="lab_coo_TermLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loans [Member]</link:label>
    <link:label id="lab_coo_TermLoansMember_documentation_en-US" xlink:label="lab_coo_TermLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoansMember" xlink:href="coo-20231031.xsd#coo_TermLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TermLoansMember" xlink:to="lab_coo_TermLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_e2ad22b1-ef0d-4e98-9ddc-61b5ddb97ae5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment gain realized before acquisition of remaining equity interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CookMedicalMember_0f322c4f-0924-4c89-a96a-70822d39f12d_terseLabel_en-US" xlink:label="lab_coo_CookMedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cook Medical</link:label>
    <link:label id="lab_coo_CookMedicalMember_label_en-US" xlink:label="lab_coo_CookMedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cook Medical [Member]</link:label>
    <link:label id="lab_coo_CookMedicalMember_documentation_en-US" xlink:label="lab_coo_CookMedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cook Medical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CookMedicalMember" xlink:href="coo-20231031.xsd#coo_CookMedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CookMedicalMember" xlink:to="lab_coo_CookMedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_48448389-482c-4ea5-914f-9f6aec6fc3f5_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityFundsMember_1d57f04c-4455-48f3-aba1-f5b47f284c96_terseLabel_en-US" xlink:label="lab_us-gaap_EquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity mutual funds</link:label>
    <link:label id="lab_us-gaap_EquityFundsMember_label_en-US" xlink:label="lab_us-gaap_EquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityFundsMember" xlink:to="lab_us-gaap_EquityFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_a104adff-c16e-494a-aa3f-41f94829634f_terseLabel_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_label_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions [Member]</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_documentation_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" xlink:href="coo-20231031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" xlink:to="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5ae8648a-745f-4667-b405-3228a259462b_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_bf546065-c8e2-44e3-b690-9408305789c6_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_d0493c28-7784-4dfb-97e8-7c888ceb5369_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_641beb3b-c485-467b-9d85-ee22ddb1234d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_8d5ea9dc-3a6b-4ef3-a9e9-b21c4d392faa_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_cc1deac9-f49c-4608-85d9-86e2a63d1405_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_ee48489e-6069-41af-a015-2f36ee493771_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_d3c75245-b7d7-49a4-9a31-45a13b79b144_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program, maximum amount authorized</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d20c53d8-54a0-437f-a26d-fdb512c203ab_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_4583c80c-6d5c-4d0f-83a4-7121d60a1908_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_10d29cee-8ec4-4fd8-99ff-d17e6b4e78a3_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of the period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_55248799-0a11-4dd0-8ce7-c2ca95a2e48b_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of the period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_5b6422cc-9a91-484b-83d7-3abc9c608706_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_216e88b5-ad19-462c-8def-9dfcf62c0808_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_cfa12a94-b2a7-44c9-b5ac-e79712bb1b02_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_ff52d905-14aa-4f4f-889d-621dbd6ec0b0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_8a1f1ab3-586b-4b13-8539-decd476c0954_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_84a6f23a-4eb0-4570-8f41-6346d2e81696_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1c74d738-88e8-4324-8879-698a43f3cd2e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_3db84a76-04d9-4fb3-bffc-1e3ee05751b9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029-2033</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_2a97774c-d5df-4b5f-8936-d0919b44e757_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_eba74985-2686-44d1-b18a-5269d859c270_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_df5e7c08-f5fd-4cba-9ce5-e70bdaca0dd0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_59976d9b-15de-4d50-8875-16f36157bd62_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:to="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_296101a4-b163-4e53-9b3e-af4189d88a16_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b97a8685-4d14-48ff-8104-32a221b058eb_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_4ae4c714-3ac5-4383-9613-f9695050b88b_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions/ Charges</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9c1a6522-83ce-4e3d-8bed-08a93d425f91_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalancedFundsMember_242205e9-e457-4ee0-b175-ca0c89a9d796_terseLabel_en-US" xlink:label="lab_us-gaap_BalancedFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balanced funds</link:label>
    <link:label id="lab_us-gaap_BalancedFundsMember_label_en-US" xlink:label="lab_us-gaap_BalancedFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balanced Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalancedFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalancedFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalancedFundsMember" xlink:to="lab_us-gaap_BalancedFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_16f114cd-0f8c-471f-b339-fc21c04f2340_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Allocation [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Allocation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_30caedc4-86b6-4711-9ecd-33163a37a1d3_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_d8222398-510f-4021-b675-456f1c1a5b9b_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_c2e776e0-da84-4d5f-941a-4d5bc06f4922_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts recognized in accumulated other comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_a933249f-ff22-4d1c-86fc-aadb193421fc_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_85adc742-7b79-4843-887f-45f665e454fb_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loans</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_649fa337-22ff-44eb-aebe-ea106484b0c6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ed475dcc-f5a9-43bf-b7be-6d4b6e67086a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisition [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_e39b3315-bb9e-4a73-9341-c788bd591584_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Cooper stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_b3d447b7-5072-412f-9b37-37e6fcd1f565_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_74755d75-63dc-4477-b1e8-b954b335f9c5_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact the effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_11649b26-80eb-4509-adc9-48ee8a77c533_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_1c1b52ed-4ee3-4763-b69f-5db4c5d71007_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_c8bebac4-f28f-47d0-93e6-e9c1986c6ca6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd3a92ab-3b0c-41b4-a6d9-f913933a9343_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_22fd18bb-f5a8-4b85-985f-1a29753e0e54_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_f5df50f2-1e33-493c-bfc7-ef6f8ac53789_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_cbe9adc2-1eba-41c7-852d-7a1ebeb726a2_verboseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected Benefit Obligation</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:to="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55bea0a7-1ad6-4588-9705-375a0adfd960_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c5f92f07-ea26-4e62-9ee7-30b136de7431_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_f6b16e62-e18e-4ad0-82a9-88dd2388fe3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_8e3782d1-d181-413f-b790-b486f29e3ba5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_e07bdd8c-5a75-4d30-a88c-beecf74767d8_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_65caaae1-c6cb-4556-9858-0d3c9b89c3ff_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_2f46083c-4f58-4bb2-95ee-f1b401fe9809_terseLabel_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in benefit obligation, changes in plan assets and funded status</link:label>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:to="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_1f0d392e-d9cb-4803-8edf-2782621b4f3d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_752f6a1f-0999-4223-8ac4-82024226575f_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2ae921d5-7fef-4fd3-9bfe-683674d37d24_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_60f9d0df-426a-4825-ab8e-53521b8ebcc7_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TermLoanFacility2021BaseRateLoansMember_96742d2e-1e53-4cc9-89c2-881f3241afbc_terseLabel_en-US" xlink:label="lab_coo_TermLoanFacility2021BaseRateLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility, 2021 Base Rate Loans</link:label>
    <link:label id="lab_coo_TermLoanFacility2021BaseRateLoansMember_label_en-US" xlink:label="lab_coo_TermLoanFacility2021BaseRateLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility, 2021 Base Rate Loans [Member]</link:label>
    <link:label id="lab_coo_TermLoanFacility2021BaseRateLoansMember_documentation_en-US" xlink:label="lab_coo_TermLoanFacility2021BaseRateLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility, 2021 Base Rate Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021BaseRateLoansMember" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2021BaseRateLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TermLoanFacility2021BaseRateLoansMember" xlink:to="lab_coo_TermLoanFacility2021BaseRateLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_0a0a4da4-afac-43e8-85af-d96a376fd3a4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_99354423-4da0-4623-8403-f3398e28e6ef_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_fa71c1b6-e454-43a3-8349-ba50397ab656_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other changes in plan assets and benefit obligations recognized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_9b7f474e-739e-4c26-8a39-f90575098397_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_957c269b-f5cc-476c-a8fa-a0f55cfb11fa_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2324a6b4-6490-4dc9-bec0-0fc8d1feb49a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_be6215e9-c770-4ef7-877c-5837af17187f_negatedTerseLabel_en-US" xlink:label="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign deferred tax liabilities</link:label>
    <link:label id="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_label_en-US" xlink:label="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Purchase Accounting Adjustments, Foreign</link:label>
    <link:label id="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_documentation_en-US" xlink:label="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Purchase Accounting Adjustments, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" xlink:href="coo-20231031.xsd#coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" xlink:to="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_b691b1b2-19ef-4b61-9bc0-3b8481338557_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CooperSurgicalSegmentMember_7b5ccd65-5497-41f8-bdb6-0b867e12f07a_terseLabel_en-US" xlink:label="lab_coo_CooperSurgicalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CooperSurgical</link:label>
    <link:label id="lab_coo_CooperSurgicalSegmentMember_label_en-US" xlink:label="lab_coo_CooperSurgicalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CooperSurgical Segment [Member]</link:label>
    <link:label id="lab_coo_CooperSurgicalSegmentMember_documentation_en-US" xlink:label="lab_coo_CooperSurgicalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coopersurgical Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperSurgicalSegmentMember" xlink:href="coo-20231031.xsd#coo_CooperSurgicalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CooperSurgicalSegmentMember" xlink:to="lab_coo_CooperSurgicalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfAssets_67c5fd28-1e7d-4d5f-a044-4d368ad57704_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intra-group transfer to UK subsidiary</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Asset, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationDispositionOfAssets" xlink:to="lab_us-gaap_IncomeTaxReconciliationDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2ebd3e20-f639-4187-a0fe-071959769288_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangibles, net (Note 4)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f3bf2566-fd41-4d46-b6a2-2e537dee6203_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_c17af655-db6a-4598-b9b2-e58d7f9c3285_terseLabel_en-US" xlink:label="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of non-employee directors in committee</link:label>
    <link:label id="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_label_en-US" xlink:label="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Terms Of Award, Grants In Period, Number Of Non Employee Directors In Committee</link:label>
    <link:label id="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_documentation_en-US" xlink:label="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Terms Of Award, Grants In Period, Number Of Non Employee Directors In Committee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" xlink:href="coo-20231031.xsd#coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" xlink:to="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_0f4e4916-8f6f-4b59-b4ed-91bbe780a5ee_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba209e39-f646-4b3d-8c3c-50ac540fe208_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f47c4390-9afe-4849-ae4c-589cf050f647_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_SightGlassVisionIncMember_f5545c46-c4f2-4530-938a-78a37a1959de_terseLabel_en-US" xlink:label="lab_coo_SightGlassVisionIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SightGlass Vision, Inc.</link:label>
    <link:label id="lab_coo_SightGlassVisionIncMember_label_en-US" xlink:label="lab_coo_SightGlassVisionIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SightGlass Vision, Inc. [Member]</link:label>
    <link:label id="lab_coo_SightGlassVisionIncMember_documentation_en-US" xlink:label="lab_coo_SightGlassVisionIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SightGlass Vision, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SightGlassVisionIncMember" xlink:href="coo-20231031.xsd#coo_SightGlassVisionIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_SightGlassVisionIncMember" xlink:to="lab_coo_SightGlassVisionIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_7f76a0f8-a326-400a-9a74-b0b8957e642d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6246960b-1de7-4a38-b563-0643ea393fb9_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average Amortization Period (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8fd6563a-5729-4d33-9fc2-20f03107e315_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3fd911c-af09-45ff-b666-3add8cd9e1d5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0ac13a8f-eef1-436d-97da-049a63a35ac2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8f34279d-205d-4db3-ace8-f84e3450f725_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e007cd6e-997d-48dc-bb52-0f8e9739a5bb_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_3df8d4aa-e877-4769-8233-7065946ee96d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset, intra-entity sale of certain intellectual property rights</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:to="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ac5c4dbb-cbc5-4e39-96e1-4e1b4b5f2e62_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_6d0c9a5f-2f21-4b46-91e0-c67a2d8d3606_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term tax payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_50262db7-1bdf-4513-bb62-b424f251ba48_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in minimum pension liability, net of tax of $1.0, $8.7 and $7.2, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_38a6b958-1214-447e-8557-0b337448fb40_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_b533a44b-a1f1-4082-ac19-5fb34f999e53_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease ROU assets, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, before Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_bb7c1a56-ff4a-4be7-ab72-454c1bceb020_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_efc8c908-6b3d-4e87-b7d6-73e02b1f8e53_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_FertilityMember_18a78e9a-9d58-4415-9ba4-15c88fde7740_terseLabel_en-US" xlink:label="lab_coo_FertilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fertility</link:label>
    <link:label id="lab_coo_FertilityMember_label_en-US" xlink:label="lab_coo_FertilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fertility [Member]</link:label>
    <link:label id="lab_coo_FertilityMember_documentation_en-US" xlink:label="lab_coo_FertilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fertility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_FertilityMember" xlink:href="coo-20231031.xsd#coo_FertilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_FertilityMember" xlink:to="lab_coo_FertilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_8c110821-9eff-4d02-a1cb-90a0e79da111_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_82e1d399-02db-4bc8-9edc-69c8e7455058_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_9c362f26-1a26-45d3-b0eb-f5ce5ce3d92d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lapses of statutes of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_dbc89c80-3f04-4b49-b1a9-ea1695a9c73e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_ea033660-bc6c-467f-af36-fba4a5d1a4ca_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_d29c8fde-2282-418c-938c-b7d1e092d9a1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_0db29e82-3254-43e5-ad0c-94d4537e0f02_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_f36fe6e1-c6d0-4034-a143-fe58b1039ed1_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7cfff5f7-c117-4dca-ba00-c724f3b5f3f1_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity (Note 8)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c30ade43-0f39-4c55-bbda-226817afe0d3_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4ca7aace-ad79-402b-b874-0e0d97489653_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_134f5547-d9a4-438d-880b-99992805e3ad_terseLabel_en-US" xlink:label="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan Facility 2020</link:label>
    <link:label id="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_label_en-US" xlink:label="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan Facility 2020 [Member]</link:label>
    <link:label id="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_documentation_en-US" xlink:label="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan Facility 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" xlink:href="coo-20231031.xsd#coo_RevolvingCreditFacilityAndTermLoanFacility2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" xlink:to="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PayablesFourthInstallmentMember_d143d3e6-d943-417a-817d-7a7805a360bd_terseLabel_en-US" xlink:label="lab_coo_PayablesFourthInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Fourth Installment</link:label>
    <link:label id="lab_coo_PayablesFourthInstallmentMember_label_en-US" xlink:label="lab_coo_PayablesFourthInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Fourth Installment [Member]</link:label>
    <link:label id="lab_coo_PayablesFourthInstallmentMember_documentation_en-US" xlink:label="lab_coo_PayablesFourthInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Fourth Installment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesFourthInstallmentMember" xlink:href="coo-20231031.xsd#coo_PayablesFourthInstallmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PayablesFourthInstallmentMember" xlink:to="lab_coo_PayablesFourthInstallmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_a5234ed3-42dd-41ff-8a30-0cf6453877a5_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c848c058-a28b-4710-a3ea-9429e01ea53d_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_049346b9-bc34-4ce6-aaf4-3f3102135f36_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares used to compute earnings per share:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_34a161f0-8a2e-4441-907a-73f427d280f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices, lower limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_b52d1adb-0c22-4e81-9c90-674bd775f41c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock option plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_578d2aae-7551-411d-8c60-ae7f47b1f3a9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_b44c1899-9258-439e-acaa-cfecb4630639_terseLabel_en-US" xlink:label="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</link:label>
    <link:label id="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_label_en-US" xlink:label="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right-Of-Use Asset And Liability, Net</link:label>
    <link:label id="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_documentation_en-US" xlink:label="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right-Of-Use Asset And Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" xlink:href="coo-20231031.xsd#coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" xlink:to="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_e61c9007-6f6f-494a-aa52-dc85c18f812b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_081445ff-3a3b-44d0-9c55-fffa8cd4c195_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bc55eb04-8c9e-4302-9d33-c100ca908ab5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b5424fe7-8521-470c-a218-4a28e15edd0d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undiscounted range of the contingent consideration, maximum</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_ab6a6762-ce26-4787-9bf4-3f53ced16b9e_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative loss expected to be realized in earnings over the next twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_3d675869-0ed6-4c37-9aa8-36f2be18981e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_4a630b1e-2901-43ad-b61d-023a9dcabc32_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_62077ed8-d4ba-4c55-a230-fdd3d9e5185b_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_85fb5d0f-11a2-4c85-a6c2-b1729a58b917_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on common stock ($0.03 per share)</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_f9e9869e-e7ad-4571-aec5-4551b8c07843_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_OverdraftAndOtherCreditFacilitiesMember_869d6436-202e-4936-9110-9fdeade8f3a5_terseLabel_en-US" xlink:label="lab_coo_OverdraftAndOtherCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overdraft and other credit facilities</link:label>
    <link:label id="lab_coo_OverdraftAndOtherCreditFacilitiesMember_label_en-US" xlink:label="lab_coo_OverdraftAndOtherCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overdraft And Other Credit Facilities [Member]</link:label>
    <link:label id="lab_coo_OverdraftAndOtherCreditFacilitiesMember_documentation_en-US" xlink:label="lab_coo_OverdraftAndOtherCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overdraft And Other Credit Facilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OverdraftAndOtherCreditFacilitiesMember" xlink:href="coo-20231031.xsd#coo_OverdraftAndOtherCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_OverdraftAndOtherCreditFacilitiesMember" xlink:to="lab_coo_OverdraftAndOtherCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_154fb8bf-6544-4071-9e42-17602a803521_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_223c23ad-d260-495c-a830-fe62e3d803a0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_d10d4802-63cc-42d7-a169-bdea53d3d9fa_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c10b90b5-683e-4584-b53b-fdbbc030c03b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to share-based compensation awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_aba83249-c54d-409d-8af2-ec78e8467ad1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_ee3981c0-afc4-47be-ab75-5eebbafafa8d_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule II</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_b31c3749-99ac-446c-b308-d7deb5c7e6bf_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_6d6d7735-1e14-48b3-9613-fb48533e1889_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0e7f294-9d30-4b38-8b12-9ccbd769852a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_a2f4ec64-a87c-4c87-9bb7-31a5c004bbca_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_5ac3671a-b90c-4f84-b150-97005edfed69_negatedLabel_en-US" xlink:label="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of businesses and assets, net of cash acquired</link:label>
    <link:label id="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_label_en-US" xlink:label="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Businesses And Assets, Net Of Cash Acquired</link:label>
    <link:label id="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_documentation_en-US" xlink:label="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Businesses And Assets, Net Of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" xlink:href="coo-20231031.xsd#coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" xlink:to="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_782c11dc-3915-47f1-9c48-6ea184080c43_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_74be43be-be84-47f5-b682-aa9d438b3b9b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_44ecd48c-0a27-4cc5-b4fe-f7981e819be3_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_7931030b-afed-48b5-8805-7592b5221489_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, expected tax deductible amount</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_dab05ac7-6793-4036-877e-0a50c4284763_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeInvestmentsMember_3097a40f-a729-48cd-a464-ad9f8fabae37_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Investments</link:label>
    <link:label id="lab_us-gaap_FixedIncomeInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeInvestmentsMember" xlink:to="lab_us-gaap_FixedIncomeInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_fd5aaa93-fa0a-48d5-ba57-f40cc00e01c0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense and related income tax benefit for share-based awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_22e715b1-83a5-4e91-9535-0269172f8e4c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_aad60183-32a3-4736-9a33-b874c19ed7e2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_82017925-52c8-46df-b6ab-4ce172062bf1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_3d4f0df8-2f81-419a-8b87-931ca94018f4_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_0ab2e0c1-a244-41b0-a599-ff0276ad746f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit charges</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_704d1e2c-2769-4e16-ac38-83917afb6642_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges, net of tax of $(2.4), $26.1 and $8.2, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_2ac831e7-61ad-4ace-8468-7d4cc623c73d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_619373c5-dd1f-42a4-bbab-659142847644_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_21d6f824-3130-49ab-8922-2bcb55e1a743_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation cost related to nonvested options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_57e9e656-bcf5-46b3-9cca-ae79c498ceb3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Term And Short Term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CookMedicalsReproductiveHealthBusinessMember_3660c532-1f4f-4cca-8891-4c4d8bd5e31e_terseLabel_en-US" xlink:label="lab_coo_CookMedicalsReproductiveHealthBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cook Medicals Reproductive Health Business</link:label>
    <link:label id="lab_coo_CookMedicalsReproductiveHealthBusinessMember_label_en-US" xlink:label="lab_coo_CookMedicalsReproductiveHealthBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cook Medicals Reproductive Health Business [Member]</link:label>
    <link:label id="lab_coo_CookMedicalsReproductiveHealthBusinessMember_documentation_en-US" xlink:label="lab_coo_CookMedicalsReproductiveHealthBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cook Medicals Reproductive Health Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CookMedicalsReproductiveHealthBusinessMember" xlink:href="coo-20231031.xsd#coo_CookMedicalsReproductiveHealthBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CookMedicalsReproductiveHealthBusinessMember" xlink:to="lab_coo_CookMedicalsReproductiveHealthBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_37544c47-e909-49f7-81ba-baaf5609914a_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_2736a02d-1d84-42f5-8723-2a4cadd6e3bb_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actuarial Gain (Loss), Immediate Recognition as Component in Net Periodic Benefit (Cost) Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_53355069-3bed-4da8-961d-7b106e9dab4d_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_92b25a5c-5384-47a0-9746-4041551e0a17_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_baba3704-e264-45c8-bd27-80a6d918c420_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_27224a64-c502-4c37-a8e1-819c4962a6ee_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9169d274-0900-48f9-9d1f-7610be089346_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_c39d54b5-c99a-4893-ba20-a13027acd583_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate for determining benefit obligations at year end</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_038e7fb8-7f6f-4ae7-bd76-e11c87f7fad4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a3f8c527-5cf2-44a4-8cbb-8c70eb56e3cb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_db4789c9-d1d7-4844-8c36-b3152755dc5d_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of business segment information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_6807ead5-5d7b-4e9f-a115-c2794956a2ce_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_cf714b9a-97f8-4299-9531-a829c41d43e6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at end of period, Weighted-Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_947efe88-1330-49fe-94ad-ee7f148f7624_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_fa4b50fa-582c-41d5-a096-d4873cb3c284_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_24af1131-0a1c-4742-8865-3f89ba741c43_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal net operating losses not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_319a879a-14b4-4408-a8c8-1d4e017d4e1c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_5134e200-ee16-40a6-b8ee-e871c6f97dbd_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_d00e50ea-e5ed-44a9-9310-d8d92a7546ba_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_ab6d88c2-12f4-46ae-87b9-01dd242f7a9a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_db2a0d7a-97be-4f1e-b0e9-bf181ad28851_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_f845be97-065f-422d-b59b-57a1da317d07_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_93534b19-c193-457a-ba41-9dabcb1cd4bc_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program, remaining authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_cd450c67-e686-453f-be0e-ab02d7bed7f4_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_0282b145-50cf-4114-b63e-9c75a1ebf638_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_60c488ab-ff6d-4c42-a1c8-e044f2310d3a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock_f8b49157-c865-4eba-aee5-4e749f072cc4_terseLabel_en-US" xlink:label="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases on the Consolidated Condensed Balance Sheet</link:label>
    <link:label id="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="coo-20231031.xsd#coo_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_2f98a692-dd00-4db4-a4f4-bf86448bd27a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_7b836bfa-cfbb-4c58-b2fe-abde1bf4a18d_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_547425fc-9b77-4e56-83a5-d6f02e525818_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments recognized in condensed consolidated statements of income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_7a37f817-7de2-41ce-8cd1-bf123d8ab912_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_74ff7cbd-4b34-4147-bcee-06612267ffb8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember_81e2ae09-683f-46ed-990d-0139a41af626_terseLabel_en-US" xlink:label="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares</link:label>
    <link:label id="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember_label_en-US" xlink:label="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Excluding Treasury Stock Par Net Value [Member]</link:label>
    <link:label id="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember_documentation_en-US" xlink:label="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Excluding Treasury Stock Par Net Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CommonStockExcludingTreasuryStockParNetValueMember" xlink:href="coo-20231031.xsd#coo_CommonStockExcludingTreasuryStockParNetValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CommonStockExcludingTreasuryStockParNetValueMember" xlink:to="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1d589e47-f50a-4e27-bc06-956d7a7c104d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_48e4fb90-dc91-4a61-963b-b9c14ecf4d5c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TermLoanFacility2021Member_c7c8a5db-884f-42eb-b07e-e9a0614ce20d_terseLabel_en-US" xlink:label="lab_coo_TermLoanFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2021</link:label>
    <link:label id="lab_coo_TermLoanFacility2021Member_label_en-US" xlink:label="lab_coo_TermLoanFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2021 [Member]</link:label>
    <link:label id="lab_coo_TermLoanFacility2021Member_documentation_en-US" xlink:label="lab_coo_TermLoanFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021Member" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TermLoanFacility2021Member" xlink:to="lab_coo_TermLoanFacility2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_462da859-1012-4f4c-b4c6-728f2b66a020_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of interest in a subsidiary</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Interest in Consolidated Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_69e29fec-b4d4-4ae9-967d-0e3b6916503a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock split, conversion ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_56ed5ce3-1284-4329-9ee0-1c127b99124d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of vested grants</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_82032bb0-4c8a-4f1d-bb29-c83dd1283a7c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_76289ae1-438c-4022-9b82-87bcd9091242_terseLabel_en-US" xlink:label="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Term and Short Term Debt Instruments [Table]</link:label>
    <link:label id="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_label_en-US" xlink:label="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Term And Short Term Debt Instruments [Table]</link:label>
    <link:label id="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_documentation_en-US" xlink:label="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Term And Short Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" xlink:href="coo-20231031.xsd#coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" xlink:to="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2be93c11-abb6-496c-bd07-5689af6a82ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_fdb42efd-7e15-442f-a260-a518f665a026_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_df83faac-c3e6-4adf-a8e6-6294a98af098_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_621e6392-2aca-4703-ac9e-e59636fe8ae6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a8d53470-d825-4750-9e53-57368bea803f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_25bb5d09-ad07-4c47-a274-c94bf823b772_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables incurred in acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BondMutualFundsMember_0d1460f4-60a0-4576-a8df-4b911093cd96_terseLabel_en-US" xlink:label="lab_coo_BondMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond mutual funds</link:label>
    <link:label id="lab_coo_BondMutualFundsMember_label_en-US" xlink:label="lab_coo_BondMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond Mutual Funds [Member]</link:label>
    <link:label id="lab_coo_BondMutualFundsMember_documentation_en-US" xlink:label="lab_coo_BondMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond Mutual Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BondMutualFundsMember" xlink:href="coo-20231031.xsd#coo_BondMutualFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BondMutualFundsMember" xlink:to="lab_coo_BondMutualFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ffeec934-dfac-4c93-a301-e9a39c9a5524_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_a469ee0d-f75c-4426-b2ff-79164c2e08c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_e852585e-7a35-4dc0-b42d-2408cc1b08a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_89c62e74-cc47-45ca-aad4-69ad91897067_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt (Note 5)</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_2b066aca-a81d-4902-9ebe-06c8a9cf83f4_totalLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_15679bdc-9718-4a5a-aa9c-1ce0d0652842_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expense and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_23d726e3-7475-4dc4-8279-3d3d317b16c5_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_5873c1e2-0274-4b87-ba52-e6e77361b059_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4bb847cb-9769-4d10-a65e-3f047de77de4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TermLoanFacility2021AdjustedLIBORRateLoansMember_3b71d172-ec41-43fd-a273-ffa920015c20_terseLabel_en-US" xlink:label="lab_coo_TermLoanFacility2021AdjustedLIBORRateLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2021, Adjusted LIBOR Rate Loans</link:label>
    <link:label id="lab_coo_TermLoanFacility2021AdjustedLIBORRateLoansMember_label_en-US" xlink:label="lab_coo_TermLoanFacility2021AdjustedLIBORRateLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2021, Adjusted LIBOR Rate Loans [Member]</link:label>
    <link:label id="lab_coo_TermLoanFacility2021AdjustedLIBORRateLoansMember_documentation_en-US" xlink:label="lab_coo_TermLoanFacility2021AdjustedLIBORRateLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2021, Adjusted LIBOR Rate Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021AdjustedLIBORRateLoansMember" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2021AdjustedLIBORRateLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TermLoanFacility2021AdjustedLIBORRateLoansMember" xlink:to="lab_coo_TermLoanFacility2021AdjustedLIBORRateLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3601aaee-4203-4786-8ae6-b97e7d4b2a1a_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8b91b8ce-3d93-4d01-94ca-095389514373_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8c02f666-8ffe-4568-9369-0599631f8c02_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ed9120eb-6d79-47e5-8067-d459a4eda7a4_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a255738a-cb89-458d-aca7-ed61b000ee73_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_7654de72-62f1-45f7-a269-2564740a2317_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_2ed62808-e2d7-4842-9c84-19eea7431c3c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ae4b8058-0f01-40ff-8af7-839b9979f09c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_daadb7e0-1687-4d57-9134-4aa2c67e0cb6_terseLabel_en-US" xlink:label="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="coo-20231031.xsd#coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_f7666e43-f33f-4e23-8fe8-82528bf30de0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices, higher limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_14397708-af0a-404e-9476-f5542980adde_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7935c162-804c-4bff-b0aa-caf2fb1d582b_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a3cf3439-75cc-4b38-974c-fb88d37f541d_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_e94c0b6c-d00b-4b06-ab23-b0c88426ab59_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_d5e447d6-ca0d-4848-b041-76bcf65a6d29_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_544229ca-4fb8-4e82-9717-53c37b15d80b_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other changes in plan assets and benefit obligations recognized in other comprehensive income:</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amount Recognized In Net Periodic Benefit Cost (Credit) And Other Comprehensive (Income) Loss, Before Tax1 [Abstract]</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" xlink:to="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock_642473eb-983e-45c3-8bf9-e7e0abae7e84_terseLabel_en-US" xlink:label="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of prepaid (accrued) pension cost</link:label>
    <link:label id="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock_label_en-US" xlink:label="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reconciliation Of Prepaid (Accrued) Pension Cost [Table Text Block]</link:label>
    <link:label id="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock_documentation_en-US" xlink:label="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reconciliation Of Prepaid (Accrued) Pension Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" xlink:href="coo-20231031.xsd#coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" xlink:to="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_def0eacb-b311-422f-b4c9-d526fdb7089a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from (repayments of) short-term debt, other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_adc96aad-081d-49f7-955c-461a97e4f7c9_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_9be00f6c-acd0-4f37-b42b-751ed8fa752d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c8e0eec8-1651-4c24-ab93-bf68465cb867_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ccd882c8-21bd-4bd2-b8ce-860cc27e9f3f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_8be0f891-d9b0-47e4-aa5f-92a5243445da_terseLabel_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cloud Computing Arrangements</link:label>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_label_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalUseSoftwarePolicy" xlink:to="lab_us-gaap_InternalUseSoftwarePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_0d316144-21c3-44bd-8845-358bc78e59fc_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_a900bfb1-ded3-4cc8-8519-7a047ad4cd6a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_b70567a7-063e-492d-990a-315081e9728b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3c8598ba-538c-4fac-a5f6-b2b33d3be903_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_18e6aebb-a4bf-4e8a-a85d-4a93fd0d7437_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_24906a33-3c20-4e22-a145-208e1e27988e_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_5eca85b7-d4f4-4fb1-b9bb-9eef4d14c3bf_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_c8d6d7b8-1bc8-4941-b06c-ffcacfa6a220_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_849765d9-0653-4467-8860-b236d344968f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes (Note 6)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_8d8c45e9-14e4-47ab-b442-1233ea782c0f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_af8c3d8d-ce12-4b0d-987d-57e2938024df_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_SingleUseSphereLensMember_066ad432-4da1-45f6-a7c8-b31d0a6f0373_terseLabel_en-US" xlink:label="lab_coo_SingleUseSphereLensMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Single-use sphere lens</link:label>
    <link:label id="lab_coo_SingleUseSphereLensMember_label_en-US" xlink:label="lab_coo_SingleUseSphereLensMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Single Use Sphere Lens [Member]</link:label>
    <link:label id="lab_coo_SingleUseSphereLensMember_documentation_en-US" xlink:label="lab_coo_SingleUseSphereLensMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Single Use Sphere Lens [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SingleUseSphereLensMember" xlink:href="coo-20231031.xsd#coo_SingleUseSphereLensMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_SingleUseSphereLensMember" xlink:to="lab_coo_SingleUseSphereLensMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_fedbecaf-9545-4b19-96e7-80faed2a06c8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_bcd9963e-09bf-4561-a52a-7722eccd1bdd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_42cd33bf-2b72-49ca-901b-4a52071ce10e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_2b72dca5-c4d4-4e67-ac99-0c980315fb4e_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_5c995304-d670-4d96-b6a9-c9cc54cfe4e9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for stock plans, net and employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a1e6ac38-1529-4c70-b37f-4df179278b9a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_5cdf0986-c2d8-43fc-8777-e87adb5940f9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign earnings in jurisdictions with different tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ec1921d-16e2-4b0d-9c68-5c983e9193ea_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_85efadd9-4f6a-44d0-a2c5-5948dc30cdc2_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_87a2745c-6f37-49f8-b9b6-2313ff455ce3_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a9afc3ba-68ed-49aa-9960-268a9357713c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_fef03c9a-81c6-4926-839c-da379ef1adf4_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_40167d4c-9c00-4f28-9b39-f4163418b115_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_97d380cd-cd5b-42ce-a979-9b8a5a01469b_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bf47a5ce-7d5e-4be1-8307-66b2463df44b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_f788a1f8-6ed9-4507-b5e9-ef3b4a1938d6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1081a2ad-d5df-40a6-9700-57480991901c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_386219d5-7fc3-4736-8fb6-515f67dabf59_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued to employees</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_4b231817-f92b-4b8d-8d3e-87146c0bbdc5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected rate of return on plan assets for determining net periodic pension cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_3cbe0c2f-3334-49c2-b88c-9597408d7fd9_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Liabilities Incurred By Type [Domain]</link:label>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_label_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Liabilities Incurred By Type [Domain]</link:label>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_documentation_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Liabilities Incurred By Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" xlink:href="coo-20231031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" xlink:to="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_be8799f6-ab7f-4bab-8677-4250d4c37008_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_5bd1c178-73e6-48fa-87f7-4cba9a1b658f_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock repurchase (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_9e1da959-1d96-4f77-bdae-dde10fd7936e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_e4f4474e-1a2e-4dd3-826c-1a3ae42a979c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_fb46182c-794f-4418-8672-800b96655065_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_2947ef91-45dc-4423-959d-2a1534755d3d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_2d972c4e-da9f-428b-b39e-ff818d3fe3f1_terseLabel_en-US" xlink:label="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target percentage of shares earned</link:label>
    <link:label id="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_label_en-US" xlink:label="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Target Percentage Of Shares Earned</link:label>
    <link:label id="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_documentation_en-US" xlink:label="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Target Percentage Of Shares Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" xlink:href="coo-20231031.xsd#coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" xlink:to="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_981fe63b-ed5c-4021-8532-4a9fb9869392_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, excluding financing leases</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_58fa4d5e-ec07-4c34-a5d0-33e1fff554ef_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_3c16cc7e-5a93-49d1-b2c2-3933f6bade08_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_458ca172-8bab-47fe-a3c3-4f6cee8c4252_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1a0a49d9-ce37-457e-b5a6-62e93cb64d30_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_a66a2c9c-934e-4dee-a60f-58cf094e057c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b3f0498b-2306-4b29-9565-2dce268438eb_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_05f83ff7-0ee7-4a47-9931-1c748c8d7fb2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount recognized in other comprehensive income on interest rate swaps contracts, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_586535f3-1420-4e71-83f8-42121525f1b0_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_2fafec0f-dd4a-4e9b-8f62-ce73c1770e28_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_d0ae1e44-0913-43c6-8775-30e7f31d834d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TermLoanFacility2020Member_30e83ffd-bec8-49e1-ac49-d146516f4623_terseLabel_en-US" xlink:label="lab_coo_TermLoanFacility2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2020</link:label>
    <link:label id="lab_coo_TermLoanFacility2020Member_label_en-US" xlink:label="lab_coo_TermLoanFacility2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2020 [Member]</link:label>
    <link:label id="lab_coo_TermLoanFacility2020Member_documentation_en-US" xlink:label="lab_coo_TermLoanFacility2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2020Member" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TermLoanFacility2020Member" xlink:to="lab_coo_TermLoanFacility2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_64f9631e-bbe4-4ce0-aa31-59226e220ce2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_e2de840e-f861-46e2-8fb9-ee4e9c0f5ed9_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_7f7eeea9-225f-46c3-87ea-73cf7a41910c_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_859ee6b4-1a0f-43bd-aa6e-5ade61d26087_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d9ebaceb-3841-41f8-adf1-b8d7849eb496_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_61a143a0-2e5c-46a9-ac88-6809f45e0cc1_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_995ea554-422c-42f4-ab40-82c14be10d9e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_011f2de4-e2b5-4b67-9c76-fa0db9cfda41_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Cost</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:to="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d488d37d-e7ba-44bc-a855-d0a0275ae150_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and issued (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_aec1ebf4-3797-4a84-91e1-f9780c4775d5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_45e0064b-fb78-4097-b4dc-751b865ec124_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_e014e5b6-b6f3-4f19-9459-e9d1915ca667_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_9c547ad5-83aa-4905-8150-e64071c84935_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_26fccc3c-9aec-44e4-b007-aafe9e4e3bae_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3b7e1b9d-47d2-425c-8cd9-a9cafef46d4f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_NonSingleUseSphereAndOtherMember_024b1c3e-21fd-471b-a631-8b84d224ec40_terseLabel_en-US" xlink:label="lab_coo_NonSingleUseSphereAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non single-use sphere, other</link:label>
    <link:label id="lab_coo_NonSingleUseSphereAndOtherMember_label_en-US" xlink:label="lab_coo_NonSingleUseSphereAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Single-Use Sphere And Other [Member]</link:label>
    <link:label id="lab_coo_NonSingleUseSphereAndOtherMember_documentation_en-US" xlink:label="lab_coo_NonSingleUseSphereAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Single-Use Sphere And Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NonSingleUseSphereAndOtherMember" xlink:href="coo-20231031.xsd#coo_NonSingleUseSphereAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_NonSingleUseSphereAndOtherMember" xlink:to="lab_coo_NonSingleUseSphereAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CooperVisionSegmentMember_750e89af-b7fd-4c29-8ddd-0cdf323c1bb6_terseLabel_en-US" xlink:label="lab_coo_CooperVisionSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CooperVision</link:label>
    <link:label id="lab_coo_CooperVisionSegmentMember_label_en-US" xlink:label="lab_coo_CooperVisionSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CooperVision Segment [Member]</link:label>
    <link:label id="lab_coo_CooperVisionSegmentMember_documentation_en-US" xlink:label="lab_coo_CooperVisionSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coopervision Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperVisionSegmentMember" xlink:href="coo-20231031.xsd#coo_CooperVisionSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CooperVisionSegmentMember" xlink:to="lab_coo_CooperVisionSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_746a165c-abaa-4538-ad89-02dae6fb9c80_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_4132cbfb-4a9d-4611-90d8-dc8a944f3d1b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified portfolio, allocation of assets in equities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_9df8e463-c503-409c-863d-5a7e9b2d1681_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_ed261857-8dd4-44c7-a301-914bc972d787_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_LicenseAndDistributionRightsAndOtherMember_40c42bf3-25a6-4b80-aa34-b3670ebc8edf_terseLabel_en-US" xlink:label="lab_coo_LicenseAndDistributionRightsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and distribution rights and other</link:label>
    <link:label id="lab_coo_LicenseAndDistributionRightsAndOtherMember_label_en-US" xlink:label="lab_coo_LicenseAndDistributionRightsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License And Distribution Rights And Other [Member]</link:label>
    <link:label id="lab_coo_LicenseAndDistributionRightsAndOtherMember_documentation_en-US" xlink:label="lab_coo_LicenseAndDistributionRightsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Distribution Rights and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LicenseAndDistributionRightsAndOtherMember" xlink:href="coo-20231031.xsd#coo_LicenseAndDistributionRightsAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_LicenseAndDistributionRightsAndOtherMember" xlink:to="lab_coo_LicenseAndDistributionRightsAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_411cc01c-8600-4f31-a7c1-bb6c2f98427e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price percentage of fair market value on date of grant of awards</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_0f7ec45e-be1b-42de-a0d9-e4f663633ec2_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_4456564f-5586-4560-81f7-9dfa1f5becee_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_a9660bdf-9ca6-4a51-9140-8a1aab05d28f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized research and experimental expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ToricLensMember_e0889303-5674-4a1c-ab18-9ddafb8950ca_terseLabel_en-US" xlink:label="lab_coo_ToricLensMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Toric lens</link:label>
    <link:label id="lab_coo_ToricLensMember_label_en-US" xlink:label="lab_coo_ToricLensMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Toric Lens [Member]</link:label>
    <link:label id="lab_coo_ToricLensMember_documentation_en-US" xlink:label="lab_coo_ToricLensMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Toric Lens [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ToricLensMember" xlink:href="coo-20231031.xsd#coo_ToricLensMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ToricLensMember" xlink:to="lab_coo_ToricLensMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_282698da-96f3-48a4-858f-55c66c267c41_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Unclassified [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAbstract" xlink:to="lab_us-gaap_LongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_20f49414-1fa8-4653-983d-36c5f435687f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18823314-9050-42e6-8934-7dd7abf2eff9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dbc5eb35-17b5-4e22-8ade-d3f47795264c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_dfe5e707-2bd7-4fc7-83fc-ecea21ff250a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_76f9b246-4385-4b52-bc73-8fc52359d773_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_b6150b91-fbf9-4782-9cfe-d92c5381145f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c6e0d919-cd29-4133-bfa7-a28e82162b06_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a473a57e-ccdd-4841-9719-7dced9fdc80d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_b6a9e9c6-f16e-4dfc-a925-65bf8e91c0ab_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_40d62be3-a472-487e-a47b-86ec3bc55d71_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase for determining expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_dd74312a-62aa-45de-a5d6-f4ecb7102bfd_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_NumberOfBusinessUnits_4e014499-3006-4c2d-825a-5c8ad7d2704d_terseLabel_en-US" xlink:label="lab_coo_NumberOfBusinessUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business units</link:label>
    <link:label id="lab_coo_NumberOfBusinessUnits_label_en-US" xlink:label="lab_coo_NumberOfBusinessUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Business Units</link:label>
    <link:label id="lab_coo_NumberOfBusinessUnits_documentation_en-US" xlink:label="lab_coo_NumberOfBusinessUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Business Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NumberOfBusinessUnits" xlink:href="coo-20231031.xsd#coo_NumberOfBusinessUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_NumberOfBusinessUnits" xlink:to="lab_coo_NumberOfBusinessUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_8d0180cb-0ee2-4d75-9baf-9fc3cb1166c8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts recognized in accumulated other comprehensive income consist of:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_337371cd-e8a8-42af-ba1e-13de3350805f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds related to share-based compensation awards</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_8af01d55-a333-45c2-a22b-556d9093e791_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_f8826835-cfde-4f80-a132-0802ea179166_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f8c30f81-12ad-4c6f-aa4c-1964b66a2cd5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5c81535c-7ea6-41b5-a9d2-641a6188eef6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_cbd4b474-eac6-4008-bf7f-f20090479861_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_5126f9c0-0789-46f4-adb6-01db565a3a14_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_a64f0a31-2819-441f-9365-a19427dd96ff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_9b888375-ab7c-4ab1-a1e7-5301f10de515_terseLabel_en-US" xlink:label="lab_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Term And Short Term Debt Instruments [Line Items]</link:label>
    <link:label id="lab_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_label_en-US" xlink:label="lab_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Term And Short Term Debt Instruments [Line Items]</link:label>
    <link:label id="lab_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_documentation_en-US" xlink:label="lab_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Term And Short Term Debt Instruments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems" xlink:href="coo-20231031.xsd#coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems" xlink:to="lab_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_f8f7764c-15ac-453c-8fbb-9cd3332a4205_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_9b1f9f6d-2a4a-48de-9676-c3567fd113fb_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_91287325-7bab-4bfd-bc9b-7be544aa34c3_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_906c9ee8-a984-4b9c-a868-4a761dbaec14_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from line of credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-Term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_ff71c102-0586-4a2e-925d-393366ca622a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_03398ed5-b33e-42f1-ab5f-aeee7f4845e0_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Liabilities Incurred By Type [Axis]</link:label>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_label_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Liabilities Incurred By Type [Axis]</link:label>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_documentation_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Liabilities Incurred By Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" xlink:href="coo-20231031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" xlink:to="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9869a859-5f4e-49fb-9cfe-3d6e345fcc20_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_956a1b9a-5ea0-4f3d-8bd8-a3982345df6c_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>coo-20231031_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:0c65df22-c15f-4b61-bd32-d5e051159c75,g:61acad92-dfa7-4255-a259-2e1b3c8d59bb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.coopercos.com/role/CoverPage" xlink:type="simple" xlink:href="coo-20231031.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_767faf3c-9b06-49a1-8099-7400309fb575" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_DocumentType_767faf3c-9b06-49a1-8099-7400309fb575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_dd01d7d6-7bc9-400e-9c59-90efca5ae290" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_DocumentAnnualReport_dd01d7d6-7bc9-400e-9c59-90efca5ae290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_caa0f714-c943-4ed3-8acd-b282fb55684a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_DocumentPeriodEndDate_caa0f714-c943-4ed3-8acd-b282fb55684a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4ea30fa2-7580-4dec-945a-7d3aae6a72ed" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_CurrentFiscalYearEndDate_4ea30fa2-7580-4dec-945a-7d3aae6a72ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_e54c240f-cd8f-4658-b3f0-5d3796af2b27" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_DocumentTransitionReport_e54c240f-cd8f-4658-b3f0-5d3796af2b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_83d1c3ba-8a7d-4581-8a23-d4e850541e39" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityFileNumber_83d1c3ba-8a7d-4581-8a23-d4e850541e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_412d5367-5755-4b17-b891-36a1a0132d4e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityRegistrantName_412d5367-5755-4b17-b891-36a1a0132d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c1f49403-9ddc-4a05-ba22-28c51b17ab68" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c1f49403-9ddc-4a05-ba22-28c51b17ab68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_06afbc45-d12a-4e5b-90f1-4945b985e2e2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityTaxIdentificationNumber_06afbc45-d12a-4e5b-90f1-4945b985e2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_49e5b6b0-1b2c-4745-981a-9656dcf1ef9b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityAddressAddressLine1_49e5b6b0-1b2c-4745-981a-9656dcf1ef9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_b326940d-34d9-4511-8284-db84eadaa725" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityAddressAddressLine2_b326940d-34d9-4511-8284-db84eadaa725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_861fed69-248c-4db1-bc16-b0aa0ae9ca53" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityAddressCityOrTown_861fed69-248c-4db1-bc16-b0aa0ae9ca53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_369a3bab-391d-4ebe-ba57-b1b7156ddadc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityAddressStateOrProvince_369a3bab-391d-4ebe-ba57-b1b7156ddadc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8a8983cc-945d-4485-95ea-648891a00de6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityAddressPostalZipCode_8a8983cc-945d-4485-95ea-648891a00de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fa500117-87ac-4bf8-978d-4054a8d9011c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_CityAreaCode_fa500117-87ac-4bf8-978d-4054a8d9011c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_7c55a1d8-b19c-4b49-978c-e4c67692c4a1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_LocalPhoneNumber_7c55a1d8-b19c-4b49-978c-e4c67692c4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_983603f3-fe5a-4f7b-b35b-1518308ac358" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_Security12bTitle_983603f3-fe5a-4f7b-b35b-1518308ac358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_48a165e8-625e-49f0-b6dc-273f282100b4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_TradingSymbol_48a165e8-625e-49f0-b6dc-273f282100b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_81d08655-263a-4679-817a-46bd15b158a2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_SecurityExchangeName_81d08655-263a-4679-817a-46bd15b158a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_ebc5b914-5d0d-4f8d-a819-02af63edc06e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_ebc5b914-5d0d-4f8d-a819-02af63edc06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_86c20220-fac2-432e-a846-9a01181f14ea" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityVoluntaryFilers_86c20220-fac2-432e-a846-9a01181f14ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7b1673a8-fb62-49ea-b1ca-7a09c33d3525" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityCurrentReportingStatus_7b1673a8-fb62-49ea-b1ca-7a09c33d3525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_93998c53-e738-450f-9ef9-c2e7ecf6380b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityInteractiveDataCurrent_93998c53-e738-450f-9ef9-c2e7ecf6380b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_140ff63e-722b-465a-9878-09ce2f7a88e4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityFilerCategory_140ff63e-722b-465a-9878-09ce2f7a88e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6a3b2ed7-8964-4261-85b5-7659d216e2c8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntitySmallBusiness_6a3b2ed7-8964-4261-85b5-7659d216e2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_03f20909-6009-4eb2-ba4f-f02fefcacb06" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityEmergingGrowthCompany_03f20909-6009-4eb2-ba4f-f02fefcacb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_bc674607-573a-48dc-b676-06bfe36ebdb3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_IcfrAuditorAttestationFlag_bc674607-573a-48dc-b676-06bfe36ebdb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_db83d8e5-9c22-49f2-ba0e-b9c01537f230" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_db83d8e5-9c22-49f2-ba0e-b9c01537f230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f5d15e88-85e5-42de-8278-0f4c93fb994f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityShellCompany_f5d15e88-85e5-42de-8278-0f4c93fb994f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_bdb5fc17-686f-467e-8a61-b409fb6901da" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityPublicFloat_bdb5fc17-686f-467e-8a61-b409fb6901da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9d16e04a-7b3d-4df2-b74e-688a9f215e1d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9d16e04a-7b3d-4df2-b74e-688a9f215e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ea067924-f502-4ea4-b02f-ed0e06c9a195" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_AmendmentFlag_ea067924-f502-4ea4-b02f-ed0e06c9a195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_64868698-c5f7-440f-bcd0-5aa5d266f03f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_DocumentFiscalYearFocus_64868698-c5f7-440f-bcd0-5aa5d266f03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_0c4b0768-8bf3-4bca-9e69-bd0d2b226e42" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_0c4b0768-8bf3-4bca-9e69-bd0d2b226e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7924b554-e214-4381-9fb1-fa10491b0974" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_EntityCentralIndexKey_7924b554-e214-4381-9fb1-fa10491b0974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_8b98408e-194c-4d18-abc6-29f2ecd1e4a8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9537248e-afc6-4fea-b27b-aaaecc9a4a6c" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_8b98408e-194c-4d18-abc6-29f2ecd1e4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AuditInformation" xlink:type="simple" xlink:href="coo-20231031.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_coo_AuditInformationAbstract_9a5eb7dd-9bfc-4261-8154-4f08cc3dfb5c" xlink:href="coo-20231031.xsd#coo_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_a43ed0ea-5951-493a-aaa0-80069cd6c7c0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AuditInformationAbstract_9a5eb7dd-9bfc-4261-8154-4f08cc3dfb5c" xlink:to="loc_dei_AuditorName_a43ed0ea-5951-493a-aaa0-80069cd6c7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_05ff58cb-5499-4a0b-a8f1-a188f63b0210" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AuditInformationAbstract_9a5eb7dd-9bfc-4261-8154-4f08cc3dfb5c" xlink:to="loc_dei_AuditorLocation_05ff58cb-5499-4a0b-a8f1-a188f63b0210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_344160cf-d044-44dd-ab58-304d41435d6d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AuditInformationAbstract_9a5eb7dd-9bfc-4261-8154-4f08cc3dfb5c" xlink:to="loc_dei_AuditorFirmId_344160cf-d044-44dd-ab58-304d41435d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="coo-20231031.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_772f14c2-275b-42ef-9507-dfb264d19e69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_772f14c2-275b-42ef-9507-dfb264d19e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c65ba8b5-87d0-44df-ad5c-52982ddefd53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c65ba8b5-87d0-44df-ad5c-52982ddefd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_33114f2f-20f8-4de6-82e4-60ac90e2d63f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_GrossProfit_33114f2f-20f8-4de6-82e4-60ac90e2d63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c1901077-74aa-478d-a7cc-d3687fcb9ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c1901077-74aa-478d-a7cc-d3687fcb9ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1b397f63-b233-480a-8188-d61d44492918" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1b397f63-b233-480a-8188-d61d44492918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_321a51bb-a575-4064-a6ea-9b265cde0e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_321a51bb-a575-4064-a6ea-9b265cde0e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_29d2301b-2a01-4ebf-b108-b597bf95ef55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_OperatingIncomeLoss_29d2301b-2a01-4ebf-b108-b597bf95ef55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2a7c75d5-ae60-47a3-938d-7977847ae2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_InterestExpense_2a7c75d5-ae60-47a3-938d-7977847ae2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ad299bf5-2248-4372-a6a0-fb7bf06c2580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ad299bf5-2248-4372-a6a0-fb7bf06c2580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d3b88a7f-5452-4606-bd51-fe30f7259db7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d3b88a7f-5452-4606-bd51-fe30f7259db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dd97b0e6-3f6e-4372-99db-11d71943750e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dd97b0e6-3f6e-4372-99db-11d71943750e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2cdc3a3d-97ce-4608-9b6f-d125c569fc54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_NetIncomeLoss_2cdc3a3d-97ce-4608-9b6f-d125c569fc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0bf88962-5866-4092-9144-f138fc64ceba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_EarningsPerShareAbstract_0bf88962-5866-4092-9144-f138fc64ceba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f4df8d52-ae88-4c8c-ae21-2e9e40d14de8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0bf88962-5866-4092-9144-f138fc64ceba" xlink:to="loc_us-gaap_EarningsPerShareBasic_f4df8d52-ae88-4c8c-ae21-2e9e40d14de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0d5778e3-80d3-4347-81c2-af8514323246" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0bf88962-5866-4092-9144-f138fc64ceba" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0d5778e3-80d3-4347-81c2-af8514323246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4993b38b-4262-4b23-95d3-3f97678d432d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42d8c410-79cd-4666-aa46-4e1bb9d0c19c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4993b38b-4262-4b23-95d3-3f97678d432d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4e0d792c-6794-4a63-bfad-15a0178b8ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4993b38b-4262-4b23-95d3-3f97678d432d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4e0d792c-6794-4a63-bfad-15a0178b8ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b08c6eeb-2fca-4456-935c-3e1921a46e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4993b38b-4262-4b23-95d3-3f97678d432d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b08c6eeb-2fca-4456-935c-3e1921a46e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="coo-20231031.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d6b09174-17bf-432c-ba1d-bbe9a8dc4474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e1484152-98fd-4478-afa0-cb3987316ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d6b09174-17bf-432c-ba1d-bbe9a8dc4474" xlink:to="loc_us-gaap_NetIncomeLoss_e1484152-98fd-4478-afa0-cb3987316ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b4937fe8-0921-4a23-ae74-1a4a01f4eb90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d6b09174-17bf-432c-ba1d-bbe9a8dc4474" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b4937fe8-0921-4a23-ae74-1a4a01f4eb90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4fcfb1da-3d64-4da4-9df0-2332066b9e86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b4937fe8-0921-4a23-ae74-1a4a01f4eb90" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4fcfb1da-3d64-4da4-9df0-2332066b9e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f86475a0-e729-41d8-bf56-cdb7987f8e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b4937fe8-0921-4a23-ae74-1a4a01f4eb90" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f86475a0-e729-41d8-bf56-cdb7987f8e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3185824d-1c0a-499a-863b-3418de58d850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b4937fe8-0921-4a23-ae74-1a4a01f4eb90" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3185824d-1c0a-499a-863b-3418de58d850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_227b3fdd-111a-4089-b145-cf973b1dd146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b4937fe8-0921-4a23-ae74-1a4a01f4eb90" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_227b3fdd-111a-4089-b145-cf973b1dd146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5e2e9105-3582-454e-8bf5-91794cb1a219" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d6b09174-17bf-432c-ba1d-bbe9a8dc4474" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5e2e9105-3582-454e-8bf5-91794cb1a219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="simple" xlink:href="coo-20231031.xsd#ConsolidatedStatementsofComprehensiveIncomeParenthetical"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f83b578a-1494-4751-b15c-1386f7b3802d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_feb2b7f8-6110-47ec-8b10-6d6ccb3aa026" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f83b578a-1494-4751-b15c-1386f7b3802d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_feb2b7f8-6110-47ec-8b10-6d6ccb3aa026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7611d567-7a5e-44e9-addc-cbd62a7b8407" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f83b578a-1494-4751-b15c-1386f7b3802d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7611d567-7a5e-44e9-addc-cbd62a7b8407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="coo-20231031.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_7417c66b-cd52-44bf-a2cd-a0d4ed304df1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e377bfb6-b8bf-4bd1-9e06-8014554a58c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7417c66b-cd52-44bf-a2cd-a0d4ed304df1" xlink:to="loc_us-gaap_AssetsAbstract_e377bfb6-b8bf-4bd1-9e06-8014554a58c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_3a4c1e3b-ec39-41f7-8a35-7e230a6bd7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e377bfb6-b8bf-4bd1-9e06-8014554a58c4" xlink:to="loc_us-gaap_AssetsCurrentAbstract_3a4c1e3b-ec39-41f7-8a35-7e230a6bd7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1cc52a08-ef2f-4bda-8b0f-b407d85c0b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3a4c1e3b-ec39-41f7-8a35-7e230a6bd7bc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1cc52a08-ef2f-4bda-8b0f-b407d85c0b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d275b17a-9593-4fb3-9c01-c5b8a89e8567" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3a4c1e3b-ec39-41f7-8a35-7e230a6bd7bc" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d275b17a-9593-4fb3-9c01-c5b8a89e8567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019d659a-d39f-46a0-82b1-6653f3f3cd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3a4c1e3b-ec39-41f7-8a35-7e230a6bd7bc" xlink:to="loc_us-gaap_InventoryNet_019d659a-d39f-46a0-82b1-6653f3f3cd6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0aeda01b-bb17-44d6-a02b-60683dea2532" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3a4c1e3b-ec39-41f7-8a35-7e230a6bd7bc" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0aeda01b-bb17-44d6-a02b-60683dea2532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_95fa1eb2-0607-40ba-912f-c914bac2be95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3a4c1e3b-ec39-41f7-8a35-7e230a6bd7bc" xlink:to="loc_us-gaap_AssetsCurrent_95fa1eb2-0607-40ba-912f-c914bac2be95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0311f18e-a79c-44f9-ad71-1257d4885c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e377bfb6-b8bf-4bd1-9e06-8014554a58c4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0311f18e-a79c-44f9-ad71-1257d4885c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f2b0c702-ecfc-4202-8f31-cd4c6b22c73b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e377bfb6-b8bf-4bd1-9e06-8014554a58c4" xlink:to="loc_us-gaap_Goodwill_f2b0c702-ecfc-4202-8f31-cd4c6b22c73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b1572bdb-3804-481e-9a48-acd31e36182f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e377bfb6-b8bf-4bd1-9e06-8014554a58c4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b1572bdb-3804-481e-9a48-acd31e36182f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_b4d00142-de63-44b3-9b6e-6aee376554d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e377bfb6-b8bf-4bd1-9e06-8014554a58c4" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_b4d00142-de63-44b3-9b6e-6aee376554d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f966c064-6551-4b9b-87c6-9d36c93c8bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e377bfb6-b8bf-4bd1-9e06-8014554a58c4" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f966c064-6551-4b9b-87c6-9d36c93c8bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6904992c-b88d-4acc-8725-9482aa1e05ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e377bfb6-b8bf-4bd1-9e06-8014554a58c4" xlink:to="loc_us-gaap_Assets_6904992c-b88d-4acc-8725-9482aa1e05ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_89f870ee-a455-4892-968b-f7ba955a7706" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7417c66b-cd52-44bf-a2cd-a0d4ed304df1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_89f870ee-a455-4892-968b-f7ba955a7706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d1d5cb9a-9970-4d81-9401-cd1b3b427c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_89f870ee-a455-4892-968b-f7ba955a7706" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d1d5cb9a-9970-4d81-9401-cd1b3b427c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_487e90be-905b-41bc-b0eb-7db80b86d24f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d1d5cb9a-9970-4d81-9401-cd1b3b427c6f" xlink:to="loc_us-gaap_DebtCurrent_487e90be-905b-41bc-b0eb-7db80b86d24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_faa84a12-39ac-457b-a7a2-b6b874d77bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d1d5cb9a-9970-4d81-9401-cd1b3b427c6f" xlink:to="loc_us-gaap_AccountsPayableCurrent_faa84a12-39ac-457b-a7a2-b6b874d77bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_553de0d6-d110-4140-beea-08edf29f302d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d1d5cb9a-9970-4d81-9401-cd1b3b427c6f" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_553de0d6-d110-4140-beea-08edf29f302d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_4f1ceb95-0943-4b61-ace0-803d783b36eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d1d5cb9a-9970-4d81-9401-cd1b3b427c6f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_4f1ceb95-0943-4b61-ace0-803d783b36eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_14c4e324-f145-441d-939e-5a0e02275eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d1d5cb9a-9970-4d81-9401-cd1b3b427c6f" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_14c4e324-f145-441d-939e-5a0e02275eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0ceffa63-90a3-44cc-917f-ba099ee65568" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d1d5cb9a-9970-4d81-9401-cd1b3b427c6f" xlink:to="loc_us-gaap_LiabilitiesCurrent_0ceffa63-90a3-44cc-917f-ba099ee65568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_922ab9d8-d4b1-4f78-951f-53203c7ce7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_89f870ee-a455-4892-968b-f7ba955a7706" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_922ab9d8-d4b1-4f78-951f-53203c7ce7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_da5ad571-9526-4e9d-a87e-8020dfaa390b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_89f870ee-a455-4892-968b-f7ba955a7706" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_da5ad571-9526-4e9d-a87e-8020dfaa390b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_5f637f42-808d-497b-b0dd-e46318483fba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_89f870ee-a455-4892-968b-f7ba955a7706" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_5f637f42-808d-497b-b0dd-e46318483fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_b5b14392-474a-4d55-86eb-f6bc7a9c4e05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_89f870ee-a455-4892-968b-f7ba955a7706" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_b5b14392-474a-4d55-86eb-f6bc7a9c4e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c4b1d235-18f6-4356-a6c8-1dbc6204b3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_89f870ee-a455-4892-968b-f7ba955a7706" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c4b1d235-18f6-4356-a6c8-1dbc6204b3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ebc113d2-7bee-41ba-a1e2-1e6e961d59f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_89f870ee-a455-4892-968b-f7ba955a7706" xlink:to="loc_us-gaap_Liabilities_ebc113d2-7bee-41ba-a1e2-1e6e961d59f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_515b7973-2eed-4a9b-90e5-51cc41b8ed0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_89f870ee-a455-4892-968b-f7ba955a7706" xlink:to="loc_us-gaap_CommitmentsAndContingencies_515b7973-2eed-4a9b-90e5-51cc41b8ed0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c5afabb5-d18d-4b61-bf93-6574eed03fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_89f870ee-a455-4892-968b-f7ba955a7706" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c5afabb5-d18d-4b61-bf93-6574eed03fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_5b97202d-abd8-4500-882b-60faf1177c71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c5afabb5-d18d-4b61-bf93-6574eed03fb1" xlink:to="loc_us-gaap_PreferredStockValue_5b97202d-abd8-4500-882b-60faf1177c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c695c3b9-b06d-4525-98ad-5f920aa0c7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c5afabb5-d18d-4b61-bf93-6574eed03fb1" xlink:to="loc_us-gaap_CommonStockValue_c695c3b9-b06d-4525-98ad-5f920aa0c7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a60d1873-8558-4f21-af6f-365431fba719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c5afabb5-d18d-4b61-bf93-6574eed03fb1" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a60d1873-8558-4f21-af6f-365431fba719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_84aca1eb-6442-48a4-9ce0-e81109d16d76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c5afabb5-d18d-4b61-bf93-6574eed03fb1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_84aca1eb-6442-48a4-9ce0-e81109d16d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a7988098-f261-4e3d-9b72-226e1eef71ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c5afabb5-d18d-4b61-bf93-6574eed03fb1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a7988098-f261-4e3d-9b72-226e1eef71ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_fbc26876-448c-49f1-9590-f3a98df28621" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c5afabb5-d18d-4b61-bf93-6574eed03fb1" xlink:to="loc_us-gaap_TreasuryStockCommonValue_fbc26876-448c-49f1-9590-f3a98df28621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a9049a45-31fe-4864-8776-f2c86f2e8174" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c5afabb5-d18d-4b61-bf93-6574eed03fb1" xlink:to="loc_us-gaap_StockholdersEquity_a9049a45-31fe-4864-8776-f2c86f2e8174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_eb2217c3-2cfd-4697-847f-cee705696d49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c5afabb5-d18d-4b61-bf93-6574eed03fb1" xlink:to="loc_us-gaap_MinorityInterest_eb2217c3-2cfd-4697-847f-cee705696d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8b07ec44-7907-4e80-bf4b-229d61e30573" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_c5afabb5-d18d-4b61-bf93-6574eed03fb1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8b07ec44-7907-4e80-bf4b-229d61e30573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b714d41c-d0c5-4153-bfa5-5602102a2386" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_89f870ee-a455-4892-968b-f7ba955a7706" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_b714d41c-d0c5-4153-bfa5-5602102a2386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="coo-20231031.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e75f0e69-a084-4ad3-92f8-75c850582d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e87dc242-98a2-4843-b5c3-84307b1cbc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e75f0e69-a084-4ad3-92f8-75c850582d73" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e87dc242-98a2-4843-b5c3-84307b1cbc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_84767ad4-9ea9-48f0-9743-433abba908ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e75f0e69-a084-4ad3-92f8-75c850582d73" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_84767ad4-9ea9-48f0-9743-433abba908ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_a8be340e-ee7e-4afb-b2e6-0be540143e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e75f0e69-a084-4ad3-92f8-75c850582d73" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_a8be340e-ee7e-4afb-b2e6-0be540143e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_5ee99a7d-55fc-478b-8dcd-21d51934a4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e75f0e69-a084-4ad3-92f8-75c850582d73" xlink:to="loc_us-gaap_PreferredStockSharesIssued_5ee99a7d-55fc-478b-8dcd-21d51934a4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_0c1506a9-573e-4e6f-bf8a-3b4e4c855c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e75f0e69-a084-4ad3-92f8-75c850582d73" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_0c1506a9-573e-4e6f-bf8a-3b4e4c855c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_e9f0762a-bf5a-4cb4-b7c6-bbdc3315aba2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e75f0e69-a084-4ad3-92f8-75c850582d73" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_e9f0762a-bf5a-4cb4-b7c6-bbdc3315aba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_6b21089d-7edf-4d92-90f8-accf2dbbdba8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e75f0e69-a084-4ad3-92f8-75c850582d73" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_6b21089d-7edf-4d92-90f8-accf2dbbdba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d3e46067-6835-4510-81dc-9e32c507c7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e75f0e69-a084-4ad3-92f8-75c850582d73" xlink:to="loc_us-gaap_CommonStockSharesIssued_d3e46067-6835-4510-81dc-9e32c507c7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_078049a1-0257-4075-aaf8-9f4e373d8e67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e75f0e69-a084-4ad3-92f8-75c850582d73" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_078049a1-0257-4075-aaf8-9f4e373d8e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_e6645122-f22e-4eec-9ac3-25d7024502c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e75f0e69-a084-4ad3-92f8-75c850582d73" xlink:to="loc_us-gaap_TreasuryStockCommonShares_e6645122-f22e-4eec-9ac3-25d7024502c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="coo-20231031.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b105f5d1-671d-4449-afba-ddd7eac57631" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6a6c5809-8844-41b6-94ac-3b65c4f8504d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b105f5d1-671d-4449-afba-ddd7eac57631" xlink:to="loc_us-gaap_StatementTable_6a6c5809-8844-41b6-94ac-3b65c4f8504d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cff218f5-2c3c-47f5-9c36-ca2b1bcdffdf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6a6c5809-8844-41b6-94ac-3b65c4f8504d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cff218f5-2c3c-47f5-9c36-ca2b1bcdffdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_89ac44dc-7c8b-4ba6-b7e0-f3e8e4e67468" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cff218f5-2c3c-47f5-9c36-ca2b1bcdffdf" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_89ac44dc-7c8b-4ba6-b7e0-f3e8e4e67468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2024e07e-7c3e-4c0d-ab8e-5db94ead187e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_89ac44dc-7c8b-4ba6-b7e0-f3e8e4e67468" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2024e07e-7c3e-4c0d-ab8e-5db94ead187e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b58dd064-fd5f-464f-84dc-934007727bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6a6c5809-8844-41b6-94ac-3b65c4f8504d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b58dd064-fd5f-464f-84dc-934007727bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b58dd064-fd5f-464f-84dc-934007727bfc" xlink:to="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CommonStockExcludingTreasuryStockParNetValueMember_28a604c6-b737-4ffc-8fb4-77c854782b93" xlink:href="coo-20231031.xsd#coo_CommonStockExcludingTreasuryStockParNetValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_coo_CommonStockExcludingTreasuryStockParNetValueMember_28a604c6-b737-4ffc-8fb4-77c854782b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_ba9d8205-6f83-484f-9a4b-f143a3b2f860" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_us-gaap_TreasuryStockCommonMember_ba9d8205-6f83-484f-9a4b-f143a3b2f860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TreasuryStockParNetValueMember_e1fb62b2-8681-4ec0-b888-d5f5cf6a8839" xlink:href="coo-20231031.xsd#coo_TreasuryStockParNetValueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_coo_TreasuryStockParNetValueMember_e1fb62b2-8681-4ec0-b888-d5f5cf6a8839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f7de1a5d-8472-4ffd-b2e8-e4c7697c8a02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f7de1a5d-8472-4ffd-b2e8-e4c7697c8a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9ba0a3cc-875a-4a96-900f-1ba81ab1ce82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9ba0a3cc-875a-4a96-900f-1ba81ab1ce82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3c467ab6-4bb2-4906-bd9c-85131f42f6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_us-gaap_RetainedEarningsMember_3c467ab6-4bb2-4906-bd9c-85131f42f6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b35fdb48-4c81-4640-9511-a5d87cd7f7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_24f4e296-01e5-4005-9a4d-1e3422794a70" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b35fdb48-4c81-4640-9511-a5d87cd7f7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_70fa125f-66f5-4bc5-b49b-4d2d8f884138" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6a6c5809-8844-41b6-94ac-3b65c4f8504d" xlink:to="loc_us-gaap_StatementLineItems_70fa125f-66f5-4bc5-b49b-4d2d8f884138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70fa125f-66f5-4bc5-b49b-4d2d8f884138" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1103d1b8-2c01-4aa6-a7a0-2db977f41b87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1103d1b8-2c01-4aa6-a7a0-2db977f41b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_7d086e60-aff6-4851-a912-7238d11c7a81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_TreasuryStockCommonShares_7d086e60-aff6-4851-a912-7238d11c7a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_111f9b29-3af3-4555-b8bb-01a65199f2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_111f9b29-3af3-4555-b8bb-01a65199f2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17e0b2f7-f8e1-471a-9f2a-e51094fe5857" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_NetIncomeLoss_17e0b2f7-f8e1-471a-9f2a-e51094fe5857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_36cedc23-3adb-46f2-a983-4e87906352fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_36cedc23-3adb-46f2-a983-4e87906352fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0d3d9b8d-b3cb-4c4d-bc69-71a18e3fa453" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0d3d9b8d-b3cb-4c4d-bc69-71a18e3fa453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_da6e71d7-6f1c-4d0c-87cd-aabbba2025cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_da6e71d7-6f1c-4d0c-87cd-aabbba2025cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_3fde649f-8cce-4017-8154-dbbbd262bda6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_3fde649f-8cce-4017-8154-dbbbd262bda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6182847f-9eae-488b-9ea8-958c1f813d35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6182847f-9eae-488b-9ea8-958c1f813d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_2baeb42f-8e1a-40be-bac1-c29146b4d32d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_DividendsCommonStockCash_2baeb42f-8e1a-40be-bac1-c29146b4d32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d635f5f0-d3b6-4eaa-a5ea-0be75c3d3942" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d635f5f0-d3b6-4eaa-a5ea-0be75c3d3942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6e63eac8-71fb-49f8-92a1-bf07a5b384a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6e63eac8-71fb-49f8-92a1-bf07a5b384a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_c98e1cd0-b557-4e1f-a761-033372d9fba1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_TreasuryStockCommonShares_c98e1cd0-b557-4e1f-a761-033372d9fba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1401d703-641c-4f27-ad3d-915ab8b2a205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_784d1a7b-aa12-4435-bef9-d65145815e2d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1401d703-641c-4f27-ad3d-915ab8b2a205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_863df111-aeb7-4430-bbbf-e5387eddeb87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70fa125f-66f5-4bc5-b49b-4d2d8f884138" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_863df111-aeb7-4430-bbbf-e5387eddeb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="coo-20231031.xsd#ConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_277b9619-b9fc-49eb-b62b-6ea56d1a92a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_2676fe3b-8dcf-4aaa-a585-5b95e7e1e547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_277b9619-b9fc-49eb-b62b-6ea56d1a92a6" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_2676fe3b-8dcf-4aaa-a585-5b95e7e1e547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="coo-20231031.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_e6a90cfc-4052-48b4-a417-a0108a54126b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9133ca8c-5ef7-481a-94ee-74abbf6e3bba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e6a90cfc-4052-48b4-a417-a0108a54126b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9133ca8c-5ef7-481a-94ee-74abbf6e3bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_83119226-32df-439d-b79f-d050fd41bc83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9133ca8c-5ef7-481a-94ee-74abbf6e3bba" xlink:to="loc_us-gaap_NetIncomeLoss_83119226-32df-439d-b79f-d050fd41bc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd6931bb-585d-4bde-8b01-7d390ab4a624" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9133ca8c-5ef7-481a-94ee-74abbf6e3bba" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd6931bb-585d-4bde-8b01-7d390ab4a624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6f4acaae-450b-4cbf-a575-21580d0b9cab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd6931bb-585d-4bde-8b01-7d390ab4a624" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6f4acaae-450b-4cbf-a575-21580d0b9cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_08f0f1cd-a617-4a43-a61d-75971ed94643" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd6931bb-585d-4bde-8b01-7d390ab4a624" xlink:to="loc_us-gaap_ShareBasedCompensation_08f0f1cd-a617-4a43-a61d-75971ed94643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_b75faef8-2e36-42fe-9394-8caac7ce2b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd6931bb-585d-4bde-8b01-7d390ab4a624" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_b75faef8-2e36-42fe-9394-8caac7ce2b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetImpairmentChargesAndOther_67a5c3ee-6cee-4a2e-bea8-3530b0c32ed3" xlink:href="coo-20231031.xsd#coo_AssetImpairmentChargesAndOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd6931bb-585d-4bde-8b01-7d390ab4a624" xlink:to="loc_coo_AssetImpairmentChargesAndOther_67a5c3ee-6cee-4a2e-bea8-3530b0c32ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_293b62f3-cf01-4b4d-a678-de77ea7b041f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd6931bb-585d-4bde-8b01-7d390ab4a624" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_293b62f3-cf01-4b4d-a678-de77ea7b041f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_de12b62a-4f45-4c44-87c2-64c21d449703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd6931bb-585d-4bde-8b01-7d390ab4a624" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_de12b62a-4f45-4c44-87c2-64c21d449703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f9d988-3a10-4dbd-90e9-ee5925b40759" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9133ca8c-5ef7-481a-94ee-74abbf6e3bba" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f9d988-3a10-4dbd-90e9-ee5925b40759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ee69f411-953d-40b4-b5f5-a87c353f26c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f9d988-3a10-4dbd-90e9-ee5925b40759" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ee69f411-953d-40b4-b5f5-a87c353f26c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_db6da844-b117-4832-860f-f7f0b74b3027" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f9d988-3a10-4dbd-90e9-ee5925b40759" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_db6da844-b117-4832-860f-f7f0b74b3027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8706ade8-d493-4189-97db-f813fe024023" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f9d988-3a10-4dbd-90e9-ee5925b40759" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8706ade8-d493-4189-97db-f813fe024023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_05a1d452-356a-4fce-ae91-4866dab5850d" xlink:href="coo-20231031.xsd#coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f9d988-3a10-4dbd-90e9-ee5925b40759" xlink:to="loc_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_05a1d452-356a-4fce-ae91-4866dab5850d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5aed0748-6f14-4280-9484-937d28c1e4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f9d988-3a10-4dbd-90e9-ee5925b40759" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5aed0748-6f14-4280-9484-937d28c1e4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_4313a81d-dcea-4ffd-b1c1-388d3a1bd2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f9d988-3a10-4dbd-90e9-ee5925b40759" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_4313a81d-dcea-4ffd-b1c1-388d3a1bd2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_cb1c35a0-cca4-4ccc-abf7-898bdb875d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f9d988-3a10-4dbd-90e9-ee5925b40759" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_cb1c35a0-cca4-4ccc-abf7-898bdb875d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2b2ef902-2e89-4a68-a86d-97c0f86677a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f9d988-3a10-4dbd-90e9-ee5925b40759" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2b2ef902-2e89-4a68-a86d-97c0f86677a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_IncreaseDecreaseInContingentConsiderationLiability_25510f51-d25d-4068-99bb-f42155c4cc2b" xlink:href="coo-20231031.xsd#coo_IncreaseDecreaseInContingentConsiderationLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f9d988-3a10-4dbd-90e9-ee5925b40759" xlink:to="loc_coo_IncreaseDecreaseInContingentConsiderationLiability_25510f51-d25d-4068-99bb-f42155c4cc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b19262a0-35e5-4f35-8d43-8ec55d040061" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9133ca8c-5ef7-481a-94ee-74abbf6e3bba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b19262a0-35e5-4f35-8d43-8ec55d040061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_756cb22b-f7f2-4e56-817f-188abe67f2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e6a90cfc-4052-48b4-a417-a0108a54126b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_756cb22b-f7f2-4e56-817f-188abe67f2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b339e355-985b-4b60-b3c5-8a35bba912cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_756cb22b-f7f2-4e56-817f-188abe67f2ac" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b339e355-985b-4b60-b3c5-8a35bba912cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_942fc472-80fd-4555-9e15-756a729c0a3a" xlink:href="coo-20231031.xsd#coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_756cb22b-f7f2-4e56-817f-188abe67f2ac" xlink:to="loc_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_942fc472-80fd-4555-9e15-756a729c0a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_c42ebff0-fcb3-4600-9ee3-7497327a66c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_756cb22b-f7f2-4e56-817f-188abe67f2ac" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_c42ebff0-fcb3-4600-9ee3-7497327a66c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0b793d3d-c197-4f59-824b-1d06de0186ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_756cb22b-f7f2-4e56-817f-188abe67f2ac" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0b793d3d-c197-4f59-824b-1d06de0186ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72d47404-d7c1-4654-bf38-e752dde4f4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e6a90cfc-4052-48b4-a417-a0108a54126b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72d47404-d7c1-4654-bf38-e752dde4f4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_69f29185-c011-4dda-8d47-bd481df73d16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72d47404-d7c1-4654-bf38-e752dde4f4e1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_69f29185-c011-4dda-8d47-bd481df73d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_584ba106-9bc9-4e72-80df-503a9689e126" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72d47404-d7c1-4654-bf38-e752dde4f4e1" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_584ba106-9bc9-4e72-80df-503a9689e126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_8d8a4df0-e676-434f-afa7-a03dc20c6b54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72d47404-d7c1-4654-bf38-e752dde4f4e1" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_8d8a4df0-e676-434f-afa7-a03dc20c6b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_74ca49c3-b7a4-4810-8ccb-64c7f3ba17de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72d47404-d7c1-4654-bf38-e752dde4f4e1" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_74ca49c3-b7a4-4810-8ccb-64c7f3ba17de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ba4761aa-ffa2-4a45-8825-ffcffed48b48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72d47404-d7c1-4654-bf38-e752dde4f4e1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ba4761aa-ffa2-4a45-8825-ffcffed48b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7213a06f-3af5-4cb1-90b4-804f5edba922" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72d47404-d7c1-4654-bf38-e752dde4f4e1" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7213a06f-3af5-4cb1-90b4-804f5edba922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_3a8ee4d3-99f9-409e-8954-b230e56e06e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72d47404-d7c1-4654-bf38-e752dde4f4e1" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_3a8ee4d3-99f9-409e-8954-b230e56e06e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_0fadf4b6-29fe-4e42-a725-707d09f1102d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72d47404-d7c1-4654-bf38-e752dde4f4e1" xlink:to="loc_us-gaap_ProceedsFromStockPlans_0fadf4b6-29fe-4e42-a725-707d09f1102d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0ff85a6c-7b90-41cc-a398-6f3e3c75b076" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72d47404-d7c1-4654-bf38-e752dde4f4e1" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0ff85a6c-7b90-41cc-a398-6f3e3c75b076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e5dc7d2-8a2d-430e-b971-f4165d061856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72d47404-d7c1-4654-bf38-e752dde4f4e1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e5dc7d2-8a2d-430e-b971-f4165d061856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_153e0b87-68a9-4b0d-b76a-478706078fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e6a90cfc-4052-48b4-a417-a0108a54126b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_153e0b87-68a9-4b0d-b76a-478706078fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_74b6c4d9-b3bf-4566-bfc6-920f6ec741ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e6a90cfc-4052-48b4-a417-a0108a54126b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_74b6c4d9-b3bf-4566-bfc6-920f6ec741ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_76b2855c-055b-4b8c-871b-b92b1282f1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e6a90cfc-4052-48b4-a417-a0108a54126b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_76b2855c-055b-4b8c-871b-b92b1282f1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_99dd058f-974b-4af6-bde1-2ec713313f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e6a90cfc-4052-48b4-a417-a0108a54126b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_99dd058f-974b-4af6-bde1-2ec713313f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_bd0338fa-5e73-49ec-b420-74456d9ccb4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e6a90cfc-4052-48b4-a417-a0108a54126b" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_bd0338fa-5e73-49ec-b420-74456d9ccb4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_20ca4700-641a-41a7-aa6b-c9a17fa5c3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_bd0338fa-5e73-49ec-b420-74456d9ccb4a" xlink:to="loc_us-gaap_InterestPaidNet_20ca4700-641a-41a7-aa6b-c9a17fa5c3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_0ea34e1b-c335-4e25-b8e9-b9df3bd39e02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_bd0338fa-5e73-49ec-b420-74456d9ccb4a" xlink:to="loc_us-gaap_IncomeTaxesPaid_0ea34e1b-c335-4e25-b8e9-b9df3bd39e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_d9e789b0-cee8-4aa9-9123-9471381e085f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_bd0338fa-5e73-49ec-b420-74456d9ccb4a" xlink:to="loc_us-gaap_OperatingLeasePayments_d9e789b0-cee8-4aa9-9123-9471381e085f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_102ee32e-83a5-4427-8d61-222c5079d8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_bd0338fa-5e73-49ec-b420-74456d9ccb4a" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_102ee32e-83a5-4427-8d61-222c5079d8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_e3a4aec1-c5f8-448c-9122-86033afb05cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e6a90cfc-4052-48b4-a417-a0108a54126b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_e3a4aec1-c5f8-448c-9122-86033afb05cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6fff014f-1310-4b24-8a06-212d8bc977dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_e3a4aec1-c5f8-448c-9122-86033afb05cc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6fff014f-1310-4b24-8a06-212d8bc977dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_909c607b-6251-4a74-b643-2cb974694e74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_e3a4aec1-c5f8-448c-9122-86033afb05cc" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_909c607b-6251-4a74-b643-2cb974694e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_a4c196cd-e01b-4f52-958e-dd16dad1570b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_e3a4aec1-c5f8-448c-9122-86033afb05cc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_a4c196cd-e01b-4f52-958e-dd16dad1570b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_425c8ad1-3b73-4812-92fd-f37e0171edb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_e3a4aec1-c5f8-448c-9122-86033afb05cc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_425c8ad1-3b73-4812-92fd-f37e0171edb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="simple" xlink:href="coo-20231031.xsd#OrganizationandSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd21c152-953f-47bd-af5d-603e89b52d11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_17723d19-ce84-42c5-9d09-825dff0d4a36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd21c152-953f-47bd-af5d-603e89b52d11" xlink:to="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_17723d19-ce84-42c5-9d09-825dff0d4a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeases" xlink:type="simple" xlink:href="coo-20231031.xsd#OperatingLeases"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OperatingLeases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_046852ec-5d9d-4e8b-8a02-8713602bc72b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_3289842d-ce5a-402f-8336-3b5f0ffa8feb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_046852ec-5d9d-4e8b-8a02-8713602bc72b" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_3289842d-ce5a-402f-8336-3b5f0ffa8feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVenture" xlink:type="simple" xlink:href="coo-20231031.xsd#AcquisitionsandJointVenture"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVenture" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_46f4f46f-c931-43a2-94d9-30ae431b8640" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionTextBlock_6b3d4f43-b4f0-40a1-b433-303aac50cc1a" xlink:href="coo-20231031.xsd#coo_BusinessCombinationAndAssetAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_46f4f46f-c931-43a2-94d9-30ae431b8640" xlink:to="loc_coo_BusinessCombinationAndAssetAcquisitionTextBlock_6b3d4f43-b4f0-40a1-b433-303aac50cc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssets" xlink:type="simple" xlink:href="coo-20231031.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_13d5be12-b923-4a56-8e6c-885d723d6c80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_804119a6-d78a-473e-90b7-1297a5836988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_13d5be12-b923-4a56-8e6c-885d723d6c80" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_804119a6-d78a-473e-90b7-1297a5836988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancingArrangements" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancingArrangements"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7e644b49-64e3-45eb-b383-6e1d8cfc7584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_4d32f05f-1b53-4a53-a646-415171b8055a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7e644b49-64e3-45eb-b383-6e1d8cfc7584" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_4d32f05f-1b53-4a53-a646-415171b8055a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxes" xlink:type="simple" xlink:href="coo-20231031.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_85c93c3a-9d31-4e59-9636-69784381cc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_39d08b18-d796-4bbc-b39a-df484561a348" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85c93c3a-9d31-4e59-9636-69784381cc2c" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_39d08b18-d796-4bbc-b39a-df484561a348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EarningsPerShare" xlink:type="simple" xlink:href="coo-20231031.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_25d90a88-ec98-4d46-afae-cb34d38444f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_6c3872dd-1aab-4a89-b0d7-9d7487fba3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_25d90a88-ec98-4d46-afae-cb34d38444f1" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_6c3872dd-1aab-4a89-b0d7-9d7487fba3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockholdersEquity" xlink:type="simple" xlink:href="coo-20231031.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_566bbb8f-95c4-4f21-9a88-4aabaaba10fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_126511ec-cb9a-47a0-bd2e-388492c8e9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_566bbb8f-95c4-4f21-9a88-4aabaaba10fa" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_126511ec-cb9a-47a0-bd2e-388492c8e9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlans" xlink:type="simple" xlink:href="coo-20231031.xsd#StockPlans"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a29c93d4-e215-4083-94bd-a9ed31a20501" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b20b1ec1-79c4-4c1e-8a56-f141f59cd861" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a29c93d4-e215-4083-94bd-a9ed31a20501" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b20b1ec1-79c4-4c1e-8a56-f141f59cd861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefits" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefits"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c617ce8a-864e-4084-b75b-288d0f7db817" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5001ce0e-ed73-412c-98b5-a76f2af6339f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c617ce8a-864e-4084-b75b-288d0f7db817" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5001ce0e-ed73-412c-98b5-a76f2af6339f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/Contingencies" xlink:type="simple" xlink:href="coo-20231031.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0be0c24c-8d4b-44a4-b02a-1c9d6885853e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1b1a6d0e-0e33-47f3-8881-f5cd3f242d15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0be0c24c-8d4b-44a4-b02a-1c9d6885853e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1b1a6d0e-0e33-47f3-8881-f5cd3f242d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformation" xlink:type="simple" xlink:href="coo-20231031.xsd#BusinessSegmentInformation"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cd8d47e2-a4c5-4c9e-a05a-38dc57e3aa4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_a583bad4-f678-40a8-89b0-6a0cb9c859bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cd8d47e2-a4c5-4c9e-a05a-38dc57e3aa4b" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_a583bad4-f678-40a8-89b0-6a0cb9c859bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedging" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancialDerivativesandHedging"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedging" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_186d472a-f96f-4df5-b02f-4afa78cd121f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9d7c3a3c-26a3-425d-87f1-d2294b03cac0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_186d472a-f96f-4df5-b02f-4afa78cd121f" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9d7c3a3c-26a3-425d-87f1-d2294b03cac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ScheduleII" xlink:type="simple" xlink:href="coo-20231031.xsd#ScheduleII"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ScheduleII" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_5b9b24f2-0832-4897-b0d8-ea1bda2b8163" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_33c1a862-37fa-46c8-992e-1d3222a44842" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_5b9b24f2-0832-4897-b0d8-ea1bda2b8163" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_33c1a862-37fa-46c8-992e-1d3222a44842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="coo-20231031.xsd#OrganizationandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_5e5fce45-6379-4519-8f2e-2095056c1f92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_5e5fce45-6379-4519-8f2e-2095056c1f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_cf6684c9-1a19-4a9d-9a17-d40cc13d7094" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_UseOfEstimates_cf6684c9-1a19-4a9d-9a17-d40cc13d7094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_da521465-3c6f-44c7-90a8-1f7d395d451b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_da521465-3c6f-44c7-90a8-1f7d395d451b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_a0c97a85-3826-45b4-ba85-247abddd2d93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_a0c97a85-3826-45b4-ba85-247abddd2d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_cb81b7d8-16cf-4999-95f6-3142df4eb103" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_cb81b7d8-16cf-4999-95f6-3142df4eb103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_dccd2bd0-bcc7-4c38-8be2-4ae55deefa9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_dccd2bd0-bcc7-4c38-8be2-4ae55deefa9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_1f177f2b-0ad7-4572-9a9a-78983dd21fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_1f177f2b-0ad7-4572-9a9a-78983dd21fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_19406039-597f-4090-bb99-eaa5ed43032a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_19406039-597f-4090-bb99-eaa5ed43032a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_72954496-6211-4964-aa1d-da6a33f49724" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_72954496-6211-4964-aa1d-da6a33f49724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_ed999b5c-fb15-4062-962a-684e660e95dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_ed999b5c-fb15-4062-962a-684e660e95dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_1bb03381-410f-490f-9a34-a4125af38e00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_1bb03381-410f-490f-9a34-a4125af38e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_980ffea8-bd96-474a-9a5e-41c64e830414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_980ffea8-bd96-474a-9a5e-41c64e830414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_c2f139ae-9368-4369-a22d-9848b887dae7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_c2f139ae-9368-4369-a22d-9848b887dae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy_eee75968-69a5-4ec1-a0b5-a9829471f620" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_InternalUseSoftwarePolicy_eee75968-69a5-4ec1-a0b5-a9829471f620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_cc0c45b1-5a44-42ad-a653-c307227a0f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_cc0c45b1-5a44-42ad-a653-c307227a0f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_7a7a9d59-a29c-4cae-bfae-8c4901531598" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_7a7a9d59-a29c-4cae-bfae-8c4901531598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_54e361c2-345f-4abc-83f9-fd6d294ac56f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_54e361c2-345f-4abc-83f9-fd6d294ac56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_402099e8-55f2-4107-9b0c-812e51c80055" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_402099e8-55f2-4107-9b0c-812e51c80055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_14a9fe01-2502-471f-af96-2b8a7cdf5feb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_14a9fe01-2502-471f-af96-2b8a7cdf5feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock_ea769d63-90d2-4979-b712-036a6ed10735" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_StockholdersEquityPolicyTextBlock_ea769d63-90d2-4979-b712-036a6ed10735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistancePolicyTextBlock_3e865860-e046-420c-ad06-e9fc818b5e55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GovernmentAssistancePolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_GovernmentAssistancePolicyTextBlock_3e865860-e046-420c-ad06-e9fc818b5e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_658c08a2-e4fe-4900-8a7f-a85713883b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e58a86f7-9e94-4017-b062-f46272da1fe5" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_658c08a2-e4fe-4900-8a7f-a85713883b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="coo-20231031.xsd#OrganizationandSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_94051c6d-6119-4050-a6d0-abdad3c12b88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e8fbe03f-5f1a-45a2-8fd7-d27c91e311ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_94051c6d-6119-4050-a6d0-abdad3c12b88" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e8fbe03f-5f1a-45a2-8fd7-d27c91e311ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_99399c6c-4b09-40be-844c-fa0a9863fbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_94051c6d-6119-4050-a6d0-abdad3c12b88" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_99399c6c-4b09-40be-844c-fa0a9863fbb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesTables" xlink:type="simple" xlink:href="coo-20231031.xsd#OperatingLeasesTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5d9a5725-183c-42d4-b4be-106744a2488f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetsAndLiabilitiesLesseeTableTextBlock_ff064f81-205a-4ec4-a42d-a73b532c5b63" xlink:href="coo-20231031.xsd#coo_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5d9a5725-183c-42d4-b4be-106744a2488f" xlink:to="loc_coo_AssetsAndLiabilitiesLesseeTableTextBlock_ff064f81-205a-4ec4-a42d-a73b532c5b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f6110958-d432-43c4-940b-10ff314bd8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5d9a5725-183c-42d4-b4be-106744a2488f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f6110958-d432-43c4-940b-10ff314bd8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="coo-20231031.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3dbeadf6-7128-45b4-aea0-5bff23c26d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_8c136315-e60c-44e0-b672-3b1f4f570dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3dbeadf6-7128-45b4-aea0-5bff23c26d7e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_8c136315-e60c-44e0-b672-3b1f4f570dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3449dad2-5c18-4345-aded-19ad0763ff5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3dbeadf6-7128-45b4-aea0-5bff23c26d7e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3449dad2-5c18-4345-aded-19ad0763ff5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_efbea294-c1bd-4210-991b-00b64308335b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3dbeadf6-7128-45b4-aea0-5bff23c26d7e" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_efbea294-c1bd-4210-991b-00b64308335b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_6cb21198-2636-47e6-bf5d-2ba0ffd14491" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3dbeadf6-7128-45b4-aea0-5bff23c26d7e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_6cb21198-2636-47e6-bf5d-2ba0ffd14491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancingArrangementsTables" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancingArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancingArrangementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_785e8f38-156c-4a60-a8d2-28ac0dcce12c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_bd1d20e1-7966-4cfc-8849-edb5dea7e3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_785e8f38-156c-4a60-a8d2-28ac0dcce12c" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_bd1d20e1-7966-4cfc-8849-edb5dea7e3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="coo-20231031.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f8ef15d4-421e-4622-aac5-e774389e86c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_9227585b-439a-41bf-a7ae-dd531fe902b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8ef15d4-421e-4622-aac5-e774389e86c7" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_9227585b-439a-41bf-a7ae-dd531fe902b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ee5d1225-522b-436e-bd5e-7f793f87e7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8ef15d4-421e-4622-aac5-e774389e86c7" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ee5d1225-522b-436e-bd5e-7f793f87e7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_f768c7f7-1fef-4f48-bbb2-50452b085346" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8ef15d4-421e-4622-aac5-e774389e86c7" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_f768c7f7-1fef-4f48-bbb2-50452b085346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_4a973347-5a09-4bbd-9e56-329e90cff60e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8ef15d4-421e-4622-aac5-e774389e86c7" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_4a973347-5a09-4bbd-9e56-329e90cff60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_8a1d3e97-da12-4d15-9c6f-1ed4391a527f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8ef15d4-421e-4622-aac5-e774389e86c7" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_8a1d3e97-da12-4d15-9c6f-1ed4391a527f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="coo-20231031.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_945b3bc0-cf24-41c0-8561-8bdcf5a4ae7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cb52a400-0642-4f6b-b06c-08b9d4c3f739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_945b3bc0-cf24-41c0-8561-8bdcf5a4ae7b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cb52a400-0642-4f6b-b06c-08b9d4c3f739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_7e403387-beee-4034-b0d5-88848e0effd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_945b3bc0-cf24-41c0-8561-8bdcf5a4ae7b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_7e403387-beee-4034-b0d5-88848e0effd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="coo-20231031.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_90315222-1094-4822-978b-876ddc4aa2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_306a8b9f-4ea3-4824-b558-bea1e6912dac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_90315222-1094-4822-978b-876ddc4aa2eb" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_306a8b9f-4ea3-4824-b558-bea1e6912dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansTables" xlink:type="simple" xlink:href="coo-20231031.xsd#StockPlansTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_428c2c46-e84f-4b0a-947c-43f2a9b73256" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9f57273f-4807-41ed-9006-b74722282790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_428c2c46-e84f-4b0a-947c-43f2a9b73256" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9f57273f-4807-41ed-9006-b74722282790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8329ad60-1457-4384-8730-79401b89c344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_428c2c46-e84f-4b0a-947c-43f2a9b73256" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8329ad60-1457-4384-8730-79401b89c344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3f061562-c072-487f-a34d-c7add58ec3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_428c2c46-e84f-4b0a-947c-43f2a9b73256" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3f061562-c072-487f-a34d-c7add58ec3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_cad0003d-4408-4593-a922-44fa9fa3311d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_428c2c46-e84f-4b0a-947c-43f2a9b73256" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_cad0003d-4408-4593-a922-44fa9fa3311d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsTables" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93007d5e-a5e6-428d-b184-f2bcd2f95b30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_e947526f-6f41-498c-8f2f-ca9db329d1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93007d5e-a5e6-428d-b184-f2bcd2f95b30" xlink:to="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_e947526f-6f41-498c-8f2f-ca9db329d1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_7f518e3d-4e5e-4243-8174-70256ba35ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93007d5e-a5e6-428d-b184-f2bcd2f95b30" xlink:to="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_7f518e3d-4e5e-4243-8174-70256ba35ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock_e3c52f42-0c6c-4bfe-b727-a37605386828" xlink:href="coo-20231031.xsd#coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93007d5e-a5e6-428d-b184-f2bcd2f95b30" xlink:to="loc_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock_e3c52f42-0c6c-4bfe-b727-a37605386828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_223ca284-b005-4128-aa45-739164355a80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93007d5e-a5e6-428d-b184-f2bcd2f95b30" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_223ca284-b005-4128-aa45-739164355a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_cc8bc5a7-2433-43b8-baf8-9b6641773ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93007d5e-a5e6-428d-b184-f2bcd2f95b30" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_cc8bc5a7-2433-43b8-baf8-9b6641773ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_b5c1437c-f646-4888-860d-7afce53fe9ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93007d5e-a5e6-428d-b184-f2bcd2f95b30" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_b5c1437c-f646-4888-860d-7afce53fe9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_b3dbea51-6a50-4013-8396-a420c4707428" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93007d5e-a5e6-428d-b184-f2bcd2f95b30" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_b3dbea51-6a50-4013-8396-a420c4707428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_fff3982f-6ab8-4889-b288-fbaaa7ef19b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93007d5e-a5e6-428d-b184-f2bcd2f95b30" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_fff3982f-6ab8-4889-b288-fbaaa7ef19b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationTables" xlink:type="simple" xlink:href="coo-20231031.xsd#BusinessSegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f4602d5f-ee0d-41bd-a4b2-38eb0620cf8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_d24332ce-27c2-4c06-a80d-c1ee2cfe2035" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f4602d5f-ee0d-41bd-a4b2-38eb0620cf8e" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_d24332ce-27c2-4c06-a80d-c1ee2cfe2035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b7226850-2472-4fad-8a36-eb44da196198" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f4602d5f-ee0d-41bd-a4b2-38eb0620cf8e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b7226850-2472-4fad-8a36-eb44da196198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_7a13cdc1-6527-4615-893f-a03b95295554" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f4602d5f-ee0d-41bd-a4b2-38eb0620cf8e" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_7a13cdc1-6527-4615-893f-a03b95295554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingTables" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancialDerivativesandHedgingTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e16b577f-db9a-42c0-baf3-e928b97c9bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_b700367d-01d7-4fb0-8e44-c7cc0cea0fee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e16b577f-db9a-42c0-baf3-e928b97c9bb1" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_b700367d-01d7-4fb0-8e44-c7cc0cea0fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_fbad37c3-175c-4596-8aa1-05d8b120df88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e16b577f-db9a-42c0-baf3-e928b97c9bb1" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_fbad37c3-175c-4596-8aa1-05d8b120df88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#OrganizationandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f83ad135-6a29-4ae5-9dd6-de3bc3e62497" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d99ffd22-4de6-4fe8-87d2-b634deb0eb14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f83ad135-6a29-4ae5-9dd6-de3bc3e62497" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d99ffd22-4de6-4fe8-87d2-b634deb0eb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc8778f8-ce98-4e20-8ca4-eeab75617b0c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d99ffd22-4de6-4fe8-87d2-b634deb0eb14" xlink:to="loc_srt_RangeAxis_cc8778f8-ce98-4e20-8ca4-eeab75617b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_71e6ada0-b13b-488a-b3dc-ba4b7eefab0b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cc8778f8-ce98-4e20-8ca4-eeab75617b0c" xlink:to="loc_srt_RangeMember_71e6ada0-b13b-488a-b3dc-ba4b7eefab0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_deda0509-d43d-4aff-a2eb-ec7c514a94e1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_71e6ada0-b13b-488a-b3dc-ba4b7eefab0b" xlink:to="loc_srt_MinimumMember_deda0509-d43d-4aff-a2eb-ec7c514a94e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1ee6f2f3-855c-470b-ac5a-438822106612" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_71e6ada0-b13b-488a-b3dc-ba4b7eefab0b" xlink:to="loc_srt_MaximumMember_1ee6f2f3-855c-470b-ac5a-438822106612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_033230f5-f8d2-4b3b-a7c2-6352216fe81f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d99ffd22-4de6-4fe8-87d2-b634deb0eb14" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_033230f5-f8d2-4b3b-a7c2-6352216fe81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02c2c02b-641b-477f-a7ae-e575d21567d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_033230f5-f8d2-4b3b-a7c2-6352216fe81f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02c2c02b-641b-477f-a7ae-e575d21567d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_b1c00219-b088-456d-86e0-242439f94f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02c2c02b-641b-477f-a7ae-e575d21567d6" xlink:to="loc_us-gaap_BuildingMember_b1c00219-b088-456d-86e0-242439f94f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1784355e-cbff-4694-acae-ed0535715629" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d99ffd22-4de6-4fe8-87d2-b634deb0eb14" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1784355e-cbff-4694-acae-ed0535715629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3e1f5238-6f76-48bf-8c01-f5808f4546df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1784355e-cbff-4694-acae-ed0535715629" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3e1f5238-6f76-48bf-8c01-f5808f4546df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_bc4a9a01-ca3e-42dc-872e-2e8a2b5b2e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3e1f5238-6f76-48bf-8c01-f5808f4546df" xlink:to="loc_us-gaap_CostOfSalesMember_bc4a9a01-ca3e-42dc-872e-2e8a2b5b2e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_056d5160-1162-45b7-9453-fa79dcce480d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3e1f5238-6f76-48bf-8c01-f5808f4546df" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_056d5160-1162-45b7-9453-fa79dcce480d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_966f5baf-c9f0-428b-b202-1fd869854b00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d99ffd22-4de6-4fe8-87d2-b634deb0eb14" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_966f5baf-c9f0-428b-b202-1fd869854b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NumberOfBusinessUnits_186435b3-71c7-4b92-a951-214d9e896428" xlink:href="coo-20231031.xsd#coo_NumberOfBusinessUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_966f5baf-c9f0-428b-b202-1fd869854b00" xlink:to="loc_coo_NumberOfBusinessUnits_186435b3-71c7-4b92-a951-214d9e896428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_fe0d3ba1-3ae6-473e-811e-35c8487b95b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_966f5baf-c9f0-428b-b202-1fd869854b00" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_fe0d3ba1-3ae6-473e-811e-35c8487b95b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_5f326213-f96e-4d3d-96d5-25662a8dfda6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_966f5baf-c9f0-428b-b202-1fd869854b00" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_5f326213-f96e-4d3d-96d5-25662a8dfda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_27447a8a-d4a8-49ed-aed1-fb9cafb32b28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_966f5baf-c9f0-428b-b202-1fd869854b00" xlink:to="loc_us-gaap_BusinessExitCosts1_27447a8a-d4a8-49ed-aed1-fb9cafb32b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#OrganizationandSignificantAccountingPoliciesInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ee868a99-e06d-4d8e-b768-5168169ca1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7f7bfada-cecb-4066-b0bd-6a331f0eca38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ee868a99-e06d-4d8e-b768-5168169ca1a9" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7f7bfada-cecb-4066-b0bd-6a331f0eca38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_b6c5d2e2-2b81-455c-a141-ec6073f49a69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ee868a99-e06d-4d8e-b768-5168169ca1a9" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_b6c5d2e2-2b81-455c-a141-ec6073f49a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_6827ced2-5c62-4d7d-9223-e6a2587e3bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ee868a99-e06d-4d8e-b768-5168169ca1a9" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_6827ced2-5c62-4d7d-9223-e6a2587e3bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_de07e2ce-75e9-49fd-9d95-02c17594e894" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ee868a99-e06d-4d8e-b768-5168169ca1a9" xlink:to="loc_us-gaap_InventoryNet_de07e2ce-75e9-49fd-9d95-02c17594e894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc3bc2b8-4a42-42a6-9a7f-252dfa9cb078" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0caec7de-9a33-452f-a62f-6e2114dfe86a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc3bc2b8-4a42-42a6-9a7f-252dfa9cb078" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0caec7de-9a33-452f-a62f-6e2114dfe86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30988206-df38-4dd5-a2bc-4c7824bbaa7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0caec7de-9a33-452f-a62f-6e2114dfe86a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30988206-df38-4dd5-a2bc-4c7824bbaa7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_239a086d-1cab-416f-b351-9bf959b43fba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30988206-df38-4dd5-a2bc-4c7824bbaa7d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_239a086d-1cab-416f-b351-9bf959b43fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_eb36c5a1-3250-483b-b9e5-f4336161a744" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_239a086d-1cab-416f-b351-9bf959b43fba" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_eb36c5a1-3250-483b-b9e5-f4336161a744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_879a9bd8-406d-45e7-838c-6d01eaaf25f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_239a086d-1cab-416f-b351-9bf959b43fba" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_879a9bd8-406d-45e7-838c-6d01eaaf25f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_0a5a11e1-ad5a-4033-858f-7348930cdec5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_239a086d-1cab-416f-b351-9bf959b43fba" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_0a5a11e1-ad5a-4033-858f-7348930cdec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_ce667a7f-c3d2-4f16-ae4b-3b871323ed5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_239a086d-1cab-416f-b351-9bf959b43fba" xlink:to="loc_us-gaap_ConstructionInProgressMember_ce667a7f-c3d2-4f16-ae4b-3b871323ed5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0caec7de-9a33-452f-a62f-6e2114dfe86a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_15bdfee1-9eb7-4a9d-86da-2fd711ab7142" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_15bdfee1-9eb7-4a9d-86da-2fd711ab7142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_28069172-b71c-45a0-81e9-225bed373ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_28069172-b71c-45a0-81e9-225bed373ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ce64b384-f8ff-4fd0-9fc3-e7a9c7596a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ce64b384-f8ff-4fd0-9fc3-e7a9c7596a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_f07ca2d6-f3fb-4a9a-8db4-28a4d6453f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_f07ca2d6-f3fb-4a9a-8db4-28a4d6453f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_25f254db-fbf4-496d-8ea7-78baea9a0f94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_90c7b9b0-b61b-4d91-a1bd-1f4bc573ceee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_25f254db-fbf4-496d-8ea7-78baea9a0f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_663b0a80-740d-4cea-99cc-e695e2b96884" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_27881110-3ef5-4d1e-bd68-0136c61b7d53" xlink:href="coo-20231031.xsd#coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_663b0a80-740d-4cea-99cc-e695e2b96884" xlink:to="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_27881110-3ef5-4d1e-bd68-0136c61b7d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_91c6c31c-12c7-4f88-b4da-63f1945677d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_27881110-3ef5-4d1e-bd68-0136c61b7d53" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_91c6c31c-12c7-4f88-b4da-63f1945677d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_9eaff76e-979a-4e9c-b5ad-f86fcb488acd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_27881110-3ef5-4d1e-bd68-0136c61b7d53" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_9eaff76e-979a-4e9c-b5ad-f86fcb488acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_07f7e4bc-e09f-458c-8afc-5d1672189346" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_27881110-3ef5-4d1e-bd68-0136c61b7d53" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_07f7e4bc-e09f-458c-8afc-5d1672189346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b5f316d6-c514-4e3e-937c-63a42195edef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_27881110-3ef5-4d1e-bd68-0136c61b7d53" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b5f316d6-c514-4e3e-937c-63a42195edef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6df7fc81-945e-47f7-8f96-dc5c2e13d3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_27881110-3ef5-4d1e-bd68-0136c61b7d53" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6df7fc81-945e-47f7-8f96-dc5c2e13d3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_c27ca52b-66a2-4218-b5be-1a47f3d4c2db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_27881110-3ef5-4d1e-bd68-0136c61b7d53" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_c27ca52b-66a2-4218-b5be-1a47f3d4c2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_1115fea8-2c1a-4b8f-8d2b-978a146aa317" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_27881110-3ef5-4d1e-bd68-0136c61b7d53" xlink:to="loc_us-gaap_OperatingLeaseLiability_1115fea8-2c1a-4b8f-8d2b-978a146aa317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_32438b18-9cc2-46d8-a271-c95b1721816e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_27881110-3ef5-4d1e-bd68-0136c61b7d53" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_32438b18-9cc2-46d8-a271-c95b1721816e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4f78b738-258d-4b87-8d3a-39121dc6c71a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_27881110-3ef5-4d1e-bd68-0136c61b7d53" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4f78b738-258d-4b87-8d3a-39121dc6c71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#OperatingLeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1b7e57aa-41fb-4bfb-8af1-1a89d9665dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_e600a7d7-3098-41c4-aefd-b0370760cb35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1b7e57aa-41fb-4bfb-8af1-1a89d9665dc9" xlink:to="loc_us-gaap_OperatingLeaseCost_e600a7d7-3098-41c4-aefd-b0370760cb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d1963149-a61e-4709-8e16-15d75257f0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4bdd2767-cff4-4f6b-880a-c64931a3fb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1963149-a61e-4709-8e16-15d75257f0b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4bdd2767-cff4-4f6b-880a-c64931a3fb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6b8b34ee-c38b-4223-a1ce-8f6f2fde57c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1963149-a61e-4709-8e16-15d75257f0b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6b8b34ee-c38b-4223-a1ce-8f6f2fde57c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5903fc2b-9076-4c4e-8efc-54f27987a013" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1963149-a61e-4709-8e16-15d75257f0b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5903fc2b-9076-4c4e-8efc-54f27987a013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_78c77a33-8474-4ab1-b220-b3325d13165a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1963149-a61e-4709-8e16-15d75257f0b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_78c77a33-8474-4ab1-b220-b3325d13165a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_87a1872e-8739-4318-bc6c-17e8a8184a40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1963149-a61e-4709-8e16-15d75257f0b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_87a1872e-8739-4318-bc6c-17e8a8184a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_02ad30b1-c3ea-40e2-8d13-b2f01c7d50af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1963149-a61e-4709-8e16-15d75257f0b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_02ad30b1-c3ea-40e2-8d13-b2f01c7d50af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ded6eda-2340-48b4-9c03-b666d8467e86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1963149-a61e-4709-8e16-15d75257f0b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ded6eda-2340-48b4-9c03-b666d8467e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_04b7770e-e15b-4d3b-98bc-d5bbfc129af7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1963149-a61e-4709-8e16-15d75257f0b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_04b7770e-e15b-4d3b-98bc-d5bbfc129af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4aea15ca-ee42-4875-b046-6e3ae50b85e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1963149-a61e-4709-8e16-15d75257f0b0" xlink:to="loc_us-gaap_OperatingLeaseLiability_4aea15ca-ee42-4875-b046-6e3ae50b85e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1" xlink:type="simple" xlink:href="coo-20231031.xsd#OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#AcquisitionsandJointVentureDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_538531aa-33e2-467d-9925-38ebf3bf7c14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_538531aa-33e2-467d-9925-38ebf3bf7c14" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b8dd938c-4876-4b6d-966a-5f25eca8d84d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b8dd938c-4876-4b6d-966a-5f25eca8d84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b8dd938c-4876-4b6d-966a-5f25eca8d84d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember_171d1b49-88ad-44a1-a821-053997b5fe61" xlink:href="coo-20231031.xsd#coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:to="loc_coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember_171d1b49-88ad-44a1-a821-053997b5fe61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CookMedicalsReproductiveHealthBusinessMember_bf7d8352-f28c-48f0-abf1-9da1fbff6b22" xlink:href="coo-20231031.xsd#coo_CookMedicalsReproductiveHealthBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:to="loc_coo_CookMedicalsReproductiveHealthBusinessMember_bf7d8352-f28c-48f0-abf1-9da1fbff6b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_GenerateLifeSciencesMember_b2ac8845-fa67-4074-b430-24abde5fae5e" xlink:href="coo-20231031.xsd#coo_GenerateLifeSciencesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:to="loc_coo_GenerateLifeSciencesMember_b2ac8845-fa67-4074-b430-24abde5fae5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_8218b4a7-a2c9-4ced-ac85-12e3deadeb63" xlink:href="coo-20231031.xsd#coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:to="loc_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_8218b4a7-a2c9-4ced-ac85-12e3deadeb63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CookMedicalMember_bb838a4c-53ee-4b12-ab27-0b51007a764b" xlink:href="coo-20231031.xsd#coo_CookMedicalMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acfac3b0-33ae-4fd7-9312-0f283e40c57a" xlink:to="loc_coo_CookMedicalMember_bb838a4c-53ee-4b12-ab27-0b51007a764b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b18bab18-8d08-439b-8f7d-da253b46d949" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b18bab18-8d08-439b-8f7d-da253b46d949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2de9ea4-2cb5-4e4a-83a4-4e8c3f33f3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b18bab18-8d08-439b-8f7d-da253b46d949" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2de9ea4-2cb5-4e4a-83a4-4e8c3f33f3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6985f89c-71fd-4539-a52b-4fe4b23a81d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2de9ea4-2cb5-4e4a-83a4-4e8c3f33f3eb" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6985f89c-71fd-4539-a52b-4fe4b23a81d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b9f4dfb2-ad4e-4772-a8b8-adbb6d335bce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2de9ea4-2cb5-4e4a-83a4-4e8c3f33f3eb" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b9f4dfb2-ad4e-4772-a8b8-adbb6d335bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_1aaa00ad-7247-4bcd-8776-d3dbc3f2740c" xlink:href="coo-20231031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_1aaa00ad-7247-4bcd-8776-d3dbc3f2740c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_a38fb42a-d9e4-4898-b6fa-394e6cdcc403" xlink:href="coo-20231031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_1aaa00ad-7247-4bcd-8776-d3dbc3f2740c" xlink:to="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_a38fb42a-d9e4-4898-b6fa-394e6cdcc403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesFirstInstallmentMember_828cc483-2738-4576-83b0-6a171716af69" xlink:href="coo-20231031.xsd#coo_PayablesFirstInstallmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_a38fb42a-d9e4-4898-b6fa-394e6cdcc403" xlink:to="loc_coo_PayablesFirstInstallmentMember_828cc483-2738-4576-83b0-6a171716af69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesSecondInstallmentMember_520b9609-290f-40f6-8e99-2884bfde353e" xlink:href="coo-20231031.xsd#coo_PayablesSecondInstallmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_a38fb42a-d9e4-4898-b6fa-394e6cdcc403" xlink:to="loc_coo_PayablesSecondInstallmentMember_520b9609-290f-40f6-8e99-2884bfde353e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesThirdInstallmentMember_6ab6efd7-e709-4723-a8f9-4a4e242a78ec" xlink:href="coo-20231031.xsd#coo_PayablesThirdInstallmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_a38fb42a-d9e4-4898-b6fa-394e6cdcc403" xlink:to="loc_coo_PayablesThirdInstallmentMember_6ab6efd7-e709-4723-a8f9-4a4e242a78ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesFourthInstallmentMember_457d20be-5f40-432f-8a37-145485f395d1" xlink:href="coo-20231031.xsd#coo_PayablesFourthInstallmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_a38fb42a-d9e4-4898-b6fa-394e6cdcc403" xlink:to="loc_coo_PayablesFourthInstallmentMember_457d20be-5f40-432f-8a37-145485f395d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a8352120-f7ea-4b4e-87df-7fe14ab6ff12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_us-gaap_CreditFacilityAxis_a8352120-f7ea-4b4e-87df-7fe14ab6ff12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b492a7f0-c3fd-4f00-875d-fcbf77322e65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_a8352120-f7ea-4b4e-87df-7fe14ab6ff12" xlink:to="loc_us-gaap_CreditFacilityDomain_b492a7f0-c3fd-4f00-875d-fcbf77322e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d19a8401-c0c8-4bb0-9ea2-0ede5a1011da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b492a7f0-c3fd-4f00-875d-fcbf77322e65" xlink:to="loc_us-gaap_LineOfCreditMember_d19a8401-c0c8-4bb0-9ea2-0ede5a1011da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1d597985-1c4e-47d6-9ce8-076c58be10a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_us-gaap_DebtInstrumentAxis_1d597985-1c4e-47d6-9ce8-076c58be10a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_de95d470-50ff-4292-83cb-163169799a67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d597985-1c4e-47d6-9ce8-076c58be10a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_de95d470-50ff-4292-83cb-163169799a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021Member_c85969d8-45c4-4bf2-974d-ed5d8503f24f" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de95d470-50ff-4292-83cb-163169799a67" xlink:to="loc_coo_TermLoanFacility2021Member_c85969d8-45c4-4bf2-974d-ed5d8503f24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8e979446-2fe3-4911-9811-eedf7b608dfa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8e979446-2fe3-4911-9811-eedf7b608dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_08a67e16-be32-499b-acfb-b8ae19bdbe99" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8e979446-2fe3-4911-9811-eedf7b608dfa" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_08a67e16-be32-499b-acfb-b8ae19bdbe99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SightGlassVisionIncMember_03cdd60e-2b18-4f4b-b1c5-3d79e4b6d5f2" xlink:href="coo-20231031.xsd#coo_SightGlassVisionIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_08a67e16-be32-499b-acfb-b8ae19bdbe99" xlink:to="loc_coo_SightGlassVisionIncMember_03cdd60e-2b18-4f4b-b1c5-3d79e4b6d5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_00a86ff3-32a3-4e7d-a05d-7d87b65ce55d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_dei_LegalEntityAxis_00a86ff3-32a3-4e7d-a05d-7d87b65ce55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_88351a64-2827-411e-aa73-e6ed36f571a5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_00a86ff3-32a3-4e7d-a05d-7d87b65ce55d" xlink:to="loc_dei_EntityDomain_88351a64-2827-411e-aa73-e6ed36f571a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EssilorInternationalSASMember_ccd56678-48de-44c5-9519-4b87f0421215" xlink:href="coo-20231031.xsd#coo_EssilorInternationalSASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_88351a64-2827-411e-aa73-e6ed36f571a5" xlink:to="loc_coo_EssilorInternationalSASMember_ccd56678-48de-44c5-9519-4b87f0421215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1dcb3d93-7bad-4dbe-a34e-3ab33d84f626" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1dcb3d93-7bad-4dbe-a34e-3ab33d84f626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_64948d6e-6d28-488c-91c0-7dd2c40d59cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1dcb3d93-7bad-4dbe-a34e-3ab33d84f626" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_64948d6e-6d28-488c-91c0-7dd2c40d59cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_3c8fa9d0-2578-480a-a017-8b9ba4b16ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_64948d6e-6d28-488c-91c0-7dd2c40d59cd" xlink:to="loc_us-gaap_SubsequentEventMember_3c8fa9d0-2578-480a-a017-8b9ba4b16ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3e9133b7-9f85-469a-bd40-1603cbed0a8b" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0d468bda-962f-4d11-8738-d5a38d6199ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0d468bda-962f-4d11-8738-d5a38d6199ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d3d85d1c-a7a0-4a0d-942f-aab10e362dca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d3d85d1c-a7a0-4a0d-942f-aab10e362dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_7b4fe420-78d3-4d96-b779-653bdd375fd9" xlink:href="coo-20231031.xsd#coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_7b4fe420-78d3-4d96-b779-653bdd375fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3c34fb2d-9eb2-4369-a5a8-b7e725810fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_Goodwill_3c34fb2d-9eb2-4369-a5a8-b7e725810fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6ca5eb8c-e3d2-4c54-876e-3e4f634ed1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_6ca5eb8c-e3d2-4c54-876e-3e4f634ed1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_efb4c23d-129b-41db-bd26-edd0d5a9752c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_efb4c23d-129b-41db-bd26-edd0d5a9752c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_e26bd4fd-b47d-4012-9857-b89941823e55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_e26bd4fd-b47d-4012-9857-b89941823e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccruedAcquisitionTerminationFee_4aa44b64-d27e-43ca-b075-4795fd474b42" xlink:href="coo-20231031.xsd#coo_AccruedAcquisitionTerminationFee"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_coo_AccruedAcquisitionTerminationFee_4aa44b64-d27e-43ca-b075-4795fd474b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ad5c6552-9cfa-4c63-a690-6312b0794557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ad5c6552-9cfa-4c63-a690-6312b0794557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_bb873c11-e954-443a-a3f9-307f95dcc5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_bb873c11-e954-443a-a3f9-307f95dcc5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_79c505d8-e2ed-4217-b47f-8a3e7d1ffbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_79c505d8-e2ed-4217-b47f-8a3e7d1ffbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a3d8aaa9-d8ad-4698-bf14-8381baced43b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_a3d8aaa9-d8ad-4698-bf14-8381baced43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationPaymentToSettleContingentConsideration_a10a0460-05cd-4cdb-a80f-4e758fb97ecc" xlink:href="coo-20231031.xsd#coo_BusinessCombinationPaymentToSettleContingentConsideration"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_coo_BusinessCombinationPaymentToSettleContingentConsideration_a10a0460-05cd-4cdb-a80f-4e758fb97ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_78c7faf5-8cf6-4e0c-9b9b-98ed768a1a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_78c7faf5-8cf6-4e0c-9b9b-98ed768a1a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_8993fee3-9113-4b0b-8af5-78a1bdedffe0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_8993fee3-9113-4b0b-8af5-78a1bdedffe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f9a4afb0-26b4-4774-8e35-e8891e7d3950" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_f9a4afb0-26b4-4774-8e35-e8891e7d3950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_c1aa2820-b2a9-40ae-9a29-377b7dfb9924" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_c1aa2820-b2a9-40ae-9a29-377b7dfb9924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_faad7a3c-a2f3-44ca-81f9-7460a634ec07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_EquityMethodInvestments_faad7a3c-a2f3-44ca-81f9-7460a634ec07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_865ec476-4f50-4ebe-8ede-9b9dce65b3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_865ec476-4f50-4ebe-8ede-9b9dce65b3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cbe01252-a451-438f-b0db-20a6a81d9f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cbe01252-a451-438f-b0db-20a6a81d9f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments_2509c1fe-c38b-419b-9a5e-6859a3ba618c" xlink:href="coo-20231031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_333e465e-548f-4633-b94c-89e2e83d6402" xlink:to="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments_2509c1fe-c38b-419b-9a5e-6859a3ba618c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dca30d2a-ab84-4176-bc3c-72ad0a33eafa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ebb7215f-cfb6-40f3-be63-7eaa94e1b15e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dca30d2a-ab84-4176-bc3c-72ad0a33eafa" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ebb7215f-cfb6-40f3-be63-7eaa94e1b15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_73ad8641-c27b-4e8d-ba95-e599c8291767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ebb7215f-cfb6-40f3-be63-7eaa94e1b15e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_73ad8641-c27b-4e8d-ba95-e599c8291767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_45e43cae-2671-4fab-803f-673fc2902e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_73ad8641-c27b-4e8d-ba95-e599c8291767" xlink:to="loc_us-gaap_SegmentDomain_45e43cae-2671-4fab-803f-673fc2902e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperSurgicalSegmentMember_32350875-42fd-4142-b8a7-6eb230848130" xlink:href="coo-20231031.xsd#coo_CooperSurgicalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_45e43cae-2671-4fab-803f-673fc2902e5b" xlink:to="loc_coo_CooperSurgicalSegmentMember_32350875-42fd-4142-b8a7-6eb230848130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperVisionSegmentMember_412d5447-2fc6-4054-b30b-121d47dbf67f" xlink:href="coo-20231031.xsd#coo_CooperVisionSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_45e43cae-2671-4fab-803f-673fc2902e5b" xlink:to="loc_coo_CooperVisionSegmentMember_412d5447-2fc6-4054-b30b-121d47dbf67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ebb7215f-cfb6-40f3-be63-7eaa94e1b15e" xlink:to="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_91517b7d-e2ef-43a6-86f4-f5f3a8563e09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:to="loc_us-gaap_NumberOfReportingUnits_91517b7d-e2ef-43a6-86f4-f5f3a8563e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_6bf9d750-6da5-48b2-bbf9-9d794da4836e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_6bf9d750-6da5-48b2-bbf9-9d794da4836e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_de3b859d-f0b0-4239-b50e-5c718857467d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_de3b859d-f0b0-4239-b50e-5c718857467d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_f5629614-a087-4a6a-bd10-141bd18a9a99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_f5629614-a087-4a6a-bd10-141bd18a9a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_a67b79ff-2412-472b-a2f5-d5e68c34dd96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3c89c32f-b245-4cd9-a64c-26cfaf29ae1a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_a67b79ff-2412-472b-a2f5-d5e68c34dd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_df9959c1-039a-41e8-93ae-7060a111f379" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5989de41-b8b1-4a6b-ba25-627ad374f304" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_df9959c1-039a-41e8-93ae-7060a111f379" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5989de41-b8b1-4a6b-ba25-627ad374f304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_93941e58-a712-4e1c-a2a1-691d49c6912b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5989de41-b8b1-4a6b-ba25-627ad374f304" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_93941e58-a712-4e1c-a2a1-691d49c6912b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0efa8e18-32fc-4201-b0e1-9b784e7d799c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_93941e58-a712-4e1c-a2a1-691d49c6912b" xlink:to="loc_us-gaap_SegmentDomain_0efa8e18-32fc-4201-b0e1-9b784e7d799c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperVisionSegmentMember_b89e2c98-f5ba-4905-9f64-9e9d0e8ddf3e" xlink:href="coo-20231031.xsd#coo_CooperVisionSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0efa8e18-32fc-4201-b0e1-9b784e7d799c" xlink:to="loc_coo_CooperVisionSegmentMember_b89e2c98-f5ba-4905-9f64-9e9d0e8ddf3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperSurgicalSegmentMember_ccdd01f5-368f-46d4-8662-5bc96abb6b09" xlink:href="coo-20231031.xsd#coo_CooperSurgicalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0efa8e18-32fc-4201-b0e1-9b784e7d799c" xlink:to="loc_coo_CooperSurgicalSegmentMember_ccdd01f5-368f-46d4-8662-5bc96abb6b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_adc2be6e-0287-473b-a377-63d4ca6c600c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5989de41-b8b1-4a6b-ba25-627ad374f304" xlink:to="loc_us-gaap_GoodwillLineItems_adc2be6e-0287-473b-a377-63d4ca6c600c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_33843e20-e2af-4e31-94c8-2b5af4b95faa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_adc2be6e-0287-473b-a377-63d4ca6c600c" xlink:to="loc_us-gaap_GoodwillRollForward_33843e20-e2af-4e31-94c8-2b5af4b95faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9ec5c176-7c09-4fe4-98dc-d3fd6a6395cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_33843e20-e2af-4e31-94c8-2b5af4b95faa" xlink:to="loc_us-gaap_Goodwill_9ec5c176-7c09-4fe4-98dc-d3fd6a6395cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_98c9ae6a-313f-4e63-89a2-e36be1cbaf71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_33843e20-e2af-4e31-94c8-2b5af4b95faa" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_98c9ae6a-313f-4e63-89a2-e36be1cbaf71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_6586314d-224f-4326-9865-45a466d16e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_33843e20-e2af-4e31-94c8-2b5af4b95faa" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_6586314d-224f-4326-9865-45a466d16e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_52ef58e1-c6b2-4cc9-995e-d6cb0ea09036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_33843e20-e2af-4e31-94c8-2b5af4b95faa" xlink:to="loc_us-gaap_Goodwill_52ef58e1-c6b2-4cc9-995e-d6cb0ea09036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IntangibleAssetsOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e22407df-f1f2-405f-883d-d5097c3af1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_14f9e95d-4735-4891-a85d-0d71690e7a26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e22407df-f1f2-405f-883d-d5097c3af1e9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_14f9e95d-4735-4891-a85d-0d71690e7a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3a198899-f44d-420c-8e37-e18a40270d06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_14f9e95d-4735-4891-a85d-0d71690e7a26" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3a198899-f44d-420c-8e37-e18a40270d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3a198899-f44d-420c-8e37-e18a40270d06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_bf324dee-49a5-4d6f-9a5e-460f3fd43b83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:to="loc_us-gaap_TrademarksMember_bf324dee-49a5-4d6f-9a5e-460f3fd43b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CompositeMember_f9226a0b-400b-4a9d-a222-82b4301c5d8a" xlink:href="coo-20231031.xsd#coo_CompositeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:to="loc_coo_CompositeMember_f9226a0b-400b-4a9d-a222-82b4301c5d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_7cc11527-9a6b-4330-a189-04cc807d27cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_7cc11527-9a6b-4330-a189-04cc807d27cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_41a17871-63bc-4a3f-8bd5-5b24bc8386fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:to="loc_us-gaap_CustomerRelationshipsMember_41a17871-63bc-4a3f-8bd5-5b24bc8386fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LicenseAndDistributionRightsAndOtherMember_4139a7f2-e1d3-4663-a5c1-1f75b5ef1e86" xlink:href="coo-20231031.xsd#coo_LicenseAndDistributionRightsAndOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b97ed33b-00ed-4b5a-aa63-543d8d21b799" xlink:to="loc_coo_LicenseAndDistributionRightsAndOtherMember_4139a7f2-e1d3-4663-a5c1-1f75b5ef1e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_14f9e95d-4735-4891-a85d-0d71690e7a26" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9e07b9ca-c7ca-4d1f-9a9c-b1af5112c5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9e07b9ca-c7ca-4d1f-9a9c-b1af5112c5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_456ffe75-962a-4777-9326-e198c19002bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_456ffe75-962a-4777-9326-e198c19002bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dcea77f9-a193-4592-856d-29c1627586de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dcea77f9-a193-4592-856d-29c1627586de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_49a3d0a5-a33b-4997-8d6d-28c012f79219" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_49a3d0a5-a33b-4997-8d6d-28c012f79219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_777d5790-490c-4e4b-8711-0414e3a3b2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_777d5790-490c-4e4b-8711-0414e3a3b2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c699fd9c-bb92-4b2d-bf6e-98206f5c7783" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3cfea19-c013-4347-985b-56dbfb4bfa5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c699fd9c-bb92-4b2d-bf6e-98206f5c7783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e3b40b31-816c-4fe7-90f6-5908af5ab227" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f4a3bb0b-28cf-4ddb-b06d-fb3b6af45c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e3b40b31-816c-4fe7-90f6-5908af5ab227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f4a3bb0b-28cf-4ddb-b06d-fb3b6af45c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3b2e0b15-aa2e-46bd-a4db-da452794d125" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e3b40b31-816c-4fe7-90f6-5908af5ab227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3b2e0b15-aa2e-46bd-a4db-da452794d125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e3a09df4-063b-46be-95e1-ceaf0288e006" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e3b40b31-816c-4fe7-90f6-5908af5ab227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e3a09df4-063b-46be-95e1-ceaf0288e006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ba840bfa-bbf1-4858-ad3c-4d3f4f3e91bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e3b40b31-816c-4fe7-90f6-5908af5ab227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ba840bfa-bbf1-4858-ad3c-4d3f4f3e91bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4df9f2e8-ed83-4b6d-8d61-5f96b20a1344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e3b40b31-816c-4fe7-90f6-5908af5ab227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4df9f2e8-ed83-4b6d-8d61-5f96b20a1344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_56fe3c25-f9f0-434b-8038-03025ae76e23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e3b40b31-816c-4fe7-90f6-5908af5ab227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_56fe3c25-f9f0-434b-8038-03025ae76e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_12f88214-8059-4cb9-a017-2fb9257beafe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e3b40b31-816c-4fe7-90f6-5908af5ab227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_12f88214-8059-4cb9-a017-2fb9257beafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancingArrangementsTotalDebtDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_19f8d0cc-4f2e-4454-bc2c-87071db772f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9c1a0b37-a0b7-4e9e-8020-c44f2926ff69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_19f8d0cc-4f2e-4454-bc2c-87071db772f6" xlink:to="loc_us-gaap_DebtInstrumentTable_9c1a0b37-a0b7-4e9e-8020-c44f2926ff69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_9cddc7b1-60a7-4636-b6ec-e68dd62dd318" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9c1a0b37-a0b7-4e9e-8020-c44f2926ff69" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_9cddc7b1-60a7-4636-b6ec-e68dd62dd318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_bf3b3727-bd04-4bf5-9202-3c1489b8be49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_9cddc7b1-60a7-4636-b6ec-e68dd62dd318" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_bf3b3727-bd04-4bf5-9202-3c1489b8be49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OverdraftAndOtherCreditFacilitiesMember_ef35a211-7b9e-407e-91e2-008dbcfd071c" xlink:href="coo-20231031.xsd#coo_OverdraftAndOtherCreditFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_bf3b3727-bd04-4bf5-9202-3c1489b8be49" xlink:to="loc_coo_OverdraftAndOtherCreditFacilitiesMember_ef35a211-7b9e-407e-91e2-008dbcfd071c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoansMember_ef129b1a-7032-4178-b548-34aef6a928ef" xlink:href="coo-20231031.xsd#coo_TermLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_bf3b3727-bd04-4bf5-9202-3c1489b8be49" xlink:to="loc_coo_TermLoansMember_ef129b1a-7032-4178-b548-34aef6a928ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b151138c-647a-47b4-972c-ba7b502e82a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9c1a0b37-a0b7-4e9e-8020-c44f2926ff69" xlink:to="loc_us-gaap_CreditFacilityAxis_b151138c-647a-47b4-972c-ba7b502e82a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4e652f42-44c7-48f7-9a08-00af0e79de10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b151138c-647a-47b4-972c-ba7b502e82a3" xlink:to="loc_us-gaap_CreditFacilityDomain_4e652f42-44c7-48f7-9a08-00af0e79de10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d0387d00-dca9-4a41-8b33-6259123b53e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_4e652f42-44c7-48f7-9a08-00af0e79de10" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d0387d00-dca9-4a41-8b33-6259123b53e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ffad2399-43a3-4118-a1cc-4b90db1fb55d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9c1a0b37-a0b7-4e9e-8020-c44f2926ff69" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ffad2399-43a3-4118-a1cc-4b90db1fb55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9eb8ae3e-ae57-436f-810c-a932d7b6195c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ffad2399-43a3-4118-a1cc-4b90db1fb55d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9eb8ae3e-ae57-436f-810c-a932d7b6195c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_a22f2f47-637e-4619-b01d-b54d0bc67b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9eb8ae3e-ae57-436f-810c-a932d7b6195c" xlink:to="loc_us-gaap_LineOfCreditMember_a22f2f47-637e-4619-b01d-b54d0bc67b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_7d827e4e-1546-479d-92e9-59bdb63592e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9eb8ae3e-ae57-436f-810c-a932d7b6195c" xlink:to="loc_us-gaap_MediumTermNotesMember_7d827e4e-1546-479d-92e9-59bdb63592e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OtherDebtMember_dfa2990d-102c-4efc-9037-5659bd359c1a" xlink:href="coo-20231031.xsd#coo_OtherDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9eb8ae3e-ae57-436f-810c-a932d7b6195c" xlink:to="loc_coo_OtherDebtMember_dfa2990d-102c-4efc-9037-5659bd359c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_52d9adbc-2430-4934-9204-33e86816fe93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9c1a0b37-a0b7-4e9e-8020-c44f2926ff69" xlink:to="loc_us-gaap_DebtInstrumentLineItems_52d9adbc-2430-4934-9204-33e86816fe93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract_638d91aa-7ebd-43f2-a47f-54036f76c179" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_52d9adbc-2430-4934-9204-33e86816fe93" xlink:to="loc_us-gaap_ShortTermBorrowingsAbstract_638d91aa-7ebd-43f2-a47f-54036f76c179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_71a13942-0d0a-4528-b7bd-723a1c842aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_638d91aa-7ebd-43f2-a47f-54036f76c179" xlink:to="loc_us-gaap_ShortTermBorrowings_71a13942-0d0a-4528-b7bd-723a1c842aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_ac03687c-e39a-4c56-a200-90a5f78b497b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_638d91aa-7ebd-43f2-a47f-54036f76c179" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_ac03687c-e39a-4c56-a200-90a5f78b497b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8fe7cfef-3cf9-41eb-82f4-1e11c4c23d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent_ac03687c-e39a-4c56-a200-90a5f78b497b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8fe7cfef-3cf9-41eb-82f4-1e11c4c23d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_d3bd79f4-0f7e-48b8-86b3-0299b3b7b00e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_638d91aa-7ebd-43f2-a47f-54036f76c179" xlink:to="loc_us-gaap_DebtCurrent_d3bd79f4-0f7e-48b8-86b3-0299b3b7b00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_52d9adbc-2430-4934-9204-33e86816fe93" xlink:to="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8773efa7-3526-46af-a6d9-9611392bc57e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8773efa7-3526-46af-a6d9-9611392bc57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_ac72c9c8-fe50-436f-a0e5-7f9e98238320" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_ac72c9c8-fe50-436f-a0e5-7f9e98238320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d6906793-8db6-4cb7-a95e-d684ec2c12b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d6906793-8db6-4cb7-a95e-d684ec2c12b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6c72f978-730a-493d-af82-01a5783187f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6c72f978-730a-493d-af82-01a5783187f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_9c812196-e514-4871-948a-e13fd579d47c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6c72f978-730a-493d-af82-01a5783187f9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_9c812196-e514-4871-948a-e13fd579d47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_89ca0df2-ec01-460a-88f9-068039ab007c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_99fdffc5-c9a7-4c09-b77c-e35a7546bf0b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_89ca0df2-ec01-460a-88f9-068039ab007c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_89526007-860d-4c71-ad65-5380aa9aa494" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_19f8d0cc-4f2e-4454-bc2c-87071db772f6" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_89526007-860d-4c71-ad65-5380aa9aa494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancingArrangementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1368902a-3a94-4f84-9ae0-54cee08c99da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:href="coo-20231031.xsd#coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1368902a-3a94-4f84-9ae0-54cee08c99da" xlink:to="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2db1ac90-febd-4172-9a1e-faef5c568343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:to="loc_us-gaap_CreditFacilityAxis_2db1ac90-febd-4172-9a1e-faef5c568343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_da256488-7ebd-4571-9d2e-68a5b6379001" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_2db1ac90-febd-4172-9a1e-faef5c568343" xlink:to="loc_us-gaap_CreditFacilityDomain_da256488-7ebd-4571-9d2e-68a5b6379001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_bf17d6ff-0f87-4894-b573-9d86b0258a45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_da256488-7ebd-4571-9d2e-68a5b6379001" xlink:to="loc_us-gaap_LineOfCreditMember_bf17d6ff-0f87-4894-b573-9d86b0258a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_47c742ea-e39d-444a-813f-f200fa5f6d97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_da256488-7ebd-4571-9d2e-68a5b6379001" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_47c742ea-e39d-444a-813f-f200fa5f6d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2020Member_8a06b78f-f0e9-40dc-8c79-633bfd06dffd" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2020Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_da256488-7ebd-4571-9d2e-68a5b6379001" xlink:to="loc_coo_TermLoanFacility2020Member_8a06b78f-f0e9-40dc-8c79-633bfd06dffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_a7e82264-ab5f-4878-b158-ace7458373f1" xlink:href="coo-20231031.xsd#coo_RevolvingCreditFacilityAndTermLoanFacility2020Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_da256488-7ebd-4571-9d2e-68a5b6379001" xlink:to="loc_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_a7e82264-ab5f-4878-b158-ace7458373f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_84e227db-7344-462c-919b-458e16dd83ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:to="loc_us-gaap_DebtInstrumentAxis_84e227db-7344-462c-919b-458e16dd83ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_84e227db-7344-462c-919b-458e16dd83ce" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021Member_484664fb-300f-4c58-a1a7-f9eae456fb3f" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_TermLoanFacility2021Member_484664fb-300f-4c58-a1a7-f9eae456fb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021BaseRateLoansMember_aee36252-047b-4e59-bd9b-cd0be53a5d3f" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2021BaseRateLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_TermLoanFacility2021BaseRateLoansMember_aee36252-047b-4e59-bd9b-cd0be53a5d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021AdjustedLIBORRateLoansMember_d9d8bbde-2066-4ac1-a481-5b19fc3fb606" xlink:href="coo-20231031.xsd#coo_TermLoanFacility2021AdjustedLIBORRateLoansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_TermLoanFacility2021AdjustedLIBORRateLoansMember_d9d8bbde-2066-4ac1-a481-5b19fc3fb606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanAgreement2021364DayMember_3bc2d083-f451-4c4e-8316-389af60e2727" xlink:href="coo-20231031.xsd#coo_TermLoanAgreement2021364DayMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_TermLoanAgreement2021364DayMember_3bc2d083-f451-4c4e-8316-389af60e2727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CreditAgreement2020Member_026824d1-9c7a-493b-91b6-5c3cd5940559" xlink:href="coo-20231031.xsd#coo_CreditAgreement2020Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_CreditAgreement2020Member_026824d1-9c7a-493b-91b6-5c3cd5940559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EuropeanCreditFacilityMember_0caa902b-7bdc-4310-a1dc-2a6396a2f54d" xlink:href="coo-20231031.xsd#coo_EuropeanCreditFacilityMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_EuropeanCreditFacilityMember_0caa902b-7bdc-4310-a1dc-2a6396a2f54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AsianPacificCreditFacilitiesYenDenominatedMember_e34bf6c5-49ea-47fb-b60d-8fa7e681cd45" xlink:href="coo-20231031.xsd#coo_AsianPacificCreditFacilitiesYenDenominatedMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9dd19c0-d07d-49d1-8e5c-467e8db1e876" xlink:to="loc_coo_AsianPacificCreditFacilitiesYenDenominatedMember_e34bf6c5-49ea-47fb-b60d-8fa7e681cd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_a1987bf1-7eb9-46e7-8ce4-9934e33eee30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:to="loc_us-gaap_VariableRateAxis_a1987bf1-7eb9-46e7-8ce4-9934e33eee30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a930e590-15d2-45af-b548-c544f9e46afa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_a1987bf1-7eb9-46e7-8ce4-9934e33eee30" xlink:to="loc_us-gaap_VariableRateDomain_a930e590-15d2-45af-b548-c544f9e46afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SecuredOvernightFinancingRateSOFRMember_f8c8f0c9-3e06-4b62-8575-93346fdaac1e" xlink:href="coo-20231031.xsd#coo_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_a930e590-15d2-45af-b548-c544f9e46afa" xlink:to="loc_coo_SecuredOvernightFinancingRateSOFRMember_f8c8f0c9-3e06-4b62-8575-93346fdaac1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_4c13a91a-ce11-406f-b137-875ad715efc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_a930e590-15d2-45af-b548-c544f9e46afa" xlink:to="loc_us-gaap_BaseRateMember_4c13a91a-ce11-406f-b137-875ad715efc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_827dbad1-b1fe-49a7-bfab-12c60fb77cde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_a930e590-15d2-45af-b548-c544f9e46afa" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_827dbad1-b1fe-49a7-bfab-12c60fb77cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_252f5a78-29bc-4f97-9219-af8aa91036f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_252f5a78-29bc-4f97-9219-af8aa91036f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_4397ef2a-121a-4106-99f4-637084e35e70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_252f5a78-29bc-4f97-9219-af8aa91036f1" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_4397ef2a-121a-4106-99f4-637084e35e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoansMember_3a51fe4f-76f6-49c1-aa4f-78ff8a3a193a" xlink:href="coo-20231031.xsd#coo_TermLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_4397ef2a-121a-4106-99f4-637084e35e70" xlink:to="loc_coo_TermLoansMember_3a51fe4f-76f6-49c1-aa4f-78ff8a3a193a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_63908419-4bde-4d94-81f2-b068da755cae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_63908419-4bde-4d94-81f2-b068da755cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_96001e60-2b59-40bc-acfd-969d135db460" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_63908419-4bde-4d94-81f2-b068da755cae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_96001e60-2b59-40bc-acfd-969d135db460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_2980ba5c-8e6f-411c-9e48-4f3bcdb72ded" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_96001e60-2b59-40bc-acfd-969d135db460" xlink:to="loc_us-gaap_LineOfCreditMember_2980ba5c-8e6f-411c-9e48-4f3bcdb72ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_49620205-2d50-4791-9ba3-cfdeb29ae9ad" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:to="loc_srt_RangeAxis_49620205-2d50-4791-9ba3-cfdeb29ae9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_51ef3e88-729d-4bd2-bc9f-46778f51ce20" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_49620205-2d50-4791-9ba3-cfdeb29ae9ad" xlink:to="loc_srt_RangeMember_51ef3e88-729d-4bd2-bc9f-46778f51ce20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_49240867-c07c-4a43-a360-3d56b8dc7d68" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_51ef3e88-729d-4bd2-bc9f-46778f51ce20" xlink:to="loc_srt_MinimumMember_49240867-c07c-4a43-a360-3d56b8dc7d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_76fd027d-4123-4423-a8a9-b1a9fc5f85ff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_51ef3e88-729d-4bd2-bc9f-46778f51ce20" xlink:to="loc_srt_MaximumMember_76fd027d-4123-4423-a8a9-b1a9fc5f85ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:href="coo-20231031.xsd#coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_948b549a-8526-449b-aab7-b1eafc3ac6c2" xlink:to="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6b963630-96ff-4704-8a3b-bc5dc59ce7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6b963630-96ff-4704-8a3b-bc5dc59ce7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_a40e1793-fa2d-4a91-af37-ffac3f5585d5" xlink:href="coo-20231031.xsd#coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_a40e1793-fa2d-4a91-af37-ffac3f5585d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_88c32dfa-96af-4b28-88b9-7ab15233bfce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_88c32dfa-96af-4b28-88b9-7ab15233bfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_b6787dfb-8c4c-42bf-990d-366751d48d01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_LongTermLineOfCredit_b6787dfb-8c4c-42bf-990d-366751d48d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_cc7b9a08-5e10-47ab-b27a-8cfda13b1d64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_cc7b9a08-5e10-47ab-b27a-8cfda13b1d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_a3aa7bcb-0b04-498f-80e3-02dfef982c11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_DebtInstrumentTerm_a3aa7bcb-0b04-498f-80e3-02dfef982c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5e6b3e90-a81b-4a6f-b180-7c93fcdf53fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5e6b3e90-a81b-4a6f-b180-7c93fcdf53fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_0323d03a-1fea-47ec-ad74-3b990766b67b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_0323d03a-1fea-47ec-ad74-3b990766b67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_625b56b8-b94a-4df1-930d-d55e561293f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_625b56b8-b94a-4df1-930d-d55e561293f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_501584be-9c52-4301-9810-c86c1942237e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_LineOfCredit_501584be-9c52-4301-9810-c86c1942237e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9193588e-64cc-4425-923d-dde2597d7107" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems_7f8b3982-ee75-4d6c-8619-b649a8d43e7e" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9193588e-64cc-4425-923d-dde2597d7107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_aeb8f69f-712b-4fca-bea5-821f92046756" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_5e2b125c-0d77-428e-ad91-7a78cd517c57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_aeb8f69f-712b-4fca-bea5-821f92046756" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_5e2b125c-0d77-428e-ad91-7a78cd517c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_9bf21a8a-106c-4f68-b60c-fafc788e9a42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5e2b125c-0d77-428e-ad91-7a78cd517c57" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_9bf21a8a-106c-4f68-b60c-fafc788e9a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_11b8a2eb-c199-4ff9-a7f5-0e4175982f42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_9bf21a8a-106c-4f68-b60c-fafc788e9a42" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_11b8a2eb-c199-4ff9-a7f5-0e4175982f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_1d32e805-92d2-49fe-b19d-b55f2bbe035a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_11b8a2eb-c199-4ff9-a7f5-0e4175982f42" xlink:to="loc_us-gaap_DomesticCountryMember_1d32e805-92d2-49fe-b19d-b55f2bbe035a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f113a992-7674-4c8c-95ac-17538e14d71c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_11b8a2eb-c199-4ff9-a7f5-0e4175982f42" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f113a992-7674-4c8c-95ac-17538e14d71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5e2b125c-0d77-428e-ad91-7a78cd517c57" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_ef65770b-84fb-49e7-a823-223520920457" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_ef65770b-84fb-49e7-a823-223520920457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_cfa7f4cb-12ad-449e-b68e-0c2d6382bc66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_cfa7f4cb-12ad-449e-b68e-0c2d6382bc66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_ab1059a9-a3c7-471f-9748-d0dada135570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_OperatingLossCarryforwards_ab1059a9-a3c7-471f-9748-d0dada135570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_db7f528f-b1d3-40fa-b2e8-419b572795d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_db7f528f-b1d3-40fa-b2e8-419b572795d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_6b3c0011-81ac-4828-a3b9-8380d11357ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_6b3c0011-81ac-4828-a3b9-8380d11357ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8c312ae5-98aa-4d5b-83bf-57a46f4b6872" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8c312ae5-98aa-4d5b-83bf-57a46f4b6872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_e9518768-a152-4755-9ec7-ea92fa7ab4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_e9518768-a152-4755-9ec7-ea92fa7ab4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_3ce97554-9139-48eb-9fe4-2c027043d542" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f81e6a07-cd7f-4c1f-b6a3-ddd278612f68" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_3ce97554-9139-48eb-9fe4-2c027043d542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7f3e047c-588d-41ba-b321-014b2ea5d749" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c0459163-bc5d-4455-83ff-5268ccde9d88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7f3e047c-588d-41ba-b321-014b2ea5d749" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c0459163-bc5d-4455-83ff-5268ccde9d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e66ee2a5-85aa-462f-8cca-b52a673bb0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c0459163-bc5d-4455-83ff-5268ccde9d88" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e66ee2a5-85aa-462f-8cca-b52a673bb0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_812384c4-d65c-496f-b356-1223257c4b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c0459163-bc5d-4455-83ff-5268ccde9d88" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_812384c4-d65c-496f-b356-1223257c4b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_697054b6-8e97-4707-83c0-0e93f29f049e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c0459163-bc5d-4455-83ff-5268ccde9d88" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_697054b6-8e97-4707-83c0-0e93f29f049e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IncomeTaxesIncomeTaxProvisionBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c0fbf1f8-5fe2-4c8a-b56a-062650ccfa18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_f74dfb98-370f-411e-a74e-6dfc3c5f528c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c0fbf1f8-5fe2-4c8a-b56a-062650ccfa18" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_f74dfb98-370f-411e-a74e-6dfc3c5f528c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8fff9c4b-87f4-48a9-b8cd-3df23864b4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_f74dfb98-370f-411e-a74e-6dfc3c5f528c" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8fff9c4b-87f4-48a9-b8cd-3df23864b4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2e25ed21-fb3f-460e-a16d-359dc59fac3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_f74dfb98-370f-411e-a74e-6dfc3c5f528c" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2e25ed21-fb3f-460e-a16d-359dc59fac3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c5987c46-cd5a-4379-9f9e-f67c0ac3a0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_f74dfb98-370f-411e-a74e-6dfc3c5f528c" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c5987c46-cd5a-4379-9f9e-f67c0ac3a0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_05d9259c-e158-4c09-a4b3-b899d070e895" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_f74dfb98-370f-411e-a74e-6dfc3c5f528c" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_05d9259c-e158-4c09-a4b3-b899d070e895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09562228-fed1-448c-930f-3bcd076a8ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c0fbf1f8-5fe2-4c8a-b56a-062650ccfa18" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09562228-fed1-448c-930f-3bcd076a8ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c30882e6-f737-47a4-9086-6418234f0480" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09562228-fed1-448c-930f-3bcd076a8ea5" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c30882e6-f737-47a4-9086-6418234f0480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_31c33219-12b8-4349-bb35-5778c9bc42a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09562228-fed1-448c-930f-3bcd076a8ea5" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_31c33219-12b8-4349-bb35-5778c9bc42a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1c160429-685f-494b-a127-c6eed4fee6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09562228-fed1-448c-930f-3bcd076a8ea5" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1c160429-685f-494b-a127-c6eed4fee6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e616e329-4329-4268-9a34-223912c3cd30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09562228-fed1-448c-930f-3bcd076a8ea5" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e616e329-4329-4268-9a34-223912c3cd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c7c15709-ebdc-4d65-bb57-8e6f0768f85f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c0fbf1f8-5fe2-4c8a-b56a-062650ccfa18" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c7c15709-ebdc-4d65-bb57-8e6f0768f85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0d36e814-c6a6-4483-99db-8506198e2850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_87c86a8e-375c-4f02-8800-7521dc5b544f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d36e814-c6a6-4483-99db-8506198e2850" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_87c86a8e-375c-4f02-8800-7521dc5b544f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_85ce0fbd-2511-4e47-9653-eaff5a131e81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d36e814-c6a6-4483-99db-8506198e2850" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_85ce0fbd-2511-4e47-9653-eaff5a131e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_01eb6594-0716-4a54-b46a-db8640e6f168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d36e814-c6a6-4483-99db-8506198e2850" xlink:to="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_01eb6594-0716-4a54-b46a-db8640e6f168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_456c6530-3815-4020-a1c3-32f8533d09a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d36e814-c6a6-4483-99db-8506198e2850" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_456c6530-3815-4020-a1c3-32f8533d09a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfAssets_e8846fee-a8d5-425e-b9b9-ec3f26c786b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationDispositionOfAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d36e814-c6a6-4483-99db-8506198e2850" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfAssets_e8846fee-a8d5-425e-b9b9-ec3f26c786b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_5233d4df-587d-4f8d-ae0f-200a62a18b03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d36e814-c6a6-4483-99db-8506198e2850" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_5233d4df-587d-4f8d-ae0f-200a62a18b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_b7f6df44-74be-4d40-bdd9-7ed59813ff0d" xlink:href="coo-20231031.xsd#coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d36e814-c6a6-4483-99db-8506198e2850" xlink:to="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_b7f6df44-74be-4d40-bdd9-7ed59813ff0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_8961c825-6501-4c81-ab38-e89d22778980" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d36e814-c6a6-4483-99db-8506198e2850" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_8961c825-6501-4c81-ab38-e89d22778980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_d43540f3-c74b-469c-8465-837bdcc2587b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d36e814-c6a6-4483-99db-8506198e2850" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_d43540f3-c74b-469c-8465-837bdcc2587b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_48602136-e37b-468e-b6fd-5b9d88b85519" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d36e814-c6a6-4483-99db-8506198e2850" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_48602136-e37b-468e-b6fd-5b9d88b85519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_64266ea7-663a-40e6-add4-16d87eed1bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_c5952ce8-896f-4f5e-8943-febe17becd24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_64266ea7-663a-40e6-add4-16d87eed1bd9" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_c5952ce8-896f-4f5e-8943-febe17becd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_9c22ebaa-f403-4ea5-8b9c-5d3d3399f434" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_c5952ce8-896f-4f5e-8943-febe17becd24" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_9c22ebaa-f403-4ea5-8b9c-5d3d3399f434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_08f2af7e-7f9f-4c8a-a187-a4ac759216ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9c22ebaa-f403-4ea5-8b9c-5d3d3399f434" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_08f2af7e-7f9f-4c8a-a187-a4ac759216ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_8d44a843-f789-40a2-b654-230b21ac1cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9c22ebaa-f403-4ea5-8b9c-5d3d3399f434" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_8d44a843-f789-40a2-b654-230b21ac1cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_f399cb66-7f60-460d-a7e1-c8d2c6e3ddbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9c22ebaa-f403-4ea5-8b9c-5d3d3399f434" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_f399cb66-7f60-460d-a7e1-c8d2c6e3ddbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_20fb4e0c-9f3e-40b6-a6ec-3b441efea5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9c22ebaa-f403-4ea5-8b9c-5d3d3399f434" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_20fb4e0c-9f3e-40b6-a6ec-3b441efea5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_21b2d118-6d03-42ab-83fb-b3bbc1f65042" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9c22ebaa-f403-4ea5-8b9c-5d3d3399f434" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_21b2d118-6d03-42ab-83fb-b3bbc1f65042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_d074f0e2-3b9c-46eb-82c9-e71686085056" xlink:href="coo-20231031.xsd#coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9c22ebaa-f403-4ea5-8b9c-5d3d3399f434" xlink:to="loc_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_d074f0e2-3b9c-46eb-82c9-e71686085056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_515af2c0-b53e-4f61-8956-c5991eaf2451" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9c22ebaa-f403-4ea5-8b9c-5d3d3399f434" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_515af2c0-b53e-4f61-8956-c5991eaf2451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_380a904e-47b9-4dfe-8c40-f5855e0cc83e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9c22ebaa-f403-4ea5-8b9c-5d3d3399f434" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_380a904e-47b9-4dfe-8c40-f5855e0cc83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8319d4b7-9259-4037-a347-b45ed6b356a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9c22ebaa-f403-4ea5-8b9c-5d3d3399f434" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8319d4b7-9259-4037-a347-b45ed6b356a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_57789dc1-4821-4de4-9f3c-cdc071df2442" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9c22ebaa-f403-4ea5-8b9c-5d3d3399f434" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_57789dc1-4821-4de4-9f3c-cdc071df2442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_81192f60-c333-4871-9993-3fd8aed486a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_c5952ce8-896f-4f5e-8943-febe17becd24" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_81192f60-c333-4871-9993-3fd8aed486a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_00813652-0992-49b9-8d54-460c6f592f52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_81192f60-c333-4871-9993-3fd8aed486a0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_00813652-0992-49b9-8d54-460c6f592f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_c46b0c00-509a-42ab-9eb3-5131b56ab822" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_81192f60-c333-4871-9993-3fd8aed486a0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_c46b0c00-509a-42ab-9eb3-5131b56ab822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_40aaa720-4317-452f-b320-1760f79539a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_81192f60-c333-4871-9993-3fd8aed486a0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_40aaa720-4317-452f-b320-1760f79539a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_f7213878-da9d-49be-bc29-a5eb7f703aa2" xlink:href="coo-20231031.xsd#coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_81192f60-c333-4871-9993-3fd8aed486a0" xlink:to="loc_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_f7213878-da9d-49be-bc29-a5eb7f703aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_10b4ba98-8391-4b2a-a6c6-8ada88cbbde1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_81192f60-c333-4871-9993-3fd8aed486a0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_10b4ba98-8391-4b2a-a6c6-8ada88cbbde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_3ca25a51-0192-4985-92ae-aece17c7ce94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_c5952ce8-896f-4f5e-8943-febe17becd24" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_3ca25a51-0192-4985-92ae-aece17c7ce94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_cab04e0a-f533-465d-88d2-5bbcf64ce88b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_36a2efdc-2cb3-40b2-af84-d12297ba3da3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cab04e0a-f533-465d-88d2-5bbcf64ce88b" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_36a2efdc-2cb3-40b2-af84-d12297ba3da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_2a5253c2-06e9-4ebe-a207-43ff2a56fb99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_36a2efdc-2cb3-40b2-af84-d12297ba3da3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_2a5253c2-06e9-4ebe-a207-43ff2a56fb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1ea534db-85a1-43d2-91a7-b315ed4d6e17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_36a2efdc-2cb3-40b2-af84-d12297ba3da3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1ea534db-85a1-43d2-91a7-b315ed4d6e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_70f3ee38-3473-43de-99d6-3bbef70fe329" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_36a2efdc-2cb3-40b2-af84-d12297ba3da3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_70f3ee38-3473-43de-99d6-3bbef70fe329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_df28db2e-4d23-4c07-a797-c5c44a1ff8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_36a2efdc-2cb3-40b2-af84-d12297ba3da3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_df28db2e-4d23-4c07-a797-c5c44a1ff8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_9d460dc3-8a8d-47e1-a433-36f1c96c1ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_36a2efdc-2cb3-40b2-af84-d12297ba3da3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_9d460dc3-8a8d-47e1-a433-36f1c96c1ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_c1708fb9-be9f-4d81-a609-922b6e406494" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_36a2efdc-2cb3-40b2-af84-d12297ba3da3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_c1708fb9-be9f-4d81-a609-922b6e406494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EarningsPerShareBasicandDilutedDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6c48d457-42cd-491a-904f-7698e4127afb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_775c665f-530f-4011-88ec-fb5fdb5e3ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6c48d457-42cd-491a-904f-7698e4127afb" xlink:to="loc_us-gaap_NetIncomeLoss_775c665f-530f-4011-88ec-fb5fdb5e3ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_ffdfa400-4182-497e-b11a-2b81815bab24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6c48d457-42cd-491a-904f-7698e4127afb" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_ffdfa400-4182-497e-b11a-2b81815bab24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_395bfa69-088e-4a67-a7ae-2668c35b7898" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ffdfa400-4182-497e-b11a-2b81815bab24" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_395bfa69-088e-4a67-a7ae-2668c35b7898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_95d761ed-c265-417c-a050-94938b600491" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ffdfa400-4182-497e-b11a-2b81815bab24" xlink:to="loc_us-gaap_EarningsPerShareBasic_95d761ed-c265-417c-a050-94938b600491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_53ddd736-e740-46ff-8783-baa9c5a0c450" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6c48d457-42cd-491a-904f-7698e4127afb" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_53ddd736-e740-46ff-8783-baa9c5a0c450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d486da49-b5e9-40df-be20-c0562b58956d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_53ddd736-e740-46ff-8783-baa9c5a0c450" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d486da49-b5e9-40df-be20-c0562b58956d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a8fa9d2d-3612-405a-a6bc-87c550f75312" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_53ddd736-e740-46ff-8783-baa9c5a0c450" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a8fa9d2d-3612-405a-a6bc-87c550f75312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3c93a2c1-8636-49cf-a66d-cd48e82f0fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_53ddd736-e740-46ff-8783-baa9c5a0c450" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3c93a2c1-8636-49cf-a66d-cd48e82f0fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e47a33a4-0cb6-4884-a571-4332e79603ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_af7f9855-b6e2-42be-9c5e-4cee50f78c51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e47a33a4-0cb6-4884-a571-4332e79603ab" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_af7f9855-b6e2-42be-9c5e-4cee50f78c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27365e83-0a98-4852-8a53-e53590bf4692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_af7f9855-b6e2-42be-9c5e-4cee50f78c51" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27365e83-0a98-4852-8a53-e53590bf4692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f26a1149-0625-4cac-b3de-8887b44e7546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27365e83-0a98-4852-8a53-e53590bf4692" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f26a1149-0625-4cac-b3de-8887b44e7546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b8f3b611-8b6f-4962-9380-a72baab596d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f26a1149-0625-4cac-b3de-8887b44e7546" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b8f3b611-8b6f-4962-9380-a72baab596d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_72f1d1d9-ca54-4555-ac44-b771f31a60a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f26a1149-0625-4cac-b3de-8887b44e7546" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_72f1d1d9-ca54-4555-ac44-b771f31a60a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6a6d6ce0-a34b-4429-8666-fe956acb0f55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_af7f9855-b6e2-42be-9c5e-4cee50f78c51" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6a6d6ce0-a34b-4429-8666-fe956acb0f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7c0b2426-4828-4dab-b47e-1a86586a9bee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6a6d6ce0-a34b-4429-8666-fe956acb0f55" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7c0b2426-4828-4dab-b47e-1a86586a9bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_005f0d55-647e-4d96-ac37-841b48e4b044" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6a6d6ce0-a34b-4429-8666-fe956acb0f55" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_005f0d55-647e-4d96-ac37-841b48e4b044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_8704c4ce-d6bd-4426-ba68-c6a2e8e33f33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6a6d6ce0-a34b-4429-8666-fe956acb0f55" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_8704c4ce-d6bd-4426-ba68-c6a2e8e33f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_2db53164-d356-40bf-9b42-326d5759e3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_379eacc6-cd0a-4168-b055-6f7cb420333f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_2db53164-d356-40bf-9b42-326d5759e3bb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_379eacc6-cd0a-4168-b055-6f7cb420333f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_46eb784c-1ae8-454b-9fd1-fe3d1752e83f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_379eacc6-cd0a-4168-b055-6f7cb420333f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_46eb784c-1ae8-454b-9fd1-fe3d1752e83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_679e8bdc-0a6c-4685-9e4c-0f5e1ebec07f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_46eb784c-1ae8-454b-9fd1-fe3d1752e83f" xlink:to="loc_us-gaap_EquityComponentDomain_679e8bdc-0a6c-4685-9e4c-0f5e1ebec07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_adf5cfd1-7df1-48f0-aa74-bb293bc21eab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_679e8bdc-0a6c-4685-9e4c-0f5e1ebec07f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_adf5cfd1-7df1-48f0-aa74-bb293bc21eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_71c33f45-27ac-429e-a218-f757788dd17e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_adf5cfd1-7df1-48f0-aa74-bb293bc21eab" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_71c33f45-27ac-429e-a218-f757788dd17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_6c090be4-659b-4538-8138-6544381787e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_adf5cfd1-7df1-48f0-aa74-bb293bc21eab" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_6c090be4-659b-4538-8138-6544381787e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b41e70d1-e256-4e02-a354-07386c8f2f60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_adf5cfd1-7df1-48f0-aa74-bb293bc21eab" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b41e70d1-e256-4e02-a354-07386c8f2f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ac2c4a79-e6f7-4ae5-a835-ec6109740008" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_379eacc6-cd0a-4168-b055-6f7cb420333f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ac2c4a79-e6f7-4ae5-a835-ec6109740008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_114ecd4d-5ec1-42a4-a10f-d8a9f0759e51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ac2c4a79-e6f7-4ae5-a835-ec6109740008" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_114ecd4d-5ec1-42a4-a10f-d8a9f0759e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b3670021-7ed8-47e9-8cc2-4f066529bb10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_114ecd4d-5ec1-42a4-a10f-d8a9f0759e51" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b3670021-7ed8-47e9-8cc2-4f066529bb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_0a766d55-c2d0-4128-8bc8-a8e6509033b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_114ecd4d-5ec1-42a4-a10f-d8a9f0759e51" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_0a766d55-c2d0-4128-8bc8-a8e6509033b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_0dc49cce-963a-454d-8beb-097e76d140ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_114ecd4d-5ec1-42a4-a10f-d8a9f0759e51" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_0dc49cce-963a-454d-8beb-097e76d140ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_906af61c-8edc-47fd-8bfc-b8cf27b60951" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_114ecd4d-5ec1-42a4-a10f-d8a9f0759e51" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_906af61c-8edc-47fd-8bfc-b8cf27b60951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_dd2f713e-2a5b-4a35-9ad4-5cfc15588fae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ca9c2002-5d58-4f83-bfde-84b1273cfa42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_dd2f713e-2a5b-4a35-9ad4-5cfc15588fae" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ca9c2002-5d58-4f83-bfde-84b1273cfa42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_909573ed-3c0f-4059-baf4-100a9507ef49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ca9c2002-5d58-4f83-bfde-84b1273cfa42" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_909573ed-3c0f-4059-baf4-100a9507ef49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2aaf6ba6-9c62-4943-b2a0-6f8c59ce2221" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_909573ed-3c0f-4059-baf4-100a9507ef49" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2aaf6ba6-9c62-4943-b2a0-6f8c59ce2221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6b41e57b-ecb6-4869-8603-90151358898b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2aaf6ba6-9c62-4943-b2a0-6f8c59ce2221" xlink:to="loc_us-gaap_SubsequentEventMember_6b41e57b-ecb6-4869-8603-90151358898b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ca9c2002-5d58-4f83-bfde-84b1273cfa42" xlink:to="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b9785214-90c0-430b-9ee2-439208ded095" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b9785214-90c0-430b-9ee2-439208ded095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b13c1474-aaef-4f42-a8fd-82f3254a4ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b13c1474-aaef-4f42-a8fd-82f3254a4ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_6f60ce58-bfdd-46a0-a84a-78fba88b5ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_6f60ce58-bfdd-46a0-a84a-78fba88b5ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b2225c7c-4b98-4e5e-a321-3c4691e48719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b2225c7c-4b98-4e5e-a321-3c4691e48719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_caaaa5c1-1c48-4293-a6e5-b71bca8e0569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_caaaa5c1-1c48-4293-a6e5-b71bca8e0569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_667cba83-1b1f-4289-adc7-67756da17108" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_667cba83-1b1f-4289-adc7-67756da17108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_056f5789-9156-4966-bb82-c0fa8176da46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_056f5789-9156-4966-bb82-c0fa8176da46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_246aad21-6a62-4bcc-830f-2bc5f40dfd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_246aad21-6a62-4bcc-830f-2bc5f40dfd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_8daf9324-552f-49a0-bb29-dba071234f71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_da040f62-56a1-4d2f-859c-b9e5dfeef194" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_8daf9324-552f-49a0-bb29-dba071234f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6741e003-d0ff-4187-8ef9-be9382241a14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1c67a-6582-4c14-8abf-fe024fefd5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6741e003-d0ff-4187-8ef9-be9382241a14" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1c67a-6582-4c14-8abf-fe024fefd5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_002900b4-a324-43cc-822c-29b7a53fe8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1c67a-6582-4c14-8abf-fe024fefd5fb" xlink:to="loc_us-gaap_PlanNameAxis_002900b4-a324-43cc-822c-29b7a53fe8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_df7e5b67-3b15-469f-ab51-051bd7e042b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_002900b4-a324-43cc-822c-29b7a53fe8f0" xlink:to="loc_us-gaap_PlanNameDomain_df7e5b67-3b15-469f-ab51-051bd7e042b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_2c2e9dd8-86b9-4878-ba46-957b6cbc8104" xlink:href="coo-20231031.xsd#coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_df7e5b67-3b15-469f-ab51-051bd7e042b5" xlink:to="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_2c2e9dd8-86b9-4878-ba46-957b6cbc8104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_A2023LongTermIncentivePlanMember_2f287d7e-3868-4378-abeb-48280aa180d4" xlink:href="coo-20231031.xsd#coo_A2023LongTermIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_df7e5b67-3b15-469f-ab51-051bd7e042b5" xlink:to="loc_coo_A2023LongTermIncentivePlanMember_2f287d7e-3868-4378-abeb-48280aa180d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember_f643cf2f-624c-4a6d-84b5-01ccbbb85f3a" xlink:href="coo-20231031.xsd#coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_df7e5b67-3b15-469f-ab51-051bd7e042b5" xlink:to="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember_f643cf2f-624c-4a6d-84b5-01ccbbb85f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EmployeeStockPurchasePlanMember_1d816314-fe27-438b-b0b7-4fb8e63f1beb" xlink:href="coo-20231031.xsd#coo_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_df7e5b67-3b15-469f-ab51-051bd7e042b5" xlink:to="loc_coo_EmployeeStockPurchasePlanMember_1d816314-fe27-438b-b0b7-4fb8e63f1beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_73088a6f-0a5b-408a-8aa9-019a8649fcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1c67a-6582-4c14-8abf-fe024fefd5fb" xlink:to="loc_us-gaap_AwardTypeAxis_73088a6f-0a5b-408a-8aa9-019a8649fcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dce7be8e-5474-40e6-a234-2635cdf09953" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_73088a6f-0a5b-408a-8aa9-019a8649fcd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dce7be8e-5474-40e6-a234-2635cdf09953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f632d539-6680-4b0b-b717-5004caa2576f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dce7be8e-5474-40e6-a234-2635cdf09953" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f632d539-6680-4b0b-b717-5004caa2576f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_71c062a0-bb14-4368-8a21-3c819102cc45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dce7be8e-5474-40e6-a234-2635cdf09953" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_71c062a0-bb14-4368-8a21-3c819102cc45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_a9cfbfdf-b02d-429b-9bf4-bc0e9f3124be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dce7be8e-5474-40e6-a234-2635cdf09953" xlink:to="loc_us-gaap_PerformanceSharesMember_a9cfbfdf-b02d-429b-9bf4-bc0e9f3124be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_21133e30-ea77-405c-a3d5-1ff59ee07a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dce7be8e-5474-40e6-a234-2635cdf09953" xlink:to="loc_us-gaap_EmployeeStockMember_21133e30-ea77-405c-a3d5-1ff59ee07a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_716409b4-cf77-46bf-aca8-a4e487726815" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1c67a-6582-4c14-8abf-fe024fefd5fb" xlink:to="loc_srt_RangeAxis_716409b4-cf77-46bf-aca8-a4e487726815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8a899e03-6588-4edd-9b52-0483eca07f6b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_716409b4-cf77-46bf-aca8-a4e487726815" xlink:to="loc_srt_RangeMember_8a899e03-6588-4edd-9b52-0483eca07f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_503fb06b-347f-4bda-93ba-d773948a57fb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8a899e03-6588-4edd-9b52-0483eca07f6b" xlink:to="loc_srt_MinimumMember_503fb06b-347f-4bda-93ba-d773948a57fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fc96e3fc-b744-4bf9-8477-e67211e2bc72" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8a899e03-6588-4edd-9b52-0483eca07f6b" xlink:to="loc_srt_MaximumMember_fc96e3fc-b744-4bf9-8477-e67211e2bc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1c67a-6582-4c14-8abf-fe024fefd5fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_6a2cd727-6eca-4aad-a168-190c40fe144a" xlink:href="coo-20231031.xsd#coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_6a2cd727-6eca-4aad-a168-190c40fe144a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_33e23bef-efcd-48fb-9865-162e9848b59e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_33e23bef-efcd-48fb-9865-162e9848b59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_428eb01a-99a9-404e-831b-a23c3d838740" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_428eb01a-99a9-404e-831b-a23c3d838740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_beb42a93-c1d8-408a-a064-10dfff3400d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_beb42a93-c1d8-408a-a064-10dfff3400d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_983be4ec-3252-4f6a-bc1e-63d122574901" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_983be4ec-3252-4f6a-bc1e-63d122574901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_283452a5-330b-4750-ab0c-7d3b3d96c027" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_283452a5-330b-4750-ab0c-7d3b3d96c027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3a50300a-f059-448f-bea4-20404c9ef6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3a50300a-f059-448f-bea4-20404c9ef6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_51f7bd06-41d4-46eb-95ec-2182f3e7532e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_51f7bd06-41d4-46eb-95ec-2182f3e7532e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6d4c3003-05b5-4734-ba4f-d942d560e121" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6d4c3003-05b5-4734-ba4f-d942d560e121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_aa9f0a15-677e-44c3-a13c-1f6bb014f4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_aa9f0a15-677e-44c3-a13c-1f6bb014f4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4b5876c0-e399-4f8c-8b10-cf83d49398bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4b5876c0-e399-4f8c-8b10-cf83d49398bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_bf44754f-74bf-413d-adb7-4353de4acdc0" xlink:href="coo-20231031.xsd#coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_bf44754f-74bf-413d-adb7-4353de4acdc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_002acd27-227e-49eb-abb6-9f683d2c3a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_002acd27-227e-49eb-abb6-9f683d2c3a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_fe70d5b8-e546-41bb-bf42-056f701b777c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_fe70d5b8-e546-41bb-bf42-056f701b777c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7e8299dd-7330-4649-a10f-fba49bb66dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7e8299dd-7330-4649-a10f-fba49bb66dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_632e8b62-f650-472a-816f-fadb152e82a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3d1d97f2-ba5e-4c68-b060-ba71624e7669" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_632e8b62-f650-472a-816f-fadb152e82a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_28b04590-de9c-46dc-b5b7-50e2a7380681" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_57eaec08-bb78-4452-a2ac-75d7b990113c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_28b04590-de9c-46dc-b5b7-50e2a7380681" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_57eaec08-bb78-4452-a2ac-75d7b990113c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ddf9d857-e311-4ff4-ac68-3999bc519949" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_57eaec08-bb78-4452-a2ac-75d7b990113c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ddf9d857-e311-4ff4-ac68-3999bc519949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ef62aa34-6809-4fa8-8871-1227aabe0d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ddf9d857-e311-4ff4-ac68-3999bc519949" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ef62aa34-6809-4fa8-8871-1227aabe0d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9b029f49-1ca2-4d13-b675-06a1a93cf694" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ef62aa34-6809-4fa8-8871-1227aabe0d8e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9b029f49-1ca2-4d13-b675-06a1a93cf694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_cd837b4a-5413-41ec-8410-24abf2248b93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ef62aa34-6809-4fa8-8871-1227aabe0d8e" xlink:to="loc_us-gaap_CostOfSalesMember_cd837b4a-5413-41ec-8410-24abf2248b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2f366185-ddde-4aa9-93e0-30dc3a057337" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ef62aa34-6809-4fa8-8871-1227aabe0d8e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2f366185-ddde-4aa9-93e0-30dc3a057337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a614e88c-4cfd-4ccf-b4a4-8ebd4031686f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_57eaec08-bb78-4452-a2ac-75d7b990113c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a614e88c-4cfd-4ccf-b4a4-8ebd4031686f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_34d53373-935a-422a-8d72-9da9c48e1006" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a614e88c-4cfd-4ccf-b4a4-8ebd4031686f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_34d53373-935a-422a-8d72-9da9c48e1006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0425cc02-3302-4a3e-b8a8-74de32cd650a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a614e88c-4cfd-4ccf-b4a4-8ebd4031686f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0425cc02-3302-4a3e-b8a8-74de32cd650a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fbb27e6a-40e0-4f06-9022-5db8cf93e7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb4ffe-d979-42c6-bb59-c9eb82d896ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fbb27e6a-40e0-4f06-9022-5db8cf93e7c5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb4ffe-d979-42c6-bb59-c9eb82d896ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_78abbc63-91cf-4676-b1b4-4db26b0beaea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb4ffe-d979-42c6-bb59-c9eb82d896ff" xlink:to="loc_us-gaap_AwardTypeAxis_78abbc63-91cf-4676-b1b4-4db26b0beaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b082733-ae33-4da5-87b0-eefb355f862c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_78abbc63-91cf-4676-b1b4-4db26b0beaea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b082733-ae33-4da5-87b0-eefb355f862c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bc2612c1-ada1-4413-9dd5-185d67cdcf7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b082733-ae33-4da5-87b0-eefb355f862c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bc2612c1-ada1-4413-9dd5-185d67cdcf7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_051b2bbf-488e-4360-8457-5e77d86f7eac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64cb4ffe-d979-42c6-bb59-c9eb82d896ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_051b2bbf-488e-4360-8457-5e77d86f7eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5f3a4cb6-b176-4dfc-acbe-203e41ab54b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_051b2bbf-488e-4360-8457-5e77d86f7eac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5f3a4cb6-b176-4dfc-acbe-203e41ab54b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8fa44e6f-2c02-4dc7-8d40-6218195ddf04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_051b2bbf-488e-4360-8457-5e77d86f7eac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8fa44e6f-2c02-4dc7-8d40-6218195ddf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f824bef4-e59e-45ef-9c95-0d94550f50b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_051b2bbf-488e-4360-8457-5e77d86f7eac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f824bef4-e59e-45ef-9c95-0d94550f50b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_05a2eca5-dd6c-4f4a-8572-104eb711f230" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_051b2bbf-488e-4360-8457-5e77d86f7eac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_05a2eca5-dd6c-4f4a-8572-104eb711f230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansStockOptionPlansDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockPlansStockOptionPlansDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlansStockOptionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c7cd4c1a-0530-460f-b020-7f930f6001ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e23b47f-9a36-4f71-9b71-ff25d5b38328" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c7cd4c1a-0530-460f-b020-7f930f6001ad" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e23b47f-9a36-4f71-9b71-ff25d5b38328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0997c194-9cec-45e8-854c-04af98ec0eca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e23b47f-9a36-4f71-9b71-ff25d5b38328" xlink:to="loc_us-gaap_AwardTypeAxis_0997c194-9cec-45e8-854c-04af98ec0eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_38b61cda-fc40-47f3-bfe4-276009905acc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0997c194-9cec-45e8-854c-04af98ec0eca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_38b61cda-fc40-47f3-bfe4-276009905acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_585cfadf-039a-4ff0-b87b-1de2d9bc81d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_38b61cda-fc40-47f3-bfe4-276009905acc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_585cfadf-039a-4ff0-b87b-1de2d9bc81d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f88fa728-3cd8-4668-bd15-d4c92993ef59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e23b47f-9a36-4f71-9b71-ff25d5b38328" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f88fa728-3cd8-4668-bd15-d4c92993ef59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f88fa728-3cd8-4668-bd15-d4c92993ef59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3c7b3571-6b6c-4cd0-8042-a780fff077e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3c7b3571-6b6c-4cd0-8042-a780fff077e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4cc09d71-2fb6-4e7a-97f4-187f38530843" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4cc09d71-2fb6-4e7a-97f4-187f38530843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d4aa6905-c77e-4e29-9d1f-1b718e237b76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d4aa6905-c77e-4e29-9d1f-1b718e237b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_8dc6fc19-865a-4406-81a5-7735ada1a3df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_8dc6fc19-865a-4406-81a5-7735ada1a3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5c079f5c-130d-4bf3-b57d-06efd24aa6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5c079f5c-130d-4bf3-b57d-06efd24aa6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_40664231-6105-48d1-ba12-3c2307aa4069" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_40664231-6105-48d1-ba12-3c2307aa4069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d3fa9458-3aa5-4373-865a-62aa4449b82c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_771e6c77-e31b-4d16-9dc9-2840e96541c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d3fa9458-3aa5-4373-865a-62aa4449b82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f88fa728-3cd8-4668-bd15-d4c92993ef59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b1ae19d2-a13b-4178-9692-ac34ee62473a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b1ae19d2-a13b-4178-9692-ac34ee62473a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fa21c192-e74f-4ce4-8a80-8bbd0294ac74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fa21c192-e74f-4ce4-8a80-8bbd0294ac74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_62cd872d-aa46-4a6d-8740-6ac9cb6dbabc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_62cd872d-aa46-4a6d-8740-6ac9cb6dbabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_630c98d5-927c-4fce-982c-24e904b6bd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_630c98d5-927c-4fce-982c-24e904b6bd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_423c772d-b398-442d-ba13-3ebc7d326114" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_423c772d-b398-442d-ba13-3ebc7d326114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_38faa7c1-9639-4c7d-b0fa-3fb73516f0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_38faa7c1-9639-4c7d-b0fa-3fb73516f0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_102a91cb-f42f-4429-b6d7-4d1871ad26da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56864cbd-bba9-4f8b-80cc-7fb1dd39a5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_102a91cb-f42f-4429-b6d7-4d1871ad26da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f88fa728-3cd8-4668-bd15-d4c92993ef59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7d0e3a76-4cce-4d69-b34f-80016e2db764" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7d0e3a76-4cce-4d69-b34f-80016e2db764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_3066fb11-8ee0-4144-9672-35a9225406b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_3066fb11-8ee0-4144-9672-35a9225406b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_98682207-e85c-4e0c-99fb-106fc0665122" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_98682207-e85c-4e0c-99fb-106fc0665122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cc74c015-2067-4570-8059-074ff582b825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cc74c015-2067-4570-8059-074ff582b825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b5ca5685-8347-4581-9ef6-2974164729bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b5ca5685-8347-4581-9ef6-2974164729bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_d9420998-312b-4a07-ab14-27a39c7c9102" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fdd33deb-66e4-4132-a3e9-a506569d10cc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_d9420998-312b-4a07-ab14-27a39c7c9102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#StockPlansNonVestedRSUsDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eee57c73-0bc2-41bc-af40-ea1f6ac4abc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6edf03d8-e582-440e-be25-cdbf8f8e87bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eee57c73-0bc2-41bc-af40-ea1f6ac4abc1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6edf03d8-e582-440e-be25-cdbf8f8e87bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b8581c5d-60b8-491e-be20-7399f5d075f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6edf03d8-e582-440e-be25-cdbf8f8e87bc" xlink:to="loc_us-gaap_AwardTypeAxis_b8581c5d-60b8-491e-be20-7399f5d075f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d524a88c-0145-4747-9f70-01c9448e56b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b8581c5d-60b8-491e-be20-7399f5d075f2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d524a88c-0145-4747-9f70-01c9448e56b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c2835fb2-7f13-4538-b11b-62cb09eb5761" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d524a88c-0145-4747-9f70-01c9448e56b8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c2835fb2-7f13-4538-b11b-62cb09eb5761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f451b457-7d2d-42f2-942e-c7f119cefc59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6edf03d8-e582-440e-be25-cdbf8f8e87bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f451b457-7d2d-42f2-942e-c7f119cefc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1b08659b-9c5b-4b9b-a69c-ba5e88cfb4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f451b457-7d2d-42f2-942e-c7f119cefc59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1b08659b-9c5b-4b9b-a69c-ba5e88cfb4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7da4730a-91c0-42e4-bdde-c2d6710e9e07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1b08659b-9c5b-4b9b-a69c-ba5e88cfb4b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7da4730a-91c0-42e4-bdde-c2d6710e9e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f9ebf840-e982-4e98-b3ef-67e4e2bf2c74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1b08659b-9c5b-4b9b-a69c-ba5e88cfb4b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f9ebf840-e982-4e98-b3ef-67e4e2bf2c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_57d82a32-3265-4f75-bb60-2d04a8cc210d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1b08659b-9c5b-4b9b-a69c-ba5e88cfb4b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_57d82a32-3265-4f75-bb60-2d04a8cc210d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1df23075-fea9-4392-b044-d61a416be598" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1b08659b-9c5b-4b9b-a69c-ba5e88cfb4b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1df23075-fea9-4392-b044-d61a416be598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b5ac9c6e-b068-4a6f-a3b1-cbf1806a9fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1b08659b-9c5b-4b9b-a69c-ba5e88cfb4b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b5ac9c6e-b068-4a6f-a3b1-cbf1806a9fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_952dcf58-27e1-4f88-8217-1deb460c2848" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f451b457-7d2d-42f2-942e-c7f119cefc59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_952dcf58-27e1-4f88-8217-1deb460c2848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f1acad1f-dc97-47b4-849f-98f8ec62b061" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_952dcf58-27e1-4f88-8217-1deb460c2848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f1acad1f-dc97-47b4-849f-98f8ec62b061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f262113a-ecb0-4b78-9aa7-f691b00dedb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_952dcf58-27e1-4f88-8217-1deb460c2848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f262113a-ecb0-4b78-9aa7-f691b00dedb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_de5b1b00-b970-4a2f-b624-7c948508bc62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_952dcf58-27e1-4f88-8217-1deb460c2848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_de5b1b00-b970-4a2f-b624-7c948508bc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d17c5349-f760-4709-9e4e-2b02b518af30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_952dcf58-27e1-4f88-8217-1deb460c2848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d17c5349-f760-4709-9e4e-2b02b518af30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_26a1658b-f1c5-4d4b-884c-8f19590c54e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_952dcf58-27e1-4f88-8217-1deb460c2848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_26a1658b-f1c5-4d4b-884c-8f19590c54e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9be7c298-398f-457e-8574-e7f047110556" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a90714c-d8e9-49bb-bde7-fc7fae6367de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9be7c298-398f-457e-8574-e7f047110556" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a90714c-d8e9-49bb-bde7-fc7fae6367de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_c0816e12-1e7e-4054-a6b0-fb02fdbff11e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a90714c-d8e9-49bb-bde7-fc7fae6367de" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_c0816e12-1e7e-4054-a6b0-fb02fdbff11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_992a15dc-2d76-4426-9b60-83367342d1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_c0816e12-1e7e-4054-a6b0-fb02fdbff11e" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_992a15dc-2d76-4426-9b60-83367342d1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_ca2ecd2b-d427-419f-9103-275a50db4d8b" xlink:href="coo-20231031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_992a15dc-2d76-4426-9b60-83367342d1f3" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_ca2ecd2b-d427-419f-9103-275a50db4d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_83f07d20-a818-4bed-a5a3-52b147984211" xlink:href="coo-20231031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_992a15dc-2d76-4426-9b60-83367342d1f3" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_83f07d20-a818-4bed-a5a3-52b147984211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_5900e5aa-c9a8-4e04-9c6b-8110a3ae409f" xlink:href="coo-20231031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_992a15dc-2d76-4426-9b60-83367342d1f3" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_5900e5aa-c9a8-4e04-9c6b-8110a3ae409f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_096c1a70-e381-4154-bc59-4d9d01ee55d6" xlink:href="coo-20231031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_992a15dc-2d76-4426-9b60-83367342d1f3" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_096c1a70-e381-4154-bc59-4d9d01ee55d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6cf52a11-f993-42ea-a82b-caa3bc5fcf87" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a90714c-d8e9-49bb-bde7-fc7fae6367de" xlink:to="loc_srt_RangeAxis_6cf52a11-f993-42ea-a82b-caa3bc5fcf87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d3bf9039-2b4d-4f1e-8319-6358f7982ddf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6cf52a11-f993-42ea-a82b-caa3bc5fcf87" xlink:to="loc_srt_RangeMember_d3bf9039-2b4d-4f1e-8319-6358f7982ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6e35ed0b-15f3-4b36-8acf-ab293f7f8812" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d3bf9039-2b4d-4f1e-8319-6358f7982ddf" xlink:to="loc_srt_MinimumMember_6e35ed0b-15f3-4b36-8acf-ab293f7f8812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_16941513-3863-4851-b249-4885b5df68b8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d3bf9039-2b4d-4f1e-8319-6358f7982ddf" xlink:to="loc_srt_MaximumMember_16941513-3863-4851-b249-4885b5df68b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dbcf8121-7a93-4284-a49d-6d3c296d6269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a90714c-d8e9-49bb-bde7-fc7fae6367de" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dbcf8121-7a93-4284-a49d-6d3c296d6269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_da867a4f-0ea6-4bec-a02a-ba97c0776dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_dbcf8121-7a93-4284-a49d-6d3c296d6269" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_da867a4f-0ea6-4bec-a02a-ba97c0776dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_ab51ea46-c246-47e2-98e0-059184d9cda8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_da867a4f-0ea6-4bec-a02a-ba97c0776dc2" xlink:to="loc_us-gaap_EquitySecuritiesMember_ab51ea46-c246-47e2-98e0-059184d9cda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a90714c-d8e9-49bb-bde7-fc7fae6367de" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_e2931fcf-79e9-4ebd-a374-2e30f2506d48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_e2931fcf-79e9-4ebd-a374-2e30f2506d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_10f3aa2a-da03-4b29-871c-83f2ba511841" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_10f3aa2a-da03-4b29-871c-83f2ba511841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_55310502-3d7f-4f4e-9610-e8bcb75d6f35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_55310502-3d7f-4f4e-9610-e8bcb75d6f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_49410d36-1274-499d-9380-4a759a29a733" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_49410d36-1274-499d-9380-4a759a29a733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_8200dd49-81b0-4e0c-bd65-15aaf18d089c" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_8200dd49-81b0-4e0c-bd65-15aaf18d089c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_47e4dfc1-61b9-4c14-9d64-87aa02c0baf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_47e4dfc1-61b9-4c14-9d64-87aa02c0baf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_fdddbe44-705f-4408-9183-eb4c3c4b6e79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_fdddbe44-705f-4408-9183-eb4c3c4b6e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_6518a7a4-e19d-4832-89b8-5f7dd92af0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_6518a7a4-e19d-4832-89b8-5f7dd92af0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_2128002d-254f-4722-a432-cd04c2839b25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5d6c1449-4400-4772-afaa-a070425708b3" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_2128002d-254f-4722-a432-cd04c2839b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_361b3969-0537-4564-9159-b62d606a9c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1d59972f-3ba6-42e1-bac9-73754cb8e40e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_361b3969-0537-4564-9159-b62d606a9c6c" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1d59972f-3ba6-42e1-bac9-73754cb8e40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8f2a1dc9-e1b3-42e9-abf6-bc475148c72e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1d59972f-3ba6-42e1-bac9-73754cb8e40e" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8f2a1dc9-e1b3-42e9-abf6-bc475148c72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_e0d359aa-dc0a-4a79-8983-4700115141a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1d59972f-3ba6-42e1-bac9-73754cb8e40e" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_e0d359aa-dc0a-4a79-8983-4700115141a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_daa57c4b-443a-4df6-a41a-e9415e85e829" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1d59972f-3ba6-42e1-bac9-73754cb8e40e" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_daa57c4b-443a-4df6-a41a-e9415e85e829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_5e1de74a-349a-424a-a256-6c4c294fd2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1d59972f-3ba6-42e1-bac9-73754cb8e40e" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_5e1de74a-349a-424a-a256-6c4c294fd2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_21328ddc-8fc3-4f8b-a9ec-652a9004858c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1d59972f-3ba6-42e1-bac9-73754cb8e40e" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_21328ddc-8fc3-4f8b-a9ec-652a9004858c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_4313de87-8f34-4d54-9491-afa2fd83416a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1d59972f-3ba6-42e1-bac9-73754cb8e40e" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_4313de87-8f34-4d54-9491-afa2fd83416a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_8735d8ef-3a58-4d9b-a8f7-18371c6349bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_361b3969-0537-4564-9159-b62d606a9c6c" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_8735d8ef-3a58-4d9b-a8f7-18371c6349bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c563efe-faab-4529-9abe-6a364fde3c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_361b3969-0537-4564-9159-b62d606a9c6c" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c563efe-faab-4529-9abe-6a364fde3c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_cb829a2e-8b34-45d3-a538-3024b4063402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c563efe-faab-4529-9abe-6a364fde3c7c" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_cb829a2e-8b34-45d3-a538-3024b4063402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_38918a08-6492-4624-a16f-207ab123b1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c563efe-faab-4529-9abe-6a364fde3c7c" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_38918a08-6492-4624-a16f-207ab123b1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_0673f0e2-059e-49dc-82ed-81ec1a8f9a79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c563efe-faab-4529-9abe-6a364fde3c7c" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_0673f0e2-059e-49dc-82ed-81ec1a8f9a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_06d2c3b1-1815-4896-9c53-442646bb9512" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c563efe-faab-4529-9abe-6a364fde3c7c" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_06d2c3b1-1815-4896-9c53-442646bb9512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_89dd84c6-8b1a-43a1-9fdf-837d99cd41c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7c563efe-faab-4529-9abe-6a364fde3c7c" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_89dd84c6-8b1a-43a1-9fdf-837d99cd41c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_f6b08a73-b062-4882-ad38-47753c5fd80e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_361b3969-0537-4564-9159-b62d606a9c6c" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_f6b08a73-b062-4882-ad38-47753c5fd80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_97621026-1d3d-4ee7-ad47-9fef6ad72ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_60283ac9-06fe-4f2f-9667-2bdfa8ffd9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_97621026-1d3d-4ee7-ad47-9fef6ad72ba5" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_60283ac9-06fe-4f2f-9667-2bdfa8ffd9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_554d365f-6f73-41fb-85a6-0b35bf30a3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_60283ac9-06fe-4f2f-9667-2bdfa8ffd9ac" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_554d365f-6f73-41fb-85a6-0b35bf30a3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_195ff9e0-902e-42c3-8352-f9bd6ce384d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_60283ac9-06fe-4f2f-9667-2bdfa8ffd9ac" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_195ff9e0-902e-42c3-8352-f9bd6ce384d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e807ace7-1b71-4aaa-95c4-45d9a90ebb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccruedPensionCostRollForward_f3009793-b3d9-45f1-97e9-6495c0f05e89" xlink:href="coo-20231031.xsd#coo_AccruedPensionCostRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e807ace7-1b71-4aaa-95c4-45d9a90ebb0e" xlink:to="loc_coo_AccruedPensionCostRollForward_f3009793-b3d9-45f1-97e9-6495c0f05e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccruedPrepaidPensionCosts_f624fc2a-efee-45e9-ab66-1d2e0f3427e6" xlink:href="coo-20231031.xsd#coo_AccruedPrepaidPensionCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AccruedPensionCostRollForward_f3009793-b3d9-45f1-97e9-6495c0f05e89" xlink:to="loc_coo_AccruedPrepaidPensionCosts_f624fc2a-efee-45e9-ab66-1d2e0f3427e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_8617986b-98de-45da-be3f-943fee062d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AccruedPensionCostRollForward_f3009793-b3d9-45f1-97e9-6495c0f05e89" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_8617986b-98de-45da-be3f-943fee062d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_a4e366e9-6eb4-472e-b9f1-7ac0f80b035c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AccruedPensionCostRollForward_f3009793-b3d9-45f1-97e9-6495c0f05e89" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_a4e366e9-6eb4-472e-b9f1-7ac0f80b035c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccruedPrepaidPensionCosts_cc6efcad-440f-4bed-bd5c-dd60d718c152" xlink:href="coo-20231031.xsd#coo_AccruedPrepaidPensionCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AccruedPensionCostRollForward_f3009793-b3d9-45f1-97e9-6495c0f05e89" xlink:to="loc_coo_AccruedPrepaidPensionCosts_cc6efcad-440f-4bed-bd5c-dd60d718c152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9a839885-66ef-4c3a-bdb8-618e0826b2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b4c69912-803b-491b-9f7c-35792dab30fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9a839885-66ef-4c3a-bdb8-618e0826b2fa" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b4c69912-803b-491b-9f7c-35792dab30fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_9c3d89fe-a6c3-4850-8ba0-1ed4ab8211b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b4c69912-803b-491b-9f7c-35792dab30fb" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_9c3d89fe-a6c3-4850-8ba0-1ed4ab8211b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_72e5444f-ae18-4c8c-aae0-5e82c03666a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b4c69912-803b-491b-9f7c-35792dab30fb" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_72e5444f-ae18-4c8c-aae0-5e82c03666a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_61d21894-fa48-47f5-a417-aa76b413d7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b4c69912-803b-491b-9f7c-35792dab30fb" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_61d21894-fa48-47f5-a417-aa76b413d7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8e416525-c312-4487-8855-3b30e38db897" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b4c69912-803b-491b-9f7c-35792dab30fb" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8e416525-c312-4487-8855-3b30e38db897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_7d666570-0913-476c-a92e-abbc1bbdab4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b4c69912-803b-491b-9f7c-35792dab30fb" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_7d666570-0913-476c-a92e-abbc1bbdab4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_612010f1-e282-46dd-bc6d-c3c2f57d56c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b4c69912-803b-491b-9f7c-35792dab30fb" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_612010f1-e282-46dd-bc6d-c3c2f57d56c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e3ffb3af-2461-4aeb-9796-caef93119aab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b4c69912-803b-491b-9f7c-35792dab30fb" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e3ffb3af-2461-4aeb-9796-caef93119aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fc74e27b-c811-4690-b4dd-19ba3be09aef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_fe20b262-b581-4c9e-92da-d6391a0a098b" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fc74e27b-c811-4690-b4dd-19ba3be09aef" xlink:to="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_fe20b262-b581-4c9e-92da-d6391a0a098b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_e8c72ad1-e443-4afa-b175-c2e88f34e925" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_fe20b262-b581-4c9e-92da-d6391a0a098b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_e8c72ad1-e443-4afa-b175-c2e88f34e925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_1f474d0f-8cb0-4066-8a1a-425b26dabdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_fe20b262-b581-4c9e-92da-d6391a0a098b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_1f474d0f-8cb0-4066-8a1a-425b26dabdc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9faf2952-d9ee-43bb-b0ff-546ab95be13f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_fe20b262-b581-4c9e-92da-d6391a0a098b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9faf2952-d9ee-43bb-b0ff-546ab95be13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_f011d8fc-207c-4460-a159-f3cc1817e114" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_fe20b262-b581-4c9e-92da-d6391a0a098b" xlink:to="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_f011d8fc-207c-4460-a159-f3cc1817e114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_33d9838b-1376-478a-bbb3-fcb5869e8a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_28b1975e-9b35-49c8-9df9-7c3f69036839" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_33d9838b-1376-478a-bbb3-fcb5869e8a7e" xlink:to="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_28b1975e-9b35-49c8-9df9-7c3f69036839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_907561a9-903d-434a-80f3-af5f6deabc11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_28b1975e-9b35-49c8-9df9-7c3f69036839" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_907561a9-903d-434a-80f3-af5f6deabc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_b44da0cb-77f5-4f4e-9ce3-cead2112e116" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_907561a9-903d-434a-80f3-af5f6deabc11" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_b44da0cb-77f5-4f4e-9ce3-cead2112e116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_fe440f2a-b719-4d04-8dca-21624aecd50d" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_907561a9-903d-434a-80f3-af5f6deabc11" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_fe440f2a-b719-4d04-8dca-21624aecd50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_73a793bb-31d6-4e10-9223-8b4ecbf71e25" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_907561a9-903d-434a-80f3-af5f6deabc11" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_73a793bb-31d6-4e10-9223-8b4ecbf71e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_1931c9a8-4301-46aa-936e-5eb14ab15431" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_28b1975e-9b35-49c8-9df9-7c3f69036839" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_1931c9a8-4301-46aa-936e-5eb14ab15431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_9a4e5d4c-94a5-49df-aa59-4778e6480c13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_28b1975e-9b35-49c8-9df9-7c3f69036839" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_9a4e5d4c-94a5-49df-aa59-4778e6480c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_63bc6674-1f9d-4c5f-b0f5-5452f42d2d29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_28b1975e-9b35-49c8-9df9-7c3f69036839" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_63bc6674-1f9d-4c5f-b0f5-5452f42d2d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_a00c7ed5-f5d6-40b1-a53b-da994cbfc0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_28b1975e-9b35-49c8-9df9-7c3f69036839" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_a00c7ed5-f5d6-40b1-a53b-da994cbfc0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd_089d0ddb-84b6-4420-9b6b-25257369fa53" xlink:href="coo-20231031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_28b1975e-9b35-49c8-9df9-7c3f69036839" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd_089d0ddb-84b6-4420-9b6b-25257369fa53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a93b472d-3cc7-45c6-bff5-927295f74b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_1b71fbeb-9d73-4994-8a15-befe85031b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a93b472d-3cc7-45c6-bff5-927295f74b2e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_1b71fbeb-9d73-4994-8a15-befe85031b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_35c0b858-4a08-4a6a-bc90-879a59406b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_1b71fbeb-9d73-4994-8a15-befe85031b9d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_35c0b858-4a08-4a6a-bc90-879a59406b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_35c0b858-4a08-4a6a-bc90-879a59406b3c" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_0497cef7-293d-4df6-b917-ae0b8d9bafb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_0497cef7-293d-4df6-b917-ae0b8d9bafb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember_def6a50b-a9ce-4f8a-88a4-1165f5504cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember_def6a50b-a9ce-4f8a-88a4-1165f5504cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember_a508276c-1647-486d-8dce-616aeb4f5af8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:to="loc_us-gaap_EquityFundsMember_a508276c-1647-486d-8dce-616aeb4f5af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalancedFundsMember_5482a628-d8be-4c97-a8c6-a401bf101797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalancedFundsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:to="loc_us-gaap_BalancedFundsMember_5482a628-d8be-4c97-a8c6-a401bf101797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AlternativeInvestmentsMember_6d8c46c3-fc91-4f37-a95e-40574a5c87a8" xlink:href="coo-20231031.xsd#coo_AlternativeInvestmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:to="loc_coo_AlternativeInvestmentsMember_6d8c46c3-fc91-4f37-a95e-40574a5c87a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BondMutualFundsMember_f106bdeb-9ebb-42ba-9d92-c810b19dbe45" xlink:href="coo-20231031.xsd#coo_BondMutualFundsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_a599c912-daee-4c5d-abe9-9d796ac8b3f6" xlink:to="loc_coo_BondMutualFundsMember_f106bdeb-9ebb-42ba-9d92-c810b19dbe45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_8aac9478-c76b-4476-95af-7cb1517ed397" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_1b71fbeb-9d73-4994-8a15-befe85031b9d" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_8aac9478-c76b-4476-95af-7cb1517ed397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_adf073e9-9f95-483e-be3a-a25cb4be9725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_8aac9478-c76b-4476-95af-7cb1517ed397" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_adf073e9-9f95-483e-be3a-a25cb4be9725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f23c5344-8410-4882-aac6-2afb564cf427" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_fd83dd3d-f6a7-4b45-a7c8-0645e91fed8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f23c5344-8410-4882-aac6-2afb564cf427" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_fd83dd3d-f6a7-4b45-a7c8-0645e91fed8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2e48546c-0436-48c8-b8fb-92d4f2ee0938" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_fd83dd3d-f6a7-4b45-a7c8-0645e91fed8c" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2e48546c-0436-48c8-b8fb-92d4f2ee0938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2e48546c-0436-48c8-b8fb-92d4f2ee0938" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_968382e3-5918-4718-8587-c3f2d338f799" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_968382e3-5918-4718-8587-c3f2d338f799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember_24e21f5d-d45b-4cac-8e96-2592d1a82738" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember_24e21f5d-d45b-4cac-8e96-2592d1a82738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember_99f3126f-8085-442e-ba09-8901e1f65f21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:to="loc_us-gaap_EquityFundsMember_99f3126f-8085-442e-ba09-8901e1f65f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalancedFundsMember_35f7d7ba-9fa8-4c65-9c85-128c06b7a2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalancedFundsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:to="loc_us-gaap_BalancedFundsMember_35f7d7ba-9fa8-4c65-9c85-128c06b7a2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AlternativeInvestmentsMember_6523427d-e673-4e68-8250-ca0268c49ff2" xlink:href="coo-20231031.xsd#coo_AlternativeInvestmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:to="loc_coo_AlternativeInvestmentsMember_6523427d-e673-4e68-8250-ca0268c49ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeInvestmentsMember_fab3f6ef-ec3d-457c-9aa7-7c252adf32f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_98530b11-d96d-4f3d-9f61-4d7c6e289533" xlink:to="loc_us-gaap_FixedIncomeInvestmentsMember_fab3f6ef-ec3d-457c-9aa7-7c252adf32f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5a575afd-8669-488d-b6a0-2950afc989e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_fd83dd3d-f6a7-4b45-a7c8-0645e91fed8c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5a575afd-8669-488d-b6a0-2950afc989e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52058789-4d78-49c1-b34e-3422fbc75651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5a575afd-8669-488d-b6a0-2950afc989e6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52058789-4d78-49c1-b34e-3422fbc75651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1b20eb79-f353-444b-aa66-534868491bad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52058789-4d78-49c1-b34e-3422fbc75651" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1b20eb79-f353-444b-aa66-534868491bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7be4a6d9-facb-4501-9aa2-407738118b60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52058789-4d78-49c1-b34e-3422fbc75651" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7be4a6d9-facb-4501-9aa2-407738118b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d886264a-f4dd-48c3-a61b-e00c66eee8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52058789-4d78-49c1-b34e-3422fbc75651" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d886264a-f4dd-48c3-a61b-e00c66eee8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_219be785-0dd4-4738-940a-dfcd32620e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_fd83dd3d-f6a7-4b45-a7c8-0645e91fed8c" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_219be785-0dd4-4738-940a-dfcd32620e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_dfde9a39-5dd0-46b9-b4a1-663e7e740b38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_219be785-0dd4-4738-940a-dfcd32620e6b" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_dfde9a39-5dd0-46b9-b4a1-663e7e740b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_78923628-e013-4041-81e2-298fdd906532" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_ae28122f-d9fd-409c-9d28-2a2305a1b3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_78923628-e013-4041-81e2-298fdd906532" xlink:to="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_ae28122f-d9fd-409c-9d28-2a2305a1b3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_44b1f148-73a5-423c-bc0b-76f1b0feb2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_ae28122f-d9fd-409c-9d28-2a2305a1b3bf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_44b1f148-73a5-423c-bc0b-76f1b0feb2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_772377ba-afbe-4455-a376-30cf8bf178bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_ae28122f-d9fd-409c-9d28-2a2305a1b3bf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_772377ba-afbe-4455-a376-30cf8bf178bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_15d18cf5-c662-4cab-8838-8e08c82c958e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_ae28122f-d9fd-409c-9d28-2a2305a1b3bf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_15d18cf5-c662-4cab-8838-8e08c82c958e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_924fb7a6-9e13-473b-a3e8-1519eef18410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_ae28122f-d9fd-409c-9d28-2a2305a1b3bf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_924fb7a6-9e13-473b-a3e8-1519eef18410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_c318384b-e027-4b3e-ac17-7fbdb987860d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_ae28122f-d9fd-409c-9d28-2a2305a1b3bf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_c318384b-e027-4b3e-ac17-7fbdb987860d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_fa1bf70a-7f2b-45d6-bd79-53e63db22825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_ae28122f-d9fd-409c-9d28-2a2305a1b3bf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_fa1bf70a-7f2b-45d6-bd79-53e63db22825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#BusinessSegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_791be432-ff80-4670-901c-d0e2a1570b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_df3499d2-f43a-40d5-a0eb-ab740d1bb062" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_791be432-ff80-4670-901c-d0e2a1570b3b" xlink:to="loc_us-gaap_NumberOfOperatingSegments_df3499d2-f43a-40d5-a0eb-ab740d1bb062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#BusinessSegmentInformationBusinessSegmentNetSalesDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5df97f7f-1dfb-4092-9164-e07763857412" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_266a6b81-d747-4824-b307-510d9aefb9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5df97f7f-1dfb-4092-9164-e07763857412" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_266a6b81-d747-4824-b307-510d9aefb9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3cc8390a-bb16-4643-a464-88bfe45393a3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_266a6b81-d747-4824-b307-510d9aefb9dd" xlink:to="loc_srt_ProductOrServiceAxis_3cc8390a-bb16-4643-a464-88bfe45393a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3cc8390a-bb16-4643-a464-88bfe45393a3" xlink:to="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ToricLensMember_0c73b885-01af-4607-9fcc-4235236310d8" xlink:href="coo-20231031.xsd#coo_ToricLensMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:to="loc_coo_ToricLensMember_0c73b885-01af-4607-9fcc-4235236310d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_MultifocalLensMember_37a56716-2322-44d2-80dc-660edeece7b3" xlink:href="coo-20231031.xsd#coo_MultifocalLensMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:to="loc_coo_MultifocalLensMember_37a56716-2322-44d2-80dc-660edeece7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SingleUseSphereLensMember_5cd03a87-4f40-48bd-a714-101e40eea28f" xlink:href="coo-20231031.xsd#coo_SingleUseSphereLensMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:to="loc_coo_SingleUseSphereLensMember_5cd03a87-4f40-48bd-a714-101e40eea28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NonSingleUseSphereAndOtherMember_66095eac-5124-4e9f-ae8c-9b7dc08429c2" xlink:href="coo-20231031.xsd#coo_NonSingleUseSphereAndOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:to="loc_coo_NonSingleUseSphereAndOtherMember_66095eac-5124-4e9f-ae8c-9b7dc08429c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OfficeAndSurgicalProductsMember_28a85ba1-e9eb-49f9-bc94-60ef2c65764e" xlink:href="coo-20231031.xsd#coo_OfficeAndSurgicalProductsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:to="loc_coo_OfficeAndSurgicalProductsMember_28a85ba1-e9eb-49f9-bc94-60ef2c65764e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_FertilityMember_d6adc49d-bce9-4956-bd8a-c1c752724cdc" xlink:href="coo-20231031.xsd#coo_FertilityMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9207c24b-cb8d-4e12-bdca-320fd41b421a" xlink:to="loc_coo_FertilityMember_d6adc49d-bce9-4956-bd8a-c1c752724cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e5cad34e-55fd-41ac-b943-2930102337c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_266a6b81-d747-4824-b307-510d9aefb9dd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e5cad34e-55fd-41ac-b943-2930102337c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2fb89488-2be6-41b8-9afd-3cc60324ae2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e5cad34e-55fd-41ac-b943-2930102337c8" xlink:to="loc_us-gaap_SegmentDomain_2fb89488-2be6-41b8-9afd-3cc60324ae2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperVisionSegmentMember_8b47f137-667b-473b-8f8f-d6ab9b7acf3f" xlink:href="coo-20231031.xsd#coo_CooperVisionSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2fb89488-2be6-41b8-9afd-3cc60324ae2f" xlink:to="loc_coo_CooperVisionSegmentMember_8b47f137-667b-473b-8f8f-d6ab9b7acf3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperSurgicalSegmentMember_91243f2b-2703-40c9-a70f-3e08e32dc478" xlink:href="coo-20231031.xsd#coo_CooperSurgicalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2fb89488-2be6-41b8-9afd-3cc60324ae2f" xlink:to="loc_coo_CooperSurgicalSegmentMember_91243f2b-2703-40c9-a70f-3e08e32dc478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f2e85690-f2ed-48dc-b557-87bf72455257" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_266a6b81-d747-4824-b307-510d9aefb9dd" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f2e85690-f2ed-48dc-b557-87bf72455257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_80039cf5-a2c9-4b0d-ab22-42c04a4f9b75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2e85690-f2ed-48dc-b557-87bf72455257" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_80039cf5-a2c9-4b0d-ab22-42c04a4f9b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#BusinessSegmentInformationBusinessSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b1bf2e42-37d7-4f05-8a4d-51ecbba1c98d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_233aa829-b765-48cb-b66c-0426e82214d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b1bf2e42-37d7-4f05-8a4d-51ecbba1c98d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_233aa829-b765-48cb-b66c-0426e82214d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7b262eb9-4026-480c-971a-2c17b6632e84" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_233aa829-b765-48cb-b66c-0426e82214d1" xlink:to="loc_srt_ConsolidationItemsAxis_7b262eb9-4026-480c-971a-2c17b6632e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_eec55be9-a387-45e0-8cb7-f7182f5c2c93" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_7b262eb9-4026-480c-971a-2c17b6632e84" xlink:to="loc_srt_ConsolidationItemsDomain_eec55be9-a387-45e0-8cb7-f7182f5c2c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_02037571-6699-44af-8139-4bc00955cb14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_eec55be9-a387-45e0-8cb7-f7182f5c2c93" xlink:to="loc_us-gaap_OperatingSegmentsMember_02037571-6699-44af-8139-4bc00955cb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9de79469-bec7-4a0e-9c94-15b80b4a4e41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_eec55be9-a387-45e0-8cb7-f7182f5c2c93" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9de79469-bec7-4a0e-9c94-15b80b4a4e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_42703a65-a282-44c9-8bf1-6b3a384a465e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_233aa829-b765-48cb-b66c-0426e82214d1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_42703a65-a282-44c9-8bf1-6b3a384a465e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e212c058-ce36-4318-bbff-c468ebb686b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_42703a65-a282-44c9-8bf1-6b3a384a465e" xlink:to="loc_us-gaap_SegmentDomain_e212c058-ce36-4318-bbff-c468ebb686b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperVisionSegmentMember_72acd82b-c48f-4e7f-9843-a2dc53120474" xlink:href="coo-20231031.xsd#coo_CooperVisionSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e212c058-ce36-4318-bbff-c468ebb686b4" xlink:to="loc_coo_CooperVisionSegmentMember_72acd82b-c48f-4e7f-9843-a2dc53120474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CooperSurgicalSegmentMember_c1ae38c3-af15-4226-8abc-56f7aa3ca9b5" xlink:href="coo-20231031.xsd#coo_CooperSurgicalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e212c058-ce36-4318-bbff-c468ebb686b4" xlink:to="loc_coo_CooperSurgicalSegmentMember_c1ae38c3-af15-4226-8abc-56f7aa3ca9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_233aa829-b765-48cb-b66c-0426e82214d1" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5abee818-8384-4965-9f5e-614515ca7976" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5abee818-8384-4965-9f5e-614515ca7976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b96f0549-a345-4df2-8696-bc6a4aa60f99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_OperatingIncomeLoss_b96f0549-a345-4df2-8696-bc6a4aa60f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_57c8c073-5d70-4a78-bf18-f0df757265f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_InterestExpense_57c8c073-5d70-4a78-bf18-f0df757265f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c21a9a2f-9198-4595-bbce-149f7a3b40e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c21a9a2f-9198-4595-bbce-149f7a3b40e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_12184966-d833-45d5-8ca2-2d90eeebe4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_12184966-d833-45d5-8ca2-2d90eeebe4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a4048ca3-b825-4dab-9bad-c4954279e545" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_Assets_a4048ca3-b825-4dab-9bad-c4954279e545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_e9885344-1423-41a5-ba27-b2d866e1de23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_Depreciation_e9885344-1423-41a5-ba27-b2d866e1de23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_1f6e8398-18ad-43b0-b326-8647baa8dd02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_AdjustmentForAmortization_1f6e8398-18ad-43b0-b326-8647baa8dd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_b0a03d49-4154-4bf7-9f73-aeecedb81f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_54f77953-4683-4500-bf65-52da88923373" xlink:to="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_b0a03d49-4154-4bf7-9f73-aeecedb81f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_be1b1a7c-d385-4b54-8634-9f3866f22036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fadd5852-a596-4402-999e-c1fc68761201" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_be1b1a7c-d385-4b54-8634-9f3866f22036" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fadd5852-a596-4402-999e-c1fc68761201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5bbb12bd-f3fc-4730-be6b-ef5cd8d5105a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fadd5852-a596-4402-999e-c1fc68761201" xlink:to="loc_srt_ConsolidationItemsAxis_5bbb12bd-f3fc-4730-be6b-ef5cd8d5105a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_649f0790-061e-41d2-8a67-fea23fbcf231" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5bbb12bd-f3fc-4730-be6b-ef5cd8d5105a" xlink:to="loc_srt_ConsolidationItemsDomain_649f0790-061e-41d2-8a67-fea23fbcf231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_GeographyEliminationsMember_8a00e904-0dea-446b-9955-094ceec567de" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_GeographyEliminationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_649f0790-061e-41d2-8a67-fea23fbcf231" xlink:to="loc_srt_GeographyEliminationsMember_8a00e904-0dea-446b-9955-094ceec567de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReportableGeographicalComponentsMember_b5fb94b8-c744-4056-a7b4-bbe7f8ddae34" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ReportableGeographicalComponentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_649f0790-061e-41d2-8a67-fea23fbcf231" xlink:to="loc_srt_ReportableGeographicalComponentsMember_b5fb94b8-c744-4056-a7b4-bbe7f8ddae34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CorporateReconcilingItemsAndEliminationsMember_3a725c15-4c4b-43e6-95ad-28a74afdc656" xlink:href="coo-20231031.xsd#coo_CorporateReconcilingItemsAndEliminationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_649f0790-061e-41d2-8a67-fea23fbcf231" xlink:to="loc_coo_CorporateReconcilingItemsAndEliminationsMember_3a725c15-4c4b-43e6-95ad-28a74afdc656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6b7eaf23-f82c-46d5-a3d5-ebdad5bdf6c9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fadd5852-a596-4402-999e-c1fc68761201" xlink:to="loc_srt_StatementGeographicalAxis_6b7eaf23-f82c-46d5-a3d5-ebdad5bdf6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f214c700-8d2b-48a8-b48d-5999191e2022" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6b7eaf23-f82c-46d5-a3d5-ebdad5bdf6c9" xlink:to="loc_srt_SegmentGeographicalDomain_f214c700-8d2b-48a8-b48d-5999191e2022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1aac54c3-32cc-4203-a6c7-48b908dd0f51" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f214c700-8d2b-48a8-b48d-5999191e2022" xlink:to="loc_country_US_1aac54c3-32cc-4203-a6c7-48b908dd0f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_d74ade00-b017-4956-8df0-f887d2721d8a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f214c700-8d2b-48a8-b48d-5999191e2022" xlink:to="loc_srt_EuropeMember_d74ade00-b017-4956-8df0-f887d2721d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_RestOfTheWorldMember_880e4990-f273-45ef-8807-1236b9a52894" xlink:href="coo-20231031.xsd#coo_RestOfTheWorldMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f214c700-8d2b-48a8-b48d-5999191e2022" xlink:to="loc_coo_RestOfTheWorldMember_880e4990-f273-45ef-8807-1236b9a52894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3fb7b0a7-0594-4277-82ed-6bccc0a45b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fadd5852-a596-4402-999e-c1fc68761201" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_3fb7b0a7-0594-4277-82ed-6bccc0a45b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fb97ccd6-12c1-45b6-a9d2-e80a702753b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fb7b0a7-0594-4277-82ed-6bccc0a45b7b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fb97ccd6-12c1-45b6-a9d2-e80a702753b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_95ab0406-5383-40e9-9761-0c3c5cb18a28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fb7b0a7-0594-4277-82ed-6bccc0a45b7b" xlink:to="loc_us-gaap_OperatingIncomeLoss_95ab0406-5383-40e9-9761-0c3c5cb18a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1d0de255-97a8-4bc5-9da5-af91ea9e72b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3fb7b0a7-0594-4277-82ed-6bccc0a45b7b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1d0de255-97a8-4bc5-9da5-af91ea9e72b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancialDerivativesandHedgingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_69aaddd7-3792-4fd8-85e4-a7483eefead7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_36b442d8-f468-45b9-80d3-c718232e832c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_69aaddd7-3792-4fd8-85e4-a7483eefead7" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_36b442d8-f468-45b9-80d3-c718232e832c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1db58933-2eb2-48d3-9ba8-ba964eadcb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_36b442d8-f468-45b9-80d3-c718232e832c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1db58933-2eb2-48d3-9ba8-ba964eadcb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f95e5d7d-1b45-4a69-a325-db66e4b59f43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1db58933-2eb2-48d3-9ba8-ba964eadcb2e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f95e5d7d-1b45-4a69-a325-db66e4b59f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_08ed26ec-258c-4b8e-af91-78878837aa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f95e5d7d-1b45-4a69-a325-db66e4b59f43" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_08ed26ec-258c-4b8e-af91-78878837aa3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_0137226d-b51e-44cd-b9f4-278fd093d13e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f95e5d7d-1b45-4a69-a325-db66e4b59f43" xlink:to="loc_us-gaap_InterestRateSwapMember_0137226d-b51e-44cd-b9f4-278fd093d13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f6b415b2-aff4-4dbb-9835-cf2e56cc724d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_36b442d8-f468-45b9-80d3-c718232e832c" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f6b415b2-aff4-4dbb-9835-cf2e56cc724d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6085cd93-9ceb-4d88-b176-11ba305d55b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f6b415b2-aff4-4dbb-9835-cf2e56cc724d" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6085cd93-9ceb-4d88-b176-11ba305d55b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_f52d1b28-6bf4-44bc-b138-75c3cc8fb23d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f6b415b2-aff4-4dbb-9835-cf2e56cc724d" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_f52d1b28-6bf4-44bc-b138-75c3cc8fb23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_b35c63a6-716a-468d-a358-f4970946b0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f6b415b2-aff4-4dbb-9835-cf2e56cc724d" xlink:to="loc_us-gaap_DerivativeTermOfContract_b35c63a6-716a-468d-a358-f4970946b0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_18fe6c84-26ae-4c48-a5a9-0afbbcdb0bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f6b415b2-aff4-4dbb-9835-cf2e56cc724d" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_18fe6c84-26ae-4c48-a5a9-0afbbcdb0bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f917342f-bf40-441c-809d-ce61bf645a17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_22e6809a-d844-4905-9017-31b43e63f715" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f917342f-bf40-441c-809d-ce61bf645a17" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_22e6809a-d844-4905-9017-31b43e63f715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5a8337a8-d8b6-44d2-9370-857fafce0b26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_22e6809a-d844-4905-9017-31b43e63f715" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5a8337a8-d8b6-44d2-9370-857fafce0b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7c762fe1-95b3-49c7-b526-d46c3e94ff77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5a8337a8-d8b6-44d2-9370-857fafce0b26" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7c762fe1-95b3-49c7-b526-d46c3e94ff77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_e4e1b8d4-2d13-4766-8101-86994e995ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7c762fe1-95b3-49c7-b526-d46c3e94ff77" xlink:to="loc_us-gaap_InterestExpenseMember_e4e1b8d4-2d13-4766-8101-86994e995ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6ffc4597-b5a4-4f12-beff-3ae6e23abffb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_22e6809a-d844-4905-9017-31b43e63f715" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6ffc4597-b5a4-4f12-beff-3ae6e23abffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d791d4e7-31d3-4fd8-8ea2-0436a7da253b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6ffc4597-b5a4-4f12-beff-3ae6e23abffb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d791d4e7-31d3-4fd8-8ea2-0436a7da253b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_867dee31-d520-48c2-800d-bd1aad533ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d791d4e7-31d3-4fd8-8ea2-0436a7da253b" xlink:to="loc_us-gaap_InterestRateSwapMember_867dee31-d520-48c2-800d-bd1aad533ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f6775ce-f3a3-4628-8efa-ab6e82ea87e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_22e6809a-d844-4905-9017-31b43e63f715" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f6775ce-f3a3-4628-8efa-ab6e82ea87e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5ce08942-a833-4401-b225-00f53f7c5981" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f6775ce-f3a3-4628-8efa-ab6e82ea87e1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5ce08942-a833-4401-b225-00f53f7c5981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bd2897e1-b6ef-4e3f-b384-a5289c74d485" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_09d5ed0c-1f69-4e24-b255-ca697ee7aeec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bd2897e1-b6ef-4e3f-b384-a5289c74d485" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_09d5ed0c-1f69-4e24-b255-ca697ee7aeec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_06e81c52-5f33-4ecd-8592-33ab90ab8e61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_09d5ed0c-1f69-4e24-b255-ca697ee7aeec" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_06e81c52-5f33-4ecd-8592-33ab90ab8e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_445e698f-6796-445e-8409-d0cbe429935c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_06e81c52-5f33-4ecd-8592-33ab90ab8e61" xlink:to="loc_us-gaap_EquityComponentDomain_445e698f-6796-445e-8409-d0cbe429935c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_1a8e68e5-f54f-420b-9a91-a89746dcf123" xlink:href="coo-20231031.xsd#coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_445e698f-6796-445e-8409-d0cbe429935c" xlink:to="loc_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_1a8e68e5-f54f-420b-9a91-a89746dcf123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5998130e-ad22-4dc3-9e98-08d802634fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_445e698f-6796-445e-8409-d0cbe429935c" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5998130e-ad22-4dc3-9e98-08d802634fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e057a8bf-9cc2-4044-b521-25fc92dde3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_09d5ed0c-1f69-4e24-b255-ca697ee7aeec" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e057a8bf-9cc2-4044-b521-25fc92dde3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:href="coo-20231031.xsd#coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e057a8bf-9cc2-4044-b521-25fc92dde3dc" xlink:to="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dea6c3fe-adc9-4aeb-99a7-34a027c90252" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dea6c3fe-adc9-4aeb-99a7-34a027c90252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1e0cec64-7073-4379-867b-f2401151fd13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1e0cec64-7073-4379-867b-f2401151fd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_d048121d-3b9c-4c12-821b-293a1e0df918" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_d048121d-3b9c-4c12-821b-293a1e0df918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_b34cc57c-4a83-4192-8804-8558bb2f1fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_b34cc57c-4a83-4192-8804-8558bb2f1fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2504d302-adf1-4917-abe9-4ce1e2f96f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2504d302-adf1-4917-abe9-4ce1e2f96f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a23f6b5-d55b-4b33-a626-bbda6a14d2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_54b529fe-9f2c-4d49-b318-6b35b7f0cd01" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a23f6b5-d55b-4b33-a626-bbda6a14d2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ScheduleIIDetails" xlink:type="simple" xlink:href="coo-20231031.xsd#ScheduleIIDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ScheduleIIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_5e94ff23-7317-47f0-8b3e-97a435cfbc05" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e8f38ba8-2e15-48e8-8d9b-d984bd8624cc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_5e94ff23-7317-47f0-8b3e-97a435cfbc05" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e8f38ba8-2e15-48e8-8d9b-d984bd8624cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a7750f35-3816-4995-811b-118ab5da7132" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e8f38ba8-2e15-48e8-8d9b-d984bd8624cc" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a7750f35-3816-4995-811b-118ab5da7132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_576797b7-6b4c-48b5-8f66-c6f8ca12f422" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a7750f35-3816-4995-811b-118ab5da7132" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_576797b7-6b4c-48b5-8f66-c6f8ca12f422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_b7c2faea-ee1e-4ff7-a7b4-13722290adce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_576797b7-6b4c-48b5-8f66-c6f8ca12f422" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_b7c2faea-ee1e-4ff7-a7b4-13722290adce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_67277ee5-e0f9-4009-8a07-6889340f5509" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_e8f38ba8-2e15-48e8-8d9b-d984bd8624cc" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_67277ee5-e0f9-4009-8a07-6889340f5509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_9ed56ad3-6c9b-43b6-8fb8-afeea7142500" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_67277ee5-e0f9-4009-8a07-6889340f5509" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_9ed56ad3-6c9b-43b6-8fb8-afeea7142500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_b14de7aa-1bd2-4a9f-a723-3cd7066bb3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_67277ee5-e0f9-4009-8a07-6889340f5509" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_b14de7aa-1bd2-4a9f-a723-3cd7066bb3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_7231c9fb-37a9-497f-a128-98e817d8cfd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_67277ee5-e0f9-4009-8a07-6889340f5509" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_7231c9fb-37a9-497f-a128-98e817d8cfd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_91c40243-996f-448f-a007-5c553d1eabca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_67277ee5-e0f9-4009-8a07-6889340f5509" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_91c40243-996f-448f-a007-5c553d1eabca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>coo-20231031_g1.jpg
<TEXT>
begin 644 coo-20231031_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HKBOB=^T5\$O@XI7XB_$?3=/GV;A9>:9;AADC(AC#/C((SC&0?2O /B'
M_P %8_AUI3R6GPS^'.I:PXR%NM3G6TB)_O!0'9A[$*?I7T.5\*<19TE+"8:4
MHO[37+'_ ,"E9?B?.YKQ;PWDC<<9B8QDOLI\TO\ P&-W^!]:4=.M?F[XZ_X*
M7_M.>+7>/0M6TSP] V0$TK3E9\>[S^8<^Z[?PKR'QC\8_BQ\0F9O&_Q)US5%
M;K%>ZG*\8]@A;:![ 5]]@/!S/*Z3Q5>%-=E>;_\ ;5_Y,?GV8>-&14&UA*$Z
MC[NT$_G[S^^)^JWBGXY?!GP063Q=\5?#VGR+UANM7A63\$W;C^ K@/$/_!0?
M]DWP_N3_ (6?]MD7_EGI^F7,N?\ @7EA/_'J_,2BOK,+X-9+!?[1B*DWY<L5
M^*E^9\AB_&K.ZC?U;#4X+^]S2?X./Y'Z&:Q_P54_9TL"4TSP]XIOV_A:+3X4
M0_B\P/Z5SU__ ,%;_A]'G^S/A!K,WIY^H11_R#5\*45[5+PJX/IKWJ<I>LW^
MECPZWBSQG4?NU(Q](1_6Y]L2_P#!7G3P&\GX!S-_=W>)0,_7_1SBO;/AQ^U>
MOQ \$:;XR;P&;,:A;"7[,-4\SR^2,;O*7/3T%?EW7W%^SE_R0_PW_P!@\?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 445F^*O&/A?P/I3:WXLURWL+9/\
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M41%+.[' 4#J2>U&X;#J\:^/O[5VC_#_SO"G@.2&_UH92:X^]#9GOG^^X_N]
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M<Y7Z30JQKT8U([-)GYE7HRP]:5.6\6U]P4445J9!1110 5]O_LU_\D,\.?\
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M4 %%%)))'#&TLKA54$LS'  '4DT -N;FWL[>2[NYTBBB0O++(P544#)))X
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M,*"Q(&37HM?"X*A+#8:-*3NU_F?>8VO'%8J56*LG_D%%%%=1RA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 7= U[4?#>J1ZMIDNV2,\J>CKW4CN
M#7MOA7Q/I_BS2$U6P;&?EFB)YC?NI_Q[BO!:V? _C"\\':PM[%N>WDPMU"#]
M]?4>XZC_ .O7D9KEL<;2YH?&MO/R_P CV,IS.6!J\D_@>_EY_P"9[G14-A?6
MFIV<6H6,XDAF0-&Z]P:FKX=IIV9]VFI*Z"BBBD,**** "BBB@ HHHH ****
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MK/&LD4JY (#(RG! (SR :V*^"O%G_!3ZZ^$'[/G[(/PJ^#GPS\*Z=\0?VC-
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M82#]ZKO_ (5O][T]+F;1117[$?C 4444 %%%% !1110 4444 %%%% !1110
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M3=S]$X!S7,,3C986K4;IQIZ+TDK>;MS.U]DVE8] HHHK\N/U4**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J_X9UN7P[KUK
MK,1/[B4%P/XD/##\035"BIG"-2#C+9Z%0G*G-3CNM3Z*AECGB6>%PR.H9&'0
M@]#3JY;X0Z[_ &QX/BMI7S+9.86R>=O53^1Q^%=37YOB*,L/7E3?1V/TS#5H
MXBA&JNJN%%%%8FP4444 %%%% !7,_&/QD? 'PQUKQ5'+LFMK)A:MZ3/\D?\
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ME!1RVK5_FG;[DO\ ,_'_ !&KN694:/\ +"_WM_Y(****_0#\["BBB@ HHHH
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MX]\#^.]4N;)0[B+S7CDABDRID@CG#CYT=G38Z,0>G_X*Z?\ !/?]MC_@H/\
ML.>&?V=M \5^!+KQ?_PFT7B'Q-JNHWUQI^FV*QP7,:6=FD=M-+*B_: HDE(9
MO*+G!D")]\45;P-%PG"[M+=7[[V]2%CZRG"=E>-K.VNFU_0\DE\ ?&&3]B1_
MA*/#6ACQJ?AZ=$%@==D_L_[5]D^S!OM7V??Y?\>?)W8XVYKX&_9N_P""$?QQ
MC_X)'^/_ /@F[^TEXE\)6&M:IXV;Q1X,\5^&=5N+Z"WO!%;K&L\<MO"RKF!X
MV*[LI<$@!E&?U4HJJF#HUI)SULFOD]R*6,K48M0TNT_FMCXS_P""8GP<_P""
MJ_P.^&?A7]GW]KOQ!\+4\)^ ;%--T_6_#5S=WVL:U901F.VMW\U(X8$11&#,
M5,C)$$\M68S#Y)O?^"'/_!3?Q1\ OVDO@KX^^/\ \*-8N/C!XHLM<M_%6I0Z
MC<:OJ\MG>I/!!<7&U5LH-J\($N-C910J'?7[!45$\!1J4U"3;2NM^ZM^1I',
M*T*DIQ23=GMU3O\ F?$_@?\ 9$_;'\$_L@?!G]F;Q[\._A1\0_#WACX?7/AC
MXI^ M3UBYBL-7MTCL8[&6UGEM)-UU']GE?<\<:#S'4%3LE'-?L+_ /!+[]I'
M]A?]AKXV_##X#?$/1O"?Q"^(WB'5-8\ V8U"74-/\(H\8BL;9KB6'=<3)$JK
M)<>41N"D(X3+??M%4L'24E+6Z5EY:6]?ZN0\;6Y7'2S=WYZWVV_JQXW^P'X$
M_:Q^&O[)_A7P9^V[\2]/\6_$FSBN!KVMZ;\R2*UQ(T"%_+C\UTA,:,^Q=Q4_
M>^^WLE%%=,(J$%%=.YS3FZDW)]>VP44451(4444 %.B;9*K^C TVE498#WH&
MMSZ+HHHK\O/U,**** "BBB@#Y]_;Y@W:-X:N<?<NKE<_58S_ .RU\TU]3_MW
MV/F?#K1]1Q_J=:$>?]^&0_\ LE?+%?N'!,^;AZFNSDO_ "9O]3\)XY@X\1U'
MW47_ .2I?H%%%%?6'R)Y+^TW^PW^S)^V/:V.G_M(>!+_ ,26FFS^?96#>+-3
MM+:*7:5\P0VUS'&7VLPW%<X8C/)KG?$G_!,[]D3QA\/;?X2^*_#_ (WU+PM:
M6L=M;^'+WXP^)Y;%(8P!'&(&U$IM0* HQA0 !BO?**Y*F7X"K.4YTHMRW;BF
MWZZ:G93S',*4(PA6DE'9*327HKZ'F_BS]DSX(>--=\*>(]9TK7HKKP/$(_"O
M]E^-]6L8M/ A,&5BMKJ-&)A)C+,I+*S*203GKC\.O Y^(:_%D^&;7_A)$T4Z
M0NL[/W_V$S"8V^?[GF /CUK:HK:-"A%MJ*5]=ENMG\C"6(KS24IMI*V[V>K7
MHSP:_P#^"9_[&NJ?':/]IR_^'FNR>/XIDEB\5'XB:Z+M&6+R5 87N OE?)MQ
MMVDC&":?\=/^":O[&W[2WCNQ^)OQP^&VKZ_KNEQJFEZA-X\UJ)K)5D,@\E8K
MQ%BPYW90#G'H*]VHKG>79?*#BZ,+-W:Y59ON]-7YG0LRS&,XR5:=XJR?,[I=
MEKHO+8\2U[_@GC^RSXN\5>'_ !IXXT'Q?XBO_"VL6^J>'SXF^*GB+4H;.\@D
M$D4JPW5_)$2&4$AE(;H002*ZOPW^RW\&_"7QJUC]H;0M.UV/Q;KT4<6KW\WC
M359H;F*,N8XC:R7+6XC0R.401A4WMM R:]"HK2."P<)<T:<4[WV6^U]M[:7(
MECL;./+*K)JUOB>V]M]KZV/%OVF_^">?[(O[9&M:?K_[2GPQO/$]QI*2+I:S
M>+=5MH;02",2>7#;W,<:%O*CW$+EB@)R:D^-?[ /[*?[17@WPCX"^-7PYN/$
M>F^!KH3^'1JOB"^GGBX4,DD[S&6X1@B!EE=PP1<]!7LM%3/ 8&;FY4HMSMS>
MZO>MM?36WF.&88^"@HU9)0OR^\_=OO;72_6P5S7QA^$'P[^/GPTU?X/?%KP]
M_:WAS7K86^K:=]KF@\^/<K;?,A=)%Y4'*L#Q72T5TSA"I!QDKIZ-/9HYH3G3
MFIP=FM4UNF>->+?^"?\ ^R9XY_9ST;]DOQ+\,KF;X>:!(CZ9X;A\4:G BE6=
MU$DL5RLLX#.S!97<!L'&54CE?@E_P21_X)Z_LZ?%'2?C1\'/V>UTCQ+H<DDF
ME:B_BC5;H0,\3Q,?*N+IXV.R1@-RG!.1@@$?1]%<DLMRZ52-1T8.4;6?*KJV
MUG;2W2VQUQS/,H4Y4XUIJ,KW7,[.^]U?6_6^YS'QF^$WASXZ?#+5OA+XQU#4
MK?2-=MQ;:J-*O#;S3VQ8&2#S "52108WVX)1V (SFM#4_ /@G6? D_POU/PK
M83>';G26TR?1&ME^S/9M'Y1M_+ V^7Y?R[>F.*UZ*ZG3IN3DUJU9^G;\6<JJ
MU%%13T3NO737\$>&_ W_ ()W_LT_ #QUHGQ$\':)JE[J/A30IM%\&'7-4:Z3
MP]I\LTLLEO:A@"-S32#S)"\NQM@?9\M>Y445%##T,-#DI145Y?UVT]-"Z^)K
MXJ?/6DY/N]?Z[^NH4445L8A1110 4444 26EK+>W<5E ,O-(J(/4DX%?0T,,
M=O"D$2X5%"J/0 8KQ'X;6"ZEXXTZ!LX2?S3_ , !<?JHKW"OE>(:EZL(=DW]
M_P#PQ]9PY3M1J5.[2^[_ (<****^=/I HHHH **** "OFC_@K!^U3XC_ &5/
MV3+C5OAS\7?#'@7QIXOUZS\-^#/%?C*>./3-*O)V,DEW<&2*5=D5M#<2<Q2
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUX^>5.3 ./\ ,TOU_0]G(:?/CU+^5-_I^ITU%%%?%GVX4444 %%%% !1110
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M 3>_O1_]N7Y/[S\O\0\J;5/,(+;W9?\ MK_-?<>=4445^GGY6%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7T#H-@=*T.STQA\UO
M:QQM@=2J@$_G7AOA73UU7Q+8:<\>Y)KN-9!C^'<-WZ9KWTDDY)KYCB*IK3AZ
MO_+]3ZGARGI4J>B_S_0****^:/IPHHHH **** "BBB@ HHHH **** "BBB@
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MT>OBL[J<^/:_E27Z_J?<9%3]GEZ?\S;_ $_0****\@]@**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI55F8*JDDG  '6@
M#H?AEX5/BCQ+&L\>;6UQ+<Y'! /"_B?T!KVJL#X<^$QX3\.QV\R 74^)+H^C
M$<+^ X^N?6M^O@\VQGUS%-Q?NQT7ZOYGW^48+ZGA%S+WI:O]%\OSN%%%%>6>
MJ%%%% !1110 4444 %%%% !1110!RWQD^&6G_%GP%=^%+K8DY'FZ?<,/]3.H
M.UOH<E3[,:^&=8TC4M U6YT36+1X+JTF:*XA<<HZG!%?H?7S]^V7\$FU.U/Q
M;\,V>9[>,)K44:\O&.%F^JCAO]G!_A-??<$9ZL'B?J-9^Y-^[Y2[>DOSMW9^
M?<=9 \;AOKU!>_!>]YQ[^L?ROV1\T4445^O'XX%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 >P?!>P-GX(2X/_ "]W,DH/L"$Q_P".'\ZZ
MRL[PAIXTOPMIUCY>UDLX_,7T<J"W_CQ-:-?G>+J>VQ4Y]VS]'P=/V.%A#LE^
M04445SG2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5VWP<\&_VOJG_  D=_%FVLW_<@CAY>H_!>OUQ7,>&O#]]XGUB'1[!
M?FD.7?'$:CJQ^G_UJ]TT;2;+0M,ATG3X]L4";5'<^I/N3S^->'G>/^KT?8P?
MO2_!?\$][(\O^L5O;37NQ_%_\ LT445\6?;!1110 4444 %%%% !1110 444
M4 %%%% !39X8;F%[>XB62.12LB.N0RD8((/44ZBC8-SXR_:5^!MQ\(_%9O\
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MO#[.UFO[R*QMQF2:140>I)P*^ATBB@00P+B-!M0>@'2OG.(:EJ=.GW;?W?\
M#GTO#E.]2I4[)+[]?T%HHHKY8^K"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BG11232+##&SNY 5%&23Z 5Z5\/?A&EH4UKQ9"&EX:&R
M/(3W?U/MT]?;DQF-H8*GS5'Z+JSLP>"KXZKR4UZOHC+^''PKEU@QZ[XCA*6G
M#0V[<--Z$^B_S^E>IQQQQ1K%$@55 "JHP !V%*  , 45\-C<=6QU7FGMT71'
MW>!P-' TN6&_5]6%%%%<9VA1110 4444 %%%% !1110 4444 %%%% !1110
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M\;R]DO\ ,^UR"GR8'F_F;_R_1A1117BGMA1110 4444 %%%% !1110 4444
M%%%% !1110 444JJS,%5223@ #K0 E7_  _X:UCQ/?"PT>T,C?QN>$C'JQ[5
MT_@WX.:IJ^R_\1E[.V/(AQ^]<?3^$?7GVKTW2=&TS0K)=/TFS2")>BH.I]2>
MI/N:\/'YW1P]X4?>E^"_S/>R_(ZV)M.M[L?Q?^1B>"/AMI'A!!=R8N;XCYKA
MEX3V0=OKU/Z5TE%%?(5J]7$5'.H[MGV-"A2PU-0IJR04445D:A1110 4444
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MG/A7X9>)?%!6=;?[+;'_ )>+@$ C_9'5OY>]>E^$_ASX=\)A9K>#S[H#FZG
M+#_='1?PY]ZWZ*^8QF;8K&7C?ECV7ZOJ?58+*,)@[2MS2[O]%T_/S"BBBO+/
M4"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWW?WL****XSL"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>coo-20231031_g2.jpg
<TEXT>
begin 644 coo-20231031_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJCXE\3^&_!>@7?BKQAX@LM*TNPA,U]J.HW2006\8ZN\CD*H'J3BKU?,G_!6;
MX!?'/]H+]E9-&_9[E\[Q!X>\466O#1]RC^U8K99?]' ?Y78.\<H1N&,(')(H
M ]2^'_[7_P"S5\3_ !6_@7P?\7])EUD73V\&F74C6T]VZ*K-]G28(;A0'4[H
M]PP>M9/QU_;Y_8__ &:?&5M\/OC;\=-*T36KI$==-,,]Q+$C?=:401OY"D<@
MR;01STKY%_8 _;)^"G[57C2Y^"G[4GAMO"7Q:M_B>/%6CV-S9-;QC488X$>&
M!I<O%*1#*KPR88I*0K,PROJ?_!47]FC]EO0/V-/B5XYUSX4Z3<^*M7G^TZ9K
MK6*RZO<ZS<7"I;1QSX,S#<RQK$IVB)=@7:* /JU_B'X"C\!_\+1?QGI8\-_V
M;_:/]O&^C^Q_9-F_S_.SL\O9\V[.,<US'PN_:C^!7QDU]?"G@'QNTVIRZ3'J
MMII^H:5=6$UYI[G:EY;I=11FYMR>!-$&CY'S<BOSP_;N\(_%']D7_@B#\-?V
M?_%=[/%JVJ^(K6S\20F4DPQRM>ZG]D8@\^6Z0QX!Q^Z..*VOVP?&&J_"O]O3
M]C37O"[M#-+HVE:5,(>"]K<SPVLD?'4&.>08]Z /O7XH_M1_ KX-:\WA;Q_X
MW:#4HM)DU6[L-/TJZOYK+3T.U[RX2UBD-M;@\&:7;'P?FX-=GX<\1^'_ !AH
M%GXJ\*:W:ZEIFHVR7%AJ%C.LL-Q$X#*Z.I(92"""*_-?]D?QEJGQ4_;=_;3\
M2>*':>6'1=4TJ$3<E+6VEN+6*/GH!' @Q[5ZC_P;\^/=>\7_ +"UWX>UFXDE
MA\,>.+[3M,+DD);M#;76P?22XE./]H4 ?<E%%% !11639^.O"-_XQO/A_9Z]
M!)K6GVD=U>Z<I/F0PR'".1Z$B@#6HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME>%^ ?\ E()X_P#^Q$TK_P!&-0![I1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %>%^ ?^4@GC__ +$32O\ T8U>Z5X7X!_Y2">/_P#L1-*_]&-0![I1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M  3/^#VI?M+?&* ^5>Z?X.N53PYX;8DKYNJZP?\ 1X55@041F)92C-&Q%/\
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M<@CTK5?$DWAVUM_%%I+H]V^L0QK+-IZP7JQO+.B-DK&''#8)VG'N% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17B'[+/\ P4$_
M9R_;!^,7QA^!_P &?% O=;^"OB^/P_XJC++MDE: ,9HL$[HQ.MU;$G!\RSDX
MVE2WM] !1110 4444 %%%% !1110 4444 %%%% !1110 5X7X!_Y2">/_P#L
M1-*_]&-7NE>%^ ?^4@GC_P#[$32O_1C4 >Z4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%>/?MA_M^?L@?L#^#+?QO\
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M+)V$RYBD1ON\9KT&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BO&?CW_ ,%$_P!@_P#9=UMO"W[0
M?[7_ ,.O">LI(B-H.K^++5-1!?!7_1 YFP0RG.S&"#T->3?'O_@L]\ O@O\
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M]M?]LO\ :VOM3_X*Y_$OX,^"_@]\4%TG2M-T4V T^SL6LDG9WDN5 B53GDG
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MC>6+MDEF)YH \E_:8_X+1_L]?L_>.-.^%W@;X"?&OXP^)-8\-V6NZ5IGP?\
MAG<ZNEQ8WD9DMIO/8QQ;749X8E1G(R,5'^TG^U'_ ,%=+GX@V_@K]B#_ ()O
M^%]0T"[T*ROH_B-\4OB7%I]O!//"LDEI+I<*?:UDA8E'(8@D<8YK[ M+.TT^
MTBL+"UC@@@C6.&&% J1HHP%4#@    #I4E 'QW^TQ^RK_P %;/V@_BI+/\+?
M^"F6A_!/X?3:99AM"\)_"ZUUC5OM/D(+I?MUZR^6AFWE'10P4@$=:=^TU_P1
M0_9@_;0^->H?&3]JCXN?&+Q=::E!9QR?#X_$^^L?#-J8+>*$M;V5HT;0>:8_
M-<+)@R2.W!-?85% 'DFJ_L$?L2>(?C'J7[0_B?\ 9-^'FL>.]8,!U'QAK7A*
MTO=2F,,$<$1^T3HSKMBBC7Y2,A!G)KUNBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHJCXE\3^&_!>@7?BKQAX@LM*TNPA,U]J.HW2006\8ZN\CD*H'J3
MB@"]17FWP_\ VO\ ]FKXG^*W\"^#_B_I,NLBZ>W@TRZD:VGNW159OLZ3!#<*
M ZG='N&#UK5^-'[1?P-_9VT6+7_C7\4-(\.P7#[;1+^Y_?739QMAA7,DQYZ(
MK&@#M**J:]KNC^%]#O?$OB'48K.PTZTDNKZ[G;"00QJ7=V/8!02?85XQX'_X
M*5?L-?$KQAIG@#P)^T3H^IZSK%['::9I]M;7)>>9VVJHS%@9)ZD@#J2!0![E
M17G_ ,4?VH_@5\&M>;PMX_\ &[0:E%I,FJW=AI^E75_-9:>AVO>7"6L4AMK<
M'@S2[8^#\W!KL_#GB/P_XPT"S\5>%-;M=2TS4;9+BPU"QG66&XB<!E='4D,I
M!!!% %VBBB@ KPOP#_RD$\?_ /8B:5_Z,:O=*\+\ _\ *03Q_P#]B)I7_HQJ
M /=**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXJ_LD>*K#X*?\%L/V9I_@YJ=U<K::3\9O":S:IX"UZ4\ BY4-+ISMU$,X8J
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M9O!&FWEKJEW;>,YM$M_%37%QYWFZA;614.\:@1(592$R"3QC[$HH \-\)_\
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M0G[3]M\/_"WP%^"&M^(7\,:[<7VJ7<4EM! $9(0BHTTJER<-T&!MY- 'NO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX,?"?]H3X;:M\'OCA\/-)\5>%]<MC;ZKH>MV2SV]PG495APP(#*PPRL RD$
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M P$MFUA<'-Y C$()R<OM;< X=0 ?K)17Q_\ \$A?V]?BC^UU\.O'?PJ_:?\
M^$93XM?!SX@7?@_QA>>$[D'3=?\ *C66WU6T4G*QSQ,25[-&QP@8(OV!0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7A?@'_E()X__P"Q
M$TK_ -&-7NE>%^ ?^4@GC_\ [$32O_1C4 >Z4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !12-(B%5=P"QPH)ZG!.!^
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M65<!V5'"_:K?)!6>,8VNA=8RP6OI^OF7_@H'_P $KOV>_P!ON/2_'FJ7VJ>
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MT?\ 9J_9X_:6GU?QWKRW+:7X;O/ ^MV$DP@MY;F4^9=6<<*XAAD?EQD+@9)
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M%% !1110 445F>)O&O@WP5!#=>,O%NF:3%<SK#;R:G?QVZRR,0%12[#<Q)
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M$L?9I"%()5E925/WWTZ444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRS,< #UKPW]N/]EKX_?M4>&=!\+? _\ ;C\8?!**QOII?$%[X+TBTGN]7@9
MJ0B:<%K8HP+!TR3N((Z$?.*?\&X_[&_CUQ<?M>?M#?M"?'EV.ZXA^*?QEOYK
M=SG.!'9FWVIZ+G@ #- 'V_X.^,'PE^(FNZIX7^'_ ,4?#FNZGHBQ'6=.T?6X
M+J>P$A<1F>.-RT6\QR!=P&[8V,[37S%^U5_P6Q_9,_97^.FL?LPO\.OB]\1/
MB)H*6S:KX1^%WPMO]6N(C<6\=Q"HE*QP2%HIHV^21@"VTD,"!ZU^R1_P3T_8
MJ_80LM1LOV1?V<O#G@8ZO%#%JUUI,#M<WJ1%C&LT\K/+*%+N0&8X+$]S7LM
M'Y^?\/3O^"I7QC^3]E;_ ((2?$6*VF_U>L?&CQ[IGA3[.#T>2SD\R9^V45L\
M^U?7_P"SWJ/[2_C#]GC2K[]I[PWX>\'_ !*O;*Y76K#PA?-?V&FS&:58&ADF
M7]Z1%Y+L&&-Y8<@5Z)10!^?G_#F3]K[XN?/^V#_P7*_:'\2B3FZLOA<+'P/:
MS>J-'9I+E#T*Y&171_"S_@W7_P""47PW\8V?Q.UWX#ZOXZ\66-S'<0>*/B'X
MYU35KKS8V#HY62X$.X, 0?+ZU]P44 ,FMK>YV&XMTD\MP\>] =K#HPST/O3Z
M** "BBB@ HHHH **** "BB@D 9)H **XK5OVD?V>=!DUJ#6/CKX/MY?#>AW6
MM>(()?$EJ)--TVV -Q>3IOW101@C?(P"KD9(R*\7\"?\%E?^":?Q:U#QCHOP
M7_:IT7QMJ/@/P-J/B_Q'I_A&TN;^2+2+$)]IFC,412=E,D8$4;-(Q;Y5.#@
M^G:*^/?@+_P6-^'G[5,/C4?L\_L<?M :L?"7@2_\2:??ZY\,YM(T[Q#);&,)
MI=E<W+@/>SF0>5$RKN".<C;1\"?VT_\ @IU\?[#QNVH_\$G;OX5)IW@>]O\
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M=<M$ PW[GB7\+OV?/@1_P22U_P#X)_R?#?P'X&^)?QD_:E^(GAAX(KG3;/\
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M2\"Z60HEL_"N@6]BLQ7HTAB13*W)^9R6)))/-=U0!^>O_#E7]I']IO\ T_\
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M=>:]IH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9\$GT?P=X%U72M;\.ZG<0:'#/>W,J^7=.8HB\\J1K@2,2PZ9H U=(_X)B?\
M!"G]I_\ 8 U_]KS]F3]ASPB^A:GX+UZ\\+ZQ>>';VPN"]H+J 3"&X*R(/.MV
M9"RC<NUL8(KW3_@@1_RAM_9[_P"R?P_^CI:\D^)OQ0_X.+OB;\-O$/PWOO\
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M^S??_M*_$/\ 9RTZX_; \#Z)X+^(&IVUW'KND>!]=DNK;3E::58/)N6 8RB
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M1'56@T_SI5;CH5S[4 ?4%%?GY_Q$._ 7XE_N/V,_V)_VE/CB9?\ CTU3P/\
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M%+B#&S4-&\%V45V2.A:X$?FN?=F)KV.B@ HHHH **** "BBB@ HHHH ****
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MCCQ%9/=1>)?%^K'Q;J0\N0KMOK;4I[:WM7+Y8++ )"IW $$9^_/A/_P;)?\
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M2D:@ )Y/GI!MX''EX&,# XKZ8^#_ /P3Z_82_9^\I_@E^QM\,/"TT/W+S1/
MMA;W!/JTRQ"1C[EB:]?HH   !@"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#Y _X+<?LE_M$?MD_L:6'PS_9<T#1
M]3\7:1\2- \16ECKNJBSMIH["Z\]U:4@XS@#CGFN _X:'_X../\ I'5^S_\
M^'=N/_C=??U% 'Q!_P $>?V7/VS_ ()>/?VA_CE^VQ\/O"_ACQ#\8_B1;>(K
M31_"?B#^T;:WC6S$+KYA (^91UYYK[?HHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\]_:
M+^/'PX^ FA:!J'Q<>S@\.>)?$L>@:GJ&HNHM;,7%O<,CS;@5\II(DB8MA0)=
MQ.%.?0JBO;&RU*TDL-1LXKB"52LL,\8='7T(/!% 'Y+2_L\Z'\-/^"C/@WXB
M_L/^*(;?4=2^,-S8:GX2\.SH]K;>'XDLY;BZQ$3Y=HR33HP;Y"0HCP5P/1/^
M#B#Q1X;30/A+HIUVT-Y;>*+NXN+1;A3)%$(X,NR@Y4<CDCO7Z$?#_P"$?PS^
M%1U,_#GP3I^C?VQJ#7NI"P@"":<JJEL?PC"K\HPHYP.3G2O/"7A34;E[W4/#
M.GSS.?GEFLHV9N,<DC)XH ^1/^"U_P '-8_:2_8,EU_X51KKDGA77K;Q"B:4
MXG-S:I%-!,8RF0X5)S(<=HC]*\?^+'@Z#]KG]N[]E ?"^_@UC3_"O@G3/$WB
M.\T^598M/MH94GC$S+D(9'A$84\DMT[C]);'3[#2[9;+3+*&WA7.V*"((HR<
MG ''6JVA^%?"_AC[1_PC7ANPT[[7,9;K[#9I#YTAZN^P#<WN>: /SB^%O@R#
M]DG]MG]K:Q^)^H0:/8^+O!.I^)O#5[J$JQ17]K-)-,XA9L!S&\YC*CD%.G0G
MVK_@AW\!O%WP,_8;M)_'&C3Z??\ C#Q#<Z^MG=QE)8K>2*&"'<IY&Y+<2 'M
M*/7%?6>N>%?"_B?[/_PDOANPU'[),);7[=9I-Y,@_C3>#M;W'-7Z "BBB@#\
MO_\ @[HM[F\_X))-9:3I5Y=ZI)\3]#.DI86DDTB3(+ERX" E<1K)\QXYQU(K
M\K/V3O\ @IM_P3O^%_[%'B']EG]HG]@GXD^+/$NL?#*\TNYA?0[2ZEO/$%T]
MRUQJR7]PPGM#(TP83+"\D("H!*(P6_J3KPOP#_RD$\?_ /8B:5_Z,:@#\O\
M_@RW/B4_!KX_S>/K'5E\07/C+1KB]N]8MIEEN83:3K&Q>4 R?,DN>I&>>HK]
MM*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KPOP#_P I!/'_ /V(FE?^C&KW
M2O"_ /\ RD$\?_\ 8B:5_P"C&H ]THHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "O"_ /_*03Q__ -B)I7_HQJ]TKPOP#_RD$\?_ /8B:5_Z,:@#W2BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *\+\ _\ *03Q_P#]B)I7_HQJ]TKPOP#_
M ,I!/'__ &(FE?\ HQJ /=**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPO
MP#_RD$\?_P#8B:5_Z,:O=*\+\ _\I!/'_P#V(FE?^C&H ]THHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O"_ /_ "D$\?\ _8B:5_Z,:O=*\+\ _P#*03Q_
M_P!B)I7_ *,:@#W2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\+\ _\I!/
M'_\ V(FE?^C&KW2O"_ /_*03Q_\ ]B)I7_HQJ /=**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD>1(
M\&1PN2 ,G&3Z4 +1110 4444 %%%% !7A?@'_E()X_\ ^Q$TK_T8U>Z5X7X!
M_P"4@GC_ /[$32O_ $8U 'NE%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X7X!_
MY2">/_\ L1-*_P#1C5[I7A?@'_E()X__ .Q$TK_T8U 'NE%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5X7X!_Y2">/_ /L1-*_]&-7NE>%^ ?\ E()X_P#^
MQ$TK_P!&-0![I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>%^ ?^4@GC__
M +$32O\ T8U>Z5X7X!_Y2">/_P#L1-*_]&-0![I1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %>%^ ?^4@GC_P#[$32O_1C5[I7A?@'_ )2">/\ _L1-*_\
M1C4 >Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7A?@'_E()X__P"Q$TK_
M -&-7NE>%^ ?^4@GC_\ [$32O_1C4 >Z4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7A?@'_E()X_\ ^Q$TK_T8U>Z5X7X!_P"4@GC_ /[$32O_ $8U 'NE
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP[W^"?\ T-OCO_PLKG_&O=** /"_^'>_P3_Z&WQW_P"%E<_XT?\ #O?X)_\
M0V^._P#PLKG_ !KW2B@#PO\ X=[_  3_ .AM\=_^%E<_XT?\.]_@G_T-OCO_
M ,+*Y_QKW2B@#PO_ (=[_!/_ *&WQW_X65S_ (T?\.]_@G_T-OCO_P +*Y_Q
MKW2B@#PO_AWO\$_^AM\=_P#A97/^-'_#O?X)_P#0V^.__"RN?\:]THH \+_X
M=[_!/_H;?'?_ (65S_C1_P .]_@G_P!#;X[_ /"RN?\ &O=** /"_P#AWO\
M!/\ Z&WQW_X65S_C1_P[W^"?_0V^._\ PLKG_&O=** /"_\ AWO\$_\ H;?'
M?_A97/\ C1_P[W^"?_0V^.__  LKG_&O=** /"_^'>_P3_Z&WQW_ .%E<_XT
M?\.]_@G_ -#;X[_\+*Y_QKW2B@#PO_AWO\$_^AM\=_\ A97/^-'_  [W^"?_
M $-OCO\ \+*Y_P :]THH \+_ .'>_P $_P#H;?'?_A97/^-'_#O?X)_]#;X[
M_P#"RN?\:]THH \+_P"'>_P3_P"AM\=_^%E<_P"-'_#O?X)_]#;X[_\ "RN?
M\:]THH \+_X=[_!/_H;?'?\ X65S_C1_P[W^"?\ T-OCO_PLKG_&O=** /"_
M^'>_P3_Z&WQW_P"%E<_XT?\ #O?X)_\ 0V^._P#PLKG_ !KW2B@#PO\ X=[_
M  3_ .AM\=_^%E<_XT?\.]_@G_T-OCO_ ,+*Y_QKW2B@#PO_ (=[_!/_ *&W
MQW_X65S_ (T?\.]_@G_T-OCO_P +*Y_QKW2B@#PO_AWO\$_^AM\=_P#A97/^
M-'_#O?X)_P#0V^.__"RN?\:]THH \+_X=[_!/_H;?'?_ (65S_C1_P .]_@G
M_P!#;X[_ /"RN?\ &O=** /"_P#AWO\ !/\ Z&WQW_X65S_C1_P[W^"?_0V^
M._\ PLKG_&O=** /"_\ AWO\$_\ H;?'?_A97/\ C1_P[W^"?_0V^.__  LK
MG_&O=** /"_^'>_P3_Z&WQW_ .%E<_XT?\.]_@G_ -#;X[_\+*Y_QKW2B@#P
MO_AWO\$_^AM\=_\ A97/^-'_  [W^"?_ $-OCO\ \+*Y_P :]THH \+_ .'>
M_P $_P#H;?'?_A97/^-'_#O?X)_]#;X[_P#"RN?\:]THH \+_P"'>_P3_P"A
MM\=_^%E<_P"-'_#O?X)_]#;X[_\ "RN?\:]THH \+_X=[_!/_H;?'?\ X65S
M_C1_P[W^"?\ T-OCO_PLKG_&O=** /"_^'>_P3_Z&WQW_P"%E<_XT?\ #O?X
M)_\ 0V^._P#PLKG_ !KW2B@#PO\ X=[_  3_ .AM\=_^%E<_XT?\.]_@G_T-
MOCO_ ,+*Y_QKW2B@#PO_ (=[_!/_ *&WQW_X65S_ (T?\.]_@G_T-OCO_P +
M*Y_QKW2B@#PO_AWO\$_^AM\=_P#A97/^-'_#O?X)_P#0V^.__"RN?\:]THH
M\+_X=[_!/_H;?'?_ (65S_C1_P .]_@G_P!#;X[_ /"RN?\ &O=** /"_P#A
MWO\ !/\ Z&WQW_X65S_C1_P[W^"?_0V^._\ PLKG_&O=** /"_\ AWO\$_\
MH;?'?_A97/\ C1_P[W^"?_0V^.__  LKG_&O=** /"_^'>_P3_Z&WQW_ .%E
M<_XT?\.]_@G_ -#;X[_\+*Y_QKW2B@#PO_AWO\$_^AM\=_\ A97/^-'_  [W
M^"?_ $-OCO\ \+*Y_P :]THH \+_ .'>_P $_P#H;?'?_A97/^-'_#O?X)_]
M#;X[_P#"RN?\:]THH \+_P"'>_P3_P"AM\=_^%E<_P"-'_#O?X)_]#;X[_\
M"RN?\:]THH \+_X=[_!/_H;?'?\ X65S_C1_P[W^"?\ T-OCO_PLKG_&O=**
M /"_^'>_P3_Z&WQW_P"%E<_XT?\ #O?X)_\ 0V^._P#PLKG_ !KW2B@#PO\
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M_P"AM\=_^%E<_P"-'_#O?X)_]#;X[_\ "RN?\:]THH \+_X=[_!/_H;?'?\
MX65S_C1_P[W^"?\ T-OCO_PLKG_&O=** /"_^'>_P3_Z&WQW_P"%E<_XT?\
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M).\HDU;4'N9MSG)!=^<>@[5TE%% !1110 4444 %%%% !1110 4444 %%%%
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MMDDFFVK\S%$(4<G%6_AA\5OAW\:/"$'CWX7>+;36=)N)'C6ZM6/R2(=KQ.C
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MS? /P_\ %#2-0\86NG2WUYH.GW/GS6L$;QHYF*96%@TJ#8Y#'=D @$U\L?\
M!#/]G3QC\*_V)KR[^*>E21V_C[6I=5LM#U"/<HT][>*%'>-N/WRH6P1\T9C/
M>O+_ -C3PEX7\#?\%Y?C#X7\%^';+2=-MO!]P;;3].M4A@BW_P!ENVU$ 5<L
MS' '4F@#]*Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** .+\8_M%_ WP#\0]%^$GBSXH:1:>*/$5TMOH_AX7/F7D[L"0?*3+(A /SL
M GO6I\3OBK\._@QX0G\>?%#Q9:Z-I4$B1M=71)WR.VU(HT4%I)&)PJ("S'@
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M"WASQ;XP\3?$ZQT[2O VK_V7XHU&^22*&TO?*BE^SJ[*!-)MFB^6+>=S[?O
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M/XS?#.R\#_#7P-?MJ&D^$6%N^I^)M29E;[7?_9BT44(V(%C+O(0'#!/,(7[
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^ OVL/@
MO^T-\1?^"JOPJ_::\%?L^^);[P;X*TVSLM8U,&U1BRW5X\CQQ/.'=%6X0] 3
MAL \9^_:* /DS_@I)^R9XX^/FK?"3]I'X4>'9=0\0?"WQ?:ZM<>'RR17-_IY
MN+>>:--[!?.0VZE49@#ND .[ /->"OV?/BDO[;OQ@_X*3W_PNU6*"#P:;'X<
M>%;VW U+5;J+3X(WE,*L3"&>!HD5B&83%B% &?MBB@#Q3X*>$/'/[*G[$6CZ
M)I/@*^\6>,-)\._;+[0[*>*.;4]:N6,]R#)(RJH:YFD+.3PH) ) 4_'/PH\6
M_P#!:/PUXDUV6/\ 8Q\-V&L>/=8#>)?'EY*DU];QL?+B*_Z>4$5K$<11",HH
M3)5V9RWZ8T4 ?(GQ]_9;\:^"O^"D/@#]OCP+X3OM>T6#1+G1O&^F:0BR7UN3
M:W$-O>1Q,P,ZGS8T=5RRB,, P)Q;_P""9/[('C?X$:U\5/C[\5=#.DZ]\5?&
M4^I6NAS2I)-ING?:+B6%)60E1*QN&+(I( 5,G=D#ZPHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *\P_;+M?%&N_LP^/? O@GP3JFOZ
MQXD\&ZII6EV.F)'DW%Q:20Q[VD=%1=S@EB>@.,G /I]% 'R1_P $@?@]\5?@
M;^R2?@-\>OA+JF@:I!K%_/+'?F"6WN;>8IC:\4C@DY8%3@_*>V*\'L/V#_VB
M/@S^Q_\ &7_@GWX/^&6HZW+XW\>6M]X'\4Q2Q+IS:<TUF7DNY2^;=XH[0AT*
MEF9AY8<'-?I?10!\Q?"#]F#7?AW\9/@_\*UTFYE\'_!7X93RV^N-!L@U+Q!>
M8M&90?XD@2[D('W?MBC/IQ7_  4Q\0?MT^-O%VC?"G]G7]D=?&?@O3;B'4/$
MLFMWL*V.O3KAX;1HUN8I'MXWVR.K$"21%4@HK"3[2HH ^>OV'OB%^W#X[TGQ
M7XR_;2^$>G^#Y;46MMX:\-:#&K*\<:S/-./W\Q9W+Q( 6 'DC"C))\'_ &?_
M (+_ +0_A+_@KO\ $']JOQ+^S[XEL_!'BO2)M.TW5'-JSJV+(+(\2SEU1OLS
M]B1N7('./OVB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH ^ OVL/@O^T-\1?^"JOPJ_::\%?L^^);[P;X*TVSLM8U,&U1BRW5X\
MCQQ/.'=%6X0] 3AL \9]*_X*2?LF>./CYJWPD_:1^%'AV74/$'PM\7VNK7'A
M\LD5S?Z>;BWGFC3>P7SD-NI5&8 [I #NP#]9T4 ?$_@K]GSXI+^V[\8/^"D]
M_P#"[58H(/!IL?AQX5O;<#4M5NHM/@C>4PJQ,(9X&B16(9A,6(4 9]M^"GA#
MQS^RI^Q%H^B:3X"OO%GC#2?#OVR^T.RGBCFU/6KEC/<@R2,JJ&N9I"SD\*"0
M"0%/M=% 'YG?"CQ;_P %H_#7B3798_V,?#=AK'CW6 WB7QY>2I-?6\;'RXBO
M^GE!%:Q'$40C**$R5=F<MZ]_P4OU[]NCQIXMT7X3_LZ?LCCQGX+TV>'4/$LN
MN7T*V6O3KAX;5HQ<Q2/;QN%D=6($DB*I!16$GVG10!\_?L)>.?VX?B/:^)O$
M_P"VE\*]*\%2QO9VGAKP_HX7RO+02M-<$^?,2SF2),%@ (1A1DD_0-%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %?5=0_LK3I=0^Q7
M%SY2;O(M(]\C^RKW-?!W_!/3X(?M#?"/]OOXU_&3XG? /Q%HWASXCZS>7&@:
MC.]K($634I)D$RQ3,T9,<@)X(&T@GIG[YHH ^/-?_9L\=?L[_P#!3;5_VW_"
M7@#5?$WA;QOX(ETW6[+P]"DMWI^I(+;8?)9E+12BT3YUSM=VW[1ACYM^SO\
M\$^_C+\%?V*(?@-XJ\+R/XB^,GQ-T^3XAIIT@F30M!5UFGBDE4[&)AMY(B02
M"]YM&0-U?H910!X5^W[XY_:E\(? V7PW^QU\(K[Q%XMUP-:0W]I<P0QZ)!M
M>XS+(F9<';&%R V6/W K>)_L':__ ,%*-.\9^&/@]\3_ -DCPO\ #3X:^';&
MZFE?1I,R7LH@D6*"21[RX8EYY1,\FTNS(2S'<P;[AHH ^2;WXL_M-?M/_L]>
M//V>_CK^P?K^A>*]9TB]TJSQ>VL^A3&5&2&Y-VTH*")BKMM5V^0-'N8A![;^
MR!^SW:?LJ_LU>$/@!:ZN+]O#FF&*ZO50JL]S)(\T[J#R%,LDA4'D+@&O2:*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH'PGOM2\-6TO,9O9FNXYI5!XWF- #Z")3VK[3DCCFC:&:-71U(96&00>H(H
MS_!WB2U\9>$=*\7V41CAU738+R%&;)598U< GOPU:5?/7B3XFZIK/[86A?L)
M?#379_"^AZ!\,V\2Z[>:2L?VF6!;F.RM+"%Y5?R4&3([@;R BJRY8G ^'/Q=
M^-WAW]JKXB_L->*_B9=ZB\'@>/Q=\/O&=W86[WUK9-*MO+;W"B,13M',V$=D
MW%0=^XXP ?4E%?GCI_QF_;"U_P#X)3:5^W7_ ,-4:O;>*=#L)]2&FV^B6'V'
M4U359(G6\5H"\A,8*KY31(BA1L)!<^J_&7X@?M$?!?XF? _XP2_'K4-4T_XE
M^/M/\.>(O \FEVD>E6T%];R.C6NV+[0CQ%,[Y)I&<_W5^2@#ZYHKY"M]6_:M
M^+W[;7Q?_9OTK]J&\\.^'M"\/Z)>Z9>Z=X>LVN[$7*2NT4.]"OS-]Z63>X5
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M6=8\?_!K]IN[\;>$7TFSB7P]K)C&H:#J DF,WFJ8HY@LB&,#S2PW1/L8J<
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M4MA^U%\$)?C9>>#W\+6\&L:C93V5]J*3&%;29HFDDD555<["2!D+_>/6O/\
M]BKXW^/O&7[2?QN^"'B#Q5KNK^'O!=QH%WX3G\5:6;74H8=0LY99890T4<C(
M'BS'YJ"0*WS$\8^;O#VG:K>_\$3_ (HW6E>,-6TAK/Q%XFFE_LF=(S=Q_P!I
M2*UO*Q1F\I@WS*A4L!M)VEE(!]C?M*_M<6_[/VF> ==TWX<W?B/3?'OC+2M
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MZ* "JFO2Z]!I$\OABPM+F_"?Z-!?W;00LV?XG2.1E&,GA3TQQG(MT4 > _\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
L* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>coo-20231031_g3.jpg
<TEXT>
begin 644 coo-20231031_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJH[2R6L)59)F*J5C7+8!<KN(8+NVMCIJ "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<HK^6.BC_B W_4Q_\H__ '4/^(W_ /4O_P#*O_W,_J<HK\Z/^#<#_DV_Q_\
M]CNG_I'%7Z+U^*\29-_J]GE?+O:<_LW;FMRWT3VN[;]V?L'#V;_V]DM''\G)
M[17Y;WMJUO97V[(****\,]H**** "BBB@ HHHH **** "BBB@ HHHH ****
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M-^;&U4F6Z,4;.(8P 27<@*H )+,  : -VBOD/X5?\%+/CEXY^-W@[X->._\
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M'-!,@9)$(P58'@@@X(-<KX"^ 7P1^%FLZCXA^&WPG\/Z%>ZL0;^XTK2HH#*
MJKM^0 *I"*2JX!.6(+$D@'R+\:?VP/V)_C)^V?X;LOB'\9+&:U^$6N.OAKPY
M86<]S/XA\3RE(T93'&8Q%;L D9+KOG9RQ6.(-)[5\8/VKX?B'I7Q"^"/['5[
M#XM^*G@^2VMM8\,Q:@-,FMHI9T2XDANKJ/R?,2,R8<>8$DV;E;[C>H6'[/\
M\!M*OX-5TOX)>$;:ZMIEEMKFW\-VJ212*05=6$>58$ @CD$5%X;^"/A'P_\
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M=G<RADB!_P!;*V<%$E*@'O%%?$O_  30\&Z%\;/^"4WA>U^+FH^(M1TVZO\
M7;WQ#;:1?7:W>L#^T[UGB=[4BXDW.V\I&P:1E"G<K,K5/^")>M>!X=!^+WP_
M\$^,->CLM&^(UP=)\">)8IDN_#FG,TBVXD\WD/((V#J/NM#\WS$D@'W+17RG
M_P %:_A7\*/$O[+?BOXA?%'0_&FNW&C^'YAX7T_PW/>&#3M0".R7LL5N1'M#
M;/,EN R)'&0H4LV_T'_@G/XHT[Q?^Q%\-]8T[XG3>, /#D<%QKURCK++/$S1
MR1L)/GS$ZM%EN2(P><YH ]KHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *\[^)7_(SM_UP2O1*\[^)7_(SM_UP2O4RG_>GZ/]#QL\_P!R^:_4Y^BB
MBOI#Y **** "BBB@#UW2_P#D&V__ %P3_P!!%?%/_!P%_P F"_\ <[Z;_P"@
M3U]K:7_R#;?_ *X)_P"@BOBG_@X"_P"3!?\ N=]-_P#0)ZY>!_\ DM,#_P!?
M8_F>[QG_ ,D=C/\ KU+\C\0****_MX_C8**** "BBB@#]A?^#<#_ )-O\?\
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MPS2S%DB@DC01+-,Y5=G"X7   'TC10!\B?LL_L0_M*?L0_LY>&?AQ^S[XF\
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M_P"A?0_\%4__ )$/]:N*/^@ZM_X-G_\ )'U/_P /K/\ @IK_ -'+?^6;HO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%'A_]I*]NK7P1>+9Q:_>6=RT,EK&;R )-O4$@))L<\$%5((()!^)_BW\,?\
M@AY\;-<TG5_''[6">7H'A?3_  _HEI8^(7C6WL;.,I&&9H6:1SDY8GTXZD@'
MT%^POX)_:P\&_&#65_:7_:_\/?%&*Y\-#^QX=#N8P=.9;A/,9XDC0?."@#\_
MZMAQ@9^K*^,?^":_PG_X)Z_"_P"+GB)/V&OBS>^)I[WPXA\2)+J'VJ*V1;A?
M(.XQH59BTO W9"Y.WC=]G4 %%%% !1110 4444 %<Y\4/^1<3_KZ7^35T=<Y
M\4/^1<3_ *^E_DU=6"_WN'J<68_[C4]#SZBBBOKCX0**** "BBB@#O/A5_R!
MKG_KZ_\ 91745R_PJ_Y US_U]?\ LHKJ*^3Q_P#OD_4^YRS_ '"GZ'\LC_?/
MUI*5_OGZTE?Z +8_AH**** "BBB@#ZF_X(J_\I-/AG]=8_\ 3-?5^^U?@3_P
M15_Y2:?#/ZZQ_P"F:^K]]J_ECQP_Y*NA_P!>(_\ IRH?TQX,_P#)+UO^OTO_
M $BF%%%%?C1^N!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7G?Q*_Y&=O
M^N"5Z)7G?Q*_Y&=O^N"5ZF4_[T_1_H>-GG^Y?-?J<_1117TA\@%%%% !1110
M!Z[I?_(-M_\ K@G_ *"*^*?^#@+_ ),%_P"YWTW_ - GK[6TO_D&V_\ UP3_
M -!%?%/_  <!?\F"_P#<[Z;_ .@3UR\#_P#):8'_ *^Q_,]WC/\ Y([&?]>I
M?D?B!1117]O'\;!1110 4444 ?L+_P &X'_)M_C_ /['=/\ TCBK]%Z_.C_@
MW _Y-O\ '_\ V.Z?^D<5?HO7\5^)/_)<8W_$O_28G]@^'O\ R1F#_P +_P#2
MI!1117PY]F%%%% !1110 4444 %%%% !1110 4444 <A\>O@EX*_:.^$&N_!
M+XB?;!HOB&T%O?-83B*95#JZLC$$ AD4\@CCD$5\)?&+_@G/_P $Z/V-/#G_
M  E'[0GPB\,:YX>7(AO4\?ZII6M2 ?PI:2W_ )%\_=C$\!_NPFOL?]MJ_P#C
M9I_[+OBL_LXW$\7CFX@MK3PT]L(O,%S/=0PC!F_=KQ(PW-@+][(QD?$/P7_X
M)*7&H>)1\5?VX_AS\7/BMXHG(>ZMYO$.BQ6>[KM>5M7-Q. >GS1KC@IB@#Z&
M_P""<WPZ_P""<5MJ.J?%7_@GUJUG%#?:4EIXFTB/5;V>XC/F!X7EBO96E@(Q
M,HX"OG()V<_5M>1_ G4K/P=XNC^"/@W]EJY^&WANS\/O?6J36^G1Q7<WG)&5
MB&GW,R913ES)AV,B'L2?7* "BBB@ HHHH **** "N<^*'_(N)_U]+_)JZ.N<
M^*'_ "+B?]?2_P FKJP7^]P]3BS'_<:GH>?4445]<?"!1110 4444 =Y\*O^
M0-<_]?7_ +**ZBN7^%7_ "!KG_KZ_P#91745\GC_ /?)^I]SEG^X4_0_ED?[
MY^M)2O\ ?/UI*_T 6Q_#04444 %%%% 'U-_P15_Y2:?#/ZZQ_P"F:^K]]J_
MG_@BK_RDT^&?UUC_ -,U]7[[5_+'CA_R5=#_ *\1_P#3E0_ICP9_Y)>M_P!?
MI?\ I%,****_&C]<"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O._B5_R
M,[?]<$KT2O._B5_R,[?]<$KU,I_WI^C_ $/&SS_<OFOU.?HHHKZ0^0"BBB@
MHHHH ]=TO_D&V_\ UP3_ -!%?%/_  <!?\F"_P#<[Z;_ .@3U]K:7_R#;?\
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M_$7Q9>:/X7F*+9RZKH-Y:7=W(X)CCCM9XDG9F ) V#Y06R%!8 'D/PK\<_\
M!3C]IN[33OB+\']!^!_A*4_\3/4!J?\ :&OW,)ZQVBAO+MG894RRIN3.Y%)
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MI-/AG]=8_P#3-?5^^U?@3_P15_Y2:?#/ZZQ_Z9KZOWVK^6/'#_DJZ'_7B/\
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MAXV>?[E\U^IS]%%%?2'R 4444 %%%% 'KNE_\@VW_P"N"?\ H(KXI_X. O\
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MC.,<4WQ-\,_AQXUU.SUOQE\/]$U>]T\YL+O4]*AN);8[@W[MW4E.0#P1R :
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MC.W_ %P2O4RG_>GZ/]#QL\_W+YK]3GZ***^D/D HHHH **** /7=+_Y!MO\
M]<$_]!%?%/\ P<!?\F"_]SOIO_H$]?:VE_\ (-M_^N"?^@BOBG_@X"_Y,%_[
MG?3?_0)ZY>!_^2TP/_7V/YGN\9_\D=C/^O4OR/Q HHHK^WC^-@HHHH ****
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M_!%7_E)I\,_KK'_IFOJ_?:OY8\</^2KH?]>(_P#IRH?TQX,_\DO6_P"OTO\
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M7\L>.'_)5T/^O$?_ $Y4/Z8\&?\ DEZW_7Z7_I%,****_&C]<"BBB@ HHHH
M**** "BBB@ KC/BU_K+#_=D_]EKLZXSXM?ZRP_W9/_9:[\M_WV/S_)GF9Q_R
M+Y_+\T<=1117U)\4%%%% !1110!Z;X"_Y%*S_P!U_P#T-J\H_P""DW_)A'Q;
M_P"Q&OO_ $6:]7\!?\BE9_[K_P#H;5Y1_P %)O\ DPCXM_\ 8C7W_HLUXF4_
M\E+0_P"OT?\ TM'U>8?\DU5_Z\R_](9_.C1117]WG\4!1110 4444 ?HM_P;
M@_\ )RGC[_L1E_\ 2R&OV&K\>?\ @W!_Y.4\??\ 8C+_ .ED-?L-7\@^+_\
MR7%;_##_ -)1_5GA3_R1E+_%/_TIA1117YB?I 4444 %%%% !1110 4444 %
M>=_$K_D9V_ZX)7HE>=_$K_D9V_ZX)7J93_O3]'^AXV>?[E\U^IS]%%%?2'R
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M;X[_ /"RN?\ &O=** /"_P#AWO\ !/\ Z&WQW_X65S_C1_P[W^"?_0V^._\
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MP[W^"?\ T-OCO_PLKG_&O=** /"_^'>_P3_Z&WQW_P"%E<_XT?\ #O?X)_\
M0V^._P#PLKG_ !KW2B@#PO\ X=[_  3_ .AM\=_^%E<_XT?\.]_@G_T-OCO_
M ,+*Y_QKW2B@#PO_ (=[_!/_ *&WQW_X65S_ (T?\.]_@G_T-OCO_P +*Y_Q
MKW2B@#PO_AWO\$_^AM\=_P#A97/^-'_#O?X)_P#0V^.__"RN?\:]THH \+_X
M=[_!/_H;?'?_ (65S_C1_P .]_@G_P!#;X[_ /"RN?\ &O=** /"_P#AWO\
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MXK2QT_7M*TK[%]M@>:[C^>'>X3'V8$88G]X02V,GZKH **** "BBB@ HHHH
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MF^'/_!.OX/ZWX7\#^$=%\4_$KQY-X9T2UTC0UM-(TF,ZC+%)=_98F4'8NT[
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MU.WF:\\.L9M]S'!&@V72..$W/$8Q@'?C)^S** /E[Q9_P3CT7PQXX^"WQ:^
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MV4/V+/B#^S[^U+\6?VA/$7C71]1M/BC?B[;2[*"5)--9)I71-[<3#$I!.$Y
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RCQ'_R,-_\
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M_P"U/?Z#IWPPU&.*VO\ 2O#&DJ&@)O-\DPDM'W$"V4X3;G)'<8_04D*"S$
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M^?XD:3)I&OA?[ O+2[$XU0LA<+;+'N:X;:K-MC#'"DXP#7PCXV^+GAGX8?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7_S''_WQH_XAHO\ J]7_ ,QQ_P#?&OU.HK[_ /XBMQ]_T&?^4Z7_ ,@?#?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>coo-20231031_g4.jpg
<TEXT>
begin 644 coo-20231031_g4.jpg
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M2OC59?#BXTRQ\'W45F?"M[8"PFF%RLT5P\GDO#OD$#(/](59&","*^@_"?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D
MZQX#\#>(KS^T?$'@S2;ZX*A3/>:=%*^T=!N92<5;T7P_H/ANT-AX=T2SL(&D
M+M#96R1(6( +84 9P!S["K=% &._P]\ OJO]NOX'T<WWG^=]L.F1&7S<[M^_
M;G=GG.<YJ*V^%_PSL_%$'C>T^'>A1:U;6YM[;5X](A6ZBA((,:RA=ZK@D;0<
M<UNT4 8_C+X=_#_XBVD%A\0? NCZ[!:SB:VAUG3(KI(9!P'42*P5O<<U<UCP
M[X?\0Z>-)U_0K.^M%='6UO+5)8PR$%3M8$9! (/8BKE% %.;P[X?N-:3Q)/H
M5F^HQVQMX[][5#.L).3&'(W!">2N<9JII/P_\!Z!?+J>A>"=(LKE 0EQ::;%
M&Z@C! 95!&16O10!1USPSX;\3PI;^)/#]CJ$<3;HTOK1)0AZ9 <'!JKI7P]\
M Z%?IJFB>!]'L[F//EW-IID4<B9!!PRJ",@D?0UL44 9'BOX?> O'C63>./!
M&D:R=.N1<:>=6TV*X^RS#I)'YBG8W ^9<&K.N>&?#?B>%+?Q)X?L=0CB;=&E
M]:)*$/3(#@X-7J* ,?2OA[X!T*_35-$\#Z/9W,>?+N;33(HY$R"#AE4$9!(^
MAJE_PICX/?\ ";GXF?\ "J/#7_"2%@Q\0?V%;_;MP& ?/V>9G''WJZ6B@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHILDL<*&6:1451RS' %&X;#J*
MQ=0^)/PZTEBFJ>/=%MF'59]4A0_D6K(O/V@O@I8Y\[XEZ4V/^>-QYG_H&:ZZ
M> QU7X*4GZ1;_0Y*F/P-+XZL5ZR2_4[&BN D_:C^ L0!;XAP'/\ =M)S_*.K
MVA_'WX2>)89+C1/%HG2)]CL+&=<'&?XD&:UEE.:PCS2H32[\LO\ (QAF^4U)
M<L<1!OLIQ_S.QHKGU^*?@)S@>(4_&&0?S6IXOB%X)F(">);49_OOM_G7.\)B
MUO3E]S.A8S"2VJ1^]&S15*W\2^';L@6NOV4A/0)=(3^AJXKHZAD8$'H0:QE"
M</B5C>,X3^%W%HHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGK^&:U:\:I3J4I<LTT_,]JG4IU8\T&FO(****@L**** "BBB@ HHHH ****
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M'K-K29Q?ZPZ9M]+A?D9Z-(?X%_4]AU(Z<)@\3CJZHT(N4GT7]:+S9S8S&87
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M117D'L!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%-EECAC:::141%+.[' 4#J
M2>U?,O[2'[5DFO?:/ 7PQOV2QYCO]6B.&N.Q2,]D]6ZMVX^]ZV3Y-C,ZQ7LJ
M"T6\NB7G^BZGD9SG6"R3"^VKO5[16\GY?J]D=/\ M!_M:V7ACS_!OPQNH[G4
MAE+K5%PT5J>A5.SO[_=7W.0/F&^OKW4[R74-1NY)YYG+S33.6=V/4DGDFHJ*
M_;\GR3!9+A_9T%J]Y/=_\#LNA^%YSGF.SS$>TKO1;16R_P"#W>[]- HHHKUS
MQ@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]/\ @+_R![__ *^5_P#0
M:\PKT_X"_P#((U#_ *^5_P#0:\K.O^1?+Y?F>MD?_(QCZ/\ ([VBBBOB#[H*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "GP3SVLRW%M,T<B-E'1L%3Z@
MTRBAI- FT[H]1^'OQ;AU/R]%\42K'<'"Q71X67V;T;WZ'V[]W7SG7??#?XK2
M6!CT'Q/<%H.%@NW/,7H&/=??M].GR^:9+9.KAUZQ_P O\ON/JLJSN]J.)?I+
M_/\ S^_N>G44BLKJ'1@01D$'@BEKY<^J"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FRRQ01-
M--(J(BEG=C@*!U)/84ZOF#]JC]I,^))9_AIX!O\ _B7(Q35+^%O^/IAUC0C_
M )9CN?XCQ]W[WK9-D^*SK&*C2T7VGT2_K9=3Q\[SK"Y'@W7K:O[,>LGV].[Z
M?<BI^TS^TY+XVDF\ ^ +QDT=&*7MZAP;XC^%?2/_ -"^G7Q&BBOW?+<MPF58
M18?#JR7WM]WY_P##+0_ \SS/%YOBWB,1*[>RZ)=EY?\ #O4****[SSPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "O3O@+_ ,@G4/\ KX3_ -!K
MS&O3O@)_R"]0'_3PG_H)KRLZ_P"1=+Y?FCULC_Y&,?1_D=]1117Q!]T%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 =M\,OB:^ANF@Z_,6L
MF.(9F.3 ?0_[/\J]51TD4.C!E89!!R"*^=*[SX5?$DZ;)'X9UZ?_ $9CMM9W
M/^J/]TG^[Z>GTZ?-YOE*FG7HK7JN_FO/\SZ;)LWY&L/7>G1]O)^7;MZ;>H44
M45\F?7!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPU(?]-H_Y-7EYU_R+I_+\T>MDG_(RA\_R9Z!1117PY]T%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110  D'(->T?##Q=_PE7A
MY5NI=UW:8CN,GEA_"_XC]0:\7K:\ ^*'\*>(X;]W/V>0^7=*.Z'O^'7\*\S-
M<%]<PK2^):K_ "^9ZF4XUX+%)M^[+1_Y_(]RHI$=9%#HP*L,@@\$4M?!'Z %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%!( R30!Y#^
MV)\4#X+^'?\ PB>FW&V_U[="=IY2V&/,/XY"?1F]*^1:[C]HCXCGXF_%/4-9
MMI]]C;-]DT[!R/)0D;A_O,6;_@5</7[UPOE2RK*80DO?E[TO5]/DK+UN?S]Q
M5FSS?.)SB[PC[L?1=?F[OTL%%%%?1'S@4444 %%%5M9U:UT'2I]8O8;J2*WC
M+R)964MS*0/[L42L[GV52?:AM)78TFW9'XR?M:?LJ?&S]C'Q/9_\%:_V/;RX
M#6OCWQ#_ ,)WI(#/';XUR]@\QD!^:SFC58I4X\MMKJ1NS'][?LI?M>?"?]N3
MXN?"SX_?#)DCDN/A7XNM=;TN1PUQI-ZNH>&C+:R$8)P2&5L .C*P W8KT#]C
MN=/'GP#U/P/\1OA/KVD&YU[Q =3T#QAX=E@6XL[W5+V>,'S%\N97@F7<JEMN
MXJP'?YU_8/\ ^"96N?L$?\%+/&WB?P':W-S\+O%7P]NW\-73,S_V7<G4+%GT
M^5C_ !*JEHV/,D:]6:-\?&X? XC XBE4PJO1K.+G'^2:L^9>MK271_A]GB<?
MA\?AJM/%.U:BI*$OYX.ZY7WM>\7U7X]._P#P4^^(?Q7\1?'C4/V9/AYX=U#P
MQ^S[ISS:W>>(;V=9O$EQ$MR\\-H81MMT5;.<+*XDWDQG: Q(A^.7_!72+P[_
M ,$Z?#G_  4(^!OP[L=7L-4U6+3]6\-ZY?/#-93L[Q21B2-2"4EC/51O1E<;
M<X/BGPB_9@^-O[#FE?M>_!"]^#WBWQ)#\5-)N&^%6K^&?#]QJ-OJ;7$-_"D%
MQ+ K+9R1F[AWF<QKA)&!("EL3XV?\$]?VA_A#_P1'\/_ +).C?#K5_$WQ#U;
MQE%KFK:+X=LVNUL2TC2/&TB90>7&(E)W8:0MLW 9KG>/SWZM4D[\W)4;T^&:
MG:"6G6.RUNM?-]*R_(?K-.*MR^TII:_%!P3FWKTEN]+.Z\E[@O\ P5>^.WA#
M]H?X$> ?C%^SSX>TGPK\>-,L9-"N--\22W6I6,MSY2(TZF)8@#)-$?+4N0CY
M,FX%*^Z;NYCLK66\F#%(HV=PBEC@#)P!R3[5^67[2GP/^/OC'XT_L2>,_#7[
M/WCB[T[X6:3X??Q[-'X7N<Z28+BQ\]&79ND=!;2DB,-D!2N=RY_4_+/'NC."
M5^7<IX^HKW,EKXRK4KPK2;2<>5M6WBF]DKJ]_38\+.\/@J5.A.A%1<E+F2;>
MJFTMV[/EMZ[GQ5^QU_P5 ^(_[:-A;>.?A5X.\&W>F-XVATOQ!X0CU2X_X2'P
MYI<ER(H]3FCVE+E&4J6\L(D6XDN_EN!A_ WXQ^ M4_X+;?$_X.3_ +,WA73_
M !UI_@WS+OXF6&H737%_;^1I\D,;VSGRXV\N>)'=,,?) W$5XA:?L2>,?$?[
M7?P5_:J_95^ _C[X2>/M0\2VM]\9?#-YX?N;30M,MODDO9H+IQY+),/-C^R)
M([.) &CA8,#ZA\&?A/\ &/0_^"\?Q*_:<UGX,>+[;P%X@\+C2M*\32^'+G[/
M-<1V6FQ'^#<J%[28!R IPI!PP)\2EBLSJ*@JZYFJL4Y633BXM\RNKQ>J3ZQ>
MEU>Q[E7"Y72==T'RIT9-1O9J2E%*+L[36C<>DEK9M7;O"'_!7C]J[XDZ=^T%
M:^!?V9_!CW?P$2ZN-9U._P#%-PEK/;VKW@GV1K"9))76T9HTRB8#[Y%(17[G
M5?\ @LGX0\-?\$P]"_X*":[\+9FU+7M0;1K+PE!?XC?55EGC93.4)6';;2R[
MMI;;A<%N:^<_V8O@#^T/X*T;]NMO%'[//CBS/Q<T75O^%?I)X8N-VJM</JL<
M2 !?D8F^MR0^TA2[' 1L)8_#M_@7_P $ M1^&O[5O[+OB6\U#0?$4QN-%O;&
M:UFTN2XU!GAU-9!C*1)*2=K88DQ.55V(QH9CG,:,I3J-/V=5WE'12C-J+TC_
M "Z];[V9M7RW))5HPA337M:2M&6LHR@N9:R_FTZ6VNCZ&\=_\%&OVJOA-^T!
M\(/V=O%OPE^'NHZI\8-#M]0T[44UR^L+?3IG!,EFX\FY:5@=JI* BNS@%4 )
MKRSX&%(_^#EOXQ,2% ^'D!)/ '_$LT7FN9_9R_;G_P""5?C_ /:>^&_CSXF_
M'+XB>)/%_A31K;PWX"U#QSX;M[33M-9@8EF=;-,&=R^#-*2BY#?)M##T#X5_
M!+XO/_P78^)W[06O?!OQ?:?#_P 6>$CH>F^*)= N$MY9UL-.@;YBN40O:S 2
M, IPISA@3?UBICI49QJJHE7@TDTW&/(_B:[ROJ[Z6]"/JU/ QKPE2=-NA--M
M.*E+GB_=4NT;:*VMSKM6_P""O'B;5?@)X\_;;^&GPMTK4?A%\/O'UOX<N4N;
MV5=7UN!IK:&74+<C]U"JO>0&.)PQD7<6>(\5]H>&/B%X,\8>&-,\8:%XAM9+
M#5].@OK"5I@ID@FC62-\$Y&493^-?EI_P3R_9T^)O[$?BSQI^R;^TA_P3/O_
M (I)=>(VO/!/CZP\(6%[8S!D6(+/>W9"6UNRQ1R#+%XR\@,>XXKZY^+?_!&[
M]A7]HGQL_P 6OC5\'R_B:_TZQM]2&A>(+RTLH_LUI%;1QP0QNJQQI'"BJ HX
M49&<UZ>5XO.:^']HXJ4]%*,KPY9)RNT^1]+)1L]%>^NOF9K@\DH8CV:DXPU<
M9QM/FBU&R:YUM[S<KK5VMII]51R)*@EB<,K %64Y!'K2UD> / _ASX9>!-$^
M&W@^T>WTCP]I%MIFEP22M(T=M!$L42EF)+$(BC)))QDUKU]1'F<5?<^4ERJ3
MY=@HHHIB"O2_@&?]!U(?]-8_Y-7FE>E_ /\ X\M2_P"NL7\FKR\Y_P"1=/Y?
MFCU<D_Y&4/G^3/0:***^'/NPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#U[X.^)SK7AS^RKF3,]@0G)Y:,_=/X<C\
M!775X?\ #OQ&?#/BJWO))-L$I\JYYXV-W_ X/X5[A7PV<X3ZMC');2U7Z_UY
MGWF28OZU@U&7Q1T?Z?UY!1117D'L!1110 4444 %%%% !1110 4444 %%%%
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MT!113I8:C0;<%J]WJWIMJ^PJV)KUXJ,WHKV6B2OOHNX4445N8!1110 4444
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M%M:R?*O1:O[VU]Q^2^(V.<\31PB>D4Y/U>B^Y)_>%%%%?HQ^:A1110 4444
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M8_$_P?\ M$Z!\8]<^'_Q/\&P1PV/C+PW:HWGQHS.HD@=N=K/)MP_W961]ZX
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MM@8']MO3_P =*UT5?FM>DZ%:5-]&T?IF'JJO0C475)A11161L%%%% !1110
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MF[+X5&7*];NZ\^A]!5'=VEK?VLMC?6T<T$T;1S0RH&21",%6!X((."#7S_\
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MS/\ "GA3PQX%\,Z?X+\%>'[+2='TFSCM-,TO3K98;>T@C4*D4<: *B*H "@
M "O*[3]@K]F>R_;+N?V^;?P==CXFWFCC2Y]9.L7!A:V$*0;?L^_R@=B*,[<\
M9ZU[)13E3A*UUMJO(4:DXWL[7T?F<7^T)\#_  [^TC\(-9^"/C'Q'K>FZ+XA
M@6VUE_#]ZMM<7-IO4S6ID*,5BF0-%)MVN8Y'"LI.X:'BGX/_  P\:?"6]^!'
MB7P/IUSX.U#06T6Z\.^0$M6T]HO)-N$3&Q!'\H"XV@#&,"NDHIN$6VVM]!*<
MTDD]M3YL_9N_X)6?LP?LS?$[PU\7?#D_B3Q!K7@?PD_ACP!+XJU.*X3PUI+S
M3RM;VHBACR3]HE3SIC+-Y9V>9MR#])T44J=.G2C:"LAU*M2K+FF[L****L@*
M*** /1?@+JF)+_17;J%GC'_CK?S6O1Z\8^$NH_V?XXM59L+<*\+?B,C]0*]G
MKXC/:7L\>Y?S)/\ 3]#[K(*OM,O4?Y6U^OZA1117C'M!1110 4444 %%%% !
M1110 4444 %%%% !02 ,DT5D>/\ 5?[#\":UK6[;]DTFXF!]UB8_TJZ<'5J1
M@MVTOO(JU(TJ<IO9)O[CX3\=:X?$_C75_$9;(OM3GG4^SR,P_0UE445_2U.$
M:5-0CLE;[C^8:E256HYRW;O]X44459 4444 %%%% !7&_M&>"_$WQ(_9[\=_
M#OP5=BWUG7_!FJ:=I,YDV>7=3VDL43;NV'93GMBNRHJ*D%4@X/9JQ=.<J513
M6Z=_N/Q'T#4[/0O^" GB_P#9JU.%K?XA?\+<BT63P9(N-4-__:5I.(1;?ZTN
M8XVP O.TXZ5WG_!3#X=>-O@/\)/V"T^+J26R^ [BUL?%VISG,&FSJ-'8Q22_
M=&U;>< YY$#$<"OUI?P5X-E\2+XRD\):8VL(FQ=5:PC-R%QC:)=N[&.,9JYJ
M6E:9K-HUAK&FP7<#$%H;F%9$)!R"0P(X/-?+/AARPSI.KKR0@G;I"7,FU?5M
MZ=+'UBXI4<5&JJ6G/.;5^LX<C2=M$EJM'<_+G_@N_P#%#X?>,/B)^RIXI\.>
M+K*YT^7QK>7T5V)@J/:"ZTU1= MC,#;&*2CY'4;E9E(-7[3Q5X:F_P"#F!Y+
M?Q%9,DG@<6BLETA#3G25(B!SR^/X>M?I?J?A;PSK4ZW6L>';"[E5 BR7-FDC
M!02< L#QDGCWIL?@[PC%>KJ,7A;35N$<.LZV,8<,.A#8SGWKHK9%5K8Z6(=1
M:U*<[<O_ #[C:V_7?R\SFHY_2HX".&5)Z4ZD+\W_ #\DI7VZ;>?D?CI^R)+\
M"/A3^T/^TA^QI_P42^*'B+P6/$_B>XO8U?6Y[&R\0022S^9O*C]X98Y(9(CG
M+J[ <C!Z7_@LOX0^#OP\\"?LB?!_PK8W>F>&=.UN=;71O$TY%Y;Z69; *;A9
M2712F1B3!4 JP5E91^LNI^#O".M:Q:>(M8\*Z;=ZA8'-C?7-C')-;\Y_=NP+
M)^!%2:GX7\,ZW<"ZUGP[8W<JIL62ZM$D8+DG&6!.,D\>]8?ZM/\ L^IA>=:[
M2Y?>Y>=3LW?7732W<W_UG7]HT\7R2TWCS>ZY<G)=+ETTUUOV,3XN?$?P=\,/
M@WXF^+WBFQDU'0M"\-W>JZC#I]NMP]U:0P/*ZQIG;(612 "0ISR0.:\\_P""
M?/[2OP7_ &K?V9M+^*OP#^&D_A#PY]NNK*#P_-ID-HMM+%(?,V) 3&4);=N7
MJ2<X8$5[1':VL-JME#;1I"D81850!0H& H'3&.,5%I.CZ3H&G1:/H6EVUE:0
M+M@M;2!8XXQG.%50 !DGI7T;IUWB8S4ERI--6UO=:WZ+RL?-JK06%E3<7S-I
MIWTLD]+=7YW/G'_@IS_P41^'W[ ?P:CU*^U>-O&'B1S:>%=-2 3O&>!+?/"6
M7?% &W;2R^8^R/<NXNOA'_!,[]M/]G'XS^']6_8[_82\-^,K+Q"WAC5_$7B?
MXA^.;&VBEN=5E\N+^T)C#-,9YY+J>-B" JQQ%1D* /T!U3PUX<UR59]:\/V5
MXZ+M1[JT20J/0%@<"C2_#7AS0Y6GT7P_96;NNUWM;1(RP]"5 R*\^M@<=5S%
M5_:I02MR\NMNMI<VC?5VV2]3T*./P%'+70]BW-N_-S:7Z7CRZI=$WNV_(_%G
M_@K1^S;^W[^SM^PWX7\*?M#_ +1/@OQ/X#T_QK:6VEZ)X?\ #OV:Y2^:UO7%
MS+.8E>4L//+L[,TDDN]LL2:_6K]ECPU\2;/]F+PEX:^/WB+2_$FOG0D36+ZS
ML%CM;I&R8U$6T# B,:'CDJ3WKT'4](TG6K<6FLZ7;W<0<,(KF!9%#8(SA@1G
MD\^]3JJHH1% 4#  ' %1@,EIY?CJE>,Y-2C&*3;=K7ZMN_EVUMN7F&>5,QP%
M.A.$4XRE)M)*][=$E;S[Z7V/F?6-)TK]KG]H6/X-^'=,MX?A%\'-7BG\40VD
M*I:Z_P")XR);?3 J@*UO992XF7HUPT*$?NW%?"7[8GQ;^-5UX[_;1\6_$3QI
MK6D>)_AO=>%$^$+6^H2V\FCV<NKHBS6*JPVF>(Q&1TY?S6!)'%?KMX:\)^%O
M!>F'1/!WAK3])LC<2SFTTRS2"+S97:2238@ W.[,S-C+,Q)R2:H>(OA1\+?%
M_B6P\:>+/AKH&J:QI>/[,U;4=&@GN;/#;AY4KJ7CPW/RD<\UGC\FJXRC95+2
M;;?;6,HI?]N73CYJ^C=S7 9U2P5>[IWBE%+OI*,I/_M^S4O)VU2L\O\ 9SUO
MXA^)?V?/ GB/XNV+6OBO4/!VF7/B:V>'RVBU![2-KA2@ V$2EQM[=.U=G117
MN4XN%-1;O9;]SP:DE.HY)6N]NP44459 5Z1\ ?\ 5:K_ +T/_L]>;UZ1\ ?]
M5JH_VH?_ &>O,SG_ )%T_E^:/5R7_D90^?Y,]$HHHKX8^["BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"UH=]
M_9FM6FHYQY%RDA^@8&OH*OG.OH#P]=_;] LKW.?.M(W)]RH-?+\1T_X<_5?D
M?5<-5/XD/1_G_P  N4445\N?5!1110 4444 %%%% !1110 4444 %%%% !7#
M?M+:@VF? OQ'<JV"UDL6?^NDB1_^S5W->8?M?RSCX'W]E;1/(]U=VT81%))Q
M('Z#_<KT\E@JF<8>+VYX_FCR\[J.EDV(DM^27W\KL?&U%69-&U>)=\NE7*CU
M:!A_2JQ!4E6&".H-?T0I1ELS^<'&4=T%%%%,04444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Z1\ ?]7JO^]!_[4KS>
MO1_@#]S5OK!_[4KS,X_Y%L_E^:/4R7_D90^?Y,]%HHHKX8^\"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KV
M_P"&ES]J\"Z=+GI"4_[Y8K_2O$*]C^#<WF^!8$S_ *N:1?\ Q[/]:\'B&-\'
M%]I?HSW^')6QLEWB_P T=31117QI]J%%%% !1110 4444 %%%% !1110 444
M4 %?-G_!4^Y,'[-5I%G_ %_BJU3_ ,@W#?\ LM?2=?,?_!5TD?LZ:0!W\9VV
M?_ 6[KZO@=*7%V#7]]'R7'<G'@_&O^XS\^$=XV#HQ5@<@@X(K0M/&'BW3U"V
M'BG48 .@AOI%_D:SJ*_KZ=.$U:23]3^-X5*E-WBVO0VS\2_B.1@_$#6\>G]J
MS?\ Q52VOQ3\?VAW)XEED/K<1I*?_'U-<_163P>$:LZ<?N1LL9C$[JI+[V=8
M/C=\2@NT:W;8]](M?_C5.@^-WCI'WW4UI<'TDLU0?E'MKD:*R>79>_\ EU'[
MDC19EF*?\:7SDW^9WD?[0/B9%PWAG1G/JT=Q_284Y/C_ *Z\F;GPWIP7/2V,
MJGOW9V]ORK@:*S_LG+G_ ,NU^/\ F:_VQF7_ #\?X?Y'ID'[05@H_P!)\%3.
M>Y35@O\ .$TX_M Z6YPO@VXC'=CJ:O\ IY2_SKS&BLGD>67OR?\ DTO\S59[
MFB7Q_P#DL?\ (]:MOCIX*8?Z79:HA]([:-_YR"I6^./P^Z1Q:QG/\5C$!^DQ
MKR"BLWD& ;Z_>:KB#,$NGW'M%I\7/ %R 9M<-OGM-:RG'_?*FK)^)WPV"Y'C
M2W/L+*Y_^-5X=163X=P3=U*2^:_^1-(\28U+6$7\G_\ )'NMIX]\%7W_ ![^
M*+,#L9IO*_\ 0\5='B#PR1N'BW1OQUBW_P#BZ^?:*SEPY1;]VH_N7_ -8\2U
MTO>IK[W_ ,$^A+;6-'O7\NPUBSN#_P!.]TDG_H)-7DT[4)5WQ6,S#U6(FOFV
MBLY<-I_#5M_V[?\ 5&L>)FOBI7_[>M^C/H^:WGMSMG@=">@=2/YTROG>VO+N
MRD\ZSNI(G_O1.5/YBM&'QWXWME"6_C+58P.@3490/T:LI<.55\-1/Y6_5FD>
M):+^*FU\[_HCW>BO"F\?^.G</+XRU20@\"6_D<?D215VV^+OQ"M1B+7P?^NE
MG"__ *$AK.7#N+2]V4?Q_P F:QXDP;?O0E^'^:/:**\;D^,WQ&E7:VNQ8_V=
M.MQ_*.K5I\<O&%N,36EA/[RPN/\ T%Q63X?Q\5O%^C?ZI&L>(<OD]I+U2_1L
M]:HKRT_'[Q05P/#VD#W$<_\ \=J6R^/>I(/^)CX=@E/?R)VC_F&K-Y'F*5^5
M?>C19[EK=N9_<STVBO/Q^T%88Y\%39_["H_^,TMK\?-,D<_;?#<\2YX\JX60
M_J%K+^Q\S2NZ?XQ_S-5G.6-V53\)?JCOZ]'^ /W=6'O!_P"U*\(3XY^!2/WE
MKJP/HMI$?_:HKU']F;XM>#=<OM6L8)[BV9OLXC:^C5 Y_>\ JS ?CBO&SO+\
M=#+*C=-V5NGFCVLCS' SS2G&-17=^O\ =9[71117YT?I(4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>M_ ]
M]W@V1?[M\X_\=4_UKR2O6/@4?^*1N/\ L(O_ .BXZ\7/E_L#]4>WP^_^%!>C
M.THHHKXD^Y"BBB@ HHHH **** "BBB@ HHHH **** "OFG_@JK TO[-VGR ?
MZKQ=:L?_  'N1_6OI:OGS_@IM8&\_99N[@#/V36K.4^V6*?^SU]1P5-4^+,$
M_P#IY%?>['RO'$'4X1QJ7_/N3^Y7_0_-ZBBBO[$/XQ"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KL_@=J*V
MOBV6QDD(%U9LJ(.A=2&S^"AZXRMCP!J#Z7XTTVZ5PH-VL;LW0*_R,?R8URXZ
ME[;!U(>3_P" => J^QQM.?9K[NI]/^"_BKK/AG98ZANO+(8 C=OGC'^R3V]C
MQQQBO4O#_B71O$]D+[1[Q95XWIT:,^C#M_G%>!59TK5]2T2\74-)O'@F3HZ'
MMZ$="/8\5^0X[)Z&*O.'NR_!^O\ G^9^Q8#.:^%M"I[T?Q7I_E^1]!T5Q'@O
MXQZ;JVS3_$H2TN3P)\XBD/OG[A^O'N.E=N"",@Y!Z&ODL1AJ^%GR5%;]?0^O
MPV*H8NGSTG?]/4****P.@**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KUKX'+M\'RG'WK]S_P".)7DM>P?!B+R_!$;X^_<R
M-]><?TKQ,_=L!\U^I[G#ZOF'R?Z'64445\4?<!1110 4444 %%%% !1110 4
M444 %%%% !7CO[?>CG6?V2?%\"KEH8+:X4^GEW4+G_QT&O8JXW]HG0/^$I^
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MNSN$EBD7*21L&5AZ@CK3Z\!IIV9]"FFKH****0!1110 4444 %%%% !1110
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M:@^KZ1::M(P+W5I%-)MZ!G0,1^!)'X58KFOA#?K?^ +1%4YM99;=V/<[M_\
MZ#(H_"NEK\VQ-+V.(G3[-K\3]-PU7VV&A4[I/\ HHHK W"BBB@ HHHH ****
M "BBB@ HHHH **** -#P[XHUOPM>?;=&O6C)QYD9Y20>C+T/?W';%>J>"_BG
MHGBK98WA6SOC@>2[?)*?]ACW_P!D\\X&[K7C=%>?C<MP^-5Y*TNZ_7N>C@<S
MQ.!=HN\>S_3L?1E%>3>"OC#JFAA-/\0B2]M!PLF<S1#V)^^/8^V" ,5Z?I&L
MZ7K]BNHZ/?)<0G@LA^Z?0@\J?8U\AC,OQ&"E[ZT[K8^QP>88;'1]QZ]4]_\
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M&U]\8]+_ &C?"-SX4TO44L-2\10:U&]G:7+@%(I)0=J,0RX!(SN ZD5\*?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9(LKC-U:$^@W$2)]=S =EKYD^*O[!W[2GPI\V[N? [:W8QY/V_P\QNEQZF,
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M;F_)-_\ #'GU:GA7P7XK\<:B-)\)>'[J_G.,I;Q$A!ZLW11[D@5]+^ /V(O
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M7/YB<5'_ ,.AM._Z+W/_ .$T/_DBNQ>)O!37^\_^25/_ )$XWX7<<)_[JO\
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9%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>coo-20231031_g5.jpg
<TEXT>
begin 644 coo-20231031_g5.jpg
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M2OC59?#BXTRQ\'W45F?"M[8"PFF%RLT5P\GDO#OD$#(/](59&","*^@_"?\
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M> (9M:\$:+;:JD'AS1=-AG"V^GV]J(Q)'.\)7?<B4,]RY?:$(0<M_P $<?\
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M_=L@HHHKW#P0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU^S<VH:'I"_M!>"#=^)R1X:M1XKL_,U8B0Q$6R^9F?$BLGR;OF4CJ,5^3O\
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M\)-1E*,K_P LHR7WQ;"BBBNHY0HHHH *]+^ ?_'EJ7_76/\ DU>:5Z7\ _\
MCRU,?]-8OY-7EYS_ ,BZ?R_-'JY)_P C*'S_ "9Z#1117PY]V%%%% !1110
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M?X\_!^S\*?\ "Z_"K:SX#O-.\1-?^5(L:S&PO%:WA$<WE.A#H74N_E]@[/\
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M_P""J'P^U[QSX.\5?MP^"O&G@[Q1?WDV@:OXH\#S-K7AZ*<MB*)()XH)E16
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M1GBL+"C6481A3YI<E[3C%IMIQO+?S3W/<=!T^ZTG0[+2K[59K^>VM(XIKZX
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MY&><+*E6C]1V]Z^]OBER_%K?DY;]+_,****]<\<**** "O2/@#_JM5_WH?\
MV>O-Z](^ /\ JM5'^U#_ .SUYF<_\BZ?R_-'J9+_ ,C*'S_)GHE%%%?#'W@4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 =1\'[W['XZMXRV!<121G_ODL/U45[)7@W@R[^P^+--N<X"WL88^Q
M8 _H:]YKX_B*%L5&7=?DS[/ARIS824.S_-(****^?/H0HHHH **** "BBB@
MHHHH **** "BBB@ I&944NQP ,DTM9_BV\_L_P *ZG?YQY&GS29_W4)_I50B
MYS45U(J24(.3Z(_/[4[V34M2N-1E.6N)WD8^[$G^M0445_3*2BK(_E]MR=V%
M%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5Z/\ ?]7JH]X/\ VI7G%>C_  !^YJWU@_\ :E>9G'_(MG\OS1ZF
M2_\ (RA\_P F>BT445\,?>!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 ^VF-M<QW"]8W##\#FOHA6#J&4Y!&
M0:^=*^@]'E\_2+6?/W[9&_-17S'$D=*4O7]#ZGAF6M6/I^I9HHHKY8^K"BBB
M@ HHHH **** "BBB@ HHHH **** "L+XH2>5\-/$4O\ =T*[/Y0O6[7/?%P,
MWPI\3A.I\/7N/^_#UTX-7Q=-?WE^9S8QVP=1_P!U_DSX(HHHK^DS^9 HHHH
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MF6 3M[6/WG7T5Q-U\=O"J#_0],U"0]A+&B?R<U33]H&T4D2>#I'&>"NI!?\
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M**^R/BPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!9OYK7H=?#9Y4]IF$EV27Z_J?>9%2]GET7_,V_T_0****\@]@**** "BBB@
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M\%T_@M^T[X8^#GCVU\!1>#ELX_$NL>"[ZU@<R6^J(KL'C#0J9;A(QYH0G&\
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M@Q\$/AEX:^+MMH.C2V>I^*KKQ)%8[9HKN>-+81RS!CY4*Q1GKAD(X(P/#/\
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M=/3UEU?RV7S?4_;N"LB>5X#ZQ57[RIKZ1Z+Y[OY+H%%%%?&'VP4444 %%%%
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M/!?PDL]2^"O_  46^+=]XCT[2(O[$^'L7A;6846=4 2R:*2?9;1J<)OEC$:
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M<JA>*=D[+GOO>[M>Q^?9CAXT<%A9*DH\T9>\I\SG:35W&[Y+;)65TKGY^?\
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MO5-.Z?HT?D%6C5P]5TZL7&2T::LT_-/8****T,PHHHH **** "BBB@ HHHH
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MO'_P*-X_B<?1117OGSP4444 %%%% !1110 4444 %%%% !1110 445UWP_\
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MN]:O5EZ.,5_Z2W^)\(^$_P#@DI\2+QE;QQ\5M%T]3RRZ9:2W;8]/G\H9_/\
M&O4/"/\ P2I^ VC[9O%?BCQ!K,@^]&+B.VA;_@*(7'_?=?3U%?-XWQ&XPQMT
M\2X+M!1C^*7-^)]-@?#7@S V:PJF^\W*7X-\OX' > OV6?V>?AIL?P?\)-&A
MFCQLN[FV^TSK[B6;<X_ UWX  P!@#H!117R&*QF,QM3VF(J2G+O)MO[W<^QP
MN"P>!I^SPU.,(]HI17W)(****YCI"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
'"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>coo-20231031_g6.jpg
<TEXT>
begin 644 coo-20231031_g6.jpg
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M2OC59?#BXTRQ\'W45F?"M[8"PFF%RLT5P\GDO#OD$#(/](59&","*^@_"?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOT_*_!E64LQQ/_;M-?\ MTO_ )$_+,U\:W=QRW"^DJC_ /;8_P#R9][>./\
M@K%\*M*+P> /AWK.L2+D++?2QV<3>X(\QB/JH->0^,/^"I_[0>N,\7A;1= T
M2(_<:.T>XF7ZM(Q0_P#? KYGHK[W >'/"& 2:PRF^\VY?@WR_@?G^8>)7&68
M-IXEP7:"4?Q2YOQ/2O%/[8?[3WC%F;6/C9KL8?[R:==?8U(],6X08K@M:\2>
M(O$D_P!J\1:_>W\N<^9>W3RM^;$U2HKZS"Y=E^!5L/1C#_#%+\DCY'%9EF..
M=\36G/\ Q2<OS;"BBBNPX@KZ=_8+_P"12U__ +",7_HLU\Q5]._L%'_BE/$
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M3J4ZL>:#37D%%%%06%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCR+G'S6LQPW_  $]&_#GV%;U?-5:-6A/DJ*S/IJ5:E7ASTW=!11169H%%%%
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M.-M"7NS[='Z?Y'04445Y![ 4444 %%%% !1110 4444 %%%% !1110 4444
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M^J"BBBOU$_*0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *^EOV!_^0)XD'_3U;?^@R5\TU]+?L#_ /(&\2C_ *>K;_T&2OEN-/\
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M'T+1117X8?O(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!Z]\'?$YUKPY_95S)F>PPG)Y:,_=/X<C\!775X?\ #OQ(
M?#/BFWO)'Q!*?)N<GC8QZ_@<'\*]PKX;.<)]6QC:7NRU7Z_UYGWF28OZU@U&
M7Q1T?Z?UY!1117D'L!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLNB](1<Y>LG9?<D__ @HHHK]K/PX**** "BBB@ HHHH **** "BBB@ HHHH
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M\ OV^_@S^T9IOC?4O"?C[P]I4.@Z[<V'A^;6]3C@>^MX;2"0WS1.RNL!EDD
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MW]N3X$>)OV:O^"3MK\#_ !A\3+/Q7<>'?'UM';7MK&5^RQ.)9%MR&9BI42'
M)X1U  &*^E/V?OV,?V=?#_PF\.?&IOAS;7GB^\^&=O;ZGKE[/+,U[YMI&\C2
M1NQC9B> VW*J BD*H [WXH_L7? #XP?";3?@;XR\-7K>%]*N_M4&FVNL7$1E
MG^8^;-('\R9RSNQ9V)9G9F))S7?>!O!6C?#WP9IW@/0I+F33]*LTM+,7URT\
MBPH-J(SMDMA0%!.3@#.:G+^%88?-Y5ZM.#IJE3A!-N;BX7_F71.RE>^FRN5F
M'%D\1D\:%*K-575J3FTE!24^7=1?5J[C:VN[L?!?_!$WPUX<O/V*/B!X@N]
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MO^2;K_\ ;O\ Z7$^JX*_Y*:A_P!O?^D2/HJBBBOPH_>@HHHH **** "BBB@
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M>OJ."IJGQ9@G_P!/(K[W8^5XX@ZG".-2_P"?<G]RO^A^;U%%%?V(?QB%%%%
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M]FGPE^RO\-?B/X?^'OASPMX@M-5@9O#\ET4%M9W-I#:Q1QRQI'$([@^N-B@
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M_P FBW\PHHHK]"/SH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M71@ZM:M3;J1M^'1='YW7R.;&4:-&HE3E=??U?;RL_F%%%%=9R!1110 4444
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MG[.M[^SI\7+G0[2WD.A:F6NO#]PV2#"3S$3W:,G:>Y&UOXJ\HK^R,OQ^%S3
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MO,NT445^/'[,%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.PY_A!&&KBS''T,LP4\36>D5][Z)>;>AW9;@*^:8V&&HKWI/[EU;\DM3V?\
M94^#7_"LO! US6K39K6LHLMR'7#6\/5(>>AYW-TY(!^Z*]3HZ]:*_GS'XVOF
M.,GB:SO*3OZ=DO)+1']%9?@:&6X.&&HKW8JWKW;\V]6%%%%<9V!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ6OB,=F%?'5+ST2V7;_@GW. R^A@*=H:M[OJ_P#@>04445PG>%%%% !1110
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MQ!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@]'$!"_F>*]RLM"T332#IVCVL!'0PVZJ?T%6JXZG$;_Y=T_O?]?F=M/AI?\
M+RI]R_K\CR+3/@IXPO<->FVM%[B67<WY+D?K72:3\"]!ML/J^IW%TPZK&!&I
M_F?U%=S17FULZS"MIS<OI_5STZ.29?1UY>9^?^6WX&?H_A7P[H( TC1X(6 _
MU@3+_P#?1Y/YUH445YDYSJ2YI.[\SU(0A3CRQ5EY!1114E!1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
0% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>coo-20231031_g7.jpg
<TEXT>
begin 644 coo-20231031_g7.jpg
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M2OC59?#BXTRQ\'W45F?"M[8"PFF%RLT5P\GDO#OD$#(/](59&","*^@_"?\
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M> (9M:\$:+;:JD'AS1=-AG"V^GV]J(Q)'.\)7?<B4,]RY?:$(0<M_P $<?\
M@M?^P]\4?VH(O 'PW^''Q$\8_M,?M'>,8;OXC^-M?\/6=AID%O;P/*UG:LEY
M--'86%C!+';Q%"TC('D*ESLL_P#!:;_@N?\ \$Y-<_:HMO\ @GU^T+J7C#Q+
M\*/ ^JPZE\6K#X?Z7;7H\4ZQ:S+);Z!-)-=0*EG!*BS710NTDL<< V;)20#[
MY_X(:^._VC/B=_P2:^"'C_\ :MU:_P!0\;:KX2:>\U'569KJ\LC=3C3YYF;Y
MI))+$6KM(V6<L68DL37U?7@7_!-;]N'P-_P42_9?L_VH_A)\.=4\,^"-4UB\
ML/!EIK4,4-U<6-FXM6FDBA=XX?\ 2(KA%1'8!(T)()*K[[0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!DZQX#\#>(KS^T?$'@S2;ZX*A3/>:=%*^
MT=!N92<5;T7P_H/ANT-AX=T2SL(&D+M#96R1(6( +84 9P!S["K=% &._P /
M? +ZK_;K^!]'-]Y_G?;#ID1E\W.[?OVYW9YSG.:BMOA?\,[/Q1!XWM/AWH46
MM6UN;>VU>/2(5NHH2"#&LH7>JX)&T''-;M% &/XR^'?P_P#B+:06'Q!\"Z/K
ML%K.)K:'6=,BNDAD' =1(K!6]QS5S6/#OA_Q#IXTG7]"L[ZT5T=;6\M4EC#(
M05.U@1D$ @]B*N44 4YO#OA^XUI/$D^A6;ZC';&WCOWM4,ZPDY,8<C<$)Y*Y
MQFJFD_#_ ,!Z!?+J>A>"=(LKE 0EQ::;%&Z@C! 95!&16O10!1USPSX;\3PI
M;^)/#]CJ$<3;HTOK1)0AZ9 <'!JKI7P]\ Z%?IJFB>!]'L[F//EW-IID4<B9
M!!PRJ",@D?0UL44 9'BOX?> O'C63>./!&D:R=.N1<:>=6TV*X^RS#I)'YBG
M8W ^9<&K.N>&?#?B>%+?Q)X?L=0CB;=&E]:)*$/3(#@X-7J* ,?2OA[X!T*_
M35-$\#Z/9W,>?+N;33(HY$R"#AE4$9!(^AJ&;X6?#&YF>XN/ASH,DDC%G=](
MA)8DY))*\FMZB@"OI>E:7H=C'I>BZ;;V=M%GRK:UA6.-,DDX50 ,DD_4U8HH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHIEQ<6]I"UQ=3I'&HRSR,% ^I-
M"3;L@;20^BN8UGXV?!KP[N_M_P"+/AJR*]1=:[;QG\F<5SE_^V+^R]IV?M'Q
MPT!L?\\+OS?_ $ &O0HY3FN(5Z5"<O2$G^2/.K9OE.'=JN(A'UG%?FSTJBO'
MYOV]_P!D>W?8_P 9+8G_ &-,NV'YB$UO^ _VIO@/\3;:XO/ _CP7T5K*(YW&
MFW485B,@?O(ESQW'%;U<@SZA2=2KA*L8KJZ<DOO:,*/$.08BJJ=+%TI2?15(
M-_<G<]!HKGU^*?@%SM'B%/QAD'\UJ>+XA>"9ON>);4?[TFW^=<#PF*CO3E]S
M.]8S"2VJ1^]&S15*W\2>'KO'V77K.3/39=(?Y&KB.CJ'1@0>A!R#6,H2A\2L
M;QG"?PNXM%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45P_P 6?VD?
M@I\$H&;XB^/K*SN0N4TZ)_.NG],1)E@#ZD!?>OF+XK?\%9)G\S3_ (+_  X"
M#D)J?B&3)^H@B;CU!,A]Q7TV3<'\19]:6$P[<']I^['[W:_RNSY?.N,N&\@O
M'%XA*:^S'WI?<KV^=D?:M<%\0OVH?V?OA:9(O&GQ7TBWGBR'L[>X^T7"GT,4
M(9Q^(K\V?B7^U1^T!\6_,A\;?%#4Y;67(;3[27[-;$>ACB"JW_ @3[UY]7ZA
ME?@SHI9CB?\ MVFO_;I?_(GY7FOC7JXY;A?^WJC_ /;8_P#R9]\^.?\ @K!\
M)-'9[?P#X UG6W7A9KN1+.%_<'YWQ]4%>0>,?^"J/Q^UMGB\)Z!H&B0G[C+:
MO<3+]6D;8?\ O@5\RT5][@/#CA# )-8?G?>;<OP^'\#\_P P\2N,LP;3Q/(N
MT$H_BES?^3'I?BK]L;]I_P 9,QUCXUZY&&ZIIMP+-<>F+<(,5P6M>)O$GB6;
M[1XC\0WVH29SYE[=O*<_5B:HT5];A<NR_ JV&HQA_ABH_DD?(8K,LQQSOB:T
MY_XI.7YMA11178<05]._L%_\BEK_ /V$8O\ T6:^8J^G/V"C_P 4KX@'_40B
M_P#19KY3C;_DG:OK'_TI'UW _P#R4=+TE_Z2SWRBBBOPX_=@J6VO;RS;?:7<
ML1]8Y"O\JBHI-)JS&FT[HV;'XA>-=.Q]G\27) Z"9_,'_C^:VM.^.'BJV(6_
MM;6Y7N2A1OS!Q^E<917+4P&#K?'37W?Y'52Q^-H_!4?W_HSU/2_CKH-P0FJZ
M5<6Q/\49$BC^1_2NDTGQMX4UPA--UV!W;I&S;'/_  %L&O"**\VMP_@Y_ W'
M\5^.OXGIT>(<;3_B)2_!_A_D?1E%>$Z-XX\5Z"573=;F5%Z12-O3_OEL@?A7
M7Z'\=W&V+Q%HX/K-:'_V5C_6O'Q&0XREK"TEY:/[G_F>UA\_P5;2=XOSU7WK
M_(]'HK,T+QCX;\2*/[(U:*1\<PL=KC_@)Y_I6G7CSISI2Y9JS\SV85*=6/-!
MIKR"BBBH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **\S^/W[67P>_9VL2OC+7/M.JNFZVT+3R)+J3/0L,XC4_P!Y
MR ><9/%?#7[07[??QJ^-YFT72[X^&M!DRO\ 9FE3D23+Z33<,_NHVJ>ZGK7V
MW#7 6>\26J4X^SHO[<M$_P#"MY?+3NT?#\3^(&0<,WIU)>TK+[$=6O\ $]H_
M/7LF?9GQV_;H^!/P,,VE7.N_VYK465_L?1G61HV])9,[(O<$EA_=-?'GQL_X
M**?'SXKF;2_#NHKX4TF3(%KHTA%PZ_[=P</G_<V ]Q7@=%?O&0>''#F1I3E#
MVU5?:GJK^4?A7E>[7<_ .(?$OB7/FZ<)^QI/[,'9V\Y?$_.UD^P^XN)[N=[J
MZG>661BTDDC%F9CR22>IIE%%??))(_/FVW=A1110 4444 %%%% !1110 5].
M?L%?\BMX@_["$/\ Z :^8Z^F_P!@H_\ %+^(1_T_P_\ H!KY3C7_ ))VKZQ_
M]*1]=P/_ ,E'2])?^DL]]HHHK\./W8**** "BBB@ HHHH **** %5F1@Z,00
M<@@\@UU'ASXN>*M"VP7<POH!_!<'YP/9^OYYKEJ*QK8>AB(\M2*:-J&(KX:7
M-2DTSVKPQ\3O"_B7; EU]EN6_P"7>Y(4D_[)Z-_/VKHJ^<ZZ;PI\5/$GAK;;
M3R_;+4<>3.W*C_9;J/IR/:OG,9P_]K#OY/\ 1_Y_>?2X/B*]HXE?-?JO\ON/
M9J*QO"WCOP]XMC TZZV3@9>UEX<?3^\/<5LU\Y4I5*,W":L_,^EI5:=:"G3=
MUY!11169H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117F7[2'[
M5?PS_9KT'[5XGN_MFKW$9;3M!M9!Y\_8,W7RX\]7/H<!B,5UX' 8S,L5'#86
M#G.6R7]:+NWHNIR8['X/+,++$XJHH4X[M[?\%]DM7LCO?%/BOPUX(T&Y\4>+
M]<M=-T^T3?<7EY,$1!]3W)X ZDG YKXH_:;_ ."F^M:^UQX._9X673K+E)O$
MEQ%BXF'0^2A_U2_[3?/SP$(KP7]H#]IOXI?M&Z__ &GXWU;R["&0G3]%M"5M
MK4>H7/S/CJ[9)]A@#SROZ$X2\+<#EJCB<UM5J[J.\(^O\S]?=\GN?SGQAXK8
M[,W+"Y3>E2V<]IR]/Y%Z>]YK8FU'4=0U>^FU35K^:ZN;B0R3W%Q*7DD<\EF9
MLDD^IJ&BBOUQ)15EL?C[;D[O<****8@HHHH **** "BBB@ HHHH **** "OI
MO]@G_D6?$/\ U_P_^@-7S)7TU^P2?^*;\1#_ *?H/_0&KY3C7_DG:OK'_P!*
M1];P/_R4E+TE_P"DL]^HHHK\./W<**** "BBB@ HHHH **** "BBB@ HHHH
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M%F,]IB'RTU\,%\,?\Y=Y/Y66@4445]2?*!1110 4444 %%%% !1110 4444
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MS&6+Q<O*,5M%=E^KW;U84445[IX(4444 %%%% !1110 4444 %%%% !1110
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M,YRWZM/VU->Z_P '_DS[7)<S^M0]C4?OK\5_FOZZFO1117A'OA1110 4444
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MBB@ HHHH **** "BBB@ HHHH **** "OI;]@?_D">)1_T]6W_H,E?--?2O[
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MNH7<ES=SMUDE=BS,?J235.BBO[,C&,(J,59(_BB4I3DY2=V]PHHHJB0HHHH
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M "BBB@ HHHH **** "BBB@ HHHH *_,']OCXF-\3/VF]>D@GWVFANND68SD
M0$B3\YC*?H17Z1?$WQK:?#CX=ZYX]OMICT?2I[LJQ^^40L%^I( _&OQ]U"_O
M-5OY]4U"=I;BYF:6>5NKNQ)8GZDFOVOP:RM5,;B<PDO@2@O66K^Y)?>?A_C5
MFKIX'#9=%_&W.7I'1?>V_N(:***_H$_G<**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *^D?V!#_H/B@?\ 36S_ )35
M\W5](_L"'_0_%(_Z:V?\IJ^7XS_Y)RM_V[_Z7$^KX)_Y*6C_ -O?^D2/H>BB
MBOPL_>0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF?R?XK9@\;QC5IIZ4HQ@ONYG^,FOD%%%%?HA^;A1110 4444 %%%% !1110
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M1]%4445^%'[T%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)+_TEGY'4445_;Q_"H4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %?1O[ 1^7Q8/>Q_\ ;BOG*OK3]C'X8ZKX
M*\#W7BO6MT<OB$PR0VK#E((P^QC[MYC''IM]37R?&U>E2X?J0D[.;BDN[4DW
M^"9]?P-0K5>(J<XJZ@I-OLG%I?BT>R4445^'G[J%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7OOA5M_A?37
M];"$_P#C@KP*O>_" QX2TL?]0Z#_ -%K7SG$?\&GZL^EX:_C5/1?F:-%%%?)
M'UX4444 %%%% !1110 4444 %%%% !1110 5ROQTM?M_P1\8V.,^=X5U!,?6
MVD%=569XUTUM:\&ZMHZC)N],GA ]=T;+_6NG!U%2Q=.?:2?W,YL;3=7!U(+K
M%K[TS\;J***_N,_A **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***TO"'A36?''B6S\*>'[;S;N]F$<2GH.Y8GLH
M))[ &IG.%*#G-V2U;[(NG3G5J*$%=MV2[MG>?LO_  5;XJ^,QJ>M6I.B:4ZR
M7NX?+<2=5A]\]6_V1CC<*^R5544(B@ #  ' %87PS^'NB_##P;9^#]$0%+=,
MSSE<-/*?OR-[D_D !T%;U?@O$F=SSO,'-?PXZ17EW]7O]RZ'[_PSD<,CRY4W
M_$EK-^?;T6WWOJ%%%%?/GT04444 %%%% !1110 4444 %%%% !1110 4444
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MSO,'6>D%I%=E_F]W]W0_H/AW):61Y=&BM9O63[O_ "6R^_J%%%%>&>Z%%%%
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MKW6DWL4T^IJJO]EAM6A%Q/*T;I(JQQL2AST5L?"G[7?A'PSX\_X.MO@1X?\
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M^'M6DTOQ+I5U936>H:-?1L5>VNK6=$E@<,K#YE .UMI.#3;P\ZEG9OY7[_\
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M/_9H^"\?PE\%"?5K=1K>J*LNHL>3"/X80?\ 9SSZL3R0!7SO$N=PR3+W./\
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MD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "NN^%'@8^)-3_M?48<V5JX.&'$LG4+]!U/X#O6)
MX2\+WWBW68]*LP57[T\N,B-.Y_P'K7N&D:38Z'IL.E:=#LAA3:H[GU)]23R:
M\/.<Q^K4O94W[\OP7^;/=R7+7BJOMJB]R/XO_)=?N+-%%%?%GVX4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M117EGJA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%E*4G=N[/;C&,59*R"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH ****
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? HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image.jpg
<TEXT>
begin 644 image.jpg
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M>_$@BX0Q4@A>2]B)@94NC*CR8&2UI+[YN*P\W O"1(=L(I!'U%1B5&T]@=Q
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M7 Y,B#ID&;M"@/Q/ OC1H)O%2U?LP\BJ<DRN+4=Z73G&U?@PI2Y B(>XO Q
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MNEBI>AY*X D).\R*UL84TU>O*](SDW09OFK-UAIHUO*67ESR,KKAU58"N9C
MLD')\A+&7L3O]B&)Y>P\EEPO@>S%672?W0O".(LP_EY>&)>4U>**LBI<4QK"
MC\M\N,'AP_DV)W2Y>?BCK03#JAP8&"Z ,9"'8>%"C*^R8A*!/(U GEKKHTLF
MB!O"F%E?B>DL<QMKZ8SKH*^JQ\":1HRH;<:PFE98JMOP:&6[VEOOCZ$6W!%H
M8JG#);ML!*\K F(>GXZ-B):-AS:';GD'SX_N6$,@:W=4L]2PP7'CO*79Z!=J
M?7'Z,^_^.'I93ELI%LM-!D/J6P,'#87!8'&<*$1QNA+G+2ES_?OW/R=:=<J2
M;?1)3;W@=-U\>GJZMF_?ON<];C:?S\]QT>I3DOD!<]>4E)2>O(YG1ZM.67?<
MD1['<[SPL<?T%P__^_ C0Q".EEL4=\<[2O6+4)SM)2<,49R.D*Y5[&W?4ZP-
M/17?4Z<?EK+NZZ%N*_O9$Q]S<5U7Q1KHJ10TGOK_BW5?HKH_>\7WHC5?7E9K
MHN)HND"1%Q/+M3@=M;4EJ'<WI[N=X^G@-:[C]3L5R=]9U@^VG*L 7S1H9R\I
MN%*[IOQEC3AD ?(**PNAG.$@K CC39QNYZT^(9= &'<AY+H1<MVR'$C<84<7
M@J]K;@#==H<)Z# N**S"A45A7$T@W^*JPJ^\E;C*48Y?.ET861G$Z&JW"N+'
M_;E((91'5I1A6(7TUK-A5*5;#5G,K ]C<7,-%C35(9TPEISCM.I&F*N;D5;3
M F-5"WI5M./^\!XU=OR[0#-^5EZ/:\H;<$FAAZ!E8U(8HC.F(RZ@.R[BN>V6
M4(6XY!#=,IUQ3CV_UT)9Z\+9JXL$[N^-;3KPA^AE.6W)@SEQQT:CY?V4E*\F
M?8U0N=)D2AMJ,)GS]49SLZ3,&8SF5C8 I2:398P\3(PN>D*93*8;#:;4R7JC
MQ68P6=K4;1DLC7J3.==D&F#I\W"?"Z*+?D')QM0_F%,'S308S/<*A+G>G=S6
M(@G7&(RIG5)2]*80ZY<;N6QTM1-*K]>?93:G]>$Q;=,;+/5&DV4_M]O&[988
M3 ,&":"CBWY!,L]H3AMA-J>.E51#J6/C\".CT31=CLMD3MN;FCIH/X\IYXB&
MQ]FZ4JE^ 8J+4+8V_SI:>V;E[+A#<;4O5!RMY=Q/I^+NW*O86VKHS#/9"/0Z
M9B.0DZ-37&V]E>#^J8<R.*Q--RN>CO%L2$H49UL+M[='W9:S/4/Q=/Y&7>:@
MRCJN55R=0[C?;*Y?RV/HY'+-_%[(S_JCYN/*/KV=O14_]^G>\U/%QV7<;7_G
MOC9RO6JNOY?'U,;/3C9DZ83K3Z)K'ENEU1?R./NIV["U5/,X][$\R;HVQ=Y<
MQOT-5=PMWX\N?:2<^WZME.^?H3B:(\]\9%L>;LO5ODEQME1QNB>RG5:7&L<O
MJ+E,7>[SDH; W9G,;4U72IM_%ZT]NHJ:?L &8Q2/MYCGVLKSW,__DT;N9ZOB
M:GV$U^3X9D/F.SO^QFN5J3C::]0425='!X^QG)\7\USN._0W3UIBNU6[U/6)
M9H47FE4$UFJG6I0U!'&FAS FT"1-C"XY,<=+ )>S$,P[;4C::4=2CH>E'-T)
MXQ[909Q-\)U?5(E+2ZMPG;T&O_<U$,HU^(,G2/=;0X<<@C%8@D?*<_&@+Q?Z
M0!'20J4P!$IA"3DQMLJ'"35!]4TB*UH;,*6^ 4-KFC"0,-83Q+TKVU08WQOJ
MQ.V!/;@MT(;_\S?C*F\]+N>^SB^B*]Y>#&U!$#J!L8"9#80F/P0EF]^S^9E
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MYB^\)850FBINT9(ZX!.#*6T*7>M1XYAZ?=KON:T#4=B^)I"-SE)%5SQ/MB,
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MXVK_%_=Q_"PA6\L0-0_Y?PUD6<;1^IPB/2>=K2?]?.5+2S)'G#PV1]O+:B]
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M.'#@>7J#N3T:0XZX-NI4@)QL-&V+@CTL#PNESF1*4V/=*7I3I[G7Z0TB=$I
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MH)<@?OQ*-4:MIM6-I#,>S<]C)3PBCGD-P;PZ FK"69=.ASQ=QJR0GGDL<W9
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M#H$\3ZU+,DQ"$N&=0$A+WG/\\,4JE*5CBI2XR?)ZJ4RU\X=VU@X6 7(Q@>R
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4+%,N:I=.,;H     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_2.jpg
<TEXT>
begin 644 image_2.jpg
M_]C_X0I317AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    D    <@$R  (    4
M    EH=I  0    !    K    -@ +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-#(#(P,3D@*$UA8VEN=&]S:"D ,C Q.3HP,CHP-2 P.3HR,SHS
M-0     #H $  P    $  0  H ( !     $   7UH , !     $   $F
M      8! P #     0 &   !&@ %     0   28!&P %     0   2X!*  #
M     0 "   " 0 $     0   38" @ $     0  "14         2     $
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M;W-H;W @,RXP #A"24T$)0      $                      X0DE-!#H
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M8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M     $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^            !"
M<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M  !2<VQT56YT1B-0>&Q <L            IV96-T;W)$871A8F]O; $
M4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M         %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O
M='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!2
M96-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#
M[0      $ $L     0 ! 2P    !  $X0DE-!"8       X
M/X   #A"24T$#0      !    %HX0DE-!!D       0    >.$))30/S
M   )           ! #A"24TG$       "@ !          $X0DE- _4
M $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@    $
M6@    8       $ -0    $ +0    8       $X0DE- _@      '   /__
M__________________________\#Z     #_________________________
M____ ^@     _____________________________P/H     /__________
M__________________\#Z   .$))300        "   X0DE-! (       0
M    .$))300P       " 0$X0DE-!"T       8  0    $X0DE-! @
M !     !   "0    D      .$))300>       $     #A"24T$&@     #
M?P    8              28   7U    )0!# &\ ;P!P &4 <@!# &\ ;0!P
M &$ ;@!I &4 <P!? $P ;P!G &\ 3 !O &, :P!U '  7P!( &\ <@!I 'H
M;P!N '0 80!L     0                         !              7U
M   !)@                     !                         !     !
M        ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M   !)@    !29VAT;&]N9P  !?4    &<VQI8V5S5FQ,<P    %/8FIC
M 0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)
M1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U
M=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   28     4F=H=&QO
M;F<   7U     W5R;%1%6%0    !        ;G5L;%1%6%0    !
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M300H       ,     C_P        .$))3004       $     SA"24T$#
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M 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MJ;CXU>.^IK&TYE=D&MK?I5FK8QUM;?S,?^9M_/\ 26LDE[LM/#3K^2/NL/4
M2.(\1TA?[WS\/'_+T/\ _]D .$))300A      !=     0$    / $$ 9 !O
M &( 90 @ %  : !O '0 ;P!S &@ ;P!P    %P!! &0 ;P!B &4 ( !0 &@
M;P!T &\ <P!H &\ <  @ $, 0P @ #( ,  Q #D    ! #A"24T$!@
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M6B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M 0  ]M8  0    #3+4A0("
M                         !%C<')T   !4    #-D97-C   !A    &QW
M='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:   "+
M !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV=65D   #
M3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#    "1T96-H
M   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $/   " QT
M97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M
M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M !)S4D="($E%0S8Q.38V+3(N,0
M                                6%E:(        /-1  $    !%LQ8
M65H@                     %A96B        !OH@  ./4   .06%E:(
M     &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M%DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O
M=W=W+FEE8RYC:
M              !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@
M4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M
M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N
M9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6
M:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                 '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>
M     5A96B       $P)5@!0    5Q_G;65A<P         !
M             H\    "<VEG(     !#4E0@8W5R=@        0     !0 *
M  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@ ;0!R '<
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M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_P  1" $F!?4# 1$
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MIDE(;T.4:]ASL7(>[;N$N+BEM"V06^-A_13''R+%<9%1U$7./O%RYRRTMG9
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MNH -^HM75?0455H\LYG*N:GP.E)XYQ() 83!&"R.)"JDE?K8O^5'LN5(AVJ
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MU4<:N%?68RKZ'-E6VMG)-=7_ (AJ6IZ9X5_+'^K/0;\&]H&N8U.HABBBM*9
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M/Q &F =6"_8[=MPG_P 44113(Q>C' (IJ*,H02'4*Z21J.I^PBD2NPF+J8S
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MI0 M72 . [;!K,7BJK*1;IARV96FDAHZ2!76"DI9JU0?NJIZ:HJ(4GIJB>-
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MXDB:,)*C169T1]8L3R2NK@,!3;;NUR5CBF\-4);45*H*$&HHV 2-.3PSIX]
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M";33?=,7N*BID2,60L2O!9KA"S'3;W6&.VG+>-1G->X9T@ U51JIJ(R. R:
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ML2K!<:=]Y>W+EZ[-KN"4!^%Q70X]5/KD54T9:BHR*]+>3N=]@YXVP;CLLH)
M'B1,0)(B:X9:\"0=+BJ-0Z34$ 1_9'T+NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__5W^/?NO=>]^Z]U[W[KW2:W?O':VP=
MNY/=N],_B]L[:PT!J<EF<Q5QT=%31W"(IDD-VDD8B.*) 7D<JB*SL 55E8WF
MY7265A$TTKFBH@))_(>0&2> &20.B[=MXVO8=OEW;>KB.UMH15Y)6"(H^9-,
MDX XDD  D@=:IO\ -<_F_;GW+B*CIOX\UN4V5L'/C)8_<.]*BDCI]P[WPM--
M_#\FE-$Y:3&XYI2(V@D"U,R!DJ536](,G^0_:R+ER./?.85$E[4&)/B2$@5U
M'R>056ARJDU740&ZYS^\WWB+_P!R[^?D/V\D,6SJI6[E'9->:BRB%:]T4#^'
M(K( )) M)2L9D3K6/7(97.2JZK6+3HRPEE,<_C$C'UL[$"--::0?4NM@6?A@
M).DDD?U/[?\ 4/\ 54]04;#9>6D+RF/Q2I<5JI- /( EV ;4::6T*0J<#TJL
M+%D6E>E>F,5-1L[13RR%EB$90SHRA4_<95*@6!4$'418GT6LM2F!Z_ZO]7Y=
M1]OUQMS1_6)*))IQW*%XDZM+"I8:0Q!J"0Q!!5> &?:.-FM))6>2I9;:%HJM
MXXDCIX!+XW0$*KEF+A H%V_25%_9C KDD$5_U5_U#J)=]OXBZQ6BZ%/'4!J)
M9J5J:D@#MJ230<021TO9]S4.!UQ/+55LU;,T@^VJ(7*QU3,8FF>@9;AO$0 V
MM=3%BOJ?4XPU$A3_ (/L_G_/I/M^UW=_I:<"*-13)*FO:6H":EEU56OIP[4'
M0@83>D\U12)+CJB?&U&5F:A@J/!/(F/R..-5-3BJC^V!BBG8RV+PF)' N!(9
M?95<6@=6<-W <?F#3AW9(QYUIY\.AEM,<4#I"5THNH9)9CD$@.-/ $-@@+DC
M+-T+VWMEX#!MCZ&$KCJ6ES&5AJ$=Z]J&#'5\C54W\5?(L!KJS#&](T4?A=9I
MT*LAC*E,][<W :5AJ)12/AJ2N!II_#4ZZG4-*D&M:R#9V?TDR+</7O"GXM*H
M*_&30#6%7P]((<O216!4@U6"V?MNN7%[D@H:'/9+;-)M_&X/+Q8R".II*"?,
MT[RPY*F/E6,+/(U2J%6#QH8]2Q3*JA&:^O(B]H6:))B[.FHD$A&^$T%:@!:B
ME"0::EJ1_';V5S:))"%N&@6(*_A@ #Q5 :1:D JS%A4D%0RCME Z.+LK!^/(
M4.15HJ&>*-*R:HV]D9*JCG2JK)(8%@I(XH92[PU=3-&D04+,2YE#!'8$;E=Z
MX&A/>,BDBT(HHJ2:D4!102>*XT\0)$Y<VGP+Q+G^Q:@<M;R%D8-(P4!-*."5
MFD90M LE7UU"LPG9"BPZM-3PFNBIZZ!OM8I14T\(HHZ**J(-)1R34T+.SRD2
M*J2R2$L[W$DJD*RW31ACI)4YI0G421Q(5C2@%"2H& *%5(MO+3;@[1KXBI*O
M:#J5= 16^!6>-"26HP"R.YU,U0\@#NISCQ3U&..*G,%'5"LIWAJ9:.*"I:,+
M-).\RN8Y1*6\,<9*B5A-KDD5F&WMUTB97%3@U&HTK4 4(!%.-:5 *4"D#H)R
M;H\<SV36[:(VUJ5<HH:E&+%@=+!R="J2 [";4[JS"/EUK:F&JUQTE)C9$FD\
M3X^G>(U<<*U,M35059]2JNKQRFGD73&."H32GMVC255))=2,ZC\-2* K^51J
M4U:G&HZUNB74\,FI4C@8,:>&A&L ,6=7X@ '0QC==,8P5"T<,3]GCX$5)<G4
M02DN*J"!I:F1JK4U)^XL<;"0WC0?N JS!')E/F36DSS4<*K#R)  I0'S(IQ/
MS JO:-)6V)M[&W'AM*Z-D,JDL==2F0BG4:JHR"&8*]9#XJJ*MIRS2K/%+&:4
M7UTQHHS5%(66;[>26-)'T/+'/)&P*MY=%B29%W$JH!H(-3Q-3IK3B 2!6A4'
M!&D$4%%Z-[B-G+"9671_#H4O0&NDLJL=)979356\32022X]C\+45R5\Q6.*2
MGFIYUHGDHKS1F\:5\T<(=R)01'*&+?ZID)4M[3W,RPZ=(XC+ ,/0Z14@8/"E
M/0'T=L=NENQ-(W:48$1DH:C(\0A03WCM8$D>;(2-18<CA9JJDHJP4JA:RI#S
M44$C2PO5([Q23Z7>725ENIL/5?B&_ W%.JR%"2-(I7S QCR^W_G[S*"[VR6X
MMXYP@_4:I0$E2P)!:A9Z4:HJ.-?[*N.D!EL2\DY$@EJI9:::.*+AEC2+4_BB
MT$QR>/4J.)6_3?4OI*^SJSNU1<46A%>-#6G'S%>(T^=*'(/0-W3:FEE(DU2L
MR,%&,::F@I56TU"L)#\-:KAEZ34^,@59I*NFD^_FUP>'5%'.YO,DT=*9P&)U
MEG'HL0;#Z@^S2&\E+JL3_IKFOD/A(+ >6 ,FH.3YCH.7&V0*CR741,[U33VA
MS_:!@A8 UU$L.VA&!6H/0;9/&54.4Q[8ZG,4<PK8J^HAIXOO=53/#40"HJ9@
MK!7*G0CN%6X<$< #?;+^V6UF^J8,ZZ2H).GM# Z5 I1016@)/"E*]1/O>UWJ
M;K;';$*1OXJRLJCQ 7:-EUNU&&LJ=*LP45#AJZ:.4=+0.1) 5\5&HK*JK2H:
M%$!F9P[3LD494,K$-K46]3I9K&GC72H5&6E.D)IU$U'DH+,#0@<,L0JM5<+1
M;;=(PDCIH@ D>0/I"T8D$N51"H(8@ZE&D%WCH]&D4E4E)JHI)X8FD9IT+5$3
M%VB;3Y8G,9N%8D.F@#U&UA]6;FSGN5^H"LZ1D*>TXJ.!R*&E"#FND>F'K*^@
MLJV+R+&\E7%74DZ21J4Z"2 20RZ1\1I0'+354T%#$9'G?[BJFUR12!:EY$JT
M\<7@FNI"WN0%4%;A$!L#[<5Y[J1@B )&M%(JH!3-&%#7@<GB 2QX@E=S;6VW
MQ"620F69M3!J.S"44!1J@@5. H&FH5 : ])ZOH34BGGH1/-,D1<2!S4.TSJO
MW+#SQR>FS*1I0 CA66WO=M*J!TNP$4FA &G KIRK+FH(R2:Y(/1#N=@;D17&
MV:Y)%4L&KXA+&@DIK23!!4C2H!&%9: ]([,XZFPJ/5'44GB2!'\$;S25QFC7
MP#[HDOPSLW-]-@."UE]I//N#K I!T$D]S4TT)!HM /( Y6N:5I4';WMMER_"
M]ZX/ZBJBGPT+&76@*5D)+<69AAM- "%+:4+498U<=0U10BL,*+XZ>1J=O#]6
M:T=(A9TLFI5)  M<L+L!9;V/T[*JRB(-Q(U=W #XC0,*T)IDUI2@'49W6]?7
M1R27%O\ 4: -*L4HG$F@C0LR44%5) 52-185;H0MM;FEEHEBEI(:Q_&4HVBD
M?&5)IAZIXB\L<E.NC40]IDN&1;,JZFK-M,:SE"2NDDD_&-1PI(#!C4?#VL!1
MJT)H!QR[S9-+8A7B68E:1Z28'T#+K5D>)=%>^DD>H-&*,JZF&79VZL/*69Y*
M['B#]@/654=.L]*UA)%YUF\#2,EB#%,6#:2%6XLU/MM[:Z9%*R!@/@!;_2D4
M74!J]5%17-!F4N6.:MGN2Z2F6V,1T_JL(ZK@,NKQ/"+E:?!(2&H0JDC2;[K'
ML"NVS64V\=J9>JPV9I:1*>@S%%+3U*5./$Z.*6I27RFHIFD5V*R1F-KV*J&M
M[+-PVN#<;1MJW*)986:K(P((<@]PI32]",@ZAY$TKUD)R9S9-M-RG,NPW#6]
MRD86.="K!H@P[&KK,D18$]RZ#6A50:=7/_'KO&#N';U5%DXZ2@WG@&BBS=!2
MEDIZVFE%J7.XV&5G98)B&1XR[&)Q9C9DOC-SQR>_*UZK6Y9[2>IC8Y*D<8W(
MH-0X@T&H9' TZ)>T_N7'[@;4\=\$BW&TH)D7"NI^&>-220CFH*DDHPH31EJ8
M?V!NI:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__6
MW^/?NO=>]^Z]TTYW.X?;&&RFXMP9&EQ.$PM#49+*9*MD$5+145+&99YYG/X"
MC@ $DV !) ]OVMK<7MREG:(9)96"JH%2S$T 'VGI)?W]GM=E+N6X2+#! C/(
M[&BJBBK,?D /M].M2O\ F,_S"=S=W;MR6T]FU$-+UYM2K$>%VS'D:3[S)>9I
MJ63/[AQ=7&#+53)%4P^&TD-.MJ=3Y&EEJ,VO;#VUV_E6R^HOT\:^E7]1O)<U
MT(?)1C."Y[C@*J\D?O,^^W,G/=VEOR_+])LT+MX0H293I*B21:59F+$.N5C0
M>&#5F>37N[:D;=>^*=94K:>GQ8AI%IJI7>,B8+&CH3I! UQM=])(L2-0M['&
M]*'NQ&H(" "AKY\3^=1]O4#^WNXML?*]UN(*2SW9+ZE9=2Z*T!H/(*0 H(!]
M%->F[%X>LI(PM%3U#1F:.:JFE=7\D?CU,8&4H9"A&K4'4(K7 (++[)Q ZBBU
M(K4G_-PX?;0#IO>=\AW&35N$@U!2L:J*:<X#5U!00:4*L7*T)!TMTO8L/,T$
M<@18H!43R"@\D<*RR14Z1)YWAENC++&&:,,X .HVM8W\%BOH*\/R'&AQ0YXG
MUZ K[M%XS1:JF@K(0S4#,2=-5SJ5J!J(3\(]0HO/!%B99:^2(03LM.\"-$B2
MK*CTLK.]A&8D9([+*2XN>&)X?4 I]OI_JX8\Z_GTE@@:6[6&U4F1#K4FNH4[
MOFVLU-2M%R,X-&2:LQY%))3SPT$IJ46KHVA--DYH:=/*K0R2O/)3JSE8X;TP
M2VMCI8Z"Y'&6.17_ "'[/]GH8V=FPB)NPTH [6K5!7B,45C2H-/.F2,@3=NX
MNMR5/%DF$E/ )*"CHZN53H@K):1)JM8I80K(@1VD"R*UU5]:EI"&K(T<3^%Q
M-"2/E4TX_/&*>7ITL6,1K]3&".X &E:*>T<?52&SVZ?*E!T>#K[(P'!5:9*:
M"*JFR$62JZ5JU*'^'E*;^,T4/\5CF29:LU!T"-(U5IG00@+$SD$[E;,+A6B!
MT@:0:5U5(5CII33I&23A0:\0.AILEU"EO+"\GQ,C$5T!2%+K1P=6MF>J@ 58
MK2A4GHU6S:Q)%>@K<?!BY(U2%GQHQ]+,<E4X^6BJH%7"O)')))3^*[,\\C:9
M"?)$ @!U[;E3XL9+@Y[JTTA@03K%0*U\E Q\+9Z'5CNJ2@VUS^@RGC$5#:VC
M964>$2&?25H29"Q#&CICH7,-N!8:6.FG*Q"?[I8X9,?D97RQKM%>DE#D(HU1
M)!)!5NB?:'0P=I+Z6DD(KJT)E+I7%,ZE&DKVY4DX[E!.K(H!QH!!MN]!;402
MT%=5 8Y#XH<AP5D5  U4D(7PCI;4S$T+NJ3DZN.>N:FKC6UF0-5-)CHR'JJ:
M5542P3--&?MEC0_;R+J#D>,\'7#[+'CC,:ZUTJE &. 1FAP>ZI[@>'Q?)NC=
MK^Z6:4PR^+),7)C&74XJI++^F%7]-@2&(*'!+1=-])F)GEIVE@BH#'2V./B\
M'B2.G5X(WI*=2L&BFG=0\LBRZ]3ET0%=);=QHH8J2P)'?FN:$ZC0M5EK0 K2
M@H30]-66Y2N\9D40D(?TAIH NI046HCTQ2$!F82:M3%E4,NE\K:[&9.\&0\\
M5#)*C4,E='%2P5:10-"ZXO[,2:'-RTWC"HJQK(QX+DB42PN);=@7X,!4TJ0Q
MU$TJ*TH#5B20!4@ _NKBPO@8+\,L+$>&7"J'"JRTBT:J-2I<KI10@=C@L<62
MKUC\4F.?+4]2BT62FJ$J7-"RP5$,U*#6Q+J 'BCD>"#7&5]3O9HB'+-@K?J%
M:590*5;(8&@./.@9J,#2@[&'5-QG!0-9^*C@1RLP8^'16C9*R*"P^%6:./4A
M6I=^^,]/R[YED"29:K@AJ?N2M=]]4F.%XI6%+0EBX2/2@D2./6 YEN ZW6VS
M;&@$"LXIC0.'F:4)-30DTJ--#0\.C2/F?.O<I$C?51_$>BD$Z4XZ5H-2HNJC
M&2HU+444,N72.C#22O0U\\3(QK(H?N4:>H8:#+ [QR*8T30Y$IMY )' ;4B!
M,DF@"J+Z$TQ\B 1GR[<T[0:='CWJ1VVMV,4SC\874"S'%5+*P*J*-WXUT=@#
M4+*C<T=$QHJ/R"**M:HDD*H*AW=R)3YH=3'1RPUM=%.LH?5I-DMV==34)(H!
MZ4X"AH,\,#CBN14!S;[':N;:VKI5]1-!J))-3J6I-./<:JIUE#1M,:HJ15/%
M+7R5=+3O"QIB[)5-+)*6J1$GA)50M[$LOZK7)4*P=4,G:E":_9C SC/K_LFA
MI+<)<%9+LO&A';6CDDU>@TD@ 5H21QP:J P2]1,87>E-68XZB<R\4\4M0\:-
MY)'>$Q^)K,VIM,CDJ3I4\*IG 0R^(%J5%.-%'IFM1Z# &,D9)#-U*87:U\72
MKMJ^ ,Y RQ*E-#4)J:.Y()TJ:A5<)=JBMI$K'\B5BGPPNS.(582:XYL>T4A0
M1,"+HUF8\E2OT76NZM:RB)2/#.2*"M.%&J*D_.I KBAZ]<\KI?V@NI*^.O:I
M).D&M0T6E](0@Y4T+')!'!)9[;38L,\<0>2.&=C5_>R3-^\'0>>%P Z*%U!G
M*Z@1ZO0"!5MM^EX*.::BO9I !H1P(R"2>"@TR=/=0@7F'EU]LK)"M2JO^KXC
M,1J##O4@!E 6H+%=0TC6- *LRXZ@G5_N%\2E::4Q#631SZ!8O),5-V4.3J8L
M-1.IM+%C*2>[C<&#)%1JQWK6I%!7@2 * *: 4%0 1I8;=/&RW78IT,4[OTWH
M!4EJ?$H8G42XU$ZFTL6C5-/40S3FJ,5:JHOVM8TCK)<RK9YG9&&H:[:/TL!J
M'XU,UCE@4VX,9K1U %#@UTT88HN3Q&%^8:FANK>X?ZPK.  8Y"QK\0H7)4C5
M5_A^%@"X]'8EE?[)'6C$(BE80+(S.R1B,E/&\:'7H3@K*/3<! HL3NXAC\<T
ME+8&K2 !6N<$XJU*%2>!)U$D HBGE^@5OIQ'I8A Q)(722*%5.K2I-5D%1J"
MIH !(<[CFDEK_-5DR4U,JU%/'YZ4/43%"[4[\ S@ E=#E?J &4^D&>VQVZ(8
MHUH['26HY&G'?GX#7S75PK2AZCKFJ::6^6XN6+QQ+X@35$"TG=^G7C.H6E5?
MP\MI5E*T(>5U13M/*X> 7,CA8X=$DI9#'H%+(SD !06)(OQ8*5)]BNVA<0KJ
MU 5 R:A1754O0"IU$4S2IK4-U%6Y75NUR[H4SJ-%6C,2I6@C+-0 *"22NK%
MA0GJ/CLD:&2D?0%J&DAU*^F%_3=@@*"Y5UD*\% >;<DGV(T@:ZU$FJQZLUU
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M52+H\=E*,!Y&!-D9C<*X+JX:,L7.BOJ:<0:8-37-?+YT%.J3VMCXX@:!?$4
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M'9@[>IM)5S=4"2"L\,=L^A"&- 3\0)K6G &@I2@[0,CB=40RV4UQ?11R2!D
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M]C';7N&N4B*,PIBHIQ\UU@-45%:D!: #NI6-KR&TABDD\10U:$ A@:5PV@E
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MVIED;D:N6?WZ+ZB(!(ZBIJ/*I^W@"#3@*#B>'3$J;;=NT\Y#%!1JT8**<-
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M(W(?1(;OJ*%M7-B;NRBYTC+,O=@Y8KP)(H<"HX<>'Y*"1U6+Q;-Z 5&$63B
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MHAB.6U@F+JPPN*?SX5XG]N*Y\\] 3QH"A\0^*&!)X"A!8+ITJ!@'2I#:05'
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MC P(CWF^V/?;F.*9C;SD4TRAJB3],Z% 7PZ' 'ALI:H:C&K,!>Y*CQ9>JQJ
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M+JQ198XK\C4%7D%Y#6@RI%?,\#4YJ3@YH3^9/34R& &1RL\$C*#51AD-.T*
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MT9<!A0>I!R, ]H&:_BZ5]-AJ;4=,<EXZ=/M*.1$*_<$:1.D*V.MWL-5CI+,
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M2/M_+S/M]AD54TGE'J[J>P$?Z'&>!(9W'#N3]W7[A7M[[76T',7N/'%S#O\
M0-21==A:/QTP0.*3NI_XD7"G(#110D$FTI55%5$541%"HB@*JJHLJJHX  X
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M%()XG33[:>OE2N ?4>9W';PQEI&+HGPH'K49T!B*T.26 4,4()TDT [CBA2
MHD-+$)*:DG:]/'$DLJ@2P+)%5I&D4JQ2/JG52 %72P5@2I@=C1L=U>%,4X&G
M UX5'V\.J2K$NJ+4S>%I/<#J8,U)%#9*:0=5&!\P*$T+Z9IY99'IZ+')+48\
M4,=/2XZDIZ0S5"-54]9]P06%. B/&4LA0 OY5$OE?$1*?$2!ZD \*$#S(-2,
MU^1X$:DOXHYQJB17<4(521EM2LU20K* K5!CP 7# LCNN+JY<C495$<XVK:J
MD297GD:(1Q(3"C>,2.56$M:1A'$#(8C(A2-0FD4A-+"ND  T&!C.:5)R>!_,
M&I,R5F<7$+A?%8L0&:C'OH.P-15)"T+*#7.E@%5>8#+IB8ZR 24575%S:F$G
MV]3%CZ.E9_V5I5:*5F0M')IIKWT@BT;/&'MPM#/(C*Q"\*T!!)H.ZM"*-G#+
M7-/(D2;%N:[?!.LB*TE0VC4RNL:@FD6@,K%HZ(=4;Z3IU<"%>*[<V*R$E+C*
M-:JJGJS!"V6H,>:RDGJ#,U/1T<U5 =$E0\OCE>S%AK5O$'62X4DM9(2TCD (
M*_$5H*48@T( '  D?B-2M.A3>WMI?:+6-'+3N%&F-9&8U_35P'#.[Z=3.JL:
MF,:!(7Z#//QST=6]32RY##9*C$CT=9CJG(4@:H6I^VA^V4.SJP34HDBD)UW1
MBAN%=:&*=&BE42(V"#1B,5J3C&00*"@J1P'48[C>7NU7<=YMSR6L\%2C)K0,
M0_AA56KU- RL0SAF/AR"K, 8WI#N3?&[*7.T.[I:3,2X*;$4])E:6NIH<ID8
MJD_;.E7C2X=9E9H9!51 QS%I$58I])FBSF'8;:PNQ;VP">(CL,8%,Z22.% 1
MC(%"_:.LJ_;7W(WWF?8I-QW<F5X)88CE59]7;J4!AI?458]M'.I8OU6(Z,1D
M9JEW;3+YS$MC'(8XUJ1H EBUQEI29A>,M*#I"K)&/*NOW&+;K@QZ=.?BK737
M@:4"]IH<<22#VGJ:[FVG>34'UZ1\) &O U"H)<^(*H==0H570>*NKIHHXX*V
M2&K,1:4U("4TY5/'$WIB,E8J*J A'<L(S&S<OZ6%D;[C=ABOBL%-:D&E3QI3
M4>!( %:@8&5ITS:65I<%+GPJN&%%?\*\!5PH"U"LQ.DHS9?#"B]IXWIE5Y)0
MQ-1')3SS".2*&26(I.B#3S&K\JQ#-H4#R&X9DBL)#4C!'YFF:\>/[!7-/081
MQM;@:FJ=0*DT(4D$$ 4^$'(/<VD4UFNIEA31Q8YJ98:@5<1CB/C6JJ()UJ 4
M*"D24^0@J-1+LRM?2QYTE]"6!)XYSQ]>)X?ZN'1TD<=FR+&^M:#&IE(8:::0
M3JR,Y)!K0G-#DEQ\-37P334KLM32N#(LL50B1)#YI:EXY7L&LY1Y&)_ !'!9
M;'(0FE<4/V'[*CTI7^?V,3V<4URLDJ$AU.00P I4L0QXD,59C7& 1Q;V.I#C
M6FF@B9:)7:!*6MEFY85"S,UJ6ZH2O.HN&:]K*?TJB!(17+8)(^SAG)]*4ICS
MZ36L!L];Q B($J%<GCJ!KV5 )&:DU-:$ \'8TK91E^XEI%BB,\\8#RO]K*LR
M 4[B9B?TN=()%B"+_P!KV_'2(=H-<#[1G./3I^2!KUQXS*%4LPR3I((HIU$^
M1-.!!!SY]!UE:B2#,D">2FIJ:**!&C1ER-20VK1)(S2H4C#,28HP;ZO6 P'L
M:;9:J]B2%JY))J1H IZ4!!./B:A%,5!K'&[W;P;P=3:(T4**!A,QK7CJ92J
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MAJ:ES+3QT915\MYI1Y9"7# <%054H02ZQ]N5EX%T58%:#(&*G.,+0#'J?6O
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M[I#):Q@JHD(5CY:N\T)(8DLQ\M/#@ %4/<WAKF6#<+AP\DENC,$"U.BL*DA
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MS(HO'ZC,.++Z"'N+'4<NI/%T]O&H(P#7C@</Q<,8H>DRH$F-HST? H0>YE&
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M[6VY49FCH\B*.2*7PR20JLGBD5M).E@>?>U%2!UH\.M8+_H(5^3/_/E>BO\
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M&&#,XRST&YMK9"9"ZXS=&WJO34T<QTOXV=#%,%+P22QV<L,I4T/5@0>'0_\
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M4L<[2BBFK4J94:62.H36[6%D\@ :@Z<%:9ZL)9E16=V"HH+,S$*JJHNS,QX
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M\M)68FAJX[KX<SO"9OL8K,&21*0U4T;"SPK[E_E+V0YUYG5;JXC&WVS4(DN
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M:T7X:#.-(#[C*VE-(U?%'"T1*SHQI92LD496E6DIGFB =V;T Q@$\+8$L/=
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MFV[N[!F99*S;6ZL4CHM51S@<@E9(GTS0213QQRKME#"AZ\#3K>_^'?RPZ_\
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MX]E[ORFZ=V9G.[TWON[+-6Y7,96IJ\QGL]F*^01AYII2\LLKL5CC07L-*(
M %. .F^KQ?B'_(I[:[9Q6*WS\D]RU?1^U<C%#6T>Q<=009+M7(44RB1&RT=?
M_D6!9T8,L=5'55*$%)Z.!A[::4# SU8+Z]7,[+_DL_R^-I4,--DNI]P;^K8D
M56S.].R-]&NG(Y+S4>TZ[$X^Y_.FB4?T %_;9D<]6TCIF['_ )(_P(WOC*BF
MVWL7=_5&4DC;PYO8O8&YZZ:*;ZQO)C-_3YJC9+V#HD"$K<!E:S#PE<?/KVD=
M:Y'SU_E?=R?"21=W"N3L_I+(5T=#0]DX?&S8^HP%952:*+$[[P/DG_A\LK?M
MT]5'/+2SMI421S.*</(X;[>JE:=!=\#?G+V)\(^VZ+=.$J*_-]9[@JZ.B[3Z
MY^Y/V&Y<&)/&V3QT$S"*',4*,TN/J_2;W@E8T\LJG;J&'6@:'K?*V!OS:G:&
MR-J=B[&S%-G]G[UP.-W)MS,4A/BKL5E:9:JED*/9HY &T2PR /&X:-U5U8!*
M00:'IWI7^]=>Z0G:7_,LNQ?_  Q-W?\ O/U'O8X]>Z^:U[6=,]6-?(_^83V!
MVU\>NB/BOLFIR6SNG^K>INN]K;SI89S39+LS>>WMNTU/DY\[)3-SB**IC*8^
M@U%973[RH#2&GCI:*@#%CUNN*=3_ (<_RL?DS\P::BW;B<91]9=25,GH[-WY
M#64])F8%?1,VRMO4Z_=Y8J;@3KX:,LK1FL612GOS2*OV]> )ZO=ZT_D!_%+;
M5%3OV3O[MKLW-*B"L>DR.%V+MN9POK>EPV,I:JNB!-S9\Q)86']26C*WEU?2
M.A@R'\COX!UE*:>GV?V%B92ND5V/[+W#)5 VMK"90U,-_P \PV_P]Z\5^O:1
MU:)UKU_MOJ?KW8_6&SJ>6EVKU]M/ ;-V]!42)-5+B-N8N+$T+UM0BH)9WCB5
MYY= +R%G(NQ]T)J:GJW0-_,SL&3J_P"+7>.\J><TU=2["RF&Q=2KE'ILQNYD
MVAAZF)A_;CJJZ*1!_4#V-O;;:!OO/>U[:XU*TZNP]4AK,X/R*H0>H)^\YSD_
M(7L#S7S-"_ARQV$L,3 T*S7A6SA8?-99T8?,#K3!]]*>OF$ZV\_Y<?64/6'Q
M"ZJ@-.L.4WQCY^R\U*%"-5S[TD&0P\T@^MTQ(QT%S_QS_P!@.>/O-OC;Y[B7
M[ZJQVK"V0>@A[7'YR^(WY]?2%]R;D2+D/[M_+T)33<;K&VYSFE-;7I\2%C\Q
M:"V3_:?ET>7W%O65_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U@JJJFH::HK:VH@HZ.C@FJJNKJIHZ>FI::GC,L]143RD(D:("SNQ  !)(
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MP!5@05(!&>MNGX"?*&7Y0]&T>;W!+!_I'V55IM/L".%(X17U\-,L^+W/%31
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MOG</\GOH/=>.JZCJ'-[EZJW$L;M04M7D*K>6T)I/UK!74F:=LD@8@()HLB=
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M@:VKYQ#HT/\ PU[\(/MO!_H=J?+HT_>?Z1^T_N=7_'33_&O#?_IU;_#V!?\
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M87%33S_<1I]T907CJ(GAJ50NL-E95,<@9NQN>Y0/M\=RT:2IHJ$5CIJ==%#
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MMT_XY8=56?!K9>U>P_E?TSL_>V#H=R[7R^X,E_%<'DXVFQV17'[9KLI2PUL
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M<];QN'PV(V]BZ'"8#%8[!X;&4\=)C<1B*&FQN,Q])$+14U%04:I%%&O]E(T
M'X'OES<7-Q>3M=7<C2RN:L[L69B>)9B22?F3U]6^V[9MNS6$6U;/;QVEK H2
M*&&-8HHT'!4C0*B*/)5  ].G+VSTNZ][]U[KWOW7NB ?S,.H,?VK\3]_9$TD
M<NXNKH$[)V[6Z 9J2/ \[HA\@]7BFQ+5FI+Z3(D3L"8UM+?LES%-L//]I#J(
MAOC]-(OD3)_9'TJ)0E#QH6 XGK#S[]/MM9^X/W>-XO#&&O=@4;G;/3N06_\
MN4*\=#VAFJM:%UC8@E!UJ74=958^KI:^AJ):2MH:F"LHZJ!S'/355-*)J>HA
MD7E71U#*P^A%_?0*2..:-H90&5@00<@@BA!^1'7SL6US<6=S'>6CF.6)E='4
MT974AE92.!4@$'R(ZWB>GM[CLOJ;K+L/T!]\;!VCNN=(P D-5GL#!DJNGTCZ
M&.61XROX((]\N^8]K_<G,%]L_E:SRQ#YB.1E!_, 'KZM/;7FH<]>W>Q<YXKN
MNWV=VP'!7N+>.5U^6EF*D>1%.A']DW0VZT9.U?\ F:'9'_A^[P_]Z&H]]2M@
M_P"2%9?\T(?^K:]?)[[@_P#*^[Y_TL+S_M(DZV-_Y0.R-HX_XVU6^Z/;N)AW
MGN#>VY\3F-SBDB;-UN*Q34PQ^+?(.#(M-$276!&6/62Y4N2WO#7[Q.Z;C-SH
MNU23.;:&")TBJ="NVK4VG@6/#4:FF*TQUVQ_NV^5>7+/V/DYMMK*%=SO+ZZB
MFNM ,[Q1>'X<1D-6$2U)$:D)J)8@L2>K9/>/_71'KWOW7NO>_=>Z][]U[K7&
M_FH_"[&=:Y)/D3U?AXL=LS<^5CH.Q-O8ZG$5#MO=.1<FBW'0T\(TPT>3>\51
M& J159323]TJ1YF>PWN7/O<)Y.WV0O<P)JMY&-6DB7C&Q.2\8RIR6CK7^S)/
M$S^\"^Z_8<C7H]Z>0K80;9?RB/<;>-:1VUW(3HN8U&$ANFJDBT"QW&G37Z@*
ME7G1'<.Y.A.V=E=K;6DD_B&U,Q!55=")3%#F\)/_ )-G<!5D<>*LI'E@8D$H
M6$BV=%(G/FOERRYLY?N=@OQV7"$!J5*.,I(/FC@-\Z4.">L"/:3W*WSVA]Q-
MK]PM@8^-M\RL\=:+/ W;/;O_ $)HB\9/%20ZT95(W6MH;JPN^=J;:WIMNJ%=
MM_=N!Q.Y,)6  ?<XK-4,>1H964$Z6,<BZEOP;@\CWS,W&PN=JOY]LO5T36\C
MQN/1D8JP_:.OJ0Y;Y@VOFSEZQYHV23Q;/<;>&Y@?^**>-9(S3-"585'D:CRZ
M47M'T==<2B,49E5FC)9"5!*,5*%D)^AL2+C\$CWNI&!Y]:*J2"14C(^6*8],
M$C[.N7O76^O>_=>Z][]U[KWOW7NJK/YNO5&,WE\9?](XI(_[P]1[FPN1IL@L
M8-5_=[=F2@VKFL7JM?Q25%1CZI_Z&G!X&J\\_=ZW^?;>=_W-J/@[A$ZE?+Q(
ME:5&^T*LBC_3_9US\_O'?;RPYF]B?Z[",?6\N74$BR =WT]W+':3Q5XZ6DDM
MY3Z&$'A6NL]LS<^0V3N_:N\\2[QY3:6Y,'N;&R(YC=*_!9.+*4C+(O*D21+R
M/I[S:W*QAW/;KC;;@5CN(WB;S[74J?Y'KA;RQOUYRKS)M_,^W$K<;=<P741!
MH1)!*LJ$'R[D&>MZRCJH*ZDI:ZF<24U93P55/(/H\%1$)HG'^NI!]\KY(VBD
M:)Q1E)!^T&AZ^L^VN(KNWCNH#5)55U/JK $'\P>I'NG3W6A=5?\  FH_Y;S?
M];#[ZO)\ ^P=?(I<?V[_ .F/^$];3/\ *DZ[V-AOBILKL#&;4PE)OC=];O:/
M<F[$H(6S^5I\5OC(8G'44^4D#2K3PP4\*I3QLL5P7T>1F9L$??S>-UN>?;K:
M)[AVM;=8?#BU'PT+P1NQ"C&HLQ)8@MY5H !W]_N]N2^4]L^[YM?.-CM\$>Z[
MD]\+F[$:FXE6*^N(8T:4U<1I'&@$:D1U!;3K9F-G'N#^L[NO>_=>Z][]U[KW
MOW7NM3K^:%TWB^HOE3GZG;]%'C\!V?@\?V524=-&(Z2DRF6K*G%[E@@"\ R9
M"CGK60<**@  +I'O/[V,YDGYAY#B2[8O-8NUL234E4"M&3]D;JE?/17C7KYX
M/O[>V=A[<?>!O)]GB$-GOT$>YHBBB)+,\L5RJTP-5Q#).5&%\8  +0=#?_)F
MWO48?O[L#8KS.N-WMUK-D_"&]$N:V?G*:3'.R?0Z:2OR-C]1>WT)L%_O);6E
MSRE:;J!WVMR%KZ),C:OVND?4K?W8W-4VV>\&\<I,Q$&Z[8TNFN#/9SQ&,D?*
M*>YSQ%?F>ME;WA3UW)Z;\M_Q:\E_VKZS_P!QV]NP?VZ?Z8?X>D>X?[@3_P#-
M-_\ CIZT-_?5OKY&NMN+^6)_V0YTA_Y4K_W[V?\ ?/?WQ_Z>CNG_ %#?]HD'
M7T:_<._\11Y5_P"IG_W>-PZ/M[B?K+SJOO\ F1_)"J^/?Q[R,&VZ]J'L+M"H
MGV3M*H@E,=;B:.:E,NZ=RTS+9E>DI&$,,J,&CJ:BGD%])]R[[+\F)S?S>CWJ
M:[.Q FE!%0Y!I%&?D[]S X9$<>?6''WW_>Z?V:]FIH=CF,6\[^S6-HRFCQ(R
M5NKE?,&&$Z$92&2>>%Q\)ZU1-N[>S6[MP83:VW,?49?<&Y,MC\'A,72*'JLC
MELK5I14%' I(&J25U07('/) ]Y]7EY;;?:2W]XXCAA1G=CP5$!9B?D ">OGH
MV79MTYCWBUV#9(6N;R^FC@@B3+232N$C1?FSL *XSD];@WPY^)VT?BGUA0[=
MH(*+([_SE/2U_8N\4B!J<UF?'K.-HJB0!TQM"6:&BA]((U3NHFED)YU>X_/^
MX<_;XUY*2EI$2MO#7")_$PX&1^+G/DH.E1U]*'W:/N\<N?=[Y#BV6T1)]XNU
M23<KT#NFGI7PD8C4+: DI"F <RLOB2.>C<^X]ZR.Z][]U[KWOW7NB;?.3XQ8
MKY.]'Y[ 04$#=B;5I:W<G6>5T(M5#N"EI_)+@6J."*7*QI]I.A.@.89RK- G
MN2/:WGB?D?FB*[=S]'.5CN4\C&3024_BB)UJ>--25 <]8R_>N]A]O]^/:J[V
M>*%3O6WJ]SMDM!K6X1:FWU<?"NU7P7!.D,8Y2"T*]:?44M;C*V.:&2IQ^1Q]
M4DL4L;2TM915M)+K22-UTO'+&Z@@BS*P_!'OHJRQ3Q%6 ='%",$,I'[""/R(
MZ^;".2ZL;I98BT,T+@@@E'1T-0011E96%0<$$>HZW-OA_P!V?[,%\=NMNRJJ
M:.7<%=A_X-O!8PJE-W;=E;#YV5H4XC%3+%][%'^(IH_?-CW%Y8_JCSC>[+&"
M(5?7#_S1D&M!7ST@Z"?XE/7TZ_=L]T_]>/V6V/GBX8->2P^#>4H*7EL3#.2H
M^$2LGCHOE'*G1F/8)ZG3K1R[HW#7;L[@[4W/DI'EK]P=B[TS%4\A8L)<AN.I
MJ60!OHJZM*K]%  ' ]]1>6K.+;^7;"Q@%$AMX4'V+&H_G2OSZ^4CW/WF[YB]
MR>8-^OF+37FXWLSD^LES(U,\ *T \@ !@=7]_P F/8. QW278G924T,FZ=S]
MBU.U*FO**T]-M_:^"H*^@QT;M<H'J<A4S2A2 _[6H'QJ1B5]Y/=KN;F>SV4L
M1!!;B4+Y&262168^M%C51Z=U.)Z[!_W8G)^SV7M9O7/*HK;A?[BUHTE.Y;>U
M@@DCC!XBLEQ([TH&_3U5T+2Y+WC?UTTZ][]U[KWOW7NO>_=>Z][]U[K_T<_?
M>0_B_?';%5/.T,^4[-WY7B9(8UJ6J)]V5L_JBC5!INQ+%CHNW.G\]6^6M$'+
M^W6XP$MK=13T6)0/M'VGKYC^?9Y;KG?F#<G&LR;E?.U3CON9&;Y!B3P5013
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M_-+B!P?R*U^7'K3N]]&>OFFZWF^JZAJOK#KBJ<EFJ=A;/J&)^I:;;U/(2?\
M8GWRUWY!'OE[&/PSS#]DC#KZP_;^8W/(>R7#9,EA9L?]M;QG_+TO?93T+NM"
MZJ_X$U'_ "WF_P"MA]]7D^ ?8.OD4N/[=_\ 3'_">MLO^5O_ -D2=3?]K#L;
M_P!^5EO?/[WU_P"GG;A_I;?_ +1HNOHC^X+_ .(K\N_\U-R_[N=WU8-[B+K,
MCKWOW7NO>_=>Z][]U[K7J_G9X^*/>O065"@35NUM\X^1^-318S+8^IB4_P"
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M_J_,XQT77MLT9SFHSC(I7Y^=#Q'E7@:]2WJHBT)$WBC-/Y&\)@22[L/]UN.
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MUI)X:ZJ%W)6) W:I?O!44.[YUEUSM7J+K_:'66R*$X[:FR<%0[?PM,[+)/\
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M=&_7O?NO=>]^Z]TP;K_X]?<G_:@S'_NND]J]O_W/@_YJ)_QX=$_,/_) OO\
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MWHY'JX]MU];+9(*N"5Y'QU5(1'>22&<K&Z34\W>S_NI_4:Z;:=XU/MMRVHD
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M6E*M+3"#1'=-;,CD,OUL""#(76GN)H/GZ?;C'^KY]!F&WN)(FM[91,%+1G0
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M0J[$2"1C&S,KQ@ M%7(4\MJ835$2QU)\-.IER$,LD2K&&=)7C96$=VA=)49
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M/_<=O;L']NG^F'^'I'N'^X$__--_^.GK0W]]6^OD:ZVXOY8G_9#G2'_E2O\
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M:N:Y'"BU%6K7.GMHO!<8NJ#/%(I$BDQR4Q)BCD5%C\K.D(UWUC] UWT@@WY
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MS:^X]Y+V-V[VIV$A+)OOLC?&\D8A@67<^YZK-J2'YN1/^>?:T"@ITSUME?R
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M@F;\:US$S1@_72]OH?;D)P1U5^J[OY0>^*;8O\P7H6>NG6"@W15[OV/4,SA
M]3NK9&1QV#@!;@F3)&B0#\D\<V]WD%4/55X];V7M+T[U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW2$[2_YEEV+_X8F[O_ 'GZCWL<>O=?-:]K.F>M
M]C^51_V[Y^,O_AGYO_WN,K[2O\9Z='#JPCW3K?7O?NO=>]^Z]U[W[KW6"JIJ
M>MIJBCJX8ZFDJX)::JIYD$D,]//&8IH98VX964E6!^H/NR.\3B2,E64@@CB"
M,@CY@]-3P0W4#VURH>.12K*PJK*PHRD'B""01YCK2;^1_45=T3WAV5U761S+
M#M7<U;!A9I]1>NVQ7$9/:V1+-]3/CYJ:1[$V8LMR0??3?DSF&+FKE>RWZ,BM
MQ$I<#\,J]LJ_[60,!\J'KY9O>WVXN_:7W6WSV_N5(7;[IU@+5J]K)26UDKYF
M2W>-CQHQ(J2.K%?Y0?R"I]A=M;@Z2W%7+3X'MRG@K-LO42:8*7?V @D:&C0M
M94.3H6EB+$W>:GI8E!9Q[AS[Q'*#[MR_#S/9KJEV\D2T&3!(14^I\-Z'Y*[L
M<#K-3^[=]XX>4?<6\]J]ZE"6G,:J]J6-%7<+=6*H*X'U,!=*DU:6&"-02_6R
MM[PIZ[E=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6C!V?M>
M79'9786RYXO!-M'?&[-LRPVMXI,#GJC%M&!_0&*P]]3-COEW39;/<T-1<012
M@^OB1JW^7KY.N?=@DY5YYWGE>9=+[;?7=J1Z&WN)(B/RT=;#W\F;>T&8Z W_
M +'>97R&RNRY\CX0?5#A=WX*EEQS,O\ M=70Y&Q_-K?@WP]^\EMCVW-UIN@'
M9=6P6OJ\+L&_8CQ]=GO[L?FF+<O9W>.5&8&;:]S:33YB"\@B,9(^<L%SGSI\
MNK@?>.O72?KWOW7NO>_=>Z][]U[KWOW7NJZOYJ.[(=L_#/?N/>58JG>N?V/M
M.@);2SS?WGI]SU<48_):DQE2"/\ 4W/X]S'[#;>U][DVDP%5M8YY6^SPFB!_
MWN1?SZPK_O N8HMB^['N]FS!7W2XL;2/U+?51W3@>I,-K+7Y5/EUJ@T\$U5/
M!2TT3SU%3-'!!#&I:2::9Q'%%&H^K,Q  _K[S[=UC0NYH%!))\@.)Z^>:&&6
MXE6"!2SN0JJ,DL30 #S))H.MZO9& &T]E[0VLH0#;6U\!@ (S= ,-B8L< A'
MX_;X]\K]TN_WAN=Q?_[_ )9)/][<M_EZ^L[E79QR]ROMNP"E+&UM[?'#]&%(
M\?+MQU2C_.X_XL/QT_[6_9W_ +AX+WDU]V+_ '+WG_26W^&?KEO_ 'J'_)(Y
M*_YK;I_QRPZK4_ET?]EI]$?]K_/_ /O$Y/W-GO)_T[3=?^:<?_5Z+K!K[E7_
M (E#RC_ST7'_ &@W76X#[YU]?29U[W[KW7O?NO=>]^Z]T1C^95_V1)WG_P!0
M&RO_ 'Y6&]RE[*_]/.VK_33?]HTW6)WWY/\ Q%?FS_FG8_\ =SLNM0[WT.Z^
M;_K>YVI_QZ^V_P#M08?_ -UT?OE5N'^Y\_\ S4?_ (\>OK9Y>_Y(%C_SSP_]
M6UZ?_:3HXZ][]U[KWOW7NF#=?_'K[D_[4&8_]UTGM7M_^Y\'_-1/^/#HGYA_
MY(%]_P \\W_5MNM$;WU5Z^2;K;Q_EJ_]D2=&?]0&]?\ WY69]\\?>K_IYVZ_
MZ:'_ +1H>OI ^XW_ .(K\I_\T[[_ +N=[T>?W%O66/6C)VK_ ,S0[(_\/W>'
M_O0U'OJ5L'_)"LO^:$/_ %;7KY/?<'_E?=\_Z6%Y_P!I$G6S!_*-_P"R0:#_
M ,2+O?\ Z'IO>$WWA?\ IXC?\\\'_/W7='^[D_\ $;HO^EE??X8NK._<'=9X
M]>]^Z]U[W[KW7O?NO=8IIH::&6HJ)8X(((I)IYI76.*&&)2\DLCM8*JJ"22;
M >[*K.P1!4DT '$D\ .FY98X(FFF8(B LS$T  %223@ #))X#K1Y[IWP.S.X
M.T>PT9VAWMV!N[<]() 5:*@S.=GKL?3Z3R!' \<8!^@4#WU#Y9VO]R<NV.SG
MC:V\41IYLB*K'\V!/Y]?*;[H\UCGOW)W_G-22NZ[A>725XB.:>22-?EI1E4#
MR ZO_P#Y,6RIL1T9V5OFHA,3;T[&CQ5&S+8U.,V?@X1'4H?RGW60K(A_M4;>
M\2/O*;FMQS39;4AK]-;ZC\FF<U'VZ8T/V$==A_[L/E:3;?:??.;)ETG=-R$2
M5_%%9P)1A\O%N)D^U&Z&W^:1W;D>H/C#E<1M^LDHMR=LYB#KREJJ>0QU5%@:
MRBFR.[*N%A]!)1P''LPY7[H,MB 0&/8KEB'F+GF.XNUU0[>AN"#P,@8+$#]C
MMXGH?#H>I4^_W[J7OMM[#7&W;/*8K[F*9=N1E-'2W='DNW4_TH4-N2,CZ@,,
MBHU4\9C:_,Y+'XC%4DU?D\K6TF-QM#3(9*BMKZZ=:6CI*>,<L\DC*B#\D@>\
M]9YHK:%[B=@B1J69CP55%23\@!4]?/G8V-WN=[#MNWQM-/<.D4<:BK/)(P5$
M4>;,Q  \R>MNKX6_"O8OQ8V/C:FHQN.S7<6:QL,N]M[RPQU-32U-3&)*G;.V
M*B0$TV.IV/B)BTM5,OFF_P!UQQ<]/<OW,W7GS='1':+;8F(A@!(! -!+*/Q2
M-QS41@Z5_$S?1W]U[[KO*?W?^5()IH([KF6ZB4WU\5#,C, 6M;5B*QVT9[25
MTM<,OBR_@2,\/N+NLK.O>_=>Z][]U[HHWST_[(]^0'_AA5?_ +G0>Y"]J/\
MIXNT?\UQ_P =;K'+[W7_ (C7SC_TKW_ZN1]:<'OH]U\S?6\GT_\ \RDZM_\
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MIL3<7U!6ET%HXRYP 5XFM>/&A]20,?/"1K-VK$0!&.XD-6@  I2M*\*BA85
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M08FC2CADG= H>:0+Y)I2+O(S.UV8GWS=W3<KO>-RGW6_;7-<R-(Y]6<EC3T
MK0#@!0# Z^CWE;EO:>3N6[#E38H_"L]N@BMX5\Q'$@1=1\V(%78Y9B6.2>E=
M[0='W7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5!W\
M]#X;U7:_5.&^3VQ<4]9O;I3'3XS?M+1PF2LS/4U15-7-DBJ LYV_622U;*
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M>>'_ *MKT_\ M)T<=>]^Z]U[W[KW3!NO_CU]R?\ :@S'_NND]J]O_P!SX/\
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MUM($(5HU*TH>'&AK1*D4P<AC04_"#UCH<H^MFJGE"AT44\IU/)&/4RP.MQH
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MBZYQ%2+H)JC+V2?)Z39ECQR^&1;@5D9'N>^2_N_<R;TZ7?,Y.VVN#HPUPX]
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M%N9> 9@.Z.VC:AFF(H!V)JE9$;4"WWOC<W96\MR[^WEDI<ONC=N8K,WFLA*
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M_P"2!??\\\W_ %;;K1&]]5>ODFZV\?Y:O_9$G1G_ % ;U_\ ?E9GWSQ]ZO\
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M?/\ Z=?N7VVW_:5!UBU]PG_Q*OEG_2[E_P!VF^ZVV_?/GKZ+^F_+?\6O)?\
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M9-8"@LD#J% )!MZO;<@J2Y-,4_P<,$U^0(I_/KT85 D.D-W%J>I[B"<JNG)
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MPND$K)52(8"O@BA<.22Q0,\C#1H)9U5A(P*BTN(I7*,16F*UX<*?LJ212F2
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M2M"=)_*AJ3QIZC)\J\3D]+;&QF+B/6!D_%J6BKPK2H!HHS732@.@5Z0(J8Y
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MYS=FXZM$&7W5N.KB51-653(H-@$BB6.GA5((HHU2L2QJ>G *#H?/>NM]%/\
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MF'S@^$W6GS>ZGDV'O(C [NP3563ZV[$HZ2.IRVS,]/$J2AHBR&JQM8$CCR-
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MBH&U1;>FJXL[M9"3=S'MC<*5= C-]&=*<,?Z\"P3Y@Y!Y.YH)??-OBFD/&0
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M/51X.@DJ8Z.*1M"U64KFTT]' #PU15RQQ+_:<>W-ZW_9>7;,W^^7,=M$/-V
MJ1Y*OQ.W]% 6/D.D_)'M[SO[D[TO+_(FUW&Z7;4[((RP0$TUROB.&.O&25TC
M'FPZV8_Y=?PK[!^*N)W3GNPM\K4YK?M#C8J[KG 2)5[6P4N/E:>DR==E9D#U
M.31))*<FE"0(CR*7JKQ2182>\?N9M'/MQ!:;/:Z8K1F*W$F)9 PH550:+$2
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M_*VVSWMM8137-Y>-5;>)8HVFE,MS(0AE*@L(@S32'X4;/0,^Q)U&/6\GT_\
M\RDZM_\ $=;(_P#>9I??+CF/_E8;_P#YZ)_^KK=?5Y[:_P#3N=@_Z5MC_P!H
ML70B^R;H:]:%U5_P)J/^6\W_ %L/OJ\GP#[!U\BEQ_;O_IC_ (3UME_RM_\
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MD[5_YFAV1_X?N\/_ 'H:CWU*V#_DA67_ #0A_P"K:]?)[[@_\K[OG_2PO/\
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M2@I+7)/J      !8 <  ?0 >XGZR\  %!UW[]U[KWOW7NO>_=>Z3.\-F;3[
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M5&@5%13XC'QX^&:<1@+K=8PS:0!<FP ]X[WUV]_?37T@"M,[R$#@"[%B!7-
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MOM?VR_\ 0?7,S_DUY[5_]-'NO[+/_K1U9E\?.E<'\>.H=H].[<R^5SN%V?\
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M:HXI9GE/%@"AU%@HNP!*@>S6UG9,Z@!3@*4/ $_X/.G'R'1)?;=#-4>$Q-:
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M:4 SG@,'I#*&+A=*@5TL#5AJ%.!(-'(KJ+&@T$%C5@,]/-53LZPB(:GC9H_
MHC42S-35A)\EI$(N!&H_6+@$(5&T9WPM*^E/4T;SH5^0\^%:4Z9GB@A >2M
M#G54FBAD_#56X$L3\)S0L"5MBX,;''#13ZY34Q>=7D(2622*F ,1AD-R8FDU
M@V_3I(Y-P;01P!1$WXA7^7"A]":\.%*=!2_EO7D:ZBH!&=) R "W$,!3O"Z3
MGXM0.!D5=F85Z:*HCDIA&9YB(#')$JBG5@%6$"PB"J> %XT_DGV=6%J8T((I
M4^1'#Y?PT'E3RZ ',VYK<2HZ/72N:@_$:\?-ZGS)SJ\J=#9C:"*&.FCB>622
M)4-3)=$$7!8-4BF<$EI'=FN+< A; 7-PH10M:D9/J<YX#/'H!/*\[O.X"*2
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M^>"]L!:Q>-!5D#%03I:FD\>- 7U5%.'SJ" .W'B&JHQ%)11B1"PE55B::"-
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M4L2/)E%1VEBNK4S$"C@XA+(6JE5?/&L$@$@G6G6K<0E(?$;(KL59GTH=+JI
M9G7V);6(-_:XKCC6FK%!3@#ZX-"!Q)'4?[K(R)2V-=)U#!75H!(+5^(@5 6K
M"JDBJA3T8;;V-91)34D8GF1XB)866:*FC0(GE.A@L?C5]2Z@0?[*L6X$2((P
M4%*XIY@>0^SCQK]G'$47LDETZSR Z36H((+')/$5)-*4 \Z$C3G8'^#_ /+&
MI=X4.S>Y.]H]&S:K'X_<&U.N(Y&7);G26H^]Q^3WY*L4<:4,L86:*B@)DJ$D
M1IG@56BFQ7]V??9MKDNN5.4<W*,T<UU0:8R,,D%#5G#5!D8!5(;2K$AEZ:?=
M7^XU#S/#MONE[KBFURQI<66V DO<*YU12WU5TQPM'I9((B7D5D,CQ!#')L%
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M;:V,<@8\70%5ET@4;R /1&\W2JBK):.&=Y9$*1Q1A8[E?W))HPS)Y1>X"Z2
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M8J:8,].U.K2S122011I=E:[*$)^C:BI D]])** )4U. >!%214*!D>5/G6E
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M\S/9ZMJD5IB1TJFM<D%;#4;"_ 8@<T:-=5&.!7^*NJ@(/[,5./0TZ916*AH
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M8F@+4"J#Y#3TAIZ;32I"H8H[R60A""6=P6> W6$NP8A&":20 /I[#TML5B"
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MW9_=+^[N6_OU_=W^Z7VC_P =_O9_#?[N_8_[L_BW\8_R;Q?35YO3_7VLV_\
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)Z]U[W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865732512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Dec. 01, 2023</div></th>
<th class="th"><div>Apr. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--10-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-08597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">THE COOPER COMPANIES, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-2657368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6101 Bollinger Canyon Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Ramon<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">460-3600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.10 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">COO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-Known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.343%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Part of Form 10-K</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portions of the Proxy Statement for the Annual Meeting<br/>of Stockholders scheduled to be held in March 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part&#160;III</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our independent registered public accounting firm is KPMG LLP, San Francisco, CA, Auditor ID: 185.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,525,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000711404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862784944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KPMG LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Francisco, CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">185<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865778112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,593.2<span></span>
</td>
<td class="nump">$ 3,308.4<span></span>
</td>
<td class="nump">$ 2,922.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">1,235.3<span></span>
</td>
<td class="nump">1,168.8<span></span>
</td>
<td class="nump">966.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,357.9<span></span>
</td>
<td class="nump">2,139.6<span></span>
</td>
<td class="nump">1,955.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expense</a></td>
<td class="nump">1,501.2<span></span>
</td>
<td class="nump">1,342.2<span></span>
</td>
<td class="nump">1,211.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">137.4<span></span>
</td>
<td class="nump">110.3<span></span>
</td>
<td class="nump">92.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="nump">186.2<span></span>
</td>
<td class="nump">179.5<span></span>
</td>
<td class="nump">146.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">533.1<span></span>
</td>
<td class="nump">507.6<span></span>
</td>
<td class="nump">505.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">105.3<span></span>
</td>
<td class="nump">57.3<span></span>
</td>
<td class="nump">23.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense (income)</a></td>
<td class="nump">14.9<span></span>
</td>
<td class="num">(25.0)<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">412.9<span></span>
</td>
<td class="nump">475.3<span></span>
</td>
<td class="nump">491.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes (Note 6)</a></td>
<td class="nump">118.7<span></span>
</td>
<td class="nump">89.5<span></span>
</td>
<td class="num">(2,453.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 294.2<span></span>
</td>
<td class="nump">$ 385.8<span></span>
</td>
<td class="nump">$ 2,944.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share (Note 7)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 5.94<span></span>
</td>
<td class="nump">$ 7.83<span></span>
</td>
<td class="nump">$ 59.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 5.91<span></span>
</td>
<td class="nump">$ 7.76<span></span>
</td>
<td class="nump">$ 59.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Number of shares used to compute earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">49.5<span></span>
</td>
<td class="nump">49.3<span></span>
</td>
<td class="nump">49.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">49.8<span></span>
</td>
<td class="nump">49.7<span></span>
</td>
<td class="nump">49.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865484528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 294.2<span></span>
</td>
<td class="nump">$ 385.8<span></span>
</td>
<td class="nump">$ 2,944.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Cash flow hedges, net of tax of $(2.4), $26.1 and $8.2, respectively</a></td>
<td class="num">(7.0)<span></span>
</td>
<td class="nump">81.3<span></span>
</td>
<td class="nump">26.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Change in minimum pension liability, net of tax of $1.0, $8.7 and $7.2, respectively</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">27.9<span></span>
</td>
<td class="nump">22.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">17.0<span></span>
</td>
<td class="num">(234.7)<span></span>
</td>
<td class="nump">82.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">13.0<span></span>
</td>
<td class="num">(125.5)<span></span>
</td>
<td class="nump">130.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">$ 307.2<span></span>
</td>
<td class="nump">$ 260.3<span></span>
</td>
<td class="nump">$ 3,075.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865571248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Cash flow hedges, tax provision (benefit)</a></td>
<td class="num">$ (2.4)<span></span>
</td>
<td class="nump">$ 26.1<span></span>
</td>
<td class="nump">$ 8.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Change in minimum pension liability, tax provision (benefit)</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 8.7<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-12<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656867638960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 120.8<span></span>
</td>
<td class="nump">$ 138.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade accounts receivable, net of allowance for credit losses of $31.3 at October&#160;31, 2023 and $20.7 at October&#160;31, 2022</a></td>
<td class="nump">609.7<span></span>
</td>
<td class="nump">557.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories (Note 1)</a></td>
<td class="nump">735.6<span></span>
</td>
<td class="nump">628.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expense and other current assets</a></td>
<td class="nump">238.8<span></span>
</td>
<td class="nump">208.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,704.9<span></span>
</td>
<td class="nump">1,533.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,632.6<span></span>
</td>
<td class="nump">1,432.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill (Note 4)</a></td>
<td class="nump">3,624.5<span></span>
</td>
<td class="nump">3,609.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangibles, net (Note 4)</a></td>
<td class="nump">1,710.3<span></span>
</td>
<td class="nump">1,885.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">2,349.5<span></span>
</td>
<td class="nump">2,443.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">637.1<span></span>
</td>
<td class="nump">587.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">11,658.9<span></span>
</td>
<td class="nump">11,492.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term debt (Note 5)</a></td>
<td class="nump">45.4<span></span>
</td>
<td class="nump">412.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">261.9<span></span>
</td>
<td class="nump">248.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="nump">174.8<span></span>
</td>
<td class="nump">152.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">123.6<span></span>
</td>
<td class="nump">93.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">363.3<span></span>
</td>
<td class="nump">373.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">969.0<span></span>
</td>
<td class="nump">1,280.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">2,523.8<span></span>
</td>
<td class="nump">2,350.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">101.5<span></span>
</td>
<td class="nump">149.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Long-term tax payable</a></td>
<td class="nump">90.2<span></span>
</td>
<td class="nump">113.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue</a></td>
<td class="nump">184.2<span></span>
</td>
<td class="nump">198.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">239.2<span></span>
</td>
<td class="nump">225.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">4,107.9<span></span>
</td>
<td class="nump">4,317.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies (Note 11)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $10 cents par value, 1.0 shares authorized, zero shares issued or outstanding</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $10 cents par value, 120.0 shares authorized, 53.9 issued and 49.5 outstanding at October&#160;31, 2023 and 53.8 issued and 49.3 outstanding at October&#160;31, 2022</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">1,833.4<span></span>
</td>
<td class="nump">1,765.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(453.8)<span></span>
</td>
<td class="num">(466.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">6,876.1<span></span>
</td>
<td class="nump">6,584.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock at cost: 4.4 shares at October&#160;31, 2023 and 4.5 shares at October&#160;31, 2022</a></td>
<td class="num">(710.3)<span></span>
</td>
<td class="num">(714.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Cooper stockholders' equity</a></td>
<td class="nump">7,550.8<span></span>
</td>
<td class="nump">7,174.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders&#8217; equity (Note 8)</a></td>
<td class="nump">7,551.0<span></span>
</td>
<td class="nump">7,174.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 11,658.9<span></span>
</td>
<td class="nump">$ 11,492.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865573600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Trade accounts receivable, allowance for credit losses</a></td>
<td class="nump">$ 31.3<span></span>
</td>
<td class="nump">$ 20.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">120,000,000.0<span></span>
</td>
<td class="nump">120,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">53,900,000<span></span>
</td>
<td class="nump">53,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">49,500,000<span></span>
</td>
<td class="nump">49,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">4,400,000<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656859902672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Shares</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Treasury Stock Par Net Value</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income Loss</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th">
<div>Cumulative Effect, Period of Adoption, Adjustment </div>
<div>Retained Earnings</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Oct. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Oct. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Oct. 31, 2020</a></td>
<td class="nump">$ 3,824.8<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="num">$ (617.3)<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 1,646.8<span></span>
</td>
<td class="num">$ (472.0)<span></span>
</td>
<td class="nump">$ 3,261.8<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="num">$ (1.4)<span></span>
</td>
<td class="num">$ (1.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">2,944.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,944.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">130.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock for stock plans, net and employee stock purchase plan</a></td>
<td class="nump">27.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock repurchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock repurchase</a></td>
<td class="num">(24.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends on common stock ($0.03 per share)</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">43.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Oct. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Oct. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 31, 2021</a></td>
<td class="nump">6,942.0<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="num">$ (639.6)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">1,715.2<span></span>
</td>
<td class="num">(341.3)<span></span>
</td>
<td class="nump">6,202.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">385.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(125.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(125.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock for stock plans, net and employee stock purchase plan</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock repurchase (in shares)</a></td>
<td class="nump">191,200<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock repurchase</a></td>
<td class="num">$ (78.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (78.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends on common stock ($0.03 per share)</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">$ 52.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Oct. 31, 2022</a></td>
<td class="nump">49,300,000<span></span>
</td>
<td class="nump">49,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Oct. 31, 2022</a></td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 31, 2022</a></td>
<td class="nump">$ 7,174.7<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="num">$ (714.5)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">1,765.5<span></span>
</td>
<td class="num">(466.8)<span></span>
</td>
<td class="nump">6,584.9<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">294.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">13.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock for stock plans, net and employee stock purchase plan</a></td>
<td class="nump">$ 11.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock repurchase (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends on common stock ($0.03 per share)</a></td>
<td class="num">$ (3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">$ 60.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Oct. 31, 2023</a></td>
<td class="nump">49,500,000<span></span>
</td>
<td class="nump">49,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Oct. 31, 2023</a></td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 31, 2023</a></td>
<td class="nump">$ 7,551.0<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="num">$ (710.3)<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 1,833.4<span></span>
</td>
<td class="num">$ (453.8)<span></span>
</td>
<td class="nump">$ 6,876.1<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862784720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="4">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends on common stock (in dollars per share)</a></td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656858606624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 294.2<span></span>
</td>
<td class="nump">$ 385.8<span></span>
</td>
<td class="nump">$ 2,944.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">367.7<span></span>
</td>
<td class="nump">346.1<span></span>
</td>
<td class="nump">309.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">62.1<span></span>
</td>
<td class="nump">54.2<span></span>
</td>
<td class="nump">43.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">40.0<span></span>
</td>
<td class="nump">32.2<span></span>
</td>
<td class="nump">31.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AssetImpairmentChargesAndOther', window );">Asset impairment charges, and other</a></td>
<td class="nump">49.4<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration</a></td>
<td class="num">(31.8)<span></span>
</td>
<td class="num">(10.3)<span></span>
</td>
<td class="nump">66.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">44.7<span></span>
</td>
<td class="nump">53.9<span></span>
</td>
<td class="num">(2,502.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(60.2)<span></span>
</td>
<td class="num">(33.8)<span></span>
</td>
<td class="num">(75.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(105.4)<span></span>
</td>
<td class="num">(40.4)<span></span>
</td>
<td class="num">(9.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(89.4)<span></span>
</td>
<td class="num">(16.9)<span></span>
</td>
<td class="num">(69.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="num">(34.2)<span></span>
</td>
<td class="num">(51.3)<span></span>
</td>
<td class="num">(27.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">49.9<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">71.8<span></span>
</td>
<td class="nump">32.4<span></span>
</td>
<td class="nump">59.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Accrued income taxes</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(27.4)<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="num">(6.4)<span></span>
</td>
<td class="num">(34.2)<span></span>
</td>
<td class="num">(21.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_IncreaseDecreaseInContingentConsiderationLiability', window );">Settlement of contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(52.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">607.5<span></span>
</td>
<td class="nump">692.4<span></span>
</td>
<td class="nump">738.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(392.5)<span></span>
</td>
<td class="num">(242.0)<span></span>
</td>
<td class="num">(214.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired', window );">Acquisitions of businesses and assets, net of cash acquired</a></td>
<td class="num">(56.5)<span></span>
</td>
<td class="num">(1,641.3)<span></span>
</td>
<td class="num">(235.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries', window );">Proceeds from sale of interest in a subsidiary</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">52.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(449.0)<span></span>
</td>
<td class="num">(1,831.2)<span></span>
</td>
<td class="num">(450.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt, net of issuance costs</a></td>
<td class="nump">2,124.2<span></span>
</td>
<td class="nump">1,511.0<span></span>
</td>
<td class="nump">1,427.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(1,953.9)<span></span>
</td>
<td class="num">(561.5)<span></span>
</td>
<td class="num">(1,416.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net proceeds from (repayments of) short-term debt, other</a></td>
<td class="num">(351.1)<span></span>
</td>
<td class="nump">329.3<span></span>
</td>
<td class="num">(321.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(78.5)<span></span>
</td>
<td class="num">(24.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds related to share-based compensation awards</a></td>
<td class="nump">15.1<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
<td class="nump">33.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments related to share-based compensation awards</a></td>
<td class="num">(13.1)<span></span>
</td>
<td class="num">(16.8)<span></span>
</td>
<td class="num">(13.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends on common stock</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Issuance of common stock for employee stock purchase plan</a></td>
<td class="nump">7.9<span></span>
</td>
<td class="nump">7.2<span></span>
</td>
<td class="nump">5.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Settlement of contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(173.9)<span></span>
</td>
<td class="nump">1,193.7<span></span>
</td>
<td class="num">(311.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(12.9)<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(17.7)<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
<td class="num">(20.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and cash held for sale at beginning of year</a></td>
<td class="nump">138.6<span></span>
</td>
<td class="nump">96.6<span></span>
</td>
<td class="nump">116.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of year</a></td>
<td class="nump">120.9<span></span>
</td>
<td class="nump">138.6<span></span>
</td>
<td class="nump">96.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">117.5<span></span>
</td>
<td class="nump">49.1<span></span>
</td>
<td class="nump">28.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes</a></td>
<td class="nump">67.8<span></span>
</td>
<td class="nump">66.6<span></span>
</td>
<td class="nump">63.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease liabilities</a></td>
<td class="nump">47.5<span></span>
</td>
<td class="nump">45.3<span></span>
</td>
<td class="nump">37.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease ROU assets obtained in exchange for lease obligations</a></td>
<td class="nump">42.6<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
<td class="nump">26.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">120.8<span></span>
</td>
<td class="nump">138.2<span></span>
</td>
<td class="nump">95.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash included in other current assets</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash held for sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, restricted cash and cash held for sale</a></td>
<td class="nump">$ 120.9<span></span>
</td>
<td class="nump">$ 138.6<span></span>
</td>
<td class="nump">$ 96.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AssetImpairmentChargesAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AssetImpairmentChargesAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_IncreaseDecreaseInContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contingent Consideration Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_IncreaseDecreaseInContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease, Right-Of-Use Asset And Liability, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Businesses And Assets, Net Of Cash Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or the sale of investment in consolidated subsidiaries (generally greater than 50 percent).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869964000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">Organization and Significant Accounting Policies</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 1. Organization and Significant Accounting Policies</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Organization</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Cooper Companies, Inc. (Cooper, we or the Company) is a global medical device company publicly traded on the Nasdaq (Nasdaq: COO). Prior to September 26, 2023, Cooper's common stock traded on the New York Stock Exchange under the symbol "COO". Cooper operates through two business units, CooperVision and CooperSurgical.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">CooperVision primarily develops, manufactures and markets a broad range of soft contact lenses for the worldwide vision correction market.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">CooperSurgical primarily develops, manufactures, markets medical devices and procedures solutions, and provides services to improve health care delivery to women, babies and families. </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The financial statements in this report include the results of all of Cooper's consolidated entities. All significant intercompany transactions and balances are eliminated on consolidation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates. The Company continually monitors and evaluates the estimates used as additional information becomes available. Adjustments will be made to these provisions periodically to reflect new facts and circumstances that may indicate that historical experience may not be indicative of current and/or future results.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Net Sales </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers may subsequently resell the Company&#8217;s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately negotiated rebates, chargebacks and discounts with respect to the purchase of the Company&#8217;s products. The Company considers purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. As part of its consideration of the contract, the Company evaluates certain factors including the customer&#8217;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Revenues from product sales are recognized when the Customer obtains control of the Company&#8217;s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less. See Note 12. Business Segment Information for disaggregation of revenue.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Reserves for Variable Consideration</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company&#8217;s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liabilities. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company applies that method consistently.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company&#8217;s historical experience, current contractual and statutory requirements, specific known </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Trade Discounts and Allowances</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. Historically, returns have been infrequent and insignificant relative to our total sales. Our refund liability for product returns is included in "Other current liabilities" in our Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Rebates and Chargebacks</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company&#8217;s direct customers. For certain office and surgical portfolio in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Deferred revenue primarily represents prepaid stem cell storage as part of the CooperSurgical business unit. Revenue related to stem cell storage is recognized over the service period, which can range from one year to the lifetime of a customer. The current portion of the deferred revenue balances at the beginning of each year presented were generally fully recognized in the subsequent 12-month period.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We grant various share-based compensation awards, including stock options, performance unit shares, restricted stock and restricted stock units. The Company accounts for share-based compensation expense based on estimated grant-date fair value, and expenses the amount over the vesting period of the award. Determining the fair value of share-based awards at the grant date requires judgment, including estimating Cooper's stock price volatility, employee exercise behaviors and related employee forfeiture rates. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The expected life of the share-based awards is based on the expected time to post-vesting forfeiture and/or exercise. Groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. In determining the expected volatility, management considers implied volatility from publicly-traded options on Cooper's common stock at the date of grant, historical volatility and other factors. The risk-free interest rate is based on the continuous rates provided by the United States Treasury with a term equal to the expected life of the award. The dividend yield is based on the projected annual dividend payment per share, divided by the stock price at the date of grant.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Forfeitures are estimated at the time of grant, based on historical experience, and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Most of our operations outside the United States use their local currency as their functional currency. We translate these assets and liabilities into U.S. dollars at year-end exchange rates. We translate income and expense accounts at average exchange rates for the period. We record gains and losses from the translation of financial statements in foreign currencies into U.S. dollars in other comprehensive income. We record gains and losses from changes in exchange rates on transactions denominated in currencies other than each reporting location's functional currency in net income for each period</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Financial Derivatives and Hedging</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Derivatives are recorded on the Consolidated Balance Sheets at fair value. Accounting for gains or losses resulting from changes in the values of those derivatives depends on the use of the derivative instrument and whether it qualifies for hedge accounting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The gain or loss on derivative instruments designated and qualifying for cash flow hedge accounting is deferred in other comprehensive income. The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period earnings. Deferred gains or losses from designated cash flow hedges are reclassified into earnings in the period that the hedged interest expense affects earnings. The effectiveness of cash flow hedges is assessed at inception and quarterly thereafter. The Company does not offset fair value amounts recognized for derivative instruments in its Consolidated Balance Sheets for presentation purposes.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%">Fair Value Measurements</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset&#8217;s or liability&#8217;s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The carrying value of the Company's revolving credit facility and term loans approximates fair value based on current market rates (Level 2). Refer to Note 5. Financing Arrangements for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the Company's&#160;interest&#160;rate&#160;swap&#160;contracts is measured on a recurring basis by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates (forward curves) derived from observable market interest rate&#160;curves. The&#160;interest&#160;rate&#160;swap&#160;contracts were categorized as Level 2 in the fair value hierarchy, as the inputs to the derivative pricing model are generally observable and do not contain a high level of subjectivity. The fair value of derivative instruments is included in "Other assets" in our Consolidated Balance Sheets. On our Consolidated Financial Statements. the gain or loss on the derivatives is recorded as a component of "Accumulated other comprehensive loss" and subsequently reclassified into "Interest expense" in the same period during which the hedged transaction affects earnings. Refer to Note 13. Financial Derivatives and Hedging for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses fair value measures for assets and liabilities acquired in an acquisition, which are considered a Level 3 measurement. C</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">ontingent consideration for which a liability is recorded and the initial measurement of the joint venture interest are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> also categorized as Level 3 in the fair value hierarchy;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and the change in fair value is recognized in "Selling, general and administrative expense" in the Consolidated Statements of Income.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> The fair value is measured by discounting expected future cash flows. The discount rate used for cash flows reflects capital market conditions and the specific risks associated with the business. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Note 3. Acquisitions and Joint Venture for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Income taxes are estimated based on enacted income tax laws and the results of operations in each jurisdiction. Deferred tax assets and liabilities are estimated based on temporary differences between the financial reporting basis and income tax basis of assets and liabilities. Deferred tax assets are also estimated based on net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance to the extent it is more likely than not they are not expected to be realized. Adjustments to deferred tax assets and liabilities due to changes in tax laws, changes in jurisdiction from intra-group transfers of assets, and changes in judgment regarding a valuation allowance are recognized in provision for income taxes in the quarter in which such changes occur. Long-term tax payable is estimated income tax to be paid for unrecognized tax benefits. A tax benefit is recognized if it is more likely than not a tax position will be sustained based on its technical merits in a tax authority examination, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. Adjustments to unrecognized tax benefits due to changes in judgment are recognized in provision for income taxes in the quarter in which such changes occur. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We determine basic earnings per share (EPS) by using the weighted-average number of shares outstanding. We determine diluted EPS by increasing the weighted-average number of shares outstanding in the denominator by the number of outstanding dilutive equity awards using the treasury stock method.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be&#160;cash equivalents.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">207.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">173.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">509.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">439.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">735.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">628.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In assessing the value of inventories, we make estimates and judgments regarding aging of inventories and other relevant issues potentially affecting the salable condition of products and estimated prices at which those products will sell. On an ongoing basis, we review the carrying value of our inventory, measuring number of months on hand and other indications of salability. We reduce the value of inventory if there are indications that the carrying value is greater than net realizable value, resulting in a new, lower-cost basis for that inventory. Subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. While estimates are involved, historically, obsolescence has not been a significant factor due to long product dating and lengthy product life cycles. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We record property, plant, and equipment at cost. We compute depreciation expense using the straight-line method over the estimated useful lives of the assets. Useful lives are generally 3 to 15 years except for buildings which are depreciated over 30 to 40 years and leasehold improvements, which we amortize over the shorter of the useful life or the lease term. We charge maintenance and repairs to expense as we incur them.</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Land and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">488.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">415.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,187.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,973.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">486.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">393.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,182.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,800.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,553.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,387.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,628.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,413.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease ROU assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,632.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,432.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Leases </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We consider an arrangement a lease if the arrangement transfers the right to control the use of an identified asset in exchange for consideration. We have operating leases, but do not have material financing leases. The Company primarily has operating leases for office, manufacturing and warehouse space, vehicles, and office equipment.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future lease payments over the lease term. The lease term reflects the noncancellable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the Consolidated Balance Sheets. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Leases with a term of one year or less are not recognized in the Consolidated Balance Sheets, while the associated lease payments are expensed in the Consolidated Statements of Income and Comprehensive Income on a straight-line basis over the lease term.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Operating leases are classified in &#8220;Other current liabilities&#8221;, &#8220;Other liabilities&#8221;, and &#8220;Other assets&#8221; in our Consolidated Balance Sheets. Operating lease expense is recognized on a straight-line basis over the expected lease term and included in "Selling, general and administrative expense" in our Consolidated Statements of Income. Financing leases are classified in "Property, plant and equipment, net", "Short-term debt", and "Long-term debt" in our Consolidated Balance Sheets. See Note 2. Operating Leases and Note 5. Financing Arrangements for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Cloud Computing Arrangements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The Company capitalizes certain costs related to the acquisition and development of internal use software, including implementation costs incurred in a cloud computing arrangement, during the application development stages of projects. Capitalized implementation costs are amortized on a straight-line basis over the expected term of the hosting arrangement, which includes consideration of the non-cancellable contractual term and reasonably certain renewals. Costs incurred during the preliminary project or the post-implementation/operation stages of the project are expensed as incurred. Implementation costs are included in &#8220;Other assets&#8221; in our Consolidated Balance Sheets. Amortization of capitalized implementation costs is included in the same line item in the Consolidated Statements of Income as the expense for fees for the associated hosting arrangement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Valuation of Goodwill</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. Goodwill is tested for impairment at the reporting unit level by performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. We perform a qualitative assessment to test each reporting unit's goodwill for impairment, which includes industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the fair value of a reporting unit will be compared with its carrying amount and an impairment charge will be recognized for the amount that the carrying value exceeds the fair value of the reporting unit.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Long-lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We review long-lived assets held and used for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group are compared to the asset group's carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds the fair value. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Indefinite-lived Intangible Assets</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We assess indefinite-lived intangible assets annually in the third quarter of the fiscal year, or whenever events or changes in circumstances indicate that the carrying amount of an indefinite-lived intangible asset (asset group) may not be recoverable. We evaluate whether the indefinite-lived intangible asset is impaired by comparing its carrying value to its fair value. If the carrying value of an indefinite-lived intangible asset is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We routinely consummate business combinations. Results of operations for acquired companies are included in our consolidated results of operations from the date of acquisition. We recognize separately from goodwill, the identifiable assets acquired, including acquired in-process research and development, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date fair values as defined by accounting standards related to fair value measurements. Key assumptions routinely utilized in allocation of purchase price to intangible assets include discount rates and projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. Direct acquisition costs are expensed as incurred.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For business acquisitions, the Company records tangible and intangible assets acquired and liabilities assumed at their fair values as of the applicable date of acquisition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are subject to various legal proceedings, claims, litigation, investigations and contingencies arising out of the ordinary course of business. If we believe the likelihood of an adverse legal outcome is probable and the amount is estimable, we accrue a liability in accordance with accounting guidance for contingencies. We consult with legal counsel on matters related to litigation and seek input both within and outside the Company.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Exit Charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">During the second quarter of fiscal 2022, the Company initiated a plan to exit its contact lens care business, a non-core business unit of the CooperVision segment, which was completed in fiscal 2023. Exit charges recognized during the year ended October 31, 2023, were not material. Exit charges recognized during the year ended October 31, 2022, were $33.2&#160;million, of which $26.7&#160;million were recognized in "Cost of sales" and $6.5&#160;million were recognized in "Selling, general and administrative expense" in our Consolidated Statements of Income. Exit charges primarily related to inventory write-down, asset impairments and employee-related costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Government Assistance</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">The Company at times receives government assistance primarily to support manufacturing capital expansion, to create or retain jobs, or to provide tax credits mainly for eligible research and development activities. The Company generally accounts for such government assistance by analogy to IAS 20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Accounting for Government Grants and Disclosure of Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> and recognizes the assistance when it is probable that it will be received by complying with the prerequisite terms and conditions. The government assistance is recognized in income as a reduction to the cost basis of the applicable property, plant, and equipment or reduction to the related expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">. This update requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. This standard was effective for fiscal years beginning after December 15, 2021. The Company adopted this guidance prospectively on November 1, 2022, and such adoption did not have a material impact on the Company's Consolidated Financial Statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reference</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Topic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"> Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> and subsequent amendment to the initial guidance: ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reference Rate Reform (Topic 848): Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> (collectively, &#8220;Topic 848&#8221;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. In December 2022, the FASB issued ASU 2022-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">. ASU 2022-06 defers the sunset date of Topic 848 from December 31, 2022, to December 31, 2024. Effective February 1, 2023, the Company transitioned its credit agreements from LIBOR to the Secured Overnight Financing Rate ("SOFR"). The Company adopted this guidance prospectively on February 1, 2023, and it did not have a material impact on the Consolidated Financial Statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements Issued Not Yet Adopted</span></div>No other recently issued accounting pronouncements had or are expected to have a material impact on our Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656872003472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Operating Leases</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 2. Operating Leases</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table presents information about leases on the Consolidated Balance Sheets: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.013%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.581%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">October&#160;31,<br/>(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-485"><span style="-sec-ix-hidden:f-486">Operating lease right-of-use assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">241.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">230.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-489"><span style="-sec-ix-hidden:f-490">Operating lease liabilities, current</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.5</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-493"><span style="-sec-ix-hidden:f-494">Operating lease liabilities, non-current</span></span> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">215.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">205.5</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">253.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">241.0</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.8</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Operating lease expense for the fiscal years ended October&#160;31, 2023, 2022 and 2021 was $48.1&#160;million, $45.0&#160;million and $44.1&#160;million.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Maturity of Lease Liabilities </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The minimum rental payments required under operating leases that have initial or remaining noncancellable lease terms in excess of one year as of October&#160;31, 2023 are: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.386%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">46.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">37.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">123.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">308.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">253.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656959373040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Joint Venture<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationAndAssetAcquisitionTextBlock', window );">Acquisitions and Joint Venture</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 3. Acquisitions and Joint Venture</span></div><div style="margin-bottom:5pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">All acquisitions were funded by cash generated from operations or facility borrowings.</span></div><div style="margin-bottom:5pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company believes these acquisitions strengthen CooperSurgical's and CooperVision's businesses through the addition of new distributors or complementary products and services.</span></div><div style="margin-bottom:5pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Fiscal Year 2023</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On November 1, 2022, CooperVision completed the acquisition of a privately-held U.S.-based company that provides a broad portfolio of technologically advanced contact lens products, including scleral and hybrid lenses. The purchase price of the acquisition was $33.0&#160;million. Assets acquired primarily comprised of $12.6&#160;million of customer relationship related intangibles, </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$7.6&#160;million of technology, $5.1&#160;million of net assets and $7.7&#160;million of goodwill. The goodwill is not deductible for tax purposes. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Fiscal Year 2022</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On May 31, 2022, CooperVision completed the acquisition of a privately-held Denmark-based contact lens distributor focusing on orthokeratology and scleral contact lenses. This acquisition expands CooperVision's ortho-k eye care portfolio in the Nordic market.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On April 6, 2022, CooperSurgical completed the acquisition of a private cryopreservation services company that specializes in cryogenic services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">Refer to the "Joint Venture" section below for details on formation of a joint venture with Essilor International and related activities that occurred in fiscal year 2023 and 2022 following the acquisition of SightGlass Vision, Inc. (SGV) in fiscal year 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On April 6, 2022, CooperSurgical entered into an asset purchase agreement to acquire Cook Medical's Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets. The aggregate consideration is $875.0&#160;million in cash, with $675.0&#160;million payable at the closing and the remaining $200.0&#160;million payable in $50.0&#160;million installments following each of the first, second, third and fourth anniversaries of the closing. The transaction is subject to customary closing conditions, such as receipt of required regulatory approvals. During the year ended October 31, 2023, CooperSurgical determined that the fulfillment of certain closing conditions related to regulatory approvals was no longer probable and paid $45.0&#160;million in expenses for a termination fee under the asset purchase agreement on August 9, 2023. The termination fee is recorded in "Selling, general and administrative expense" on the Consolidated Statements of Income. Refer to the "Subsequent Event" section below for details on the revised scope of the transaction and the closing of the updated transaction.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">On December 17, 2021, CooperSurgical completed the acquisition of 100% of the equity interests in Generate Life Sciences (Generate), a privately held leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood &amp; cord tissue), and paid an aggregate purchase consideration of approximately $1.663&#160;billion, reflecting working capital, and other adjustments. The cash consideration was funded through a combination of $1.5&#160;billion in proceeds from the issuance of a senior unsecured term loan and available cash on hand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%">Joint Venture</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On January 19, 2021, CooperVision acquired all of the remaining equity interests of SGV, a privately-held medical device company that developed spectacle lenses for myopia management. The transaction included potential payments of future consideration that were contingent upon the achievement of the regulatory approval milestone (the regulatory approval payment) and the acquired business reaching certain revenue thresholds over a specified period (the revenue payments). The undiscounted range of the contingent consideration was zero to $139.1&#160;million payable to the other former equity interest owners.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the regulatory approval payment was determined using an option pricing framework based on the expected payment under the contractual terms and the estimates of the probability of achieving the regulatory approval. The fair value of the revenue payments was determined using a Monte Carlo simulation based on the revenue projections and the expected payment for each simulation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In March 2022, the entities amended the terms of the contingent consideration, which resulted in CooperVision paying $42.9&#160;million to the former equity interest owners in exchange for the elimination of the revenue payments to such former equity interest owners. CooperVision recognized a net gain of $12.2&#160;million during fiscal 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Further, CooperVision and Essilor International SAS (Essilor) executed a Contribution Agreement and a Stock Purchase Agreement (the "Agreements") in March 2022. Essilor paid CooperVision $52.1&#160;million in exchange for a 50% interest in SGV and their proportionate share of the revenue payments. As part of the Agreements, each party contributed their interest in SGV and $10&#160;million in cash to form a new joint venture. CooperVision then remeasured the fair value of its retained equity investment in the joint venture at $90.0&#160;million which resulted in a $56.9&#160;million gain in Other (income) expense on deconsolidation of SGV in fiscal 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">During fiscal 2023, CooperVision determined that approval would not be achieved within the timeline set forth in the contractual terms of the regulatory approval payment and released the remaining $31.8&#160;million contingent consideration liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Subsequent Event</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On November 1, 2023, CooperSurgical closed the acquisition of select assets of Cook Medical for an aggregate consideration of $300.0&#160;million, with $200.0&#160;million paid at closing and $100.0&#160;million to be paid in two $50.0&#160;million annual installments. The </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">assets acquired primarily comprised of minimally invasive medical devices within the obstetrics, doppler monitoring and gynecology surgery markets. The Company is in the process of finalizing purchase accounting information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationAndAssetAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination And Asset Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationAndAssetAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865854704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 4. Intangible Assets</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company has three reporting units: CooperVision and within the CooperSurgical segment, Office/Surgical and Fertility, reflecting the current way the Company manages its business. There was no impairment of goodwill in its reporting units in fiscal 2023, 2022, and 2021.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperVision</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperSurgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,710.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,899.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,609.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net changes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,747.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,876.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,624.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Of the October&#160;31, 2023, goodwill balance, $237.6 million for CooperSurgical and $20.1 million for CooperVision is expected to be deductible for tax purposes. Of the October&#160;31, 2022, goodwill balance, $214.1&#160;million for CooperSurgical and $22.4&#160;million for CooperVision was expected to be deductible for tax purposes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31, 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Weighted-average Amortization Period (in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">208.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">209.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Composite intangible asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,061.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">424.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,061.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">354.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">494.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">335.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">504.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">317.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,099.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">345.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,092.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">287.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">License and distribution rights and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,916.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,215.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,919.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,044.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: accumulated amortization and translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,215.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,044.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,701.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,874.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total other intangibles, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,710.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,885.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Intangible assets with indefinite lives include technology and trademarks.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Balances include foreign currency translation adjustments. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2023, the estimate of future amortization expenses for intangible assets with definite lives is as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal years:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">179.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">169.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">162.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">143.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">899.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total remaining amortization for intangible assets with definite lives</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,701.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the fourth quarter of fiscal 2023, CooperVision fully impaired some intangible assets associated with the discontinuation of certain products. The carrying value of these intangible assets were immaterial. The Company performed its annual impairment assessment in the third quarter of fiscal 2023 and determined there was no other impairment to either its definite-lived or indefinite-lived intangible assets during fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023. </span></div>There were no impairment to the Company's definite-lived or indefinite-lived intangible assets during fiscal 2022 and 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869795520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Financing Arrangements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 5. Financing Arrangements</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company had outstanding debt as follows:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.413%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Overdraft and other credit facilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">338.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt, excluding financing leases</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">395.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-635"><span style="-sec-ix-hidden:f-636">Financing lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Revolving credit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">172.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,350.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,350.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt, excluding financing leases</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,520.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,347.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-651"><span style="-sec-ix-hidden:f-652">Financing lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,523.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,350.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,569.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,763.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2023, the Company was in compliance with all debt covenants. On February 1, 2023, the Company amended its credit agreements to transition the interest rates applicable to the loans denominated in U.S. dollars from LIBOR to SOFR, as defined in the credit agreements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Term Loan Agreement on December 17, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On December 17, 2021, the Company entered into a Term Loan Agreement (the 2021 Credit Agreement) by and among the Company, the lenders from time to time party thereto, and PNC Bank, National Association, as administrative agent. The 2021 Credit Agreement provides for a term loan facility (the 2021 Term Loan Facility) in an aggregate principal amount of $1.5&#160;billion, which, unless terminated earlier, matures on December 17, 2026. In addition, the Company has the ability from time to time to request an increase to the commitments under the 2021 Term Loan Facility or to establish a new term loan facility under the 2021 Credit Agreement in an aggregate principal amount not to exceed $1.125&#160;billion, upon prior written </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">notice to the administrative agent and subject to the discretionary participation of the lenders funding such term loans and certain limitations set forth in the 2021 Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Amounts outstanding under the 2021 Term Loan Facility will bear interest, at the Company&#8217;s option, at either (i) the alternate base rate, which is a rate per annum equal to the greatest of (a) the administrative agent&#8217;s prime rate, (b) one-half of one percent in excess of the federal funds effective rate and (c) one percent in excess of the adjusted SOFR for a one-month interest period in effect on such day, or (ii) the adjusted SOFR, plus, in each case, an applicable rate of, initially, zero basis points, in respect of base rate loans, and 75 basis points, in respect of adjusted SOFR loans. Following a specified period after the closing date, the applicable rates will be determined quarterly by reference to a grid based upon the Company&#8217;s ratio of consolidated net indebtedness to consolidated EBITDA, each as defined in the 2021 Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company may prepay loan balances from time to time, in whole or in part, without premium or penalty (other than any related breakage costs).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On October&#160;31, 2023, the Company had $1.5&#160;billion outstanding on the 2021 Term Loan Facility and the weighted-average interest rate was 6.41%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio, each as defined in the 2021 Credit Agreement, consistent with the 2020 Credit Agreement discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Term Loan Agreement on November 2, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On November 2, 2021, the Company entered into a 364-day, $840.0&#160;million, term loan agreement by and among the Company, the lenders party thereto and The Bank of Nova Scotia, as administrative agent, which matured subsequent to year end on November 1, 2022. The Company used part of the funds to partially repay outstanding borrowings under the 2020 Revolving Credit Facility and for general corporate purposes. The loan was fully repaid by the maturity date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Revolving Credit and Term Loan Agreement on April 1, 2020</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On April 1, 2020, the Company entered into a Revolving Credit and Term Loan Agreement (the 2020 Credit Agreement), among the Company, CooperVision International Holding Company, LP, CooperSurgical Netherlands B.V., CooperVision Holding Kft. the lenders from time to time party thereto, and KeyBank National Association, as administrative agent. The 2020 Credit Agreement provides for (a)&#160;a multicurrency revolving credit facility (the 2020 Revolving Credit Facility) in an aggregate principal amount of $1.29 billion and (b)&#160;a term loan facility (the 2020 Term Loan Facility) in an aggregate principal amount of $850.0 million, each of which, unless terminated earlier, mature on April 1, 2025. The Company used $850.0&#160;million under the 2020 Term Loan Facility and $445.0&#160;million under the 2020 Revolving Credit Facility to fully repay all borrowings outstanding under a previously existing term loan agreement and transfer all letters of credit and borrowings outstanding under a previously existing credit agreement to the 2020 Credit Agreement. The Company has an uncommitted option to increase the revolving credit facility or establish a new term loan in an aggregate amount up to $1.605&#160;billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On October 30, 2020, the Company entered into Amendment No. 1 to the 2020 Credit Agreement, adding CooperVision International Limited as a revolving borrower and releasing certain borrowers in the 2020 Credit Agreement. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">On December 17, 2021, the Company entered into Amendment No.2 to the 2020 Credit Agreement, modifying the 2020 Credit Agreement by, among other things, adding CooperSurgical Holdings Limited as a revolving borrower, releasing CooperVision Holding Kft as a borrower, and updating the benchmark replacement language in the 2020 Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">The 2020 Credit Agreement will bear interest, at the Company&#8217;s option, at either the alternate base rate, or the adjusted SOFR, or adjusted foreign currency rate, plus, in each case, an applicable rate of between 0.00% and 0.50% in respect of base rate loans, and between 0.75% and 1.50% in respect of adjusted SOFR or adjusted foreign currency rate loans, in each case in accordance with a pricing grid tied to the Total Leverage Ratio, as defined in the 2020 Credit Agreement. The Company may borrow, repay and re-borrow amounts available under the Revolving Credit Facility, subject to voluntary reduction of the revolving commitment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company pays an annual commitment fee that ranges from 0.10% to 0.20% of the unused portion of the 2020 Revolving Credit Facility based upon the Company&#8217;s Total Leverage Ratio, as defined in the 2020 Credit Agreement. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On October&#160;31, 2023, the Company had $850.0 million outstanding under the 2020 Term Loan Facility and $172.6 million outstanding under the 2020 Revolving Credit Facility. The interest rate on the 2020 Term Loan Facility was 6.41% at October&#160;31, 2023. The weighted-average interest rate on the 2020 Revolving Credit Facility was 6.41% at October&#160;31, 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Payments on the outstanding long-term debt balance of $850.0&#160;million are due in the fiscal year ending October 31, 2025.</span></div><div style="margin-top:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">European and Asian Pacific Credit Facilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company maintains European credit facilities. The aggregate facility limit was $32.9 million and $30.7&#160;million at October&#160;31, 2023 and 2022, respectively. At October&#160;31, 2023, $0.7 million of the facilities was utilized and the weighted-average interest rate on the outstanding balances was 7.82%. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company maintains yen-denominated credit facilities in Japan. The aggregate facility limit was $74.3 million and $73.0&#160;million at October&#160;31, 2023 and 2022, respectively. At October&#160;31, 2023, $41.4 million of the combined facilities was utilized and the weighted-average interest rate on the outstanding balances was 0.40%. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Each facility is supported by a continuing and unconditional guaranty.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869834704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 6. Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In November 2020, the Company completed an intra-group transfer of certain intellectual property and related assets of CooperVision to a UK subsidiary as part of a group restructuring to establish headquarters operations in the UK. Determining fair value involved significant judgment related to future revenue growth, operating margins, and discount rates. The transfer resulted in a step-up of the UK tax-deductible basis in the intellectual property and goodwill, creating a temporary difference between the book basis and the tax basis of these assets. As a result, the Company recognized a deferred tax asset of $1,987.9&#160;million, with a corresponding income tax benefit, during the first quarter of fiscal 2021. During the third quarter of fiscal 2021, the Company recognized a $536.7&#160;million tax benefit related primarily to the remeasurement of this deferred tax asset caused by the UK enactment of a 25% corporate tax rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Components of income before income taxes:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/>(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(135.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(31.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">548.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">443.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">522.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">412.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">475.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Components of provision for income taxes: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">74.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(36.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,492.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,502.2)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,453.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes at United States statutory tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">99.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">103.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Decrease) increase in taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign earnings in jurisdictions with different tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign earnings subject to United States tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Excess tax benefits from share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intra-group transfer to UK subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,987.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Remeasurement of deferred tax assets from UK rate change</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(536.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,453.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Components of deferred tax assets and liabilities:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued liabilities, reserves and compensation accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">79.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign deferred tax assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,369.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,500.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net operating loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capitalized research and experimental expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,548.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,641.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(60.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,528.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,581.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax deductible goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(47.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(132.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153.8)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(51.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(48.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(49.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(45.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(280.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(287.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,248.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,293.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, the Company analyzes whether some or all deferred tax assets will not be realized. This analysis considers historical taxable income, the projected reversal of deferred tax liabilities, projected taxable income and tax planning strategies. Based upon this analysis, it is more likely than not the deferred tax assets, net of valuation allowance, will be realized. The decrease in valuation allowance is primarily related to foreign tax attributes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">At October&#160;31, 2023, the Company had federal net operating loss carryforwards of $78.7&#160;million and state net operating loss carryforwards of $87.1&#160;million. Federal net operating loss carryforwards of $46.0&#160;million expire on various dates between 2024 and 2037 and $32.7&#160;million do not expire. The state net operating loss carryforwards expire on various dates between 2027 through 2044.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A tax benefit is recognized if it is more likely than not that a tax position will be sustained on its technical merits, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Changes in unrecognized tax benefits:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">353.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Decrease based on tax positions in prior fiscal years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lapses of statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">336.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Decrease based on tax positions in prior fiscal years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Increase based on tax positions in current fiscal year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lapses of statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">331.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">These tax benefits, if recognized, would reduce provision for income taxes for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">, by $323.2&#160;million, $324.3&#160;million, and $336.5&#160;million, respectively. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes. As of October 31, 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">, accrued gross interest and penalties related to unrecognized tax benefits was $5.8&#160;million, $5.4&#160;million, and $6.4&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Included in the balance of unrecognized tax benefits at October&#160;31, 2023, is $8.1&#160;million related to tax positions for which it is reasonably possible that the total amounts could change during the next twelve months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Filed tax returns are subject to examination by tax authorities in major tax jurisdictions after fiscal 2018, including the UK and the US.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869746208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 7. Earnings Per Share</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.135%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions, except for earnings per share)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">294.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">385.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,944.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted-average common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.94&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.83&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59.80&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted-average common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effect of dilutive stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted weighted-average common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.91&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59.16&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth stock options to purchase our common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except exercise prices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stock option shares excluded</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exercise prices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$300.12 - $406.17</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$300.12 - $406.17</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">345.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restricted stock units excluded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869829920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 8. Stockholders&#8217; Equity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Analysis of Changes in Accumulated Other Comprehensive Income (Loss):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Minimum Pension Liability</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(402.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(56.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(472.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(320.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(341.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(234.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">107.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(90.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(555.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(466.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(538.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(453.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share Repurchases </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In December 2011, the Company's Board of Directors authorized the 2012 Program and through subsequent amendments, the most recent in March 2017, the total repurchase authorization was increased from $500.0 million to $1.0 billion of the Company's common stock. This program has no expiration date and may be discontinued at any time. Purchases under the 2012 Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements. As of October&#160;31, 2023, $256.4 million remained authorized for repurchase under the program.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">During the year ended October&#160;31, 2023, there were no share repurchases under the 2012 Program. During the year ended October&#160;31, 2022, the Company repurchased 191.2 thousand</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">shares of its common stock for $78.5 million, at an average purchase price of $410.41 per share. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In fiscal 2023 and 2022, the Company declared regular dividends of 6&#160;cents per share (a semiannual dividend of 3&#160;cents per share) and paid a total of $3.0&#160;million in each fiscal year. In December 2023, our Board of Directors decided to end the declaration of the semiannual dividend.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Subsequent Event</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On December 7, 2023, we announced that our Board of Directors had approved a four-for-one stock split of our outstanding shares of common stock which we expect to be effected as of February 16, 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869660352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Plans</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 9. Stock Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2007 Long-Term Incentive Plan (2007 Plan)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In March 2007, we received stockholder approval of the 2007 Plan. The 2007 Plan was subsequently amended and restated, and granted stockholder approval in March 2009, March 2011, and March 2016.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Third Amended and Restated 2007 Plan authorizes either our Board of Directors, or a designated committee thereof composed of two or more Non-Employee Directors, to grant to eligible individuals during the period ending December&#160;31, 2026, up to 6,930,000 shares in the form of specified equity awards including stock options, restricted stock units and performance share awards. RSUs have no dividend or voting rights prior to vesting. Awards under the 2007 Plan remain outstanding but new awards are no longer being granted.</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023 Long-Term Incentive Plan (2023 Plan)</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In March 2023, we received stockholder approval of the 2023 Plan. The 2023 Plan authorizes either our Board of Directors, or a designated committee thereof composed of two or more Non-Employee Directors, to grant to eligible individuals up to 1,365,000 shares in the form of specified equity awards including stock options, restricted stock units (RSUs) and performance share units (PSUs), subject to adjustment for future stock splits, stock dividends, expirations, forfeitures, and similar events. In addition, the 2023 Plan includes any shares which were available for issuance under the 2007 Plan at the time of stockholder approval of this plan and shares which become available as a result of the forfeiture or expiration of awards made under the 2007 Plan. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2023, 1,376,240 shares remained available under the 2023 Plan for future grants. The amount of available shares includes shares which may be distributed under performance shares.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The compensation expense and related income tax benefit recognized in our Consolidated Statements of Income for share-based awards, including the Employee Stock Purchase Plan, were as follows:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October 31,</span></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">46.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Related income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Stock Options </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of each stock option award granted is estimated on the date of grant using the Black-Scholes option valuation model and assumptions noted in the following table. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.037%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The activity and status of our stock option plans are summarized below: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise&#160;Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Outstanding at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,063,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">329.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(71,808)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">155.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(720)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">337.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Outstanding at October&#160;31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,077,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">277.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.36</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,510,367&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and expected to vest at October 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,059,841&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">276.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.32</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53,475,275&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and exercisable at October&#160;31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">729,591&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">248.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.38</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50,797,891&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The weighted-average fair value of options granted during fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">, estimated as of the grant date using the Black-Scholes option pricing model, was $103.17, $90.41 and $84.10, respectively. The total intrinsic value of options exercised during the fiscal years ended October&#160;31, 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> was $13.4&#160;million, $6.6&#160;million and $64.7&#160;million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Stock options outstanding under our current plans have been granted at prices which are either equal to or above the market value of the common stock on the date of grant. Options granted under the 2007 Plan and 2023 Plan generally vest over a range of <span style="-sec-ix-hidden:f-975">three</span> to five years based on service conditions and expire no later than ten years after the grant date. We generally recognize compensation expense ratably over the vesting period. As of October&#160;31, 2023, there was $17.6&#160;million of total unrecognized compensation cost related to nonvested options, which is expected to be recognized over a remaining weighted-average vesting period of 2.1 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">RSUs granted under the 2007 Plan and the 2023 Plan generally vest over <span style="-sec-ix-hidden:f-980">three</span> to five years. The grant-date fair value of RSUs is estimated based on the market price of our common stock. We recognize compensation expense ratably over the vesting period. As of October&#160;31, 2023, there was $63.1&#160;million of total unrecognized compensation cost related to nonvested RSUs, which is expected to be recognized over a remaining weighted-average vesting period of 2.4 years. The total fair value of RSU grants that vested during the fiscal years ended October&#160;31, 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> was $37.3&#160;million, $46.1&#160;million and $50.1&#160;million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The status of our non-vested RSUs is summarized below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant&#160;Date&#160;Fair<br/>Value&#160;Per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-vested RSUs at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">289,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">340.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">145,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">335.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(107,403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">320.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(37,461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">344.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-vested RSUs at October&#160;31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">290,029&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">345.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Performance Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Performance units may be granted to selected key employees with vesting contingent upon meeting certain performance goals over a defined performance cycle, usually three years. Performance units, if earned, may be paid in cash or shares of common stock. We granted performance unit awards on December 13, 2022, December 7, 2021, and December 8, 2020, under the 2007 Plan, with three-year performance periods ending in fiscal 2025, fiscal 2024, and fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> respectively. The performance shares actually earned will range from zero to 200% of the target number of performance shares. Subject to limited exceptions set forth in the performance share agreement, any shares earned will be distributed in the subsequent fiscal year after the performance period. The fair value of performance unit awards is estimated on the date of grant based on the current market price of our common stock. The amount of compensation expense related to these performance unit awards is reviewed each fiscal quarter and adjustments are recorded after assessing the probability of achieving the performance goals.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We recognize compensation expense ratably over the vesting period. As of October&#160;31, 2023, there was $12.3&#160;million of total unrecognized compensation cost related to non-vested performance units, which is expected to be recognized over a remaining weighted-average vesting period of 1.7 years.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On March 18, 2019, the Company received stockholder approval for the Employee Stock Purchase Plan (ESPP). The first offering period began on November 4, 2019, and offerings are generally made on a quarterly basis. The purpose of the ESPP is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at 85% of the market price on the last business day of each offering period by means of accumulated payroll deductions. The ESPP initially authorized the issuance of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">1,000,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> shares of common stock. These shares will be made available from shares of common stock reacquired by the Company as Treasury Stock. During fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> and 2022, we issued 26,116 and 22,695 shares to our employees under the ESPP, respectively. At October&#160;31, 2023, the number of shares remaining available for future issuance under the ESPP was 921,975 shares. Total ESPP share-based compensation recognized during fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> and 2022 was $1.3&#160;million and $1.1 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869770432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefits</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 10. Employee Benefits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cooper's Retirement Income Plan</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company's Retirement Income Plan (Plan), a defined benefit plan, is only available to full-time United States employees, subject to the soft freeze mentioned below. The Company's contributions are designed to fund normal cost on a current basis and to fund the estimated prior service cost of benefit improvements. The unit credit actuarial cost method is used to determine the annual cost. The Company pays the entire cost of the Plan and funds such costs as they accrue. Virtually all of the assets of the Plan are comprised of equities and participation in equity and fixed income funds.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses individual spot rates along the yield curve that correspond with the timing of each benefit payment to determine the service and interest costs of components of its net periodic benefit cost utilizing the correlation of projected cash outflows and corresponding spot rates on the yield curve. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth the Plan's benefit obligations and fair value of the Plan assets at October&#160;31, 2023, 2022 and 2021 and the funded status of the Plan and net periodic pension costs for each of the years in the three-year periods ended October&#160;31, 2023. The net amounts recognized in the Consolidated Balance Sheets consist of noncurrent liabilities. The accumulated benefit obligation was $131.5 million, $134.9 million and $207.6 million for the years ended October&#160;31, 2023, 2022 and 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Retirement Income Plan</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change in benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">148.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">230.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1022"><span style="-sec-ix-hidden:f-1023"><span style="-sec-ix-hidden:f-1024">Interest cost</span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(93.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">144.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">148.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">230.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">142.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">199.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">142.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">199.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Funded status at end of year</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(31.4)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amounts recognized in accumulated other comprehensive income consist of:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reconciliation of (prepaid) accrued pension cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Prepaid)/Accrued pension cost at prior fiscal year end</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Contributions made during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Prepaid)/Accrued pension cost at fiscal year end</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1082"><span style="-sec-ix-hidden:f-1083"><span style="-sec-ix-hidden:f-1084">Expected return on plan assets</span></span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1088"><span style="-sec-ix-hidden:f-1089"><span style="-sec-ix-hidden:f-1090">Recognized actuarial loss</span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Other changes in plan assets and benefit obligations recognized in other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net (gain) loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortizations of net gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in other comprehensive (income) loss</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(36.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and other comprehensive (income) loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate for determining net periodic pension cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Projected Benefit Obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service Cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest Cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate for determining benefit obligations at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rate of compensation increase for determining expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rate of compensation increase for determining benefit obligations at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected rate of return on plan assets for determining net periodic pension cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected rate of return on plan assets at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Measurement date for determining assets and benefit obligations at year end</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2021</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The discount rate enables us to state expected future cash flows at a present value on the measurement date. The discount rate used for the Plan is based primarily on the yields of a universe of high-quality corporate bonds rated AA or above, with durations corresponding to the expected durations of the benefit obligations. A change in the discount rate will cause the present value of benefit obligations to change in the opposite direction.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The expected rate of return on plan assets was determined based on a review of historical returns, both for this plan and for medium- to large-sized defined benefit pension funds with similar asset allocations. This review generated separate expected returns for each asset class listed below. These expected future returns were then blended based on this Plan's target asset allocation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Reasons for Significant Liability Gains and Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The projected benefit obligation experienced a net gain of approximately $10.9 million during the year. This net gain is the result of assumption changes resulting in a gain of approximately $12.9 million, offset by losses of approximately $2.0 million due to demographic experience. The key assumption changes were the increase in the discount rate (gain of $7.8 million), a changes in assumptions for lump sum determination (gain of $5.1 million). Demographic losses were due to the net effect of retirement rates, termination rates, salary increases and other experience that was different from assumed. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Assets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Weighted-average asset allocations at year end, by asset category are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Asset category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Corporate common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity mutual funds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balanced funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Alternative investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Bond mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Plan invests in a diversified portfolio of assets intended to minimize risk of poor returns while maximizing expected portfolio returns. To achieve the long-term rate of return, plan assets will be invested in a mixture of instruments, including but not limited to, corporate common stock (may include the Company's stock), investment grade bond funds, cash, balanced funds, real estate funds, small or large cap equity funds and international equity funds. The allocation of assets will be determined by the investment manager and will typically include 50% to 70% equities with the remainder invested in fixed income, hedging strategy funds and cash. Presently, this diversified portfolio is expected to return roughly 8% in the long run.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of the measurement date of October&#160;31, 2023, the fair value measurement of plan assets is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.541%"><tr><td style="width:1.0%"></td><td style="width:47.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.499%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets for<br/>Identical&#160;Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Significant<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Asset category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Corporate common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balanced Funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Alternative investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">39.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">113.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Plan has an established process for determining the fair value of plan assets. For investments in equity and bond mutual funds, and real estate funds, fair value is based on observable, Level 1 inputs.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Cash Flows</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Contributions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company made $1.1 million and no contributions to the Plan in fiscal 2023 and fiscal 2022, respectively. The Company contribution to the Plan was $12.7&#160;million for fiscal 2021. The Company closely monitors the funded status of the Plan with respect to legislative and accounting rules. The Company expected to make contributions totaling $1.1 million to the Plan during fiscal 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Estimated Future Benefit Payments</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.451%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2025</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2027</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2028</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2029-2033</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">65.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Soft Freeze</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On June 18, 2019, the Board of Directors of the Company approved a soft freeze of the Plan effective August 1, 2019. The Plan was closed to employees hired on or after August 1, 2019, including former participants or employees rehired on or after August 1, 2019, and employees hired in connection with a stock or asset acquisition, merger or other similar transaction on or after August 1, 2019. Existing employees already covered by the Plan, continue to accrue their benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cooper's 401(k) Savings Plan</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Cooper's 401(k) savings plan provides for the deferral of compensation as described in the Internal Revenue Code and is available to substantially all United States employees. Employees who participate in the 401(k) plan may elect to have up to 75% of their pre-tax salary or wages deferred and contributed to the trust established under the Plan. Cooper's contributions on account of participating employees, were $10.1 million, $9.0 million and $7.2 million for the years ended October&#160;31, 2023, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869742480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 11. Contingencies </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company is involved in various lawsuits, claims and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company does not believe that the ultimate resolution of these proceedings or claims pending against it could have a material adverse effect on its financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">. Legal fees are expensed as incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869660352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment Information</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 12. Business Segment Information</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company discloses information about its operating segments, which were established based on the way that management organizes segments within the Company for making operating decisions and assessing financial performance. The Company's two operating segments are described below. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.68pt">CooperVision. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Competes in the worldwide contact lens market by developing, manufacturing and marketing a broad range of products for contact lens wearers, featuring advanced materials and optics.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.68pt">CooperSurgical. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Competes in the general health care market with a focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women's health and fertility.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses operating income, as presented in our financial reports, as the primary measure of segment profitability. The Company does not allocate costs from corporate functions to segment operating income. The Company uses the same accounting policies to generate segment results as it does for consolidated results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">No customers accounted for 10% or more of our consolidated net revenue in fiscal 2023, 2022 and 2021. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Total identifiable assets are those used in continuing operations except cash and cash equivalents, which the Company includes as corporate assets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table presents a summary of our business segment net sales:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision net sales by category:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Toric lens</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">828.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">737.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">697.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Multifocal lens</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">305.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Single-use sphere lens</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">705.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">661.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">616.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non single-use sphere, other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">583.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">579.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">599.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total CooperVision net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,423.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,243.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical net sales by category:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Office and surgical </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">689.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">633.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">451.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fertility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">480.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">431.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">319.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total CooperSurgical net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,169.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,065.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">770.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,593.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information by business segment for each of the years in the three-year period ended October&#160;31, 2023 follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.120%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperVision</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperSurgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,423.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,169.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,593.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">587.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(70.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">533.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">412.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,044.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,351.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">263.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,658.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">156.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">181.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">186.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">364.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">392.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,243.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,065.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">494.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(53.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">507.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">475.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,778.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,407.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">305.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,492.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">144.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">166.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">179.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">223.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">242.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">770.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">481.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">71.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(47.3)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">505.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,965.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,395.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">244.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,606.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">148.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">110.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">190.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">214.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information by geographical area by country of domicile for each of the years in the three-year period ended October&#160;31, 2023 follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Rest of<br/>World,&#160;Other<br/>Eliminations<br/>&amp; Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,812.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,041.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">739.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,593.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">563.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,016.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,579.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,375.3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,057.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(840.0)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,593.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">516.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">533.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,027.6&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">325.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">279.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,632.6&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,638.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">987.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">682.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">514.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">897.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,411.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,884.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(729.0)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">71.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">403.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">507.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">856.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">310.8&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">266.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,432.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,339.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">957.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">625.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">494.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">815.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,310.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,834.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,773.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(684.6)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">416.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">505.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">737.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">377.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">232.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,347.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869746208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Derivatives and Hedging<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Financial Derivatives and Hedging</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 13. Financial Derivatives and Hedging</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As part of the Company&#8217;s overall risk management practices the Company enters into financial derivatives, interest rate swaps designated as cash flow hedges, to hedge the Company's exposure to changes in cash flows associated with its variable rate debt.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Credit risk related to derivative transactions reflects the risk that a party to the transaction could fail to meet its obligation under the derivative contracts. Therefore, the Company&#8217;s exposure to the counterparty&#8217;s credit risk is generally limited to the amounts, if any, by which the counterparty&#8217;s obligations to the Company exceed the Company&#8217;s obligations to the counterparty. The Company&#8217;s policy is to enter into contracts only with financial institutions which meet certain minimum credit ratings to help mitigate counterparty credit risk. From time to time, the Company enters into foreign currency forward contracts to minimize the short-term impact of foreign currency exchange rate fluctuations on certain trade and intercompany receivables and payables. These foreign currency forward contracts are not designated as hedging instruments, and therefore the net change in their fair value is reported as a gain or loss in the Consolidated Statements of Income and Comprehensive Income. As of October&#160;31, 2023, the notional amount of outstanding foreign currency forward contracts was $56.2&#160;million. The resulting impact on our Consolidated Financial Statements from currency hedging activities was not significant for the years ended October&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2023, the Company has six interest rate swap contracts that have a total notional amount of $1.3&#160;billion and remaining maturities of four years or less. </span></div><div style="margin-bottom:7pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table summarizes the amounts recognized with respect to our derivative instruments within the accompanying Consolidated Statements of Income:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.301%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Periods Ended October 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Location of (Gain)/Loss Recognized on Derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense (income)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The cumulative pre-tax impact of the gain on derivatives designated for hedge accounting is recognized in "Accumulated other comprehensive loss". The following table details the changes in the cumulative pre-tax impact of the gain on derivatives designated for hedge accounting:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.658%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($79.7, net of tax)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">105.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($1.7, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">124.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($25.7, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($(32.7), net of tax)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">115.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Refer to Note 8. Stockholders&#8217; Equity for amounts presented net of the related tax impact in "Accumulated other comprehensive loss".</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company expects that $(48.2)&#160;million recorded as a component of "Accumulated other comprehensive loss" will be realized in our Consolidated Statements of Income over the next twelve months and the amount will vary depending on prevailing interest rates.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869754496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II</a></td>
<td class="text"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Schedule II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Three Years Ended October&#160;31, 2023 </span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.203%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reductions/ Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance<br/>at End<br/>of Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income tax valuation allowance:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Year Ended October&#160;31, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(42.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Year Ended October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Year Ended October&#160;31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865601568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The financial statements in this report include the results of all of Cooper's consolidated entities. All significant intercompany transactions and balances are eliminated on consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates. The Company continually monitors and evaluates the estimates used as additional information becomes available. Adjustments will be made to these provisions periodically to reflect new facts and circumstances that may indicate that historical experience may not be indicative of current and/or future results.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Net Sales </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers may subsequently resell the Company&#8217;s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately negotiated rebates, chargebacks and discounts with respect to the purchase of the Company&#8217;s products. The Company considers purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. As part of its consideration of the contract, the Company evaluates certain factors including the customer&#8217;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Revenues from product sales are recognized when the Customer obtains control of the Company&#8217;s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less. See Note 12. Business Segment Information for disaggregation of revenue.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Reserves for Variable Consideration</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company&#8217;s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liabilities. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company applies that method consistently.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company&#8217;s historical experience, current contractual and statutory requirements, specific known </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Trade Discounts and Allowances</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. Historically, returns have been infrequent and insignificant relative to our total sales. Our refund liability for product returns is included in "Other current liabilities" in our Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Rebates and Chargebacks</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company&#8217;s direct customers. For certain office and surgical portfolio in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Deferred revenue primarily represents prepaid stem cell storage as part of the CooperSurgical business unit. Revenue related to stem cell storage is recognized over the service period, which can range from one year to the lifetime of a customer. The current portion of the deferred revenue balances at the beginning of each year presented were generally fully recognized in the subsequent 12-month period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We grant various share-based compensation awards, including stock options, performance unit shares, restricted stock and restricted stock units. The Company accounts for share-based compensation expense based on estimated grant-date fair value, and expenses the amount over the vesting period of the award. Determining the fair value of share-based awards at the grant date requires judgment, including estimating Cooper's stock price volatility, employee exercise behaviors and related employee forfeiture rates. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The expected life of the share-based awards is based on the expected time to post-vesting forfeiture and/or exercise. Groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. In determining the expected volatility, management considers implied volatility from publicly-traded options on Cooper's common stock at the date of grant, historical volatility and other factors. The risk-free interest rate is based on the continuous rates provided by the United States Treasury with a term equal to the expected life of the award. The dividend yield is based on the projected annual dividend payment per share, divided by the stock price at the date of grant.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Forfeitures are estimated at the time of grant, based on historical experience, and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Most of our operations outside the United States use their local currency as their functional currency. We translate these assets and liabilities into U.S. dollars at year-end exchange rates. We translate income and expense accounts at average exchange rates for the period. We record gains and losses from the translation of financial statements in foreign currencies into U.S. dollars in other comprehensive income. We record gains and losses from changes in exchange rates on transactions denominated in currencies other than each reporting location's functional currency in net income for each period</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Financial Derivatives and Hedging</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Financial Derivatives and Hedging</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Derivatives are recorded on the Consolidated Balance Sheets at fair value. Accounting for gains or losses resulting from changes in the values of those derivatives depends on the use of the derivative instrument and whether it qualifies for hedge accounting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The gain or loss on derivative instruments designated and qualifying for cash flow hedge accounting is deferred in other comprehensive income. The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period earnings. Deferred gains or losses from designated cash flow hedges are reclassified into earnings in the period that the hedged interest expense affects earnings. The effectiveness of cash flow hedges is assessed at inception and quarterly thereafter. The Company does not offset fair value amounts recognized for derivative instruments in its Consolidated Balance Sheets for presentation purposes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%">Fair Value Measurements</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset&#8217;s or liability&#8217;s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The carrying value of the Company's revolving credit facility and term loans approximates fair value based on current market rates (Level 2). Refer to Note 5. Financing Arrangements for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the Company's&#160;interest&#160;rate&#160;swap&#160;contracts is measured on a recurring basis by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates (forward curves) derived from observable market interest rate&#160;curves. The&#160;interest&#160;rate&#160;swap&#160;contracts were categorized as Level 2 in the fair value hierarchy, as the inputs to the derivative pricing model are generally observable and do not contain a high level of subjectivity. The fair value of derivative instruments is included in "Other assets" in our Consolidated Balance Sheets. On our Consolidated Financial Statements. the gain or loss on the derivatives is recorded as a component of "Accumulated other comprehensive loss" and subsequently reclassified into "Interest expense" in the same period during which the hedged transaction affects earnings. Refer to Note 13. Financial Derivatives and Hedging for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses fair value measures for assets and liabilities acquired in an acquisition, which are considered a Level 3 measurement. C</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">ontingent consideration for which a liability is recorded and the initial measurement of the joint venture interest are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> also categorized as Level 3 in the fair value hierarchy;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and the change in fair value is recognized in "Selling, general and administrative expense" in the Consolidated Statements of Income.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> The fair value is measured by discounting expected future cash flows. The discount rate used for cash flows reflects capital market conditions and the specific risks associated with the business. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Note 3. Acquisitions and Joint Venture for further information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Income taxes are estimated based on enacted income tax laws and the results of operations in each jurisdiction. Deferred tax assets and liabilities are estimated based on temporary differences between the financial reporting basis and income tax basis of assets and liabilities. Deferred tax assets are also estimated based on net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance to the extent it is more likely than not they are not expected to be realized. Adjustments to deferred tax assets and liabilities due to changes in tax laws, changes in jurisdiction from intra-group transfers of assets, and changes in judgment regarding a valuation allowance are recognized in provision for income taxes in the quarter in which such changes occur. Long-term tax payable is estimated income tax to be paid for unrecognized tax benefits. A tax benefit is recognized if it is more likely than not a tax position will be sustained based on its technical merits in a tax authority examination, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. Adjustments to unrecognized tax benefits due to changes in judgment are recognized in provision for income taxes in the quarter in which such changes occur. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We determine basic earnings per share (EPS) by using the weighted-average number of shares outstanding. We determine diluted EPS by increasing the weighted-average number of shares outstanding in the denominator by the number of outstanding dilutive equity awards using the treasury stock method.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be&#160;cash equivalents.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.</span></div>In assessing the value of inventories, we make estimates and judgments regarding aging of inventories and other relevant issues potentially affecting the salable condition of products and estimated prices at which those products will sell. On an ongoing basis, we review the carrying value of our inventory, measuring number of months on hand and other indications of salability. We reduce the value of inventory if there are indications that the carrying value is greater than net realizable value, resulting in a new, lower-cost basis for that inventory. Subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. While estimates are involved, historically, obsolescence has not been a significant factor due to long product dating and lengthy product life cycles.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We record property, plant, and equipment at cost. We compute depreciation expense using the straight-line method over the estimated useful lives of the assets. Useful lives are generally 3 to 15 years except for buildings which are depreciated over 30 to 40 years and leasehold improvements, which we amortize over the shorter of the useful life or the lease term. We charge maintenance and repairs to expense as we incur them.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Leases </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We consider an arrangement a lease if the arrangement transfers the right to control the use of an identified asset in exchange for consideration. We have operating leases, but do not have material financing leases. The Company primarily has operating leases for office, manufacturing and warehouse space, vehicles, and office equipment.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future lease payments over the lease term. The lease term reflects the noncancellable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the Consolidated Balance Sheets. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Leases with a term of one year or less are not recognized in the Consolidated Balance Sheets, while the associated lease payments are expensed in the Consolidated Statements of Income and Comprehensive Income on a straight-line basis over the lease term.</span></div>Operating leases are classified in &#8220;Other current liabilities&#8221;, &#8220;Other liabilities&#8221;, and &#8220;Other assets&#8221; in our Consolidated Balance Sheets. Operating lease expense is recognized on a straight-line basis over the expected lease term and included in "Selling, general and administrative expense" in our Consolidated Statements of Income. Financing leases are classified in "Property, plant and equipment, net", "Short-term debt", and "Long-term debt" in our Consolidated Balance Sheets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Cloud Computing Arrangements</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Cloud Computing Arrangements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The Company capitalizes certain costs related to the acquisition and development of internal use software, including implementation costs incurred in a cloud computing arrangement, during the application development stages of projects. Capitalized implementation costs are amortized on a straight-line basis over the expected term of the hosting arrangement, which includes consideration of the non-cancellable contractual term and reasonably certain renewals. Costs incurred during the preliminary project or the post-implementation/operation stages of the project are expensed as incurred. Implementation costs are included in &#8220;Other assets&#8221; in our Consolidated Balance Sheets. Amortization of capitalized implementation costs is included in the same line item in the Consolidated Statements of Income as the expense for fees for the associated hosting arrangement.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Valuation of Goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Valuation of Goodwill</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. Goodwill is tested for impairment at the reporting unit level by performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. We perform a qualitative assessment to test each reporting unit's goodwill for impairment, which includes industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the fair value of a reporting unit will be compared with its carrying amount and an impairment charge will be recognized for the amount that the carrying value exceeds the fair value of the reporting unit.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Long-lived Assets</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Long-lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#160;</span></div>We review long-lived assets held and used for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group are compared to the asset group's carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds the fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy', window );">Indefinite-lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Indefinite-lived Intangible Assets</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We assess indefinite-lived intangible assets annually in the third quarter of the fiscal year, or whenever events or changes in circumstances indicate that the carrying amount of an indefinite-lived intangible asset (asset group) may not be recoverable. We evaluate whether the indefinite-lived intangible asset is impaired by comparing its carrying value to its fair value. If the carrying value of an indefinite-lived intangible asset is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We routinely consummate business combinations. Results of operations for acquired companies are included in our consolidated results of operations from the date of acquisition. We recognize separately from goodwill, the identifiable assets acquired, including acquired in-process research and development, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date fair values as defined by accounting standards related to fair value measurements. Key assumptions routinely utilized in allocation of purchase price to intangible assets include discount rates and projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. Direct acquisition costs are expensed as incurred.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For business acquisitions, the Company records tangible and intangible assets acquired and liabilities assumed at their fair values as of the applicable date of acquisition.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Litigation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Litigation</span></div>We are subject to various legal proceedings, claims, litigation, investigations and contingencies arising out of the ordinary course of business. If we believe the likelihood of an adverse legal outcome is probable and the amount is estimable, we accrue a liability in accordance with accounting guidance for contingencies. We consult with legal counsel on matters related to litigation and seek input both within and outside the Company.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Treasury Stock</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistancePolicyTextBlock', window );">Government Assistance</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Government Assistance</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">The Company at times receives government assistance primarily to support manufacturing capital expansion, to create or retain jobs, or to provide tax credits mainly for eligible research and development activities. The Company generally accounts for such government assistance by analogy to IAS 20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Accounting for Government Grants and Disclosure of Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> and recognizes the assistance when it is probable that it will be received by complying with the prerequisite terms and conditions. The government assistance is recognized in income as a reduction to the cost basis of the applicable property, plant, and equipment or reduction to the related expense.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Pronouncements Recently Adopted and Accounting Pronouncements Issued Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">. This update requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. This standard was effective for fiscal years beginning after December 15, 2021. The Company adopted this guidance prospectively on November 1, 2022, and such adoption did not have a material impact on the Company's Consolidated Financial Statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reference</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Topic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"> Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> and subsequent amendment to the initial guidance: ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reference Rate Reform (Topic 848): Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> (collectively, &#8220;Topic 848&#8221;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. In December 2022, the FASB issued ASU 2022-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">. ASU 2022-06 defers the sunset date of Topic 848 from December 31, 2022, to December 31, 2024. Effective February 1, 2023, the Company transitioned its credit agreements from LIBOR to the Secured Overnight Financing Rate ("SOFR"). The Company adopted this guidance prospectively on February 1, 2023, and it did not have a material impact on the Consolidated Financial Statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements Issued Not Yet Adopted</span></div>No other recently issued accounting pronouncements had or are expected to have a material impact on our Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480598/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistancePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for government assistance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483507/832-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483507/832-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistancePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -SubTopic 40<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482633/350-40-30-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -SubTopic 50<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482610/350-50-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869737344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventory</a></td>
<td class="text"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">207.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">173.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">509.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">439.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">735.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">628.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property, plant and equipment</a></td>
<td class="text"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Land and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">488.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">415.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,187.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,973.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">486.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">393.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,182.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,800.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,553.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,387.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,628.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,413.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease ROU assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,632.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,432.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869866016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Leases on the Consolidated Condensed Balance Sheet</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table presents information about leases on the Consolidated Balance Sheets: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.013%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.581%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">October&#160;31,<br/>(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-485"><span style="-sec-ix-hidden:f-486">Operating lease right-of-use assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">241.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">230.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-489"><span style="-sec-ix-hidden:f-490">Operating lease liabilities, current</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.5</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-493"><span style="-sec-ix-hidden:f-494">Operating lease liabilities, non-current</span></span> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">215.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">205.5</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">253.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">241.0</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.8</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Minimum rental payments required under operating leases</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The minimum rental payments required under operating leases that have initial or remaining noncancellable lease terms in excess of one year as of October&#160;31, 2023 are: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.386%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">46.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">37.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">123.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">308.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">253.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865533088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of goodwill</a></td>
<td class="text"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperVision</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperSurgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,710.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,899.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,609.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net changes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,747.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,876.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,624.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of finite-lived intangible assets</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31, 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Weighted-average Amortization Period (in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">208.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">209.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Composite intangible asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,061.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">424.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,061.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">354.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">494.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">335.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">504.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">317.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,099.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">345.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,092.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">287.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">License and distribution rights and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,916.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,215.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,919.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,044.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: accumulated amortization and translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,215.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,044.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,701.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,874.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total other intangibles, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,710.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,885.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Intangible assets with indefinite lives include technology and trademarks.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of indefinite-lived intangible assets</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31, 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Weighted-average Amortization Period (in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">208.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">209.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Composite intangible asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,061.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">424.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,061.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">354.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">494.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">335.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">504.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">317.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,099.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">345.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,092.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">287.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">License and distribution rights and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,916.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,215.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,919.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,044.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: accumulated amortization and translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,215.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,044.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,701.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,874.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total other intangibles, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,710.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,885.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Intangible assets with indefinite lives include technology and trademarks.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Remaining amortization expenses for intangible assets with definite lives</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2023, the estimate of future amortization expenses for intangible assets with definite lives is as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal years:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">179.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">169.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">162.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">143.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">899.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total remaining amortization for intangible assets with definite lives</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,701.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869845280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of debt</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company had outstanding debt as follows:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.413%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Overdraft and other credit facilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">338.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt, excluding financing leases</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">395.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-635"><span style="-sec-ix-hidden:f-636">Financing lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Revolving credit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">172.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,350.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,350.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt, excluding financing leases</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,520.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,347.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-651"><span style="-sec-ix-hidden:f-652">Financing lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,523.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,350.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,569.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,763.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862478560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Income before income taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Components of income before income taxes:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/>(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(135.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(31.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">548.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">443.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">522.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">412.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">475.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision for income taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Components of provision for income taxes: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">74.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(36.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,492.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,502.2)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,453.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes at United States statutory tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">99.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">103.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Decrease) increase in taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign earnings in jurisdictions with different tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign earnings subject to United States tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Excess tax benefits from share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intra-group transfer to UK subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,987.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Remeasurement of deferred tax assets from UK rate change</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(536.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,453.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Deferred tax assets and liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Components of deferred tax assets and liabilities:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued liabilities, reserves and compensation accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">79.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign deferred tax assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,369.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,500.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net operating loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capitalized research and experimental expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,548.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,641.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(60.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,528.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,581.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax deductible goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(47.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(132.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153.8)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(51.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(48.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(49.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(45.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(280.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(287.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,248.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,293.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Changes in unrecognized tax benefits</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Changes in unrecognized tax benefits:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">353.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Decrease based on tax positions in prior fiscal years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lapses of statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">336.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Decrease based on tax positions in prior fiscal years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Increase based on tax positions in current fiscal year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lapses of statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">331.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656871767456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of earnings per share</a></td>
<td class="text"><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.135%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions, except for earnings per share)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">294.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">385.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,944.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted-average common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.94&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.83&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59.80&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted-average common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effect of dilutive stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted weighted-average common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.91&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59.16&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Stock options to purchase common stock and restricted stock units not included in diluted earnings per share calculation due to antidilutive effect</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth stock options to purchase our common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except exercise prices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stock option shares excluded</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exercise prices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$300.12 - $406.17</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$300.12 - $406.17</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">345.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restricted stock units excluded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869808624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in accumulated other comprehensive (loss) income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Analysis of Changes in Accumulated Other Comprehensive Income (Loss):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Minimum Pension Liability</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(402.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(56.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(472.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(320.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(341.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(234.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">107.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(90.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(555.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(466.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(538.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(453.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div>The following table details the changes in the cumulative pre-tax impact of the gain on derivatives designated for hedge accounting:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.658%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($79.7, net of tax)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">105.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($1.7, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">124.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($25.7, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($(32.7), net of tax)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">115.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656871032640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Compensation expense and related income tax benefit for share-based awards</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The compensation expense and related income tax benefit recognized in our Consolidated Statements of Income for share-based awards, including the Employee Stock Purchase Plan, were as follows:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October 31,</span></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">46.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Related income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Assumptions used in estimating fair value of stock options award granted</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.037%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option plans</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The activity and status of our stock option plans are summarized below: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise&#160;Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Outstanding at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,063,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">329.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(71,808)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">155.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(720)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">337.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Outstanding at October&#160;31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,077,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">277.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.36</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,510,367&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and expected to vest at October 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,059,841&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">276.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.32</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53,475,275&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and exercisable at October&#160;31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">729,591&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">248.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.38</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50,797,891&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of non-vested RSUs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The status of our non-vested RSUs is summarized below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant&#160;Date&#160;Fair<br/>Value&#160;Per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-vested RSUs at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">289,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">340.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">145,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">335.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(107,403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">320.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(37,461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">344.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-vested RSUs at October&#160;31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">290,029&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">345.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865597520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock', window );">Changes in benefit obligation, changes in plan assets and funded status</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth the Plan's benefit obligations and fair value of the Plan assets at October&#160;31, 2023, 2022 and 2021 and the funded status of the Plan and net periodic pension costs for each of the years in the three-year periods ended October&#160;31, 2023. The net amounts recognized in the Consolidated Balance Sheets consist of noncurrent liabilities. The accumulated benefit obligation was $131.5 million, $134.9 million and $207.6 million for the years ended October&#160;31, 2023, 2022 and 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Retirement Income Plan</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change in benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">148.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">230.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1022"><span style="-sec-ix-hidden:f-1023"><span style="-sec-ix-hidden:f-1024">Interest cost</span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(93.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">144.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">148.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">230.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">142.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">199.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">142.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">199.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Funded status at end of year</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(31.4)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock', window );">Amounts recognized in accumulated other comprehensive Income</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amounts recognized in accumulated other comprehensive income consist of:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock', window );">Reconciliation of prepaid (accrued) pension cost</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reconciliation of (prepaid) accrued pension cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Prepaid)/Accrued pension cost at prior fiscal year end</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Contributions made during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Prepaid)/Accrued pension cost at fiscal year end</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Components of net periodic pension costs and other amounts recognized in other comprehensive income</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1082"><span style="-sec-ix-hidden:f-1083"><span style="-sec-ix-hidden:f-1084">Expected return on plan assets</span></span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1088"><span style="-sec-ix-hidden:f-1089"><span style="-sec-ix-hidden:f-1090">Recognized actuarial loss</span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Other changes in plan assets and benefit obligations recognized in other comprehensive income</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Other changes in plan assets and benefit obligations recognized in other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net (gain) loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortizations of net gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in other comprehensive (income) loss</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(36.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and other comprehensive (income) loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Weighted-average assumptions used in computing net periodic pension cost and projected benefit obligation</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate for determining net periodic pension cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Projected Benefit Obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service Cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest Cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate for determining benefit obligations at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rate of compensation increase for determining expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rate of compensation increase for determining benefit obligations at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected rate of return on plan assets for determining net periodic pension cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected rate of return on plan assets at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Measurement date for determining assets and benefit obligations at year end</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2021</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Weighted-average asset allocations and fair value measurement of plan assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Assets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Weighted-average asset allocations at year end, by asset category are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Asset category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Corporate common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity mutual funds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balanced funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Alternative investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Bond mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of the measurement date of October&#160;31, 2023, the fair value measurement of plan assets is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.541%"><tr><td style="width:1.0%"></td><td style="width:47.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.499%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets for<br/>Identical&#160;Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Significant<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Asset category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Corporate common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balanced Funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Alternative investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">39.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">113.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Estimated future benefit payments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Estimated Future Benefit Payments</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.451%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2025</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2027</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2028</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2029-2033</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">65.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Reconciliation Of Prepaid (Accrued) Pension Cost [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (a)(b)(c)<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (d)(5)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (f)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (h)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income or loss that have not yet been recognized as components of net periodic benefit cost, such as the net gain (loss), net prior service cost or credit, and net transition asset or obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (j)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869718080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Schedule of business segment net sales</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table presents a summary of our business segment net sales:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision net sales by category:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Toric lens</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">828.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">737.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">697.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Multifocal lens</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">305.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Single-use sphere lens</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">705.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">661.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">616.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non single-use sphere, other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">583.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">579.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">599.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total CooperVision net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,423.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,243.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical net sales by category:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Office and surgical </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">689.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">633.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">451.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fertility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">480.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">431.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">319.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total CooperSurgical net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,169.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,065.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">770.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,593.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of business segment information</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information by business segment for each of the years in the three-year period ended October&#160;31, 2023 follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.120%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperVision</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperSurgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,423.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,169.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,593.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">587.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(70.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">533.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">412.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,044.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,351.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">263.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,658.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">156.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">181.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">186.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">364.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">392.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,243.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,065.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">494.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(53.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">507.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">475.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,778.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,407.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">305.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,492.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">144.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">166.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">179.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">223.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">242.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">770.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">481.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">71.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(47.3)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">505.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,965.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,395.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">244.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,606.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">148.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">110.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">190.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">214.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of information by geographical area by country of domicile</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information by geographical area by country of domicile for each of the years in the three-year period ended October&#160;31, 2023 follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Rest of<br/>World,&#160;Other<br/>Eliminations<br/>&amp; Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,812.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,041.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">739.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,593.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">563.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,016.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,579.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,375.3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,057.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(840.0)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,593.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">516.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">533.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,027.6&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">325.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">279.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,632.6&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,638.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">987.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">682.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">514.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">897.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,411.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,884.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(729.0)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">71.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">403.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">507.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">856.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">310.8&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">266.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,432.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,339.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">957.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">625.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">494.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">815.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,310.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,834.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,773.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(684.6)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">416.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">505.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">737.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">377.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">232.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,347.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865750016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Derivatives and Hedging (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivative instruments recognized in condensed consolidated statements of income</a></td>
<td class="text"><div style="margin-bottom:7pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table summarizes the amounts recognized with respect to our derivative instruments within the accompanying Consolidated Statements of Income:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.301%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Periods Ended October 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Location of (Gain)/Loss Recognized on Derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense (income)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in accumulated other comprehensive (loss) income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Analysis of Changes in Accumulated Other Comprehensive Income (Loss):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Minimum Pension Liability</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(402.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(56.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(472.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(320.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(341.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(234.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">107.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(90.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(555.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(466.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(538.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(453.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div>The following table details the changes in the cumulative pre-tax impact of the gain on derivatives designated for hedge accounting:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.658%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($79.7, net of tax)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">105.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($1.7, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">124.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($25.7, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($(32.7), net of tax)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">115.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862469984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>business_unit</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_NumberOfBusinessUnits', window );">Number of business units | business_unit</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized contract cost, amortization period (or less)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_NumberOfBusinessUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Business Units</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_NumberOfBusinessUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -SubTopic 40<br> -Topic 340<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656871762848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Inventory (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 207.3<span></span>
</td>
<td class="nump">$ 173.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">19.0<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">509.3<span></span>
</td>
<td class="nump">439.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">$ 735.6<span></span>
</td>
<td class="nump">$ 628.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862517040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Property Plant and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 3,182.1<span></span>
</td>
<td class="nump">$ 2,800.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="nump">1,553.3<span></span>
</td>
<td class="nump">1,387.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,628.8<span></span>
</td>
<td class="nump">1,413.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Finance lease ROU assets, net</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">19.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,632.6<span></span>
</td>
<td class="nump">1,432.9<span></span>
</td>
<td class="nump">$ 1,347.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember', window );">Land and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">20.2<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">488.5<span></span>
</td>
<td class="nump">415.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">2,187.1<span></span>
</td>
<td class="nump">1,973.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 486.3<span></span>
</td>
<td class="nump">$ 393.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862470912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Leases on the Consolidated Condensed Balance Sheet (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 241.5<span></span>
</td>
<td class="nump">$ 230.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">$ 38.2<span></span>
</td>
<td class="nump">$ 35.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">Other current liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">$ 215.6<span></span>
</td>
<td class="nump">$ 205.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other liabilities<span></span>
</td>
<td class="text">Other liabilities<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 253.8<span></span>
</td>
<td class="nump">$ 241.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">9 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Assets And Liabilities, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869866016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 48.1<span></span>
</td>
<td class="nump">$ 45.0<span></span>
</td>
<td class="nump">$ 44.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865634400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 46.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">41.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">37.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">32.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">26.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">123.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">308.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: interest</a></td>
<td class="nump">54.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 253.8<span></span>
</td>
<td class="nump">$ 241.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656861437648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Joint Venture (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2023 </div>
<div>USD ($) </div>
<div>installment</div>
</th>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 06, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 17, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 19, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,624,500,000<span></span>
</td>
<td class="nump">$ 3,609,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries', window );">Proceeds from sale of interest in a subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,100,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">52,100,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to form joint venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Equity method investment realized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Decrease in contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,800,000<span></span>
</td>
<td class="nump">10,300,000<span></span>
</td>
<td class="num">$ (66,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=coo_EssilorInternationalSASMember', window );">Essilor International SAS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to form joint venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=coo_SightGlassVisionIncMember', window );">SightGlass Vision, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember', window );">Privately-Held U.S.-Based Company, Technologically Advanced Contact Lens Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill, expected tax deductible amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember', window );">Privately-Held U.S.-Based Company, Technologically Advanced Contact Lens Products | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember', window );">Privately-Held U.S.-Based Company, Technologically Advanced Contact Lens Products | Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember', window );">Cook Medicals Reproductive Health Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 875,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">675,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Payables incurred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AccruedAcquisitionTerminationFee', window );">Acquisition termination fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember', window );">Cook Medicals Reproductive Health Business | Payables First Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Payables incurred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember', window );">Cook Medicals Reproductive Health Business | Payables Second Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Payables incurred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember', window );">Cook Medicals Reproductive Health Business | Payables Third Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Payables incurred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember', window );">Cook Medicals Reproductive Health Business | Payables Fourth Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Payables incurred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember', window );">Generate Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,663,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember', window );">Generate Life Sciences | Line of Credit | Term Loan Facility 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember', window );">Privately-Held Medical Device Company, Spectacle Lenses, Portion Attributable To Former Equity Interest Owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow', window );">Undiscounted range of the contingent consideration, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Undiscounted range of the contingent consideration, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 139,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationPaymentToSettleContingentConsideration', window );">Payment to settle former equity interest owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss', window );">Equity investment gain realized before acquisition of remaining equity interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Decrease in contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalMember', window );">Cook Medical | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate consideration</a></td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Payables incurred in acquisition</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments', window );">Number of installments | installment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalMember', window );">Cook Medical | Payables First Installment | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Payables incurred in acquisition</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalMember', window );">Cook Medical | Payables Second Installment | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Payables incurred in acquisition</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AccruedAcquisitionTerminationFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Acquisition Termination Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AccruedAcquisitionTerminationFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Assets Acquired And Liabilities Assumed, Tangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Liabilities Incurred, Number of Installments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationPaymentToSettleContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Payment to Settle Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationPaymentToSettleContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of net gain (loss) recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or the sale of investment in consolidated subsidiaries (generally greater than 50 percent).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=coo_EssilorInternationalSASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=coo_EssilorInternationalSASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=coo_SightGlassVisionIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=coo_SightGlassVisionIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesFirstInstallmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesFirstInstallmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesSecondInstallmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesSecondInstallmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesThirdInstallmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesThirdInstallmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesFourthInstallmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesFourthInstallmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=coo_CookMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865266800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($) </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of definite-lived intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of indefinite-lived intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperSurgicalSegmentMember', window );">CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="nump">237,600,000<span></span>
</td>
<td class="nump">214,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperVisionSegmentMember', window );">CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="nump">$ 20,100,000<span></span>
</td>
<td class="nump">$ 22,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperSurgicalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CooperSurgicalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperVisionSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CooperVisionSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656861426192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning</a></td>
<td class="nump">$ 3,609.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Net changes</a></td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustment</a></td>
<td class="nump">10.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, ending</a></td>
<td class="nump">3,624.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperVisionSegmentMember', window );">CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning</a></td>
<td class="nump">1,710.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Net changes</a></td>
<td class="nump">7.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustment</a></td>
<td class="nump">29.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, ending</a></td>
<td class="nump">1,747.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperSurgicalSegmentMember', window );">CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning</a></td>
<td class="nump">1,899.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Net changes</a></td>
<td class="num">(3.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustment</a></td>
<td class="num">(18.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, ending</a></td>
<td class="nump">$ 1,876.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperVisionSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CooperVisionSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperSurgicalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CooperSurgicalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865508288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Other Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 2,916.1<span></span>
</td>
<td class="nump">$ 2,919.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,215.1<span></span>
</td>
<td class="nump">1,044.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets with definite lives, net</a></td>
<td class="nump">1,701.0<span></span>
</td>
<td class="nump">1,874.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Intangible assets with indefinite lives, net</a></td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total other intangibles, net</a></td>
<td class="nump">$ 1,710.3<span></span>
</td>
<td class="nump">1,885.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average Amortization Period (in years)</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 208.9<span></span>
</td>
<td class="nump">209.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 81.1<span></span>
</td>
<td class="nump">62.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average Amortization Period (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=coo_CompositeMember', window );">Composite intangible asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,061.9<span></span>
</td>
<td class="nump">1,061.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 424.8<span></span>
</td>
<td class="nump">354.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average Amortization Period (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 494.5<span></span>
</td>
<td class="nump">504.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 335.4<span></span>
</td>
<td class="nump">317.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average Amortization Period (in years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,099.2<span></span>
</td>
<td class="nump">1,092.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 345.8<span></span>
</td>
<td class="nump">287.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average Amortization Period (in years)</a></td>
<td class="text">19 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=coo_LicenseAndDistributionRightsAndOtherMember', window );">License and distribution rights and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 51.6<span></span>
</td>
<td class="nump">50.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 28.0<span></span>
</td>
<td class="nump">$ 23.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average Amortization Period (in years)</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=coo_CompositeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=coo_CompositeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=coo_LicenseAndDistributionRightsAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=coo_LicenseAndDistributionRightsAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656860068784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Estimated Amortization Expenses for Intangible Assets with Definite Lives (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 179.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">169.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">162.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">147.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">143.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">899.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets with definite lives, net</a></td>
<td class="nump">$ 1,701.0<span></span>
</td>
<td class="nump">$ 1,874.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865521088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financing Arrangements - Total Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowingsAbstract', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">$ 44.4<span></span>
</td>
<td class="nump">$ 395.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Financing lease liabilities</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 16.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Short-term debt<span></span>
</td>
<td class="text">Short-term debt<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term debt</a></td>
<td class="nump">$ 45.4<span></span>
</td>
<td class="nump">$ 412.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Less: unamortized debt issuance cost</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, excluding financing leases</a></td>
<td class="nump">2,520.4<span></span>
</td>
<td class="nump">2,347.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing lease liabilities</a></td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Long-term debt<span></span>
</td>
<td class="text">Long-term debt<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">$ 2,523.8<span></span>
</td>
<td class="nump">$ 2,350.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total debt</a></td>
<td class="nump">2,569.2<span></span>
</td>
<td class="nump">2,763.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">2,350.0<span></span>
</td>
<td class="nump">2,350.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=coo_OtherDebtMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">172.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=coo_OverdraftAndOtherCreditFacilitiesMember', window );">Overdraft and other credit facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowingsAbstract', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">44.4<span></span>
</td>
<td class="nump">57.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=coo_TermLoansMember', window );">Term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowingsAbstract', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 338.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=coo_OtherDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=coo_OtherDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=coo_OverdraftAndOtherCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=coo_OverdraftAndOtherCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=coo_TermLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=coo_TermLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656858456240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financing Arrangements - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 17, 2021</div></th>
<th class="th"><div>Nov. 02, 2021</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_TermLoanAgreement2021364DayMember', window );">Term Loan Agreement 2021, 364 Day | Term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">364 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 840,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Term Loan Facility 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate principal amount</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit', window );">Potential additional borrowing capacity</a></td>
<td class="nump">$ 1,125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Term Loan Facility 2021 | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Term Loan Facility 2021 | Fed Funds Effective Rate Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Term Loan Facility, 2021 Base Rate Loans | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Term Loan Facility 2021, Adjusted LIBOR Rate Loans | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Credit Agreement 2020 | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,290,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 172,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 445,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Credit Agreement 2020 | Line of Credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Credit Agreement 2020 | Line of Credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | European Credit Facilities | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,900,000<span></span>
</td>
<td class="nump">$ 30,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Asian Pacific Credit Facilities - Yen-Denominated | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,300,000<span></span>
</td>
<td class="nump">$ 73,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=coo_TermLoanFacility2020Member', window );">Term Loan Facility 2020 | Credit Agreement 2020 | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=coo_RevolvingCreditFacilityAndTermLoanFacility2020Member', window );">Revolving Credit Facility And Term Loan Facility 2020 | Credit Agreement 2020 | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit', window );">Potential additional borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,605,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=coo_RevolvingCreditFacilityAndTermLoanFacility2020Member', window );">Revolving Credit Facility And Term Loan Facility 2020 | Credit Agreement 2020 | Secured Overnight Financing Rate (SOFR) | Line of Credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=coo_RevolvingCreditFacilityAndTermLoanFacility2020Member', window );">Revolving Credit Facility And Term Loan Facility 2020 | Credit Agreement 2020 | Secured Overnight Financing Rate (SOFR) | Line of Credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=coo_RevolvingCreditFacilityAndTermLoanFacility2020Member', window );">Revolving Credit Facility And Term Loan Facility 2020 | Credit Agreement 2020 | Base Rate | Line of Credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=coo_RevolvingCreditFacilityAndTermLoanFacility2020Member', window );">Revolving Credit Facility And Term Loan Facility 2020 | Credit Agreement 2020 | Base Rate | Line of Credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term And Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Accordion Feature, Increase Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Long Term And Short Term Debt Instruments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481573/470-10-45-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481573/470-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_TermLoanAgreement2021364DayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_TermLoanAgreement2021364DayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=coo_TermLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=coo_TermLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=coo_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=coo_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021BaseRateLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021BaseRateLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021AdjustedLIBORRateLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021AdjustedLIBORRateLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_CreditAgreement2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_CreditAgreement2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_EuropeanCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_EuropeanCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_AsianPacificCreditFacilitiesYenDenominatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_AsianPacificCreditFacilitiesYenDenominatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=coo_TermLoanFacility2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=coo_TermLoanFacility2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=coo_RevolvingCreditFacilityAndTermLoanFacility2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=coo_RevolvingCreditFacilityAndTermLoanFacility2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656861413104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory', window );">Deferred tax asset, intra-entity sale of certain intellectual property rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,987.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Remeasurement of deferred tax assets from UK rate change</a></td>
<td class="num">$ (536.7)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (536.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact the effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">323.2<span></span>
</td>
<td class="nump">324.3<span></span>
</td>
<td class="nump">336.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued gross interest and penalties related to uncertain tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.8<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
<td class="nump">$ 6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Significant change in unrecognized tax benefits that is reasonably possible during the next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Federal net operating losses expiring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Federal net operating losses not subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from intra-entity transfer of asset within consolidated group. Excludes intra-entity transfer of inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656871803744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Before Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Income before income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="num">$ (135.7)<span></span>
</td>
<td class="nump">$ 31.4<span></span>
</td>
<td class="num">$ (31.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">548.6<span></span>
</td>
<td class="nump">443.9<span></span>
</td>
<td class="nump">522.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">$ 412.9<span></span>
</td>
<td class="nump">$ 475.3<span></span>
</td>
<td class="nump">$ 491.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865736576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Provision (Benefit) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 37.3<span></span>
</td>
<td class="nump">$ 10.2<span></span>
</td>
<td class="nump">$ 21.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">33.0<span></span>
</td>
<td class="nump">21.7<span></span>
</td>
<td class="nump">26.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax expense (benefit)</a></td>
<td class="nump">74.0<span></span>
</td>
<td class="nump">35.7<span></span>
</td>
<td class="nump">49.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(36.7)<span></span>
</td>
<td class="nump">10.5<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(7.5)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">88.9<span></span>
</td>
<td class="nump">45.6<span></span>
</td>
<td class="num">(2,492.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax expense (benefit)</a></td>
<td class="nump">44.7<span></span>
</td>
<td class="nump">53.9<span></span>
</td>
<td class="num">(2,502.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 118.7<span></span>
</td>
<td class="nump">$ 89.5<span></span>
</td>
<td class="num">$ (2,453.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656858394896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation between the Expected Provision for Income taxes at the US Federal Statutory Rate and the Provision for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Provision for income taxes at United States statutory tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86.7<span></span>
</td>
<td class="nump">$ 99.8<span></span>
</td>
<td class="nump">$ 103.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign earnings in jurisdictions with different tax rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="num">(22.3)<span></span>
</td>
<td class="num">(43.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings', window );">Foreign earnings subject to United States tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.3<span></span>
</td>
<td class="nump">21.1<span></span>
</td>
<td class="nump">25.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Excess tax benefits from share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDispositionOfAssets', window );">Intra-group transfer to UK subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1,987.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Remeasurement of deferred tax assets from UK rate change</a></td>
<td class="num">$ (536.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(536.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount', window );">Change in unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(12.7)<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.2)<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118.7<span></span>
</td>
<td class="nump">$ 89.5<span></span>
</td>
<td class="num">$ (2,453.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change In Unrecognized Tax Benefits, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to disposition of asset. Includes, but is not limited to, intra-entity transfer of asset other than inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862552240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Accounts receivable</a></td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventories</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities, reserves and compensation accruals</a></td>
<td class="nump">94.8<span></span>
</td>
<td class="nump">79.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign', window );">Foreign deferred tax assets</a></td>
<td class="nump">2,369.5<span></span>
</td>
<td class="nump">2,500.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">14.8<span></span>
</td>
<td class="nump">14.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards', window );">Net operating loss and tax credit carryforwards</a></td>
<td class="nump">24.3<span></span>
</td>
<td class="nump">19.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Capitalized research and experimental expenses</a></td>
<td class="nump">23.6<span></span>
</td>
<td class="nump">15.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">2,548.8<span></span>
</td>
<td class="nump">2,641.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(20.7)<span></span>
</td>
<td class="num">(60.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">2,528.1<span></span>
</td>
<td class="nump">2,581.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Tax deductible goodwill</a></td>
<td class="num">(47.4)<span></span>
</td>
<td class="num">(39.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(132.4)<span></span>
</td>
<td class="num">(153.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Plant and equipment</a></td>
<td class="num">(51.2)<span></span>
</td>
<td class="num">(48.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign', window );">Foreign deferred tax liabilities</a></td>
<td class="num">(49.0)<span></span>
</td>
<td class="num">(45.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total gross deferred tax liabilities</a></td>
<td class="num">(280.0)<span></span>
</td>
<td class="num">(287.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 2,248.1<span></span>
</td>
<td class="nump">$ 2,293.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Purchase Accounting Adjustments, Foreign</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479692/805-740-25-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479692/805-740-25-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656870915376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Changes in Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning of the period</a></td>
<td class="nump">$ 336.9<span></span>
</td>
<td class="nump">$ 353.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease based on tax positions in prior fiscal years</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(12.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Lapses of statutes of limitations</a></td>
<td class="num">(6.9)<span></span>
</td>
<td class="num">(4.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase based on tax positions in current fiscal year</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">End of the period</a></td>
<td class="nump">$ 331.5<span></span>
</td>
<td class="nump">$ 336.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862858864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Basic and Diluted (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 294.2<span></span>
</td>
<td class="nump">$ 385.8<span></span>
</td>
<td class="nump">$ 2,944.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares (in shares)</a></td>
<td class="nump">49.5<span></span>
</td>
<td class="nump">49.3<span></span>
</td>
<td class="nump">49.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (in dollars per share)</a></td>
<td class="nump">$ 5.94<span></span>
</td>
<td class="nump">$ 7.83<span></span>
</td>
<td class="nump">$ 59.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive stock options (in shares)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares (in shares)</a></td>
<td class="nump">49.8<span></span>
</td>
<td class="nump">49.7<span></span>
</td>
<td class="nump">49.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (in dollars per share)</a></td>
<td class="nump">$ 5.91<span></span>
</td>
<td class="nump">$ 7.76<span></span>
</td>
<td class="nump">$ 59.16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862857696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Stock Options to Purchase Common Stock and Restricted Stock Units Not Included in Diluted Earnings Per Share Due to Antidilutive Effect (Details) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices, lower limit (in dollars per share)</a></td>
<td class="nump">$ 300.12<span></span>
</td>
<td class="nump">$ 300.12<span></span>
</td>
<td class="nump">$ 345.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices, higher limit (in dollars per share)</a></td>
<td class="nump">$ 406.17<span></span>
</td>
<td class="nump">$ 406.17<span></span>
</td>
<td class="nump">$ 345.74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock option shares and restricted stock units excluded (in shares)</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock option shares and restricted stock units excluded (in shares)</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656861387568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Changes in Accumulated Other Comprehensive Income (Loss) Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 7,174.7<span></span>
</td>
<td class="nump">$ 6,942.0<span></span>
</td>
<td class="nump">$ 3,824.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Gross change in value</a></td>
<td class="nump">11.6<span></span>
</td>
<td class="num">(90.7)<span></span>
</td>
<td class="nump">146.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax effect</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="num">(34.8)<span></span>
</td>
<td class="num">(15.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">7,551.0<span></span>
</td>
<td class="nump">7,174.7<span></span>
</td>
<td class="nump">6,942.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(466.8)<span></span>
</td>
<td class="num">(341.3)<span></span>
</td>
<td class="num">(472.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(453.8)<span></span>
</td>
<td class="num">(466.8)<span></span>
</td>
<td class="num">(341.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(555.0)<span></span>
</td>
<td class="num">(320.3)<span></span>
</td>
<td class="num">(402.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Gross change in value</a></td>
<td class="nump">17.0<span></span>
</td>
<td class="num">(234.7)<span></span>
</td>
<td class="nump">82.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax effect</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(538.0)<span></span>
</td>
<td class="num">(555.0)<span></span>
</td>
<td class="num">(320.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">94.4<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Gross change in value</a></td>
<td class="num">(9.4)<span></span>
</td>
<td class="nump">107.4<span></span>
</td>
<td class="nump">34.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax effect</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="num">(26.1)<span></span>
</td>
<td class="num">(8.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">87.4<span></span>
</td>
<td class="nump">94.4<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Minimum Pension Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(6.2)<span></span>
</td>
<td class="num">(34.1)<span></span>
</td>
<td class="num">(56.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Gross change in value</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">36.6<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax effect</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(8.7)<span></span>
</td>
<td class="num">(7.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (3.2)<span></span>
</td>
<td class="num">$ (6.2)<span></span>
</td>
<td class="num">$ (34.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656861540576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 07, 2023</div></th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2011 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase program, maximum amount authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Share repurchase program, remaining authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 256.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 256.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Stock repurchase (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">191,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78.5<span></span>
</td>
<td class="nump">$ 24.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average repurchase price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared on common stock (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends on common stock (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends on common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock split, conversion ratio</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656861186032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>director </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 18, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2016 </div>
<div>director </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Total unrecognized compensation cost related to nonvested options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62.1<span></span>
</td>
<td class="nump">$ 54.2<span></span>
</td>
<td class="nump">$ 44.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Total unrecognized compensation cost expected to be recognized over a remaining weighted-average vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Total unrecognized compensation cost expected to be recognized over a remaining weighted-average vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Total unrecognized compensation cost related to nonvested units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of vested grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.3<span></span>
</td>
<td class="nump">46.1<span></span>
</td>
<td class="nump">50.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Total unrecognized compensation cost expected to be recognized over a remaining weighted-average vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Total unrecognized compensation cost related to nonvested units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned', window );">Target percentage of shares earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned', window );">Target percentage of shares earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember', window );">Third Amended and Restated 2007 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee', window );">Number of non-employee directors in committee | director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized to be granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,930,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_A2023LongTermIncentivePlanMember', window );">2023 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee', window );">Number of non-employee directors in committee | director</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized to be granted | shares</a></td>
<td class="nump">1,365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares remaining for future grant (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,376,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember', window );">Third Amended And Restated 2007 Long-Term Incentive Plan And 2023 Long-Term Incentive Plan | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.4<span></span>
</td>
<td class="nump">$ 6.6<span></span>
</td>
<td class="nump">$ 64.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value of each option granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103.17<span></span>
</td>
<td class="nump">$ 90.41<span></span>
</td>
<td class="nump">$ 84.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration date (no more than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember', window );">Third Amended And Restated 2007 Long-Term Incentive Plan And 2023 Long-Term Incentive Plan | Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember', window );">Third Amended And Restated 2007 Long-Term Incentive Plan And 2023 Long-Term Incentive Plan | Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember', window );">Third Amended And Restated 2007 Long-Term Incentive Plan And 2023 Long-Term Incentive Plan | Restricted Stock Units (RSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember', window );">Third Amended And Restated 2007 Long-Term Incentive Plan And 2023 Long-Term Incentive Plan | Restricted Stock Units (RSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan | Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized to be granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Exercise price percentage of fair market value on date of grant of awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of shares issued to employees | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,116<span></span>
</td>
<td class="nump">22,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares remaining available for future issuance | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">921,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Target Percentage Of Shares Earned</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Terms Of Award, Grants In Period, Number Of Non Employee Directors In Committee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=coo_A2023LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=coo_A2023LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=coo_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=coo_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862530752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans - Compensation Expense and Related Income Tax Benefit for Share-Based Awards (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total compensation expense</a></td>
<td class="nump">$ 62.1<span></span>
</td>
<td class="nump">$ 54.2<span></span>
</td>
<td class="nump">$ 44.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Related income tax benefit</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total compensation expense</a></td>
<td class="nump">54.8<span></span>
</td>
<td class="nump">46.7<span></span>
</td>
<td class="nump">38.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total compensation expense</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total compensation expense</a></td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656871628448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans - Assumptions Used in Estimating Fair Value of Stock Options Award Granted (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">29.50%<span></span>
</td>
<td class="nump">25.80%<span></span>
</td>
<td class="nump">30.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.02%<span></span>
</td>
<td class="nump">0.02%<span></span>
</td>
<td class="nump">0.02%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656861150176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans - Stock Option Plans (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at end of period (in shares) | shares</a></td>
<td class="nump">1,059,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Vested and exercisable at end of period (in shares) | shares</a></td>
<td class="nump">729,591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise&#160;Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 276.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Vested and exercisable at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 248.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest at end of period, Weighted-Average Remaining Contractual Term (in years)</a></td>
<td class="text">5 years 3 months 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Vested and exercisable at end of period, Weighted-Average Remaining Contractual Term (in years)</a></td>
<td class="text">4 years 4 months 17 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest at end of period, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 53,475,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Vested and exercisable at end of period, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 50,797,891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance (in shares) | shares</a></td>
<td class="nump">1,063,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">86,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(71,808)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited or expired (in shares) | shares</a></td>
<td class="num">(720)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance (in shares) | shares</a></td>
<td class="nump">1,077,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise&#160;Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 264.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">329.83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">155.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited or expired (in dollars per share) | $ / shares</a></td>
<td class="nump">337.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 277.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, ending balance, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">5 years 4 months 9 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, ending balance, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 53,510,367<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862546816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans - Non-Vested RSUs (Details) - Restricted Stock Units (RSUs)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number&#160;of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested RSUs, beginning balance (in shares) | shares</a></td>
<td class="nump">289,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">145,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested and issued (in shares) | shares</a></td>
<td class="num">(107,403)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited or expired (in shares) | shares</a></td>
<td class="num">(37,461)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested RSUs, ending balance (in shares) | shares</a></td>
<td class="nump">290,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted- Average Grant&#160;Date&#160;Fair Value&#160;Per&#160;Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested RSUs, beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 340.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">335.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested and issued (in dollars per share) | $ / shares</a></td>
<td class="nump">320.22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited or exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">344.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested RSUs, ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 345.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656860912432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">$ 131.5<span></span>
</td>
<td class="nump">$ 134.9<span></span>
</td>
<td class="nump">$ 207.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation', window );">Discount rate</a></td>
<td class="nump">5.74%<span></span>
</td>
<td class="nump">2.76%<span></span>
</td>
<td class="nump">2.78%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined benefit obligation, actuarial gain (loss)</a></td>
<td class="nump">$ 10.9<span></span>
</td>
<td class="nump">$ 93.2<span></span>
</td>
<td class="num">$ (2.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage', window );">Expected long-term return on diversified portfolio</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">12.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Expected future employer contributions</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Maximum annual contributions per employee in 401k savings plan</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer', window );">Contributions by employer in 401k savings plan</a></td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Diversified portfolio, allocation of assets in equities</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Diversified portfolio, allocation of assets in equities</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember', window );">Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined benefit obligation, actuarial gain (loss)</a></td>
<td class="nump">$ 12.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember', window );">Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined benefit obligation, actuarial gain (loss)</a></td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember', window );">Change In Assumptions For Defined Benefit Plans, Change In Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined benefit obligation, actuarial gain (loss)</a></td>
<td class="nump">7.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember', window );">Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined benefit obligation, actuarial gain (loss)</a></td>
<td class="nump">$ 5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Target Allocation, Expected Long Term Return, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions made by employer into fund established for purposes of making future disbursement to individual in accordance with deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862753232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Changes in Benefit Obligation, Changes in Plan Assets and Funded Status (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation, beginning of year</a></td>
<td class="nump">$ 148.0<span></span>
</td>
<td class="nump">$ 230.9<span></span>
</td>
<td class="nump">$ 218.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="nump">18.3<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">7.9<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(10.5)<span></span>
</td>
<td class="num">(13.1)<span></span>
</td>
<td class="num">(11.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain)/loss</a></td>
<td class="num">(10.9)<span></span>
</td>
<td class="num">(93.2)<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation, end of year</a></td>
<td class="nump">$ 144.5<span></span>
</td>
<td class="nump">$ 148.0<span></span>
</td>
<td class="nump">$ 230.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Other liabilities<span></span>
</td>
<td class="text">Other liabilities<span></span>
</td>
<td class="text">Other liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, beginning of year</a></td>
<td class="nump">$ 142.9<span></span>
</td>
<td class="nump">$ 199.5<span></span>
</td>
<td class="nump">$ 159.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="num">(43.5)<span></span>
</td>
<td class="nump">38.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">12.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(10.5)<span></span>
</td>
<td class="num">(13.1)<span></span>
</td>
<td class="num">(11.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, end of year</a></td>
<td class="nump">137.6<span></span>
</td>
<td class="nump">142.9<span></span>
</td>
<td class="nump">199.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">$ (6.9)<span></span>
</td>
<td class="num">$ (5.1)<span></span>
</td>
<td class="num">$ (31.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes interest cost component of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656867833376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract', window );"><strong>Amounts recognized in accumulated other comprehensive income consist of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net loss</a></td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 44.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 44.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656859787136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Reconciliation of Prepaid (Accrued) Pension Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AccruedPensionCostRollForward', window );"><strong>Reconciliation of (prepaid) accrued pension cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AccruedPrepaidPensionCosts', window );">(Prepaid)/Accrued pension cost at prior fiscal year end</a></td>
<td class="num">$ (2.9)<span></span>
</td>
<td class="num">$ (13.0)<span></span>
</td>
<td class="num">$ (14.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">14.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Contributions made during the year</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(12.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AccruedPrepaidPensionCosts', window );">(Prepaid)/Accrued pension cost at fiscal year end</a></td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="num">$ (2.9)<span></span>
</td>
<td class="num">$ (13.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AccruedPensionCostRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Pension Cost [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AccruedPensionCostRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AccruedPrepaidPensionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued (Prepaid) Pension Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AccruedPrepaidPensionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865709088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Components of Net Periodic Pension Costs and Other Amounts Recognized in Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="nump">$ 18.3<span></span>
</td>
<td class="nump">$ 17.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="nump">$ 5.1<span></span>
</td>
<td class="nump">$ 4.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">$ (11.1)<span></span>
</td>
<td class="num">$ (15.5)<span></span>
</td>
<td class="num">$ (12.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Immediate Recognition of Actuarial Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Recognized actuarial loss</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension cost</a></td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="nump">$ 14.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss), recognized immediately as component of net periodic benefit (cost) credit, for change in value of benefit obligation or plan assets from experience different from that assumed, change in actuarial assumption, or consequence of temporarily deviating from substantive plan. Includes, but is not limited to, amount in excess of 10 percent of greater of fair value of plan assets or benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes expected return (loss) on plan asset component of net periodic benefit (cost) credit for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes actuarial gain (loss) recognized immediately as component of net periodic benefit (cost) credit for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865815216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract', window );"><strong>Other changes in plan assets and benefit obligations recognized in other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax', window );">Net (gain) loss</a></td>
<td class="num">$ (4.0)<span></span>
</td>
<td class="num">$ (34.1)<span></span>
</td>
<td class="num">$ (24.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax', window );">Amortizations of net gain</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total recognized in other comprehensive (income) loss</a></td>
<td class="num">(4.0)<span></span>
</td>
<td class="num">(36.6)<span></span>
</td>
<td class="num">(29.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax', window );">Total recognized in net periodic benefit cost and other comprehensive (income) loss</a></td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="num">$ (26.2)<span></span>
</td>
<td class="num">$ (15.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized in net periodic benefit cost (credit) and other comprehensive (income) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net period benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865751936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Weighted-Average Assumptions Used in Computing Net Periodic Pension Cost and Projected Benefit Obligation (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Discount rate for determining net periodic pension cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation', window );">Projected Benefit Obligation</a></td>
<td class="nump">5.74%<span></span>
</td>
<td class="nump">2.76%<span></span>
</td>
<td class="nump">2.78%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost', window );">Service Cost</a></td>
<td class="nump">5.77%<span></span>
</td>
<td class="nump">2.79%<span></span>
</td>
<td class="nump">2.86%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost', window );">Interest Cost</a></td>
<td class="nump">5.51%<span></span>
</td>
<td class="nump">2.28%<span></span>
</td>
<td class="nump">2.07%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate for determining benefit obligations at year end</a></td>
<td class="nump">6.22%<span></span>
</td>
<td class="nump">5.74%<span></span>
</td>
<td class="nump">2.76%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase for determining expense</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase for determining benefit obligations at year end</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets for determining net periodic pension cost</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd', window );">Expected rate of return on plan assets at year end</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate Of Return On Plan Assets At Year End</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862421264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Weighted-Average Asset Allocations by Asset Category (Details)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Asset allocation</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Asset allocation</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember', window );">Corporate common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Asset allocation</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">33.60%<span></span>
</td>
<td class="nump">31.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember', window );">Equity mutual funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Asset allocation</a></td>
<td class="nump">39.10%<span></span>
</td>
<td class="nump">33.90%<span></span>
</td>
<td class="nump">32.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_BalancedFundsMember', window );">Balanced funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Asset allocation</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_AlternativeInvestmentsMember', window );">Alternative investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Asset allocation</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_BondMutualFundsMember', window );">Bond mutual funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Asset allocation</a></td>
<td class="nump">28.90%<span></span>
</td>
<td class="nump">27.80%<span></span>
</td>
<td class="nump">28.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_BalancedFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_BalancedFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_AlternativeInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_AlternativeInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_BondMutualFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_BondMutualFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656860827152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Fair Value Measurement of Plan Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 137.6<span></span>
</td>
<td class="nump">$ 142.9<span></span>
</td>
<td class="nump">$ 199.5<span></span>
</td>
<td class="nump">$ 159.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">113.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">24.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | Significant Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember', window );">Corporate common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">35.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember', window );">Corporate common stock | Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">35.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember', window );">Corporate common stock | Significant Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember', window );">Corporate common stock | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember', window );">Equity mutual funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">53.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember', window );">Equity mutual funds | Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">53.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember', window );">Equity mutual funds | Significant Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember', window );">Equity mutual funds | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_BalancedFundsMember', window );">Balanced funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_BalancedFundsMember', window );">Balanced funds | Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_BalancedFundsMember', window );">Balanced funds | Significant Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_BalancedFundsMember', window );">Balanced funds | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_AlternativeInvestmentsMember', window );">Alternative investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_AlternativeInvestmentsMember', window );">Alternative investments | Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_AlternativeInvestmentsMember', window );">Alternative investments | Significant Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_AlternativeInvestmentsMember', window );">Alternative investments | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeInvestmentsMember', window );">Fixed Income Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">39.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeInvestmentsMember', window );">Fixed Income Investments | Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">15.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeInvestmentsMember', window );">Fixed Income Investments | Significant Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">24.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeInvestmentsMember', window );">Fixed Income Investments | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_BalancedFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_BalancedFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_AlternativeInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_AlternativeInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656859956272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Estimated Future Benefit Payments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 10.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2025</a></td>
<td class="nump">11.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2026</a></td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2027</a></td>
<td class="nump">11.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2028</a></td>
<td class="nump">12.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2029-2033</a></td>
<td class="nump">$ 65.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869955952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2023 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862698080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information - Business Segment Net Sales (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,593.2<span></span>
</td>
<td class="nump">$ 3,308.4<span></span>
</td>
<td class="nump">$ 2,922.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperVisionSegmentMember', window );">CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,423.7<span></span>
</td>
<td class="nump">2,243.3<span></span>
</td>
<td class="nump">2,152.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperSurgicalSegmentMember', window );">CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,169.5<span></span>
</td>
<td class="nump">1,065.1<span></span>
</td>
<td class="nump">770.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=coo_ToricLensMember', window );">Toric lens | CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">828.7<span></span>
</td>
<td class="nump">737.4<span></span>
</td>
<td class="nump">697.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=coo_MultifocalLensMember', window );">Multifocal lens | CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">305.7<span></span>
</td>
<td class="nump">264.4<span></span>
</td>
<td class="nump">238.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=coo_SingleUseSphereLensMember', window );">Single-use sphere lens | CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">705.4<span></span>
</td>
<td class="nump">661.6<span></span>
</td>
<td class="nump">616.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=coo_NonSingleUseSphereAndOtherMember', window );">Non single-use sphere, other | CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">583.9<span></span>
</td>
<td class="nump">579.9<span></span>
</td>
<td class="nump">599.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=coo_OfficeAndSurgicalProductsMember', window );">Office and surgical | CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">689.5<span></span>
</td>
<td class="nump">633.6<span></span>
</td>
<td class="nump">451.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=coo_FertilityMember', window );">Fertility | CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 480.0<span></span>
</td>
<td class="nump">$ 431.5<span></span>
</td>
<td class="nump">$ 319.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperVisionSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CooperVisionSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperSurgicalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CooperSurgicalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=coo_ToricLensMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=coo_ToricLensMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=coo_MultifocalLensMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=coo_MultifocalLensMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=coo_SingleUseSphereLensMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=coo_SingleUseSphereLensMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=coo_NonSingleUseSphereAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=coo_NonSingleUseSphereAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=coo_OfficeAndSurgicalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=coo_OfficeAndSurgicalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=coo_FertilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=coo_FertilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656858298544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information - Business Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,593,200<span></span>
</td>
<td class="nump">$ 3,308,400<span></span>
</td>
<td class="nump">$ 2,922,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">533,100<span></span>
</td>
<td class="nump">507,600<span></span>
</td>
<td class="nump">505,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">105,300<span></span>
</td>
<td class="nump">57,300<span></span>
</td>
<td class="nump">23,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="nump">14,900<span></span>
</td>
<td class="num">(25,000)<span></span>
</td>
<td class="num">(8,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">412,900<span></span>
</td>
<td class="nump">475,300<span></span>
</td>
<td class="nump">491,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">11,658,900<span></span>
</td>
<td class="nump">11,492,300<span></span>
</td>
<td class="nump">9,606,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">181,500<span></span>
</td>
<td class="nump">166,600<span></span>
</td>
<td class="nump">163,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">186,200<span></span>
</td>
<td class="nump">179,500<span></span>
</td>
<td class="nump">146,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Capital expenditures</a></td>
<td class="nump">392,500<span></span>
</td>
<td class="nump">242,000<span></span>
</td>
<td class="nump">214,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperVisionSegmentMember', window );">CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,423,700<span></span>
</td>
<td class="nump">2,243,300<span></span>
</td>
<td class="nump">2,152,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperSurgicalSegmentMember', window );">CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,169,500<span></span>
</td>
<td class="nump">1,065,100<span></span>
</td>
<td class="nump">770,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,423,700<span></span>
</td>
<td class="nump">2,243,300<span></span>
</td>
<td class="nump">2,152,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">587,700<span></span>
</td>
<td class="nump">494,300<span></span>
</td>
<td class="nump">481,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">7,044,000<span></span>
</td>
<td class="nump">6,778,900<span></span>
</td>
<td class="nump">6,965,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">156,900<span></span>
</td>
<td class="nump">144,500<span></span>
</td>
<td class="nump">148,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">32,900<span></span>
</td>
<td class="nump">32,300<span></span>
</td>
<td class="nump">35,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Capital expenditures</a></td>
<td class="nump">364,400<span></span>
</td>
<td class="nump">223,000<span></span>
</td>
<td class="nump">190,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,169,500<span></span>
</td>
<td class="nump">1,065,100<span></span>
</td>
<td class="nump">770,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">16,100<span></span>
</td>
<td class="nump">67,100<span></span>
</td>
<td class="nump">71,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">4,351,800<span></span>
</td>
<td class="nump">4,407,800<span></span>
</td>
<td class="nump">2,395,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">24,600<span></span>
</td>
<td class="nump">22,100<span></span>
</td>
<td class="nump">14,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">153,300<span></span>
</td>
<td class="nump">147,200<span></span>
</td>
<td class="nump">110,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Capital expenditures</a></td>
<td class="nump">28,100<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="nump">24,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(70,700)<span></span>
</td>
<td class="num">(53,800)<span></span>
</td>
<td class="num">(47,300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">263,100<span></span>
</td>
<td class="nump">305,600<span></span>
</td>
<td class="nump">244,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Capital expenditures</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentExpenditureAdditionToLongLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperVisionSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CooperVisionSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CooperSurgicalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CooperSurgicalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656862837568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information - Information by Geographical Area by Country of Domicile (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,593.2<span></span>
</td>
<td class="nump">$ 3,308.4<span></span>
</td>
<td class="nump">$ 2,922.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">533.1<span></span>
</td>
<td class="nump">507.6<span></span>
</td>
<td class="nump">505.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Long-lived assets</a></td>
<td class="nump">1,632.6<span></span>
</td>
<td class="nump">1,432.9<span></span>
</td>
<td class="nump">1,347.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,812.2<span></span>
</td>
<td class="nump">1,638.5<span></span>
</td>
<td class="nump">1,339.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,041.2<span></span>
</td>
<td class="nump">987.2<span></span>
</td>
<td class="nump">957.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=coo_RestOfTheWorldMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">739.8<span></span>
</td>
<td class="nump">682.7<span></span>
</td>
<td class="nump">625.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_GeographyEliminationsMember', window );">Geography Eliminations | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(563.1)<span></span>
</td>
<td class="num">(514.4)<span></span>
</td>
<td class="num">(494.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_GeographyEliminationsMember', window );">Geography Eliminations | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(1,016.7)<span></span>
</td>
<td class="num">(897.3)<span></span>
</td>
<td class="num">(815.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_GeographyEliminationsMember', window );">Geography Eliminations | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(1,579.8)<span></span>
</td>
<td class="num">(1,411.7)<span></span>
</td>
<td class="num">(1,310.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_ReportableGeographicalComponentsMember', window );">Reportable Geographical Components | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,375.3<span></span>
</td>
<td class="nump">2,152.9<span></span>
</td>
<td class="nump">1,834.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">71.8<span></span>
</td>
<td class="num">(26.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Long-lived assets</a></td>
<td class="nump">1,027.6<span></span>
</td>
<td class="nump">856.1<span></span>
</td>
<td class="nump">737.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_ReportableGeographicalComponentsMember', window );">Reportable Geographical Components | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,057.9<span></span>
</td>
<td class="nump">1,884.5<span></span>
</td>
<td class="nump">1,773.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">516.2<span></span>
</td>
<td class="nump">403.8<span></span>
</td>
<td class="nump">416.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Long-lived assets</a></td>
<td class="nump">325.9<span></span>
</td>
<td class="nump">310.8<span></span>
</td>
<td class="nump">377.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=coo_CorporateReconcilingItemsAndEliminationsMember', window );">Eliminations, Corporate and Reconciling Items | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(840.0)<span></span>
</td>
<td class="num">(729.0)<span></span>
</td>
<td class="num">(684.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">16.9<span></span>
</td>
<td class="nump">32.0<span></span>
</td>
<td class="nump">116.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Long-lived assets</a></td>
<td class="nump">$ 279.1<span></span>
</td>
<td class="nump">$ 266.0<span></span>
</td>
<td class="nump">$ 232.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=coo_RestOfTheWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=coo_RestOfTheWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=srt_GeographyEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=srt_GeographyEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=srt_ReportableGeographicalComponentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=srt_ReportableGeographicalComponentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=coo_CorporateReconcilingItemsAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=coo_CorporateReconcilingItemsAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656871795840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Derivatives and Hedging - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($) </div>
<div>interest_rate_swap_contract</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Derivative loss expected to be realized in earnings over the next twelve months</a></td>
<td class="num">$ (48.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">56.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 1,300.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest rate swap contracts held | interest_rate_swap_contract</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative, term of contract (or less)</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480870/815-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656959143072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Derivatives and Hedging - Derivative Instruments Recognized in Condensed Consolidated Statements of Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Loss recognized on derivatives within interest expense</a></td>
<td class="num">$ (43.1)<span></span>
</td>
<td class="num">$ (2.3)<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656859928576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Derivatives and Hedging - Changes in Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward', window );"><strong>AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 7,174.7<span></span>
</td>
<td class="nump">$ 6,942.0<span></span>
</td>
<td class="nump">$ 3,824.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Amount recognized in other comprehensive income on interest rate swaps contracts, net of tax</a></td>
<td class="nump">25.7<span></span>
</td>
<td class="nump">79.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount reclassified from other comprehensive income into earnings, net of tax</a></td>
<td class="num">(32.7)<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">7,551.0<span></span>
</td>
<td class="nump">7,174.7<span></span>
</td>
<td class="nump">6,942.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember', window );">Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward', window );"><strong>AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">124.5<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">115.1<span></span>
</td>
<td class="nump">124.5<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward', window );"><strong>AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">94.4<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount recognized in other comprehensive income on interest rate swap contracts, gross</a></td>
<td class="nump">33.7<span></span>
</td>
<td class="nump">105.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Amount reclassified from other comprehensive income into earnings, gross</a></td>
<td class="num">(43.1)<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 87.4<span></span>
</td>
<td class="nump">$ 94.4<span></span>
</td>
<td class="nump">$ 13.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480627/815-20-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656865837040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II (Details) - SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance Beginning of Year</a></td>
<td class="nump">$ 60.1<span></span>
</td>
<td class="nump">$ 51.8<span></span>
</td>
<td class="nump">$ 45.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Reductions/ Charges</a></td>
<td class="num">(42.0)<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">$ 20.7<span></span>
</td>
<td class="nump">$ 60.1<span></span>
</td>
<td class="nump">$ 51.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C(1)))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C(2)))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140656869891776">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
<td class="text">Accounting Standards Update 2016-13 [Member]<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=coo_CommonStockExcludingTreasuryStockParNetValueMember', window );">Common Stock, Excluding Treasury Stock Par Net Value [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147477123/405-50-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 72: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=coo_CommonStockExcludingTreasuryStockParNetValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=coo_CommonStockExcludingTreasuryStockParNetValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>coo-20231031_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:coo="http://www.coopercos.com/20231031"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="coo-20231031.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2023-12-01</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-06</startDate>
            <endDate>2022-04-06</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesFourthInstallmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-06</startDate>
            <endDate>2022-04-06</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesThirdInstallmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-06</startDate>
            <endDate>2022-04-06</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesFirstInstallmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-06</startDate>
            <endDate>2022-04-06</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesSecondInstallmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-06</startDate>
            <endDate>2022-04-06</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-17</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-17</startDate>
            <endDate>2021-12-17</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-17</startDate>
            <endDate>2021-12-17</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-19</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">coo:SightGlassVisionIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">coo:EssilorInternationalSASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesFirstInstallmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesSecondInstallmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:CompositeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:CompositeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:LicenseAndDistributionRightsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:LicenseAndDistributionRightsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:OverdraftAndOtherCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:OverdraftAndOtherCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">coo:OtherDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">coo:OtherDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-17</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">coo:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-17</startDate>
            <endDate>2021-12-17</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021BaseRateLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">coo:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-17</startDate>
            <endDate>2021-12-17</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021AdjustedLIBORRateLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">coo:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-17</startDate>
            <endDate>2021-12-17</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanAgreement2021364DayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-02</startDate>
            <endDate>2021-11-02</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanAgreement2021364DayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-02</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:TermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:TermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">coo:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">coo:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:TermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:EuropeanCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:EuropeanCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:AsianPacificCreditFacilitiesYenDenominatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:AsianPacificCreditFacilitiesYenDenominatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-17</startDate>
            <endDate>2021-12-17</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2011-12-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-07</startDate>
            <endDate>2023-12-07</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-01</startDate>
            <endDate>2016-03-31</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:A2023LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:A2023LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:A2023LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-18</startDate>
            <endDate>2019-03-18</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-18</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:BalancedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:BalancedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:BalancedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:AlternativeInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:AlternativeInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:AlternativeInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:BalancedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:BalancedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:BalancedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:AlternativeInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:AlternativeInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:AlternativeInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:ToricLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:ToricLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:ToricLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:MultifocalLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:MultifocalLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:MultifocalLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:SingleUseSphereLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:SingleUseSphereLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:SingleUseSphereLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:NonSingleUseSphereAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:NonSingleUseSphereAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:NonSingleUseSphereAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:OfficeAndSurgicalProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:OfficeAndSurgicalProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:OfficeAndSurgicalProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:FertilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:FertilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:FertilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperVisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CooperSurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="business_unit">
        <measure>coo:business_unit</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="installment">
        <measure>coo:installment</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>coo:reporting_unit</measure>
    </unit>
    <unit id="director">
        <measure>coo:director</measure>
    </unit>
    <unit id="segment">
        <measure>coo:segment</measure>
    </unit>
    <unit id="interest_rate_swap_contract">
        <measure>coo:interest_rate_swap_contract</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-36">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-37">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-38">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-39">0000711404</dei:EntityCentralIndexKey>
    <us-gaap:AccountingStandardsUpdateExtensibleList contextRef="c-22" id="f-230">http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-7" id="f-485">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-486">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-7" id="f-489">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-490">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-493">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-7" id="f-494">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-635">http://fasb.org/us-gaap/2023#DebtCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-7" id="f-636">http://fasb.org/us-gaap/2023#DebtCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-7" id="f-651">http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-652">http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-145" decimals="3" id="f-692" unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-204" id="f-975">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-206" id="f-980">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-6" id="f-1022">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-1" id="f-1023">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-5" id="f-1024">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-6" id="f-1082">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-5" id="f-1083">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-1" id="f-1084">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-5" id="f-1088">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-1" id="f-1089">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-6" id="f-1090">http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-4">2023-10-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-3">--10-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-08597</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">THE COOPER COMPANIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">94-2657368</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">6101 Bollinger Canyon Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-11">Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-12">San Ramon</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-13">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-14">94583</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-15">925</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-16">460-3600</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, $.10 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">COO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-20">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-21">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-22">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-23">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-24">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-25">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-26">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-27">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-28">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-29">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="-8" id="f-30" unitRef="usd">18800000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-31" unitRef="shares">49525982</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-32">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.343%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Document&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Part of Form 10-K&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Portions of the Proxy Statement for the Annual Meeting&lt;br/&gt;of Stockholders scheduled to be held in March 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Part&#160;III&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our independent registered public accounting firm is KPMG LLP, San Francisco, CA, Auditor ID: 185.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName contextRef="c-1" id="f-33">KPMG LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-34">San Francisco, CA</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="c-1" id="f-35">185</dei:AuditorFirmId>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-5" id="f-40" unitRef="usd">735600000</us-gaap:InventoryNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-41" unitRef="usd">3593200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-42" unitRef="usd">3593200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-43" unitRef="usd">3308400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-44" unitRef="usd">2922500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-5" id="f-45" unitRef="usd">1235300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-5" id="f-46" unitRef="usd">1168800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-6" decimals="-5" id="f-47" unitRef="usd">966700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-5" id="f-48" unitRef="usd">2357900000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-5" decimals="-5" id="f-49" unitRef="usd">2139600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-6" decimals="-5" id="f-50" unitRef="usd">1955800000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-5" id="f-51" unitRef="usd">1501200000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-5" decimals="-5" id="f-52" unitRef="usd">1342200000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-6" decimals="-5" id="f-53" unitRef="usd">1211200000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-5" id="f-54" unitRef="usd">137400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-5" id="f-55" unitRef="usd">110300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-5" id="f-56" unitRef="usd">92700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-57" unitRef="usd">186200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-5" decimals="-5" id="f-58" unitRef="usd">179500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-6" decimals="-5" id="f-59" unitRef="usd">146100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-60" unitRef="usd">533100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-5" id="f-61" unitRef="usd">507600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-5" id="f-62" unitRef="usd">505800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-5" id="f-63" unitRef="usd">105300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-5" decimals="-5" id="f-64" unitRef="usd">57300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-6" decimals="-5" id="f-65" unitRef="usd">23100000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-66" unitRef="usd">-14900000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-67" unitRef="usd">25000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-5" id="f-68" unitRef="usd">8800000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-69" unitRef="usd">412900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-70" unitRef="usd">475300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-5" id="f-71" unitRef="usd">491500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-72" unitRef="usd">118700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-73" unitRef="usd">89500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-74" unitRef="usd">-2453200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-75" unitRef="usd">294200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-76" unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-77" unitRef="usd">2944700000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-78"
      unitRef="usdPerShare">5.94</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-79"
      unitRef="usdPerShare">7.83</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-80"
      unitRef="usdPerShare">59.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-81"
      unitRef="usdPerShare">5.91</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-82"
      unitRef="usdPerShare">7.76</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-83"
      unitRef="usdPerShare">59.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-84" unitRef="shares">49500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-85" unitRef="shares">49300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-5" id="f-86" unitRef="shares">49200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-87" unitRef="shares">49800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-88" unitRef="shares">49700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-5" id="f-89" unitRef="shares">49800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-90" unitRef="usd">294200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-91" unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-92" unitRef="usd">2944700000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax contextRef="c-1" decimals="-5" id="f-93" unitRef="usd">-2400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax contextRef="c-5" decimals="-5" id="f-94" unitRef="usd">26100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax contextRef="c-6" decimals="-5" id="f-95" unitRef="usd">8200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-1" decimals="-5" id="f-96" unitRef="usd">-7000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-5" decimals="-5" id="f-97" unitRef="usd">81300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-6" decimals="-5" id="f-98" unitRef="usd">26100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax contextRef="c-1" decimals="-5" id="f-99" unitRef="usd">-1000000.0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax contextRef="c-5" decimals="-5" id="f-100" unitRef="usd">-8700000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax contextRef="c-6" decimals="-5" id="f-101" unitRef="usd">-7200000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-1" decimals="-5" id="f-102" unitRef="usd">-3000000.0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-5" decimals="-5" id="f-103" unitRef="usd">-27900000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-6" decimals="-5" id="f-104" unitRef="usd">-22600000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-5" id="f-105" unitRef="usd">17000000.0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-5" decimals="-5" id="f-106" unitRef="usd">-234700000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-6" decimals="-5" id="f-107" unitRef="usd">82000000.0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-5" id="f-108" unitRef="usd">13000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-5" id="f-109" unitRef="usd">-125500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-6" decimals="-5" id="f-110" unitRef="usd">130700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-111" unitRef="usd">307200000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-112" unitRef="usd">260300000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-6" decimals="-5" id="f-113" unitRef="usd">3075400000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-114" unitRef="usd">120800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-7" decimals="-5" id="f-115" unitRef="usd">138200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-4" decimals="-5" id="f-116" unitRef="usd">31300000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-7" decimals="-5" id="f-117" unitRef="usd">20700000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-5" id="f-118" unitRef="usd">609700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-7" decimals="-5" id="f-119" unitRef="usd">557800000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-5" id="f-120" unitRef="usd">735600000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-7" decimals="-5" id="f-121" unitRef="usd">628700000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-5" id="f-122" unitRef="usd">238800000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-7" decimals="-5" id="f-123" unitRef="usd">208900000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-5" id="f-124" unitRef="usd">1704900000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-7" decimals="-5" id="f-125" unitRef="usd">1533600000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-5" id="f-126" unitRef="usd">1632600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-7" decimals="-5" id="f-127" unitRef="usd">1432900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:Goodwill contextRef="c-4" decimals="-5" id="f-128" unitRef="usd">3624500000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-7" decimals="-5" id="f-129" unitRef="usd">3609700000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-5" id="f-130" unitRef="usd">1710300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-7" decimals="-5" id="f-131" unitRef="usd">1885100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-4" decimals="-5" id="f-132" unitRef="usd">2349500000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-7" decimals="-5" id="f-133" unitRef="usd">2443100000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-5" id="f-134" unitRef="usd">637100000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-7" decimals="-5" id="f-135" unitRef="usd">587900000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-4" decimals="-5" id="f-136" unitRef="usd">11658900000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-7" decimals="-5" id="f-137" unitRef="usd">11492300000</us-gaap:Assets>
    <us-gaap:DebtCurrent contextRef="c-4" decimals="-5" id="f-138" unitRef="usd">45400000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent contextRef="c-7" decimals="-5" id="f-139" unitRef="usd">412600000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-5" id="f-140" unitRef="usd">261900000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-7" decimals="-5" id="f-141" unitRef="usd">248800000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-142" unitRef="usd">174800000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-7" decimals="-5" id="f-143" unitRef="usd">152100000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-5" id="f-144" unitRef="usd">123600000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-7" decimals="-5" id="f-145" unitRef="usd">93600000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-146" unitRef="usd">363300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-7" decimals="-5" id="f-147" unitRef="usd">373100000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-148" unitRef="usd">969000000.0</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-7" decimals="-5" id="f-149" unitRef="usd">1280200000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-4" decimals="-5" id="f-150" unitRef="usd">2523800000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-7" decimals="-5" id="f-151" unitRef="usd">2350800000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-5" id="f-152" unitRef="usd">101500000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-7" decimals="-5" id="f-153" unitRef="usd">149900000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:AccruedIncomeTaxesNoncurrent contextRef="c-4" decimals="-5" id="f-154" unitRef="usd">90200000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent contextRef="c-7" decimals="-5" id="f-155" unitRef="usd">113200000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-156" unitRef="usd">184200000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-7" decimals="-5" id="f-157" unitRef="usd">198300000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-5" id="f-158" unitRef="usd">239200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-7" decimals="-5" id="f-159" unitRef="usd">225200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-4" decimals="-5" id="f-160" unitRef="usd">4107900000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-7" decimals="-5" id="f-161" unitRef="usd">4317600000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-162" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-7" id="f-163" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="2"
      id="f-164"
      unitRef="usdPerShare">0.10</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-7"
      decimals="2"
      id="f-165"
      unitRef="usdPerShare">0.10</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-7" decimals="-5" id="f-166" unitRef="shares">1000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="-5" id="f-167" unitRef="shares">1000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="0" id="f-168" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-7" decimals="0" id="f-169" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-7" decimals="0" id="f-170" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="0" id="f-171" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-5" id="f-172" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-7" decimals="-5" id="f-173" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="2"
      id="f-174"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-7"
      decimals="2"
      id="f-175"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-7" decimals="-5" id="f-176" unitRef="shares">120000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="-5" id="f-177" unitRef="shares">120000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="-5" id="f-178" unitRef="shares">53900000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="-5" id="f-179" unitRef="shares">49500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-7" decimals="-5" id="f-180" unitRef="shares">53800000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-7" decimals="-5" id="f-181" unitRef="shares">49300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-5" id="f-182" unitRef="usd">5400000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-7" decimals="-5" id="f-183" unitRef="usd">5400000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-5" id="f-184" unitRef="usd">1833400000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-7" decimals="-5" id="f-185" unitRef="usd">1765500000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-5" id="f-186" unitRef="usd">-453800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-7" decimals="-5" id="f-187" unitRef="usd">-466800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-5" id="f-188" unitRef="usd">6876100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-7" decimals="-5" id="f-189" unitRef="usd">6584900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="-5" id="f-190" unitRef="shares">4400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-7" decimals="-5" id="f-191" unitRef="shares">4500000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="-5" id="f-192" unitRef="usd">710300000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-7" decimals="-5" id="f-193" unitRef="usd">714500000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-5" id="f-194" unitRef="usd">7550800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-5" id="f-195" unitRef="usd">7174500000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-4" decimals="-5" id="f-196" unitRef="usd">200000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-7" decimals="-5" id="f-197" unitRef="usd">200000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-5" id="f-198" unitRef="usd">7551000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-7" decimals="-5" id="f-199" unitRef="usd">7174700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-5" id="f-200" unitRef="usd">11658900000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-7" decimals="-5" id="f-201" unitRef="usd">11492300000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="-5" id="f-202" unitRef="shares">49100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-8" decimals="-5" id="f-203" unitRef="usd">4900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-9" decimals="-5" id="f-204" unitRef="shares">4300000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-10" decimals="-5" id="f-205" unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-11" decimals="-5" id="f-206" unitRef="usd">1646800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-12" decimals="-5" id="f-207" unitRef="usd">-472000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-13" decimals="-5" id="f-208" unitRef="usd">3261800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-9" decimals="-5" id="f-209" unitRef="usd">-617300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-14" decimals="-5" id="f-210" unitRef="usd">200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-15" decimals="-5" id="f-211" unitRef="usd">3824800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-16" decimals="-5" id="f-212" unitRef="usd">2944700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-213" unitRef="usd">2944700000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-17" decimals="-5" id="f-214" unitRef="usd">130700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-6" decimals="-5" id="f-215" unitRef="usd">130700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-18" decimals="-5" id="f-216" unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-19" decimals="-5" id="f-217" unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-20" decimals="-5" id="f-218" unitRef="usd">24600000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-21" decimals="-5" id="f-219" unitRef="usd">2500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-6" decimals="-5" id="f-220" unitRef="usd">27200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-18" decimals="-5" id="f-221" unitRef="shares">100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-21" decimals="-5" id="f-222" unitRef="shares">100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-21" decimals="-5" id="f-223" unitRef="usd">24800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-6" decimals="-5" id="f-224" unitRef="usd">24800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-6"
      decimals="2"
      id="f-225"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash contextRef="c-16" decimals="-5" id="f-226" unitRef="usd">3000000.0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-6" decimals="-5" id="f-227" unitRef="usd">3000000.0</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-20" decimals="-5" id="f-228" unitRef="usd">43800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-5" id="f-229" unitRef="usd">43800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-23" decimals="-5" id="f-231" unitRef="usd">-1400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-24" decimals="-5" id="f-232" unitRef="usd">-1400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-25" decimals="-5" id="f-233" unitRef="shares">49300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-5" id="f-234" unitRef="usd">5000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-26" decimals="-5" id="f-235" unitRef="shares">4400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-5" id="f-236" unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-5" id="f-237" unitRef="usd">1715200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-5" id="f-238" unitRef="usd">-341300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-5" id="f-239" unitRef="usd">6202100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-26" decimals="-5" id="f-240" unitRef="usd">-639600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="-5" id="f-241" unitRef="usd">200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-32" decimals="-5" id="f-242" unitRef="usd">6942000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-33" decimals="-5" id="f-243" unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-244" unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-34" decimals="-5" id="f-245" unitRef="usd">-125500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-5" id="f-246" unitRef="usd">-125500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-35" decimals="-5" id="f-247" unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-36" decimals="-5" id="f-248" unitRef="usd">-2100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-37" decimals="-5" id="f-249" unitRef="usd">3600000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-5" decimals="-5" id="f-250" unitRef="usd">1500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-35" decimals="-5" id="f-251" unitRef="shares">100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-37" decimals="-5" id="f-252" unitRef="shares">100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-37" decimals="-5" id="f-253" unitRef="usd">78500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-5" decimals="-5" id="f-254" unitRef="usd">78500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-5"
      decimals="2"
      id="f-255"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash contextRef="c-33" decimals="-5" id="f-256" unitRef="usd">3000000.0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-5" decimals="-5" id="f-257" unitRef="usd">3000000.0</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-36" decimals="-5" id="f-258" unitRef="usd">52400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-5" id="f-259" unitRef="usd">52400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-38" decimals="-5" id="f-260" unitRef="shares">49300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-38" decimals="-5" id="f-261" unitRef="usd">5000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-39" decimals="-5" id="f-262" unitRef="shares">4500000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-40" decimals="-5" id="f-263" unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-41" decimals="-5" id="f-264" unitRef="usd">1765500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-42" decimals="-5" id="f-265" unitRef="usd">-466800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-43" decimals="-5" id="f-266" unitRef="usd">6584900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-39" decimals="-5" id="f-267" unitRef="usd">-714500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-44" decimals="-5" id="f-268" unitRef="usd">200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-7" decimals="-5" id="f-269" unitRef="usd">7174700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-45" decimals="-5" id="f-270" unitRef="usd">294200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-271" unitRef="usd">294200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-46" decimals="-5" id="f-272" unitRef="usd">13000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-5" id="f-273" unitRef="usd">13000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-47" decimals="-5" id="f-274" unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-48" decimals="-5" id="f-275" unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-49" decimals="-5" id="f-276" unitRef="usd">7100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-48" decimals="-5" id="f-277" unitRef="usd">4200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-1" decimals="-5" id="f-278" unitRef="usd">11300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-1"
      decimals="2"
      id="f-279"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash contextRef="c-45" decimals="-5" id="f-280" unitRef="usd">3000000.0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-1" decimals="-5" id="f-281" unitRef="usd">3000000.0</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-49" decimals="-5" id="f-282" unitRef="usd">60800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-5" id="f-283" unitRef="usd">60800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-50" decimals="-5" id="f-284" unitRef="shares">49500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-50" decimals="-5" id="f-285" unitRef="usd">5000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-51" decimals="-5" id="f-286" unitRef="shares">4400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-52" decimals="-5" id="f-287" unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-53" decimals="-5" id="f-288" unitRef="usd">1833400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-54" decimals="-5" id="f-289" unitRef="usd">-453800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-55" decimals="-5" id="f-290" unitRef="usd">6876100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-51" decimals="-5" id="f-291" unitRef="usd">-710300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-56" decimals="-5" id="f-292" unitRef="usd">200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-5" id="f-293" unitRef="usd">7551000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-294" unitRef="usd">294200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-295" unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-296" unitRef="usd">2944700000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-5" id="f-297" unitRef="usd">367700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-5" decimals="-5" id="f-298" unitRef="usd">346100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-6" decimals="-5" id="f-299" unitRef="usd">309300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-5" id="f-300" unitRef="usd">62100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-5" decimals="-5" id="f-301" unitRef="usd">54200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-6" decimals="-5" id="f-302" unitRef="usd">43800000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-5" id="f-303" unitRef="usd">40000000.0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-5" decimals="-5" id="f-304" unitRef="usd">32200000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-6" decimals="-5" id="f-305" unitRef="usd">31800000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <coo:AssetImpairmentChargesAndOther contextRef="c-1" decimals="-5" id="f-306" unitRef="usd">49400000</coo:AssetImpairmentChargesAndOther>
    <coo:AssetImpairmentChargesAndOther contextRef="c-5" decimals="-5" id="f-307" unitRef="usd">4500000</coo:AssetImpairmentChargesAndOther>
    <coo:AssetImpairmentChargesAndOther contextRef="c-6" decimals="-5" id="f-308" unitRef="usd">-5000000.0</coo:AssetImpairmentChargesAndOther>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-1" decimals="-5" id="f-309" unitRef="usd">-31800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-5" decimals="-5" id="f-310" unitRef="usd">-10300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-6" decimals="-5" id="f-311" unitRef="usd">66100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-312" unitRef="usd">44700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-313" unitRef="usd">53900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-314" unitRef="usd">-2502200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-5" id="f-315" unitRef="usd">60200000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-5" decimals="-5" id="f-316" unitRef="usd">33800000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-6" decimals="-5" id="f-317" unitRef="usd">75500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-5" id="f-318" unitRef="usd">105400000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-5" decimals="-5" id="f-319" unitRef="usd">40400000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-6" decimals="-5" id="f-320" unitRef="usd">9200000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-1" decimals="-5" id="f-321" unitRef="usd">89400000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-5" decimals="-5" id="f-322" unitRef="usd">16900000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-6" decimals="-5" id="f-323" unitRef="usd">69100000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet contextRef="c-1" decimals="-5" id="f-324" unitRef="usd">-34200000</coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet>
    <coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet contextRef="c-5" decimals="-5" id="f-325" unitRef="usd">-51300000</coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet>
    <coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet contextRef="c-6" decimals="-5" id="f-326" unitRef="usd">-27500000</coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-5" id="f-327" unitRef="usd">5500000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-5" decimals="-5" id="f-328" unitRef="usd">49900000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-6" decimals="-5" id="f-329" unitRef="usd">-16000000.0</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-1" decimals="-5" id="f-330" unitRef="usd">71800000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-5" decimals="-5" id="f-331" unitRef="usd">32400000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-6" decimals="-5" id="f-332" unitRef="usd">59100000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-1" decimals="-5" id="f-333" unitRef="usd">-500000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-5" decimals="-5" id="f-334" unitRef="usd">-27400000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-6" decimals="-5" id="f-335" unitRef="usd">10000000.0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-1" decimals="-5" id="f-336" unitRef="usd">-6400000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-5" decimals="-5" id="f-337" unitRef="usd">-34200000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-6" decimals="-5" id="f-338" unitRef="usd">-21700000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <coo:IncreaseDecreaseInContingentConsiderationLiability contextRef="c-1" decimals="-5" id="f-339" unitRef="usd">0</coo:IncreaseDecreaseInContingentConsiderationLiability>
    <coo:IncreaseDecreaseInContingentConsiderationLiability contextRef="c-5" decimals="-5" id="f-340" unitRef="usd">-52300000</coo:IncreaseDecreaseInContingentConsiderationLiability>
    <coo:IncreaseDecreaseInContingentConsiderationLiability contextRef="c-6" decimals="-5" id="f-341" unitRef="usd">0</coo:IncreaseDecreaseInContingentConsiderationLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-342" unitRef="usd">607500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-5" decimals="-5" id="f-343" unitRef="usd">692400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-6" decimals="-5" id="f-344" unitRef="usd">738600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-5" id="f-345" unitRef="usd">392500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-5" decimals="-5" id="f-346" unitRef="usd">242000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-6" decimals="-5" id="f-347" unitRef="usd">214400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired contextRef="c-1" decimals="-5" id="f-348" unitRef="usd">56500000</coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired>
    <coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired contextRef="c-5" decimals="-5" id="f-349" unitRef="usd">1641300000</coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired>
    <coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired contextRef="c-6" decimals="-5" id="f-350" unitRef="usd">235900000</coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries contextRef="c-1" decimals="-5" id="f-351" unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries contextRef="c-5" decimals="-5" id="f-352" unitRef="usd">52100000</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries contextRef="c-6" decimals="-5" id="f-353" unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-5" id="f-354" unitRef="usd">-449000000.0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-5" decimals="-5" id="f-355" unitRef="usd">-1831200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-6" decimals="-5" id="f-356" unitRef="usd">-450300000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-1" decimals="-5" id="f-357" unitRef="usd">2124200000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-5" decimals="-5" id="f-358" unitRef="usd">1511000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-6" decimals="-5" id="f-359" unitRef="usd">1427400000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-1" decimals="-5" id="f-360" unitRef="usd">1953900000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-5" decimals="-5" id="f-361" unitRef="usd">561500000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-6" decimals="-5" id="f-362" unitRef="usd">1416000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="c-1" decimals="-5" id="f-363" unitRef="usd">-351100000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="c-5" decimals="-5" id="f-364" unitRef="usd">329300000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="c-6" decimals="-5" id="f-365" unitRef="usd">-321300000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-5" id="f-366" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-5" decimals="-5" id="f-367" unitRef="usd">78500000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-6" decimals="-5" id="f-368" unitRef="usd">24800000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-1" decimals="-5" id="f-369" unitRef="usd">15100000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-5" decimals="-5" id="f-370" unitRef="usd">8900000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-6" decimals="-5" id="f-371" unitRef="usd">33700000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-5" id="f-372" unitRef="usd">13100000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-5" decimals="-5" id="f-373" unitRef="usd">16800000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-6" decimals="-5" id="f-374" unitRef="usd">13200000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-1" decimals="-5" id="f-375" unitRef="usd">3000000.0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-5" decimals="-5" id="f-376" unitRef="usd">3000000.0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-6" decimals="-5" id="f-377" unitRef="usd">3000000.0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromStockPlans contextRef="c-1" decimals="-5" id="f-378" unitRef="usd">7900000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans contextRef="c-5" decimals="-5" id="f-379" unitRef="usd">7200000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans contextRef="c-6" decimals="-5" id="f-380" unitRef="usd">5800000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-1" decimals="-5" id="f-381" unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-5" decimals="-5" id="f-382" unitRef="usd">2900000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-6" decimals="-5" id="f-383" unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-5" id="f-384" unitRef="usd">-173900000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-5" decimals="-5" id="f-385" unitRef="usd">1193700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-6" decimals="-5" id="f-386" unitRef="usd">-311400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-5" id="f-387" unitRef="usd">-2300000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-5" id="f-388" unitRef="usd">-12900000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-5" id="f-389" unitRef="usd">2900000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-5" id="f-390" unitRef="usd">-17700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-5" decimals="-5" id="f-391" unitRef="usd">42000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-6" decimals="-5" id="f-392" unitRef="usd">-20200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-5" id="f-393" unitRef="usd">138600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-32" decimals="-5" id="f-394" unitRef="usd">96600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-15" decimals="-5" id="f-395" unitRef="usd">116800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-5" id="f-396" unitRef="usd">120900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-5" id="f-397" unitRef="usd">138600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-32" decimals="-5" id="f-398" unitRef="usd">96600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-5" id="f-399" unitRef="usd">117500000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-5" decimals="-5" id="f-400" unitRef="usd">49100000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-6" decimals="-5" id="f-401" unitRef="usd">28400000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid contextRef="c-1" decimals="-5" id="f-402" unitRef="usd">67800000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-5" decimals="-5" id="f-403" unitRef="usd">66600000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-6" decimals="-5" id="f-404" unitRef="usd">63200000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-5" id="f-405" unitRef="usd">47500000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-5" decimals="-5" id="f-406" unitRef="usd">45300000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-6" decimals="-5" id="f-407" unitRef="usd">37400000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-5" id="f-408" unitRef="usd">42600000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-5" decimals="-5" id="f-409" unitRef="usd">29800000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-6" decimals="-5" id="f-410" unitRef="usd">26500000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-411" unitRef="usd">120800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-7" decimals="-5" id="f-412" unitRef="usd">138200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-32" decimals="-5" id="f-413" unitRef="usd">95900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-414" unitRef="usd">100000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="c-7" decimals="-5" id="f-415" unitRef="usd">400000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="c-32" decimals="-5" id="f-416" unitRef="usd">400000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents contextRef="c-4" decimals="-5" id="f-417" unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents contextRef="c-7" decimals="-5" id="f-418" unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents contextRef="c-32" decimals="-5" id="f-419" unitRef="usd">300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-5" id="f-420" unitRef="usd">120900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-5" id="f-421" unitRef="usd">138600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-32" decimals="-5" id="f-422" unitRef="usd">96600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="c-1" id="f-423">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 1. Organization and Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Organization&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Cooper Companies, Inc. (Cooper, we or the Company) is a global medical device company publicly traded on the Nasdaq (Nasdaq: COO). Prior to September 26, 2023, Cooper's common stock traded on the New York Stock Exchange under the symbol "COO". Cooper operates through two business units, CooperVision and CooperSurgical.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt"&gt;CooperVision primarily develops, manufactures and markets a broad range of soft contact lenses for the worldwide vision correction market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt"&gt;CooperSurgical primarily develops, manufactures, markets medical devices and procedures solutions, and provides services to improve health care delivery to women, babies and families. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The financial statements in this report include the results of all of Cooper's consolidated entities. All significant intercompany transactions and balances are eliminated on consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates. The Company continually monitors and evaluates the estimates used as additional information becomes available. Adjustments will be made to these provisions periodically to reflect new facts and circumstances that may indicate that historical experience may not be indicative of current and/or future results.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Sales &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers may subsequently resell the Company&#x2019;s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately negotiated rebates, chargebacks and discounts with respect to the purchase of the Company&#x2019;s products. The Company considers purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. As part of its consideration of the contract, the Company evaluates certain factors including the customer&#x2019;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recognized when the Customer obtains control of the Company&#x2019;s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less. See Note 12. Business Segment Information for disaggregation of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reserves for Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company&#x2019;s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liabilities. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company applies that method consistently.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company&#x2019;s historical experience, current contractual and statutory requirements, specific known &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#x2019;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade Discounts and Allowances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company&#x2019;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. Historically, returns have been infrequent and insignificant relative to our total sales. Our refund liability for product returns is included in "Other current liabilities" in our Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rebates and Chargebacks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company&#x2019;s direct customers. For certain office and surgical portfolio in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Deferred revenue primarily represents prepaid stem cell storage as part of the CooperSurgical business unit. Revenue related to stem cell storage is recognized over the service period, which can range from one year to the lifetime of a customer. The current portion of the deferred revenue balances at the beginning of each year presented were generally fully recognized in the subsequent 12-month period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We grant various share-based compensation awards, including stock options, performance unit shares, restricted stock and restricted stock units. The Company accounts for share-based compensation expense based on estimated grant-date fair value, and expenses the amount over the vesting period of the award. Determining the fair value of share-based awards at the grant date requires judgment, including estimating Cooper's stock price volatility, employee exercise behaviors and related employee forfeiture rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The expected life of the share-based awards is based on the expected time to post-vesting forfeiture and/or exercise. Groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. In determining the expected volatility, management considers implied volatility from publicly-traded options on Cooper's common stock at the date of grant, historical volatility and other factors. The risk-free interest rate is based on the continuous rates provided by the United States Treasury with a term equal to the expected life of the award. The dividend yield is based on the projected annual dividend payment per share, divided by the stock price at the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Forfeitures are estimated at the time of grant, based on historical experience, and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Most of our operations outside the United States use their local currency as their functional currency. We translate these assets and liabilities into U.S. dollars at year-end exchange rates. We translate income and expense accounts at average exchange rates for the period. We record gains and losses from the translation of financial statements in foreign currencies into U.S. dollars in other comprehensive income. We record gains and losses from changes in exchange rates on transactions denominated in currencies other than each reporting location's functional currency in net income for each period&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Financial Derivatives and Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Derivatives are recorded on the Consolidated Balance Sheets at fair value. Accounting for gains or losses resulting from changes in the values of those derivatives depends on the use of the derivative instrument and whether it qualifies for hedge accounting.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;The gain or loss on derivative instruments designated and qualifying for cash flow hedge accounting is deferred in other comprehensive income. The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period earnings. Deferred gains or losses from designated cash flow hedges are reclassified into earnings in the period that the hedged interest expense affects earnings. The effectiveness of cash flow hedges is assessed at inception and quarterly thereafter. The Company does not offset fair value amounts recognized for derivative instruments in its Consolidated Balance Sheets for presentation purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset&#x2019;s or liability&#x2019;s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs reflecting the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company's revolving credit facility and term loans approximates fair value based on current market rates (Level 2). Refer to Note 5. Financing Arrangements for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The fair value of the Company's&#160;interest&#160;rate&#160;swap&#160;contracts is measured on a recurring basis by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates (forward curves) derived from observable market interest rate&#160;curves. The&#160;interest&#160;rate&#160;swap&#160;contracts were categorized as Level 2 in the fair value hierarchy, as the inputs to the derivative pricing model are generally observable and do not contain a high level of subjectivity. The fair value of derivative instruments is included in "Other assets" in our Consolidated Balance Sheets. On our Consolidated Financial Statements. the gain or loss on the derivatives is recorded as a component of "Accumulated other comprehensive loss" and subsequently reclassified into "Interest expense" in the same period during which the hedged transaction affects earnings. Refer to Note 13. Financial Derivatives and Hedging for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company uses fair value measures for assets and liabilities acquired in an acquisition, which are considered a Level 3 measurement. C&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;ontingent consideration for which a liability is recorded and the initial measurement of the joint venture interest are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; also categorized as Level 3 in the fair value hierarchy;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;and the change in fair value is recognized in "Selling, general and administrative expense" in the Consolidated Statements of Income.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; The fair value is measured by discounting expected future cash flows. The discount rate used for cash flows reflects capital market conditions and the specific risks associated with the business. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Note 3. Acquisitions and Joint Venture for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;Income taxes are estimated based on enacted income tax laws and the results of operations in each jurisdiction. Deferred tax assets and liabilities are estimated based on temporary differences between the financial reporting basis and income tax basis of assets and liabilities. Deferred tax assets are also estimated based on net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance to the extent it is more likely than not they are not expected to be realized. Adjustments to deferred tax assets and liabilities due to changes in tax laws, changes in jurisdiction from intra-group transfers of assets, and changes in judgment regarding a valuation allowance are recognized in provision for income taxes in the quarter in which such changes occur. Long-term tax payable is estimated income tax to be paid for unrecognized tax benefits. A tax benefit is recognized if it is more likely than not a tax position will be sustained based on its technical merits in a tax authority examination, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. Adjustments to unrecognized tax benefits due to changes in judgment are recognized in provision for income taxes in the quarter in which such changes occur. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We determine basic earnings per share (EPS) by using the weighted-average number of shares outstanding. We determine diluted EPS by increasing the weighted-average number of shares outstanding in the denominator by the number of outstanding dilutive equity awards using the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be&#160;cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.649%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.650%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;207.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;173.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;509.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;439.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;735.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;628.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In assessing the value of inventories, we make estimates and judgments regarding aging of inventories and other relevant issues potentially affecting the salable condition of products and estimated prices at which those products will sell. On an ongoing basis, we review the carrying value of our inventory, measuring number of months on hand and other indications of salability. We reduce the value of inventory if there are indications that the carrying value is greater than net realizable value, resulting in a new, lower-cost basis for that inventory. Subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. While estimates are involved, historically, obsolescence has not been a significant factor due to long product dating and lengthy product life cycles. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We record property, plant, and equipment at cost. We compute depreciation expense using the straight-line method over the estimated useful lives of the assets. Useful lives are generally 3 to 15 years except for buildings which are depreciated over 30 to 40 years and leasehold improvements, which we amortize over the shorter of the useful life or the lease term. We charge maintenance and repairs to expense as we incur them.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.649%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.650%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;488.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;415.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,187.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,973.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;486.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;393.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,182.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,800.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,553.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,387.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,628.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,413.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease ROU assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,632.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,432.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We consider an arrangement a lease if the arrangement transfers the right to control the use of an identified asset in exchange for consideration. We have operating leases, but do not have material financing leases. The Company primarily has operating leases for office, manufacturing and warehouse space, vehicles, and office equipment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future lease payments over the lease term. The lease term reflects the noncancellable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the Consolidated Balance Sheets. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Leases with a term of one year or less are not recognized in the Consolidated Balance Sheets, while the associated lease payments are expensed in the Consolidated Statements of Income and Comprehensive Income on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Operating leases are classified in &#x201c;Other current liabilities&#x201d;, &#x201c;Other liabilities&#x201d;, and &#x201c;Other assets&#x201d; in our Consolidated Balance Sheets. Operating lease expense is recognized on a straight-line basis over the expected lease term and included in "Selling, general and administrative expense" in our Consolidated Statements of Income. Financing leases are classified in "Property, plant and equipment, net", "Short-term debt", and "Long-term debt" in our Consolidated Balance Sheets. See Note 2. Operating Leases and Note 5. Financing Arrangements for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Cloud Computing Arrangements &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;The Company capitalizes certain costs related to the acquisition and development of internal use software, including implementation costs incurred in a cloud computing arrangement, during the application development stages of projects. Capitalized implementation costs are amortized on a straight-line basis over the expected term of the hosting arrangement, which includes consideration of the non-cancellable contractual term and reasonably certain renewals. Costs incurred during the preliminary project or the post-implementation/operation stages of the project are expensed as incurred. Implementation costs are included in &#x201c;Other assets&#x201d; in our Consolidated Balance Sheets. Amortization of capitalized implementation costs is included in the same line item in the Consolidated Statements of Income as the expense for fees for the associated hosting arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Valuation of Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We evaluate goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. Goodwill is tested for impairment at the reporting unit level by performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. We perform a qualitative assessment to test each reporting unit's goodwill for impairment, which includes industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the fair value of a reporting unit will be compared with its carrying amount and an impairment charge will be recognized for the amount that the carrying value exceeds the fair value of the reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Long-lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We review long-lived assets held and used for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group are compared to the asset group's carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds the fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Indefinite-lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We assess indefinite-lived intangible assets annually in the third quarter of the fiscal year, or whenever events or changes in circumstances indicate that the carrying amount of an indefinite-lived intangible asset (asset group) may not be recoverable. We evaluate whether the indefinite-lived intangible asset is impaired by comparing its carrying value to its fair value. If the carrying value of an indefinite-lived intangible asset is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We routinely consummate business combinations. Results of operations for acquired companies are included in our consolidated results of operations from the date of acquisition. We recognize separately from goodwill, the identifiable assets acquired, including acquired in-process research and development, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date fair values as defined by accounting standards related to fair value measurements. Key assumptions routinely utilized in allocation of purchase price to intangible assets include discount rates and projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. Direct acquisition costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;For business acquisitions, the Company records tangible and intangible assets acquired and liabilities assumed at their fair values as of the applicable date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We are subject to various legal proceedings, claims, litigation, investigations and contingencies arising out of the ordinary course of business. If we believe the likelihood of an adverse legal outcome is probable and the amount is estimable, we accrue a liability in accordance with accounting guidance for contingencies. We consult with legal counsel on matters related to litigation and seek input both within and outside the Company.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Exit Charges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;During the second quarter of fiscal 2022, the Company initiated a plan to exit its contact lens care business, a non-core business unit of the CooperVision segment, which was completed in fiscal 2023. Exit charges recognized during the year ended October 31, 2023, were not material. Exit charges recognized during the year ended October 31, 2022, were $33.2&#160;million, of which $26.7&#160;million were recognized in "Cost of sales" and $6.5&#160;million were recognized in "Selling, general and administrative expense" in our Consolidated Statements of Income. Exit charges primarily related to inventory write-down, asset impairments and employee-related costs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Government Assistance&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;The Company at times receives government assistance primarily to support manufacturing capital expansion, to create or retain jobs, or to provide tax credits mainly for eligible research and development activities. The Company generally accounts for such government assistance by analogy to IAS 20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Accounting for Government Grants and Disclosure of Government Assistance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; and recognizes the assistance when it is probable that it will be received by complying with the prerequisite terms and conditions. The government assistance is recognized in income as a reduction to the cost basis of the applicable property, plant, and equipment or reduction to the related expense.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In November 2021, the FASB issued ASU 2021-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;. This update requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. This standard was effective for fiscal years beginning after December 15, 2021. The Company adopted this guidance prospectively on November 1, 2022, and such adoption did not have a material impact on the Company's Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;In March 2020, the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Reference&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Reform&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Topic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;848&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt; Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; and subsequent amendment to the initial guidance: ASU 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Reference Rate Reform (Topic 848): Scope&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; (collectively, &#x201c;Topic 848&#x201d;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. In December 2022, the FASB issued ASU 2022-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;. ASU 2022-06 defers the sunset date of Topic 848 from December 31, 2022, to December 31, 2024. Effective February 1, 2023, the Company transitioned its credit agreements from LIBOR to the Secured Overnight Financing Rate ("SOFR"). The Company adopted this guidance prospectively on February 1, 2023, and it did not have a material impact on the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Issued Not Yet Adopted&lt;/span&gt;&lt;/div&gt;No other recently issued accounting pronouncements had or are expected to have a material impact on our Consolidated Financial Statements.</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <coo:NumberOfBusinessUnits
      contextRef="c-1"
      decimals="INF"
      id="f-424"
      unitRef="business_unit">2</coo:NumberOfBusinessUnits>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-425">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The financial statements in this report include the results of all of Cooper's consolidated entities. All significant intercompany transactions and balances are eliminated on consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-426">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates. The Company continually monitors and evaluates the estimates used as additional information becomes available. Adjustments will be made to these provisions periodically to reflect new facts and circumstances that may indicate that historical experience may not be indicative of current and/or future results.</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-427">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Sales &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers may subsequently resell the Company&#x2019;s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately negotiated rebates, chargebacks and discounts with respect to the purchase of the Company&#x2019;s products. The Company considers purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. As part of its consideration of the contract, the Company evaluates certain factors including the customer&#x2019;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recognized when the Customer obtains control of the Company&#x2019;s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less. See Note 12. Business Segment Information for disaggregation of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reserves for Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company&#x2019;s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liabilities. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company applies that method consistently.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company&#x2019;s historical experience, current contractual and statutory requirements, specific known &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#x2019;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade Discounts and Allowances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company&#x2019;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. Historically, returns have been infrequent and insignificant relative to our total sales. Our refund liability for product returns is included in "Other current liabilities" in our Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rebates and Chargebacks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company&#x2019;s direct customers. For certain office and surgical portfolio in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Deferred revenue primarily represents prepaid stem cell storage as part of the CooperSurgical business unit. Revenue related to stem cell storage is recognized over the service period, which can range from one year to the lifetime of a customer. The current portion of the deferred revenue balances at the beginning of each year presented were generally fully recognized in the subsequent 12-month period.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:CapitalizedContractCostAmortizationPeriod contextRef="c-57" id="f-428">P1Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-429">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We grant various share-based compensation awards, including stock options, performance unit shares, restricted stock and restricted stock units. The Company accounts for share-based compensation expense based on estimated grant-date fair value, and expenses the amount over the vesting period of the award. Determining the fair value of share-based awards at the grant date requires judgment, including estimating Cooper's stock price volatility, employee exercise behaviors and related employee forfeiture rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The expected life of the share-based awards is based on the expected time to post-vesting forfeiture and/or exercise. Groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. In determining the expected volatility, management considers implied volatility from publicly-traded options on Cooper's common stock at the date of grant, historical volatility and other factors. The risk-free interest rate is based on the continuous rates provided by the United States Treasury with a term equal to the expected life of the award. The dividend yield is based on the projected annual dividend payment per share, divided by the stock price at the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Forfeitures are estimated at the time of grant, based on historical experience, and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-430">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Most of our operations outside the United States use their local currency as their functional currency. We translate these assets and liabilities into U.S. dollars at year-end exchange rates. We translate income and expense accounts at average exchange rates for the period. We record gains and losses from the translation of financial statements in foreign currencies into U.S. dollars in other comprehensive income. We record gains and losses from changes in exchange rates on transactions denominated in currencies other than each reporting location's functional currency in net income for each period&lt;/span&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c-1" id="f-431">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Financial Derivatives and Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Derivatives are recorded on the Consolidated Balance Sheets at fair value. Accounting for gains or losses resulting from changes in the values of those derivatives depends on the use of the derivative instrument and whether it qualifies for hedge accounting.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;The gain or loss on derivative instruments designated and qualifying for cash flow hedge accounting is deferred in other comprehensive income. The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period earnings. Deferred gains or losses from designated cash flow hedges are reclassified into earnings in the period that the hedged interest expense affects earnings. The effectiveness of cash flow hedges is assessed at inception and quarterly thereafter. The Company does not offset fair value amounts recognized for derivative instruments in its Consolidated Balance Sheets for presentation purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-432">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset&#x2019;s or liability&#x2019;s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs reflecting the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company's revolving credit facility and term loans approximates fair value based on current market rates (Level 2). Refer to Note 5. Financing Arrangements for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The fair value of the Company's&#160;interest&#160;rate&#160;swap&#160;contracts is measured on a recurring basis by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates (forward curves) derived from observable market interest rate&#160;curves. The&#160;interest&#160;rate&#160;swap&#160;contracts were categorized as Level 2 in the fair value hierarchy, as the inputs to the derivative pricing model are generally observable and do not contain a high level of subjectivity. The fair value of derivative instruments is included in "Other assets" in our Consolidated Balance Sheets. On our Consolidated Financial Statements. the gain or loss on the derivatives is recorded as a component of "Accumulated other comprehensive loss" and subsequently reclassified into "Interest expense" in the same period during which the hedged transaction affects earnings. Refer to Note 13. Financial Derivatives and Hedging for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company uses fair value measures for assets and liabilities acquired in an acquisition, which are considered a Level 3 measurement. C&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;ontingent consideration for which a liability is recorded and the initial measurement of the joint venture interest are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; also categorized as Level 3 in the fair value hierarchy;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;and the change in fair value is recognized in "Selling, general and administrative expense" in the Consolidated Statements of Income.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; The fair value is measured by discounting expected future cash flows. The discount rate used for cash flows reflects capital market conditions and the specific risks associated with the business. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Note 3. Acquisitions and Joint Venture for further information.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-433">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;Income taxes are estimated based on enacted income tax laws and the results of operations in each jurisdiction. Deferred tax assets and liabilities are estimated based on temporary differences between the financial reporting basis and income tax basis of assets and liabilities. Deferred tax assets are also estimated based on net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance to the extent it is more likely than not they are not expected to be realized. Adjustments to deferred tax assets and liabilities due to changes in tax laws, changes in jurisdiction from intra-group transfers of assets, and changes in judgment regarding a valuation allowance are recognized in provision for income taxes in the quarter in which such changes occur. Long-term tax payable is estimated income tax to be paid for unrecognized tax benefits. A tax benefit is recognized if it is more likely than not a tax position will be sustained based on its technical merits in a tax authority examination, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. Adjustments to unrecognized tax benefits due to changes in judgment are recognized in provision for income taxes in the quarter in which such changes occur. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-434">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We determine basic earnings per share (EPS) by using the weighted-average number of shares outstanding. We determine diluted EPS by increasing the weighted-average number of shares outstanding in the denominator by the number of outstanding dilutive equity awards using the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-435">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be&#160;cash equivalents.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="c-1" id="f-436">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.&lt;/span&gt;&lt;/div&gt;In assessing the value of inventories, we make estimates and judgments regarding aging of inventories and other relevant issues potentially affecting the salable condition of products and estimated prices at which those products will sell. On an ongoing basis, we review the carrying value of our inventory, measuring number of months on hand and other indications of salability. We reduce the value of inventory if there are indications that the carrying value is greater than net realizable value, resulting in a new, lower-cost basis for that inventory. Subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. While estimates are involved, historically, obsolescence has not been a significant factor due to long product dating and lengthy product life cycles.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-437">&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.649%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.650%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;207.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;173.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;509.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;439.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;735.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;628.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-4" decimals="-5" id="f-438" unitRef="usd">207300000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-7" decimals="-5" id="f-439" unitRef="usd">173700000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-4" decimals="-5" id="f-440" unitRef="usd">19000000.0</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-7" decimals="-5" id="f-441" unitRef="usd">15200000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-4" decimals="-5" id="f-442" unitRef="usd">509300000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-7" decimals="-5" id="f-443" unitRef="usd">439800000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-5" id="f-444" unitRef="usd">735600000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-7" decimals="-5" id="f-445" unitRef="usd">628700000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-446">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We record property, plant, and equipment at cost. We compute depreciation expense using the straight-line method over the estimated useful lives of the assets. Useful lives are generally 3 to 15 years except for buildings which are depreciated over 30 to 40 years and leasehold improvements, which we amortize over the shorter of the useful life or the lease term. We charge maintenance and repairs to expense as we incur them.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-57" id="f-447">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-58" id="f-448">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-59" id="f-449">P30Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-60" id="f-450">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-451">&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.649%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.650%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;488.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;415.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,187.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,973.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;486.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;393.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,182.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,800.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,553.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,387.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,628.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,413.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease ROU assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,632.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,432.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-61" decimals="-5" id="f-452" unitRef="usd">20200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-62" decimals="-5" id="f-453" unitRef="usd">18700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-63" decimals="-5" id="f-454" unitRef="usd">488500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-64" decimals="-5" id="f-455" unitRef="usd">415600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-65" decimals="-5" id="f-456" unitRef="usd">2187100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-66" decimals="-5" id="f-457" unitRef="usd">1973600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-67" decimals="-5" id="f-458" unitRef="usd">486300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-68" decimals="-5" id="f-459" unitRef="usd">393000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-5" id="f-460" unitRef="usd">3182100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-7" decimals="-5" id="f-461" unitRef="usd">2800900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-5" id="f-462" unitRef="usd">1553300000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-7" decimals="-5" id="f-463" unitRef="usd">1387200000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-5" id="f-464" unitRef="usd">1628800000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-7" decimals="-5" id="f-465" unitRef="usd">1413700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization contextRef="c-4" decimals="-5" id="f-466" unitRef="usd">3800000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization contextRef="c-7" decimals="-5" id="f-467" unitRef="usd">19200000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-5" id="f-468" unitRef="usd">1632600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-7" decimals="-5" id="f-469" unitRef="usd">1432900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-470">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We consider an arrangement a lease if the arrangement transfers the right to control the use of an identified asset in exchange for consideration. We have operating leases, but do not have material financing leases. The Company primarily has operating leases for office, manufacturing and warehouse space, vehicles, and office equipment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future lease payments over the lease term. The lease term reflects the noncancellable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the Consolidated Balance Sheets. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Leases with a term of one year or less are not recognized in the Consolidated Balance Sheets, while the associated lease payments are expensed in the Consolidated Statements of Income and Comprehensive Income on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;Operating leases are classified in &#x201c;Other current liabilities&#x201d;, &#x201c;Other liabilities&#x201d;, and &#x201c;Other assets&#x201d; in our Consolidated Balance Sheets. Operating lease expense is recognized on a straight-line basis over the expected lease term and included in "Selling, general and administrative expense" in our Consolidated Statements of Income. Financing leases are classified in "Property, plant and equipment, net", "Short-term debt", and "Long-term debt" in our Consolidated Balance Sheets.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:InternalUseSoftwarePolicy contextRef="c-1" id="f-471">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Cloud Computing Arrangements &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;The Company capitalizes certain costs related to the acquisition and development of internal use software, including implementation costs incurred in a cloud computing arrangement, during the application development stages of projects. Capitalized implementation costs are amortized on a straight-line basis over the expected term of the hosting arrangement, which includes consideration of the non-cancellable contractual term and reasonably certain renewals. Costs incurred during the preliminary project or the post-implementation/operation stages of the project are expensed as incurred. Implementation costs are included in &#x201c;Other assets&#x201d; in our Consolidated Balance Sheets. Amortization of capitalized implementation costs is included in the same line item in the Consolidated Statements of Income as the expense for fees for the associated hosting arrangement.&lt;/span&gt;&lt;/div&gt;</us-gaap:InternalUseSoftwarePolicy>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="c-1" id="f-472">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Valuation of Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We evaluate goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. Goodwill is tested for impairment at the reporting unit level by performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. We perform a qualitative assessment to test each reporting unit's goodwill for impairment, which includes industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the fair value of a reporting unit will be compared with its carrying amount and an impairment charge will be recognized for the amount that the carrying value exceeds the fair value of the reporting unit.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="c-1" id="f-473">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Long-lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;We review long-lived assets held and used for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group are compared to the asset group's carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds the fair value.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy contextRef="c-1" id="f-474">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Indefinite-lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We assess indefinite-lived intangible assets annually in the third quarter of the fiscal year, or whenever events or changes in circumstances indicate that the carrying amount of an indefinite-lived intangible asset (asset group) may not be recoverable. We evaluate whether the indefinite-lived intangible asset is impaired by comparing its carrying value to its fair value. If the carrying value of an indefinite-lived intangible asset is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy>
    <us-gaap:BusinessCombinationsPolicy contextRef="c-1" id="f-475">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We routinely consummate business combinations. Results of operations for acquired companies are included in our consolidated results of operations from the date of acquisition. We recognize separately from goodwill, the identifiable assets acquired, including acquired in-process research and development, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date fair values as defined by accounting standards related to fair value measurements. Key assumptions routinely utilized in allocation of purchase price to intangible assets include discount rates and projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. Direct acquisition costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;For business acquisitions, the Company records tangible and intangible assets acquired and liabilities assumed at their fair values as of the applicable date of acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="c-1" id="f-476">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;We are subject to various legal proceedings, claims, litigation, investigations and contingencies arising out of the ordinary course of business. If we believe the likelihood of an adverse legal outcome is probable and the amount is estimable, we accrue a liability in accordance with accounting guidance for contingencies. We consult with legal counsel on matters related to litigation and seek input both within and outside the Company.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:StockholdersEquityPolicyTextBlock contextRef="c-1" id="f-477">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:BusinessExitCosts1 contextRef="c-5" decimals="-5" id="f-478" unitRef="usd">33200000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1 contextRef="c-69" decimals="-5" id="f-479" unitRef="usd">26700000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1 contextRef="c-70" decimals="-5" id="f-480" unitRef="usd">6500000</us-gaap:BusinessExitCosts1>
    <us-gaap:GovernmentAssistancePolicyTextBlock contextRef="c-1" id="f-481">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Government Assistance&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;The Company at times receives government assistance primarily to support manufacturing capital expansion, to create or retain jobs, or to provide tax credits mainly for eligible research and development activities. The Company generally accounts for such government assistance by analogy to IAS 20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Accounting for Government Grants and Disclosure of Government Assistance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; and recognizes the assistance when it is probable that it will be received by complying with the prerequisite terms and conditions. The government assistance is recognized in income as a reduction to the cost basis of the applicable property, plant, and equipment or reduction to the related expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:GovernmentAssistancePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-482">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In November 2021, the FASB issued ASU 2021-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;. This update requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. This standard was effective for fiscal years beginning after December 15, 2021. The Company adopted this guidance prospectively on November 1, 2022, and such adoption did not have a material impact on the Company's Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;In March 2020, the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Reference&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Reform&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Topic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;848&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt; Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; and subsequent amendment to the initial guidance: ASU 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Reference Rate Reform (Topic 848): Scope&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; (collectively, &#x201c;Topic 848&#x201d;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. In December 2022, the FASB issued ASU 2022-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;. ASU 2022-06 defers the sunset date of Topic 848 from December 31, 2022, to December 31, 2024. Effective February 1, 2023, the Company transitioned its credit agreements from LIBOR to the Secured Overnight Financing Rate ("SOFR"). The Company adopted this guidance prospectively on February 1, 2023, and it did not have a material impact on the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Issued Not Yet Adopted&lt;/span&gt;&lt;/div&gt;No other recently issued accounting pronouncements had or are expected to have a material impact on our Consolidated Financial Statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-483">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 2. Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table presents information about leases on the Consolidated Balance Sheets: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.013%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.581%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;October&#160;31,&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-485"&gt;&lt;span style="-sec-ix-hidden:f-486"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;241.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;230.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-489"&gt;&lt;span style="-sec-ix-hidden:f-490"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-493"&gt;&lt;span style="-sec-ix-hidden:f-494"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;215.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;205.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;253.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;241.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Operating lease expense for the fiscal years ended October&#160;31, 2023, 2022 and 2021 was $48.1&#160;million, $45.0&#160;million and $44.1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Maturity of Lease Liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The minimum rental payments required under operating leases that have initial or remaining noncancellable lease terms in excess of one year as of October&#160;31, 2023 are: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.650%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;46.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;41.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;37.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;123.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;308.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;253.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <coo:AssetsAndLiabilitiesLesseeTableTextBlock contextRef="c-1" id="f-484">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table presents information about leases on the Consolidated Balance Sheets: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.013%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.581%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;October&#160;31,&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-485"&gt;&lt;span style="-sec-ix-hidden:f-486"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;241.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;230.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-489"&gt;&lt;span style="-sec-ix-hidden:f-490"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-493"&gt;&lt;span style="-sec-ix-hidden:f-494"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;215.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;205.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;253.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;241.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</coo:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-5" id="f-487" unitRef="usd">241500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-7" decimals="-5" id="f-488" unitRef="usd">230100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-5" id="f-491" unitRef="usd">38200000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-7" decimals="-5" id="f-492" unitRef="usd">35500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-495" unitRef="usd">215600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-7" decimals="-5" id="f-496" unitRef="usd">205500000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-5" id="f-497" unitRef="usd">253800000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-7" decimals="-5" id="f-498" unitRef="usd">241000000.0</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-499">P10Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-7" id="f-500">P9Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="2" id="f-501" unitRef="number">0.04</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-7" decimals="2" id="f-502" unitRef="number">0.03</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-5" id="f-503" unitRef="usd">48100000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-5" decimals="-5" id="f-504" unitRef="usd">45000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-6" decimals="-5" id="f-505" unitRef="usd">44100000</us-gaap:OperatingLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-506">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The minimum rental payments required under operating leases that have initial or remaining noncancellable lease terms in excess of one year as of October&#160;31, 2023 are: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.650%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;46.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;41.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;37.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;123.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;308.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;253.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-5" id="f-507" unitRef="usd">46400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-5" id="f-508" unitRef="usd">41600000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-5" id="f-509" unitRef="usd">37700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-5" id="f-510" unitRef="usd">32800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-4" decimals="-5" id="f-511" unitRef="usd">26800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-4" decimals="-5" id="f-512" unitRef="usd">123400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-5" id="f-513" unitRef="usd">308700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-5" id="f-514" unitRef="usd">54900000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-5" id="f-515" unitRef="usd">253800000</us-gaap:OperatingLeaseLiability>
    <coo:BusinessCombinationAndAssetAcquisitionTextBlock contextRef="c-1" id="f-516">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 3. Acquisitions and Joint Venture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;All acquisitions were funded by cash generated from operations or facility borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company believes these acquisitions strengthen CooperSurgical's and CooperVision's businesses through the addition of new distributors or complementary products and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Fiscal Year 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, CooperVision completed the acquisition of a privately-held U.S.-based company that provides a broad portfolio of technologically advanced contact lens products, including scleral and hybrid lenses. The purchase price of the acquisition was $33.0&#160;million. Assets acquired primarily comprised of $12.6&#160;million of customer relationship related intangibles, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;$7.6&#160;million of technology, $5.1&#160;million of net assets and $7.7&#160;million of goodwill. The goodwill is not deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Fiscal Year 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On May 31, 2022, CooperVision completed the acquisition of a privately-held Denmark-based contact lens distributor focusing on orthokeratology and scleral contact lenses. This acquisition expands CooperVision's ortho-k eye care portfolio in the Nordic market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;On April 6, 2022, CooperSurgical completed the acquisition of a private cryopreservation services company that specializes in cryogenic services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%"&gt;Refer to the "Joint Venture" section below for details on formation of a joint venture with Essilor International and related activities that occurred in fiscal year 2023 and 2022 following the acquisition of SightGlass Vision, Inc. (SGV) in fiscal year 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;On April 6, 2022, CooperSurgical entered into an asset purchase agreement to acquire Cook Medical's Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets. The aggregate consideration is $875.0&#160;million in cash, with $675.0&#160;million payable at the closing and the remaining $200.0&#160;million payable in $50.0&#160;million installments following each of the first, second, third and fourth anniversaries of the closing. The transaction is subject to customary closing conditions, such as receipt of required regulatory approvals. During the year ended October 31, 2023, CooperSurgical determined that the fulfillment of certain closing conditions related to regulatory approvals was no longer probable and paid $45.0&#160;million in expenses for a termination fee under the asset purchase agreement on August 9, 2023. The termination fee is recorded in "Selling, general and administrative expense" on the Consolidated Statements of Income. Refer to the "Subsequent Event" section below for details on the revised scope of the transaction and the closing of the updated transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;On December 17, 2021, CooperSurgical completed the acquisition of 100% of the equity interests in Generate Life Sciences (Generate), a privately held leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood &amp;amp; cord tissue), and paid an aggregate purchase consideration of approximately $1.663&#160;billion, reflecting working capital, and other adjustments. The cash consideration was funded through a combination of $1.5&#160;billion in proceeds from the issuance of a senior unsecured term loan and available cash on hand.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%"&gt;Joint Venture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On January 19, 2021, CooperVision acquired all of the remaining equity interests of SGV, a privately-held medical device company that developed spectacle lenses for myopia management. The transaction included potential payments of future consideration that were contingent upon the achievement of the regulatory approval milestone (the regulatory approval payment) and the acquired business reaching certain revenue thresholds over a specified period (the revenue payments). The undiscounted range of the contingent consideration was zero to $139.1&#160;million payable to the other former equity interest owners.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The fair value of the regulatory approval payment was determined using an option pricing framework based on the expected payment under the contractual terms and the estimates of the probability of achieving the regulatory approval. The fair value of the revenue payments was determined using a Monte Carlo simulation based on the revenue projections and the expected payment for each simulation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In March 2022, the entities amended the terms of the contingent consideration, which resulted in CooperVision paying $42.9&#160;million to the former equity interest owners in exchange for the elimination of the revenue payments to such former equity interest owners. CooperVision recognized a net gain of $12.2&#160;million during fiscal 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;Further, CooperVision and Essilor International SAS (Essilor) executed a Contribution Agreement and a Stock Purchase Agreement (the "Agreements") in March 2022. Essilor paid CooperVision $52.1&#160;million in exchange for a 50% interest in SGV and their proportionate share of the revenue payments. As part of the Agreements, each party contributed their interest in SGV and $10&#160;million in cash to form a new joint venture. CooperVision then remeasured the fair value of its retained equity investment in the joint venture at $90.0&#160;million which resulted in a $56.9&#160;million gain in Other (income) expense on deconsolidation of SGV in fiscal 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;During fiscal 2023, CooperVision determined that approval would not be achieved within the timeline set forth in the contractual terms of the regulatory approval payment and released the remaining $31.8&#160;million contingent consideration liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Subsequent Event&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On November 1, 2023, CooperSurgical closed the acquisition of select assets of Cook Medical for an aggregate consideration of $300.0&#160;million, with $200.0&#160;million paid at closing and $100.0&#160;million to be paid in two $50.0&#160;million annual installments. The &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;assets acquired primarily comprised of minimally invasive medical devices within the obstetrics, doppler monitoring and gynecology surgery markets. The Company is in the process of finalizing purchase accounting information.&lt;/span&gt;&lt;/div&gt;</coo:BusinessCombinationAndAssetAcquisitionTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-71" decimals="-5" id="f-517" unitRef="usd">33000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-72" decimals="-5" id="f-518" unitRef="usd">12600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-73" decimals="-5" id="f-519" unitRef="usd">7600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <coo:BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets contextRef="c-74" decimals="-5" id="f-520" unitRef="usd">5100000</coo:BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:Goodwill contextRef="c-74" decimals="-5" id="f-521" unitRef="usd">7700000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount contextRef="c-74" decimals="0" id="f-522" unitRef="usd">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-75" decimals="-5" id="f-523" unitRef="usd">875000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-75" decimals="-5" id="f-524" unitRef="usd">675000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-75" decimals="-5" id="f-525" unitRef="usd">200000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-76" decimals="-5" id="f-526" unitRef="usd">50000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-77" decimals="-5" id="f-527" unitRef="usd">50000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-78" decimals="-5" id="f-528" unitRef="usd">50000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-79" decimals="-5" id="f-529" unitRef="usd">50000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <coo:AccruedAcquisitionTerminationFee contextRef="c-80" decimals="-5" id="f-530" unitRef="usd">45000000</coo:AccruedAcquisitionTerminationFee>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-81"
      decimals="INF"
      id="f-531"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-82" decimals="-6" id="f-532" unitRef="usd">1663000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:ProceedsFromLongTermLinesOfCredit contextRef="c-83" decimals="-8" id="f-533" unitRef="usd">1500000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow contextRef="c-84" decimals="0" id="f-534" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="c-84" decimals="-5" id="f-535" unitRef="usd">139100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <coo:BusinessCombinationPaymentToSettleContingentConsideration contextRef="c-85" decimals="-5" id="f-536" unitRef="usd">42900000</coo:BusinessCombinationPaymentToSettleContingentConsideration>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss contextRef="c-86" decimals="-5" id="f-537" unitRef="usd">12200000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries contextRef="c-87" decimals="-5" id="f-538" unitRef="usd">52100000</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-88" decimals="2" id="f-539" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-87" decimals="-6" id="f-540" unitRef="usd">10000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-89" decimals="-6" id="f-541" unitRef="usd">10000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-90" decimals="-5" id="f-542" unitRef="usd">90000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal contextRef="c-5" decimals="-5" id="f-543" unitRef="usd">56900000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-91" decimals="-5" id="f-544" unitRef="usd">-31800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-92" decimals="-5" id="f-545" unitRef="usd">300000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-92" decimals="-5" id="f-546" unitRef="usd">200000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-92" decimals="-5" id="f-547" unitRef="usd">100000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments
      contextRef="c-92"
      decimals="0"
      id="f-548"
      unitRef="installment">2</coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-93" decimals="-5" id="f-549" unitRef="usd">50000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-94" decimals="-5" id="f-550" unitRef="usd">50000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-551">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 4. Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company has three reporting units: CooperVision and within the CooperSurgical segment, Office/Surgical and Fertility, reflecting the current way the Company manages its business. There was no impairment of goodwill in its reporting units in fiscal 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.334%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.582%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperVision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperSurgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,710.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,899.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,609.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net changes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(18.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,747.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,876.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,624.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Of the October&#160;31, 2023, goodwill balance, $237.6 million for CooperSurgical and $20.1 million for CooperVision is expected to be deductible for tax purposes. Of the October&#160;31, 2022, goodwill balance, $214.1&#160;million for CooperSurgical and $22.4&#160;million for CooperVision was expected to be deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.359%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:10pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Weighted-average Amortization Period (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;208.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;209.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;62.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Composite intangible asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,061.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;424.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,061.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;354.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;494.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;335.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;504.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;317.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,099.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;345.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,092.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;287.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;License and distribution rights and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;51.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,916.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,215.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,919.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,044.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: accumulated amortization and translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,215.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,044.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with definite lives, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,701.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,874.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with indefinite lives, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total other intangibles, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,710.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,885.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible assets with indefinite lives include technology and trademarks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Balances include foreign currency translation adjustments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;As of October&#160;31, 2023, the estimate of future amortization expenses for intangible assets with definite lives is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.786%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.014%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal years:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;179.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;169.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;162.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;147.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;143.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;899.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total remaining amortization for intangible assets with definite lives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,701.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of fiscal 2023, CooperVision fully impaired some intangible assets associated with the discontinuation of certain products. The carrying value of these intangible assets were immaterial. The Company performed its annual impairment assessment in the third quarter of fiscal 2023 and determined there was no other impairment to either its definite-lived or indefinite-lived intangible assets during fiscal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023. &lt;/span&gt;&lt;/div&gt;There were no impairment to the Company's definite-lived or indefinite-lived intangible assets during fiscal 2022 and 2021.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:NumberOfReportingUnits
      contextRef="c-1"
      decimals="0"
      id="f-552"
      unitRef="reporting_unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-6" decimals="INF" id="f-553" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="INF" id="f-554" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-5" decimals="INF" id="f-555" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c-1" id="f-556">&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.334%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.582%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperVision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperSurgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,710.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,899.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,609.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net changes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(18.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,747.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,876.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,624.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c-95" decimals="-5" id="f-557" unitRef="usd">1710300000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-96" decimals="-5" id="f-558" unitRef="usd">1899400000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-7" decimals="-5" id="f-559" unitRef="usd">3609700000</us-gaap:Goodwill>
    <us-gaap:GoodwillPeriodIncreaseDecrease contextRef="c-97" decimals="-5" id="f-560" unitRef="usd">7700000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease contextRef="c-98" decimals="-5" id="f-561" unitRef="usd">-3600000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease contextRef="c-1" decimals="-5" id="f-562" unitRef="usd">4100000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-97" decimals="-5" id="f-563" unitRef="usd">29600000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-98" decimals="-5" id="f-564" unitRef="usd">-18900000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-1" decimals="-5" id="f-565" unitRef="usd">10700000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill contextRef="c-99" decimals="-5" id="f-566" unitRef="usd">1747600000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-100" decimals="-5" id="f-567" unitRef="usd">1876900000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-5" id="f-568" unitRef="usd">3624500000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount contextRef="c-100" decimals="-5" id="f-569" unitRef="usd">237600000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount contextRef="c-99" decimals="-5" id="f-570" unitRef="usd">20100000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount contextRef="c-96" decimals="-5" id="f-571" unitRef="usd">214100000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount contextRef="c-95" decimals="-5" id="f-572" unitRef="usd">22400000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-574">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.359%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:10pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Weighted-average Amortization Period (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;208.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;209.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;62.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Composite intangible asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,061.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;424.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,061.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;354.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;494.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;335.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;504.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;317.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,099.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;345.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,092.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;287.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;License and distribution rights and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;51.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,916.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,215.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,919.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,044.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: accumulated amortization and translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,215.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,044.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with definite lives, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,701.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,874.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with indefinite lives, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total other intangibles, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,710.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,885.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible assets with indefinite lives include technology and trademarks.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-573">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.359%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:10pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Weighted-average Amortization Period (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;208.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;209.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;62.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Composite intangible asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,061.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;424.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,061.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;354.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;494.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;335.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;504.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;317.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,099.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;345.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,092.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;287.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;License and distribution rights and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;51.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,916.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,215.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,919.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,044.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: accumulated amortization and translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,215.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,044.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with definite lives, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,701.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,874.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with indefinite lives, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total other intangibles, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,710.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,885.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible assets with indefinite lives include technology and trademarks.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-101" decimals="-5" id="f-575" unitRef="usd">208900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-101" decimals="-5" id="f-576" unitRef="usd">81100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-102" decimals="-5" id="f-577" unitRef="usd">209600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-102" decimals="-5" id="f-578" unitRef="usd">62400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-101" id="f-579">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-103" decimals="-5" id="f-580" unitRef="usd">1061900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-103" decimals="-5" id="f-581" unitRef="usd">424800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-104" decimals="-5" id="f-582" unitRef="usd">1061900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-104" decimals="-5" id="f-583" unitRef="usd">354000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-103" id="f-584">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-105" decimals="-5" id="f-585" unitRef="usd">494500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-105" decimals="-5" id="f-586" unitRef="usd">335400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-106" decimals="-5" id="f-587" unitRef="usd">504100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-106" decimals="-5" id="f-588" unitRef="usd">317500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-105" id="f-589">P13Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-107" decimals="-5" id="f-590" unitRef="usd">1099200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-107" decimals="-5" id="f-591" unitRef="usd">345800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-108" decimals="-5" id="f-592" unitRef="usd">1092700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-108" decimals="-5" id="f-593" unitRef="usd">287000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-107" id="f-594">P19Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-109" decimals="-5" id="f-595" unitRef="usd">51600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-109" decimals="-5" id="f-596" unitRef="usd">28000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-110" decimals="-5" id="f-597" unitRef="usd">50700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-110" decimals="-5" id="f-598" unitRef="usd">23800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-109" id="f-599">P11Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-4" decimals="-5" id="f-600" unitRef="usd">2916100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-5" id="f-601" unitRef="usd">1215100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-7" decimals="-5" id="f-602" unitRef="usd">2919000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-7" decimals="-5" id="f-603" unitRef="usd">1044700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-4" id="f-604">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-5" id="f-605" unitRef="usd">1215100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-7" decimals="-5" id="f-606" unitRef="usd">1044700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-5" id="f-607" unitRef="usd">1701000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-7" decimals="-5" id="f-608" unitRef="usd">1874300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-4" decimals="-5" id="f-609" unitRef="usd">9300000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-7" decimals="-5" id="f-610" unitRef="usd">10800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-5" id="f-611" unitRef="usd">1710300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-7" decimals="-5" id="f-612" unitRef="usd">1885100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock contextRef="c-1" id="f-613">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;As of October&#160;31, 2023, the estimate of future amortization expenses for intangible assets with definite lives is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.786%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.014%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal years:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;179.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;169.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;162.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;147.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;143.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;899.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total remaining amortization for intangible assets with definite lives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,701.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-4" decimals="-5" id="f-614" unitRef="usd">179500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-4" decimals="-5" id="f-615" unitRef="usd">169500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-4" decimals="-5" id="f-616" unitRef="usd">162000000.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-4" decimals="-5" id="f-617" unitRef="usd">147700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-4" decimals="-5" id="f-618" unitRef="usd">143200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-4" decimals="-5" id="f-619" unitRef="usd">899100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-5" id="f-620" unitRef="usd">1701000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-1" decimals="0" id="f-621" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-1" decimals="0" id="f-622" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-6" decimals="0" id="f-623" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-5" decimals="0" id="f-624" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-6" decimals="0" id="f-625" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-5" decimals="0" id="f-626" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-627">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 5. Financing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company had outstanding debt as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.107%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.416%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Overdraft and other credit facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Term loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;338.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Short-term debt, excluding financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;395.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-635"&gt;&lt;span style="-sec-ix-hidden:f-636"&gt;Financing lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Revolving credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;172.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Term loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,350.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,350.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-term debt, excluding financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,520.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,347.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-651"&gt;&lt;span style="-sec-ix-hidden:f-652"&gt;Financing lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,523.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,350.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,569.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,763.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;As of October&#160;31, 2023, the Company was in compliance with all debt covenants. On February 1, 2023, the Company amended its credit agreements to transition the interest rates applicable to the loans denominated in U.S. dollars from LIBOR to SOFR, as defined in the credit agreements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Term Loan Agreement on December 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On December 17, 2021, the Company entered into a Term Loan Agreement (the 2021 Credit Agreement) by and among the Company, the lenders from time to time party thereto, and PNC Bank, National Association, as administrative agent. The 2021 Credit Agreement provides for a term loan facility (the 2021 Term Loan Facility) in an aggregate principal amount of $1.5&#160;billion, which, unless terminated earlier, matures on December 17, 2026. In addition, the Company has the ability from time to time to request an increase to the commitments under the 2021 Term Loan Facility or to establish a new term loan facility under the 2021 Credit Agreement in an aggregate principal amount not to exceed $1.125&#160;billion, upon prior written &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;notice to the administrative agent and subject to the discretionary participation of the lenders funding such term loans and certain limitations set forth in the 2021 Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Amounts outstanding under the 2021 Term Loan Facility will bear interest, at the Company&#x2019;s option, at either (i) the alternate base rate, which is a rate per annum equal to the greatest of (a) the administrative agent&#x2019;s prime rate, (b) one-half of one percent in excess of the federal funds effective rate and (c) one percent in excess of the adjusted SOFR for a one-month interest period in effect on such day, or (ii) the adjusted SOFR, plus, in each case, an applicable rate of, initially, zero basis points, in respect of base rate loans, and 75 basis points, in respect of adjusted SOFR loans. Following a specified period after the closing date, the applicable rates will be determined quarterly by reference to a grid based upon the Company&#x2019;s ratio of consolidated net indebtedness to consolidated EBITDA, each as defined in the 2021 Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company may prepay loan balances from time to time, in whole or in part, without premium or penalty (other than any related breakage costs).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On October&#160;31, 2023, the Company had $1.5&#160;billion outstanding on the 2021 Term Loan Facility and the weighted-average interest rate was 6.41%.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The 2021 Credit Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio, each as defined in the 2021 Credit Agreement, consistent with the 2020 Credit Agreement discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Term Loan Agreement on November 2, 2021&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On November 2, 2021, the Company entered into a 364-day, $840.0&#160;million, term loan agreement by and among the Company, the lenders party thereto and The Bank of Nova Scotia, as administrative agent, which matured subsequent to year end on November 1, 2022. The Company used part of the funds to partially repay outstanding borrowings under the 2020 Revolving Credit Facility and for general corporate purposes. The loan was fully repaid by the maturity date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Revolving Credit and Term Loan Agreement on April 1, 2020&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;On April 1, 2020, the Company entered into a Revolving Credit and Term Loan Agreement (the 2020 Credit Agreement), among the Company, CooperVision International Holding Company, LP, CooperSurgical Netherlands B.V., CooperVision Holding Kft. the lenders from time to time party thereto, and KeyBank National Association, as administrative agent. The 2020 Credit Agreement provides for (a)&#160;a multicurrency revolving credit facility (the 2020 Revolving Credit Facility) in an aggregate principal amount of $1.29 billion and (b)&#160;a term loan facility (the 2020 Term Loan Facility) in an aggregate principal amount of $850.0 million, each of which, unless terminated earlier, mature on April 1, 2025. The Company used $850.0&#160;million under the 2020 Term Loan Facility and $445.0&#160;million under the 2020 Revolving Credit Facility to fully repay all borrowings outstanding under a previously existing term loan agreement and transfer all letters of credit and borrowings outstanding under a previously existing credit agreement to the 2020 Credit Agreement. The Company has an uncommitted option to increase the revolving credit facility or establish a new term loan in an aggregate amount up to $1.605&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On October 30, 2020, the Company entered into Amendment No. 1 to the 2020 Credit Agreement, adding CooperVision International Limited as a revolving borrower and releasing certain borrowers in the 2020 Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;On December 17, 2021, the Company entered into Amendment No.2 to the 2020 Credit Agreement, modifying the 2020 Credit Agreement by, among other things, adding CooperSurgical Holdings Limited as a revolving borrower, releasing CooperVision Holding Kft as a borrower, and updating the benchmark replacement language in the 2020 Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;The 2020 Credit Agreement will bear interest, at the Company&#x2019;s option, at either the alternate base rate, or the adjusted SOFR, or adjusted foreign currency rate, plus, in each case, an applicable rate of between 0.00% and 0.50% in respect of base rate loans, and between 0.75% and 1.50% in respect of adjusted SOFR or adjusted foreign currency rate loans, in each case in accordance with a pricing grid tied to the Total Leverage Ratio, as defined in the 2020 Credit Agreement. The Company may borrow, repay and re-borrow amounts available under the Revolving Credit Facility, subject to voluntary reduction of the revolving commitment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company pays an annual commitment fee that ranges from 0.10% to 0.20% of the unused portion of the 2020 Revolving Credit Facility based upon the Company&#x2019;s Total Leverage Ratio, as defined in the 2020 Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On October&#160;31, 2023, the Company had $850.0 million outstanding under the 2020 Term Loan Facility and $172.6 million outstanding under the 2020 Revolving Credit Facility. The interest rate on the 2020 Term Loan Facility was 6.41% at October&#160;31, 2023. The weighted-average interest rate on the 2020 Revolving Credit Facility was 6.41% at October&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Payments on the outstanding long-term debt balance of $850.0&#160;million are due in the fiscal year ending October 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;European and Asian Pacific Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company maintains European credit facilities. The aggregate facility limit was $32.9 million and $30.7&#160;million at October&#160;31, 2023 and 2022, respectively. At October&#160;31, 2023, $0.7 million of the facilities was utilized and the weighted-average interest rate on the outstanding balances was 7.82%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company maintains yen-denominated credit facilities in Japan. The aggregate facility limit was $74.3 million and $73.0&#160;million at October&#160;31, 2023 and 2022, respectively. At October&#160;31, 2023, $41.4 million of the combined facilities was utilized and the weighted-average interest rate on the outstanding balances was 0.40%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Each facility is supported by a continuing and unconditional guaranty.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c-1" id="f-628">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company had outstanding debt as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.107%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.416%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Overdraft and other credit facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Term loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;338.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Short-term debt, excluding financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;395.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-635"&gt;&lt;span style="-sec-ix-hidden:f-636"&gt;Financing lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Revolving credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;172.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Term loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,350.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,350.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-term debt, excluding financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,520.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,347.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-651"&gt;&lt;span style="-sec-ix-hidden:f-652"&gt;Financing lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,523.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,350.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,569.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,763.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:ShortTermBorrowings contextRef="c-111" decimals="-5" id="f-629" unitRef="usd">44400000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c-112" decimals="-5" id="f-630" unitRef="usd">57700000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c-113" decimals="-5" id="f-631" unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c-114" decimals="-5" id="f-632" unitRef="usd">338000000.0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c-4" decimals="-5" id="f-633" unitRef="usd">44400000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c-7" decimals="-5" id="f-634" unitRef="usd">395700000</us-gaap:ShortTermBorrowings>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-4" decimals="-5" id="f-637" unitRef="usd">1000000.0</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-7" decimals="-5" id="f-638" unitRef="usd">16900000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:DebtCurrent contextRef="c-4" decimals="-5" id="f-639" unitRef="usd">45400000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent contextRef="c-7" decimals="-5" id="f-640" unitRef="usd">412600000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-115" decimals="-5" id="f-641" unitRef="usd">172600000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-116" decimals="-5" id="f-642" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-117" decimals="-5" id="f-643" unitRef="usd">2350000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-118" decimals="-5" id="f-644" unitRef="usd">2350000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-119" decimals="-5" id="f-645" unitRef="usd">200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-120" decimals="-5" id="f-646" unitRef="usd">200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNoncurrentNet contextRef="c-4" decimals="-5" id="f-647" unitRef="usd">2400000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet contextRef="c-7" decimals="-5" id="f-648" unitRef="usd">3100000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-5" id="f-649" unitRef="usd">2520400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-7" decimals="-5" id="f-650" unitRef="usd">2347100000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-653" unitRef="usd">3400000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-7" decimals="-5" id="f-654" unitRef="usd">3700000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-4" decimals="-5" id="f-655" unitRef="usd">2523800000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-7" decimals="-5" id="f-656" unitRef="usd">2350800000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount contextRef="c-4" decimals="-5" id="f-657" unitRef="usd">2569200000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount contextRef="c-7" decimals="-5" id="f-658" unitRef="usd">2763400000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-121" decimals="-8" id="f-659" unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <coo:LineOfCreditFacilityAccordionFeatureIncreaseLimit contextRef="c-121" decimals="-6" id="f-660" unitRef="usd">1125000000</coo:LineOfCreditFacilityAccordionFeatureIncreaseLimit>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-122" decimals="2" id="f-661" unitRef="number">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-123" decimals="0" id="f-662" unitRef="number">0</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-124" decimals="4" id="f-663" unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LongTermLineOfCredit contextRef="c-125" decimals="-8" id="f-664" unitRef="usd">1500000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="c-125" decimals="4" id="f-665" unitRef="number">0.0641</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:DebtInstrumentTerm contextRef="c-126" id="f-666">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-127" decimals="INF" id="f-667" unitRef="usd">840000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-128" decimals="INF" id="f-668" unitRef="usd">1290000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-129" decimals="INF" id="f-669" unitRef="usd">850000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLongTermLinesOfCredit contextRef="c-130" decimals="-5" id="f-670" unitRef="usd">850000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit contextRef="c-131" decimals="-5" id="f-671" unitRef="usd">445000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <coo:LineOfCreditFacilityAccordionFeatureIncreaseLimit contextRef="c-132" decimals="-6" id="f-672" unitRef="usd">1605000000</coo:LineOfCreditFacilityAccordionFeatureIncreaseLimit>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-133"
      decimals="INF"
      id="f-673"
      unitRef="number">0.0000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-134"
      decimals="INF"
      id="f-674"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-135"
      decimals="INF"
      id="f-675"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-136"
      decimals="INF"
      id="f-676"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-137"
      decimals="INF"
      id="f-677"
      unitRef="number">0.0010</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-138"
      decimals="INF"
      id="f-678"
      unitRef="number">0.0020</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LongTermLineOfCredit contextRef="c-139" decimals="-5" id="f-679" unitRef="usd">850000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit contextRef="c-140" decimals="-5" id="f-680" unitRef="usd">172600000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="c-139" decimals="4" id="f-681" unitRef="number">0.0641</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="c-140" decimals="4" id="f-682" unitRef="number">0.0641</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LongTermLineOfCredit contextRef="c-139" decimals="-5" id="f-683" unitRef="usd">850000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-141" decimals="INF" id="f-684" unitRef="usd">32900000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-142" decimals="INF" id="f-685" unitRef="usd">30700000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit contextRef="c-141" decimals="-5" id="f-686" unitRef="usd">700000</us-gaap:LineOfCredit>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="c-141" decimals="4" id="f-687" unitRef="number">0.0782</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-143" decimals="INF" id="f-688" unitRef="usd">74300000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-144" decimals="INF" id="f-689" unitRef="usd">73000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit contextRef="c-143" decimals="-5" id="f-690" unitRef="usd">41400000</us-gaap:LineOfCredit>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="c-143" decimals="4" id="f-691" unitRef="number">0.0040</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-693">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 6. Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;In November 2020, the Company completed an intra-group transfer of certain intellectual property and related assets of CooperVision to a UK subsidiary as part of a group restructuring to establish headquarters operations in the UK. Determining fair value involved significant judgment related to future revenue growth, operating margins, and discount rates. The transfer resulted in a step-up of the UK tax-deductible basis in the intellectual property and goodwill, creating a temporary difference between the book basis and the tax basis of these assets. As a result, the Company recognized a deferred tax asset of $1,987.9&#160;million, with a corresponding income tax benefit, during the first quarter of fiscal 2021. During the third quarter of fiscal 2021, the Company recognized a $536.7&#160;million tax benefit related primarily to the remeasurement of this deferred tax asset caused by the UK enactment of a 25% corporate tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;Components of income before income taxes:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.064%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(135.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(31.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;548.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;443.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;522.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;412.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;475.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;Components of provision for income taxes: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.064%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;37.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;74.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(36.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;88.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;45.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,492.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,502.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;118.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;89.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,453.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.064%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Provision for income taxes at United States statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;86.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;99.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;103.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(Decrease) increase in taxes resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign earnings in jurisdictions with different tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(22.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign earnings subject to United States tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Excess tax benefits from share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intra-group transfer to UK subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,987.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Remeasurement of deferred tax assets from UK rate change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(536.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Change in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;State tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;118.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;89.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,453.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Components of deferred tax assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.811%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Accrued liabilities, reserves and compensation accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;94.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;79.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign deferred tax assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,369.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,500.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net operating loss and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capitalized research and experimental expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,548.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,641.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(20.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(60.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,528.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,581.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax deductible goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(47.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(132.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(51.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(48.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(49.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(45.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(280.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(287.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,248.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,293.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In assessing the realizability of deferred tax assets, the Company analyzes whether some or all deferred tax assets will not be realized. This analysis considers historical taxable income, the projected reversal of deferred tax liabilities, projected taxable income and tax planning strategies. Based upon this analysis, it is more likely than not the deferred tax assets, net of valuation allowance, will be realized. The decrease in valuation allowance is primarily related to foreign tax attributes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;At October&#160;31, 2023, the Company had federal net operating loss carryforwards of $78.7&#160;million and state net operating loss carryforwards of $87.1&#160;million. Federal net operating loss carryforwards of $46.0&#160;million expire on various dates between 2024 and 2037 and $32.7&#160;million do not expire. The state net operating loss carryforwards expire on various dates between 2027 through 2044.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;A tax benefit is recognized if it is more likely than not that a tax position will be sustained on its technical merits, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Changes in unrecognized tax benefits:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.737%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;353.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Decrease based on tax positions in prior fiscal years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Lapses of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;336.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Decrease based on tax positions in prior fiscal years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Increase based on tax positions in current fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Lapses of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;331.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;These tax benefits, if recognized, would reduce provision for income taxes for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;, by $323.2&#160;million, $324.3&#160;million, and $336.5&#160;million, respectively. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes. As of October 31, 2023, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;, accrued gross interest and penalties related to unrecognized tax benefits was $5.8&#160;million, $5.4&#160;million, and $6.4&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Included in the balance of unrecognized tax benefits at October&#160;31, 2023, is $8.1&#160;million related to tax positions for which it is reasonably possible that the total amounts could change during the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Filed tax returns are subject to examination by tax authorities in major tax jurisdictions after fiscal 2018, including the UK and the US.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory contextRef="c-146" decimals="-5" id="f-694" unitRef="usd">1987900000</us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-147" decimals="-5" id="f-695" unitRef="usd">-536700000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c-1" id="f-696">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;Components of income before income taxes:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.064%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(135.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(31.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;548.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;443.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;522.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;412.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;475.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-1" decimals="-5" id="f-697" unitRef="usd">-135700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-5" decimals="-5" id="f-698" unitRef="usd">31400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-6" decimals="-5" id="f-699" unitRef="usd">-31000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-1" decimals="-5" id="f-700" unitRef="usd">548600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-5" decimals="-5" id="f-701" unitRef="usd">443900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-6" decimals="-5" id="f-702" unitRef="usd">522500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-703" unitRef="usd">412900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-704" unitRef="usd">475300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-5" id="f-705" unitRef="usd">491500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-706">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;Components of provision for income taxes: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.064%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;37.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;74.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(36.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;88.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;45.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,492.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,502.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;118.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;89.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,453.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-707" unitRef="usd">37300000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-708" unitRef="usd">10200000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-709" unitRef="usd">21000000.0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-710" unitRef="usd">3700000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-711" unitRef="usd">3800000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-712" unitRef="usd">1300000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-713" unitRef="usd">33000000.0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-714" unitRef="usd">21700000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-715" unitRef="usd">26700000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-716" unitRef="usd">74000000.0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-717" unitRef="usd">35700000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-718" unitRef="usd">49000000.0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-719" unitRef="usd">-36700000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-720" unitRef="usd">10500000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-721" unitRef="usd">-8800000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-722" unitRef="usd">-7500000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-723" unitRef="usd">-2200000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-724" unitRef="usd">-500000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-725" unitRef="usd">88900000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-726" unitRef="usd">45600000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-727" unitRef="usd">-2492900000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-728" unitRef="usd">44700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-729" unitRef="usd">53900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-730" unitRef="usd">-2502200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-731" unitRef="usd">118700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-732" unitRef="usd">89500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-733" unitRef="usd">-2453200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-734">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.064%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Provision for income taxes at United States statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;86.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;99.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;103.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(Decrease) increase in taxes resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign earnings in jurisdictions with different tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(22.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign earnings subject to United States tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Excess tax benefits from share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intra-group transfer to UK subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,987.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Remeasurement of deferred tax assets from UK rate change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(536.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Change in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;State tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;118.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;89.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,453.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="-5" id="f-735" unitRef="usd">86700000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-5" decimals="-5" id="f-736" unitRef="usd">99800000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-6" decimals="-5" id="f-737" unitRef="usd">103200000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="-5" id="f-738" unitRef="usd">7000000.0</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-5" decimals="-5" id="f-739" unitRef="usd">-22300000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-6" decimals="-5" id="f-740" unitRef="usd">-43600000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings contextRef="c-1" decimals="-5" id="f-741" unitRef="usd">34300000</us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings>
    <us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings contextRef="c-5" decimals="-5" id="f-742" unitRef="usd">21100000</us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings>
    <us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings contextRef="c-6" decimals="-5" id="f-743" unitRef="usd">25400000</us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="-5" id="f-744" unitRef="usd">-2400000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-5" decimals="-5" id="f-745" unitRef="usd">-2600000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-6" decimals="-5" id="f-746" unitRef="usd">-13000000.0</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationDispositionOfAssets contextRef="c-1" decimals="-5" id="f-747" unitRef="usd">0</us-gaap:IncomeTaxReconciliationDispositionOfAssets>
    <us-gaap:IncomeTaxReconciliationDispositionOfAssets contextRef="c-5" decimals="-5" id="f-748" unitRef="usd">0</us-gaap:IncomeTaxReconciliationDispositionOfAssets>
    <us-gaap:IncomeTaxReconciliationDispositionOfAssets contextRef="c-6" decimals="-5" id="f-749" unitRef="usd">-1987800000</us-gaap:IncomeTaxReconciliationDispositionOfAssets>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-1" decimals="-5" id="f-750" unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-5" decimals="-5" id="f-751" unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-6" decimals="-5" id="f-752" unitRef="usd">-536700000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount contextRef="c-1" decimals="-5" id="f-753" unitRef="usd">0</coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount>
    <coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount contextRef="c-5" decimals="-5" id="f-754" unitRef="usd">-12700000</coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount>
    <coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount contextRef="c-6" decimals="-5" id="f-755" unitRef="usd">-7600000</coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="-5" id="f-756" unitRef="usd">-4200000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-5" decimals="-5" id="f-757" unitRef="usd">5000000.0</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-6" decimals="-5" id="f-758" unitRef="usd">800000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-1" decimals="-5" id="f-759" unitRef="usd">-2700000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-5" decimals="-5" id="f-760" unitRef="usd">1200000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-6" decimals="-5" id="f-761" unitRef="usd">6100000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-762" unitRef="usd">118700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-763" unitRef="usd">89500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-764" unitRef="usd">-2453200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-765">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Components of deferred tax assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.811%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.062%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Accrued liabilities, reserves and compensation accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;94.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;79.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign deferred tax assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,369.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,500.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net operating loss and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capitalized research and experimental expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,548.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,641.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(20.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(60.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,528.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,581.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax deductible goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(47.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(132.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(51.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(48.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(49.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(45.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(280.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(287.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,248.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,293.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-4" decimals="-5" id="f-766" unitRef="usd">7500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-7" decimals="-5" id="f-767" unitRef="usd">4900000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsInventory contextRef="c-4" decimals="-5" id="f-768" unitRef="usd">14300000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory contextRef="c-7" decimals="-5" id="f-769" unitRef="usd">6300000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-4" decimals="-5" id="f-770" unitRef="usd">94800000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-7" decimals="-5" id="f-771" unitRef="usd">79900000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign contextRef="c-4" decimals="-5" id="f-772" unitRef="usd">2369500000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign contextRef="c-7" decimals="-5" id="f-773" unitRef="usd">2500500000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-4" decimals="-5" id="f-774" unitRef="usd">14800000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-7" decimals="-5" id="f-775" unitRef="usd">14500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <coo:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards contextRef="c-4" decimals="-5" id="f-776" unitRef="usd">24300000</coo:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards>
    <coo:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards contextRef="c-7" decimals="-5" id="f-777" unitRef="usd">19600000</coo:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c-4" decimals="-5" id="f-778" unitRef="usd">23600000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c-7" decimals="-5" id="f-779" unitRef="usd">15400000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-4" decimals="-5" id="f-780" unitRef="usd">2548800000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-7" decimals="-5" id="f-781" unitRef="usd">2641100000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-5" id="f-782" unitRef="usd">20700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-7" decimals="-5" id="f-783" unitRef="usd">60100000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-4" decimals="-5" id="f-784" unitRef="usd">2528100000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-7" decimals="-5" id="f-785" unitRef="usd">2581000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill contextRef="c-4" decimals="-5" id="f-786" unitRef="usd">47400000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill contextRef="c-7" decimals="-5" id="f-787" unitRef="usd">39700000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="c-4" decimals="-5" id="f-788" unitRef="usd">132400000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="c-7" decimals="-5" id="f-789" unitRef="usd">153800000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-4" decimals="-5" id="f-790" unitRef="usd">51200000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-7" decimals="-5" id="f-791" unitRef="usd">48800000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <coo:DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign contextRef="c-4" decimals="-5" id="f-792" unitRef="usd">49000000.0</coo:DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign>
    <coo:DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign contextRef="c-7" decimals="-5" id="f-793" unitRef="usd">45500000</coo:DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-4" decimals="-5" id="f-794" unitRef="usd">280000000.0</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-7" decimals="-5" id="f-795" unitRef="usd">287800000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-4" decimals="-5" id="f-796" unitRef="usd">2248100000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-7" decimals="-5" id="f-797" unitRef="usd">2293200000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards contextRef="c-148" decimals="-5" id="f-798" unitRef="usd">78700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-149" decimals="-5" id="f-799" unitRef="usd">87100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-148" decimals="-5" id="f-800" unitRef="usd">46000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="c-148" decimals="-5" id="f-801" unitRef="usd">32700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c-1" id="f-802">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Changes in unrecognized tax benefits:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.737%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;353.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Decrease based on tax positions in prior fiscal years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Lapses of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;336.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Decrease based on tax positions in prior fiscal years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Increase based on tax positions in current fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Lapses of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;331.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-32" decimals="-5" id="f-803" unitRef="usd">353800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-5" decimals="-5" id="f-804" unitRef="usd">12500000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-5" decimals="-5" id="f-805" unitRef="usd">200000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-5" decimals="-5" id="f-806" unitRef="usd">4200000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-7" decimals="-5" id="f-807" unitRef="usd">336900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-5" id="f-808" unitRef="usd">500000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-5" id="f-809" unitRef="usd">2000000.0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-1" decimals="-5" id="f-810" unitRef="usd">6900000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-5" id="f-811" unitRef="usd">331500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-4" decimals="-5" id="f-812" unitRef="usd">323200000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-7" decimals="-5" id="f-813" unitRef="usd">324300000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-32" decimals="-5" id="f-814" unitRef="usd">336500000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-4" decimals="-5" id="f-815" unitRef="usd">5800000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-7" decimals="-5" id="f-816" unitRef="usd">5400000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-32" decimals="-5" id="f-817" unitRef="usd">6400000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit contextRef="c-4" decimals="-5" id="f-818" unitRef="usd">8100000</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-819">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 7. Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.132%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.135%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions, except for earnings per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;294.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;385.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,944.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;Basic:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;59.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;Diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Effect of dilutive stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;59.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table sets forth stock options to purchase our common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.248%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.248%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.251%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except exercise prices)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Stock option shares excluded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Exercise prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$300.12 - $406.17&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$300.12 - $406.17&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;345.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Restricted stock units excluded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-820">&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.132%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.135%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions, except for earnings per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;294.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;385.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,944.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;Basic:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;59.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;Diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Effect of dilutive stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;59.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-821" unitRef="usd">294200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-822" unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-823" unitRef="usd">2944700000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-824" unitRef="shares">49500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-825" unitRef="shares">49300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-5" id="f-826" unitRef="shares">49200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-827"
      unitRef="usdPerShare">5.94</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-828"
      unitRef="usdPerShare">7.83</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-829"
      unitRef="usdPerShare">59.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-830" unitRef="shares">49500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-831" unitRef="shares">49300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-5" id="f-832" unitRef="shares">49200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-1" decimals="-5" id="f-833" unitRef="shares">300000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-5" decimals="-5" id="f-834" unitRef="shares">400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-6" decimals="-5" id="f-835" unitRef="shares">600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-836" unitRef="shares">49800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-837" unitRef="shares">49700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-5" id="f-838" unitRef="shares">49800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-839"
      unitRef="usdPerShare">5.91</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-840"
      unitRef="usdPerShare">7.76</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-841"
      unitRef="usdPerShare">59.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-842">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table sets forth stock options to purchase our common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.248%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.248%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.251%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except exercise prices)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Stock option shares excluded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Exercise prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$300.12 - $406.17&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$300.12 - $406.17&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;345.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Restricted stock units excluded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-150"
      decimals="-3"
      id="f-843"
      unitRef="shares">311000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-151"
      decimals="-3"
      id="f-844"
      unitRef="shares">227000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-152"
      decimals="-3"
      id="f-845"
      unitRef="shares">107000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-1"
      decimals="2"
      id="f-846"
      unitRef="usdPerShare">300.12</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-1"
      decimals="2"
      id="f-847"
      unitRef="usdPerShare">406.17</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-5"
      decimals="2"
      id="f-848"
      unitRef="usdPerShare">300.12</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-5"
      decimals="2"
      id="f-849"
      unitRef="usdPerShare">406.17</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-6"
      decimals="2"
      id="f-850"
      unitRef="usdPerShare">345.74</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-6"
      decimals="2"
      id="f-851"
      unitRef="usdPerShare">345.74</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-153"
      decimals="-3"
      id="f-852"
      unitRef="shares">15000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-154"
      decimals="-3"
      id="f-853"
      unitRef="shares">87000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-155"
      decimals="-3"
      id="f-854"
      unitRef="shares">2000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-855">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 8. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Analysis of Changes in Accumulated Other Comprehensive Income (Loss):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.983%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Minimum Pension Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(402.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(56.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(472.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Gross change in value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;146.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(320.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(341.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Gross change in value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(234.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;107.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(90.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(555.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(466.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Gross change in value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(538.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;87.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(453.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Share Repurchases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In December 2011, the Company's Board of Directors authorized the 2012 Program and through subsequent amendments, the most recent in March 2017, the total repurchase authorization was increased from $500.0 million to $1.0 billion of the Company's common stock. This program has no expiration date and may be discontinued at any time. Purchases under the 2012 Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements. As of October&#160;31, 2023, $256.4 million remained authorized for repurchase under the program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;During the year ended October&#160;31, 2023, there were no share repurchases under the 2012 Program. During the year ended October&#160;31, 2022, the Company repurchased 191.2 thousand&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;shares of its common stock for $78.5 million, at an average purchase price of $410.41 per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In fiscal 2023 and 2022, the Company declared regular dividends of 6&#160;cents per share (a semiannual dividend of 3&#160;cents per share) and paid a total of $3.0&#160;million in each fiscal year. In December 2023, our Board of Directors decided to end the declaration of the semiannual dividend.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Subsequent Event&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On December 7, 2023, we announced that our Board of Directors had approved a four-for-one stock split of our outstanding shares of common stock which we expect to be effected as of February 16, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-856">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Analysis of Changes in Accumulated Other Comprehensive Income (Loss):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.983%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Minimum Pension Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(402.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(56.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(472.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Gross change in value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;146.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(320.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(341.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Gross change in value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(234.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;107.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(90.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(555.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(466.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Gross change in value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(538.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;87.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(453.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The following table details the changes in the cumulative pre-tax impact of the gain on derivatives designated for hedge accounting:&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance gain as of October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount recognized in other comprehensive income on interest rate swap contracts, gross ($79.7, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;105.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount reclassified from other comprehensive income into earnings, gross ($1.7, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance gain as of October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;124.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount recognized in other comprehensive income on interest rate swap contracts, gross ($25.7, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount reclassified from other comprehensive income into earnings, gross ($(32.7), net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance gain as of October 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;115.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-156" decimals="-5" id="f-857" unitRef="usd">-402300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-157" decimals="-5" id="f-858" unitRef="usd">-13000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-158" decimals="-5" id="f-859" unitRef="usd">-56700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-12" decimals="-5" id="f-860" unitRef="usd">-472000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-159" decimals="-5" id="f-861" unitRef="usd">82200000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-160" decimals="-5" id="f-862" unitRef="usd">34300000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-161" decimals="-5" id="f-863" unitRef="usd">29800000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-6" decimals="-5" id="f-864" unitRef="usd">146300000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax contextRef="c-159" decimals="-5" id="f-865" unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax contextRef="c-160" decimals="-5" id="f-866" unitRef="usd">8200000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax contextRef="c-161" decimals="-5" id="f-867" unitRef="usd">7200000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax contextRef="c-6" decimals="-5" id="f-868" unitRef="usd">15600000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-162" decimals="-5" id="f-869" unitRef="usd">-320300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-163" decimals="-5" id="f-870" unitRef="usd">13100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-164" decimals="-5" id="f-871" unitRef="usd">-34100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-5" id="f-872" unitRef="usd">-341300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-165" decimals="-5" id="f-873" unitRef="usd">-234700000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-166" decimals="-5" id="f-874" unitRef="usd">107400000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-167" decimals="-5" id="f-875" unitRef="usd">36600000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-5" decimals="-5" id="f-876" unitRef="usd">-90700000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax contextRef="c-165" decimals="-5" id="f-877" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax contextRef="c-166" decimals="-5" id="f-878" unitRef="usd">26100000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax contextRef="c-167" decimals="-5" id="f-879" unitRef="usd">8700000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax contextRef="c-5" decimals="-5" id="f-880" unitRef="usd">34800000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-168" decimals="-5" id="f-881" unitRef="usd">-555000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-169" decimals="-5" id="f-882" unitRef="usd">94400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-170" decimals="-5" id="f-883" unitRef="usd">-6200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-42" decimals="-5" id="f-884" unitRef="usd">-466800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-171" decimals="-5" id="f-885" unitRef="usd">17000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-172" decimals="-5" id="f-886" unitRef="usd">-9400000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-173" decimals="-5" id="f-887" unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-1" decimals="-5" id="f-888" unitRef="usd">11600000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax contextRef="c-171" decimals="-5" id="f-889" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax contextRef="c-172" decimals="-5" id="f-890" unitRef="usd">-2400000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax contextRef="c-173" decimals="-5" id="f-891" unitRef="usd">1000000.0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax contextRef="c-1" decimals="-5" id="f-892" unitRef="usd">-1400000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-174" decimals="-5" id="f-893" unitRef="usd">-538000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-175" decimals="-5" id="f-894" unitRef="usd">87400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-176" decimals="-5" id="f-895" unitRef="usd">-3200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-54" decimals="-5" id="f-896" unitRef="usd">-453800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-177" decimals="-5" id="f-897" unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-178" decimals="-8" id="f-898" unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-4" decimals="-5" id="f-899" unitRef="usd">256400000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-1" decimals="INF" id="f-900" unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-5" decimals="INF" id="f-901" unitRef="shares">191200</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-5" decimals="-5" id="f-902" unitRef="usd">78500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-5"
      decimals="2"
      id="f-903"
      unitRef="usdPerShare">410.41</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1"
      decimals="2"
      id="f-904"
      unitRef="usdPerShare">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-5"
      decimals="2"
      id="f-905"
      unitRef="usdPerShare">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-179"
      decimals="2"
      id="f-906"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-180"
      decimals="2"
      id="f-907"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-181"
      decimals="2"
      id="f-908"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-182"
      decimals="2"
      id="f-909"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-1" decimals="-5" id="f-910" unitRef="usd">3000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-5" decimals="-5" id="f-911" unitRef="usd">3000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="c-183"
      decimals="INF"
      id="f-912"
      unitRef="number">4</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-913">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 9. Stock Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;2007 Long-Term Incentive Plan (2007 Plan)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In March 2007, we received stockholder approval of the 2007 Plan. The 2007 Plan was subsequently amended and restated, and granted stockholder approval in March 2009, March 2011, and March 2016.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Third Amended and Restated 2007 Plan authorizes either our Board of Directors, or a designated committee thereof composed of two or more Non-Employee Directors, to grant to eligible individuals during the period ending December&#160;31, 2026, up to 6,930,000 shares in the form of specified equity awards including stock options, restricted stock units and performance share awards. RSUs have no dividend or voting rights prior to vesting. Awards under the 2007 Plan remain outstanding but new awards are no longer being granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;2023 Long-Term Incentive Plan (2023 Plan)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In March 2023, we received stockholder approval of the 2023 Plan. The 2023 Plan authorizes either our Board of Directors, or a designated committee thereof composed of two or more Non-Employee Directors, to grant to eligible individuals up to 1,365,000 shares in the form of specified equity awards including stock options, restricted stock units (RSUs) and performance share units (PSUs), subject to adjustment for future stock splits, stock dividends, expirations, forfeitures, and similar events. In addition, the 2023 Plan includes any shares which were available for issuance under the 2007 Plan at the time of stockholder approval of this plan and shares which become available as a result of the forfeiture or expiration of awards made under the 2007 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;As of October&#160;31, 2023, 1,376,240 shares remained available under the 2023 Plan for future grants. The amount of available shares includes shares which may be distributed under performance shares.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The compensation expense and related income tax benefit recognized in our Consolidated Statements of Income for share-based awards, including the Employee Stock Purchase Plan, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.593%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;54.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;46.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;62.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;54.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Related income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Stock Options &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option award granted is estimated on the date of grant using the Black-Scholes option valuation model and assumptions noted in the following table. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.511%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.178%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Years Ended October&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;30.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The activity and status of our stock option plans are summarized below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Outstanding at October&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,063,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;86,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;329.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(71,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;155.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;337.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Outstanding at October&#160;31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,077,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;277.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.36&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,510,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at October 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,059,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;276.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;53,475,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at October&#160;31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;729,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;248.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;50,797,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The weighted-average fair value of options granted during fiscal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;, estimated as of the grant date using the Black-Scholes option pricing model, was $103.17, $90.41 and $84.10, respectively. The total intrinsic value of options exercised during the fiscal years ended October&#160;31, 2023, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; was $13.4&#160;million, $6.6&#160;million and $64.7&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Stock options outstanding under our current plans have been granted at prices which are either equal to or above the market value of the common stock on the date of grant. Options granted under the 2007 Plan and 2023 Plan generally vest over a range of &lt;span style="-sec-ix-hidden:f-975"&gt;three&lt;/span&gt; to five years based on service conditions and expire no later than ten years after the grant date. We generally recognize compensation expense ratably over the vesting period. As of October&#160;31, 2023, there was $17.6&#160;million of total unrecognized compensation cost related to nonvested options, which is expected to be recognized over a remaining weighted-average vesting period of 2.1 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;RSUs granted under the 2007 Plan and the 2023 Plan generally vest over &lt;span style="-sec-ix-hidden:f-980"&gt;three&lt;/span&gt; to five years. The grant-date fair value of RSUs is estimated based on the market price of our common stock. We recognize compensation expense ratably over the vesting period. As of October&#160;31, 2023, there was $63.1&#160;million of total unrecognized compensation cost related to nonvested RSUs, which is expected to be recognized over a remaining weighted-average vesting period of 2.4 years. The total fair value of RSU grants that vested during the fiscal years ended October&#160;31, 2023, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; was $37.3&#160;million, $46.1&#160;million and $50.1&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The status of our non-vested RSUs is summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.248%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.190%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.192%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&#160;Fair&lt;br/&gt;Value&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Non-vested RSUs at October&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;289,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;340.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;145,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;335.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(107,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;320.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(37,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;344.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Non-vested RSUs at October&#160;31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;290,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;345.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Performance Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Performance units may be granted to selected key employees with vesting contingent upon meeting certain performance goals over a defined performance cycle, usually three years. Performance units, if earned, may be paid in cash or shares of common stock. We granted performance unit awards on December 13, 2022, December 7, 2021, and December 8, 2020, under the 2007 Plan, with three-year performance periods ending in fiscal 2025, fiscal 2024, and fiscal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; respectively. The performance shares actually earned will range from zero to 200% of the target number of performance shares. Subject to limited exceptions set forth in the performance share agreement, any shares earned will be distributed in the subsequent fiscal year after the performance period. The fair value of performance unit awards is estimated on the date of grant based on the current market price of our common stock. The amount of compensation expense related to these performance unit awards is reviewed each fiscal quarter and adjustments are recorded after assessing the probability of achieving the performance goals.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We recognize compensation expense ratably over the vesting period. As of October&#160;31, 2023, there was $12.3&#160;million of total unrecognized compensation cost related to non-vested performance units, which is expected to be recognized over a remaining weighted-average vesting period of 1.7 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On March 18, 2019, the Company received stockholder approval for the Employee Stock Purchase Plan (ESPP). The first offering period began on November 4, 2019, and offerings are generally made on a quarterly basis. The purpose of the ESPP is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at 85% of the market price on the last business day of each offering period by means of accumulated payroll deductions. The ESPP initially authorized the issuance of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;1,000,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; shares of common stock. These shares will be made available from shares of common stock reacquired by the Company as Treasury Stock. During fiscal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; and 2022, we issued 26,116 and 22,695 shares to our employees under the ESPP, respectively. At October&#160;31, 2023, the number of shares remaining available for future issuance under the ESPP was 921,975 shares. Total ESPP share-based compensation recognized during fiscal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; and 2022 was $1.3&#160;million and $1.1 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee
      contextRef="c-184"
      decimals="INF"
      id="f-914"
      unitRef="director">2</coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-185"
      decimals="INF"
      id="f-915"
      unitRef="shares">6930000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee
      contextRef="c-186"
      decimals="INF"
      id="f-916"
      unitRef="director">2</coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-187"
      decimals="INF"
      id="f-917"
      unitRef="shares">1365000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-188"
      decimals="INF"
      id="f-918"
      unitRef="shares">1376240</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-919">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The compensation expense and related income tax benefit recognized in our Consolidated Statements of Income for share-based awards, including the Employee Stock Purchase Plan, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.593%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;54.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;46.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;62.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;54.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Related income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-189" decimals="-5" id="f-920" unitRef="usd">54800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-70" decimals="-5" id="f-921" unitRef="usd">46700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-190" decimals="-5" id="f-922" unitRef="usd">38400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-191" decimals="-5" id="f-923" unitRef="usd">4200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-69" decimals="-5" id="f-924" unitRef="usd">4500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-192" decimals="-5" id="f-925" unitRef="usd">3900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-193" decimals="-5" id="f-926" unitRef="usd">3100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-194" decimals="-5" id="f-927" unitRef="usd">3000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-195" decimals="-5" id="f-928" unitRef="usd">2400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-5" id="f-929" unitRef="usd">62100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-5" id="f-930" unitRef="usd">54200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-6" decimals="-5" id="f-931" unitRef="usd">44700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-1" decimals="-5" id="f-932" unitRef="usd">5000000.0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-5" decimals="-5" id="f-933" unitRef="usd">5000000.0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-6" decimals="-5" id="f-934" unitRef="usd">5600000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-935">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.511%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.178%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Years Ended October&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;30.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-196" id="f-936">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-197" id="f-937">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-6" id="f-938">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-196" decimals="3" id="f-939" unitRef="number">0.295</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-197" decimals="3" id="f-940" unitRef="number">0.258</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-198" decimals="3" id="f-941" unitRef="number">0.303</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-196" decimals="3" id="f-942" unitRef="number">0.038</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-197" decimals="3" id="f-943" unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-198" decimals="3" id="f-944" unitRef="number">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-196" decimals="4" id="f-945" unitRef="number">0.0002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-197" decimals="4" id="f-946" unitRef="number">0.0002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-198" decimals="4" id="f-947" unitRef="number">0.0002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-948">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The activity and status of our stock option plans are summarized below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Outstanding at October&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,063,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;86,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;329.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(71,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;155.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;337.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Outstanding at October&#160;31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,077,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;277.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.36&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,510,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at October 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,059,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;276.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;53,475,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at October&#160;31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;729,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;248.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;50,797,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-199"
      decimals="INF"
      id="f-949"
      unitRef="shares">1063843</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-199"
      decimals="2"
      id="f-950"
      unitRef="usdPerShare">264.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-196"
      decimals="INF"
      id="f-951"
      unitRef="shares">86241</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-196"
      decimals="2"
      id="f-952"
      unitRef="usdPerShare">329.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-196"
      decimals="INF"
      id="f-953"
      unitRef="shares">71808</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-196"
      decimals="2"
      id="f-954"
      unitRef="usdPerShare">155.45</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c-196"
      decimals="INF"
      id="f-955"
      unitRef="shares">720</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-196"
      decimals="2"
      id="f-956"
      unitRef="usdPerShare">337.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-200"
      decimals="INF"
      id="f-957"
      unitRef="shares">1077556</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-200"
      decimals="2"
      id="f-958"
      unitRef="usdPerShare">277.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-196" id="f-959">P5Y4M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-200" decimals="0" id="f-960" unitRef="usd">53510367</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="c-4" decimals="INF" id="f-961" unitRef="shares">1059841</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-962"
      unitRef="usdPerShare">276.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-963">P5Y3M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c-4" decimals="0" id="f-964" unitRef="usd">53475275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c-4" decimals="INF" id="f-965" unitRef="shares">729591</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-966"
      unitRef="usdPerShare">248.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-967">P4Y4M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-4" decimals="0" id="f-968" unitRef="usd">50797891</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-201"
      decimals="2"
      id="f-969"
      unitRef="usdPerShare">103.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-202"
      decimals="2"
      id="f-970"
      unitRef="usdPerShare">90.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-203"
      decimals="2"
      id="f-971"
      unitRef="usdPerShare">84.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-201" decimals="-5" id="f-972" unitRef="usd">13400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-202" decimals="-5" id="f-973" unitRef="usd">6600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-203" decimals="-5" id="f-974" unitRef="usd">64700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-205" id="f-976">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-201" id="f-977">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-4" decimals="-5" id="f-978" unitRef="usd">17600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-196" id="f-979">P2Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-207" id="f-981">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-208" decimals="-5" id="f-982" unitRef="usd">63100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-209" id="f-983">P2Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-209" decimals="-5" id="f-984" unitRef="usd">37300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-210" decimals="-5" id="f-985" unitRef="usd">46100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-211" decimals="-5" id="f-986" unitRef="usd">50100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock contextRef="c-1" id="f-987">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The status of our non-vested RSUs is summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.248%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.190%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.192%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&#160;Fair&lt;br/&gt;Value&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Non-vested RSUs at October&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;289,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;340.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;145,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;335.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(107,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;320.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(37,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;344.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Non-vested RSUs at October&#160;31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;290,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;345.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-212"
      decimals="INF"
      id="f-988"
      unitRef="shares">289238</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-212"
      decimals="2"
      id="f-989"
      unitRef="usdPerShare">340.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-209"
      decimals="INF"
      id="f-990"
      unitRef="shares">145655</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-209"
      decimals="2"
      id="f-991"
      unitRef="usdPerShare">335.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-209"
      decimals="INF"
      id="f-992"
      unitRef="shares">107403</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-209"
      decimals="2"
      id="f-993"
      unitRef="usdPerShare">320.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-209"
      decimals="INF"
      id="f-994"
      unitRef="shares">37461</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-209"
      decimals="2"
      id="f-995"
      unitRef="usdPerShare">344.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-208"
      decimals="INF"
      id="f-996"
      unitRef="shares">290029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-208"
      decimals="2"
      id="f-997"
      unitRef="usdPerShare">345.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-213" id="f-998">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-213" id="f-999">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned
      contextRef="c-214"
      decimals="INF"
      id="f-1000"
      unitRef="number">0</coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned>
    <coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned
      contextRef="c-215"
      decimals="INF"
      id="f-1001"
      unitRef="number">2</coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-216" decimals="-5" id="f-1002" unitRef="usd">12300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-213" id="f-1003">P1Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="c-217"
      decimals="INF"
      id="f-1004"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-218"
      decimals="INF"
      id="f-1005"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c-219"
      decimals="INF"
      id="f-1006"
      unitRef="shares">26116</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c-220"
      decimals="INF"
      id="f-1007"
      unitRef="shares">22695</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-221"
      decimals="INF"
      id="f-1008"
      unitRef="shares">921975</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-219" decimals="-5" id="f-1009" unitRef="usd">1300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-220" decimals="-5" id="f-1010" unitRef="usd">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c-1" id="f-1011">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 10. Employee Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Cooper's Retirement Income Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company's Retirement Income Plan (Plan), a defined benefit plan, is only available to full-time United States employees, subject to the soft freeze mentioned below. The Company's contributions are designed to fund normal cost on a current basis and to fund the estimated prior service cost of benefit improvements. The unit credit actuarial cost method is used to determine the annual cost. The Company pays the entire cost of the Plan and funds such costs as they accrue. Virtually all of the assets of the Plan are comprised of equities and participation in equity and fixed income funds.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company uses individual spot rates along the yield curve that correspond with the timing of each benefit payment to determine the service and interest costs of components of its net periodic benefit cost utilizing the correlation of projected cash outflows and corresponding spot rates on the yield curve. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Plan's benefit obligations and fair value of the Plan assets at October&#160;31, 2023, 2022 and 2021 and the funded status of the Plan and net periodic pension costs for each of the years in the three-year periods ended October&#160;31, 2023. The net amounts recognized in the Consolidated Balance Sheets consist of noncurrent liabilities. The accumulated benefit obligation was $131.5 million, $134.9 million and $207.6 million for the years ended October&#160;31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Retirement Income Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;148.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;218.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1022"&gt;&lt;span style="-sec-ix-hidden:f-1023"&gt;&lt;span style="-sec-ix-hidden:f-1024"&gt;Interest cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(11.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(93.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;144.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;148.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;142.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;199.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(11.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;137.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;142.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;199.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(31.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amounts recognized in accumulated other comprehensive income consist of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Reconciliation of (prepaid) accrued pension cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(Prepaid)/Accrued pension cost at prior fiscal year end&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Contributions made during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(Prepaid)/Accrued pension cost at fiscal year end&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1082"&gt;&lt;span style="-sec-ix-hidden:f-1083"&gt;&lt;span style="-sec-ix-hidden:f-1084"&gt;Expected return on plan assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1088"&gt;&lt;span style="-sec-ix-hidden:f-1089"&gt;&lt;span style="-sec-ix-hidden:f-1090"&gt;Recognized actuarial loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Other changes in plan assets and benefit obligations recognized in other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(24.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortizations of net gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total recognized in other comprehensive (income) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(36.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(29.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total recognized in net periodic benefit cost and other comprehensive (income) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Years Ended October&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Discount rate for determining net periodic pension cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Projected Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Service Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Discount rate for determining benefit obligations at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase for determining expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase for determining benefit obligations at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets for determining net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Measurement date for determining assets and benefit obligations at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10/31/2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The discount rate enables us to state expected future cash flows at a present value on the measurement date. The discount rate used for the Plan is based primarily on the yields of a universe of high-quality corporate bonds rated AA or above, with durations corresponding to the expected durations of the benefit obligations. A change in the discount rate will cause the present value of benefit obligations to change in the opposite direction.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The expected rate of return on plan assets was determined based on a review of historical returns, both for this plan and for medium- to large-sized defined benefit pension funds with similar asset allocations. This review generated separate expected returns for each asset class listed below. These expected future returns were then blended based on this Plan's target asset allocation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Reasons for Significant Liability Gains and Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The projected benefit obligation experienced a net gain of approximately $10.9 million during the year. This net gain is the result of assumption changes resulting in a gain of approximately $12.9 million, offset by losses of approximately $2.0 million due to demographic experience. The key assumption changes were the increase in the discount rate (gain of $7.8 million), a changes in assumptions for lump sum determination (gain of $5.1 million). Demographic losses were due to the net effect of retirement rates, termination rates, salary increases and other experience that was different from assumed. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Weighted-average asset allocations at year end, by asset category are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.719%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.450%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.450%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.453%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Years Ended October&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Asset category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Corporate common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Equity mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balanced funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Alternative investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Bond mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;27.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Plan invests in a diversified portfolio of assets intended to minimize risk of poor returns while maximizing expected portfolio returns. To achieve the long-term rate of return, plan assets will be invested in a mixture of instruments, including but not limited to, corporate common stock (may include the Company's stock), investment grade bond funds, cash, balanced funds, real estate funds, small or large cap equity funds and international equity funds. The allocation of assets will be determined by the investment manager and will typically include 50% to 70% equities with the remainder invested in fixed income, hedging strategy funds and cash. Presently, this diversified portfolio is expected to return roughly 8% in the long run.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;As of the measurement date of October&#160;31, 2023, the fair value measurement of plan assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.541%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.287%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.499%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.188%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.568%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Asset category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Corporate common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Equity mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balanced Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Alternative investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Fixed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;39.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;137.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;113.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Plan has an established process for determining the fair value of plan assets. For investments in equity and bond mutual funds, and real estate funds, fair value is based on observable, Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Plan Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Contributions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company made $1.1 million and no contributions to the Plan in fiscal 2023 and fiscal 2022, respectively. The Company contribution to the Plan was $12.7&#160;million for fiscal 2021. The Company closely monitors the funded status of the Plan with respect to legislative and accounting rules. The Company expected to make contributions totaling $1.1 million to the Plan during fiscal 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Estimated Future Benefit Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:88.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.451%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2029-2033&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;65.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Plan Soft Freeze&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On June 18, 2019, the Board of Directors of the Company approved a soft freeze of the Plan effective August 1, 2019. The Plan was closed to employees hired on or after August 1, 2019, including former participants or employees rehired on or after August 1, 2019, and employees hired in connection with a stock or asset acquisition, merger or other similar transaction on or after August 1, 2019. Existing employees already covered by the Plan, continue to accrue their benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Cooper's 401(k) Savings Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Cooper's 401(k) savings plan provides for the deferral of compensation as described in the Internal Revenue Code and is available to substantially all United States employees. Employees who participate in the 401(k) plan may elect to have up to 75% of their pre-tax salary or wages deferred and contributed to the trust established under the Plan. Cooper's contributions on account of participating employees, were $10.1 million, $9.0 million and $7.2 million for the years ended October&#160;31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock contextRef="c-1" id="f-1012">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Plan's benefit obligations and fair value of the Plan assets at October&#160;31, 2023, 2022 and 2021 and the funded status of the Plan and net periodic pension costs for each of the years in the three-year periods ended October&#160;31, 2023. The net amounts recognized in the Consolidated Balance Sheets consist of noncurrent liabilities. The accumulated benefit obligation was $131.5 million, $134.9 million and $207.6 million for the years ended October&#160;31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Retirement Income Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;148.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;218.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1022"&gt;&lt;span style="-sec-ix-hidden:f-1023"&gt;&lt;span style="-sec-ix-hidden:f-1024"&gt;Interest cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(11.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(93.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;144.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;148.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;142.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;199.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(11.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;137.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;142.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;199.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(31.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="c-4" decimals="-5" id="f-1013" unitRef="usd">131500000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="c-7" decimals="-5" id="f-1014" unitRef="usd">134900000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="c-32" decimals="-5" id="f-1015" unitRef="usd">207600000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-7" decimals="-5" id="f-1016" unitRef="usd">148000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-32" decimals="-5" id="f-1017" unitRef="usd">230900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-15" decimals="-5" id="f-1018" unitRef="usd">218800000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-1" decimals="-5" id="f-1019" unitRef="usd">10000000.0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-5" decimals="-5" id="f-1020" unitRef="usd">18300000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-6" decimals="-5" id="f-1021" unitRef="usd">17200000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-1" decimals="-5" id="f-1025" unitRef="usd">7900000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-5" decimals="-5" id="f-1026" unitRef="usd">5100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-6" decimals="-5" id="f-1027" unitRef="usd">4400000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-1" decimals="-5" id="f-1028" unitRef="usd">10500000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-5" decimals="-5" id="f-1029" unitRef="usd">13100000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-6" decimals="-5" id="f-1030" unitRef="usd">11500000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-1" decimals="-5" id="f-1031" unitRef="usd">10900000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-5" decimals="-5" id="f-1032" unitRef="usd">93200000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-6" decimals="-5" id="f-1033" unitRef="usd">-2000000.0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-4" decimals="-5" id="f-1034" unitRef="usd">144500000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-7" decimals="-5" id="f-1035" unitRef="usd">148000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-32" decimals="-5" id="f-1036" unitRef="usd">230900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-7" decimals="-5" id="f-1037" unitRef="usd">142900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-32" decimals="-5" id="f-1038" unitRef="usd">199500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-15" decimals="-5" id="f-1039" unitRef="usd">159500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-1" decimals="-5" id="f-1040" unitRef="usd">4100000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-5" decimals="-5" id="f-1041" unitRef="usd">-43500000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-6" decimals="-5" id="f-1042" unitRef="usd">38800000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-1" decimals="-5" id="f-1043" unitRef="usd">1100000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-5" decimals="-5" id="f-1044" unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-6" decimals="-5" id="f-1045" unitRef="usd">12700000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid contextRef="c-1" decimals="-5" id="f-1046" unitRef="usd">10500000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid contextRef="c-5" decimals="-5" id="f-1047" unitRef="usd">13100000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid contextRef="c-6" decimals="-5" id="f-1048" unitRef="usd">11500000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-4" decimals="-5" id="f-1049" unitRef="usd">137600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-7" decimals="-5" id="f-1050" unitRef="usd">142900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-32" decimals="-5" id="f-1051" unitRef="usd">199500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-4" decimals="-5" id="f-1052" unitRef="usd">-6900000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-7" decimals="-5" id="f-1053" unitRef="usd">-5100000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-32" decimals="-5" id="f-1054" unitRef="usd">-31400000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock contextRef="c-1" id="f-1055">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amounts recognized in accumulated other comprehensive income consist of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="c-4" decimals="-5" id="f-1056" unitRef="usd">-4100000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="c-7" decimals="-5" id="f-1057" unitRef="usd">-8000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="c-32" decimals="-5" id="f-1058" unitRef="usd">-44400000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax contextRef="c-4" decimals="-5" id="f-1059" unitRef="usd">4100000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax contextRef="c-7" decimals="-5" id="f-1060" unitRef="usd">8000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax contextRef="c-32" decimals="-5" id="f-1061" unitRef="usd">44400000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <coo:ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock contextRef="c-1" id="f-1062">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Reconciliation of (prepaid) accrued pension cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(Prepaid)/Accrued pension cost at prior fiscal year end&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Contributions made during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(Prepaid)/Accrued pension cost at fiscal year end&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</coo:ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock>
    <coo:AccruedPrepaidPensionCosts contextRef="c-7" decimals="-5" id="f-1063" unitRef="usd">-2900000</coo:AccruedPrepaidPensionCosts>
    <coo:AccruedPrepaidPensionCosts contextRef="c-32" decimals="-5" id="f-1064" unitRef="usd">-13000000.0</coo:AccruedPrepaidPensionCosts>
    <coo:AccruedPrepaidPensionCosts contextRef="c-15" decimals="-5" id="f-1065" unitRef="usd">-14800000</coo:AccruedPrepaidPensionCosts>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-1" decimals="-5" id="f-1066" unitRef="usd">6800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-5" decimals="-5" id="f-1067" unitRef="usd">10100000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-6" decimals="-5" id="f-1068" unitRef="usd">14500000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-1" decimals="-5" id="f-1069" unitRef="usd">1100000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-5" decimals="-5" id="f-1070" unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-6" decimals="-5" id="f-1071" unitRef="usd">12700000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <coo:AccruedPrepaidPensionCosts contextRef="c-4" decimals="-5" id="f-1072" unitRef="usd">2800000</coo:AccruedPrepaidPensionCosts>
    <coo:AccruedPrepaidPensionCosts contextRef="c-7" decimals="-5" id="f-1073" unitRef="usd">-2900000</coo:AccruedPrepaidPensionCosts>
    <coo:AccruedPrepaidPensionCosts contextRef="c-32" decimals="-5" id="f-1074" unitRef="usd">-13000000.0</coo:AccruedPrepaidPensionCosts>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock contextRef="c-1" id="f-1075">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1082"&gt;&lt;span style="-sec-ix-hidden:f-1083"&gt;&lt;span style="-sec-ix-hidden:f-1084"&gt;Expected return on plan assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1088"&gt;&lt;span style="-sec-ix-hidden:f-1089"&gt;&lt;span style="-sec-ix-hidden:f-1090"&gt;Recognized actuarial loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-1" decimals="-5" id="f-1076" unitRef="usd">10000000.0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-5" decimals="-5" id="f-1077" unitRef="usd">18300000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-6" decimals="-5" id="f-1078" unitRef="usd">17200000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-1" decimals="-5" id="f-1079" unitRef="usd">7900000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-5" decimals="-5" id="f-1080" unitRef="usd">5100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-6" decimals="-5" id="f-1081" unitRef="usd">4400000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-1" decimals="-5" id="f-1085" unitRef="usd">11100000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-5" decimals="-5" id="f-1086" unitRef="usd">15500000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-6" decimals="-5" id="f-1087" unitRef="usd">12500000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit contextRef="c-1" decimals="-5" id="f-1091" unitRef="usd">0</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit contextRef="c-5" decimals="-5" id="f-1092" unitRef="usd">-2200000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit contextRef="c-6" decimals="-5" id="f-1093" unitRef="usd">-5400000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-1" decimals="-5" id="f-1094" unitRef="usd">6800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-5" decimals="-5" id="f-1095" unitRef="usd">10100000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-6" decimals="-5" id="f-1096" unitRef="usd">14500000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-1097">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Other changes in plan assets and benefit obligations recognized in other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(24.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortizations of net gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total recognized in other comprehensive (income) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(36.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(29.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total recognized in net periodic benefit cost and other comprehensive (income) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax contextRef="c-1" decimals="-5" id="f-1098" unitRef="usd">-4000000.0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax contextRef="c-5" decimals="-5" id="f-1099" unitRef="usd">-34100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax contextRef="c-6" decimals="-5" id="f-1100" unitRef="usd">-24400000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="c-1" decimals="-5" id="f-1101" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="c-5" decimals="-5" id="f-1102" unitRef="usd">2500000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="c-6" decimals="-5" id="f-1103" unitRef="usd">5400000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax contextRef="c-1" decimals="-5" id="f-1104" unitRef="usd">-4000000.0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax contextRef="c-5" decimals="-5" id="f-1105" unitRef="usd">-36600000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax contextRef="c-6" decimals="-5" id="f-1106" unitRef="usd">-29800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax contextRef="c-1" decimals="-5" id="f-1107" unitRef="usd">2800000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax contextRef="c-5" decimals="-5" id="f-1108" unitRef="usd">-26200000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax contextRef="c-6" decimals="-5" id="f-1109" unitRef="usd">-15200000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock contextRef="c-1" id="f-1110">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Years Ended October&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Discount rate for determining net periodic pension cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Projected Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Service Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Discount rate for determining benefit obligations at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase for determining expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase for determining benefit obligations at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets for determining net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Measurement date for determining assets and benefit obligations at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10/31/2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation contextRef="c-1" decimals="4" id="f-1111" unitRef="number">0.0574</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation contextRef="c-5" decimals="4" id="f-1112" unitRef="number">0.0276</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation contextRef="c-6" decimals="4" id="f-1113" unitRef="number">0.0278</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost contextRef="c-1" decimals="4" id="f-1114" unitRef="number">0.0577</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost contextRef="c-5" decimals="4" id="f-1115" unitRef="number">0.0279</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost contextRef="c-6" decimals="4" id="f-1116" unitRef="number">0.0286</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost contextRef="c-1" decimals="4" id="f-1117" unitRef="number">0.0551</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost contextRef="c-5" decimals="4" id="f-1118" unitRef="number">0.0228</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost contextRef="c-6" decimals="4" id="f-1119" unitRef="number">0.0207</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate contextRef="c-4" decimals="4" id="f-1120" unitRef="number">0.0622</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate contextRef="c-7" decimals="4" id="f-1121" unitRef="number">0.0574</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate contextRef="c-32" decimals="4" id="f-1122" unitRef="number">0.0276</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease contextRef="c-1" decimals="4" id="f-1123" unitRef="number">0.0360</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease contextRef="c-5" decimals="4" id="f-1124" unitRef="number">0.0360</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease contextRef="c-6" decimals="4" id="f-1125" unitRef="number">0.0360</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease contextRef="c-4" decimals="4" id="f-1126" unitRef="number">0.0360</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease contextRef="c-7" decimals="4" id="f-1127" unitRef="number">0.0360</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease contextRef="c-32" decimals="4" id="f-1128" unitRef="number">0.0360</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets contextRef="c-1" decimals="4" id="f-1129" unitRef="number">0.0800</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets contextRef="c-5" decimals="4" id="f-1130" unitRef="number">0.0800</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets contextRef="c-6" decimals="4" id="f-1131" unitRef="number">0.0800</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd contextRef="c-4" decimals="4" id="f-1132" unitRef="number">0.0800</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd contextRef="c-7" decimals="4" id="f-1133" unitRef="number">0.0800</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd contextRef="c-32" decimals="4" id="f-1134" unitRef="number">0.0800</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-1" decimals="-5" id="f-1135" unitRef="usd">10900000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-222" decimals="-5" id="f-1136" unitRef="usd">12900000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-223" decimals="-5" id="f-1137" unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-224" decimals="-5" id="f-1138" unitRef="usd">7800000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-225" decimals="-5" id="f-1139" unitRef="usd">5100000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock contextRef="c-1" id="f-1140">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Weighted-average asset allocations at year end, by asset category are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.719%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.450%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.450%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.453%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Years Ended October&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Asset category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Corporate common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Equity mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balanced funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Alternative investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Bond mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;27.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;As of the measurement date of October&#160;31, 2023, the fair value measurement of plan assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.541%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.287%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.499%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.188%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.568%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Asset category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Corporate common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Equity mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balanced Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Alternative investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Fixed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;39.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;137.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;113.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-226"
      decimals="3"
      id="f-1141"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-227"
      decimals="3"
      id="f-1142"
      unitRef="number">0.020</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-228"
      decimals="3"
      id="f-1143"
      unitRef="number">0.050</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-229"
      decimals="3"
      id="f-1144"
      unitRef="number">0.260</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-230"
      decimals="3"
      id="f-1145"
      unitRef="number">0.336</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-231"
      decimals="3"
      id="f-1146"
      unitRef="number">0.316</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-232"
      decimals="3"
      id="f-1147"
      unitRef="number">0.391</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-233"
      decimals="3"
      id="f-1148"
      unitRef="number">0.339</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-234"
      decimals="3"
      id="f-1149"
      unitRef="number">0.328</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-235"
      decimals="3"
      id="f-1150"
      unitRef="number">0.024</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-236"
      decimals="3"
      id="f-1151"
      unitRef="number">0.018</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-237"
      decimals="3"
      id="f-1152"
      unitRef="number">0.014</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-238"
      decimals="3"
      id="f-1153"
      unitRef="number">0.007</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-239"
      decimals="3"
      id="f-1154"
      unitRef="number">0.009</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-240"
      decimals="3"
      id="f-1155"
      unitRef="number">0.010</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-241"
      decimals="3"
      id="f-1156"
      unitRef="number">0.289</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-242"
      decimals="3"
      id="f-1157"
      unitRef="number">0.278</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-243"
      decimals="3"
      id="f-1158"
      unitRef="number">0.282</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="c-4" decimals="3" id="f-1159" unitRef="number">1.000</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="c-7" decimals="3" id="f-1160" unitRef="number">1.000</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="c-32" decimals="3" id="f-1161" unitRef="number">1.000</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="c-244"
      decimals="2"
      id="f-1162"
      unitRef="number">0.50</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="c-245"
      decimals="2"
      id="f-1163"
      unitRef="number">0.70</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <coo:DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage contextRef="c-4" decimals="2" id="f-1164" unitRef="number">0.08</coo:DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-226" decimals="-5" id="f-1165" unitRef="usd">3900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-246" decimals="-5" id="f-1166" unitRef="usd">3900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-247" decimals="-5" id="f-1167" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-248" decimals="-5" id="f-1168" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-229" decimals="-5" id="f-1169" unitRef="usd">35800000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-249" decimals="-5" id="f-1170" unitRef="usd">35800000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-250" decimals="-5" id="f-1171" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-251" decimals="-5" id="f-1172" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-232" decimals="-5" id="f-1173" unitRef="usd">53900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-252" decimals="-5" id="f-1174" unitRef="usd">53900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-253" decimals="-5" id="f-1175" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-254" decimals="-5" id="f-1176" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-235" decimals="-5" id="f-1177" unitRef="usd">3300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-255" decimals="-5" id="f-1178" unitRef="usd">3300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-256" decimals="-5" id="f-1179" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-257" decimals="-5" id="f-1180" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-238" decimals="-5" id="f-1181" unitRef="usd">900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-258" decimals="-5" id="f-1182" unitRef="usd">900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-259" decimals="-5" id="f-1183" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-260" decimals="-5" id="f-1184" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-261" decimals="-5" id="f-1185" unitRef="usd">39800000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-262" decimals="-5" id="f-1186" unitRef="usd">15800000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-263" decimals="-5" id="f-1187" unitRef="usd">24000000.0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-264" decimals="-5" id="f-1188" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-4" decimals="-5" id="f-1189" unitRef="usd">137600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-265" decimals="-5" id="f-1190" unitRef="usd">113600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-266" decimals="-5" id="f-1191" unitRef="usd">24000000.0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-267" decimals="-5" id="f-1192" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-1" decimals="-5" id="f-1193" unitRef="usd">1100000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-5" decimals="-5" id="f-1194" unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-6" decimals="-5" id="f-1195" unitRef="usd">12700000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear contextRef="c-4" decimals="-5" id="f-1196" unitRef="usd">1100000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock contextRef="c-1" id="f-1197">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Estimated Future Benefit Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:88.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.451%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2029-2033&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;65.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths contextRef="c-4" decimals="-5" id="f-1198" unitRef="usd">10900000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo contextRef="c-4" decimals="-5" id="f-1199" unitRef="usd">11000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree contextRef="c-4" decimals="-5" id="f-1200" unitRef="usd">10300000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour contextRef="c-4" decimals="-5" id="f-1201" unitRef="usd">11200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive contextRef="c-4" decimals="-5" id="f-1202" unitRef="usd">12300000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter contextRef="c-4" decimals="-5" id="f-1203" unitRef="usd">65900000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="c-1"
      decimals="INF"
      id="f-1204"
      unitRef="number">0.75</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer contextRef="c-1" decimals="-5" id="f-1205" unitRef="usd">10100000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer contextRef="c-5" decimals="-5" id="f-1206" unitRef="usd">9000000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer contextRef="c-6" decimals="-5" id="f-1207" unitRef="usd">7200000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1208">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 11. Contingencies &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company is involved in various lawsuits, claims and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company does not believe that the ultimate resolution of these proceedings or claims pending against it could have a material adverse effect on its financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;. Legal fees are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1209">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 12. Business Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company discloses information about its operating segments, which were established based on the way that management organizes segments within the Company for making operating decisions and assessing financial performance. The Company's two operating segments are described below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.68pt"&gt;CooperVision. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Competes in the worldwide contact lens market by developing, manufacturing and marketing a broad range of products for contact lens wearers, featuring advanced materials and optics.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.68pt"&gt;CooperSurgical. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Competes in the general health care market with a focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women's health and fertility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company uses operating income, as presented in our financial reports, as the primary measure of segment profitability. The Company does not allocate costs from corporate functions to segment operating income. The Company uses the same accounting policies to generate segment results as it does for consolidated results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;No customers accounted for 10% or more of our consolidated net revenue in fiscal 2023, 2022 and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Total identifiable assets are those used in continuing operations except cash and cash equivalents, which the Company includes as corporate assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of our business segment net sales:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.593%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;CooperVision net sales by category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Toric lens&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;828.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;737.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;697.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Multifocal lens&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;305.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Single-use sphere lens&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;705.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;661.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;616.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Non single-use sphere, other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;583.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;579.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;599.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total CooperVision net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,423.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,243.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,152.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;CooperSurgical net sales by category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Office and surgical &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;689.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;633.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;451.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fertility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;480.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;431.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;319.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total CooperSurgical net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,169.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,065.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;770.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,593.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Information by business segment for each of the years in the three-year period ended October&#160;31, 2023 follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.312%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.120%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperVision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperSurgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,423.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,169.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,593.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;587.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(70.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;533.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;105.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;412.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,044.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4,351.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;263.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11,658.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;156.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;181.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;186.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;364.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;392.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,243.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,065.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;494.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(53.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;507.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(25.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;475.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6,778.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4,407.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;305.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11,492.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;144.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;166.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;147.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;179.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;223.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;242.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,152.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;770.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;481.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;71.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(47.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;505.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6,965.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,395.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;244.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9,606.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;148.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;110.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;146.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;190.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;214.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Information by geographical area by country of domicile for each of the years in the three-year period ended October&#160;31, 2023 follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;United&lt;br/&gt;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Rest of&lt;br/&gt;World,&#160;Other&lt;br/&gt;Eliminations&lt;br/&gt;&amp;amp; Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales to unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,812.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,041.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;739.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,593.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Sales between geographic areas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;563.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,016.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,579.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,375.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,057.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(840.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,593.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;516.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;533.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,027.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;325.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;279.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,632.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales to unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,638.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;987.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;682.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Sales between geographic areas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;514.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;897.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,411.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,152.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,884.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(729.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;71.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;403.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;507.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;856.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;310.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;266.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,432.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales to unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,339.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;957.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;625.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Sales between geographic areas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;494.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;815.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,310.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,834.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,773.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(684.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;416.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;116.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;505.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;737.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;377.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;232.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,347.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1210"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock contextRef="c-1" id="f-1211">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of our business segment net sales:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.593%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;CooperVision net sales by category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Toric lens&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;828.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;737.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;697.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Multifocal lens&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;305.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Single-use sphere lens&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;705.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;661.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;616.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Non single-use sphere, other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;583.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;579.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;599.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total CooperVision net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,423.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,243.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,152.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;CooperSurgical net sales by category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Office and surgical &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;689.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;633.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;451.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fertility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;480.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;431.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;319.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total CooperSurgical net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,169.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,065.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;770.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,593.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-268" decimals="-5" id="f-1212" unitRef="usd">828700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-269" decimals="-5" id="f-1213" unitRef="usd">737400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-270" decimals="-5" id="f-1214" unitRef="usd">697500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-271" decimals="-5" id="f-1215" unitRef="usd">305700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-272" decimals="-5" id="f-1216" unitRef="usd">264400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-273" decimals="-5" id="f-1217" unitRef="usd">238600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-274" decimals="-5" id="f-1218" unitRef="usd">705400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-275" decimals="-5" id="f-1219" unitRef="usd">661600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-276" decimals="-5" id="f-1220" unitRef="usd">616300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-277" decimals="-5" id="f-1221" unitRef="usd">583900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-278" decimals="-5" id="f-1222" unitRef="usd">579900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-279" decimals="-5" id="f-1223" unitRef="usd">599600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-97" decimals="-5" id="f-1224" unitRef="usd">2423700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-280" decimals="-5" id="f-1225" unitRef="usd">2243300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-281" decimals="-5" id="f-1226" unitRef="usd">2152000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-282" decimals="-5" id="f-1227" unitRef="usd">689500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-283" decimals="-5" id="f-1228" unitRef="usd">633600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-284" decimals="-5" id="f-1229" unitRef="usd">451300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-285" decimals="-5" id="f-1230" unitRef="usd">480000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-286" decimals="-5" id="f-1231" unitRef="usd">431500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-287" decimals="-5" id="f-1232" unitRef="usd">319200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-98" decimals="-5" id="f-1233" unitRef="usd">1169500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-288" decimals="-5" id="f-1234" unitRef="usd">1065100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-289" decimals="-5" id="f-1235" unitRef="usd">770500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-1236" unitRef="usd">3593200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-1237" unitRef="usd">3308400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-1238" unitRef="usd">2922500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-1239">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Information by business segment for each of the years in the three-year period ended October&#160;31, 2023 follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.312%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.120%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperVision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperSurgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,423.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,169.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,593.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;587.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(70.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;533.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;105.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;412.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,044.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4,351.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;263.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11,658.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;156.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;181.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;186.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;364.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;392.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,243.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,065.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;494.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(53.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;507.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(25.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;475.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6,778.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4,407.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;305.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11,492.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;144.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;166.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;147.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;179.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;223.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;242.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,152.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;770.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;481.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;71.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(47.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;505.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6,965.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,395.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;244.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9,606.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;148.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;110.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;146.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;190.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;214.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-290" decimals="-5" id="f-1240" unitRef="usd">2423700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-291" decimals="-5" id="f-1241" unitRef="usd">1169500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-292" decimals="-5" id="f-1242" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-1243" unitRef="usd">3593200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss contextRef="c-290" decimals="-5" id="f-1244" unitRef="usd">587700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-291" decimals="-5" id="f-1245" unitRef="usd">16100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-292" decimals="-5" id="f-1246" unitRef="usd">-70700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-1247" unitRef="usd">533100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-5" id="f-1248" unitRef="usd">105300000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-1249" unitRef="usd">-14900000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-1250" unitRef="usd">412900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets contextRef="c-293" decimals="-5" id="f-1251" unitRef="usd">7044000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-294" decimals="-5" id="f-1252" unitRef="usd">4351800000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-295" decimals="-5" id="f-1253" unitRef="usd">263100000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-5" id="f-1254" unitRef="usd">11658900000</us-gaap:Assets>
    <us-gaap:Depreciation contextRef="c-290" decimals="-5" id="f-1255" unitRef="usd">156900000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-291" decimals="-5" id="f-1256" unitRef="usd">24600000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-292" decimals="-5" id="f-1257" unitRef="usd">0</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-1258" unitRef="usd">181500000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization contextRef="c-290" decimals="-5" id="f-1259" unitRef="usd">32900000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-291" decimals="-5" id="f-1260" unitRef="usd">153300000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-292" decimals="-5" id="f-1261" unitRef="usd">0</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-1" decimals="-5" id="f-1262" unitRef="usd">186200000</us-gaap:AdjustmentForAmortization>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-290" decimals="-5" id="f-1263" unitRef="usd">364400000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-291" decimals="-5" id="f-1264" unitRef="usd">28100000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-292" decimals="-5" id="f-1265" unitRef="usd">0</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-1" decimals="-5" id="f-1266" unitRef="usd">392500000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-296" decimals="-5" id="f-1267" unitRef="usd">2243300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-297" decimals="-5" id="f-1268" unitRef="usd">1065100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-298" decimals="-5" id="f-1269" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-1270" unitRef="usd">3308400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss contextRef="c-296" decimals="-5" id="f-1271" unitRef="usd">494300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-297" decimals="-5" id="f-1272" unitRef="usd">67100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-298" decimals="-5" id="f-1273" unitRef="usd">-53800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-5" id="f-1274" unitRef="usd">507600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="c-5" decimals="-5" id="f-1275" unitRef="usd">57300000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-1276" unitRef="usd">25000000.0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-1277" unitRef="usd">475300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets contextRef="c-299" decimals="-5" id="f-1278" unitRef="usd">6778900000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-300" decimals="-5" id="f-1279" unitRef="usd">4407800000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-301" decimals="-5" id="f-1280" unitRef="usd">305600000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-7" decimals="-5" id="f-1281" unitRef="usd">11492300000</us-gaap:Assets>
    <us-gaap:Depreciation contextRef="c-296" decimals="-5" id="f-1282" unitRef="usd">144500000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-297" decimals="-5" id="f-1283" unitRef="usd">22100000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-298" decimals="-5" id="f-1284" unitRef="usd">0</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-5" decimals="-5" id="f-1285" unitRef="usd">166600000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization contextRef="c-296" decimals="-5" id="f-1286" unitRef="usd">32300000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-297" decimals="-5" id="f-1287" unitRef="usd">147200000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-298" decimals="-5" id="f-1288" unitRef="usd">0</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-5" decimals="-5" id="f-1289" unitRef="usd">179500000</us-gaap:AdjustmentForAmortization>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-296" decimals="-5" id="f-1290" unitRef="usd">223000000.0</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-297" decimals="-5" id="f-1291" unitRef="usd">19000000.0</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-298" decimals="-5" id="f-1292" unitRef="usd">0</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-5" decimals="-5" id="f-1293" unitRef="usd">242000000.0</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-302" decimals="-5" id="f-1294" unitRef="usd">2152000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-303" decimals="-5" id="f-1295" unitRef="usd">770500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-304" decimals="-5" id="f-1296" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-1297" unitRef="usd">2922500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss contextRef="c-302" decimals="-5" id="f-1298" unitRef="usd">481300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-303" decimals="-5" id="f-1299" unitRef="usd">71800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-304" decimals="-5" id="f-1300" unitRef="usd">-47300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-5" id="f-1301" unitRef="usd">505800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="c-6" decimals="-5" id="f-1302" unitRef="usd">23100000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-6" decimals="-5" id="f-1303" unitRef="usd">8800000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-5" id="f-1304" unitRef="usd">491500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets contextRef="c-305" decimals="-5" id="f-1305" unitRef="usd">6965900000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-306" decimals="-5" id="f-1306" unitRef="usd">2395600000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-307" decimals="-5" id="f-1307" unitRef="usd">244700000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-32" decimals="-5" id="f-1308" unitRef="usd">9606200000</us-gaap:Assets>
    <us-gaap:Depreciation contextRef="c-302" decimals="-5" id="f-1309" unitRef="usd">148300000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-303" decimals="-5" id="f-1310" unitRef="usd">14900000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-304" decimals="-5" id="f-1311" unitRef="usd">0</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-6" decimals="-5" id="f-1312" unitRef="usd">163200000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization contextRef="c-302" decimals="-5" id="f-1313" unitRef="usd">35700000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-303" decimals="-5" id="f-1314" unitRef="usd">110400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-304" decimals="-5" id="f-1315" unitRef="usd">0</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-6" decimals="-5" id="f-1316" unitRef="usd">146100000</us-gaap:AdjustmentForAmortization>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-302" decimals="-3" id="f-1317" unitRef="usd">190000000.0</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-303" decimals="-3" id="f-1318" unitRef="usd">24400000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-304" decimals="-3" id="f-1319" unitRef="usd">0</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-6" decimals="-3" id="f-1320" unitRef="usd">214400000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="c-1" id="f-1321">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Information by geographical area by country of domicile for each of the years in the three-year period ended October&#160;31, 2023 follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;United&lt;br/&gt;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Rest of&lt;br/&gt;World,&#160;Other&lt;br/&gt;Eliminations&lt;br/&gt;&amp;amp; Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales to unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,812.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,041.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;739.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,593.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Sales between geographic areas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;563.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,016.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,579.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,375.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,057.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(840.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,593.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;516.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;533.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,027.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;325.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;279.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,632.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales to unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,638.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;987.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;682.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Sales between geographic areas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;514.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;897.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,411.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,152.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,884.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(729.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;71.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;403.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;507.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;856.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;310.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;266.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,432.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales to unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,339.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;957.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;625.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Sales between geographic areas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;494.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;815.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,310.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,834.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,773.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(684.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;416.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;116.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;505.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;737.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;377.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;232.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,347.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-308" decimals="-5" id="f-1322" unitRef="usd">1812200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-309" decimals="-5" id="f-1323" unitRef="usd">1041200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-310" decimals="-5" id="f-1324" unitRef="usd">739800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-1325" unitRef="usd">3593200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-311" decimals="-5" id="f-1326" unitRef="usd">-563100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-312" decimals="-5" id="f-1327" unitRef="usd">-1016700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-313" decimals="-5" id="f-1328" unitRef="usd">-1579800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-314" decimals="-5" id="f-1329" unitRef="usd">2375300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-315" decimals="-5" id="f-1330" unitRef="usd">2057900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-316" decimals="-5" id="f-1331" unitRef="usd">-840000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-1332" unitRef="usd">3593200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss contextRef="c-314" decimals="-5" id="f-1333" unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-315" decimals="-5" id="f-1334" unitRef="usd">516200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-316" decimals="-5" id="f-1335" unitRef="usd">16900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-1336" unitRef="usd">533100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-317" decimals="-5" id="f-1337" unitRef="usd">1027600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-318" decimals="-5" id="f-1338" unitRef="usd">325900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-319" decimals="-5" id="f-1339" unitRef="usd">279100000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-5" id="f-1340" unitRef="usd">1632600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-320" decimals="-5" id="f-1341" unitRef="usd">1638500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-321" decimals="-5" id="f-1342" unitRef="usd">987200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-322" decimals="-5" id="f-1343" unitRef="usd">682700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-1344" unitRef="usd">3308400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-323" decimals="-5" id="f-1345" unitRef="usd">-514400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-324" decimals="-5" id="f-1346" unitRef="usd">-897300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-325" decimals="-5" id="f-1347" unitRef="usd">-1411700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-326" decimals="-5" id="f-1348" unitRef="usd">2152900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-327" decimals="-5" id="f-1349" unitRef="usd">1884500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-328" decimals="-5" id="f-1350" unitRef="usd">-729000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-1351" unitRef="usd">3308400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss contextRef="c-326" decimals="-5" id="f-1352" unitRef="usd">71800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-327" decimals="-5" id="f-1353" unitRef="usd">403800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-328" decimals="-5" id="f-1354" unitRef="usd">32000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-5" id="f-1355" unitRef="usd">507600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-329" decimals="-5" id="f-1356" unitRef="usd">856100000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-330" decimals="-5" id="f-1357" unitRef="usd">310800000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-331" decimals="-5" id="f-1358" unitRef="usd">266000000.0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-7" decimals="-5" id="f-1359" unitRef="usd">1432900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-332" decimals="-5" id="f-1360" unitRef="usd">1339200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-333" decimals="-5" id="f-1361" unitRef="usd">957900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-334" decimals="-5" id="f-1362" unitRef="usd">625400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-1363" unitRef="usd">2922500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-335" decimals="-5" id="f-1364" unitRef="usd">-494900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-336" decimals="-5" id="f-1365" unitRef="usd">-815100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-337" decimals="-5" id="f-1366" unitRef="usd">-1310000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-338" decimals="-5" id="f-1367" unitRef="usd">1834100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-339" decimals="-5" id="f-1368" unitRef="usd">1773000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-340" decimals="-5" id="f-1369" unitRef="usd">-684600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-1370" unitRef="usd">2922500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss contextRef="c-338" decimals="-5" id="f-1371" unitRef="usd">-26800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-339" decimals="-5" id="f-1372" unitRef="usd">416200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-340" decimals="-5" id="f-1373" unitRef="usd">116400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-5" id="f-1374" unitRef="usd">505800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-341" decimals="-5" id="f-1375" unitRef="usd">737500000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-342" decimals="-5" id="f-1376" unitRef="usd">377200000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-343" decimals="-5" id="f-1377" unitRef="usd">232900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-32" decimals="-5" id="f-1378" unitRef="usd">1347600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c-1" id="f-1379">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 13. Financial Derivatives and Hedging&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;As part of the Company&#x2019;s overall risk management practices the Company enters into financial derivatives, interest rate swaps designated as cash flow hedges, to hedge the Company's exposure to changes in cash flows associated with its variable rate debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Credit risk related to derivative transactions reflects the risk that a party to the transaction could fail to meet its obligation under the derivative contracts. Therefore, the Company&#x2019;s exposure to the counterparty&#x2019;s credit risk is generally limited to the amounts, if any, by which the counterparty&#x2019;s obligations to the Company exceed the Company&#x2019;s obligations to the counterparty. The Company&#x2019;s policy is to enter into contracts only with financial institutions which meet certain minimum credit ratings to help mitigate counterparty credit risk. From time to time, the Company enters into foreign currency forward contracts to minimize the short-term impact of foreign currency exchange rate fluctuations on certain trade and intercompany receivables and payables. These foreign currency forward contracts are not designated as hedging instruments, and therefore the net change in their fair value is reported as a gain or loss in the Consolidated Statements of Income and Comprehensive Income. As of October&#160;31, 2023, the notional amount of outstanding foreign currency forward contracts was $56.2&#160;million. The resulting impact on our Consolidated Financial Statements from currency hedging activities was not significant for the years ended October&#160;31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;As of October&#160;31, 2023, the Company has six interest rate swap contracts that have a total notional amount of $1.3&#160;billion and remaining maturities of four years or less. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amounts recognized with respect to our derivative instruments within the accompanying Consolidated Statements of Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.080%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.301%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Periods Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Derivatives designated as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Location of (Gain)/Loss Recognized on Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense (income)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The cumulative pre-tax impact of the gain on derivatives designated for hedge accounting is recognized in "Accumulated other comprehensive loss". The following table details the changes in the cumulative pre-tax impact of the gain on derivatives designated for hedge accounting:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance gain as of October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount recognized in other comprehensive income on interest rate swap contracts, gross ($79.7, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;105.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount reclassified from other comprehensive income into earnings, gross ($1.7, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance gain as of October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;124.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount recognized in other comprehensive income on interest rate swap contracts, gross ($25.7, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount reclassified from other comprehensive income into earnings, gross ($(32.7), net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance gain as of October 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;115.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Refer to Note 8. Stockholders&#x2019; Equity for amounts presented net of the related tax impact in "Accumulated other comprehensive loss".&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company expects that $(48.2)&#160;million recorded as a component of "Accumulated other comprehensive loss" will be realized in our Consolidated Statements of Income over the next twelve months and the amount will vary depending on prevailing interest rates.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount contextRef="c-344" decimals="-5" id="f-1380" unitRef="usd">56200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="c-345"
      decimals="INF"
      id="f-1381"
      unitRef="interest_rate_swap_contract">6</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount contextRef="c-345" decimals="-8" id="f-1382" unitRef="usd">1300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeTermOfContract contextRef="c-346" id="f-1383">P4Y</us-gaap:DerivativeTermOfContract>
    <us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock contextRef="c-1" id="f-1384">&lt;div style="margin-bottom:7pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amounts recognized with respect to our derivative instruments within the accompanying Consolidated Statements of Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.080%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.564%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.301%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Periods Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Derivatives designated as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Location of (Gain)/Loss Recognized on Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense (income)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-347" decimals="-5" id="f-1385" unitRef="usd">43100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-348" decimals="-5" id="f-1386" unitRef="usd">2300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-349" decimals="-5" id="f-1387" unitRef="usd">-8000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-350" decimals="-5" id="f-1388" unitRef="usd">17200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-5" decimals="-5" id="f-1389" unitRef="usd">79700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-166" decimals="-5" id="f-1390" unitRef="usd">105100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-5" decimals="-5" id="f-1391" unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-166" decimals="-5" id="f-1392" unitRef="usd">-2200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-351" decimals="-5" id="f-1393" unitRef="usd">124500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-1" decimals="-5" id="f-1394" unitRef="usd">25700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-172" decimals="-5" id="f-1395" unitRef="usd">33700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-1" decimals="-5" id="f-1396" unitRef="usd">32700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-172" decimals="-5" id="f-1397" unitRef="usd">43100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-352" decimals="-5" id="f-1398" unitRef="usd">115100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths contextRef="c-1" decimals="-5" id="f-1399" unitRef="usd">-48200000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="c-1" id="f-1400">&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Schedule II&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;THE COOPER COMPANIES, INC. AND SUBSIDIARIES&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Three Years Ended October&#160;31, 2023 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.201%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.201%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.201%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.203%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;Beginning&lt;br/&gt;of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Reductions/ Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;at End&lt;br/&gt;of Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred income tax valuation allowance:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Year Ended October&#160;31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(42.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Year Ended October&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Year Ended October&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;45.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-353" decimals="-5" id="f-1401" unitRef="usd">60100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-354" decimals="-5" id="f-1402" unitRef="usd">2600000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-354" decimals="-5" id="f-1403" unitRef="usd">42000000.0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-355" decimals="-5" id="f-1404" unitRef="usd">20700000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-356" decimals="-5" id="f-1405" unitRef="usd">51800000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-357" decimals="-5" id="f-1406" unitRef="usd">13300000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-357" decimals="-5" id="f-1407" unitRef="usd">5000000.0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-353" decimals="-5" id="f-1408" unitRef="usd">60100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-358" decimals="-5" id="f-1409" unitRef="usd">45300000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-359" decimals="-5" id="f-1410" unitRef="usd">8800000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-359" decimals="-5" id="f-1411" unitRef="usd">2300000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-356" decimals="-5" id="f-1412" unitRef="usd">51800000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>108
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M[A7M:ZG[?RR,@?Z^YER]#\P"[3^*^7]02P,$%     @ YH&(5YQ3MJ3+ @
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MN /-83_/?9Q(G%&O@K@A)J,N>0!FZ>R:3 :^(WZ^FVJ=9[#VOI)Q\I+CRB4
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M ]\:F-]OA9F!_L9^T#Q\P%[_"U!+ P04    " #F@8A7>^<]/U4#  "F"P
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M:^\K6A=MAEW46G@I:WVWMFJ1V]7BNB<%.NLBZD>D2:47/5 "$)A>](  @K#
MFP7X70;]&TQ;(>B=ZW[U%W:M!-/3MDJ3LAODQ">ES"9G_'8(#PHU%VRY4=#P
M6.P,J,^Q%7S>><'7%W$HB_-GE^<AH0>UV6B7VVN5F6=79K]+HTEP9?Y6X8IR
MKG[6&\3K4*1A,$2D(;!S(FW>>73A(-1C^0A([I0W:U0/ 32?-H^9W)4/5PP^
M_T2NP^IAD=9,]>S*ETAIM9[K.K_3)MW90E^?JAX'J=X4\E@^(+&112$/Y<N]
MB/1VW@#T]SLIB]<WY@>:AW)6_P-02P,$%     @ YH&(5S]A9@G")   %G(
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M2-%0^@L \EG/WV-ZAS- ,>&,A(TH$F7NY%$,DE@#<7.\G"_A$XA)/9CF3 Y
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M'_]AZ/;\RW\4R W=CO_<FI*B+[Q S]==-_@/6"#\%.3W_Q]02P,$%     @
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MZ*=P9UC5^EMCJ2S=07ZYIDL?M7.@][6BTV5KN \,?R/FWP%02P,$%     @
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M'."V@!1='3HZJ"] 6QD.LXEE/KX5:J>0YTC[/?"T94/>.5_J0I"R"IP-']S
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MM:HT_\1H(</>US:\-NUGWX>( 8,*E$4F<I%8#1T^] #EBM(1EF=TF+"SW/H
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MVM.J ,K45%+$@^_)&N0Q'TQ -UV6U!18QBZI+#15*+JJ82_E+L6_E+05W J
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MI8-796D!OL^,\?4#;;#][>CFOU!+ P04    " #F@8A77#W8V(0#   Y"
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M7-()]J&8YEPR47:"^6:[PY)U9)A4.!5+'\FCZD0%-<6&SI$ZLK1\#*TK*F>
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M" !"0>;33KK!1W\',G;4JF?@HE\[GCKR%")%\$?OWNX6.?9)&CG [1V+>8E
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MI+@'1RG*CTK49N7=D7S4!EI<)*K)&L%I&R_E7CRD&G:RN756M-VS+36'52Z
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M3$"?]A].E6%P72D8QW0@@'-U"8^Y1%Y-T^FVM+M]T=PIV('&%:3[CO9N5=1
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M3;&J-?DV4?/N(VXM<EG6TVC_+6 9R.ZCQ#/ACQY')*$-<DI[LX_4W7@Z<@1
M$OFUUE--FPS>%F@'A 25;(L\ LX5DQQ <H;FKF^;'$AG'E[I=0M+:-$AL[?L
M/=$^D05:@SZC3@%NF28!LI7N;K77,]E,'"JSB;-Q,S'S-B+.#3;;M(CBY:@^
MC&DKLUMP,T-UIW-N841'+B )XHYM!\@6@C?P5S"Z+D"UPV,T._P:-1!'@H?
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MHQ^WNH P A^ []?6=OX7G"#\+:?G_P=02P,$%     @ YH&(5[)*S 1O P
MTP<  !D   !X;"]W;W)K<VAE971S+W-H965T,C8N>&ULG55M;]LV$/XK!VT8
M6D#5JV7+F6T@SE:T0(,8\;I^&/:!ELXR48I422IN]NMWI!PUQ3POV >;+[I[
M[KF'Q^/BJ/1G<T"T\+45TBR#@[7=51R;ZH M,Y'J4-*7O=(ML[3436PZC:SV
M3JV(LR29QBWC,E@M_-Y&KQ:JMX)+W&@P?=LR_;A&H8[+( V>-NYY<[!N(UXM
M.M;@%NW';J-I%8\H-6]1&JXD:-PO@^OT:ETX>V_P.\>C>38'E\E.J<]N\;Y>
M!HDCA (KZQ 8#0]X@T(X(*+QY809C"&=X_/Y$_I;GSOELF,&;Y3XQ&M[6 9E
M #7N62_LO3J^PU,^GF"EA/'_<#S9)@%4O;&J/3D3@Y;+861?3SJ\Q"$[.62>
M]Q#(L_R%6;9::'4$[:P)S4U\JMZ;R''I#F5K-7WEY&=7=[IADO_%!HED#5O>
M2+[G%9,6KJM*]=)RV<!&"5YQ-/#J-[83:%XO8DOA'4A<G4*MAU#9OX1*,[A5
MTAX,_"IKK+\'B(GW2#Y[(K_.+B+>53:"/ TA2[+\ EX^BI%[O/P%8H1PHZ2A
MK.MOVFPT&I1VV%![>,LEDQ5G K:TB52KUL ?USMC-57;G^<D&@A,SA-P-_#*
M=*S"9="Y6/H!@]5//Z33Y.<+Z4W&]":7T%=;NM%U+]!1Y_*!V"K]>([D19CS
M).DHU ZU/XU7[R65JA"DDGGMS\;]97#/CE2Z%C4I9N!'VIQ%.8WI+(]F\(EN
M[QLNWW1:56@,I/,H@;2(,B<SIPJOH5&J-E D<W*;Y/.H).=97D13&J=922 7
M5"I&E8H7JT1<.M3V,81.N OAB@"_]+QS1WU.N8O0_U^Y#RZP^_&6*#V<*LTI
M2/*0@"[U=<]%35?5_--P4I91 9/4*77+J@/1TH_?)P-9F):S*(4TG--Q3'WU
M6]T/O9-+)T6CW;E,RBG)G\]S.I[-)7U"8!8J92PQS D](W2B')9)$LWA V%=
MN0[3M[V@HJBIEY(H=)M\Q#0LBISBI&%.M++_BB3114E#5P6EGTU25U3##440
M2)T;[N\^ C,&K1D\<K*E,LL&USSSA42N-)N?+:7X6:-M43?^.3'@N^30<\?=
M\<6Z'AKU-_/AN;MENN'2$+,]N2;1C$I'#T_(L+"J\VU[IRP] GYZH%<7M3.@
M[WNE[-/"!1C?\=7?4$L#!!0    ( .:!B%=^5;;$@@,  &H(   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(W+GAM;)U676_;-A3]*Q=:.Z1 HV\YKF<;B+,-
M*]"@09.M#\,>:.G*(DJ1+DG%R;_?)64K[F+K82\22?$<GLM[KJ_G.Z6_F0;1
MPE,KI%D$C;7;6129LL&6F5!M4=*76NF669KJ362V&EGE0:V(TCB>1"WC,EC.
M_=J=7LY59P67>*?!=&W+]/,*A=HM@B0X+'SAF\:ZA6@YW[(-WJ/]<WNG:18-
M+!5O41JN)&BL%\%U,EL5;K_?\!?'G3D:@XMDK=0W-_E8+8+8"4*!I74,C%Z/
M>(-"."*2\7W/&0Q'.N#Q^,#^NX^=8EDS@S=*?.65;1;!-( *:]8)^T7M_L!]
M/%Y@J83Q3]CU>XM) &5GK&KW8%+0<MF_V=/^'HX T_@,(-T#4J^[/\BK_)59
MMIQKM0/M=A.;&_A0/9K$<>F2<F\U?>6$L\O/6]3,<KF!3TC!&;AX8&N!YMT\
MLD3O-D7EGFK54Z5GJ)(4;I6TC8'?9(75CP01Z1K$I0=QJW24\7-I0\B2]Y#&
M:3;"EPW!9IXO.\.W#_'OZ[6QFOSPSZD@>XK\-(6KD9G9LA(7 16!0?V(P?+G
MGY))_,N(P'P0F(^Q'P226VV#<*.D48)7S&+E)A75 HU63#!9(MR[I)^*8/R,
M!V*NE:!J=%FW+MO@0Y'6 )=]G?N"65,1@S@OZ0<A9@:4+K5&/63,/5)XY;"7
M!<\-VA7.I:HO.YHP8X@+WD":)V'AWED<)J\P@K,U%]QR-.^I3+0F]9!-PQ2R
M@F"CVZ62EP=(FA3AA'0ZT(.R3( Z#W5JBBR<[M7%\-77/%:7[)% &PH%W>_@
M"]BB;N&"2WA&ILT[2&)"?2"&5\B*FU)UI(@.1\C?0O9VQ$_%X*=B-->W)*;M
M6G"Q4FQ;]MSZ-&O\WG%-*>S(5/J_,9M3IAH]Z'19.*>U_T\!F8U9:.AVR))T
M^2XQ^NAZ*8>E\YX0WK\OM^TL#/A4HB'/UF1;]'=/OG+35PYE&F=P\5&23B'(
M])0C6L\AGX2Y&Q5 B78&22>07857;G0%64HII!$])C2B.*D?UG0\)&E&P-Y)
MO:@AXC>0Q5-B^$329J22MJ.Q4.3A![CKZP\>F>C0"3WOO5.NB(Y^_UO4&]_E
M#'A#]:U@6!T:Z77?/UZV]UWXEND-EX8$U 2-PRO*N^X[6S^Q:NN[R5I9ZDU^
MV-"? =1N WVOE;*'B3M@^'NQ_!=02P,$%     @ YH&(5\[G# :Z!   3P\
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M4__'4#\XO?3G^JEV3E=^N! <#1Y-P/>9UF[[0 LT?_0<_PM02P,$%     @
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M4C<D\!LU$RY+U2"<0;K,PY3^L\4L7+CY^3+/PP*NF.'E!7SU=8/5&_: FMH
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MG:^BS_K%'91BOBD5T7,R;0$SS08JJ%R3 4R'O.ZU>]CK^Z4B<UU"M6)0+&8
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MT(IU\W!M)E9MW6-QK2P\/=VPA+<^TW@ ]@NE['Z" 0[_/2S^ 5!+ P04
M" #F@8A7Z^D[87$$   M&0  &0   'AL+W=O<FMS:&5E=',O<VAE970S-RYX
M;6RU65UOVS84_2N$5@P)X%HBY8\TLPW$3H85F%NC1K>'81@8B;:)4J)+4G%2
M[,>7E&3)ZF1F3N@76Y1TC^XYO"2/J-&.BR]R0X@"CPE+Y=C;*+6]]GT9;4B"
M99=O2:JOK+A(L-)-L?;E5A <YT$)\U$0#/P$T]2;C/)S"S$9\4PQFI*% #)+
M$BR>IH3QW=B#WO[$)[K>*'/"GXRV>$V61'W>+H1N^15*3!.22LI3(,AJ[-W
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MNX6JRV%;E0/9ET,'9)*L,@887;5.Y\^ ASGKMBEA9H]\*>W:=T&[\2I'N[;
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MHFD\H%54C(=I#VYRDUHX=F:[+>S7[SI)LT)#Q<->$G_<<WSNL7T]WDCUI)<
MACR77.B)LS2FNO0\G2ZAI-J5%0B<R:4JJ<&N*CQ=*:!9#2JY%_A^[)64"2<9
MUV,SE8SERG F8*:(7I4E52_7P.5FX@R<[< ]*Y;&#GC)N*(%S,$\5#.%/:]C
MR5@)0C,IB()\XEP-+J>QC:\#?C#8Z)TVL9DLI'RRG=MLXOA6$'!(C66@^%O#
M%#BW1"CC=\OI=$M:X&Y[R_ZUSAUS65 -4\D?66:6$^?<(1GD=,7-O=Q\@S:?
MR/*EDNOZ2S9MK.^0=*6-+%LP*BB9:/[TN?5A!S 8O@,(6D#P44#8 L(ZT499
MG=8--309*[DARD8CFVW4WM1HS(8)NXMSHW"6(<XDWU5!!?M#&T]%1N:L$"QG
M*16&7*6I7 G#1$%FDK.4@29GY%:L01BI7LCQ#1C*N#[!T8?Y#3D^.B%'A ER
MQSA'0CWV#&JT*WEIJ^>ZT1.\IR<U+@D'IR3P@[ '/OTX/'@-]]"9SIZ@LR>H
M^<(/V'-*II@2^I#]<VNF0*,9S8#,R5<FJ$@9Y62.@X#'W6CR\VJAC<(#^ZO/
MCT; L%^ O<27NJ(I3)S*KJ76X"2?/PUB_TN?._^)[)578>=5>(@]N:<;/)D&
M%*;?N_,-/*KAMKJLD\ ?N;C+Z]T4]J,&H] ==5&OM T[;<.#VAZQEIPQ<58I
MF8+N5=<0Q+OK7KR1UH2,=D,B-^A7%G7*HH/*\,0PO+X9*:3,>H5%>ZM&_L6>
M;?M1P_#"/>\7%W?BXH/BME<=+_XI$6#ZY,5[^S4*(S=^(V\_*@[.]W;5VRED
M]A&YHZI@0A,..>)\=X0$JBG,3<?(JJYM"VFP4M;-);YEH&P SN=2FFW'ELON
M=4S^ E!+ P04    " #F@8A7GUMLO$T$  #!&   &0   'AL+W=O<FMS:&5E
M=',O<VAE970S.2YX;6RU65V/VC@4_2M6MEJUTFP2)P'"+"!U)EMMI8Z*9C3M
MPVH?/,& U<2FM@.=_?5KAQ#R-1'#F <@3NX]ON<XU[XVDQWC/\0:8PE^I0D5
M4VLMY>;:<42\QBD2-MM@JIXL&4^15$V^<L2&8[3(G=+$\5QWZ*2(4&LVR>_-
M^6S",ID0BN<<B"Q-$7^^P0G;32UH'6[<D]5:ZAO.;+)!*_R Y>-FSE7+*5$6
M),54$$8!Q\NI]1%>1W"L'7*+;P3O1.4::"I/C/W0C<^+J>7JB'""8ZDAD/K9
MXEN<)!I)Q?&S +7*/K5C]?J _BDGK\@\(8%O6?*=+.1Z:H466. ERA)YSW9_
MXX+00./%+!'Y-]@5MJX%XDQ(EA;.*H*4T/TO^E4(47& P0L.7N'@G>K@%P[^
MJ0Y!X1#DRNRIY#I$2*+9A+,=X-I:H>F+7,S<6]$G5(_[@^3J*5%^<O:5KQ E
M_Z'](- %>" K2I8D1E2"CW',,BH)78$Y2TA,L !_@#E7;QV7SV">:"/M]-?/
MC&S4VR#!^PA+1!+Q01D^/D3@_;L/X!T@%-R1)%%]B(DC5=BZ<R<N0KS9A^B]
M%&(L;>##*^"YGM_A?GNZN]?A'IWN#NONCM*Z%-PK!?=R//\%O(-Z5YWR_?-%
MF8//$J?BWRZE]MA!-[:>(Z[%!L5X:JE)0&"^Q=;L]]_@T/VS2S>38)$AL)JF
M?JFIWX=>T713:HH/FEX!)$',A.S2<X\[R''U%+F=^3#T;#70VZI2;3,O=%U[
M7#>+>J,\4X.@U"#HU> +%N):9VR69@F2>*%F/]5-3/+4[N*^QQM52,'!P+?]
M!O<.,S\<V5Z#>V]T9W(?E-P';QE_BCO'?M F-O1".VSP[S +H&^/&OQ[(SR3
M_[#D/^SE_XE01&,,$JQ60'#_]1$@(; 4+U(?MCCY+=YM&SANC7IO7&>R'I6L
M1Q<8]5''J/N>/6RP[S +E%DSXT>MB0'ZP:B"5F,6ELS"_ES65/2'I!O.ME@3
MZEPX>V%>NQR8!(L,@=7D&Y?RC2^XQ(Y-:FH2+#($5M,4NL="T;W0(EL 5Y/)
M<YM3R6V'%0Q;TVQ_D.>*4*F68:\(-QE)%JH>%B>E9S_8:]\EHVB1*;2ZD,<J
M&%ZR#(9&ZV"C:)$IM+JPQU(87JH6+H"K"1B$H3UHYFF'&1PT%]"H/\QS93A6
MP["_'+Y#\5K=XL]U 3IY&RI="WE,HD6FT.HJ'NMJ.+ADEAJJB0MA3:)%IM#J
MPAX+=MA?L;\A2]MUN0?5?JRY9>VP@^.1W\[32Y3P\%C#P_XB_I91(7FV/P0D
M%*@%=:7ZZ5Y.>Z%>_3Z91(M,H=5E/&X88'C)1#6ZCS"*%IE"JPM[W$K WJKZ
M+8DZ;NT-@W#8.EXIS,;5O?C8;R:IT=+?J1P7Z\/].\17A J0X*6"=^V1BIGO
MS\OW#<DV^0GR$Y.2I?GE&J,%YMI /5\R)@\-?2A=_FLQ^Q]02P,$%     @
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M+#O<\D2+K.CY%D*;#K(X7 -)0%H#<W\IA-Z>V ?4_S.$OP!02P,$%     @
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M\)E%D?Y-Y,Q6VE(J;"^+Z3_FTZ..Z;\LE04P_ "0@[ A_.KUX:@9;NM"E-5
M9350IH<[]#ZQA"EZ?JM7ULI0@+]O]7APHV@L_S'EFHN[9O'TA+R06[*D\XD^
MXR053W2R^/47Z#N_F3(?2*Q1!US6 ?>I+WX77$IP181X9LD:7,9\ERA3QKF,
ME\FD'>-I@4+H6W!F/]5SR8>%S6%A.:CAT2T]NKT>+Y?+7;R+B-(_E38H%/N/
MI)W!9#-7"FKS0P2]EDW#,,=UK<!LU"N->KU&:^N(Y.MHS]0F[379:@.17FWR
M TBHL<*YME_W%#B'QKVV\6G@6MALW"^-^V\QSI)76O=;KD(+._7781[M".A8
M4W,609E%T)O%GUR1"/"LI[$RHV[706M)PT"[P =6 T/)I_4EU3 [+<U.>\U^
MS[8=NCHG3U3H;;2QLL$=%8ROP)ENN<^4"/G>Y+]_ NCGH::.TQOYQHX3EHF'
M_;^2("L-*!I>3#GUQI[:6 <2:Z0)G6J_=<;<8@KU@4HQE%JS%C7V@,-L,X5.
M8Y]QIE9X<$X6PX+&L-#RS><DK*@ ]FZV)VTUA53=ZA1:3EA_'=I&+=L^LMP.
MU]4>#OLW\0%ZR9$9H-?=3/I#W[JT*CB _71PQ>,ME^D>Q0YV,6.>O6(GGU4#
MJ353KW #>J-VF%Z:.;D6 ZDU:U$1#.Q'F-=W&+^][3L^;+<8$Z(TQC6=5I0"
M^S'EI![39A07N350*KP&+7;$7E=;J0@%CHXH1V;H;2MC0 JL* 4>P12ZW"0\
MXNMG8UZ#<LI0:LTKX0I4T*B@@@8%E:'4FK6H0 4-!"JH#2INZ%K>P9F)VJ#B
M.6[7Q0.JW;X8#E10&U0P]FK845AMPPF&02VCIM6*3M#H=')D!HB[VTA_Z%O7
M4T4GZ B=9#?V] 6IH%&6L-RPK?'*IU_HY--H##)!%9F@4<D$#4HF0ZDU:U&1
M"1J(3)")3,+00H<GJHE,0M1U]PI59(*&(Q/4)A/L>BTR06TR0=,NHQ69H-')
MY,@,,.QI*6.0":K(!/63R2U;TD3J:YQD!59,*L$>=EG>(BV*S#[/;H(9TQX4
M7(92:]ZZKL %CPHN>%!P&4JM68L*7/! X(+;X.+!VIV3(AL3MW1U&%QA"QX.
M6PJIQK.$P_:"VVB#<-=]9%Q[*#(ZLAR9 <+N_M(?>NI*LFN/#-/GM9^)6+-$
M@H@^:GG]F^KBB?P1:'Z@^#9[BOC E4:7[.V&DA45Z0#]_2/GZN4@?3!9/HA>
M_ ]02P,$%     @ YH&(5S>1)COK @  U@D  !D   !X;"]W;W)K<VAE971S
M+W-H965T-#<N>&ULK9;1;ILP%(9?Q6+5U$D=$$@@= E2FG1;I56KVG6[F';A
MP$FP:G!F.Z';T\\&@DA"217M!FSC__=W#N#C4<[XDT@ )'I.:2;&1B+EZM*R
M1)1 BH7)5I"I)PO&4RQ5ER\ML>* XT*44LNQ;<]*,<F,<%2,W?%PQ-:2D@SN
M.!+K-,7\SQ50EH^-GK$=N"?+1.H!*QRM\!(>0#ZN[KCJ6;5+3%+(!&$9XK 8
M&Y/>Y330\XL)WPGDHM%&.I(Y8T^Z<Q./#5L# 85(:@>L;AN8 J7:2&'\KCR-
M>DDM;+:W[A^+V%4L<RQ@RN@/$LMD; P-%,,"KZF\9_EGJ.(9:+^(45%<45[-
MM0T4K85D:256!"G)RCM^KO+0$/3Z+PB<2N"\5N!6 K<(M"0KPIIAB<,19SGB
M>K9RTXTB-X5:14,R_18?)%=/B=+)\":3.%N2.04T$0*D0._1M9!$)0AB-$D9
ME^0O+C)^_:P^'0$"J6\''>IR(A,T@P7)B 3T1;T<@<YG(#&AXIUR?7R8H?.S
M=^@,D0S=$DJ5IQA94@6A4:RH KXJ@9T7@+]&TD1N[P(YMN.VR*>OESN[<DNE
MKLZ?4^?/*?S<%_P^,1;G*AB$L[@E*3,B(LK$F@/Z.9D+R=5G^ZLMZ'*5?OLJ
M^E>^%"L<P=A0_ZH O@$C?/NFY]D?VE+PG\QV$N+6"7&[W$.5UWY;@*5J4*CT
MUK()>WY@#D;6IDG>Z7TB>;\F[Q\C'[21ERJ_2>X=DG=ZGT@^J,D'Q\B]-O)2
MY>V0.WO<G<XG<GLUMW>,VV_C]@XSWO=-?X^\T_M$<K\F]X^1#]O(_19RU]S/
M>:?WB>3#FGS82?XM 57M%Q)X&__P@'\8!&9OC[]SA1/Y@YH_Z.1O[+&X47CB
M;>&ANO!<H QD6WRE=["S"]G[X06'6]70[YMN/:T$MQI55Y]X;C%?DDP@"@LE
MM$U?.?#R%%%V)%L5A7C.I"KK13-1!R_@>H)ZOF!,;CNZMM='N? ?4$L#!!0
M   ( .:!B%>NQ5H/UP0  &H9   9    >&PO=V]R:W-H965T<R]S:&5E=#0X
M+GAM;+59;6_;-A#^*X16#"V06!+EU\PVT#@-.B!=@J;=/@S[0$NT3502/9*V
MTV$_?J2D2*)%,7&M?4DL^>[1\_".=R=Z>J#L&]]@+,!3$J=\YFR$V%ZY+@\W
M.$&\1[<XE=^L*$N0D)=L[?(MPRC*G)+8A9XW=!-$4F<^S>X]L/F4[D1,4OS
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MZ]2L7F>G9[;9'XC<L%(A3M?@" ( $62]<ZU/M-A5F[\GH6$K61UN8;=/I3&
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MSQ.#G6.AUC:L5!_L2?85.'4^L"E?H4'V(5O7'0:[*1JU3<=*^,'7*+_"N4[
M:L;_K F&!MEGM89>R3[X6MT'=;$V=&UMK)NLFE6'H:X/&U6GTJBT'^P6?YCR
MX$#2%1OSBWRO&K!7--P7FIJY2@;"M]*!L%<AV"L:[@M-7=:II"#J00HB7>+-
MG)%CU3[-URV#"[1'#2N,#)H0MK0<JB0AZI:$)P]P9%!R,^W=UV %K4G3#!O,
MY)QO(U.)0M0M"KLG>.%<ORG2">A&0^3I#\-@-AW!F?)IH5.I,=0I1$Z8Z@6
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M*0:":=*[V$COPGC*GX4R\JC2U2H$5MX >??YX6OQODTH1EQ7H2!A/A)&D;
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M!/4-7R:XLK]DW<0&'LF62HNB 6,&!2OK)WUNC-@"A!<' %$#B/8 47P $#>
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M>([+NM2O.UI4MOA]%!I+:=M<X/4(I G ]S,A]$O'3-!>N)+_ 5!+ P04
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MK4&7TZE8T1C.!JI>!/![&(Q__@G[]B\&?&Z#SS5I']^"D) @6B0('E8JQ=5
M,G2OIA&5"-2\PKX"GK($':5%'9F/Z-_.&%4.52;]TJ0NY_LQMKTH=/'(NN_
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M '-(- Q[CA/24@8Q4\9^&1\"S7T*#7O>T.V+6<L6Q/S)UUO6AZ#T.@+H!,.
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M$?$W7_;  'X R$6#E@XM3U='+>K>Z>K08,V@')!!AC<X@N>I48C(>C\>X"'
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MO<TIWIK63YI3W&I:;PM-9Z]*[*$YLU_N<+15GA>!&R&2,,[3E8^,@S:7%1]
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M37@JH-YO&)/[F[2!\C36XA]02P,$%     @ YH&(5S.+(KNV!   CQ(  !D
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MP@3H]17G:C<P'^CZN.P_4$L#!!0    ( .:!B%<OUER]J0,  '(-   9
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M%($T /Q_(X0^#<P"S34K_@]02P,$%     @ YH&(5Q0BWK,N!   TQH  !D
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M7 >H\VO&Y.N.7J:HUK&"_P!02P,$%     @ YH&(5WNT6V1<"@  ]8D  !D
M  !X;"]W;W)K<VAE971S+W-H965T-S,N>&ULO9W=;MM($H5?A= .%A,@8XG_
M<M86D+A[, $F&,\$F;U8[ 4MM6W"%*F0E)T ^_#;I!BURJ+*:OB(-XEDL[\B
MJ]0GJ2,V^^*I*!^J>Z5JY]LRRZO+T7U=K]Z-Q]7\7BV3ZJQ8J5S_YK8HETFM
MWY9WXVI5JF31#EIF8V\RB<;+),U'LXOV9]?E[*)8UUF:J^O2J=;+95)^_Z"R
MXNERY(Y^_."O].Z^;GXPGEVLDCOU6=5?5M>E?C?>4A;I4N556N1.J6XO1^_=
M=W(:- /:(_Y.U5.U\]II+N6F*!Z:-Q\7EZ-)<T8J4_.Z023ZKT=UI;*L(>GS
M^-I!1]N8S<#=US_HO[87KR_F)JG459'].UW4]Y>CZ<A9J-MDG=5_%4^_J>Z"
MPH8W+[*J_=-YZHZ=C)SYNJJ+93=8G\$RS3=_)]^Z1.P,<(,# [QN@'?L +\;
MX!\[(.@&!,<."+L![:6/-]?>)DXD=3*[*(LGIVR.UK3F19O]=K3.5YHW'Y3/
M=:E_F^IQ]4PN5UGQ72GG@\K5;5I7SB_.KTE:.G\GV5HYGU12K4NE/QFU4]PZ
MUUF2.^^K2NGC?A:J3M*L>J-'?/DLG)]_>N/\Y*2Y\RG-,OT9J"[&M3[!)LQX
MWIW,A\W)> =.YH]Y?>;X[EO'FWA^S_"KXX=[/</%\</=GN'R^.$3.GRLB[*M
MC+>MC-?R_ ,\H<N1J\6/PK2Y?[M;@;?.55*KNZ+\[OSG=WVH\[%6R^J_?6G?
M1 KZ(S5:]*Y:)7-U.=)B4ZGR48UF__R'&TW^U5<$)$P@81($(^7RM^7R.?JL
MG32/[:31$V75E"EIR]17CPTJ;%&-E#_.7#\^BR[&C[N)[CDJ\,[.Z5&BYZCS
M\[.0'B5[C@IWCR+7'&RO.6"O^<]U4:O%)H7793I753/_W[?:[WQ*RH=&)_0_
M9L['A1:0=)YDFV-_*,COZE%ECONF+T5L9-N/+!(FD# )@I'RA=ORA8,I3(@L
M%Q(FD# )@I%R1=MR13B%V:#BW?GN^GL*PP:T3302)D$PDNAXF^B83?3G]"Y/
M;[5<Z?_T_''3T).;3'_X\]7:J);7JUHLV'8:(&$""9,@&*G.=%N=Z6"J-466
M"PD32)@$P4BYSK?E.L>IU@85[:B6%SR3+#::;9:1, F"D2R[$]/'38X6K2]Y
M<4BV_%[9XMFV$P%*$U":1-%HE7:Z;7<P\>I"H8J&I DH3:)HM&BF$7?9QM%.
MPCK6KH9-GDD8'\XZU= 6&D6CJ39-M,MWT5=)=>\D^<*9-R_4UW6J\ZY[Q_Y4
MLRSK"8"D"2A-HFBT*J;-=X/A5 O:V$-I DJ3*!HMFFGN7;89M52M<*]?])\[
M35=\0.MD0QMS%(TFV[3F+M^;']0MYW_.*5TR_K2L9Q/4#X#2)(I&"VPL 3<>
M3@*A+@&4)J TB:+1HAFGP&4[6TL)G!XC@= F'TJ3*!I-MNGS7;[1YR3P%8X:
M']5ZLD#M RA-HFCTVT9C('B3X;YOA/H)4)J TB2*1HMF_ 2/;7WM%*YC<:TI
M'\XZU5 7 $6CJ=[Y.IYW 8[5-VOSC8]K/5FP7\]COY\_A;G@&7/!\X=3.*CW
M *4)*$VB:+1HQGOP^'L,[!0N>%GAH(X!E"91-)IJXQAXO&-P592KHM0SP)D7
MRV61.U5=S!]Z\PS]NA]*$U":1-%H28ROX$7#21;4*X#2!)0F431:-.,5>/S]
M W:2%>^WG>'9]+EJ09M\*$VB:#3;ILGW^":_7[5.[+OQYV0]EZ"N I0F431:
M7>,J>.?#"2#42H#2!)0F431Z)ZRQ$GS^7@2[>V$GQP@@']$VVU":1-%HMHT'
MX/,>P$$!?(7KQH>TG2I0FH#2)(I&BV=<!7^XN_Q]J)$ I0DH3:)HM&@[M_HC
M[_7W7^Q)^7#6J8:V_R@:3;5I_WV^_3]*W*PM-SZH]4R!6@I0FD31:/F,I> /
MM\3 AYH.4)J TB2*1HMF3 <?N-"@8['R!K4*H#2)HM%4&ZO YZT"^76=UM^=
MY;I>)YESN\X7_4F&WC$ I0DH3:)HM![&3/"'6US@0ST"*$U :1)%HT4S'H$/
M7&+0L7;;S7#_/@\^HG6VH<T]BD:7?)KF/N";^Q[).K'9QI^0[42"T@24)E$T
M6EKC) 3#K4X(H X"E":@-(FBT:(9!R$ KD[H6"^H'Q_1.MO0UA]%H]DVK7_
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MG6IHDX^BT52;)C_DFWQ6U*P--3Z8]0R!&@90FD31:-F,81 .M^P@A%H+4)J
MTB2*1A^/:ZR%"+CLH&-QLL:'LTTUE"91-)IJ8PA$O"'P/JM5F2=M!YKFCZJJ
MEX>>TL:3;#_^4)J TB2*1FMB?(-HN*4$$=06@-($E"91-%HT8PM$P*4$'6NW
MPYSLW;S!![1.-K2=1]%HLDT['_'M_ '5.K'%QI^4]5R"&@A0FD31:'F-@1 -
MM]@@@AH(4)J TB2*1HNVLZD!<E>#_6T->@00NZL!=EN#4S3^D6G\([[Q/RR
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M?L$%."R!K]EM%'IG 90FH#2)HM$=1XVS,!UNT<(4:B= :0)*DR@:+9JQ$Z;
M10O3_;T1]K8>Y>-9YQKJ J!H--?&!9B^X (<IV_6WAL?UGJR0+T%*$VB:+2
MQEN8#K<\80KU'J T :5)%(T6S7@/4_Y^!CN%V[#.&>^-#V>=:JAC@*)M4CVN
M[I6J15(GLXM5<J=TJWF7YI63J5N-GYPU'7.9WMUOW]3%ZG*D-?:FJ.MBV;Z\
M5\E"E<T!^O>WA6YDNS=CS7\JRH<VQNS_4$L#!!0    ( .:!B%>KU133=0(
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M8T!R*%A7XT[V7V'(9V'Y,EEK]R6]]UV8B%FG438#V-@-%_[/GH8ZG &BZ 5
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MH*R#.2^DQ)-A XRO5/H74$L#!!0    ( .:!B%=@7C:-% 4  -(A   9
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M)>&*Y$6 .+^FE#_O%!=H/N-8_ ]02P,$%     @ YH&(5U9,)GG&!@  +BH
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MR49LL:E!E7(<G7)%%UG5ZE;9B"TV-;!2JZ-G+.LVMFK2><%05&J!+H0#6=D
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MX.B8>JJN9J!J855>SAT+96F**1]3FAM1NP/T?JF4W2V<@V82G?T"4$L#!!0
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M2)Z#]^='#YU].$<?M/]M&$6PW')D*@A>AV#Z6:"S-%#K1*#80K><J;5$/[.
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M)UPB8Y;(N/&CYG2:+2VP_7Y@?U]J-UH>B<*E8/_03&]GSK4#&:Y)P?2#V'_
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MQ(5R^E'6P\>M%#ZK?*DQ)B6#@%D&<[A'O@$53*<8B=) P*P!,@EI)70!Y8.
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MU^77SLFM<L6YOJ\8GO\"4$L#!!0    ( .:!B%<@< [9) (  *DO   3
M6T-O;G1E;G1?5'EP97-=+GAM;,W:36[;,! %X*L8V@86S7^UB+-INVVSZ 58
M:1P+ED2"9%+G]J7D)$"+U$C@ GT;"S;)>2,.\*U\_?TQ4%H=QV%*VVJ?<_C(
M6&KW-+I4^T!36=GY.+I<OL8[%EQ[<'?$Q&9C6.NG3%->Y[E&=7/]F7;N?LBK
M+\?R<^K]M*TB#:E:?3IMG+.VE0MAZ%N7RSI[F+H_4M9/"74YN>Q)^SZDJ[*A
M8J\FS"M_#W@Z]^V!8NP[6MVZF+^ZL>QBQX&E_#A0JL^7>*5'O]OU+76^O1_+
MD3J%2*Y+>Z(\#O6IZ-7YY%QNF$Z?_.+\I<RYP++S-OJ0RL0BO3_N>23SZ74H
MA2CF_OPKOB26TA>_'\W3[JA[8W:YWI\^'I9Y)+8\+K_CWV?\4O^=?0B0/B1(
M'PJD#PW2AP'IPX+TT8#T\0&D#[Y!:01%5(Y"*D<QE:.@RE%4Y2BL<A17.0JL
M'$56@2*K0)%5H,@J4&05*+(*%%D%BJP"15:!(JM D56BR"I19)4HLDH4626*
MK!)%5HDBJT215:+(*E%D52BR*A19%8JL"D56A2*K0I%5H<BJ4&15*+(J%%DU
MBJP:15:-(JM&D56CR*I19-4HLFH4636*K!I%5H,BJT&1U:#(:E!D-2BR&A19
M#8JL!D56@R*K09'5HLAJ462U*+):%%DMBJP615:+(JM%D=6BR&I19&U09&U0
M9&U09&W^IZP_O#_\X_CE68^NGY[SV?(/_9M?4$L! A0#%     @ YH&(5P=!
M36*!    L0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q0
M2P$"% ,4    " #F@8A7E'_I'^\    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #F@8A7F5R<(Q &  "<)P
M$P              @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( .:!B%>HC'WFZ@<  )HQ   8              " @0X(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #F@8A7Q/QDW3,"  "M!0
M&               @($N$   >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L!
M A0#%     @ YH&(5]7>3U\Q!0  <!4  !@              ("!EQ(  'AL
M+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( .:!B%=PJ^41J0,
M %T,   8              " @?X7  !X;"]W;W)K<VAE971S+W-H965T-"YX
M;6Q02P$"% ,4    " #F@8A7G%.VI,L"  #.!P  &               @('=
M&P  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ YH&(5Q$A
M;78D!P  S!X  !@              ("!WAX  'AL+W=O<FMS:&5E=',O<VAE
M970V+GAM;%!+ 0(4 Q0    ( .:!B%=[YST_50,  *8+   8
M  " @3@F  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " #F
M@8A7VB^EH#@+   ;?@  &               @('#*0  >&PO=V]R:W-H965T
M<R]S:&5E=#@N>&UL4$L! A0#%     @ YH&(5^B8G;G? @  I@H  !@
M         ("!,34  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0
M   ( .:!B%>%JS(2-@H  * S   9              " @48X  !X;"]W;W)K
M<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ YH&(5S]A9@G")   %G(
M !D              ("!LT(  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q0
M2P$"% ,4    " #F@8A771-VCJ<#  !2"   &0              @(&L9P
M>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( .:!B%?PG##B
MXPH  #P<   9              " @8IK  !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&UL4$L! A0#%     @ YH&(5YG!H!_E!0  :@X  !D
M ("!I'8  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " #F
M@8A7\_T?UET+  "V(@  &0              @(' ?   >&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( .:!B%>0YA%3(@H  $<:   9
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M970R,"YX;6Q02P$"% ,4    " #F@8A7?4(Y0(@#  "+!P  &0
M    @(&YM@  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (
M .:!B%<NH# LDP@  ,T5   9              " @7BZ  !X;"]W;W)K<VAE
M971S+W-H965T,C(N>&UL4$L! A0#%     @ YH&(5_U3&P^Y!@  +A(  !D
M             ("!0L,  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"
M% ,4    " #F@8A7"M?"#]8"   O!@  &0              @($RR@  >&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( .:!B%=QJ#X]'"
M -=I   9              " @3_-  !X;"]W;W)K<VAE971S+W-H965T,C4N
M>&UL4$L! A0#%     @ YH&(5[)*S 1O P  TP<  !D              ("!
MDNT  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " #F@8A7
M?E6VQ((#  !J"   &0              @($X\0  >&PO=V]R:W-H965T<R]S
M:&5E=#(W+GAM;%!+ 0(4 Q0    ( .:!B%?.YPP&N@0  $\/   9
M      " @?'T  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%
M  @ YH&(5Z*U6X8O P  Y 8  !D              ("!XOD  'AL+W=O<FMS
M:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " #F@8A7Z/F"WG(&  #T$0
M&0              @(%(_0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+
M 0(4 Q0    ( .:!B%>FO:JVK0,  % )   9              " @?$# 0!X
M;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ YH&(5QH>0;G\
M P  Q0D  !D              ("!U0<! 'AL+W=O<FMS:&5E=',O<VAE970S
M,BYX;6Q02P$"% ,4    " #F@8A7X@A@$Q,%  "+#   &0
M@($(# $ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( .:!
MB%<\(([X3 @  .4;   9              " @5(1 0!X;"]W;W)K<VAE971S
M+W-H965T,S0N>&UL4$L! A0#%     @ YH&(5\?MO7>L!@  *A(  !D
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M=#,Y+GAM;%!+ 0(4 Q0    ( .:!B%?2:;_:A ,  '$,   9
M  " @=(Q 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @
MYH&(5RL(]NMM @  @@8  !D              ("!C34! 'AL+W=O<FMS:&5E
M=',O<VAE970T,2YX;6Q02P$"% ,4    " #F@8A7X -L.@L#   I"P  &0
M            @($Q. $ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4
M Q0    ( .:!B%<=2K=OC \  -O;   9              " @7,[ 0!X;"]W
M;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ YH&(5W]+YKN3 P
M<Q   !D              ("!-DL! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX
M;6Q02P$"% ,4    " #F@8A7E^MU%E\#  "X#   &0              @($
M3P$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( .:!B%<?
MCH!7-@4  )0>   9              " @992 0!X;"]W;W)K<VAE971S+W-H
M965T-#8N>&UL4$L! A0#%     @ YH&(5S>1)COK @  U@D  !D
M     ("! U@! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4
M" #F@8A7KL5:#]<$  !J&0  &0              @($E6P$ >&PO=V]R:W-H
M965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( .:!B%<8::"8RPH  %""   9
M              " @3-@ 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L!
M A0#%     @ YH&(5TTE2X=<!0  SQX  !D              ("!-6L! 'AL
M+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " #F@8A7F.[Z);<"
M   ="   &0              @('(< $ >&PO=V]R:W-H965T<R]S:&5E=#4Q
M+GAM;%!+ 0(4 Q0    ( .:!B%<]0X=3K ,  /T-   9              "
M@;9S 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ YH&(
M5TD;"@_%!   IA(  !D              ("!F7<! 'AL+W=O<FMS:&5E=',O
M<VAE970U,RYX;6Q02P$"% ,4    " #F@8A75*IF=64$  !+$   &0
M        @(&5? $ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0
M   ( .:!B%=\$!,'50,  -,)   9              " @3&! 0!X;"]W;W)K
M<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ YH&(5^UM=3&5 P  APT
M !D              ("!O80! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q0
M2P$"% ,4    " #F@8A7KV&.B<(#  #5#P  &0              @(&)B $
M>&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( .:!B%=H20BC
MJ 4  .8>   9              " @8*, 0!X;"]W;W)K<VAE971S+W-H965T
M-3@N>&UL4$L! A0#%     @ YH&(5_O+5;^N!0  <2X  !D
M ("!89(! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " #F
M@8A7L#@[D7$+  #L@0  &0              @(%&F $ >&PO=V]R:W-H965T
M<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( .:!B%=XK"];X0,  'D2   9
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M970V-2YX;6Q02P$"% ,4    " #F@8A7,XLBN[8$  "/$@  &0
M    @(&"N@$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    (
M .:!B%?$6#VE>0(   L'   9              " @6^_ 0!X;"]W;W)K<VAE
M971S+W-H965T-C<N>&UL4$L! A0#%     @ YH&(5XF:#B@? P  :0D  !D
M             ("!'\(! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"
M% ,4    " #F@8A7\??D+P,$   <#@  &0              @(%UQ0$ >&PO
M=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( .:!B%??HE7L/ ,
M -,)   9              " @:_) 0!X;"]W;W)K<VAE971S+W-H965T-S N
M>&UL4$L! A0#%     @ YH&(5R_67+VI P  <@T  !D              ("!
M(LT! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    " #F@8A7
M%"+>LRX$  #3&@  &0              @($"T0$ >&PO=V]R:W-H965T<R]S
M:&5E=#<R+GAM;%!+ 0(4 Q0    ( .:!B%=[M%MD7 H  /6)   9
M      " @6?5 0!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%
M  @ YH&(5ZO5%--U @  >@8  !D              ("!^M\! 'AL+W=O<FMS
M:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    " #F@8A7"!EHH2T"  "Q!
M&0              @(&FX@$ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+
M 0(4 Q0    ( .:!B%=@7C:-% 4  -(A   9              " @0KE 0!X
M;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @ YH&(5U9,)GG&
M!@  +BH  !D              ("!5>H! 'AL+W=O<FMS:&5E=',O<VAE970W
M-RYX;6Q02P$"% ,4    " #F@8A7?BZM.(L&  #>*P  &0
M@(%2\0$ >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( .:!
MB%?:UQ+M5P,  )4*   9              " @13X 0!X;"]W;W)K<VAE971S
M+W-H965T-SDN>&UL4$L! A0#%     @ YH&(5Q/$;8CJ @  ?0@  !D
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M<R\N<F5L<U!+ 0(4 Q0    ( .:!B%>W3;=X*@8  +$V   /
M  "  >T- @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #F@8A7-$X[?7H"
M    ,0  &@              @ %$% ( >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " #F@8A7(' .V20"  "I+P  $P
M@ 'V%@( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     6P!; /08  !+&0(
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>359</ContextCount>
  <ElementCount>469</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>105</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Organization and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Operating Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OperatingLeases</Role>
      <ShortName>Operating Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Acquisitions and Joint Venture</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/AcquisitionsandJointVenture</Role>
      <ShortName>Acquisitions and Joint Venture</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Financing Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancingArrangements</Role>
      <ShortName>Financing Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Stock Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlans</Role>
      <ShortName>Stock Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Employee Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefits</Role>
      <ShortName>Employee Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Business Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/BusinessSegmentInformation</Role>
      <ShortName>Business Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Financial Derivatives and Hedging</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancialDerivativesandHedging</Role>
      <ShortName>Financial Derivatives and Hedging</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Schedule II</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ScheduleII</Role>
      <ShortName>Schedule II</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Organization and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Organization and Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables</Role>
      <ShortName>Organization and Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Operating Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OperatingLeasesTables</Role>
      <ShortName>Operating Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/OperatingLeases</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/IntangibleAssets</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Financing Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancingArrangementsTables</Role>
      <ShortName>Financing Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/FinancingArrangements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/IncomeTaxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/EarningsPerShare</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/StockholdersEquity</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Stock Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlansTables</Role>
      <ShortName>Stock Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/StockPlans</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Employee Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsTables</Role>
      <ShortName>Employee Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/EmployeeBenefits</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Business Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/BusinessSegmentInformationTables</Role>
      <ShortName>Business Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/BusinessSegmentInformation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Financial Derivatives and Hedging (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancialDerivativesandHedgingTables</Role>
      <ShortName>Financial Derivatives and Hedging (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/FinancialDerivativesandHedging</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Organization and Significant Accounting Policies - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Organization and Significant Accounting Policies - Property Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Property Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Operating Leases - Leases on the Consolidated Condensed Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails</Role>
      <ShortName>Operating Leases - Leases on the Consolidated Condensed Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Operating Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OperatingLeasesNarrativeDetails</Role>
      <ShortName>Operating Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails</Role>
      <ShortName>Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Acquisitions and Joint Venture (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/AcquisitionsandJointVentureDetails</Role>
      <ShortName>Acquisitions and Joint Venture (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/AcquisitionsandJointVenture</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails</Role>
      <ShortName>Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Intangible Assets - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails</Role>
      <ShortName>Intangible Assets - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Intangible Assets - Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets - Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Intangible Assets - Estimated Amortization Expenses for Intangible Assets with Definite Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails</Role>
      <ShortName>Intangible Assets - Estimated Amortization Expenses for Intangible Assets with Definite Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Financing Arrangements - Total Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails</Role>
      <ShortName>Financing Arrangements - Total Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Financing Arrangements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails</Role>
      <ShortName>Financing Arrangements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Income Taxes - Income Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Income Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Income Taxes - Income Tax Provision (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails</Role>
      <ShortName>Income Taxes - Income Tax Provision (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Income Taxes - Reconciliation between the Expected Provision for Income taxes at the US Federal Statutory Rate and the Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Reconciliation between the Expected Provision for Income taxes at the US Federal Statutory Rate and the Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Income Taxes - Changes in Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Changes in Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Earnings Per Share - Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails</Role>
      <ShortName>Earnings Per Share - Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Earnings Per Share - Stock Options to Purchase Common Stock and Restricted Stock Units Not Included in Diluted Earnings Per Share Due to Antidilutive Effect (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails</Role>
      <ShortName>Earnings Per Share - Stock Options to Purchase Common Stock and Restricted Stock Units Not Included in Diluted Earnings Per Share Due to Antidilutive Effect (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Stockholders' Equity - Changes in Accumulated Other Comprehensive Income (Loss) Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails</Role>
      <ShortName>Stockholders' Equity - Changes in Accumulated Other Comprehensive Income (Loss) Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Stock Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlansNarrativeDetails</Role>
      <ShortName>Stock Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Stock Plans - Compensation Expense and Related Income Tax Benefit for Share-Based Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails</Role>
      <ShortName>Stock Plans - Compensation Expense and Related Income Tax Benefit for Share-Based Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - Stock Plans - Assumptions Used in Estimating Fair Value of Stock Options Award Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails</Role>
      <ShortName>Stock Plans - Assumptions Used in Estimating Fair Value of Stock Options Award Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - Stock Plans - Stock Option Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlansStockOptionPlansDetails</Role>
      <ShortName>Stock Plans - Stock Option Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - Stock Plans - Non-Vested RSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails</Role>
      <ShortName>Stock Plans - Non-Vested RSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - Employee Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails</Role>
      <ShortName>Employee Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - Employee Benefits - Changes in Benefit Obligation, Changes in Plan Assets and Funded Status (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails</Role>
      <ShortName>Employee Benefits - Changes in Benefit Obligation, Changes in Plan Assets and Funded Status (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - Employee Benefits - Reconciliation of Prepaid (Accrued) Pension Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails</Role>
      <ShortName>Employee Benefits - Reconciliation of Prepaid (Accrued) Pension Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954515 - Disclosure - Employee Benefits - Components of Net Periodic Pension Costs and Other Amounts Recognized in Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Employee Benefits - Components of Net Periodic Pension Costs and Other Amounts Recognized in Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954516 - Disclosure - Employee Benefits - Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Employee Benefits - Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954517 - Disclosure - Employee Benefits - Weighted-Average Assumptions Used in Computing Net Periodic Pension Cost and Projected Benefit Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails</Role>
      <ShortName>Employee Benefits - Weighted-Average Assumptions Used in Computing Net Periodic Pension Cost and Projected Benefit Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9954518 - Disclosure - Employee Benefits - Weighted-Average Asset Allocations by Asset Category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails</Role>
      <ShortName>Employee Benefits - Weighted-Average Asset Allocations by Asset Category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9954519 - Disclosure - Employee Benefits - Fair Value Measurement of Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails</Role>
      <ShortName>Employee Benefits - Fair Value Measurement of Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9954520 - Disclosure - Employee Benefits - Estimated Future Benefit Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails</Role>
      <ShortName>Employee Benefits - Estimated Future Benefit Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9954521 - Disclosure - Business Segment Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/BusinessSegmentInformationNarrativeDetails</Role>
      <ShortName>Business Segment Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9954522 - Disclosure - Business Segment Information - Business Segment Net Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails</Role>
      <ShortName>Business Segment Information - Business Segment Net Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9954523 - Disclosure - Business Segment Information - Business Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails</Role>
      <ShortName>Business Segment Information - Business Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9954524 - Disclosure - Business Segment Information - Information by Geographical Area by Country of Domicile (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails</Role>
      <ShortName>Business Segment Information - Information by Geographical Area by Country of Domicile (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9954525 - Disclosure - Financial Derivatives and Hedging - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails</Role>
      <ShortName>Financial Derivatives and Hedging - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9954526 - Disclosure - Financial Derivatives and Hedging - Derivative Instruments Recognized in Condensed Consolidated Statements of Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails</Role>
      <ShortName>Financial Derivatives and Hedging - Derivative Instruments Recognized in Condensed Consolidated Statements of Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9954527 - Disclosure - Financial Derivatives and Hedging - Changes in Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Financial Derivatives and Hedging - Changes in Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9954528 - Disclosure - Schedule II (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ScheduleIIDetails</Role>
      <ShortName>Schedule II (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/ScheduleII</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="coo-20231031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - coo-20231031.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - coo-20231031.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="coo-20231031.htm">coo-20231031.htm</File>
    <File>coo-20231031.xsd</File>
    <File>coo-20231031_cal.xml</File>
    <File>coo-20231031_def.xml</File>
    <File>coo-20231031_lab.xml</File>
    <File>coo-20231031_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>coo-20231031_g1.jpg</File>
    <File>coo-20231031_g2.jpg</File>
    <File>coo-20231031_g3.jpg</File>
    <File>coo-20231031_g4.jpg</File>
    <File>coo-20231031_g5.jpg</File>
    <File>coo-20231031_g6.jpg</File>
    <File>coo-20231031_g7.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2023</BaseTaxonomy>
    <BaseTaxonomy items="1320">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>114
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "coo-20231031.htm": {
   "nsprefix": "coo",
   "nsuri": "http://www.coopercos.com/20231031",
   "dts": {
    "inline": {
     "local": [
      "coo-20231031.htm"
     ]
    },
    "schema": {
     "local": [
      "coo-20231031.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "coo-20231031_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "coo-20231031_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "coo-20231031_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "coo-20231031_pre.xml"
     ]
    }
   },
   "keyStandard": 445,
   "keyCustom": 24,
   "axisStandard": 28,
   "axisCustom": 1,
   "memberStandard": 53,
   "memberCustom": 49,
   "hidden": {
    "total": 27,
    "http://fasb.org/us-gaap/2023": 23,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 359,
   "entityCount": 1,
   "segmentCount": 105,
   "elementCount": 733,
   "unitCount": 10,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1320,
    "http://xbrl.sec.gov/dei/2023": 39,
    "http://fasb.org/srt/2023": 1
   },
   "report": {
    "R1": {
     "role": "http://www.coopercos.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.coopercos.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "dei:DocumentsIncorporatedByReferenceTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "dei:DocumentsIncorporatedByReferenceTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
     "longName": "0000003 - Statement - Consolidated Statements of Income",
     "shortName": "Consolidated Statements of Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "longName": "0000004 - Statement - Consolidated Statements of Comprehensive Income",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical",
     "longName": "0000005 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)",
     "shortName": "Consolidated Statements of Comprehensive Income (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
     "longName": "0000006 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "0000007 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
     "longName": "0000008 - Statement - Consolidated Statements of Stockholders' Equity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
     "longName": "0000009 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "shortName": "Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-180",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareCashPaid",
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R10": {
     "role": "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "0000010 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies",
     "longName": "0000011 - Disclosure - Organization and Significant Accounting Policies",
     "shortName": "Organization and Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.coopercos.com/role/OperatingLeases",
     "longName": "0000012 - Disclosure - Operating Leases",
     "shortName": "Operating Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.coopercos.com/role/AcquisitionsandJointVenture",
     "longName": "0000013 - Disclosure - Acquisitions and Joint Venture",
     "shortName": "Acquisitions and Joint Venture",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "coo:BusinessCombinationAndAssetAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "coo:BusinessCombinationAndAssetAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.coopercos.com/role/IntangibleAssets",
     "longName": "0000014 - Disclosure - Intangible Assets",
     "shortName": "Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.coopercos.com/role/FinancingArrangements",
     "longName": "0000015 - Disclosure - Financing Arrangements",
     "shortName": "Financing Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.coopercos.com/role/IncomeTaxes",
     "longName": "0000016 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.coopercos.com/role/EarningsPerShare",
     "longName": "0000017 - Disclosure - Earnings Per Share",
     "shortName": "Earnings Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.coopercos.com/role/StockholdersEquity",
     "longName": "0000018 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.coopercos.com/role/StockPlans",
     "longName": "0000019 - Disclosure - Stock Plans",
     "shortName": "Stock Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.coopercos.com/role/EmployeeBenefits",
     "longName": "0000020 - Disclosure - Employee Benefits",
     "shortName": "Employee Benefits",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.coopercos.com/role/Contingencies",
     "longName": "0000021 - Disclosure - Contingencies",
     "shortName": "Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.coopercos.com/role/BusinessSegmentInformation",
     "longName": "0000022 - Disclosure - Business Segment Information",
     "shortName": "Business Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.coopercos.com/role/FinancialDerivativesandHedging",
     "longName": "0000023 - Disclosure - Financial Derivatives and Hedging",
     "shortName": "Financial Derivatives and Hedging",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.coopercos.com/role/ScheduleII",
     "longName": "0000024 - Disclosure - Schedule II",
     "shortName": "Schedule II",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies",
     "longName": "9954471 - Disclosure - Organization and Significant Accounting Policies (Policies)",
     "shortName": "Organization and Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables",
     "longName": "9954472 - Disclosure - Organization and Significant Accounting Policies (Tables)",
     "shortName": "Organization and Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.coopercos.com/role/OperatingLeasesTables",
     "longName": "9954473 - Disclosure - Operating Leases (Tables)",
     "shortName": "Operating Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "coo:AssetsAndLiabilitiesLesseeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "coo:AssetsAndLiabilitiesLesseeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.coopercos.com/role/IntangibleAssetsTables",
     "longName": "9954474 - Disclosure - Intangible Assets (Tables)",
     "shortName": "Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.coopercos.com/role/FinancingArrangementsTables",
     "longName": "9954475 - Disclosure - Financing Arrangements (Tables)",
     "shortName": "Financing Arrangements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.coopercos.com/role/IncomeTaxesTables",
     "longName": "9954476 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.coopercos.com/role/EarningsPerShareTables",
     "longName": "9954477 - Disclosure - Earnings Per Share (Tables)",
     "shortName": "Earnings Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.coopercos.com/role/StockholdersEquityTables",
     "longName": "9954478 - Disclosure - Stockholders' Equity (Tables)",
     "shortName": "Stockholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R33": {
     "role": "http://www.coopercos.com/role/StockPlansTables",
     "longName": "9954479 - Disclosure - Stock Plans (Tables)",
     "shortName": "Stock Plans (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.coopercos.com/role/EmployeeBenefitsTables",
     "longName": "9954480 - Disclosure - Employee Benefits (Tables)",
     "shortName": "Employee Benefits (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.coopercos.com/role/BusinessSegmentInformationTables",
     "longName": "9954481 - Disclosure - Business Segment Information (Tables)",
     "shortName": "Business Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.coopercos.com/role/FinancialDerivativesandHedgingTables",
     "longName": "9954482 - Disclosure - Financial Derivatives and Hedging (Tables)",
     "shortName": "Financial Derivatives and Hedging (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
     "longName": "9954483 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)",
     "shortName": "Organization and Significant Accounting Policies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "coo:NumberOfBusinessUnits",
      "unitRef": "business_unit",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "coo:NumberOfBusinessUnits",
      "unitRef": "business_unit",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails",
     "longName": "9954484 - Disclosure - Organization and Significant Accounting Policies - Inventory (Details)",
     "shortName": "Organization and Significant Accounting Policies - Inventory (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails",
     "longName": "9954485 - Disclosure - Organization and Significant Accounting Policies - Property Plant and Equipment (Details)",
     "shortName": "Organization and Significant Accounting Policies - Property Plant and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails",
     "longName": "9954486 - Disclosure - Operating Leases - Leases on the Consolidated Condensed Balance Sheet (Details)",
     "shortName": "Operating Leases - Leases on the Consolidated Condensed Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "coo:AssetsAndLiabilitiesLesseeTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "coo:AssetsAndLiabilitiesLesseeTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.coopercos.com/role/OperatingLeasesNarrativeDetails",
     "longName": "9954487 - Disclosure - Operating Leases - Narrative (Details)",
     "shortName": "Operating Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails",
     "longName": "9954488 - Disclosure - Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details)",
     "shortName": "Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
     "longName": "9954489 - Disclosure - Acquisitions and Joint Venture (Details)",
     "shortName": "Acquisitions and Joint Venture (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-87",
      "name": "us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails",
     "longName": "9954490 - Disclosure - Intangible Assets - Narrative (Details)",
     "shortName": "Intangible Assets - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportingUnits",
      "unitRef": "reporting_unit",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportingUnits",
      "unitRef": "reporting_unit",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
     "longName": "9954491 - Disclosure - Intangible Assets - Goodwill (Details)",
     "shortName": "Intangible Assets - Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillPeriodIncreaseDecrease",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails",
     "longName": "9954492 - Disclosure - Intangible Assets - Other Intangible Assets (Details)",
     "shortName": "Intangible Assets - Other Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails",
     "longName": "9954493 - Disclosure - Intangible Assets - Estimated Amortization Expenses for Intangible Assets with Definite Lives (Details)",
     "shortName": "Intangible Assets - Estimated Amortization Expenses for Intangible Assets with Definite Lives (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails",
     "longName": "9954494 - Disclosure - Financing Arrangements - Total Debt (Details)",
     "shortName": "Financing Arrangements - Total Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShortTermBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShortTermBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
     "longName": "9954495 - Disclosure - Financing Arrangements - Narrative (Details)",
     "shortName": "Financing Arrangements - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-126",
      "name": "us-gaap:DebtInstrumentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-126",
      "name": "us-gaap:DebtInstrumentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails",
     "longName": "9954496 - Disclosure - Income Taxes - Narrative (Details)",
     "shortName": "Income Taxes - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-146",
      "name": "us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-146",
      "name": "us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails",
     "longName": "9954497 - Disclosure - Income Taxes - Income Before Income Taxes (Details)",
     "shortName": "Income Taxes - Income Before Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails",
     "longName": "9954498 - Disclosure - Income Taxes - Income Tax Provision (Benefit) (Details)",
     "shortName": "Income Taxes - Income Tax Provision (Benefit) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails",
     "longName": "9954499 - Disclosure - Income Taxes - Reconciliation between the Expected Provision for Income taxes at the US Federal Statutory Rate and the Provision for Income Taxes (Details)",
     "shortName": "Income Taxes - Reconciliation between the Expected Provision for Income taxes at the US Federal Statutory Rate and the Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9954500 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails",
     "longName": "9954501 - Disclosure - Income Taxes - Changes in Unrecognized Tax Benefits (Details)",
     "shortName": "Income Taxes - Changes in Unrecognized Tax Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-32",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails",
     "longName": "9954502 - Disclosure - Earnings Per Share - Basic and Diluted (Details)",
     "shortName": "Earnings Per Share - Basic and Diluted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails",
     "longName": "9954503 - Disclosure - Earnings Per Share - Stock Options to Purchase Common Stock and Restricted Stock Units Not Included in Diluted Earnings Per Share Due to Antidilutive Effect (Details)",
     "shortName": "Earnings Per Share - Stock Options to Purchase Common Stock and Restricted Stock Units Not Included in Diluted Earnings Per Share Due to Antidilutive Effect (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails",
     "longName": "9954504 - Disclosure - Stockholders' Equity - Changes in Accumulated Other Comprehensive Income (Loss) Income (Details)",
     "shortName": "Stockholders' Equity - Changes in Accumulated Other Comprehensive Income (Loss) Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails",
     "longName": "9954505 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-178",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-8",
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-178",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-8",
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.coopercos.com/role/StockPlansNarrativeDetails",
     "longName": "9954506 - Disclosure - Stock Plans - Narrative (Details)",
     "shortName": "Stock Plans - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails",
     "longName": "9954507 - Disclosure - Stock Plans - Compensation Expense and Related Income Tax Benefit for Share-Based Awards (Details)",
     "shortName": "Stock Plans - Compensation Expense and Related Income Tax Benefit for Share-Based Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails",
     "longName": "9954508 - Disclosure - Stock Plans - Assumptions Used in Estimating Fair Value of Stock Options Award Granted (Details)",
     "shortName": "Stock Plans - Assumptions Used in Estimating Fair Value of Stock Options Award Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails",
     "longName": "9954509 - Disclosure - Stock Plans - Stock Option Plans (Details)",
     "shortName": "Stock Plans - Stock Option Plans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails",
     "longName": "9954510 - Disclosure - Stock Plans - Non-Vested RSUs (Details)",
     "shortName": "Stock Plans - Non-Vested RSUs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-212",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-212",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
     "longName": "9954511 - Disclosure - Employee Benefits - Narrative (Details)",
     "shortName": "Employee Benefits - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails",
     "longName": "9954512 - Disclosure - Employee Benefits - Changes in Benefit Obligation, Changes in Plan Assets and Funded Status (Details)",
     "shortName": "Employee Benefits - Changes in Benefit Obligation, Changes in Plan Assets and Funded Status (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails",
     "longName": "9954513 - Disclosure - Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Details)",
     "shortName": "Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails",
     "longName": "9954514 - Disclosure - Employee Benefits - Reconciliation of Prepaid (Accrued) Pension Cost (Details)",
     "shortName": "Employee Benefits - Reconciliation of Prepaid (Accrued) Pension Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "coo:AccruedPrepaidPensionCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "coo:ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-15",
      "name": "coo:AccruedPrepaidPensionCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "coo:ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails",
     "longName": "9954515 - Disclosure - Employee Benefits - Components of Net Periodic Pension Costs and Other Amounts Recognized in Other Comprehensive Income (Details)",
     "shortName": "Employee Benefits - Components of Net Periodic Pension Costs and Other Amounts Recognized in Other Comprehensive Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails",
     "longName": "9954516 - Disclosure - Employee Benefits - Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Details)",
     "shortName": "Employee Benefits - Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails",
     "longName": "9954517 - Disclosure - Employee Benefits - Weighted-Average Assumptions Used in Computing Net Periodic Pension Cost and Projected Benefit Obligation (Details)",
     "shortName": "Employee Benefits - Weighted-Average Assumptions Used in Computing Net Periodic Pension Cost and Projected Benefit Obligation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails",
     "longName": "9954518 - Disclosure - Employee Benefits - Weighted-Average Asset Allocations by Asset Category (Details)",
     "shortName": "Employee Benefits - Weighted-Average Asset Allocations by Asset Category (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
     "longName": "9954519 - Disclosure - Employee Benefits - Fair Value Measurement of Plan Assets (Details)",
     "shortName": "Employee Benefits - Fair Value Measurement of Plan Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-265",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails",
     "longName": "9954520 - Disclosure - Employee Benefits - Estimated Future Benefit Payments (Details)",
     "shortName": "Employee Benefits - Estimated Future Benefit Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.coopercos.com/role/BusinessSegmentInformationNarrativeDetails",
     "longName": "9954521 - Disclosure - Business Segment Information - Narrative (Details)",
     "shortName": "Business Segment Information - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
     "longName": "9954522 - Disclosure - Business Segment Information - Business Segment Net Sales (Details)",
     "shortName": "Business Segment Information - Business Segment Net Sales (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-268",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
     "longName": "9954523 - Disclosure - Business Segment Information - Business Segment Information (Details)",
     "shortName": "Business Segment Information - Business Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NonoperatingIncomeExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails",
     "longName": "9954524 - Disclosure - Business Segment Information - Information by Geographical Area by Country of Domicile (Details)",
     "shortName": "Business Segment Information - Information by Geographical Area by Country of Domicile (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-308",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails",
     "longName": "9954525 - Disclosure - Financial Derivatives and Hedging - Narrative (Details)",
     "shortName": "Financial Derivatives and Hedging - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
     "longName": "9954526 - Disclosure - Financial Derivatives and Hedging - Derivative Instruments Recognized in Condensed Consolidated Statements of Income (Details)",
     "shortName": "Financial Derivatives and Hedging - Derivative Instruments Recognized in Condensed Consolidated Statements of Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-347",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-347",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
     "longName": "9954527 - Disclosure - Financial Derivatives and Hedging - Changes in Accumulated Other Comprehensive Income (Details)",
     "shortName": "Financial Derivatives and Hedging - Changes in Accumulated Other Comprehensive Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.coopercos.com/role/ScheduleIIDetails",
     "longName": "9954528 - Disclosure - Schedule II (Details)",
     "shortName": "Schedule II (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-353",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-358",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "unique": true
     }
    },
    "R9999": {
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "longName": "Uncategorized Items - coo-20231031.htm",
     "shortName": "Uncategorized Items - coo-20231031.htm",
     "isDefault": "false",
     "groupType": "",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-19",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "coo-20231031.htm",
      "first": true
     },
     "uniqueAnchor": null
    }
   },
   "tag": {
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Funded status at end of year",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r522",
      "r932"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Debt, Type [Domain]",
        "label": "Short-Term Debt, Type [Domain]",
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanAssetCategoriesDomain",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "documentation": "Defined benefit plan asset investment."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r524",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r545",
      "r930",
      "r931",
      "r932"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r903"
     ]
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanInterestCost",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest cost",
        "label": "Defined Benefit Plan, Interest Cost",
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r512",
      "r515",
      "r536",
      "r555",
      "r932",
      "r933"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted average common shares (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r344"
     ]
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net loss",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r539"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Derivatives and Hedging",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r130",
      "r131",
      "r134",
      "r140",
      "r309"
     ]
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actual return on plan assets",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r932"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic earnings per share (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r335",
      "r337",
      "r342",
      "r343",
      "r344",
      "r348",
      "r689",
      "r690",
      "r749",
      "r769",
      "r916"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net periodic benefit cost",
        "totalLabel": "Net periodic pension cost",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r553",
      "r932",
      "r933"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited or exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average common shares (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r344"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted- Average Grant\u00a0Date\u00a0Fair Value\u00a0Per\u00a0Share",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal net operating losses expiring",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal net operating losses not subject to expiration",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r909"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Pronouncements Recently Adopted and Accounting Pronouncements Issued Not Yet Adopted",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work-in-process",
        "label": "Inventory, Work in Process, Net of Reserves",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r910"
     ]
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rate of compensation increase for determining benefit obligations at year end",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent [Member]",
        "documentation": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "coo_OtherDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "OtherDebtMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Debt [Member]",
        "documentation": "Other Debt [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanServiceCost",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service cost",
        "label": "Defined Benefit Plan, Service Cost",
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r514",
      "r535",
      "r554",
      "r932",
      "r933"
     ]
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw materials",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r911"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails",
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Debt, Type [Axis]",
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "coo_PayablesThirdInstallmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "PayablesThirdInstallmentMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables Third Installment",
        "label": "Payables Third Installment [Member]",
        "documentation": "Payables Third Installment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Table]",
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r321",
      "r327",
      "r333",
      "r398",
      "r404",
      "r605",
      "r606",
      "r607",
      "r640",
      "r641",
      "r671",
      "r672",
      "r673",
      "r675",
      "r676",
      "r677",
      "r683",
      "r686",
      "r688",
      "r689",
      "r733"
     ]
    },
    "us-gaap_SegmentExpenditureAdditionToLongLivedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentExpenditureAdditionToLongLivedAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital expenditures",
        "label": "Segment, Expenditure, Addition to Long-Lived Assets",
        "documentation": "Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r919"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Significant Observable Inputs (Level 2)",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r466",
      "r526",
      "r531",
      "r692",
      "r738",
      "r923",
      "r924",
      "r930",
      "r931",
      "r932"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r321",
      "r327",
      "r333",
      "r398",
      "r404",
      "r605",
      "r606",
      "r607",
      "r640",
      "r641",
      "r671",
      "r672",
      "r673",
      "r675",
      "r676",
      "r677",
      "r683",
      "r686",
      "r688",
      "r689",
      "r733"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Quoted\u00a0Prices in Active Markets for Identical\u00a0Assets (Level 1)",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r466",
      "r526",
      "r531",
      "r692",
      "r737",
      "r930",
      "r931",
      "r932"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r321",
      "r327",
      "r333",
      "r398",
      "r404",
      "r605",
      "r606",
      "r607",
      "r640",
      "r641",
      "r671",
      "r672",
      "r673",
      "r675",
      "r676",
      "r677",
      "r683",
      "r686",
      "r688",
      "r689",
      "r733"
     ]
    },
    "coo_TermLoanFacility2021BaseRateLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "TermLoanFacility2021BaseRateLoansMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan Facility, 2021 Base Rate Loans",
        "label": "Term Loan Facility, 2021 Base Rate Loans [Member]",
        "documentation": "Term Loan Facility, 2021 Base Rate Loans"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "verboseLabel": "Identifiable assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r268",
      "r306",
      "r355",
      "r370",
      "r376",
      "r394",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r446",
      "r448",
      "r450",
      "r451",
      "r659",
      "r662",
      "r695",
      "r752",
      "r838",
      "r942",
      "r959",
      "r1023",
      "r1024",
      "r1073"
     ]
    },
    "coo_CommonStockExcludingTreasuryStockParNetValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "CommonStockExcludingTreasuryStockParNetValueMember",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Shares",
        "label": "Common Stock, Excluding Treasury Stock Par Net Value [Member]",
        "documentation": "Common Stock, Excluding Treasury Stock Par Net Value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination Consideration Transferred Liabilities Incurred By Type [Axis]",
        "label": "Business Combination Consideration Transferred Liabilities Incurred By Type [Axis]",
        "documentation": "Business Combination Consideration Transferred Liabilities Incurred By Type"
       }
      }
     },
     "auth_ref": []
    },
    "coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Privately-Held Medical Device Company, Spectacle Lenses, Portion Attributable To Former Equity Interest Owners",
        "label": "Privately-Held Medical Device Company, Portion Attributable To Former Equity Interest Owners [Member]",
        "documentation": "Privately-Held Medical Device Company, Portion Attributable To Former Equity Interest Owners"
       }
      }
     },
     "auth_ref": []
    },
    "coo_CookMedicalsReproductiveHealthBusinessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "CookMedicalsReproductiveHealthBusinessMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cook Medicals Reproductive Health Business",
        "label": "Cook Medicals Reproductive Health Business [Member]",
        "documentation": "Cook Medicals Reproductive Health Business"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Line Items]",
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in benefit obligation",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Significant Unobservable Inputs (Level 3)",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r466",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r692",
      "r739",
      "r923",
      "r924",
      "r930",
      "r931",
      "r932"
     ]
    },
    "coo_ToricLensMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "ToricLensMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Toric lens",
        "label": "Toric Lens [Member]",
        "documentation": "Toric Lens [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in plan assets",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "coo_BusinessCombinationAndAssetAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "BusinessCombinationAndAssetAcquisitionTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVenture"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions and Joint Venture",
        "label": "Business Combination And Asset Acquisition [Text Block]",
        "documentation": "Business Combination And Asset Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateSwapMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap",
        "label": "Interest Rate Swap [Member]",
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period."
       }
      }
     },
     "auth_ref": [
      "r904",
      "r951",
      "r952"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate for determining net periodic pension cost:",
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanBenefitObligation",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Benefit obligation, beginning of year",
        "periodEndLabel": "Benefit obligation, end of year",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r513"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of earnings per share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer contributions",
        "negatedNetLabel": "Contributions made during the year",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets."
       }
      }
     },
     "auth_ref": [
      "r520",
      "r526",
      "r558",
      "r930",
      "r931",
      "r932",
      "r933"
     ]
    },
    "coo_SingleUseSphereLensMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "SingleUseSphereLensMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Single-use sphere lens",
        "label": "Single Use Sphere Lens [Member]",
        "documentation": "Single Use Sphere Lens [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "parentTag": "us-gaap_DebtCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Short-term debt",
        "label": "Short-Term Debt",
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r211",
      "r942",
      "r1082"
     ]
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]",
        "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested."
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r869"
     ]
    },
    "us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "coo_PayablesFourthInstallmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "PayablesFourthInstallmentMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables Fourth Installment",
        "label": "Payables Fourth Installment [Member]",
        "documentation": "Payables Fourth Installment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r97",
      "r98",
      "r99",
      "r100"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property, plant and equipment, at cost",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r263",
      "r764"
     ]
    },
    "us-gaap_ShortTermBorrowingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermBorrowingsAbstract",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Debt",
        "label": "Short-Term Debt [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Cost",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost",
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate for determining benefit obligations at year end",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and exercisable at end of period, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change In Assumptions For Defined Benefit Plans, Change In Discount Rate",
        "label": "Change In Assumptions For Defined Benefit Plans, Change In Discount Rate [Member]",
        "documentation": "Change In Assumptions For Defined Benefit Plans, Change In Discount Rate [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Property, plant and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r751",
      "r764",
      "r942"
     ]
    },
    "coo_BondMutualFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "BondMutualFundsMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bond mutual funds",
        "label": "Bond Mutual Funds [Member]",
        "documentation": "Bond Mutual Funds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r619",
      "r620"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r891"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from (repayments of) short-term debt, other",
        "label": "Proceeds from (Repayments of) Short-Term Debt",
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "coo_AccruedPensionCostRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "AccruedPensionCostRollForward",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of (prepaid) accrued pension cost:",
        "label": "Accrued Pension Cost [Roll Forward]",
        "documentation": "Accrued Pension Cost [Roll Forward]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Treasury stock repurchase",
        "terseLabel": "Treasury stock repurchase",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r95",
      "r195"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expected return on plan assets",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r512",
      "r537",
      "r556",
      "r932",
      "r933"
     ]
    },
    "coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected long-term return on diversified portfolio",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Expected Long Term Return, Percentage",
        "documentation": "Defined Benefit Plan, Plan Assets, Target Allocation, Expected Long Term Return, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r262",
      "r907"
     ]
    },
    "coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination Consideration Transferred Liabilities Incurred By Type [Domain]",
        "label": "Business Combination Consideration Transferred Liabilities Incurred By Type [Domain]",
        "documentation": "Business Combination Consideration Transferred Liabilities Incurred By Type [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value of plan assets, beginning of year",
        "periodEndLabel": "Fair value of plan assets, end of year",
        "terseLabel": "Fair value of plan assets",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee."
       }
      }
     },
     "auth_ref": [
      "r518",
      "r524",
      "r526",
      "r527",
      "r930",
      "r931",
      "r932"
     ]
    },
    "coo_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases on the Consolidated Condensed Balance Sheet",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InternalUseSoftwarePolicy",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cloud Computing Arrangements",
        "label": "Internal Use Software, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r224",
      "r228",
      "r762"
     ]
    },
    "coo_NonSingleUseSphereAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "NonSingleUseSphereAndOtherMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non single-use sphere, other",
        "label": "Non Single-Use Sphere And Other [Member]",
        "documentation": "Non Single-Use Sphere And Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation expense and related income tax benefit for share-based awards",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r152",
      "r153",
      "r211",
      "r214",
      "r310",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r459",
      "r464",
      "r465",
      "r466",
      "r467",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r715",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r989"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount recognized in other comprehensive income on interest rate swaps contracts, net of tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r280"
     ]
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Arrangements",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r304",
      "r452",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r468",
      "r475",
      "r476",
      "r478"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares remaining for future grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total intrinsic value of options exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average fair value of each option granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanEquitySecuritiesCommonStockMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate common stock",
        "label": "Defined Benefit Plan, Equity Securities, Common Stock [Member]",
        "documentation": "Security representing ownership in corporation or other legal entity, for which ownership is represented by share of common stock; in which defined benefit plan asset is invested."
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r310",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r459",
      "r464",
      "r465",
      "r466",
      "r467",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r477",
      "r715",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r989"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount recognized in other comprehensive income on interest rate swap contracts, gross",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r280",
      "r664",
      "r665",
      "r667"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long Term And Short Term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r91",
      "r94",
      "r142",
      "r143",
      "r145",
      "r147",
      "r193",
      "r194",
      "r310",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r459",
      "r464",
      "r465",
      "r466",
      "r467",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r477",
      "r715",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r989"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding, ending balance, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning balance (in shares)",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r576"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow hedges, net of tax of $(2.4), $26.1 and $8.2, respectively",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r280"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning balance (in dollars per share)",
        "periodEndLabel": "Outstanding, ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r576"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow hedges, tax provision (benefit)",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and exercisable at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r729",
      "r941"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and exercisable at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt, gross",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r214",
      "r479"
     ]
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives",
        "verboseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r292",
      "r293",
      "r661",
      "r913",
      "r981"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of goodwill",
        "label": "Schedule of Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r921",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r319",
      "r320",
      "r349",
      "r743",
      "r801",
      "r811",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r826",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r845",
      "r847",
      "r848",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r865",
      "r947"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss recognized on derivatives within interest expense",
        "negatedLabel": "Amount reclassified from other comprehensive income into earnings, gross",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r280",
      "r283"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r596"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amount reclassified from other comprehensive income into earnings, net of tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r283"
     ]
    },
    "us-gaap_EquityFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityFundsMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity mutual funds",
        "label": "Equity Funds [Member]",
        "documentation": "An investment that pools funds from many investors to invest in a combination of underlying investments, primarily equity investments."
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investments",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r390",
      "r979",
      "r1004"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails",
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r571",
      "r572",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails",
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r566",
      "r568",
      "r571",
      "r572",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables incurred in acquisition",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4",
      "r120",
      "r657"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails",
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r566",
      "r568",
      "r571",
      "r572",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares remaining available for future issuance",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Face Amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r145",
      "r453",
      "r715",
      "r923",
      "r924"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investment, ownership percentage",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accumulated other comprehensive income",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r52",
      "r1030"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum rental payments required under operating leases",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1072"
     ]
    },
    "coo_SecuredOvernightFinancingRateSOFRMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "SecuredOvernightFinancingRateSOFRMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Overnight Financing Rate (SOFR)",
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "documentation": "Secured Overnight Financing Rate (SOFR)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquitySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Securities",
        "label": "Equity Securities [Member]",
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r954",
      "r955",
      "r956",
      "r1090"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of property, plant and equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination And Asset Acquisition [Abstract]",
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Machinery and equipment",
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for stock plans, net and employee stock purchase plan",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r157",
      "r158",
      "r195",
      "r810",
      "r865",
      "r886",
      "r958"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r605",
      "r606",
      "r607",
      "r810",
      "r997",
      "r998",
      "r999",
      "r1068",
      "r1087"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r964",
      "r965",
      "r966",
      "r968"
     ]
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill impairment",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r411",
      "r417",
      "r422",
      "r921"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued to employees",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r157",
      "r158",
      "r195",
      "r803",
      "r865",
      "r886"
     ]
    },
    "us-gaap_ChangeInAccountingEstimateByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangeInAccountingEstimateByTypeAxis",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Accounting Estimate by Type [Axis]",
        "label": "Change in Accounting Estimate by Type [Axis]",
        "documentation": "Information by type of change in accounting estimate."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r328"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r80",
      "r744"
     ]
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Asset allocation",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan."
       }
      }
     },
     "auth_ref": [
      "r1027"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "us-gaap_ChangeInAccountingEstimateTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangeInAccountingEstimateTypeDomain",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Accounting Estimate, Type [Domain]",
        "label": "Change in Accounting Estimate, Type [Domain]",
        "documentation": "Identification of the accounting estimate that was changed that had the effect of adjusting the carrying amount of an existing asset or liability, or that will alter the subsequent accounting for existing or future assets or liabilities."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r328"
     ]
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of indefinite-lived intangible assets",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r187"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of finite-lived intangible assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r80"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price percentage of fair market value on date of grant of awards",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r48",
      "r254",
      "r291",
      "r292",
      "r293",
      "r318",
      "r319",
      "r320",
      "r323",
      "r330",
      "r332",
      "r349",
      "r398",
      "r404",
      "r496",
      "r605",
      "r606",
      "r607",
      "r640",
      "r641",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r677",
      "r688",
      "r702",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r735",
      "r791",
      "r792",
      "r793",
      "r810",
      "r865"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r318",
      "r319",
      "r320",
      "r323",
      "r330",
      "r332",
      "r398",
      "r404",
      "r605",
      "r606",
      "r607",
      "r640",
      "r641",
      "r671",
      "r673",
      "r674",
      "r677",
      "r688",
      "r791",
      "r793",
      "r810",
      "r1087"
     ]
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum Pension Liability",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r23",
      "r52",
      "r981",
      "r982",
      "r983"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected rate of return on plan assets for determining net periodic pension cost",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r559"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number\u00a0of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued income taxes",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average repurchase price per share (in dollars per share)",
        "label": "Shares Acquired, Average Cost Per Share",
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r157",
      "r158",
      "r195",
      "r580"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedTranslationAdjustmentMember",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation Adjustment",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r23",
      "r52",
      "r292",
      "r293",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r981"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r254",
      "r291",
      "r292",
      "r293",
      "r318",
      "r319",
      "r320",
      "r323",
      "r330",
      "r332",
      "r349",
      "r398",
      "r404",
      "r496",
      "r605",
      "r606",
      "r607",
      "r640",
      "r641",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r677",
      "r688",
      "r702",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r735",
      "r791",
      "r792",
      "r793",
      "r810",
      "r865"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range of exercise prices, lower limit (in dollars per share)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "documentation": "The effective interest rate at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Treasury stock repurchase (in shares)",
        "terseLabel": "Stock repurchase (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r158",
      "r195"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income Loss",
        "verboseLabel": "Total",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r23",
      "r52",
      "r672",
      "r675",
      "r735",
      "r791",
      "r792",
      "r981",
      "r982",
      "r983",
      "r997",
      "r998",
      "r999"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate principal amount",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rate of compensation increase for determining expense",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expense",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Intangible assets with definite lives, net",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r744"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, basis spread on variable rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GovernmentAssistancePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GovernmentAssistancePolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government Assistance",
        "label": "Government Assistance [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for government assistance."
       }
      }
     },
     "auth_ref": [
      "r710",
      "r711"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amortizations of net gain",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax",
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net period benefit cost (credit) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r167",
      "r284",
      "r1029"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill (Note 4)",
        "verboseLabel": "Goodwill",
        "periodStartLabel": "Balance, beginning",
        "periodEndLabel": "Balance, ending",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r410",
      "r746",
      "r921",
      "r942",
      "r1007",
      "r1014"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]",
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Carrying Amount",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r745"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum annual contributions per employee in 401k savings plan",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets with indefinite lives, net",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and Local Jurisdiction",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.coopercos.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r964",
      "r965",
      "r966"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, $10 cents par value, 120.0 shares authorized, 53.9 issued and 49.5 outstanding at October\u00a031, 2023 and 53.8 issued and 49.3 outstanding at October\u00a031, 2022",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r757",
      "r942"
     ]
    },
    "us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in benefit obligation, changes in plan assets and funded status",
        "label": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]",
        "documentation": "Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://www.coopercos.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r964",
      "r965",
      "r966"
     ]
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r826"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, outstanding (in shares)",
        "periodStartLabel": "Common stock, beginning balance (in shares)",
        "periodEndLabel": "Common stock, ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r158",
      "r826",
      "r844",
      "r1087",
      "r1088"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r728",
      "r941"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.coopercos.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r964",
      "r965",
      "r966"
     ]
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative notional amount",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r1065",
      "r1066"
     ]
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefits"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Benefits",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r523",
      "r525",
      "r531",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r560",
      "r561",
      "r563",
      "r932"
     ]
    },
    "us-gaap_CorporateNonSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateNonSegmentMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate",
        "label": "Corporate, Non-Segment [Member]",
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r369",
      "r370",
      "r371",
      "r372",
      "r378",
      "r1003"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Plant and equipment",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r1062"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails",
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Provision for income taxes (Note 6)",
        "totalLabel": "Provision for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r230",
      "r331",
      "r332",
      "r363",
      "r621",
      "r643",
      "r770"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments related to share-based compensation awards",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r565",
      "r574",
      "r593",
      "r594",
      "r595",
      "r596",
      "r599",
      "r608",
      "r609",
      "r610",
      "r611"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from long-term debt, net of issuance costs",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r803"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total gross deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r156",
      "r213",
      "r633"
     ]
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignExchangeForwardMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Exchange Forward",
        "label": "Foreign Exchange Forward [Member]",
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate."
       }
      }
     },
     "auth_ref": [
      "r832",
      "r836",
      "r841",
      "r855",
      "r861",
      "r880",
      "r881",
      "r882",
      "r946"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from line of credit",
        "label": "Proceeds from Long-Term Lines of Credit",
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r723",
      "r726"
     ]
    },
    "us-gaap_NumberOfReportingUnits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportingUnits",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reporting units",
        "label": "Number of Reporting Units",
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r208",
      "r287",
      "r289",
      "r296",
      "r748",
      "r768"
     ]
    },
    "us-gaap_BalancedFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalancedFundsMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balanced funds",
        "label": "Balanced Funds [Member]",
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match a moderate investment objective."
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity:",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r466",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r692",
      "r737",
      "r738",
      "r739",
      "r923",
      "r924",
      "r930",
      "r931",
      "r932"
     ]
    },
    "us-gaap_LongTermDebtAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtAbstract",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt",
        "label": "Long-Term Debt, Unclassified [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease ROU assets, net",
        "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
        "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r701"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r177"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r942"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents, restricted cash and cash held for sale at beginning of year",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of year",
        "totalLabel": "Total cash, cash equivalents, restricted cash and cash held for sale",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r177",
      "r303"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease ROU assets obtained in exchange for lease obligations",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r727",
      "r941"
     ]
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interests",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r496",
      "r997",
      "r998",
      "r999",
      "r1087"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails",
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net",
        "verboseLabel": "Long-lived assets",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r974",
      "r1018"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r301",
      "r302"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of information by geographical area by country of domicile",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r170"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Stockholders\u2019 equity (Note 8)",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r126",
      "r128",
      "r254",
      "r255",
      "r292",
      "r318",
      "r319",
      "r320",
      "r323",
      "r330",
      "r398",
      "r404",
      "r496",
      "r605",
      "r606",
      "r607",
      "r640",
      "r641",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r677",
      "r688",
      "r702",
      "r704",
      "r708",
      "r735",
      "r792",
      "r793",
      "r809",
      "r828",
      "r844",
      "r866",
      "r867",
      "r887",
      "r958",
      "r990",
      "r1005",
      "r1069",
      "r1087"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets and liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for income taxes",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income before income taxes",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax asset, intra-entity sale of certain intellectual property rights",
        "label": "Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from intra-entity transfer of asset within consolidated group. Excludes intra-entity transfer of inventory."
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, useful life",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends declared on common stock (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total debt",
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "documentation": "Disclosure of information about derivatives and hedging activities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LandAndLandImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LandAndLandImprovementsMember",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land and improvements",
        "label": "Land and Land Improvements [Member]",
        "documentation": "Real estate held and assets that are an addition or improvement to real estate held."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessExitCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessExitCosts1",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exit charges",
        "label": "Business Exit Costs",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt",
        "totalLabel": "Long-term debt",
        "label": "Long-Term Debt and Lease Obligation",
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r754"
     ]
    },
    "us-gaap_DerivativeTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeTermOfContract",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, term of contract (or less)",
        "label": "Derivative, Term of Contract",
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingAndBuildingImprovementsMember",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings and improvements",
        "label": "Building and Building Improvements [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term debt (Note 5)",
        "totalLabel": "Short-term debt",
        "label": "Debt, Current",
        "documentation": "Amount of debt and lease obligation, classified as current."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expense",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r613",
      "r1081"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "coo_OverdraftAndOtherCreditFacilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "OverdraftAndOtherCreditFacilitiesMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Overdraft and other credit facilities",
        "label": "Overdraft And Other Credit Facilities [Member]",
        "documentation": "Overdraft And Other Credit Facilities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r976",
      "r991"
     ]
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to form joint venture",
        "label": "Payments to Acquire Equity Method Investments",
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r430",
      "r849"
     ]
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combinations",
        "label": "Business Combinations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FederalFundsEffectiveSwapRateMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fed Funds Effective Rate Overnight Index Swap Rate",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "coo_AccruedAcquisitionTerminationFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "AccruedAcquisitionTerminationFee",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition termination fee",
        "label": "Accrued Acquisition Termination Fee",
        "documentation": "Accrued Acquisition Termination Fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r195",
      "r759",
      "r795",
      "r800",
      "r807",
      "r827",
      "r942"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r849"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property, plant and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of dilutive stock options (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r344",
      "r569"
     ]
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r976",
      "r991",
      "r1064"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r260",
      "r306",
      "r394",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r446",
      "r448",
      "r450",
      "r451",
      "r660",
      "r662",
      "r663",
      "r695",
      "r942",
      "r1023",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "coo_RestOfTheWorldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "RestOfTheWorldMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rest of World",
        "label": "Rest Of The World [Member]",
        "documentation": "Rest Of The World [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current income tax expense (benefit)",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r639",
      "r645",
      "r991"
     ]
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investment realized gain",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment."
       }
      }
     },
     "auth_ref": [
      "r984",
      "r985",
      "r987"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "verboseLabel": "Net income",
        "terseLabel": "Net income",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r179",
      "r218",
      "r258",
      "r285",
      "r288",
      "r293",
      "r306",
      "r322",
      "r325",
      "r326",
      "r327",
      "r328",
      "r331",
      "r332",
      "r341",
      "r355",
      "r369",
      "r375",
      "r378",
      "r394",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r446",
      "r448",
      "r450",
      "r451",
      "r690",
      "r695",
      "r766",
      "r846",
      "r863",
      "r864",
      "r918",
      "r957",
      "r1023"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/StockPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock Plans",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r565",
      "r570",
      "r601",
      "r602",
      "r604",
      "r937"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority [Axis]",
        "label": "Income Tax Authority [Axis]",
        "documentation": "Information by tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total unrecognized compensation cost expected to be recognized over a remaining weighted-average vesting period",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repurchase of common stock",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income before income taxes:",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r319",
      "r320",
      "r349",
      "r743",
      "r801",
      "r811",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r826",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r845",
      "r847",
      "r848",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r865",
      "r947"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total recognized in net periodic benefit cost and other comprehensive (income) loss",
        "label": "Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax",
        "documentation": "Amount recognized in net periodic benefit cost (credit) and other comprehensive (income) loss."
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r306",
      "r394",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r446",
      "r448",
      "r450",
      "r451",
      "r660",
      "r662",
      "r663",
      "r695",
      "r824",
      "r917",
      "r959",
      "r1023",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "verboseLabel": "Total compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r612"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average Amortization Period (in years)",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related income tax benefit",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other assets",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling interests",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r215",
      "r306",
      "r394",
      "r439",
      "r442",
      "r443",
      "r444",
      "r450",
      "r451",
      "r695",
      "r760",
      "r828"
     ]
    },
    "us-gaap_ProceedsFromStockPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for employee stock purchase plan",
        "label": "Proceeds from Stock Plans",
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r976",
      "r991",
      "r1064"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Cooper stockholders' equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r161",
      "r162",
      "r182",
      "r828",
      "r844",
      "r866",
      "r867",
      "r942",
      "r959",
      "r990",
      "r1005",
      "r1069",
      "r1087"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r216",
      "r761",
      "r942",
      "r990",
      "r1005",
      "r1069"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "LineOfCreditFacilityAccordionFeatureIncreaseLimit",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential additional borrowing capacity",
        "label": "Line Of Credit Facility, Accordion Feature, Increase Limit",
        "documentation": "Line Of Credit Facility, Accordion Feature, Increase Limit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other intangibles, net (Note 4)",
        "totalLabel": "Total other intangibles, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangibles",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r77",
      "r81"
     ]
    },
    "us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of interest in a subsidiary",
        "label": "Proceeds from Divestiture of Interest in Consolidated Subsidiaries",
        "documentation": "The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or the sale of investment in consolidated subsidiaries (generally greater than 50 percent)."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Income Taxes Paid",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r61"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r261",
      "r276",
      "r406",
      "r407",
      "r408",
      "r742",
      "r915"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r815",
      "r817",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r839",
      "r840",
      "r841",
      "r842",
      "r853",
      "r854",
      "r855",
      "r856",
      "r859",
      "r860",
      "r861",
      "r862",
      "r878",
      "r879",
      "r882",
      "r883",
      "r945",
      "r946"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r242",
      "r382",
      "r383",
      "r812",
      "r813",
      "r814",
      "r872",
      "r874",
      "r877",
      "r885",
      "r889",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r906",
      "r929",
      "r946",
      "r1026",
      "r1084"
     ]
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative loss expected to be realized in earnings over the next twelve months",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "coo_CookMedicalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "CookMedicalMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cook Medical",
        "label": "Cook Medical [Member]",
        "documentation": "Cook Medical"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease expense",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r725",
      "r941"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r382",
      "r383",
      "r812",
      "r813",
      "r814",
      "r872",
      "r874",
      "r877",
      "r885",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r906",
      "r929",
      "r946",
      "r1026",
      "r1084"
     ]
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleII"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule II",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r317"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r380",
      "r743",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r905",
      "r928",
      "r943",
      "r975",
      "r1021",
      "r1022",
      "r1026",
      "r1084"
     ]
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: unamortized debt issuance cost",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_FixedIncomeInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FixedIncomeInvestmentsMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed Income Investments",
        "label": "Fixed Income Investments [Member]",
        "documentation": "Investments that regularly generate a fixed amount of interest income. Examples include, but are not limited to, bonds, certificates of deposit, notes and debt securities."
       }
      }
     },
     "auth_ref": [
      "r948",
      "r949",
      "r950",
      "r953"
     ]
    },
    "coo_GenerateLifeSciencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "GenerateLifeSciencesMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Generate Life Sciences",
        "label": "Generate Life Sciences [Member]",
        "documentation": "Generate Life Sciences"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r380",
      "r743",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r905",
      "r928",
      "r943",
      "r975",
      "r1021",
      "r1022",
      "r1026",
      "r1084"
     ]
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "documentation": "Disclosure of valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r311",
      "r312",
      "r313",
      "r315",
      "r316"
     ]
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r311",
      "r312",
      "r313",
      "r315",
      "r316"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diversified portfolio, allocation of assets in equities",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r932"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r942"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r466",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r737",
      "r738",
      "r739",
      "r923",
      "r924",
      "r930",
      "r931",
      "r932"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign deferred tax assets",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r110",
      "r1062"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Excess tax benefits from share-based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other, net",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized research and experimental expenses",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r110",
      "r1062"
     ]
    },
    "us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationRepatriationOfForeignEarnings",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign earnings subject to United States tax",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State tax provision",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedging"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Derivatives and Hedging",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r666",
      "r678"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, $10 cents par value, 1.0 shares authorized, zero shares issued or outstanding",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r756",
      "r942"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r646"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted- Average Exercise\u00a0Price Per Share",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r1062"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss):",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r709",
      "r736"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossTax",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Tax effect",
        "label": "Other Comprehensive Income (Loss), Tax",
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r291",
      "r295",
      "r621",
      "r648",
      "r649",
      "r702",
      "r706",
      "r708",
      "r747",
      "r767"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockDividendsPerShareCashPaid",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends on common stock (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities, reserves and compensation accruals",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r1062"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r646"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes interest cost component of net periodic benefit cost (credit) for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r553"
     ]
    },
    "us-gaap_PerformanceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PerformanceSharesMember",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Units",
        "label": "Performance Shares [Member]",
        "documentation": "Share-based payment arrangement awarded for meeting performance target."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r310",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r459",
      "r464",
      "r465",
      "r466",
      "r467",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r715",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r989"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r1062"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes expected return (loss) on plan asset component of net periodic benefit (cost) credit for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r553"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r709",
      "r736"
     ]
    },
    "coo_AssetImpairmentChargesAndOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "AssetImpairmentChargesAndOther",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset impairment charges, and other",
        "label": "Asset Impairment Charges And Other",
        "documentation": "Asset Impairment Charges And Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfInterestRateDerivativesHeld",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of interest rate swap contracts held",
        "label": "Number of Interest Rate Derivatives Held",
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r133"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r82"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Immediate Recognition of Actuarial Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Immediate Recognition of Actuarial Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes actuarial gain (loss) recognized immediately as component of net periodic benefit (cost) credit for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r553"
     ]
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividendsCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Dividends on common stock",
        "terseLabel": "Dividends on common stock",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding, ending balance, Weighted Average Remaining Contractual Term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingMember",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Building",
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and exercisable at end of period, Weighted-Average Remaining Contractual Term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "us-gaap_AdjustmentForAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentForAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization expense",
        "label": "Amortization",
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r81"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at end of period, Weighted-Average Remaining Contractual Term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r942",
      "r1085"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic Tax Authority",
        "label": "Domestic Tax Authority [Member]",
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in fair value of contingent consideration",
        "negatedLabel": "Decrease in contingent consideration liability",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r986"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029-2033",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "coo_A2023LongTermIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "A2023LongTermIncentivePlanMember",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Long-Term Incentive Plan",
        "label": "2023 Long-Term Incentive Plan [Member]",
        "documentation": "2023 Long-Term Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "coo_EssilorInternationalSASMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "EssilorInternationalSASMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Essilor International SAS",
        "label": "Essilor International SAS [Member]",
        "documentation": "Essilor International SAS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Tax deductible goodwill",
        "label": "Deferred Tax Liabilities, Goodwill",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r123",
      "r124",
      "r1062"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Intangible assets",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r1062"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade accounts receivable, allowance for credit losses",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r387",
      "r405"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining amortization expenses for intangible assets with definite lives",
        "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r991",
      "r1063",
      "r1064"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r424",
      "r425",
      "r426",
      "r744",
      "r745"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r991",
      "r1063"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories (Note 1)",
        "totalLabel": "Inventories, net",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r908",
      "r942"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership percentage",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share repurchase program, maximum amount authorized",
        "label": "Stock Repurchase Program, Authorized Amount",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r80"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share repurchase program, remaining authorized amount",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "documentation": "Amount remaining of a stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill, expected tax deductible amount",
        "verboseLabel": "Goodwill deductible for tax purposes",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "totalLabel": "Total deferred income tax expense (benefit)",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r207",
      "r229",
      "r644",
      "r645",
      "r991"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r115",
      "r652",
      "r934",
      "r935"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r964",
      "r965",
      "r966"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r115",
      "r652"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r652",
      "r934",
      "r935"
     ]
    },
    "coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "ScheduleofLongTermAndShortTermDebtInstrumentsTable",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long Term and Short Term Debt Instruments [Table]",
        "label": "Schedule of Long Term And Short Term Debt Instruments [Table]",
        "documentation": "Schedule of Long Term And Short Term Debt Instruments [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade accounts receivable, net of allowance for credit losses of $31.3 at October\u00a031, 2023 and $20.7 at October\u00a031, 2022",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited or expired (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited or expired (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "coo_TermLoanFacility2021Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "TermLoanFacility2021Member",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan Facility 2021",
        "label": "Term Loan Facility 2021 [Member]",
        "documentation": "Term Loan Facility 2021"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority [Domain]",
        "label": "Income Tax Authority [Domain]",
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award expiration date (no more than)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r278",
      "r306",
      "r394",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r446",
      "r448",
      "r450",
      "r451",
      "r659",
      "r662",
      "r695",
      "r942",
      "r1023",
      "r1024",
      "r1073"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r66",
      "r67",
      "r222",
      "r223",
      "r225",
      "r226"
     ]
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "ThirdAmendedAndRestated2007LongTermIncentivePlanMember",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third Amended and Restated 2007 Long-Term Incentive Plan",
        "label": "Third Amended And Restated 2007 Long-Term Incentive Plan [Member]",
        "documentation": "Third Amended And Restated 2007 Long-Term Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Expense [Member]",
        "documentation": "Primary financial statement caption encompassing interest expense."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_BaseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BaseRateMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base Rate",
        "label": "Base Rate [Member]",
        "documentation": "Minimum rate investor will accept."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of stock option plans",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r102"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assumptions used in estimating fair value of stock options award granted",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Domain]",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service Cost",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost",
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Axis]",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative instruments recognized in condensed consolidated statements of income",
        "label": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived intangibles",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r117"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds related to share-based compensation awards",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r28"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash operating lease expense",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r987"
     ]
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign currency translation adjustment",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current:",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock split, conversion ratio",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of Deferred Tax Assets and Liabilities [Abstract]",
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingTables",
      "http://www.coopercos.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in accumulated other comprehensive (loss) income",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r1070",
      "r1071"
     ]
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitment fee percentage",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Undiscounted range of the contingent consideration, maximum",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred:",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Undiscounted range of the contingent consideration, minimum",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low",
        "documentation": "For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r481"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of debt",
        "label": "Schedule of Debt [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average interest rate",
        "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r425"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r826"
     ]
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r826",
      "r844",
      "r1087",
      "r1088"
     ]
    },
    "us-gaap_TrademarksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TrademarksMember",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademarks",
        "label": "Trademarks [Member]",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r167",
      "r274",
      "r758",
      "r796",
      "r800"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r438",
      "r564",
      "r741",
      "r788",
      "r816",
      "r817",
      "r871",
      "r873",
      "r875",
      "r876",
      "r884",
      "r901",
      "r902",
      "r920",
      "r927",
      "r936",
      "r944",
      "r1025",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r438",
      "r523",
      "r564",
      "r596",
      "r597",
      "r598",
      "r740",
      "r741",
      "r788",
      "r816",
      "r817",
      "r871",
      "r873",
      "r875",
      "r876",
      "r884",
      "r901",
      "r902",
      "r920",
      "r927",
      "r936",
      "r944",
      "r946",
      "r1019",
      "r1025",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r264",
      "r763"
     ]
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity investment gain realized before acquisition of remaining equity interest",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net",
        "documentation": "In a business combination achieved in stages, this element represents the amount of net gain (loss) recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated benefit obligation",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation",
        "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets."
       }
      }
     },
     "auth_ref": [
      "r551",
      "r552",
      "r932"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (gain) loss",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax",
        "documentation": "Amount, before tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r167"
     ]
    },
    "coo_CooperVisionSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "CooperVisionSegmentMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CooperVision",
        "label": "CooperVision Segment [Member]",
        "documentation": "Coopervision Segment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of cash flow information:",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r438",
      "r564",
      "r741",
      "r788",
      "r816",
      "r817",
      "r871",
      "r873",
      "r875",
      "r876",
      "r884",
      "r901",
      "r902",
      "r920",
      "r927",
      "r936",
      "r944",
      "r1025",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r438",
      "r523",
      "r564",
      "r596",
      "r597",
      "r598",
      "r740",
      "r741",
      "r788",
      "r816",
      "r817",
      "r871",
      "r873",
      "r875",
      "r876",
      "r884",
      "r901",
      "r902",
      "r920",
      "r927",
      "r936",
      "r944",
      "r946",
      "r1019",
      "r1025",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r481"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts recognized in accumulated other comprehensive income consist of:",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsCommonStockCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsCommonStockCash",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends on common stock ($0.03 per share)",
        "label": "Dividends, Common Stock, Cash",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Roll Forward]",
        "label": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillPeriodIncreaseDecrease",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net changes",
        "label": "Goodwill, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward."
       }
      }
     },
     "auth_ref": [
      "r992",
      "r993",
      "r994",
      "r995",
      "r996"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Benefits [Abstract]",
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning of the period",
        "periodEndLabel": "End of the period",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r615",
      "r625"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Settlements",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities."
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic:",
        "label": "Earnings Per Share, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r614",
      "r623",
      "r631",
      "r637",
      "r642",
      "r647",
      "r650",
      "r651",
      "r808"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt term",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decrease based on tax positions in prior fiscal years",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r626"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r178",
      "r179"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesDeductions",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Reductions/ Charges",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Lapses of statutes of limitations",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued gross interest and penalties related to uncertain tax positions",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r624"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase based on tax positions in current fiscal year",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r627"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesBalance",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance Beginning of Year",
        "periodEndLabel": "Balance at End of Year",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "documentation": "Amount of valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r311",
      "r316"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unrecognized tax benefits that would impact the effective tax rate",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate consideration",
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4",
      "r21"
     ]
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average asset allocations and fair value measurement of plan assets",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall."
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDilutedAbstract",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted:",
        "label": "Earnings Per Share, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesDomain",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "documentation": "Valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r311",
      "r312",
      "r313",
      "r315",
      "r316"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r617",
      "r618",
      "r631",
      "r632",
      "r636",
      "r638",
      "r802"
     ]
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other changes in plan assets and benefit obligations recognized in other comprehensive income",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "documentation": "Information by valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r311",
      "r312",
      "r313",
      "r315",
      "r316"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average assumptions used in computing net periodic pension cost and projected benefit obligation",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate."
       }
      }
     },
     "auth_ref": [
      "r540"
     ]
    },
    "us-gaap_CapitalizedContractCostAmortizationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedContractCostAmortizationPeriod",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized contract cost, amortization period (or less)",
        "label": "Capitalized Contract Cost, Amortization Period",
        "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock option shares and restricted stock units excluded (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "us-gaap_IncomeTaxReconciliationDispositionOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationDispositionOfAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intra-group transfer to UK subsidiary",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Asset, Amount",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to disposition of asset. Includes, but is not limited to, intra-entity transfer of asset other than inventory."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings per share (Note 7)",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before income taxes",
        "verboseLabel": "Income before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r168",
      "r217",
      "r355",
      "r369",
      "r375",
      "r378",
      "r750",
      "r765",
      "r918"
     ]
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated future benefit payments",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter."
       }
      }
     },
     "auth_ref": [
      "r198"
     ]
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of net periodic pension costs and other amounts recognized in other comprehensive income",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r139",
      "r815",
      "r817",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r839",
      "r840",
      "r841",
      "r842",
      "r853",
      "r854",
      "r855",
      "r856",
      "r859",
      "r860",
      "r861",
      "r862",
      "r878",
      "r879",
      "r882",
      "r883",
      "r912",
      "r945",
      "r946"
     ]
    },
    "us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts recognized in accumulated other comprehensive Income",
        "label": "Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income or loss that have not yet been recognized as components of net periodic benefit cost, such as the net gain (loss), net prior service cost or credit, and net transition asset or obligation."
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expense and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails",
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remeasurement of deferred tax assets from UK rate change",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r622"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/Contingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r433",
      "r434",
      "r890",
      "r1020"
     ]
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of non-vested RSUs",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options to purchase common stock and restricted stock units not included in diluted earnings per share calculation due to antidilutive effect",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Technology",
        "label": "Technology-Based Intangible Assets [Member]",
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for income taxes at United States statutory tax rate",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r622"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign earnings in jurisdictions with different tax rates",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "coo_RevolvingCreditFacilityAndTermLoanFacility2020Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "RevolvingCreditFacilityAndTermLoanFacility2020Member",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility And Term Loan Facility 2020",
        "label": "Revolving Credit Facility And Term Loan Facility 2020 [Member]",
        "documentation": "Revolving Credit Facility And Term Loan Facility 2020 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total unrecognized compensation cost related to nonvested units",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r1058"
     ]
    },
    "coo_BusinessCombinationPaymentToSettleContingentConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "BusinessCombinationPaymentToSettleContingentConsideration",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment to settle former equity interest owners",
        "label": "Business Combination, Payment to Settle Contingent Consideration",
        "documentation": "Business Combination, Payment to Settle Contingent Consideration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingStandardsUpdateExtensibleList",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Standards Update [Extensible Enumeration]",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "documentation": "Indicates amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r322",
      "r323",
      "r324",
      "r388",
      "r389",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r429",
      "r605",
      "r606",
      "r607",
      "r640",
      "r641",
      "r653",
      "r654",
      "r655",
      "r668",
      "r669",
      "r670",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r693",
      "r694",
      "r696",
      "r697",
      "r698",
      "r699",
      "r712",
      "r713",
      "r716",
      "r717",
      "r718",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r1000"
     ]
    },
    "coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other changes in plan assets and benefit obligations recognized in other comprehensive income:",
        "label": "Defined Benefit Plan, Amount Recognized In Net Periodic Benefit Cost (Credit) And Other Comprehensive (Income) Loss, Before Tax1 [Abstract]",
        "documentation": ""
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r292",
      "r702",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708"
     ]
    },
    "coo_NumberOfBusinessUnits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "NumberOfBusinessUnits",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of business units",
        "label": "Number Of Business Units",
        "documentation": "Number Of Business Units"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-Known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total unrecognized compensation cost related to nonvested options",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1058"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross change in value",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r702",
      "r703",
      "r708",
      "r747",
      "r767",
      "r981",
      "r982"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total recognized in other comprehensive (income) loss",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r167",
      "r932",
      "r1029"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r360"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative expense",
        "label": "Selling, General and Administrative Expenses [Member]",
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in minimum pension liability, net of tax of $1.0, $8.7 and $7.2, respectively",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r167"
     ]
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant change in unrecognized tax benefits that is reasonably possible during the next twelve months",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r206"
     ]
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Benefits paid",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r562"
     ]
    },
    "coo_TermLoanFacility2020Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "TermLoanFacility2020Member",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan Facility 2020",
        "label": "Term Loan Facility 2020 [Member]",
        "documentation": "Term Loan Facility 2020 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Benefits paid",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r1031"
     ]
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "coo_CompositeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "CompositeMember",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Composite intangible asset",
        "label": "Composite [Member]",
        "documentation": "Composite [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCompensationArrangementWithIndividualContributionsByEmployer",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contributions by employer in 401k savings plan",
        "label": "Deferred Compensation Arrangement with Individual, Contributions by Employer",
        "documentation": "Amount of contributions made by employer into fund established for purposes of making future disbursement to individual in accordance with deferred compensation arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Operating Lease, Assets And Liabilities, Lessee [Abstract]",
        "documentation": "Operating Lease, Assets And Liabilities, Lessee [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive income (loss)",
        "terseLabel": "Other comprehensive income (loss), net of tax",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r34",
      "r286",
      "r289",
      "r295",
      "r702",
      "r703",
      "r708",
      "r747",
      "r767",
      "r981",
      "r982"
     ]
    },
    "coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss and tax credit carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards",
        "documentation": "Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards"
       }
      }
     },
     "auth_ref": []
    },
    "coo_CreditAgreement2020Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "CreditAgreement2020Member",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Agreement 2020",
        "label": "Credit Agreement 2020 [Member]",
        "documentation": "Credit Agreement 2020 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in minimum pension liability, tax provision (benefit)",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r12",
      "r208"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "coo_BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "BusinessCombinationAssetsAcquiredAndLiabilitiesAssumedTangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net assets",
        "label": "Business Combination, Assets Acquired And Liabilities Assumed, Tangible Assets",
        "documentation": "Business Combination, Assets Acquired And Liabilities Assumed, Tangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayments of long-term debt",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r806"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "coo_ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "ThirdAmendedAndRestated2007LongTermIncentivePlanAnd2023LongTermIncentivePlanMember",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third Amended And Restated 2007 Long-Term Incentive Plan And 2023 Long-Term Incentive Plan",
        "label": "Third Amended And Restated 2007 Long-Term Incentive Plan And 2023 Long-Term Incentive Plan [Member]",
        "documentation": "Third Amended And Restated 2007 Long-Term Incentive Plan And 2023 Long-Term Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r498",
      "r509"
     ]
    },
    "coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisitions of businesses and assets, net of cash acquired",
        "label": "Payments To Acquire Businesses And Assets, Net Of Cash Acquired",
        "documentation": "Payments To Acquire Businesses And Assets, Net Of Cash Acquired"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Contract with Customer, Liability, Noncurrent",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r498",
      "r509"
     ]
    },
    "coo_OfficeAndSurgicalProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "OfficeAndSurgicalProductsMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office and surgical",
        "label": "Office And Surgical Products [Member]",
        "documentation": "Office And Surgical Products [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsAllocationTable",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Allocation [Table]",
        "label": "Defined Benefit Plan, Plan Assets, Allocation [Table]",
        "documentation": "Disclosure of information about investment allocation of defined benefit plan assets. Includes, but is not limited to, investment allocation percentage or range of percentages."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r932"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "coo_AlternativeInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "AlternativeInvestmentsMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alternative investments",
        "label": "Alternative Investments [Member]",
        "documentation": "Alternative Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails",
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating lease liabilities",
        "verboseLabel": "Present value of lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "verboseLabel": "Projected Benefit Obligation",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation",
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsAllocationLineItems",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Allocation [Line Items]",
        "label": "Defined Benefit Plan, Plan Assets, Allocation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r932"
     ]
    },
    "coo_ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "ScheduleOfLongTermAndShortTermDebtInstrumentsLineItems",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long Term And Short Term Debt Instruments [Line Items]",
        "label": "Schedule of Long Term And Short Term Debt Instruments [Line Items]",
        "documentation": "Schedule of Long Term And Short Term Debt Instruments [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MediumTermNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MediumTermNotesMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term loans",
        "label": "Medium-term Notes [Member]",
        "documentation": "Debt instruments with maturities ranging from five to ten years."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsCategoryTable",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Table]",
        "label": "Defined Benefit Plan, Plan Assets, Category [Table]",
        "documentation": "Disclosure of information about defined benefit plan asset investment. Includes, but is not limited to, fair value of category of plan asset and its level within fair value hierarchy."
       }
      }
     },
     "auth_ref": [
      "r524",
      "r526",
      "r531",
      "r932"
     ]
    },
    "coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Foreign deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Purchase Accounting Adjustments, Foreign",
        "documentation": "Deferred Tax Liabilities, Purchase Accounting Adjustments, Foreign"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsCategoryLineItems",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Line Items]",
        "label": "Defined Benefit Plan, Plan Assets, Category [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r524",
      "r526",
      "r531",
      "r932"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liabilities, current",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "coo_PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "PrivatelyHeldUSBasedCompanyTechnologicallyAdvancedContactLensProductsMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Privately-Held U.S.-Based Company, Technologically Advanced Contact Lens Products",
        "label": "Privately-Held U.S.-Based Company, Technologically Advanced Contact Lens Products [Member]",
        "documentation": "Privately-Held U.S.-Based Company, Technologically Advanced Contact Lens Products"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Long-term debt, excluding financing leases",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of prepaid (accrued) pension cost",
        "label": "Schedule Of Reconciliation Of Prepaid (Accrued) Pension Cost [Table Text Block]",
        "documentation": "Schedule Of Reconciliation Of Prepaid (Accrued) Pension Cost [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "coo_IncreaseDecreaseInContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "IncreaseDecreaseInContingentConsiderationLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settlement of contingent consideration",
        "label": "Increase (Decrease) In Contingent Consideration Liability",
        "documentation": "Increase (Decrease) In Contingent Consideration Liability"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "coo_TermLoanAgreement2021364DayMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "TermLoanAgreement2021364DayMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan Agreement 2021, 364 Day",
        "label": "Term Loan Agreement 2021, 364 Day [Member]",
        "documentation": "Term Loan Agreement 2021, 364 Day"
       }
      }
     },
     "auth_ref": []
    },
    "coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of non-employee directors in committee",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Terms Of Award, Grants In Period, Number Of Non Employee Directors In Committee",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Terms Of Award, Grants In Period, Number Of Non Employee Directors In Committee"
       }
      }
     },
     "auth_ref": []
    },
    "coo_AsianPacificCreditFacilitiesYenDenominatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "AsianPacificCreditFacilitiesYenDenominatedMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asian Pacific Credit Facilities - Yen-Denominated",
        "label": "Asian Pacific Credit Facilities - Yen-Denominated [Member]",
        "documentation": "Asian Pacific Credit Facilities - Yen-Denominated [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in unrecognized tax benefits",
        "label": "Effective Income Tax Rate Reconciliation, Change In Unrecognized Tax Benefits, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Change In Unrecognized Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "coo_AccruedPrepaidPensionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "AccruedPrepaidPensionCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "(Prepaid)/Accrued pension cost at prior fiscal year end",
        "periodEndLabel": "(Prepaid)/Accrued pension cost at fiscal year end",
        "label": "Accrued (Prepaid) Pension Costs",
        "documentation": "Accrued (Prepaid) Pension Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r219",
      "r294",
      "r359",
      "r714",
      "r850",
      "r957",
      "r1086"
     ]
    },
    "coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:",
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost And Benefit Obligation [Abstract]",
        "documentation": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost And Benefit Obligation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurredNumberOfInstallments",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of installments",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred, Number of Installments",
        "documentation": "Business Combination, Consideration Transferred, Liabilities Incurred, Number of Installments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liabilities, non-current",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions",
        "label": "Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions [Member]",
        "documentation": "Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "coo_TermLoanFacility2021AdjustedLIBORRateLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "TermLoanFacility2021AdjustedLIBORRateLoansMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan Facility 2021, Adjusted LIBOR Rate Loans",
        "label": "Term Loan Facility 2021, Adjusted LIBOR Rate Loans [Member]",
        "documentation": "Term Loan Facility 2021, Adjusted LIBOR Rate Loans"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other expense (income), net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination",
        "label": "Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination [Member]",
        "documentation": "Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Settlement of contingent consideration",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "coo_EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Purchase Plan",
        "label": "Employee Stock Purchase Plan [Member]",
        "documentation": "Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization and Significant Accounting Policies",
        "label": "Business Description and Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r181"
     ]
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined benefit obligation, actuarial gain (loss)",
        "negatedTerseLabel": "Actuarial (gain)/loss",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan."
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r991",
      "r1063",
      "r1064"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]",
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r310",
      "r357",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r378",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r445",
      "r447",
      "r449",
      "r450",
      "r977",
      "r978",
      "r1023",
      "r1024"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r257",
      "r352",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r384",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r428",
      "r431",
      "r432",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r921",
      "r975",
      "r1084"
     ]
    },
    "srt_ReportableGeographicalComponentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ReportableGeographicalComponentsMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Geographical Components",
        "label": "Reportable Geographical Components [Member]",
        "documentation": "Geographical components of an entity reporting separate financial information in the entity's financial statements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted earnings per share (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r337",
      "r342",
      "r343",
      "r344",
      "r348",
      "r689",
      "r690",
      "r749",
      "r769",
      "r916"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Segment Information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r367",
      "r372",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r384"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]",
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r310",
      "r357",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r378",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r445",
      "r447",
      "r449",
      "r450",
      "r977",
      "r978",
      "r1023",
      "r1024"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of business segment net sales",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails",
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating income",
        "terseLabel": "Operating income (loss)",
        "verboseLabel": "Operating income",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r369",
      "r375",
      "r378",
      "r918"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of business segment information",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r70",
      "r75"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total gross deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "srt_EuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EuropeMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Europe",
        "label": "Europe [Member]",
        "documentation": "Continent of Europe."
       }
      }
     },
     "auth_ref": [
      "r1089",
      "r1091",
      "r1092",
      "r1093"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "srt_GeographyEliminationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "GeographyEliminationsMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geography Eliminations",
        "label": "Geography Eliminations [Member]",
        "documentation": "Eliminating entries used in geographic consolidation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r70",
      "r75"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term liabilities",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r345",
      "r346",
      "r347"
     ]
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsInventory",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Deferred Tax Assets, Inventory",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r1062"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative expense",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r914"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares used to compute earnings per share:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedIncomeTaxesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term tax payable",
        "label": "Accrued Income Taxes, Noncurrent",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r212"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash included in other current assets",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r262",
      "r303"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r292",
      "r702",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of inventory",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r164",
      "r165",
      "r166"
     ]
    },
    "coo_TermLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "TermLoansMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term loans",
        "label": "Term Loans [Member]",
        "documentation": "Term Loans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Recognized actuarial loss",
        "label": "Defined Benefit Plan, Actuarial Gain (Loss), Immediate Recognition as Component in Net Periodic Benefit (Cost) Credit",
        "documentation": "Amount of gain (loss), recognized immediately as component of net periodic benefit (cost) credit, for change in value of benefit obligation or plan assets from experience different from that assumed, change in actuarial assumption, or consequence of temporarily deviating from substantive plan. Includes, but is not limited to, amount in excess of 10 percent of greater of fair value of plan assets or benefit obligation."
       }
      }
     },
     "auth_ref": [
      "r512",
      "r538",
      "r557"
     ]
    },
    "coo_PayablesFirstInstallmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "PayablesFirstInstallmentMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables First Installment",
        "label": "Payables First Installment [Member]",
        "documentation": "Payables First Installment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "coo_PayablesSecondInstallmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "PayablesSecondInstallmentMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables Second Installment",
        "label": "Payables Second Installment [Member]",
        "documentation": "Payables Second Installment"
       }
      }
     },
     "auth_ref": []
    },
    "coo_EuropeanCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "EuropeanCreditFacilityMember",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "European Credit Facilities",
        "label": "European Credit Facility [Member]",
        "documentation": "European Credit Facility [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock (in shares)",
        "periodStartLabel": "Treasury stock, beginning balance (in shares)",
        "periodEndLabel": "Treasury stock, ending balance (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash held for sale",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r149",
      "r150",
      "r189"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock at cost: 4.4 shares at October\u00a031, 2023 and 4.5 shares at October\u00a031, 2022",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r95",
      "r96"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected future employer contributions",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r933"
     ]
    },
    "coo_SightGlassVisionIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "SightGlassVisionIncMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SightGlass Vision, Inc.",
        "label": "SightGlass Vision, Inc. [Member]",
        "documentation": "SightGlass Vision, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Schedule of Stock by Class [Table]",
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r93",
      "r94",
      "r193",
      "r194",
      "r195",
      "r271",
      "r272",
      "r273",
      "r350",
      "r481",
      "r482",
      "r483",
      "r485",
      "r488",
      "r493",
      "r495",
      "r803",
      "r804",
      "r805",
      "r806",
      "r927",
      "r971",
      "r988"
     ]
    },
    "coo_FertilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "FertilityMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fertility",
        "label": "Fertility [Member]",
        "documentation": "Fertility [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r272",
      "r273",
      "r350",
      "r481",
      "r482",
      "r483",
      "r485",
      "r488",
      "r493",
      "r495",
      "r803",
      "r804",
      "r805",
      "r806",
      "r927",
      "r971",
      "r988"
     ]
    },
    "coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected rate of return on plan assets at year end",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate Of Return On Plan Assets At Year End",
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate Of Return On Plan Assets At Year End"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in unrecognized tax benefits",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r940",
      "r1060"
     ]
    },
    "coo_LicenseAndDistributionRightsAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "LicenseAndDistributionRightsAndOtherMember",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License and distribution rights and other",
        "label": "License And Distribution Rights And Other [Member]",
        "documentation": "License and Distribution Rights and Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "coo_CooperSurgicalSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "CooperSurgicalSegmentMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CooperSurgical",
        "label": "CooperSurgical Segment [Member]",
        "documentation": "Coopersurgical Segment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets and liabilities, net",
        "label": "Increase (Decrease) In Operating Lease, Right-Of-Use Asset And Liability, Net",
        "documentation": "Increase (Decrease) In Operating Lease, Right-Of-Use Asset And Liability, Net"
       }
      }
     },
     "auth_ref": []
    },
    "coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Target percentage of shares earned",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Target Percentage Of Shares Earned",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Target Percentage Of Shares Earned"
       }
      }
     },
     "auth_ref": []
    },
    "coo_CorporateReconcilingItemsAndEliminationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "CorporateReconcilingItemsAndEliminationsMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Eliminations, Corporate and Reconciling Items",
        "label": "Corporate Reconciling Items And Eliminations [Member]",
        "documentation": "Corporate Reconciling Items And Eliminations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at end of period, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "coo_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails",
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net sales",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357",
      "r368",
      "r373",
      "r374",
      "r380",
      "r382",
      "r384",
      "r507",
      "r508",
      "r743"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited or expired (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "coo_TreasuryStockParNetValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "TreasuryStockParNetValueMember",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock Par Net Value",
        "label": "Treasury Stock Par Net Value [Member]",
        "documentation": "Treasury Stock Par Net Value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails",
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r571",
      "r572",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Nonvested RSUs, beginning balance (in shares)",
        "periodEndLabel": "Nonvested RSUs, ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r584"
     ]
    },
    "coo_MultifocalLensMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "MultifocalLensMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Multifocal lens",
        "label": "Multifocal Lens [Member]",
        "documentation": "Multifocal Lens [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Non-vested RSUs, beginning balance (in dollars per share)",
        "periodEndLabel": "Non-vested RSUs, ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r584"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "parentTag": "us-gaap_DebtCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease liabilities",
        "label": "Finance Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Vested and issued (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of vested grants",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "AOCIAttributableToParentBeforeReclassificationAndTaxRollForward",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]",
        "label": "AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]",
        "documentation": "AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and issued (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r743"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contingencies (Note 11)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r146",
      "r755",
      "r825"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease liabilities",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range of exercise prices, higher limit (in dollars per share)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares authorized to be granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r709",
      "r736"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r352",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r384",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r431",
      "r432",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r921",
      "r975",
      "r1084"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r107",
      "r567"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r378"
     ]
    },
    "us-gaap_LongTermLineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermLineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt outstanding",
        "label": "Long-Term Line of Credit, Noncurrent",
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r85",
      "r86"
     ]
    },
    "coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.coopercos.com/20231031",
     "localname": "ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience",
        "label": "Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience [Member]",
        "documentation": "Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r306",
      "r355",
      "r369",
      "r375",
      "r378",
      "r394",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r446",
      "r448",
      "r450",
      "r451",
      "r695",
      "r918",
      "r1023"
     ]
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt outstanding",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r214",
      "r1083"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets."
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r964",
      "r965",
      "r966"
     ]
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Line Items]",
        "label": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r921"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation of Goodwill",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r422",
      "r921"
     ]
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' Equity Note [Abstract]",
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stockholders' Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r305",
      "r480",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r494",
      "r496",
      "r679",
      "r868",
      "r870",
      "r888"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill [Table]",
        "label": "Schedule of Goodwill [Table]",
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons."
       }
      }
     },
     "auth_ref": [
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r921"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee compensation and benefits",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible Assets",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r619",
      "r620",
      "r753"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other expense (income)",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosures of cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r87"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of indefinite-lived intangible assets",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value."
       }
      }
     },
     "auth_ref": [
      "r987",
      "r1017"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to acquire business",
        "label": "Payments to Acquire Businesses, Gross",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r656"
     ]
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "documentation": "Information by defined benefit plan asset investment."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r524",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r545",
      "r930",
      "r931",
      "r932"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "crdr": "debit",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of definite-lived intangible assets",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value."
       }
      }
     },
     "auth_ref": [
      "r987",
      "r1017"
     ]
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureDetails",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "SubTopic": "50",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482610/350-50-25-6"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "SubTopic": "40",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482633/350-40-30-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a),(b),(c)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i),(j),(k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i-k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(f)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b),(d)",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(a)(b)(c)",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "270",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-14"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-13"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-14"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(CFRR 211.02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)-(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-5"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "740",
   "Section": "25",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479692/805-740-25-8"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "740",
   "Section": "25",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479692/805-740-25-9"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350/tableOfContent"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r200": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r201": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r202": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r203": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r204": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r205": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r206": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r207": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r208": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r209": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//815/tableOfContent"
  },
  "r210": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r211": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r212": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r213": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r214": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r215": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r216": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r217": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r218": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r219": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "09",
   "Publisher": "SEC"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iii)(C)",
   "Publisher": "SEC"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-20/tableOfContent"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715/tableOfContent"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-4"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-15"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-11"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-4"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483507/832-10-50-3"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483507/832-10-50-5"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(1)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-48"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "340",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-2"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(ii)",
   "Publisher": "SEC"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iii)",
   "Publisher": "SEC"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-4"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>115
<FILENAME>0000711404-23-000072-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000711404-23-000072-xbrl.zip
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M6(@U#E"4SD11_.AK*2H+?0:7Y\?23:,XAUA?BB2+)5V._E(OHK_3?^,JTW#
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MBH+A^=M-],V%Z&C19YR8$2O0HN0]8GN^!:6,:I*WX_Z!HE04;J^^TZB?;3>
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M7U>=M"EBE>;CQ-+"O5US/!_31+* \ -0U0?^V(T9VCBOG3X'N$5YF3<-+WW
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MP_6BN(\5.ATL9\4(B<BP04\H=2NYS<OO9UL,46E4F.:P5I$(T"%"<@+)+G;
M&K(%-^!9K*$R9+CAFAL-L/N8BAA23%C%#.%;>(E/13V7Y"B<&#4FJXHW#AN
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M^;Y@-UFP((YK]I!FR1>'X0Y5SX4%G/*UR/V:DHD7N'03 ^LK)-ML5N[:V3_
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M$F8GOB7EI8G6G&CFB%F2D^+JUT3& FLNA#XU>\Y&Y<,%X*)G&C ET2#*Q(2
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MTWSY6;%Y\D7^IT\^S=?+)\7F_SW]RW\\>+YWU?.UF>:J<-_LPHA^#Q&G VT
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M!G J?XAP:ZX+K9R#"YZQNLG=G!U,[=Y2$/0*.=1AB'>PHK&]N;@"'BCQ[+
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M4K+';19NZV>W)3D?6I)^_0(Q@*/K/2-H+339?KD>%N%#UA[5#0Z>2YAL.BY
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MO3&?%K/STLE/8;K/PW6"G^/F>NVOVO.Q[M"=GH%O76Z<[AJ7_6%^(/%2$@1
M)K7@F)Z.Q;THM]YS1S! 34B$]6*S442BO<SQE'@R[ILC\#>[L?EITEO8M".9
M0KWN$PV^8I030BHA?B<)T2B %]H>-+QB?=>6<]XT?D4W*(#KR F&_\T2D @8
M#UJ\\%IZH3PLX+2I+W#%>^";JVDJ6*VP8O= J^4L6;R!!,KCSL^Z'01K/"+-
M&(&B\<FOGI]([$7?!X:!X'S(4L:5$LP +Y4I*F%7'/RRC $"/GSW\"<Z 5>
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MD7/.BH0V&%49-J"0!5XY$5):;D83^/DS*;5H<J'1.GKT81D%N@ =Y]B8".8
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MPC!&7:6S&R..0/4D1U^LPTF^_],G4@:ZTC1=>HMFPHYFQY"JVWR==ZER$,X
MH7:\K4)H"B,H@PQ>TE41=B2^+(LH1E?*\AV;[L!LR_51F*W/W-[$AK7%RBLP
M\7G> J04+VJB:3;W@F-,[@7><#_!:BXK(3/[74-MF_7B!0)-ZO 5>GMP,A-E
MA$)G&A862K:'0@Y^M:^$0S2,<_M&XVR5W[MVV<\7O%&O'UGFF(A,.6L.- ES
M2@;99K2M0:*!2\BP2^65JTPDM>SL,"W4&%31;N\3/G3>/3^A*<F-<W_^&LE
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M4W<!-8*I4XKNSG<142VL.D .<CA'<*AFKBE)*J2*'H+>I(4^I"PNF%-+^%;
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M<N'B E+LMO<.:U:KH Y"[K5 H'4+ENX\S.6FQW(=_2@G<,WE_"/E$P9%$<I
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MM??<I2@=FNE>AX <C66!3'6? .HXU\K8$*4<$K0"<Y6)5GYVZ6US0QEWTJG
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MKF1H X1O I]%0EB4-'2UL[WJ2I<%6%H[.;"D.2'_<2.7I^,'>$<*KE2\%,B
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M)3;K [5AO[XY/5%SZ"FJ*.5#[R4<RCTG;_IHFN^[UVWXI"F$T0KL([P\:+T
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MEPI3/.W?U*U@Q>$9?"D\D87\:GM7[][LXS ,!LV9?@C!<J0.]H[$F^&*OR/
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MUO;Z!CQ4F,(!^(,:@T_N,D2M!YN9[V9?4NMNT=1PP93<4YR-23STQ^RNI7F
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M?CTGPK0RGURK<J87+<OB?EQYP:-#F(%IS.V[/^N6:=MQBAUQSE5BQSOV$G]
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M3_IKT;#T3MN'I^LV]-U/F/(4Y"ZG_=Z6C+7;>2(FFL/#+1KLTTC!V=EZ=]V
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M+\>J[H40?9G96"<I9IDL\O(";?*Q L.@-+I[Z=" ]36T"I"G!LA;A03(NRI
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ME#T2:[<.Q-HM+GJGB/7$B#4SHK-/8M6!6/MZ8:56Y6L,/<:(P3T>.4DG5>'
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MQ_9K3;VST5-7_]:I;W;G*:VUO]93,\(2.5-<G-SB4FN?S$JD_2]F>+YVXYC
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M&]=8K.(A ?UK ?Q'A#U_([IY$2;68Z$VF.AI(2P59"@YM6UW)/T&LKM8NNN
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M6L]<2:TD9:F72NH?B&[[TKKO'@O=%FG='X4R61A21?%Y?ZF*V5#]\SE@ETT
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M+JM:>AEEU5D,M?F^[MG"VWCG0]<#\K@(W.DE(L-W;<O4<',GSU$9"6Z _C4
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M30C F%<GG+ P5SAD8@$\,IQP.46L#,G:YW47H?NQ QK_>V@58[)".-H\FD5
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MM=*<SJG%1$L8O:3L:*BR38:,2H=/B==CEHIK.,+L.OM%51I#ZERAKQ<3&AA
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M+6DR8XXQXE47\EK--EXC@H]-QHX5X5BB&N,/,*%\G&&#E!)E)? IRVR"]&6
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MY>5+@5DF_(E^AKMH6H(#HT09+'8?\RZF%'2<V$*5P#+V=7DSO,H+VATV+@:
MV['=!;!VV-T.=N.FQ"^\PD\=<Y-G=&E&]6RA2=2*V_1URG=%I92B\2C64L0#
M?HEY]C:?YTO%D_Z#O(Y6*VM5K7#:>URB1F18C,X^JCS'XXI2-'CE"6_:2EVM
MQ')JTHO?PSG4-\P]$$4U%6>."1]X&J(87$P15]TYV#1N@Y^GZ:;TB9%I\#98
MC+8,3<7QUP00FZE:" D)+MCL 7M.ST+3TPS,"V>60E-^L"0 %T-3U.10+R'>
MQ]Q-T]<,&NK#)^9,>*T,59<P_<VF5DG\)VHWKBP5C9+@5_/<I1UR3YY,K-*Q
MES@6PQ[I$TR36_B=M**Y)^UN\5.AW$U5)=H6@=3;6-%[][D)L*)+\,+;RT*C
MQNC$B]S-(!-"E"7R%JE0V/L0;E;#TRO\5%*L>\577>%KW:GCWF@*G\TY%ILZ
M&N#>._,Z3_'"I)KT/?A;N$G#6OSK]%(C('_%-\#\BL0K*_^WHH+XM)AR/7%,
M;"'M(V6O,FRM"D<J(EV[F/Y^%M-'=V)D-7B-A3V=&:@#R._&CJI-**79K^OW
MCLZ=";1^ X/];&  T*QG!F>WOI?5=.J583NZ&@Y.SBR!I<\,G+<PQ^(A=UH[
MA^H'M3<TL=U<8,H29K%R42JZ@W)LQJ$._ IZ*#7OX:3%I[O-96PJH/,:.SYL
M4E9-RE[U&C5A;Q24- X]:'ZP+,)$8$=Y>"=M.FN9/UCF#Y;Y@V7^8)D_6.8/
M9O#M?'.-TJ! +O,(RRRGS:Z^;F.]KR]1R_G-I$9G$>]?IXE4F#6X7^80EM1U
MCM35S)NZ6F#K9G>ME_F#.1S\%\]_L$G4EJF$ 1)HY4T"[<JPW>_7.F4>X0EA
MP8:P?78LZ  6-#('\LLDPI2'^[NLS.!+<QGV?Y?9A&MPO+,;C@<<L]>Z,[^:
M&.3+P.?%$4 7].QJH]^K-0J4+%8F&N:/5MV#HE4/%,SJH-?:/47J\#F()\%9
ML3V4;3K\X'G_M3<S73W*V:/ZAL2C[%I"'W7%;M9<[%(E/,1A]_,^; RC#EI9
M"XQ*E3#EX3Z%,R/"BF'5S8PHW<ZE8VSG+.Y\=9IN'1@#J,K-W%3ETBM=$E^Q
M=IYC>G?.Q-= .[5?K]<&IT)\YV1M? /+XEH*#BT*9BN6-L<F212 W&T </!9
M8_@!Z&/$T]WH^T3:R4PV3;3#.YU6:;L4$&DV<-"C(0U&!ZNM?J^LK3^.#:2S
M_.R?R]:_SE;YVM;RH5J[C.R@C>P 2_'RJB=/=URG:O24%'>6%+>MN;,-Q760
MXMJ- W3X*J"E XO,&Q\V3^5P6]Y0C0BO(GE^_.Y-=(J1R+GIJ_M)=4ZYY1QE
MCH#>-P3>,[[B<?K=8B.$X!<&!, "^FQ0;XTC@&YEV,HJ;K;#9 _ZQS193@8%
M-C#!/%&@1VW>#F*!A'%@5PMD2T4BOF-!J6;L#ILS4D*V5?OA\QK:'.$,L01O
MPXJ3(;,JTR?CH=7,+1$D#Y0X#=.BY @E1]B;67(\CC @XP8X0LZ1G*-PA!3-
M?C*5@V.@A?$C29SBU:M'AQWUZJ<P[(CO:Z7Q2>&:(5%/#CX]"_L R::);6QX
MWPYA&ZJBKT;@)W\2,+6PP>?12%=XG6EH;L,"&A.,[96PH=%4Q?E)2&\T9?HG
M[Y?#1[:+!?#!Y-C+8":_L^!L9@)E51H[MMM$AZYP!T"X0Z2]2_F$>'<\V,($
M\C0!>-3U9O6QM 1C.E455H4GZ@[VO^'=C-!5_2&;;&;@;N!\\))W-E.QRPUO
M<\)O]!W:Y0#8+ -@N^4 V'( ['X&P&[J6I(P';8=.QVVD]PUC@NC&!'5/%"?
MB7C\(>G#.?.5,;UR++<Q$C:$,9E%7#S(N^D*5+_P<*B#&F?6TTBWF:K?TB8T
M8S[\8&,,B,<A!4^G7GD+><F;XP$SIE9/-&'>?[C\9C(Z;6+?_HI7A]FO#.1V
M.[\9\SFV-B,!);KF\.?R >DTT!R_=%?I]9?#+Z<.\'SW!F^A7C>>8*^=U]#?
ML)*IQK#A&XU.-70%]4R-M^H#4:/RZ>J!AQAOC!KAT=Q)?@7."(17X2CX);7C
M6[B  ]IA*&9,B<^ Q6'L_K,^9DQ'F24+N4Q3Z67+T.'M2TD!94YV^\BI-N_Z
MQWXR4U%1G.&8=/ZBFG3C=Z\+;Q?/P)GSY2B&PSL8@8#TD6<%O9)PPSLN<0HA
MBO\B:^2,?IDQZMTULJC%H!#0]G+!>]BYPA^I3:96?;#;"0IV=T0N01U6",HD
M;!@8#J-FAOX$W40$"*_9'=C+&QTJ)H$7&!(HV*;Q@;_@L[UYD'1O" %Q7P+Q
MC A,::@C=26RL2,9@25NGF-!.[\%=*O__G_]9J/W:XQ6Y1\:P$]S)D0;5QZD
M@!B)P@@+99J1.8??@;3E4 LKS(]>4>=0B6-(<@ UH)"UCR<:6R%JEZ,M''-A
M<"T5%JJ@\>>M/QFU?:2NXMNI'QW2J.WUH%P2@YJJ/]FD)CW$K8K/_#09(3-=
M2'^)_ERH)O/N7";__ [\DA [O)$HLA3+M! &$!V!+!!_"KC/J#&:-U;7A4.
M1:@;602U3M.8V_#/$/WH5DXZ!-2XA_KZ!2[M7H<SXEW3$-= [X<[<>*U^('(
M-MR:D+<&C1,343L@4>\OQG&M47! E7E<I6^$K:(![+EE!]!%7M"L__I(PDWA
MTV&#]$*_-WZMAB^,NP!/('01)T#Q.[X+^?):";*R7J_WG;HJBS:<*-ZG^*C%
M12+V,N!<AS9>>0%Y#Z^JNBTFZ0IY,L<Y!K8I\ZGI? &5V-7'X6'-U8/7P;RR
M.;NJ4H4%>B.Q012.\2N\KO+-T-\"WZ8!;$QKUQ?&)%3DI680[(+Z\3WT8R>X
MGY'O2^#\>.J8HCDP=["A4K)#H\%[M'9T6?MNL1=C:J,-SQU,OE^IV!ZD1A/+
M'C7#X:S(L2-0*[JF0#L(#6F7%ZI-RH[E::8DW25R<7!A3OQ< ?SEK@Q"GPE[
M9YJQ</5Z59PM62R6.-VJ($CJX0SJ']?7A-:*[_#D*:F-"D%6\2 ;\&U5I0EW
M_M!2%JA)\N<$EV'9\AOO.+LPC3]1^P<5VMO?)'X)2+UNG\],K,<5G?CE#!X5
M63%O(RI8DA7VI[DWHGH4-$W(5R=&C7M<+<9X "[./F3-XN/, X ,@ E$I::B
M]FTN78"X34I!P[*OPN#X1>B*AAZ (W\,OS5)%ZI)]TEP#;+C'25'T-_/=<,-
MYZI:H=?S5NUSM"7@3%7@ZQE4#\L[>116Q!D9\U76@*H3@P@'Z^.*@WG0F!SI
M$^"T\'H5,(IB*9;[TRJ[;<:QVR/QU3_ [O..UUUPP97I?P!6O-.Z&0TI(UL>
MT0+-<=7D#GL=9#*9R3YI3E4,2L%'U9Q(_W9DZBE,?FUT'<!&V#OQ505(S$*B
M#;>L%UYZLM)<-T+8R0 $;N'QBY_]U<SE)2"RBHV_71CCK3:S$'U7ERX<"FR!
MQ =KQS @J#W <M$E @P#]0+"=]P%Z(M<J^*C&GA,P@B8^; [KD_0<H&BD1Q_
M,%@O'P-@^.::-(5%A'T!*\N )Y"E0K>J0+#A(0,4L1 K7+L\W+K$9 !E^ 5_
MM9*.-,+:57WB@-#@+68 ,W\P.\SNP3)" 2)K7E $3E\LSNL)O3)Y@E" JVJ\
M][\5F#P1L]X:\$SAV$!N&K_A*L:-5EPOL0"78\ =?V"&-&9))P&"U<&7IG@^
MP7G,#7(9)1E9J#%/XVJ\'L13T63;?43 E/!8-+\U:2 %-E=G$RL5XFW@Y]DT
M8F\/C^:M:@'5RMKC% V ;W!N$\Z\[UT=:I6K<VZ>&*-MQ3C 6P6/T9(D( ,(
M)P1,)+[1 W5BCM>65S("3GN:#B$ 'Q)!@V0T']3"G39C&F_!ZUA1@8#BB:$F
M+)@32B;?1QT64F(0#(LA.D&-/!#- QJ85K$@Z<3GGQ 1(\L$; <-<\J%8E!%
M\"[@GF&2?V"BF#AB964>!:S$4O"5N",>4E!D:R9-->/#"JIOQ'.\<15B463?
MNUS)M8;\W_\:Y5 AH:<BL_LP0>6\FA@?>G"AM#$*RP=7&%R:&62M,3"LKG!"
M#>2^ZTTQ)_YZ5YRAD17',\"<1\:L45"C?T\82$H &C'"5;VU76@F1A3H[T#0
ME[_%%:Y67-V6ZPU(R>&MJ/Y6/">\4'*%4176;-UH'M=ZT<]<1=:Q#VZR<:W2
MIP#M?D[D.$'-WE5;\:V;GX^&)Q$DCQMRSD$>D(B.2H$2]+7Y%.=RA.ATKU2;
M4RW/:R^VLHY#""4I%! 3T(25NS/*4FI+![-SOV 0$/#RQIB/,?2*^O4J@^C$
MZ#Z=>-WG2/S!W844W$:9II0A3:E7IBF5:4K[25-*SD2*82SP;7>-QHULIYCB
M'20@+!>M>716./,Y94>X?$D)\*6:]$SC$<DKZCF*N0>4 @,FXXY[67=3@8+.
M5_1'*,%#,N.?YB8>49H&BCP_YB#&4 J9)5D,A"I<!6NGNUQ/#5?]W=Q6.:BA
M**YQX,<DO*7#<2Q,0\%M8Q:*;&+Z0SC(P9\<2GC"'!Q\('=(+"G-B.?::GQJ
M)5 -.I>$3B3>YN6G!",JM&-?EN+#)9+U(OE((>, GXH*T40V)Z$ 3<!GP:=^
M<KRO27_'O <O5\@*'#G\J[EA?=#<#,4SK!8.;)\B]CBNE"=SK.I[;GJ':[90
MX@UW5HEX 9I:'BD& HA>;HF)6I_CQ1<\? J@D>*:22-_CN *T*J^DPX]5'SS
M$]]E3V>*\8)0].4-9*)>]8,Z.( TX06A4Q'7K,,O@D$"JM2D6[@$8RF!E_CA
MDMCH2L&MA*\TCU"PC,"VK*H(KO P([='X5 \/-)CS8@@$&, *$@'#F2%5MS#
MXY%!?&(<#TF1_9&3C@K[GJLV$2%8NS?TEC<&Q+"FIJ(;H[-V"Z6S?@,POH7[
M;9VX.ZPKW&%(?I8SID G,#S,[3(<##"\H:,>10.CB1E5S/10Y_"OYL&B2K.'
M+?=/,6,X>.1>:BUP7Q=5#9Q#C:%9X)\FSW=SZ8B,P \0Q4Q3@4D*;O(#_IH9
M/&\5W6838%Z8&TE+A =3J!)X(*QV++LD%K#HX"?N$B.C$*=;*@H@%!:4>.F5
M* L4I%0*2O <,5_TO#DJ_T&4A_@;%%-D=1JA+++[<%EXJ\4TM"V!^]M8FA*0
M6CX(::T68S]@!0N $9@E,WJ.RG^"[2'W#K*4&-]4G*?V>/F8<:O)Q$->;& /
M.)X4P(9%<W:RJ[]7(";Q:I(07DJT_F.Y[A./H'"\R9_8;+N0LQ!RGAYF\?1_
MD4X/^J28O/R!,]?'2Z[H !F8XN>@(H.RE#\MZ!1&[2CTKLV^FV(Y5^]^JC9F
MQYMO+(MQ=[R4JUL_]F_!*>@AWZCPB^+(Q[#6A*X^'IB0*9&0EQY@,-:V>+H]
MCG@'G1$]=+[I!A8)3RPR E_R**O C1L#S:X_0"BA0L[>@E'M#Y[WC1W^N'7@
M+Z]5DPCR/-X:\B$&DALHCYCIB&ABKJK4:E3I?I0[(K'8K1+<\9%-\<C_RE*Q
MO&&^B>N:PX51>E4C:X5QKU\9MEJ)K4/$^-8J'@<'>J;E=P=[7_^@,FQV$WL_
MB?5SR(<SQ"LW@@59\$BK0M([T^:PM'B_F^O7*\-NXM2M=7O;4T9QB #\LMB
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M*\]SN:Z0 P>+BL+A^LCU9!HZ?.15CQORQ/K-J-^IWRR4WRE ->&=2<\,@U/
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M!@,ZQ986\I+*@H&V\?P5S2")AB>.?_N5R\<ZS("Z?<\[VDXRPP+C7O5Z:EC
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M=OQI %^-:9T=\5B7J%,8U-DZ[IL'OVE6ANW$ZKMC($WI4[L4G]I7PX0_=9'
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MLB\]5R1+.5KI.(!H B":B5DSB9B&-7D94"V70JRO*D"9?5/?6:2&]Q79>[1
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MMTS@F<% )+Q& 9 "?Y06IC%Q%,P1 15"4F337"+/?)<UAU(:X'8K[C4?H&_
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MGU<S6!+3K_'$.ILOZ6+9=XB%2YHJCU>]9>%_#J:3[<F->H24.^RS\PW!^TU
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MX@7XSIEDF%B($MN]#N.,DF[8TMA]'9O4I->9:O%G6? !,-12X= L";[&QLX
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M)2>)YH\$2* XFFC]QQ39P8;UL'Y38CR(R1O4S^1W!K\S'1;AGR&U,L(7+&C
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M<$G%C79A4<<PP^+8;0E>.]]3=?<._RW,<N-UB,? @?5<<_(#'14ZF!4*^>5
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M6G-C$_4>\5@,6JC(.2V?S0EVRA4:[@83$$='=^!/BESX81%MR0,CR%YT-/:
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MSXA??#-MD% FV#:/J/2IDY+#=ED[3H$+PR(2:]<&W9@8YT9*=&<N(V12C<[
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MF^_F!:[@)-L.DAU6DF2QG5F_M]]\KN$DVXH P'?3^W$U<PEB7?L$49H%%^B
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M'%@=*_K"8"_9YJ&8H3MOK/RYPVIK\;V834:%+TK(&*\H\5SH8ER6NQ#H;"<
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M1AL1/RD6"6! .]Y6N:4U)\_:D&=J6L41]*E0L+W],PY.H)Q \^. IC47.()
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M8D_@:X.F/+P8V%\<;* EW/@33"2?@(GTGP5VVHN)=DS\%9ABAH5;C)O;03*
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MK+)?.T[V/Y(7%/S?0S([+/#USMKGFX[]\$-\:CWT@-03O@1B3 AF#@X),QN
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M[(P\\^<>J<68,U&1B$IV;@#'&B >?2"L&(;,R5W;J [#8KE+C\Q8ZHS$GIS
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M&+R6>8'%KU#%)5@^-S%%@)W13<03/K& D'GA&UQPZMEV(E)\=I$HE8=< *2
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M>J05=D%%$<TTW= )4/'>6K@M]2CE4KQ<L2G,*IM3,E(="PD1.669/JXBH?M
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MMR1N2=P"W.HPC_F4"P;TG#E'CELK4Z/N>/0\?8D!BOM) 95_\WX/Z03R,IG
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M;A )H*/4,/^G%]^A7MWB@X@3>O\5I7?9N&[I083[O$'A4?H!WA/N?CPX%S"
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MZ4)&5XSBN2]H(G%/ HQ/9KQX7-= 4PT:[GM.SV.".E6SY"RN=U>LF*2T"V[
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M48S._D*5P0$JDN'FU (ROQ4N"=E4[7>+6WV'9^!,V8Q^^N'_ 5!+ P04
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M:)T7V K8D-S#_7EQ8Q>^N4S:%2*E-#TC,.1T(@&CP)14U_F8C47,UI-5ULF
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M\_9%S3G2^&?KRLKU&;]-LZ UE[[4OO_*D#UF]>(\YBBL,2EIJY,SNG6NXB#
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M$$QC7_TF&/+T2.EQ!L;;FK_)Y'PY]" S6I>3TUJW3K?U:WUO&R@&I[@-#)S
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M]A@"KW+=^@W%*15R>_=I"UB#:NW3/T<.E$M_A+FDC>N@HT1&HXX@8VWV%I2
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M ;Z<GL5%.1NOX\+Y2#B6%%H-3%NSZNL48V9 P:!U62/]K\?PJM$HAN@!'Y?
M?8J]=0YI-89UU\/)I]H0\8J=H#%L-B CSYCBA5$ (:*M=^9)"($6G24/Q;O"
M@KF>Q+POF[0WEB&56C>DW(.(JC_]^&;R!2?UF,I(&'JK= *$I!E1+#*((B00
M)J@BD1?!>M]9OT SI'+J8^BK_<3PT&:S_HWYRFZG2*74%L)%:_)<;>00BQ?
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M_?7]ZY^>C]+Y&0ZG/ST;8YAB_NG/_O333]-/^--_C<;_Z'\)/[T;A&D9C<\
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M:X042ZWG]HHLISK*S+34EH8I?&/EWP/GJ,V15FKH(/:[ MK%3%@'7$<&R+W
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MF]#<7+L/S]&1J)GP.\A)O>P/ZPW&KVNSX??U.N>WY8\)GDPF./T5RVB,UV;
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MS 8)^<5]O:^&DVD8#.9[@M#,)UX0DG2U.J3ZO8$T8)SV0<9@N'MDP&Q+9$=
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MJU6QD'DJ,X0<+2BI94854DZWTG&-ZRSNA??=,/M05+R$MFU2R8\)+;R[;'9
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M0KWR3SGA6 C<L;P.$1YZSY-5>5,![GGNT]\\-)IB:"$LH@ 9U E4,+EV3M'
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M2<)KI:GK[D T[-PNSW.,PM0E-!\>1.85H+)XS)*<ZO#03:W3R2S]QI;?$VE
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M5KP3F?MH?8YYXY!TB2Q.5,3U-=?XM8*P,G=PD[:" PW=XK]MSY:D_^S,3MW
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MT$0&5 ?/@)&2EOCYY3";\X\'WJJ?GB69E8EW!3\=MN%W-%W5K.<S#C36^IE
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MBN,?Z),3VE_FE]N]CZJ"F0R\CM?.^B@+O^1V5,WQ*;L?VJR;@C[P'=X&2^4
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MZ=11+?XSRKZU56MW GK;RT.D?!:6^O+P/HM.VEE7'MOHE>_1N,\U89QDR!V
M!I'!]!_&^+EX#_?N!K$D6.QYQ7@4@KPI]-U*918538PV5S4\IQ#YILZB<F@W
M;,KJC)Z%8(YHAI01Y!Y3BI6*(99"FR5C5VK14IC^HY8VM$4N!4\P1_8J,:U
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M>I^]?^Y=K>AW7[G97_S-W4ECD"_=6_V?Q*6/Q2%O].V_ +6D80:/P.D46M"
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M0[O^-15UE(_+ 0/R!X9.TH>NR&-_FD]M39]J2V,/?#],+#')52H-?ZVY_U6
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M/=&-A*A='D!4Q+;.O])>_!^5_WQMR3+ :Y,1//L]ER 9LDW'&<8?4!>IGSB
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M/V3KHM]Q@+9V+(6'>BW::?$8E0-P\UVFLR5;F\IBK?Q6<,.''%H\SQ:X_^3
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M,:8X*WC5MB1.AJ;2NU3X0.4RF4E+WMH G,UD<M*17H%X^#3V,[+..I[-QSW
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M<\5VM&3+Q)],PA#SCK]R=$5>X/)@AY' )7PJ3@9C',)PYPK^ 7+)ZUTYXP_
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M<AWC (\S>%L]VD7?X;@[:J_6O6R^PCBO"\]$8E/9')8]>RL5[2381RM+-!/
M=N-J5CI7A$!GNSR-(#-]MANC]NOT@IV*Z+N5P-))C;=6J4VG!QX<O!>Z@_
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M(H%/ZW69"7)65GZ\BQN:-'0BL0'!ECPUP;S?#"#O$LGYL^+#9N(_"PZFCUT
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MT3.SV2B#'8V*7<#O[-%W+#=[-.Z1G[-ZYG<SIJ1!?:0B,%#U_-4(I#U6C?/
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M_Q6VR$8SLJCR77JO]>%:V', ):F\-?U]J&1+M1?9ZKFDF&[NQ"OA]%1PO(<
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MJ7J6%M??>W@C!]K$[?=ZZ0^9[SGY.Z;K8AHDMLH6^QAHHY/2GG+:3=9NSTN
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MUXJ=0Z]<2OVIUY#B;R]P]+09H=4[?3T5LD&"8"@THQ1V"&T-"O91)?J2&MY
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M:<8@MY'@X__]K;W_K__MDMF<_!=02P,$%     @ YH&(5VH(6D2W=@  XIH
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MUM6WMK5W='9][/[T=?#;T/#(Z-@XD30[]^/GK_F%1<KZQN86]3>XO?,G+C:
M@^VO[=^,2Q"*B_U/'W#_B8N-/>3/"8*<7+)'=PD96W&[!@K+:4;M%CF5\;*L
MA4=>RYHL>OWV *^8@C91D?(GM'^(['\ML.C_5Y']C\#^*:YQ@)^##>H\#D$
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MM6?00=YTH[PB+'S ^/"+M)*&C,8-)L]+$G*,!5"30/D[XBV$I'IJ6G"36.D
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MLA5D'+;1+.=W"EW4 R/D,YY&#IT+XSDJE1B+%3$95LFXV'QDE_&B@09-$:5
M#EE1>H?^-LYY[YF,_#>Z&G?"CTK']<-R%8F=ETP!B=.)>=+!J4(B8M>-#'E
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M>/GKFY5)1" YZJ\J9!BYD&DT@MC:8@'ER8NJV: --&+\<#L[$":9!(FNA[*
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M:;1>A.\ )\N9@B?^+M\QY+\>@%OK_TL3B&-9@7.ERG*404[8RFFFK7(L>Z$
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M7W_.!M^V1(7_AKT_Z_Y=CG/>Y]_QGAXP9EETO(+Y.8?1^T*%KRF68U=^(%.
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M3A11C@LANP9P#F((C1Q0+I\FJ7B61AFFO7$@#D+# T'X9OBZ+"J("WF0U@>
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M0FI";XXJRTFAOP9*D@+W+!C?5)_ >"],+#&> $>8H:P#[&=-(ES(%>+W;/C
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MC^B1Q^)[9=-B^0Y>_51R=S8![BXR*4NUG\N@X"*(TGA/8;[!-D=&O&26:PD
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M]<#8L(QF,U]@0/^CX*20=&\>V]DMJ"CZ/YH"YURL !70E4*"C?TCE%8.-ZB
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MKP;+8G,U@7IOIY3!'SM/\F*J_GN4*RT"26\.%4ZV_T:Y_T8.@ I8ZK0 'J!
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M [I:R86_L K>$AZ[J9AZT1HIXD=^?QXIX,,V]'V3!KBN?@EJW%X.E>X <3<
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MMA JHYTWQ)\$I7;N3UEKB2,C?D?C?[[@\743MO!2"3MW=2)$'#$=1#5EI62
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M?Y$ZW%@7_KL. D'(LTS^.L74XS"#698$3QZ>SK"7'[/N-IIK X?SA0IN?\E
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M-3,;+-Q.E0Z5 XXW#L/4"+U)-59?C;YBFQ-Y\J=^YV@SWC&]<>421Q%>BR!
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M,/2LY*H=]T,^YOK:3N"X,UHSY?)++)A+2?OGXDT&-PN@J*;AT)1KWHF%BWW
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M(^/"-1ZYQ33;#6W@[:39N;HC=5VVB+:Q7)T[>=FB7_.&X22W^LK9I.1D&^3
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MKK3FO'M[W@+=4C&S>35SR<9BG2//;A*1OD$#/$;.ES,A6>)>F'!#1(KS9VF
M^+\8T]93+\E^]%_YE?;?5QG\)ED5A^PPH)\CLG4I/_:O<R-;W?YX\GUK([!(
MK(5)Z9SI*$>^>)6S28R.EZNAOY[SL)7<[XVA?-O$[R.1B?;%PZ-R1WI^("#&
M%3%IUPFJ4(Q&5!R>$=[Y$"1X_9J%.:X<#9;$M_;D?ML=\1SN!1)$%J7;4/0P
M,]R'M7<- 3D=B*]S7R=??O(JF1S\'\U=>SC3_=]?N8NDEJ*#PU2DM$KWC:C8
M4LF-.TMDB2Q2HIA#,LR^2@X)RR'G+*=T&Q9B<EHV.22-R2EA4V*;PY9AL]D>
M_?%<O^NYGNM^GOMW_7Y__/YX_?/YY_.Y/H?WY_7^X_5ZU1$CV]W:C41$,5+:
MCEOM,TW/^2IVOA3>_.%NV.AEG\?9DZVA$X%36F\9A&(GRO'7)@*V)H<"[5K*
M<M\79\T<X7/K&&Q G[]Z89X*0TLK!E4FHM&7ZHN_B=M>U]U9J,*96Z@@.?(3
M_Z?TXG\($]#-9N:EDB#-X@Q5_<,WXTZ'KQ5%X ZKX5O?'&QD)5PRU-_JM?SI
MI=-A???,3\!6X@/+\?50P@Z;898GH@X SA3+(P?=67:"V[--E/MSG^Q?/&)F
M,E/4D^)JP/[G25U+<)O!OR9ZC7),Y%NPLL2CK^6=*]V"_&3CR%D2ZO)7^BC0
M$Y@R"+GCJK_I/NU]8TC .U\9J+PQJ3>R>=Q?&-N=!_$R2U^HG'TO \E)Y3&/
MO^K'KJLN::QY>N>KV-(.2MU<OTW\T=)\^,\E,9R:J]J-W?;<&>-)<]S@XWD;
M,EC@*BU%W-N?C+AXBT=X*($S$]:.T6 [>Y/[/PX=:U/;7%S_*^=#:'*(40$J
MUG^'LKO!!XOT>FNX$H"<%-VI(XM)FWBC6GMH(^*^&WP;@2LJ=R[?0L4.=2S\
MZ+\2..T(Q&&A++JZ,'2.FGNXY_DG0^[4'TC'=+TW.O:26(["MRT*N^.Z\TNV
M/3O^9_-0F;US\<@VD].E&KKEN0EF]E<S15WB:]+F7%WA+K,V/$SCG3\18Y71
MT("N9;05UHI[EJV&"ZX_&#N!G%&IL#3T4>HA%OR)/+=+"7S!,E0H7OQIL.@S
MQ#T?Q <O8JH2/T]_=Z9O_*9C#RDJZQ@_)@.]\)R 4Y%K$',YJN-1)]Z;:'QW
M3.LA]H@05=)%>AD9H#?XLZY:'[D\G6R<^*.H+X16)YWE%BVBP':.1E?W.W17
MZPE\T+:Y'V?[[36[RCZ<.[[7S^_2TU?FD&CBP$Q%JD>*+9L0;?U;?)9WU]_U
M-)'OAFA\.D=BC< =MF:JA>W,<@+SK5YM@/-Y?0%O\)&AD2@)G!S5KG6]+FO$
M(6@XZ0AP_'<)M)C4Q7=H3-3UFQZ;S%N^N9540Z46WVT2_PQE"7SVO^<Y7\Q>
M6JZ>ON*;?N/PNY;9K3MWQU?50R+6=!@)TM\"@XN;]%A\]+L,[5RFVXS )3K1
M8/!]Z'$9Z!JVJ5  L?5Y=BW &]*K?#C4PG=E![>"^TVD"S_9$F9J>M>Y8[H1
MQ7Y#E=)EH,I1,O_@9:S]5X6)BFYSI0A)Y2C^K)032@%8=+N%Z,?Y;)@FXWF/
MH1D,ZFQSBVJ.5F39 73<9%;E/VR+;%!QDR&+QJ:DKDN?H:RXU6(Z+TD21UO2
MA(?B8O;M"Z'$(8*E-IWS/P6=T6%_::SR3T(^5<J 5\I3*9\M$<9J,X1%WWJ-
M,!\C\8&VG-JIRLV_=$@[O@56I^M28, M\)#S*O]C$W>:>N9G"CITACW+A_3"
MG%;6W+EI+ .YO<*8K/9FR(,U%05>D#V,R1ZCF2.CBQ\Y!II=15^@.@%YG-)2
M!>W!@3&_XMCCE$U7XBEA9T3J?4"40- 7LO]/T=)V85 *_T305W&)#/0Q+5D&
M4N-R"QL^=TL\\IN^K>2O$OKTK".5GGS$]-)+74) P!QK6&1%?K+0\EM.!CV_
M!KE_[H JOSA1JBG\RHJ)U>&16\ ;1[V,^4'DAMARULJ$F6;X+BOY"M)4N=9X
M0\HCK\!KG+"1:X*LA:O(K+IY>#8FYF'@QUUEG0E%LX*L?G"/ &=+;V_-CX.R
MP5G_;]"R]B) N6CDH_' I=!8;ZJD*(EBH .D5X?NPRPU^UA.PTP?C$P,:8XT
MO.J0#K1?E1^?>CIMQ!/-Z'MF&$LZX+T"V-P>XLQOWRC_;128&/8/\:1J 0M0
M$&:W9I7<RE7I.:(_2RATY$_*]>$M(-\B#GJ:V$>FCB2/-"I?>,CI.KVA9M'&
M\0-GNDD%J\2??,?M;M+JE62K8%V\@W>7_KH< 210AES$S$#7'AY^\0!#0(<Z
M"TGWR"GQO[&/E9\] + +$EW$2N![JG-JN&=NA4,6+]CW[)R=J??W/%"@[CTP
M#6(J2F2@DU]+89HGG "*_G= 43 G"B7D>V#7Q;88.1_%)DDO\>&N8X2\5JR6
M4(X)1/;GWGRZIO[3R*_^)5^>SZOW7;B;$!ZS_XU)^?<XZ(\OCOK;$LJYR)14
M G(%)\\9=-%5ES.WRUNWL_SQLB1X=7/??/RG;"+^#DJU8@D;FR 2IVYG&DJY
M8=\-HE.-=5O0]BM[@4<:;@7HQ=3(.>=/CJFW'6E]E_2L6FT<>JL0'67Q7+N"
MV$)V7URJ:X+1W8&L4(-Q5"+ LVX\/?)B  <2YKA8=FZ2=WH"Q2]>)Z@[=\MO
M3)R]/0&&8(^MTNT5KP8S_D:J\;+%X,=!DL][>3EA4MT)&>AU(3YTY5$I?;M0
MGPHSZRGD+25@C:Z7#'8NS:!GTASH+Y4V*TQ;:E?CB$\P53D3[(L?M&=88UZD
M7(:(2/D.UQW74@AP>5?WYF[CPS%$''BB 6?;68AHY4#GYAZ/\6RTHESUO(S@
M#T>UZWE]O1Z/H?$C5[9-&2OO#0\^JIG6Y"$DBN5QC-4F>;B>(%=#O@Y!#$M,
M6]G^G.L@ZP)-JU-FW,5#V7@,ZJ2U(?'E^95,,:GWJE9'%3^>2Y,>;!]^>F6S
M'\H;\F.A=Q2U^,,RT<XV:U?9Q*TC>SWNNI<GUAZTO& ^Y56]>)*PXZ^,P=<$
MT[(JNK%GW,H5EM2A[<4;N16TZP+2\W(WL5E+V@0MQ!?I-^7GGR6B-HJIRP\X
MH]M[C0S=1^\1MB_YDO:6=X!7%DDH_9942HQ]'XZX "-&K]:/K82"%:TIU]7'
M.T$O4=3K:=-A'+K0^G':KZ1 AW *2N%93C?S4]K6Z9)Y]>Q^.EY0YB#:B+]0
MB-;^HJ?:%=?J=M1!Q%=5V9'].X?*K,C@Y&2$^J([5LN<4LB"-P;9C(/R6_,-
M"1LP.(XT,+ZHX>Q#2.F(2ECRNG!])GCP\=NL[9UT3>\JKK'<+\-M&8>;!6]/
M#G-KY=BNM#Q,L#FO*2<+$6,8=EO=0_SJ"E4YD'O_DWB!%/NA5BQG;L)D<FSJ
M&?#O,A#8?C: #JY8^)Q[S#LG[/ -J0U?  L3WA!O=OF]AP.H!N6I\8!*P62G
MEF?Z\R5%<)7BTI@BQH#:M)XQ<(Z7%H5VN]-X48'GLEP5='W6RJC8 A>4.9F9
MBX:.'[P*'&1 )Y;K*0:"'-*>]S\PPYMLZ:6YE0"\Q^GO!@3^&Z"!;T%$4-8W
M'=(&J#2A3R$GH)(Y<MY[.Q-L_IN[A42M07W<6+(UF[6>\OTJUH2?1F2)LO?Y
MS)YJ(*-.R:D^";>I#D=8A VA5/S7G[\1V?)>[V[C5QDHHKZ-9ZHT$%4;?**^
MU2U/=_DS0P9Z6^"%VS^)2H0STX'7Z.BE+I:7 +6E!3;N-!:R37FV*NH"+O%V
MN^D-L9G$7XB=-G7C$5PKSW+]EN\D@%E['\3PC)8G+<)GY5HU5@_F1ER1(K&I
M @C]:;V H,^#UV/"E(.CB"<0-<FHP*K50?P[JF)RJ<+N'YOVX5HP!:P8&EH]
M&F(@!/*]AV/V7V2,9TA]7S0LN:Y$4CS&ME19!?-"&?+H\5>-M>3/X6G'UTHS
M2*5485=J%_":Y:G%J^V<_P8[LX/Y BTO[8I[2&DITNK,D;S)IU@$483[VJ;I
M)1[L 9A.KY68XM&G'"$#42HH\^7WQ-(->KP7?\A -[$7^4JP7.Q1*\G3<.*7
M@G&*@@,R=5+K,IPQ&>5,M?VU<&;G:=<4E#@('WF 1/8%F$EJVE;9B$3RK:9D
M3+B+U-W?3@:BY;V>6]8/E(%8AG#1WOH=CQI4!L1TJ96]#)1D,A;UQ8_P\_-N
M3I6!1 ;CWM"98;10YUPT/IN>2 [0+\1I.< S<_JK\9*M]JP_,%*&L&A\5S@V
M]AI>1 SK#^2?B=Q3?6]E#[S_0!U.U?_U$JV(:X)+]FQ.14[5/)*!?JE=R12\
M*K:KY>L66HZ*74OBP"O+"=!7W<"UN2%CVH?**UC(ZV<#SP:6R#MVP;@Z\92B
M$ Q^A] ]+95U$9<4AXI/D8"18.:82E]_(?M,_T4T[S'JD>CN&G=5<YU<$"D/
M\)R+UE+%NC%/AETU>'NEH75T]K+;]6M3N7;#NWVFU_Y@P'%]R^M80#1\DV1+
M29/2ZEFR3UK*GV>,1TAOY9.A7^=)VZ44RR$W7EI57<#3U16G ]]A=!T>((:1
MJUO&YX)N%JC?XPS/2(K;1]56XF#Z7'6/_C%;QH65B=JZ>1VYP7,[M=Y%A2(>
M4MP((*\P3WYP+&G!2?YRWMI1[>E37\92%)<4H<R*G!L$][ZGMA8K?>@VI)#P
M_)H0&L/SG26<G-L/T"R$.R%;A,Z\^;?6<)8R+SPAY3[>;,^('B3Z7*=62_^*
M"O)#7]F5AB^<CHZFLI&5Z>50PULL9I[U0;V[UIVSJ\3=\>:_BUS^)T!>-O1?
M4$L#!!0    ( .:!B%>'7G?",(\  ,*>   3    8V]O+3(P,C,Q,#,Q7V<U
M+FIP9^R["3B4[_LW/(6((MF73(5LH:R)S+<%(2'9ETE"" D18Z8H.Q-"A,E.
MELF>;2;[%K+OAK'O,Y8QS/9.W__RO/_G_2^_Y_\<[_$<[W&\E^.\#_<]<U_W
M>5[7>9Z?SWG=U]#&:7. <WK:NMJ $R=/ )[0_P"T;0#[[6>>3QT!C@!Z.T&;
M MP%G#SQI_TYGOS3&!G^')D8&1D83S&=.O6W,)]FH0OSJ5,L;"RG6?\T^G]G
MV%C/_#GYT\D_W7J2B8&!B97Y%#/K_W*C_01PLIS4.&G!<.(RX"3G"0;.$[16
M )"N(]/?ZIT _',[<9*!D>D4,UT--OH7JL[1U6=@H"O-1->8_FD0_7, (R?3
M^4O7;Y_B,K9GONS%K? N+I-%]$Y9$\^C 9R8XM-7P:=9>?GX!03%KTA(2DDK
M*:NHWE"[>?>>EK;.?5T]D\>F9N86EE8.SQR=G)^[N'K[^+[V\W\3$/+^0VA8
M>$1D?,*GQ*3DSRFI6=DYN7GY!87?RBLJJZIK?M36-;>TMK5W='9U#PX-CXR.
MC4],SF,7%I>65U;7UO&[>_L'A$/BT?$?NTX &$[\2_MW[>*DVW7RSQPP_['K
MQ$F_/U_@9&2Z=/W4^=O&S/9>7)<5WK%PWXG++&LZ+:KX",?S]-4 *Z^8TKPX
M_H]I?UOVCQD6_-^R[%\-^Q]V30+.,)R@3QX#)P $H)"S(B4!_TUAP'^A<JA%
M4<\9CO?/P]O@# 9R4=@W*"F=/$/D&I=RU?2H>]YLI_NL17=%!TIR7.;\"9MH
M;SN$.TD(UG03] (YT=,$*C-\^W10"1D#O4+YTA'MWF Z+\]EZ!F497?W5 JC
MN5_[J,&O\AEPJ)2D_>463>ZXN$48+E BLD&1!C@CCZMH0N ^CM, ;C5M/[;'
M]$F/@K[^K+/=K439^;TX*_:D^GJR\;3Y% AG !I'$QX,["-"T#7.FP?S'"PN
M-V=V-O'N\W!NC/^==I9D:U6I;#NQL2L8-K$!Y;200(9+?/Q/[Q0 1(3DPT$.
M)<Y4=I\AQU&-0'R%'G'$$8==>%"&"QHV<VZNJ3[9[/*ANY>GI6NQ07WQG +'
M_@=+?M&3,JN@TS1 DQ/:&1;N%X"JP?7/';:BSQ.!=XE(=]R&$?%+YEJ SZ12
MP.98TN@[O: &N]RZ'C]>CXR1)Z+;]?'O4,QX6#3Y(AH7  [U\\]_**0IB$I;
MG,WCW5Q5M:C1P$M-:QHV=BZD'@UA.5K2P833E&*(+ W Q$ #!*M !\TTK^!@
M[?(QG/[F6.;-L4)PVRU*:87X9GN07*#P]PSN>#5R863QZ#S6QUEG[SD#H8*0
M0[\QF\Q ^4R5<46?*&G@60"&9ZCA#ELV,,+^^<TPCJO%^;4#&B#7$_&$I1V/
MDDR#UK<?BV,T/B2_>*:0$.)(?W81Y>V!_'A-$[K&(*RUO@:7#"??Y@MKD,C3
M?_9]W:]NJAL/<_J<ZQLK9;H0-*A[^><WE/TG;=/^Y=DJDO8J#*</(MXTP>ZT
MPJ:ZY_<]0V% C5.IL#"R2]&D1JK_VZ9\_IKO9I3A5Y;ZSA>;6&P%RH"]=@CZ
M4ZLII; G'!,MU--AN*''E'304V!8AB1.KA:OWD5T+G"%,@1ZLCU7E8XW4*EA
M*C[-9BO#^Z7'=.K"J#BD1_#=1>898$48F<=ZCGF+A_2$.$8]32F!J.-K6C!1
M&:<'%X9]0:?\"3V&,V\<Q5YVK4S9N(PEOQZ2U/_,CTP%GG=VF21!3]( (3!?
M ZL>*ILS*0!RHV94GCF,#%H0FG)GOJ?JX:XTSF?3^#B2)6*"5?IMIA& FYY'
M6/']X];8_+=/Z?<6;T-\_?!CK2+7ON/SFZW]]SF$B1UW$Q[4X@U:Z[3"][Y6
MN_F?_-G//6L4*QZNQ?NX7&YO#8SS[(^&B'^CNU@ R+,LSQ]A^(,ZBL_+U4Q>
MM!,-*A<;0ZHV6( :C&M?F5_T$*D\<5Q+<H+V95RG%%'/HG_"V,D^>+Z6&0E;
M]'VR?2E19=[](,7G:[R [-5M 0NKAO(WTKM;#HM'W0#G,V@X$/?0<T(>.T8^
M3Z*RV]52/H </6.H<GA0TY;U_%9_!,0OUS^8!M@ZU3=J+65UJI:%]\H/@[N;
MF1(LI0YUD]Z-/= JNIY:-,#<5Q #;"X55-Z.)AE#?(??50]EDS0_9+8HE(S6
M%]XL"VX'>._5/K+\?L^KJ!,C+4ANICOE#?J];C2 _4XDJ(K1#D#TQ"U@):)A
M+O!)]?9K,V0=?#5Z?D/]K );H+^(6475LX;4YYM7KSY)4O>/Y(W[J/%!/_TM
MM\99_*LI*FL"W5VN4E#[_?!18V(8O7,&JI";B #1-&N=;7G*WV-Y5#_J396^
MF,9MR-Y$9=;6=850UE*>QQPV=#6DR5:4KW03*L X+5G%><_6_LG M@RA$1\.
MX1E_5:Q$+/E6@"B>MR1[REK'5]C(M@Z=H!$W,]$BWB-3W\8]\2N>3T0"QSR?
MF$_F^D)E]:5K<N$WZI8;;X;@(.HR^>J8AO><K:'%#VM_Y2#-9;>B%*8*M9-F
MH=;]E^)>-2V(7CB]!9N+1I_7D* !&(%TIPG: ;G"IN0?U WL-'AB-V@ [N<B
M''4BVMG?^KW=/=WR)[2C%4HTS&2\XCF2S\2( GC> O;01 G5S62\&_5T$ W
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M_%12GQEWIC **Q2(7HS;5R[3 CSS1\X?OFWP'S58@#.Z"'8-E6JU9_BZJ\C
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M8&L&VG@8:KO!&]E7(FF6-Z_LTRMEFBX8F7,A53.BJK:FL3IV=]18[-%7_YF
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MH(2-H%3( K\A3@AV7TQ4!G\Y_LP'2..I'7!-[$&-W%+KF?D^'=%8':6=,*
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MOK1;.[[_CI<:6.C$V^5863UP\<>O%TV1@.BY1 '%@P:04G9OL>DLR6_OB.=
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M3/8;_TER_]4(. Z]TH]I5Y<E*<@PD]Z8O9_Y@7I[<\D@Z(+Z3W'DQPL=;A'
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M(L+M=*N;Y-K_)O2JW[3,3SA^U1,<I(5;"H=PO%^5M)(J*/R.W#DL. =<ZZ(
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MGFOIP.VI%8)0#;*U&3GF5%]=,R&W457<E#;C6M9_M9;?0(23*M&*JSQH2.+
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M77QX*0V46K_^RG;V[TZ [7VJ!,N[ FW#@: R>]RP@I'V?OM$@#2H6^^5_[M
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MCF:FN,"@)K<<#E5CHCR4%P?LCPN;MN'$/<M6;+$VT/J"U"VI?"\IB!:7O;3
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M]JQQE2^9'*&]IKDZ\CEJ%E?*.5M%Q'2,]%D\-"=?KK%MK]5/98"T22XXYJ]
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M'X$M[O/C9YV 2K 7Y:Y<Q+[^+.6^GL+XT+7UTYLFXI,;M3$AX>Z%YDP2W><
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M"K&G&D/T/A2NV^[WF,>)W7D0YJ4U8>$1*[<7 :S93:R"32]1%V0?]Z2,+RQ
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M+=ZTGD5$L<(=_\%'>R[7("-J&Q#-1[CW#3EXE[_JQKUA60P!>4M:#Y\V#TU
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MBOV[7F/ $586YN2Q'@7  (V:$WT6^&\**RF#SJL60^<S&>G!H]I0K$:*,81
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MRW#UN:<3)_U!'X2*.<U:(7%GU\\D[M6+0HJ/:W)8I/8:X1)K]]1)D#:]#K
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M\JG5Z^CJ[10+UJLU119J=XV#M'56,.NJ<S2;[WWQ(AQFRJO<SK/5_KMFFPQ
MDXH:/B>W63Y3L&H^@QY3HG,%O$<V79PB0*.HTM-*/'"-VL'M#PW2!/',TPS
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M!C>,$$P<U61(!R&;G2C*O\BAD]S#$N(#[[!FN?,;(Z\?@F[K,R.L%IHQ2+/
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M7'F?%N]2%59YH$$SISTZMO_7A,E]#;9?O]A#7?-KO!6.OC%]M3JQ7P]%@TZ
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M_D;?W(,6%BX%F-5V"KWL^-KVQH#WJ,EY &=(D[M:YVOU5:)_(^U.( -0UE^
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MNL,)>\L=7B[="527;M;G,5_AVVN*\D-F3Z7.2BU]&'_Z!>&OOV%MN:5C-,$
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M_'51G$%8RJ,'ZDFA+LQ[%]*>[ZB-8AJQ&/.(EAH,(26>>D$XHE8^S^S!U^6
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MK_L4:R*QP>FX>_)&[]/?I)<G.)@8Q?:$.<,(O7E: .EQJ):%,(UK;[$0H0^
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MP(<<0C+OE$T95R4'/WI.+UC4W</VUZVV*&<]RRDJ#5+:VM0]5ZM8B,G+?NV
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MK)]&O["/K["VHO#4%WZ8N[,DD\4&N4HN8!><L[*7DD4-4]WV7#,-CKKP1%V
M[2U,UIWKT,J)K-?2(N -60]W-L<3BLX,*@25K VR00FLNB[)$V0/S#0=4N;6
MMY[4N+4N'MP/6=0ML(]1F.7@LKV'M]]#NKQ/7E_8"\$$3BIZ_^4_@:*_M2)$
M.Y8'AQ3P;/C">R\P0.4T(P%"B]P69Z+R,RL^1!5&Y/6:C_Q);.EK_?&S0"RK
M2<>09.[73$3>'3KW=A^L-BG : ^R-%16L!@T)J9H.O)YF]=N/KI=]-+)8VBM
MZ6 $^>I9#6=_B]G;*S23,4QFI><'QLKREYO;HA5Q:-^=)38(M*OCH6>?-&<P
MZ53#!C7IC,:4Y2^.%D7Z/-Q&'5'\"6DY/0N=IDJ/VSS8F?V]1R.V!AIH^4;6
M3>'"7RE2_J45:-G&Y:-2] DF7Q)F#!C*15[K\,NZW8&'PJ&'#4\Y] HY1NJ&
M=G)YL4'[/=@@O5VBI (DHJE]6[;8(^>NP+Z8]JZ!V9Q0;$ +X-=<LQ#CT4#(
M&E&=9FQ6'L9:,[6(N8 JR3:6%)9"'*ZK%X^6"#7NI4L3Q[>H1<E=[;WF%0[:
MO':D:&XAS0&0O/VNSA/OJ#;G"SLN -XVY F7; M)\1*]GR&<R?S5^RA."_M_
M)$;.LY><E+TBE-U[HR3&'T,V?=M1185NMP"8:?>TL2(=Y=#;'IF3T\G(IAI,
MA_KB282MF%ATLW9_4EU-2,<9.:[PM@*;.,8><R%LI>$8!1(Q'H<T35;K.?#>
MPX#SV,1MW4.$%A-^B[]R]/.%&R_#%-*(T). AL.WV)QW)G &#J>-IDS5[B&^
MDZIBP*:4RE0V2 GP7O#2N:2VH8_81"^P04?]ZP7'5V!<ZBN.G9G+QR:*_TC<
M\63J,=H>UQ2',PP_)#(+LASU#U%P]SR95$U8>I"/\O U(_(\=F''P]^7K%FG
M09$BSNT4\G J4U_QOT8H0;0)&1]5W@\K]4%%OTGSM/L*IR^285IO>T[.!F@K
MJ7PX,I"46<2(.8GPSF0<)191SE3F&MROG\7L8/9N@;\1D1^"SY*?1%R):)SH
M@LU]&IEB@^*94_UUGZ_Z/<OZB%3=9(-T,0[@U[,K*[)==6P0P;O+1^DP@&F-
M%S;J__C:^_E9L>OH1@QDJ+:8C\&'>UK8$;WQK9NX2ON9SU(<8(D4,8]+7W^=
M:\,%VO?TH**_YN<=8:1IZ,SFU 8;I #1"__ZR$<];P.OV["Q58TT[_>9D!R^
MN62K[- ."Y/A@BX,T <Y;B1D]29]K%:WJEW9]K^BH,&_IU7X+]KA [<XCG8T
MW;JQX=C0$11S_WC),B6['18S/<2=159MT9"IP*)]'\(-STD835]%VZ_=+ZJQ
M8[B"P[*0L+ZTI$<B\AS*4V/9,Q<WZ1M/1P?^8(/NKB3W8_8>QIUB:MC:3#6#
M)4;9H((?TFG\Y'&E31E1FKU"0T8()H(66L#X'+"MB5;*(#IC&.O^YAW/=%Q1
M6(T6C1P)T\M(SJ[NMD[1'^(40<BL"3DZ;17V*>2@H4]'U(I23"I]BB&0[*AN
MR%"'C..G(=KJY<TA@'C(C1\@F6F>/96802]I-@B+W-5@<,&V7=&]4XP4UI&M
M4@?'KUX2M274P^9PH<C"<7&]K EHX,-*%T8XYZ/-9DRH.0 ;U"A*^M.W $ W
MZ9R9:LQ0J9$R)+WKRW@WK< &?;B#<X<>\U__B5$UBS\61'B$_9[H3#"\#3W=
MAH\X&\(&S7ORBS<KQ5BA'S/!2J4 7Z')\UQ4<E_@[N_]+EMC#H'HQMZC#J1R
M7GI!LL3E6S%HD.H>$67H-="CRH/UF$Q&DBU&;UYT,G,VVYO@_! 5'_Q^P,BH
MJ>2[8@L_YK3G;:#"' 4"-8IPO<^,V5JP^H0(J)C*R,FR2-(R_1YCUFG'\9NP
MYO_OKU#XOVM@]LC_ %!+ P04    " #F@8A7<%4X[E1G 0"+U@X %    &-O
M;RTR,#(S,3 S,5]L86(N>&ULY+WK<MRXDB[Z?S\%3L_$;'>$L)H@P=N:RPZU
M+?=2;+?EL>4U>\)QH@)7B3.EHA99I;;6TV^ ERI*=0-8((L^YX?E4HED9GX@
M/B2 1.:__*_O#W/P)(HRRQ?_^A/ZD_<3$ N6\VQQ]Z\_?;U]#Y.?_M>__8__
M\2__#X3_Y]?/'\"[G*T>Q&()WA:"+ 4'?V3+>["\%^ _\N*_LR<"/LW)4N;%
M X3_5MWV-G]\+K*[^R7P/3]H+VO_6OS98U'(I>]#AD(),8T0I#SP(0^%%R(4
MIBP.+^[^'"'""$_5]Y+$$/MA"(D?IM 7B 8LX6%*:?70>;;X[S_K'Y24 BCS
M%F7UZ[_^=+]</O[YEU_^^..//WVGQ?Q/>7'WB^]YP2_MU3\UEW_?NOZ/H+H:
MI6GZ2_77]:5EMNM"]5CTR__Y_<,7=B\>",P6Y9(LF!909G\NJR\_Y(PL*]2/
MZ@7V7J%_@^UE4'\%D0\#]*?O)?_IW_X' #4<13X7GX4$^O^OGZ_WBDQ_T5?\
MLA!WNFT_B2++^9<E*98?"!5SI7WUM.7SH_C7G\KLX7$NVN_N"R%W/W9>%"^>
MJK5,M98HTEK^PSYAOYR@OB-]E]NZ.E"N,O>C*QT/8?K1F;JWBB'$\ IWQ)RL
M<OU"72WX6._N6M3)J@^OL:O7(E^2^0BOQ49,1^6Y_N*#^M2(T0\Z0*:5G(:Z
M.ZJ*[TNQX*)FRQ>/!AG_UY_4I]FJA'>$/,[^2HJ,4(63TNE=_D"RQ0R%D11)
M%$,B?0(Q"=2G6 U2'DT2Z8>^)RF;+==O]4PLX-<OK0*5E&,B?K*P;KFGEQ:B
MS%<%VXQO#_-=@Y8:K_0(E_RR( ^B?"3-#4I/[0S4JO];JR'0*H)OM9+_[[_\
MLK&H%Y#S$>"93PJ9G+W09*[=@;QX;7S.#(S?=+!2Z5U9+DE)*]6;NW_1SM<O
M8KXLVV^@_J;J90<$_++5F)=%JS<IV!'4FRM^8;GR?1Z7\$4#R")_,#5PF9N^
M!S682O!/("^X*)1/N\.(]1M9%LO9;R*_*\CC_?/5/'O(%I535OXN'J@H9M)'
M$OLIAHC*$&(FI?(Z4_6#Q%PBY:%2Z9OT[R-RIM;)UZJ"KJYFG?P8I(=[ND.@
M!N[NNS$"WVI%'?1[0R@.=7[UB$['5[]M.OVQIX_2\PU-;+N_Z>5V',!%-KM:
M++/E\U_S^6JA9B#/[[.YZF6S.)$A8VI,3WV&(,:)!U-,"8Q(1#S$J1K>N4GO
MWRMA:OV^5A*LM02UFF8=?S^.A[N\$W0&[NRVP!AW\J/&[^C>I6!_NLN??E'W
MUKU;?=AT[/U/'*5+'S6H[<S'+[3KQJUO<+U@^8.X)=\_"ZUJ-L\JCO@L'LFR
MJ#_?R/=Y(;*[Q14I%MGBKIRQB!">" REX!'$"4X@"7@,F8@\7R8QYV8]_10E
MID8&C7I -/J!<D7_2[ E6.;@ZR+3BW]?ELH!*\&2?+>; /1J([,IPM#(#TTT
M4BJ(LR<!:D. LJ2>4+RTYP)T+0*Y!&USM49=@,N'7/4K=Q.04Z!U-$7II<*H
MDYA30'H]S3GI6?83H<_J112-E^Y+'J<!X5 &,H#81PRF(N"0Q;&,D\!+?(%-
M)SZ=YTZ-XS2!9>4R8V0.?A>D7!6BVMVP6]=X#=[Q*4Y/2 8FG]YH6,UI=MA^
MPARF^[31YBP[3.C.47;]N9\S\R%;B!OYMA \6[XGF@&6S[^3[]G#ZN'7O"CR
M/U27?TM4<ZKO9SQ(N>^3!(K$QQ"+%$.*8@^*F&&*L:2<Q39.C(WPJ77LR[N[
MHEH\!H]%IJCS4;W2Y/!X>'H#F'DH0\$Z,#EHM;6?42L.6LTO0*,[6"L/6NW=
MN1Y],'/D<EB)'M75Z /*:Q>CUS/Z<=EG4:JI!+N_7/!WXDG,\T<]N%Q]?Q2+
M4LPH32@+(P[]1#*("260Q(C",%)S,^D+'X61#7D=E#8UMFJ5!63! =^H"T2M
MKQUG'0;:C*2<P3<P*[U KJ,IN#J"G#4%&2'BB',.RQJ59(S,?LTJ9C?U7M\I
ME&\JWHGZ_^O%S:,HE.-:$56V)/-+6BX+PI8SDB+JAVH2P[S(AYA["*9$^&I.
M$X9<.4,H2D++51U#T5,CF+?WVB4%V0*0LA3+LNHN:CI)->%GHORS]?J-:1L8
MK]H,@.S W-,J#=ZT:O^L$5YK#AK5P;=6>8>[P?:(N5N",14\]L*+)2 [EEML
MG]"/PK[<DT+HB#W^-G_0G%@MY5P6A>ZDFBE_?=Y<\HD\ZZ\N_R %5PR:%=7%
M=<C1+$!Q2J(T4>06*J\I\4*8^GX$(Y(DD4 LQ,RS83AGFDV- "LEM3O5: FX
MGAN^6>3@(2\$6"I^_-F. ]TUHAE%GJ5IAEYPT@K#7[7&H&L5Z)@%Z#/H7M>8
M!BK;+L#&.E";YXYBG2/NB('=Z34J03N'\S5_NQ=P KW_>D"/LE'DU]>*5#]N
ME53E.']2/>6CZCM-@%Q"A4=DBB%'4;5#R6":>!1*'@B/I4G@Q]*:Z1TK.4W2
MUZKV#%0<I"4MZ/Z,[3,P\]LT33_B'@@[EQSN6L7QZ7P@D'<R^U"R[$B>Y?GL
MG9#90O!?Q4)]6.K'_H?0)YP$OWQ2$X8[<5F6JX?'*C3MJU(H6[PE<[::5U.)
MCV)9CS(9:Q[P-B^72KWFMQLZS^YJ^]HY-/819PDE,*6)K[@_2"!%/( ^"2*.
M ^*3Q"C*_ RZ3VU(:(V%I+96KX>TYH*5]B_5#)ZIEVQ5S>#UP;:%6(+'QFJ@
M7S[M:S)E=[6(\ECD.BA&W4AK#$"^!@&0)7@6I !BP0U76,[Q>AT>D";^T@P\
M3C66@T97?;IQ<0%:ZT%C/NC8#[XV;U$' J P "T(ZV=I&(#"8?W%!@F3):.S
MOS>\.0M:??NCOC\OC/C_Y7MD[%Z=L25KKTLI4'E2R*M/N/[#.30:Q<DZ(]2M
M[W5.%>QCUZ[^MM([UV)YG_/KQ9,HET)TYEPB0-2G-(*<$S5[]AB!-%4_(A01
MR:47)<PXG.VPJ*DY/+6&FN$N@-:R1VC;$6P/NP]N$1M\1\<6+*O(-S,<3@B&
M.R)@M/@X,T.[(7.&=PRT(+=O]EAK=;U0]%0Y">6-FA 4M_=D<5.3WL>\UI5_
M7%61GXBG2>C%%%)) H@I32!!$8)"1H*S-&"8D]GCJU0'IZ\%N=+?IBN^MF*X
M7KE6$GS^\K6\4!.MNVRA@YT!)7.=5@.\46Y2J1$H^VSBC/)FI"CP&(UB2+D7
MZCF\&H'4[Q!+BH3P<!ABKWDSVD0"/_)[L3OOPI!OA9IC_V"OA*.%X',T\@^P
M+UA9#SKF@\K^:JL7- BH4;[%0'VL4!AQ%=IUPXVU-.U,[VFM5[MN#NM%;.<*
MN#MS<+U0<Q4E0I]$NURN\]W,?.I%OI0)C&),((Y3!A//9^JEBD@DU>]!(DX]
M<K!']O0F6K6:H%!ZGG[(8!_B9H/&0#@.3/L?]ATQ6&-;G80D[1H84.H/>\;@
M"&8#'C'8)_GL)PR.0&)RP.#8(_KQUCM!E^^RDLUS?7#M5GQ?_JIL^>]9)!"-
MDI"I.9E.,!A2 9-4(LC2!'D12@7G5I$3>^1,C8_>9POE"&N7N+M/:D=,^R U
M(R$'0 V^NT.78*,B^*:5!)66#L,1CN#@B$3V21F5,(Z8^IH<CEW>EPA>KUKO
M7HJN24F?2M#[MY_%<E4L/N1E664UT+WE1M8GL&\*[;$5XEYO_CZ)^LLKG3BN
MS.A<?,C*Y2R0&%&=/"+$0GE"42S4_!XQR&@2A#20?BH".Y89WXBI4=CN3;.=
M>V!O-!8_-YY#%15:;\K7@( W&I*?+\ :%>UF-!D6\@*\0*;]_ML&'.5H*,^[
M#A&T#"$[R\MHRL_3?L7.LK4_V;>KQ[!SON9U-J:=P821!\SS-=+V:'Q&7>RC
M\-:I<C9I4I3\EZE2ZG-OUXNOBT)]?[?(_BZXNK QIJPSY,Q$D@:A5%,"3TA/
M[PXCF#+.(<4$D10ED0B-X^N<:36UP7ASA'#545OG?FHCWPPG%V[;[GCPVEE:
M9."QRSQ-5--LUPO0M:VZOK7N:*:H 9O//(;L+,TX4G38N,UI%?#E'/8#H5SN
M9(T6I.4<GF[XE?N']XR?V SL7Y9J?GZ?S]7-9;TOL0X'182'2813&*$T@)CY
M$J8ZH8<(@R 27HRY9W<6U43JU$;)%U. KMK_L]V1M(WLM6L$PSUEU] .O1_L
M E7[#5P;E%QMOAK)''?CU :&K4U/JYO[T5.S5UK>YI=,/;<0OZY*-9$I2U'^
M5JAYR2S"G(C4XQ 1BB .$@_2U!,P03&)D!1A%%GM !P3.#52:O75F5M)K3&@
MC<IV)'04:C/^<0G@P-33Q:Y1%FRTO0"5ONXXQQ091W1S5-RH3&-J_&N2,;ZO
M;^*RIWS^I+. O$R35B?[9-@+6)@2B$0H( [5#YJB!/J)\FWC- D"/[%+7'9
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MOTQC33='H7#$+?OEC$HD1\U]S1K';^A'$6IR^I!53E5YN>!UR/6=6# ]N++
M9P$3,>2A8! 3%L.$I!(*25/II8GOB62FYJ0T-W5P#DBS>>6[,H=[\U^H!]Y\
MS)<"(&2Y-'D(7S.2<(39P#31T;):%'ZAISN:, ##$5$<DC0J51B8_)HL3&YQ
M']1^O6BCMJM@U*OO;+[2Q0%^RW/^1S:?SWC(,&(TA83'0O$)]R'Q*(+""X7B
M%)\FU"KHZQ1EIC9]>AFBG2W&"X _VFR&<ZR1&F/H.=>Q4/F-+76XO':&&G-
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MR=9VZ8\;PRS#>4YJ/#.7;?BV&"E$J%DPU>E&-Y: %Z9TZUFNK0$;<QP&$KE
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M*V+:VM>I8^J01GNC[(H^[148ES9[ [1%E_V?Y+["UEM2WK^?YW_\1? [T68
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M&9C;KZ04=<7)VK*J.-IGLA3@I8'5ANS&Q#:<Y&)W[IM-FI(+YT&Z3EO W4D
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MQ1 +3"$-4Q]RB40<>?J BE5=U!XZ3(X3\^(Q+W05Y.YJX:D[K,>;HN\NJU.
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M3G<R[FW$146/KALN/^V?C/?]8E-LGC\4<U4E<)LQCABFD80BS@1$2MM@EIA
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M4\T%@2S/L+VS-OL-Q31,5!;E$B<H);K)''+OD2DH@&Q.L^]E6I'[44Y!*AU
M64+0YKFP7EW?&ZEM!;/O5B&@B[4MD%Q65O7,111B9-U8<+2!&BGO44N=T@.H
M4>@&[,9MIU(5#E(J!2JMRE=V>@5,C!00Y5#IE$*(-&X2IH @'J5N"MFV?\3N
M[586YAOTH3#&J9RA2%#-=0S3*"40&0,1LH@BR.,\58F."4Z<2K,<M3PU>[ 6
M#ECIP,??W0-U7^)UF>EZH3 P7;D"X!6?>U+93L&Y+UL:+3+WI +ML-S3#W2S
MHFZ?EJM-\<\Z8.OCPAAJ#P6?JSJA%Z)YQG"FH$AS"I&([*XMRZ#(4Q*I.(_,
M/WQV;9>[F]P$;4EK[RV*G;R>%LT5E-ULE7#8#3VM#V#;BQH\'9H;)H%LABN=
MC6H-N"E^N,X[OM4UY\:W1S6?VPA0MGB>:<QD&F$,L;1)&7D60VZ][V(M4L05
MD4(X^=R=;GYJ5%%GFRA%!+6,OIDW7L!W?57O!\K '."%1X?\&Z?4[I&!XT5S
M(^?@.*7*<1:.DT\-ZT-K7=3N#:AJEI (Y[D0,.:V6F+,*:3:6.BQ)(G.L0VF
M]G+M]Y9@:M/=?(7R8;QF]Z"[606#0CDP2?AZRY9^LJ42XSO*'N$WLI/LOO])
M.L@>P=/5.?:XH6XD]W:[+A:V/(GXGVU1'5&4/YJ6Z^QU>9(R%FL&$Y7F$.4B
MA8PR#FE"$XVEX;34B]2N]C@U$FL$!BV);T C<\=4@==Q=^.UH&@.S&-]@?0F
M+6=P I'4]?Y&)25G]0])R/W%;J3SH5@4&T-K/Y0\W%Q]5IL9RA%+8XJ@3G-C
M1F&=0&:S$>(\R:SK+,\3/MLL-VSNQCB7N_.BFUVGP\V2UC% E8@>_"PVCT#:
MQ-M&#3 W>JQOP$)Y^N-? =V-;L)!.3#75(+"4M+CDY4;\/D"?-X\XX9*()*Y
MTMFH#..F^"&].+[5C5N^K&Q&#6,KF:_#YG8AWQO>^FZMID^[&&#&(RT)R6"2
MQPPBCC6DE.<PU4A$3/$T]LMS?+W+J9DTC<15S:A-F75D)W6/"&P'\-UX)BRD
M W-- #2]*<<=H$"TX]#AJ-3C#L A_7B\V8V"/JN?MZ(L_FAV<*:WA?E1E!5R
MUY5OSZ$K&D,4Q<:J@5AD"*(L-X248@1)C!1%*>(LBWP(R5> J='37GCP4GKP
M55FGS/DSN)7+[]8!V,ZU\X]_7*^WYJ'/RPWX3[5I7O+C-._1=&.X(<=H8+XS
MHI_'?)P:8EW1"T2&WMV/2HU=P3DDRL[M=*/-O[/YMKQRNYW/ES^M)^2=/LKI
M4T=(,)[G@B@$LSA-H(W/AEQ8-VDB4H'3));*JV:A1]]3(\MO[]^!)O7L#8@3
M&-$;L-,'[!2ROFV'&;+\F-!G@-Q(<"#8!^:_/H@'3*'9 \1 -.C3\Z@,V &2
M0_+KTD3H&HX?MIOM2C557U\4@_UL2/=#Z3IL;P)F6C%*$$H@38B&2-BR'01I
M&,<X8CS+N$I$OW+?WC)-C2=W%0AUJ0%0@Q0&]Q\Z-Z8<>4 &9M K-2(KE785
MJU_6LK9G=\:BK/0J[SK'*!OIC?+@U23=)9I(D4EO"-UK3_HW[1_+WUR*O%L^
M<9MDV2X-Y2)07XW8&,-/^ZPYYG?;)[M4O'!A3&*J#2%+F$<VD$;D'%*N*;0U
MN"71&"&W\+Y0 DV-I&U&9)_RN\$&YC(+OP;<8UW&MO2YJ:]'FCO9*MBZI12H
MM;H!]\S-5768T7(/D!][U$8*B1]I]+S"X$-"?2'P/4@WHX6ZAP2E'=P>M-UN
M^Y9[&_2T73U_VRS%?^^Z_:%6[$&]6ZXW33F;62H%S5.;72]*E76+-#\E+(%I
M0B.S\/$H44Z12KX=3VUQJT4$*_7=-/EHHPR_KPIA_C0V[KJL*?6F6 "YG,_9
M:KW_U#-9EO.XN.T\AD![Z ,:*\^>!PTQULA;>?<5O,+M&WPQ"K0Y<.YVU!V
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MBS"U#6]+3-"6,UBDX;FA<&/180$>F#JO121Z8Q\R3/$*?,.'+IX38"KAC%<
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M9A(GD*N$098HF7 L\T1Y!0J<[6EJ%/7"5<F/B,ZCZ<8]03 :F&X:&5^X= W
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M8[OF!%+,&4SR5"5*F]]IKU(=9_J9&I_M$X0V<G9,HWH IQLY!0!I8 XZQF>
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MY1[7:!LP;\ZKCE:HM#ROH\2X67]>=:".D@J]KC2!DO3N[/%9BM*$2IY#3;&
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MHZFM$HVLM3\#J*5U/K^^"NQE7@X)U]#6ZFFDGCM$1E[^)CI'2(8";J1(R>X
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M;Y9@7<IM'32?U JHJF1(8</"RS)X/Q=&''<GB.[C=)F$1T-_8-YM=  M)6Y
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MH:=&Q)W4#O>^HZXQ9Y)0P<T:,ZH/2WIY<98(6%#]"\F*)*>)W37_5%=YG*"
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MPY.W\/0\H[H#+ZK[W-]W^8%AO/#;<KVKWGQ'O[>WR=5G:0C(I+9\EM5V89*
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M&.4%%4Y.OG.33<V([&0U>;UM-2/' O=GH;4V'+T %MXX;+ RW-4(VF3PAG#
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M6<H+AD-"\KNY=_K1VH11O)'5O[NSR?(S?;;+K3C!"8,H YI]]((90@18GDI
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M/.C8G8.6>NL2#[\9)W\W?[:[MI];??N;\56_ +^W!)%;*;[?&H\#+OV'[)!
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MJHAU&S,WINR)Q,#D6$V&:KO"EMTY<#9@E9WFR:,7U3EPZ50-G<-+^DH42I/
M72_@[Y?"1C77VK#U:P>SO"!,<$ *B &BF>$YP@'D>@D4YUF"W3)8/=J<&O_5
M)N^B6\T^Q\IF4/#*X(A:\WW%!B^#[_;-!X9T8"YHT'S;0K/*1]F)2X?F"0^
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M2_]7U=&?C8;Y:GF_V:SG;+LQQ5X?5J9NDCGC72T65M^\,FH&8PQI0@40F5
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MU<2XIQX=3AX=771=V^]S?UA+6F[7SU:@J]K:NN?_N9WKEF89$Y## H,BE3E
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MJ12W5A::E=M8V[*#O[V1U4^_VQ3'NBOJW+5*J&/0G+4+: Z7?7:NX5OGD5T
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M:[/CEB#S!..H*)GO_?T(ZO7*3OBY(3W->>O5HWX3RSK/4L80R8SE@.7*%&.
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MW"_%RU^TKJQVB9KDFJ;NA?[OJISWVU_\N]F*,M$4;Y62?#-+62$A(P*@0B0
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MY0^1-_ET0A"(6TZW,2IU=+IYR S=%_?[\*N)F7P9=/VZ%N>2(LDAS@JSF88
M0KP -(WU3 DBQDF1B,)-0-JEL:G1P'YQ4J5H]!8_ZT38C0]"X38P+=1FGLC!
M>!U:!,T%D4 LT=G4J&3AXO0A9SC=X[\5_V'.C6+R_5*\F9M#6+:U&J<F4;H\
M.%Q",4<)4RE(,IH#Q+"M H0 2_,BEHQC*93KWKQ[LU.CD]IR&YLA6K9':VN\
M_;WGL:A''US>VA\&V8$)IP'5'.:US8XJNZ\Z-/5 U_U$8!B41SHB:+_"I]"F
M QVI^H/6<9#@\;#13A;\'6P?-?2X^PJ=BB-=Z^,,9':8@?Q9OX'?]2\_K[6I
MGY2^^\=J^76SXO^LUZ\S!"'G,33+RS@&2*40T()#P%C.$T4P2@J_@/?!3)W:
MN/+VE[9K;E*(C<5&:ZK>$# [=<JH_/R@ZW_*3?33*)5$^FL5)II/__'1J@&9
M_3SCN.>D=L!WP6U*/(T>'GA\"R!3T;@;67]-=U<>1];EW<9A8'V*03LFI##%
M,(:.KT@Q*. GI2B&;;'G"&5* N@Q[X-^2Q?_[W8]+\7<IH0VH9BJD!QE$C )
M&4")D(#&@@")5)ZG>9I*[E60]$)[4QLKK+EVFF8-CMH6>]+_!: =.3P<?$,3
M<0=R Z1].P(3B@@OM#8NF[FY?D1)CK?UXY7WRY^:G%;KYW]?K?]IT\NY+,N/
M<O-)-37J9PAE>98C!;(,YT#_1PPP5 4@0E&H,B:Y])K".K0Y-7XQEH+Y$CQ5
MMOI1B@O&;K02&+F!J65G[5UD[*T%)8S%=U8/6\_8&JO#$8P'1(%(QJ7%48G&
M X)#LO&YM7=0BUROI7B@OYJ#WU^O]7_/-Z_I>OVL5FN[9C.MZ6=_GU&2YS$3
M"A!N]EAI9L]H- -12"F+,Y%@ISW6GNU/C8CJ0ESS_Y(V =+::$=O4^AO/;=[
M98NFZI]_](I7U[AQUH" #\Q?C>61MK@5H?(KJLR/7MAODQ6M!T'#5/I %RX^
MQ:OUL0-3^D!S(B*EUV/\CY4>5GIE^$%_E3M9+HQ)&J<@RPND>0V:*&:(]:1*
M4,4PR6).7<^.#IX]-<ZRYD4+;9_[&<4A7)>/>:X 86 >J?PWIO4XK#D$POU$
MY@I 1CIV\0'&ZUSEC.L=AR>'=XQV0G+&U/8QR+E+>JJ9KI:/#W+]XXUDFUW$
M?H*3G&!! ;$B@9@B@#-L5GP\SWF2%]RM3%=7(U.C)6,CT W]B(R5GOJDIT!T
MFP]="\W0!\\&E8<&E;OHCR5?T+(.G!XB@Z$+CU#BHJ>:&%=(M,/)(]'0KFO[
M+KK89E\4X,-\*=]OY(]REL0*$001@(IB@/(L!02G J0YSQ1*LQP7GHNKD^U,
M[<LW9K:JCD3?C*61-=4S%/8<L*Y+HZOA&GP)U .I'NN<3AR"K6=.MS+RNJ73
MU>/U2??E_>C@H.S'QZV95GQ2]F2K_+3=E!NZ-&HBKV@YYS.(<9*FFB1(G,4
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MR<4'CT(<KNXU'.%\?;\9YZX$QONE'K+EAU59SHI<$9:@'* 4F]+P60(8+U*
M%<^2-".B*%(?#=43;7B1P A"I_MB+G-KH]\LY12(+(=9S @$BBD"4($30+C2
M4T22\"S%$*+,:P5_+8@C,.DAB-%O"VVEYXSO%)8\E[$@D  N$HTE3%/ %"T
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MZ-F^GKAH^KM?"OOK5X>"6M:'7=%2*Y/UJ=JDF*5ID1:0"R"Q24E*3.4["B6
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MXGN'2@O9=@&29SF3"E87?[R9SI%/E">Z363 HR"D6V+'.Q[ &VUR*AR+CPT
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MWW"S5=R$2<X+K\-DK$^T64I-;%D.7&B;E2-?;V>__</,UM!<]>!C-0D .P-
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MT5[6\Z.S.0E5)WR'FF)2M%\T>2GT!;.1IYB:MPM[$H%C7]4UQM&]C.!@RNK
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M+L8*\,1!.I=)B#&+N[GT8>!VAZ[>FO*<#G''**AGT%WED/!J/R5B1.K (*5
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M6W>9Y#A-M!DVE2KS?/L'-WYSPK5$%IT%XP*Y+9'53LCU7:6MKW^9=:7Y1>0
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M=- ]F4Z[C5,N4I+S3\^62^)_FY0\.%C9]6E-!Q?\F-YF4POB0V/%K-/HBG3
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M;*:GON!WXZKP.EB\R]VF783F8()FM:<Z^=32F]KGD"5EF55WW<R6*-R#PKW
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MZI I^C,EQ=KJ-+6.NQN1/DZ.J"_<#J3H[FSHI6B_/S]?5NU,F"T6R;\&9+Z
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M-/7] I"]\OJD*U&) -DC70#..XBFU)D."DW**2FV2]BE'47CS1T>!TF-H7R
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M\%Q<O:(W?,WD?*J+@J)0NE;)> B&?$UA4@E%^(!\*//]FHB1(3* C7&<G#L
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M)D7=X.P@:N5 JH#%!"\<[K(O\M:/';D+HS$,CI%9!\_+3Z#]OKX[(]><2Y?
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MN?[LUW]]Q=D2?\,9ENGJY7RVFLXNI[.S]T3M9N_.]>*#@-$5XPM8+LC.+RE
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M^NUYV0>;MV_/KI#002CS ?XG(FBA91+ #'I0]"Y!$(Q\,UD*?<^4Z%MWICU
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MOX/GO=Y(=:#SNA2!,>$9BZJ&@A0H64T3(1(('VW0LJ KK1M>;GY^-R4^IX3
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M#G#^\**Z8J3(6GHPQC%0=/?7"A0+FC&50A#:FN9S=_O<%#@^3G;>+KB/TCI
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M-3FUKCQ]DIB11R$/I?[9$+KH %1792-?,5W.)Q?$Q>J>#E%S#,I $O2#LBC
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M2BB)CJWQZ((]TN;EAS?>B_H,9ZD.';BKT;O7S0-%WDA2N,B]U73+1:E!^>3
MY^+!)EF,9](XN4D[](')/IYHXC9(?3Z:V \..HA.;"N>#QN(YZ:)@%EM>/!
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MSJN$_ON*$5X,.DF6 7>$<R4C2436N)]1-H;@<F:M9VD]2<Q& ')'"Z V2N@
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MT8#7(8-PP:I0<C+ZGJ_Q1"7A-M\ZWNS*I@ :6-PCWTPW5=EWW.3ZOIMH,9!
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MCS'Z9;+XSV7(F^>HG9<2!$91!T_+VHKB( 9O%(DO1=%ZK-9S]!P=%'>!Q 9
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M2__Y?79&VEM<O3@DS*N9?[_7853$XAUA/+$B.6,P29;Z5"0Z^@'KOI!@0:K
MA$V>"=UZ,V@;RL=!]<&!]L W/KC6=\;Z'SB?S&IQ_/QBG&S2<PHYX<@2)J/
M,DONI;0>G+$1BE",<\U+YJVGH31E8!SS8FS\CX>!#J[\5LS768:5_<R4XX)G
MD-&3(A(7X 2/(+P,))I</&\^3+4M"^-4$+R60[ +#H[Q&#R=58Y2I:0M,1WJ
M5%ON19T5K\!I[6(4A9<P^B.P7U5!\Y[0HP-_&^WO6U/0!_)OCKS03&7)!!F
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M >8%-**24:BO@.ZIL%PEM"YA,O7@BWV(!N7.>#_Q=1CK=;@=S&29DL\ ?D5
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M?<)I15:+&&EH!/@4:$'O5'%3JKRC*OON]J8#?+;]94/(#6F8GUSBDTVEL!(
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MIMS> E&9T<0WT$%K-$X*:S2Q)4Q^N(X1 5UK<S$"?ULVJJ1=RK55Q@9:]<C
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M:JEY^TY74+*&^O=>K&Q>[K4+F^"I,S>W71ZYX=BQNQENMS?2GU!+ P04
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MU2D/=IUW/NN?I&SS3V'^ %!+ P04    " #F@8A7P]Z*PNH'  !!(P  &@
M &-O;RUE>#,Q,E\R,#(S,3 S,7@Q,&LN:'1MW5I14]M($GZ_7S%'ZA*HLHUM
M[  V294#SBYU6Y "<KOW=#72M/ 4DD8[(]EX?_U]TY*QL4UB9[-+$1Z,I>F9
MZ>ZO^^L>R2>C/(G?GXQ(JO?_./EGO2[.3%@DE.8BM"1S4J)P.KT5ORIR=Z)>
MKZ1.33:U^G:4BW:S?2!^-?9.CV4YGNL\IO>S=4[VR^N3?=[D)#!J^OY$Z;'0
MZMV.CL*H\_8HZH;=5M Y/%8!';>IV5+MM\>M=M#J_*^U@ZD0+^>X?!K3NYU$
MI_41^?U[A^TL[T^TRD>]5K/YKYU'<CG=YW49Z]NTQ]IB-#)I#BTL5BV_KBS^
MQ*39<&AB8WNOFOS7]R/U2"8ZGO;>W.B$G+B@B;@RB4S?U)Q,7=V1U5$IZ/0?
M!#6A,5].*A.P3JQ3FIG4:GL[AO<C'>A<'+0:;;&B[).&?,F<$'B0?19[^JR&
MHM!8F6N3]HI4D?52.^]/AU<WYQ_/3P<WYY<7XM/GJ^O/@XL;<7,IAK^=_CRX
M^&DH!J<WXNKS+T/1.I#U5F=7[KU^U3GLM[JJO%IUT,LQ?W M!F>7GVZ&9X]L
MOQZ>LC\.FFO@?SG677X4-S\/Q?7@ZL/@8GA=O_SME^%_&4^,M)O-]I.V)=+>
M(L]SD_6.L[\^"SMKL_"\)CY8+5/Q4T,,4F5IXFHB))OK:"KRD<Q?O^H>];?(
MSX>QO]N25D.<BY$<D[ TUC0!M><C[81,TT+&N)D9FPN3BH_&)J+5K/];F$C<
MC AD;S*R^)=D,M4$!YRG84/LYAA[_>JHW6[V+=UJEUN9YGRCU4=^=H_[+\ M
M[8;X(!V< <N3J;A+S20F=4NUTCN56Y3!CJE!5<2"4J?PVE04:6X+@L*HDUPR
MX2\I$EPA8F(1R1"WK# )6#PWI=R*0$HA.2?MU(LD\HZ$=^O#F@[W%)3!EC'7
M6^SA!4)M45\AEF*ZX'P3DY$.1\(5_F,^?T*6JD6\ 8EV,0JQK^D3G8]@H,LH
M9 7]N@!:&P4SQYBF1#!==,-+P?3@"YB2B'0*KWD YEZJ 5"(8]@NC.LT0BXP
MI>%[&!<*:P*)!9?4@**V\51D<*2/ 1\;<3P'N?*O6]H:<:2T7[CF)8H8 D#6
MYQEOYUB?4+J1B&(S<3/8YWDFI+]9Z@TM:POHN9DR*]HR@"^!K#H-9IZYN6]<
MA4[%O3Y^311I7+(+SH6TQ,Z&\W00DW>*(" <Q-J-O+@72Y"[/G_]M=(NC(TK
M,,]GM35QZ?7,FI 4;CNQ"R<K FJE)X?WX4BFMR0&2)BK(H8$]R/=7=KCJ=R/
M^*OR4ON*G)9H^_6%SZJ%("A!\;ILO%'T:*,(&WD[ET,#$I[IN39MA?8,YTPJ
M3Q'UF") <O1LY1>=G3@CA_X&CF%F^SIJ-4^ZH2S<YE,\^P4$!*J=2CXUA<4"
MR*FQ=IRID**4U_&5?Y[CBSQA*98,:46H<UAJ%8?X08U\AR[.Q%KQ*<L5@=-*
M2\OU59>TS\R5^I4*YZF8,\ Q;W->&T=0".<KGI1)Q%)8Q-+3$<QB)>:4CAEE
M@5BL:_@6D!<$8V ^J?44_[6P>!G!%.PMQ=+&^;D24IMG]L:1A6@<:^4#1CJ3
M2D]ATB'8?(7W422MFB&*&-,RT+'.I[XPK-O6QS>#S[B6H?E(=*%#8*:\KPS*
M"ILAKAP7LA =O6(%N%>XI13U*49X880R'[=>!'U0&4*(;YV!K'[D( K!2,.Q
MC M.6^]BBB(4>#V&<]R:0HW*M0$!E9?KJS:'"R:"/%S9&P2FR)_>>Q.*E _2
MY!N?Z.O-GPAF+15G )4^@#YE4X$-?E#$E:]!I4M7H?'G@*I6\\@2\EOPA*\H
M)@P+ZUV_0-^/UDN,RW''G_6QB@NQQ.\%>!^+[JX(1X@;9.V27*4F>DOB TOZ
M^ 2X5VHRDNZAOOE\YS@CQ43(UE<D-<6QY([BZO2R)%_[$P[YWE'U/+'3W;Z/
MY2.ZFL5;;9YVG@46\9]GH,=QBUJVTIE *8F^)#?6/10.OH'%$IQ><Z*UO!88
M%"4_HC1TXNF[B _0B/,TA?^^+YH%,OU>:*C,H5ND(1]S]GZ,%G6 $Y\O\!I
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M1#I/2\@,1;Q0+Y=L!;'Q6;X,:YJ7</\ 4$L#!!0    ( .:!B%<I/@]VB00
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M;V\M,C R,S$P,S$N>'-D4$L! A0#%     @ YH&(5TE>.PEJ+0  ELP! !0
M             ( ! -<" &-O;RTR,#(S,3 S,5]C86PN>&UL4$L! A0#%
M  @ YH&(5VMQQ$'B<   W@4% !0              ( !G 0# &-O;RTR,#(S
M,3 S,5]D968N>&UL4$L! A0#%     @ YH&(5X<*3W?S6@  1V8  !,
M         ( !L'4# &-O;RTR,#(S,3 S,5]G,2YJ<&=02P$"% ,4    " #F
M@8A7O5\XQEK0  "&#@$ $P              @ '4T , 8V]O+3(P,C,Q,#,Q
M7V<R+FIP9U!+ 0(4 Q0    ( .:!B%=J"%I$MW8  .*:   3
M  "  5^A! !C;V\M,C R,S$P,S%?9S,N:G!G4$L! A0#%     @ YH&(5U?<
M)*WXCP  +I\  !,              ( !1Q@% &-O;RTR,#(S,3 S,5]G-"YJ
M<&=02P$"% ,4    " #F@8A7AUYWPC"/  #"G@  $P              @ %P
MJ 4 8V]O+3(P,C,Q,#,Q7V<U+FIP9U!+ 0(4 Q0    ( .:!B%=%J_X9(E\
M  EP   3              "  =$W!@!C;V\M,C R,S$P,S%?9S8N:G!G4$L!
M A0#%     @ YH&(5Z'^RZ/*7@  OF\  !,              ( !))<& &-O
M;RTR,#(S,3 S,5]G-RYJ<&=02P$"% ,4    " #F@8A7<%4X[E1G 0"+U@X
M%               @ $?]@8 8V]O+3(P,C,Q,#,Q7VQA8BYX;6Q02P$"% ,4
M    " #F@8A7N\YLE)[/   _F D %               @ &E70@ 8V]O+3(P
M,C,Q,#,Q7W!R92YX;6Q02P$"% ,4    " #F@8A7.BW18*<1  #<:0  &P
M            @ %U+0D 8V]O+65X,3 S,E\R,#(S,3 S,7@Q,&LN:'1M4$L!
M A0#%     @ YH&(5U_CA@2B)0  H!<! !D              ( !53\) &-O
M;RUE>#$Y7S(P,C,Q,#,Q>#$P:RYH=&U02P$"% ,4    " #F@8A7"SUZN]P*
M  !)&0$ &0              @ $N90D 8V]O+65X,C%?,C R,S$P,S%X,3!K
M+FAT;5!+ 0(4 Q0    ( .:!B%<:UA;5(0,  )@*   9              "
M 4%P"0!C;V\M97@R,U\R,#(S,3 S,7@Q,&LN:'1M4$L! A0#%     @ YH&(
M5\%E/A[)!P  $2,  !H              ( !F7,) &-O;RUE>#,Q,5\R,#(S
M,3 S,7@Q,&LN:'1M4$L! A0#%     @ YH&(5\/>BL+J!P  02,  !H
M         ( !FGL) &-O;RUE>#,Q,E\R,#(S,3 S,7@Q,&LN:'1M4$L! A0#
M%     @ YH&(5_&.#".#!   BQ,  !H              ( !O(,) &-O;RUE
M>#,R,5\R,#(S,3 S,7@Q,&LN:'1M4$L! A0#%     @ YH&(5RD^#W:)!
MX1(  !H              ( !=X@) &-O;RUE>#,R,E\R,#(S,3 S,7@Q,&LN
9:'1M4$L%!@     5 !4 B04  #B-"0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
